Psyllid ID: psy16292
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | 2.2.26 [Sep-21-2011] | |||||||
| O77819 | 1354 | Rho-associated protein ki | yes | N/A | 0.644 | 0.116 | 0.629 | 2e-58 | |
| P70335 | 1354 | Rho-associated protein ki | yes | N/A | 0.644 | 0.116 | 0.629 | 2e-58 | |
| Q13464 | 1354 | Rho-associated protein ki | yes | N/A | 0.644 | 0.116 | 0.629 | 2e-58 | |
| Q63644 | 1369 | Rho-associated protein ki | yes | N/A | 0.644 | 0.115 | 0.629 | 2e-58 | |
| O75116 | 1388 | Rho-associated protein ki | no | N/A | 0.640 | 0.113 | 0.608 | 1e-57 | |
| Q28021 | 1388 | Rho-associated protein ki | yes | N/A | 0.640 | 0.113 | 0.614 | 2e-57 | |
| Q62868 | 1388 | Rho-associated protein ki | no | N/A | 0.640 | 0.113 | 0.608 | 6e-57 | |
| P70336 | 1388 | Rho-associated protein ki | no | N/A | 0.640 | 0.113 | 0.608 | 6e-57 | |
| A8WVU9 | 1194 | Rho-associated protein ki | N/A | N/A | 0.648 | 0.133 | 0.547 | 2e-50 | |
| P92199 | 1173 | Rho-associated protein ki | yes | N/A | 0.648 | 0.135 | 0.547 | 6e-50 |
| >sp|O77819|ROCK1_RABIT Rho-associated protein kinase 1 OS=Oryctolagus cuniculus GN=ROCK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 225 bits (574), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 112/178 (62%), Positives = 135/178 (75%), Gaps = 20/178 (11%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F+ RY+ R + + EV ++ L++++ T +YA L S+
Sbjct: 50 KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 109
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 110 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation. Oryctolagus cuniculus (taxid: 9986) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P70335|ROCK1_MOUSE Rho-associated protein kinase 1 OS=Mus musculus GN=Rock1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 112/178 (62%), Positives = 135/178 (75%), Gaps = 20/178 (11%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F+ RY+ R + + EV ++ L++++ T +YA L S+
Sbjct: 50 KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 109
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 110 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. Promotes keratinocyte terminal differentiation (By similarity). Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q13464|ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 112/178 (62%), Positives = 135/178 (75%), Gaps = 20/178 (11%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F+ RY+ R + + EV ++ L++++ T +YA L S+
Sbjct: 50 KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 109
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 110 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q63644|ROCK1_RAT Rho-associated protein kinase 1 OS=Rattus norvegicus GN=Rock1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 112/178 (62%), Positives = 135/178 (75%), Gaps = 20/178 (11%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F+ RY+ R + + EV ++ L++++ T +YA L S+
Sbjct: 50 KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 109
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 110 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 1e-57, Method: Composition-based stats.
Identities = 109/179 (60%), Positives = 130/179 (72%), Gaps = 22/179 (12%)
Query: 2 KNVEAFMHRYRRYRQK---------------------YSEVPRLFEYLLKYRYTLYALYS 40
KN++ F++RY + +K + EV +L + + L S
Sbjct: 66 KNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLS 124
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNY
Sbjct: 125 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY 184
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFY AEVVLALDAIH +G +HRDVKPDNMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 185 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 243
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q28021|ROCK2_BOVIN Rho-associated protein kinase 2 OS=Bos taurus GN=ROCK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (566), Expect = 2e-57, Method: Composition-based stats.
Identities = 110/179 (61%), Positives = 129/179 (72%), Gaps = 22/179 (12%)
Query: 2 KNVEAFMHRYRRYRQK---------------------YSEVPRLFEYLLKYRYTLYALYS 40
KN++ F++RY + +K + EV +L + + L S
Sbjct: 66 KNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLS 124
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL AFQD K LYMVM+YMPGGDLVNLMSNY
Sbjct: 125 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY 184
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFY AEVVLALDAIH +G +HRDVKPDNMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 185 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 243
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q62868|ROCK2_RAT Rho-associated protein kinase 2 OS=Rattus norvegicus GN=Rock2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 6e-57, Method: Composition-based stats.
Identities = 109/179 (60%), Positives = 129/179 (72%), Gaps = 22/179 (12%)
Query: 2 KNVEAFMHRYRRYRQK---------------------YSEVPRLFEYLLKYRYTLYALYS 40
KN++ F++RY + +K + EV +L + + L S
Sbjct: 66 KNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLS 124
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL AFQD + LYMVM+YMPGGDLVNLMSNY
Sbjct: 125 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDRYLYMVMEYMPGGDLVNLMSNY 184
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFY AEVVLALDAIH +G +HRDVKPDNMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 185 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 243
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P70336|ROCK2_MOUSE Rho-associated protein kinase 2 OS=Mus musculus GN=Rock2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 6e-57, Method: Composition-based stats.
Identities = 109/179 (60%), Positives = 129/179 (72%), Gaps = 22/179 (12%)
Query: 2 KNVEAFMHRYRRYRQK---------------------YSEVPRLFEYLLKYRYTLYALYS 40
KN++ F++RY + +K + EV +L + + L S
Sbjct: 66 KNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLS 124
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL AFQD + LYMVM+YMPGGDLVNLMSNY
Sbjct: 125 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDRYLYMVMEYMPGGDLVNLMSNY 184
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFY AEVVLALDAIH +G +HRDVKPDNMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 185 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 243
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8WVU9|ROCK_CAEBR Rho-associated protein kinase let-502 OS=Caenorhabditis briggsae GN=let-502 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 98/179 (54%), Positives = 129/179 (72%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRR-------YRQKYSEVPRL-------FEYLLKYRYT----LYAL--YS 40
MK+V+ F+ RY R R K ++ +L F + R+T +YA+ +
Sbjct: 41 MKSVDNFISRYERIVESVAALRMKATDFRQLKVIGRGAFGEVHLVRHTRTNTVYAMKMLN 100
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
+ IKR+DSAFFWEERDIMAHANSEWIV+L +AFQD + LYMVM+YMPGGDLVNLM++Y
Sbjct: 101 KDDMIKRADSAFFWEERDIMAHANSEWIVRLQYAFQDPRHLYMVMEYMPGGDLVNLMTSY 160
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
+V EKW +FY AE+V AL A+H +G++HRDVKPDNML+ + GH+KLADFGTC++MN G
Sbjct: 161 EVSEKWTRFYTAEIVEALAALHNMGYIHRDVKPDNMLISRSGHIKLADFGTCVKMNSNG 219
|
Negatively regulates mel-11 to relieve the inhibition of mlc-4, allowing contraction of the circumferentially oriented microfilaments in epidermal cells and thereby regulating myosin II contractility during spermathecal contraction, cleavage furrow contraction in early embryos, and embryonic elongation and morphogenesis. Required for P-cell migration. May also play a role in oocyte cellularization. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P92199|ROCK_CAEEL Rho-associated protein kinase let-502 OS=Caenorhabditis elegans GN=let-502 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 98/179 (54%), Positives = 128/179 (71%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRY-------RQKYSEVPRL-------FEYLLKYRYT----LYAL--YS 40
MK+V+ F+ RY R R K ++ +L F + R+T +YA+ +
Sbjct: 41 MKSVDNFISRYERVVESLAALRMKAADFRQLKVIGRGAFGEVHLVRHTRTNTVYAMKMLN 100
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
+ IKR+DSAFFWEERDIMAHANSEWIV+L +AFQD + LYMVM+YMPGGDLVNLM++Y
Sbjct: 101 KDDMIKRADSAFFWEERDIMAHANSEWIVRLQYAFQDPRHLYMVMEYMPGGDLVNLMTSY 160
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
+V EKW +FY AE+V AL A+H +G++HRDVKPDNML+ GH+KLADFGTC++MN G
Sbjct: 161 EVSEKWTRFYTAEIVEALAALHSMGYIHRDVKPDNMLISISGHIKLADFGTCVKMNANG 219
|
Negatively regulates mel-11 to relieve the inhibition of mlc-4, allowing contraction of the circumferentially oriented microfilaments in epidermal cells and thereby regulating myosin II contractility during spermathecal contraction, cleavage furrow contraction in early embryos, and embryonic elongation and morphogenesis. Required for P-cell migration. May also play a role in oocyte cellularization. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| 334325877 | 1318 | PREDICTED: LOW QUALITY PROTEIN: rho-asso | 0.975 | 0.181 | 0.538 | 4e-83 | |
| 328705451 | 1366 | PREDICTED: rho-associated protein kinase | 0.644 | 0.115 | 0.688 | 8e-65 | |
| 307212717 | 1370 | Rho-associated protein kinase 2 [Harpegn | 0.648 | 0.116 | 0.692 | 5e-64 | |
| 383861819 | 1370 | PREDICTED: rho-associated protein kinase | 0.648 | 0.116 | 0.687 | 2e-63 | |
| 380023438 | 1370 | PREDICTED: rho-associated protein kinase | 0.648 | 0.116 | 0.687 | 2e-63 | |
| 328792632 | 1370 | PREDICTED: rho-associated protein kinase | 0.648 | 0.116 | 0.687 | 2e-63 | |
| 345482974 | 1370 | PREDICTED: rho-associated protein kinase | 0.648 | 0.116 | 0.692 | 2e-63 | |
| 345482976 | 1344 | PREDICTED: rho-associated protein kinase | 0.648 | 0.118 | 0.692 | 3e-63 | |
| 350413242 | 1370 | PREDICTED: rho-associated protein kinase | 0.648 | 0.116 | 0.681 | 6e-63 | |
| 340708620 | 1342 | PREDICTED: rho-associated protein kinase | 0.648 | 0.118 | 0.681 | 1e-62 |
| >gi|334325877|ref|XP_003340692.1| PREDICTED: LOW QUALITY PROTEIN: rho-associated protein kinase 1-like [Monodelphis domestica] | Back alignment and taxonomy information |
|---|
Score = 313 bits (802), Expect = 4e-83, Method: Composition-based stats.
Identities = 168/312 (53%), Positives = 201/312 (64%), Gaps = 73/312 (23%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F+ +Y+ R + + EV ++ L++++ T +YA L S+
Sbjct: 50 KNIDNFLSKYKDTISKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 109
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL++AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 110 FEMIKRSDSAFFWEERDIMAFANSPWVVQLYYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK---- 157
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKKILS 229
Query: 158 ----------------TGTETK---------------------------------RLGRN 168
GT +K RLGRN
Sbjct: 230 NLLYFSGDTPFXEDSLVGTYSKIMSHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN 289
Query: 169 GIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF 228
G+EEIK H FF NDQW + LR+ V PVVP+LS D DTSNFDD+E+D+ EE FPVPKAF
Sbjct: 290 GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGDEETFPVPKAF 349
Query: 229 AGNHLPFVGFTY 240
GN LPFVGFTY
Sbjct: 350 VGNQLPFVGFTY 361
|
Source: Monodelphis domestica Species: Monodelphis domestica Genus: Monodelphis Family: Didelphidae Order: Didelphimorphia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|328705451|ref|XP_001945269.2| PREDICTED: rho-associated protein kinase 2-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 252 bits (644), Expect = 8e-65, Method: Composition-based stats.
Identities = 124/180 (68%), Positives = 134/180 (74%), Gaps = 22/180 (12%)
Query: 1 MKNVEAFMHRYRRY---------------------RQKYSEVPRLFEYLLKYRYTLYALY 39
MKNVEAFMHRY ++ R + EV +L + + L
Sbjct: 54 MKNVEAFMHRYDKFASDICQLRMKPDDFNLIKVIGRGAFGEV-QLVRHKSNNKVYAMKLL 112
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN 99
S++ IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD K LYMVMDYMPGGDLVNLMSN
Sbjct: 113 SKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDHKYLYMVMDYMPGGDLVNLMSN 172
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
YDVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDK+GHLKLADFGTCMRM G
Sbjct: 173 YDVPEKWAKFYCAEVVLALDAIHSMGFVHRDVKPDNMLLDKYGHLKLADFGTCMRMGSDG 232
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307212717|gb|EFN88393.1| Rho-associated protein kinase 2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 5e-64, Method: Composition-based stats.
Identities = 124/179 (69%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQK-YSEVPRLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q+ Y R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQEIYKMRMRTDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDADG 229
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383861819|ref|XP_003706382.1| PREDICTED: rho-associated protein kinase 2 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 248 bits (633), Expect = 2e-63, Method: Composition-based stats.
Identities = 123/179 (68%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEVP-RLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRTDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDVDG 229
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380023438|ref|XP_003695530.1| PREDICTED: rho-associated protein kinase 2 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 248 bits (633), Expect = 2e-63, Method: Composition-based stats.
Identities = 123/179 (68%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEVP-RLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRTDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDVDG 229
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792632|ref|XP_003251752.1| PREDICTED: rho-associated protein kinase 2-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 248 bits (632), Expect = 2e-63, Method: Composition-based stats.
Identities = 123/179 (68%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEVP-RLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRTDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDIDG 229
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345482974|ref|XP_001603493.2| PREDICTED: rho-associated protein kinase 2-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 248 bits (632), Expect = 2e-63, Method: Composition-based stats.
Identities = 124/179 (69%), Positives = 138/179 (77%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEV---PRLFEY-------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ P F L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRPDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD K LYMVMDYMPGGDLVNLMS Y
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSQY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHNMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDVDG 229
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345482976|ref|XP_003424715.1| PREDICTED: rho-associated protein kinase 2-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 247 bits (631), Expect = 3e-63, Method: Composition-based stats.
Identities = 124/179 (69%), Positives = 138/179 (77%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEV---PRLFEY-------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ P F L++++ T +YA L S
Sbjct: 52 MKNIEAYMNRYDSVAQDICKMRMRPDDFTLIKVIGRGAFGEVQLVRHKSTQKVYAMKLLS 111
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD K LYMVMDYMPGGDLVNLMS Y
Sbjct: 112 KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSQY 171
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM+ G
Sbjct: 172 DVPEKWAKFYCAEVVLALDAIHNMGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMDVDG 230
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350413242|ref|XP_003489930.1| PREDICTED: rho-associated protein kinase 2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 246 bits (628), Expect = 6e-63, Method: Composition-based stats.
Identities = 122/179 (68%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEVP-RLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRTDDFTLIKVIGRGSFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDK+GHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKYGHLKLADFGTCMRMDADG 229
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340708620|ref|XP_003392920.1| PREDICTED: rho-associated protein kinase 2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 245 bits (625), Expect = 1e-62, Method: Composition-based stats.
Identities = 122/179 (68%), Positives = 140/179 (78%), Gaps = 20/179 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEVP-RLFEY---------------LLKYRYT--LYA--LYS 40
MKN+EA+M+RY Q ++ R ++ L++++ T +YA L S
Sbjct: 51 MKNIEAYMNRYDSVAQDICKMRMRTDDFTLIKVIGRGSFGEVQLVRHKSTQKVYAMKLLS 110
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMAHANS+WIVQLHFAFQD K LYMVMDYMPGGDLVNLMSNY
Sbjct: 111 KFEMIKRSDSAFFWEERDIMAHANSQWIVQLHFAFQDQKYLYMVMDYMPGGDLVNLMSNY 170
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFYCAEVVLALDAIH +GFVHRDVKPDNMLLDK+GHLKLADFGTCMRM+ G
Sbjct: 171 DVPEKWAKFYCAEVVLALDAIHLMGFVHRDVKPDNMLLDKYGHLKLADFGTCMRMDVDG 229
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| UNIPROTKB|D6REE7 | 446 | ROCK2 "Rho-associated protein | 0.587 | 0.322 | 0.717 | 5.9e-86 | |
| FB|FBgn0026181 | 1390 | rok "Rho-kinase" [Drosophila m | 0.510 | 0.089 | 0.763 | 4.7e-85 | |
| UNIPROTKB|F1N319 | 1341 | ROCK2 "Rho-associated protein | 0.587 | 0.107 | 0.724 | 1.5e-82 | |
| UNIPROTKB|F1SCR1 | 1348 | ROCK2 "Uncharacterized protein | 0.587 | 0.106 | 0.724 | 1.6e-82 | |
| UNIPROTKB|Q28021 | 1388 | ROCK2 "Rho-associated protein | 0.587 | 0.103 | 0.724 | 1.9e-82 | |
| UNIPROTKB|O75116 | 1388 | ROCK2 "Rho-associated protein | 0.587 | 0.103 | 0.717 | 3.8e-82 | |
| MGI|MGI:107926 | 1388 | Rock2 "Rho-associated coiled-c | 0.587 | 0.103 | 0.717 | 4e-82 | |
| UNIPROTKB|D3ZZU3 | 1445 | Rock2 "Rho-associated protein | 0.587 | 0.099 | 0.717 | 5.1e-82 | |
| UNIPROTKB|F1NMU2 | 865 | ROCK1 "Uncharacterized protein | 0.587 | 0.166 | 0.724 | 2.8e-81 | |
| ZFIN|ZDB-GENE-100712-2 | 1359 | rock1 "Rho-associated, coiled- | 0.538 | 0.097 | 0.757 | 3.1e-81 |
| UNIPROTKB|D6REE7 ROCK2 "Rho-associated protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 5.9e-86, Sum P(3) = 5.9e-86
Identities = 104/145 (71%), Positives = 119/145 (82%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL +A
Sbjct: 100 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 158
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD + LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 159 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 218
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 219 NMLLDKHGHLKLADFGTCMKMDETG 243
|
|
| FB|FBgn0026181 rok "Rho-kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 4.7e-85, Sum P(2) = 4.7e-85
Identities = 97/127 (76%), Positives = 109/127 (85%)
Query: 35 LYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGD 92
+YA+ S++ +KR DSAFFWEER IMAHANSEWIVQLHFAFQDAK LYMVMD+MPGGD
Sbjct: 112 VYAMKRLSKFEMMKRPDSAFFWEERHIMAHANSEWIVQLHFAFQDAKYLYMVMDFMPGGD 171
Query: 93 LVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+V+LM +YD+PEKWA FY EVVLALD IH +GFVHRDVKPDNMLLD +GHLKLADFGTC
Sbjct: 172 IVSLMGDYDIPEKWAIFYTMEVVLALDTIHNMGFVHRDVKPDNMLLDSYGHLKLADFGTC 231
Query: 153 MRMNKTG 159
MRM G
Sbjct: 232 MRMGANG 238
|
|
| UNIPROTKB|F1N319 ROCK2 "Rho-associated protein kinase 2" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.5e-82, Sum P(3) = 1.5e-82
Identities = 105/145 (72%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL A
Sbjct: 53 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD K LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMDETG 196
|
|
| UNIPROTKB|F1SCR1 ROCK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.6e-82, Sum P(3) = 1.6e-82
Identities = 105/145 (72%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL A
Sbjct: 53 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD K LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMDETG 196
|
|
| UNIPROTKB|Q28021 ROCK2 "Rho-associated protein kinase 2" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.9e-82, Sum P(3) = 1.9e-82
Identities = 105/145 (72%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL A
Sbjct: 100 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 158
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD K LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 159 FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 218
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 219 NMLLDKHGHLKLADFGTCMKMDETG 243
|
|
| UNIPROTKB|O75116 ROCK2 "Rho-associated protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 3.8e-82, Sum P(3) = 3.8e-82
Identities = 104/145 (71%), Positives = 119/145 (82%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL +A
Sbjct: 100 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 158
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD + LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 159 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 218
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 219 NMLLDKHGHLKLADFGTCMKMDETG 243
|
|
| MGI|MGI:107926 Rock2 "Rho-associated coiled-coil containing protein kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 4.0e-82, Sum P(3) = 4.0e-82
Identities = 104/145 (71%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL A
Sbjct: 100 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 158
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD + LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 159 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 218
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 219 NMLLDKHGHLKLADFGTCMKMDETG 243
|
|
| UNIPROTKB|D3ZZU3 Rock2 "Rho-associated protein kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 5.1e-82, Sum P(3) = 5.1e-82
Identities = 104/145 (71%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + + L S++ IKRSDSAFFWEERDIMA ANS W+VQL A
Sbjct: 100 RGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 158
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD + LYMVM+YMPGGDLVNLMSNYDVPEKWAKFY AEVVLALDAIH +G +HRDVKPD
Sbjct: 159 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 218
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 219 NMLLDKHGHLKLADFGTCMKMDETG 243
|
|
| UNIPROTKB|F1NMU2 ROCK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 2.8e-81, Sum P(2) = 2.8e-81
Identities = 105/145 (72%), Positives = 118/145 (81%)
Query: 15 RQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA 74
R + EV +L + R L S++ IKRSDSAFFWEERDIMA ANS W+VQL +A
Sbjct: 14 RGAFGEV-QLVRHKSSRRVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 72
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
FQD + LYMVM+YMPGGDLVNLMSNYDVPEKWA+FY AEVVLALDAIH +GF+HRDVKPD
Sbjct: 73 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 132
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTG 159
NMLLDK GHLKLADFGTCM+MNK G
Sbjct: 133 NMLLDKAGHLKLADFGTCMKMNKEG 157
|
|
| ZFIN|ZDB-GENE-100712-2 rock1 "Rho-associated, coiled-coil containing protein kinase 1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 3.1e-81, Sum P(2) = 3.1e-81
Identities = 103/136 (75%), Positives = 118/136 (86%)
Query: 28 LLKYRYT--LYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83
L++++ T +YA L S++ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYM
Sbjct: 94 LVRHKATRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSNWVVQLFYAFQDDRYLYM 153
Query: 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143
VM+YMPGGDLVNLMSNYDVPEKWA+FY AEVVLALD IH +GF+HRDVKPDNMLLDK GH
Sbjct: 154 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDGIHSMGFIHRDVKPDNMLLDKSGH 213
Query: 144 LKLADFGTCMRMNKTG 159
LKLADFGTCM+MNK G
Sbjct: 214 LKLADFGTCMKMNKDG 229
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P92199 | ROCK_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.5474 | 0.6489 | 0.1355 | yes | N/A |
| Q28021 | ROCK2_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.6145 | 0.6408 | 0.1131 | yes | N/A |
| Q6CFS5 | CBK1_YARLI | 2, ., 7, ., 1, 1, ., 1 | 0.5480 | 0.4204 | 0.1751 | yes | N/A |
| P70335 | ROCK1_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6292 | 0.6448 | 0.1166 | yes | N/A |
| Q13464 | ROCK1_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6292 | 0.6448 | 0.1166 | yes | N/A |
| Q63644 | ROCK1_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6292 | 0.6448 | 0.1154 | yes | N/A |
| O77819 | ROCK1_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.6292 | 0.6448 | 0.1166 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 245 | |||
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-87 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-71 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-70 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-66 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-51 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-48 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-47 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-44 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-44 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-42 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-42 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-41 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-41 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-39 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-36 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-35 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-34 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-34 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-34 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-27 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-25 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-25 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-18 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-10 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 7e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-09 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 5e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 0.003 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.003 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 1e-87
Identities = 113/184 (61%), Positives = 134/184 (72%), Gaps = 30/184 (16%)
Query: 1 MKNVEAFMHRYRRY---------------------RQKYSEVPRLFEYLLKYRYT--LYA 37
KN++ F+ RY + R + EV L++++ + +YA
Sbjct: 18 NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV-----QLVRHKSSKQVYA 72
Query: 38 --LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN 95
L S++ IKRSDSAFFWEERDIMAHANSEWIVQLH+AFQD K LYMVM+YMPGGDLVN
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN 132
Query: 96 LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
LMSNYD+PEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+M
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 156 NKTG 159
+ G
Sbjct: 193 DANG 196
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 221 bits (563), Expect = 9e-71
Identities = 112/178 (62%), Positives = 136/178 (76%), Gaps = 20/178 (11%)
Query: 2 KNVEAFMHRYR---------RYRQKYSEVPRLFE-------YLLKYRYT--LYA--LYSR 41
KN++ F++RY+ R + + EV ++ L++++ T +YA L S+
Sbjct: 19 KNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 78
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNYD
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
VPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 3e-70
Identities = 110/179 (61%), Positives = 128/179 (71%), Gaps = 22/179 (12%)
Query: 2 KNVEAFMHRYRRY---------------------RQKYSEVPRLFEYLLKYRYTLYALYS 40
KN++ F++RY + R + EV +L + + L S
Sbjct: 19 KNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLS 77
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL AFQD K LYMVM+YMPGGDLVNLMSNY
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY 137
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
DVPEKWAKFY AEVVLALDAIH +G +HRDVKPDNMLLDKHGHLKLADFGTCM+M++TG
Sbjct: 138 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-66
Identities = 70/119 (58%), Positives = 93/119 (78%), Gaps = 1/119 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-P 103
IKR+ A ERDI+A A+S WIV+L+++FQD + LY+VM+YMPGGDL+NL+ DV P
Sbjct: 40 IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFP 99
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ A+FY AE+VLALD++H LGF+HRD+KPDN+L+D GH+KLADFG C +MNK
Sbjct: 100 EETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 65/118 (55%), Positives = 95/118 (80%), Gaps = 2/118 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--V 102
+KR+++A F EERD++ + + WI LH+AFQD +LY+VMDY GGDL+ L+S ++ +
Sbjct: 40 LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
PE A+FY AE+VLA+D++H LG+VHRD+KPDN+LLDK+GH++LADFG+C+R+ GT
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-48
Identities = 53/120 (44%), Positives = 81/120 (67%), Gaps = 1/120 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVP 103
IKR + ER+I++ N +IV+LH+AFQ + LY+V++Y PGG+L + +S
Sbjct: 32 IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS 91
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
E+ A+FY AE+VLAL+ +H LG ++RD+KP+N+LLD GH+KL DFG ++ G+ T
Sbjct: 92 EERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-47
Identities = 58/112 (51%), Positives = 86/112 (76%), Gaps = 2/112 (1%)
Query: 51 AFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAK 108
+FF EERDI++ +NS WI QL +AFQD +LY+VM+Y PGGDL++L++ Y+ E A+
Sbjct: 46 SFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ 105
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
FY AE+VLA+ ++H +G+VHRD+KP+N+L+D+ GH+KLADFG+ R+
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 60/83 (72%), Positives = 67/83 (80%)
Query: 160 TETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
RLGRNG++EIK+HPFF NDQWTF N+RE V PVVPELS D DTSNFDDIE D+ E
Sbjct: 288 DREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNE 347
Query: 220 ENFPVPKAFAGNHLPFVGFTYSG 242
E FP+PKAFAGN LPF+GFTYS
Sbjct: 348 ETFPLPKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-44
Identities = 66/136 (48%), Positives = 104/136 (76%), Gaps = 4/136 (2%)
Query: 29 LKYRYTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86
+K+ +YA+ +++ +KR+++A F EER+++ + + +WI LH+AFQD LY+VMD
Sbjct: 22 MKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81
Query: 87 YMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144
Y GGDL+ L+S ++ +PE A+FY AE+VLA+ +IH L +VHRD+KPDN+LLD +GH+
Sbjct: 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHI 141
Query: 145 KLADFGTCMRMNKTGT 160
+LADFG+C++MN+ GT
Sbjct: 142 RLADFGSCLKMNQDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 53/109 (48%), Positives = 84/109 (77%), Gaps = 1/109 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-P 103
+ R+ +A ERDI+A A++EW+V+L+++FQD +LY VMDY+PGGD+++L+ +
Sbjct: 40 LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE 99
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A+FY AE+ A++++H +GF+HRD+KPDN+L+D+ GH+KL DFG C
Sbjct: 100 EDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-42
Identities = 53/109 (48%), Positives = 81/109 (74%), Gaps = 1/109 (0%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERDI+A A++ W+V+L+++FQD LY++M+Y+PGGD++ L+ D E+ +FY AE
Sbjct: 51 ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
+LA+D+IH LG++HRD+KPDN+LLD GH+KL+DFG C + K+
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-41
Identities = 51/96 (53%), Positives = 74/96 (77%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERDI++ A S ++V+L+++FQ K+LY+VM+Y+PGGDL +L+ N E A+ Y AE+
Sbjct: 43 ERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEI 102
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VLAL+ +H G +HRD+KPDN+L+D +GHLKL DFG
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-41
Identities = 60/125 (48%), Positives = 100/125 (80%), Gaps = 2/125 (1%)
Query: 38 LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM 97
+ +++ +KR+++A F EERD++ + +++WI LH+AFQD +LY+VMDY GGDL+ L+
Sbjct: 33 ILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL 92
Query: 98 SNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
S ++ +PE A+FY AE+V+A+D++H L +VHRD+KPDN+L+D +GH++LADFG+C+++
Sbjct: 93 SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152
Query: 156 NKTGT 160
+ GT
Sbjct: 153 MEDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-41
Identities = 46/122 (37%), Positives = 71/122 (58%), Gaps = 1/122 (0%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPE 104
+ D E I+ IV+L+ F+D LY+VM+Y GGDL +L+ + E
Sbjct: 37 IKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE 96
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
A+FY +++ AL+ +H G VHRD+KP+N+LLD+ GH+KLADFG +++ T
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF 156
Query: 165 LG 166
+G
Sbjct: 157 VG 158
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 54/114 (47%), Positives = 84/114 (73%), Gaps = 1/114 (0%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PE 104
K+ A ERD++A ++S W+V L+++FQDA+ LY++M+++PGGDL+ ++ YD E
Sbjct: 41 KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE 100
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+FY AE VLA++A+H LGF+HRD+KPDN+L+D+ GH+KL+DFG +K
Sbjct: 101 DVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 56/109 (51%), Positives = 85/109 (77%), Gaps = 1/109 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-P 103
+ R+ A ERDI+A A++EW+V+L+++FQD +LY VMDY+PGGD+++L+ +V P
Sbjct: 40 LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A+FY AE+ LA++++H +GF+HRD+KPDN+L+D GH+KL DFG C
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 51/96 (53%), Positives = 71/96 (73%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERDI+ SEW+V+L +AFQD + LY+ M+Y+PGGD L++N V E A+FY AE+
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A+DA+H LG++HRD+KP+N L+D GH+KL DFG
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 54/107 (50%), Positives = 83/107 (77%), Gaps = 1/107 (0%)
Query: 47 RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEK 105
R+ A ERDI+A A++EW+V+L+++FQD +LY VMDY+PGGD+++L+ + PE
Sbjct: 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED 101
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
A+FY AE+ A++++H +GF+HRD+KPDN+L+D+ GH+KL DFG C
Sbjct: 102 LARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 55/77 (71%), Positives = 62/77 (80%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
RLGRNG+EEIK H FF NDQW + LR+ V PVVP+LS D DTSNFDDIE+D+ EE FP
Sbjct: 292 RLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFP 351
Query: 224 VPKAFAGNHLPFVGFTY 240
+PKAF GN LPFVGFTY
Sbjct: 352 IPKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-35
Identities = 42/98 (42%), Positives = 69/98 (70%), Gaps = 2/98 (2%)
Query: 56 ERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAE 113
E++++ N I++L++ FQD ++LY V++Y P G+L+ + Y + EK +FY AE
Sbjct: 51 EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE 110
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
++LAL+ +H G +HRD+KP+N+LLDK H+K+ DFGT
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-34
Identities = 54/77 (70%), Positives = 61/77 (79%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
RLGRNG+EEIK HPFF NDQW + N+RE PVVPELS D D+SNFDDIE D+ E FP
Sbjct: 292 RLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFP 351
Query: 224 VPKAFAGNHLPFVGFTY 240
+PKAF GN LPF+GFTY
Sbjct: 352 IPKAFVGNQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 54/114 (47%), Positives = 84/114 (73%), Gaps = 1/114 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VP 103
+++ A ERDI+ A+ W+V++ ++FQD ++LY++M+++PGGD++ L+ D +
Sbjct: 40 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157
E+ +FY AE VLA+DAIH LGF+HRD+KPDN+LLD GH+KL+DFG C + K
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 53/103 (51%), Positives = 80/103 (77%), Gaps = 1/103 (0%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
ERDI+ A+S W+V++ ++FQD +LY++M+++PGGD++ L+ D + E+ +FY AE
Sbjct: 51 ERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAET 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157
VLA+D+IH LGF+HRD+KPDN+LLD GH+KL+DFG C + K
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 47/108 (43%), Positives = 72/108 (66%), Gaps = 2/108 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
E+ I+ ++V L+ +FQD +LY+VM+Y+PGG+L + + PE A+FY A+V
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
VLAL+ +H L V+RD+KP+N+LLD G++K+ DFG R+ K T T
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYT 157
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 41/96 (42%), Positives = 64/96 (66%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYCAEV 114
ER I+ N ++V L ++FQD +++Y+V+D + GGDL +L E+ KF+ E+
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VLAL+ +H G +HRD+KPDN+LLD+ GH+ + DF
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFN 145
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 46/135 (34%), Positives = 75/135 (55%), Gaps = 15/135 (11%)
Query: 27 YLLKYRYT--LYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82
L+K + +AL + ++ + E++I+ N +IV+L+ F+D K +Y
Sbjct: 10 ELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIY 69
Query: 83 MVMDYMPGGDL------VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNM 136
M+M+Y GG+L L Y A+FY A VVLA + +H G ++RD+KP+N+
Sbjct: 70 MLMEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENL 124
Query: 137 LLDKHGHLKLADFGT 151
LLD +G++KL DFG
Sbjct: 125 LLDSNGYVKLVDFGF 139
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-29
Identities = 58/150 (38%), Positives = 85/150 (56%), Gaps = 20/150 (13%)
Query: 27 YLLKYRYTLYALYSRYFQIK---RSD-------SAFFWEERDIMAHANSEWIVQLHFAFQ 76
YL K R T YF IK +SD + E +M S ++ +L+++FQ
Sbjct: 13 YLAKKRST-----GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ 67
Query: 77 DAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
LY+VM+Y+ GGD +L+ PE WAK Y AEVVL ++ +H G +HRD+KP+N
Sbjct: 68 SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127
Query: 136 MLLDKHGHLKLADFGTCMRMNKTGTETKRL 165
+L+D+ GHLKL DFG +++ G E K+
Sbjct: 128 LLIDQTGHLKLTDFG----LSRNGLENKKF 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 49/98 (50%), Positives = 70/98 (71%), Gaps = 1/98 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERDI+A N +IV+LH+AFQ LY+++D++ GGDL +S + E+ KFY AE+
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 107
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
LALD +H LG ++RD+KP+N+LLD+ GH+KL DFG
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 40/111 (36%), Positives = 66/111 (59%), Gaps = 1/111 (0%)
Query: 54 WEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCA 112
E I+ + IV+L AF+D LY+VM+Y GGDL + +S + E AK
Sbjct: 46 RREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIAL 105
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
+++ L+ +H G +HRD+KP+N+LLD++G +K+ADFG ++ K+ +
Sbjct: 106 QILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT 156
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-28
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 52 FFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKF 109
E +I+ N IV+L+ F+D LY+VM+Y GG L +L+ + + E
Sbjct: 37 ELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILR 96
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKTGTETK 163
+++ L+ +H G +HRD+KP+N+LLD +G +KLADFG + + K
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 44/117 (37%), Positives = 71/117 (60%), Gaps = 3/117 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKFYCA 112
E++I+A + ++ L+ +FQ L +VMDY PGG+L L+ + E+ A+FY A
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
EV+LAL+ +H LG V+RD+KP+N+LL + GH+ L+DF + + + R G
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 46/96 (47%), Positives = 67/96 (69%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
ERD +A + S +IV L+++ Q A ++Y+VM+Y+ GGD+ +L+ Y E+ A Y +EV
Sbjct: 54 ERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV 113
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
LALD +H G +HRD+KPDNML+ GH+KL DFG
Sbjct: 114 ALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 2/113 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E I+ IV+ + ++ L++VM++ GG L +L+ + + E + C E
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
++ L+ +H G +HRD+K N+LL G +KL DFG +++ T +G
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-25
Identities = 44/105 (41%), Positives = 67/105 (63%), Gaps = 1/105 (0%)
Query: 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWA 107
D+A ER+I+ +IV L +AFQ LY++++Y+ GG+L ++L E A
Sbjct: 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA 102
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
FY +E+ LAL+ +H G ++RD+KP+N+LLD GH+KL DFG C
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC 147
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-25
Identities = 44/96 (45%), Positives = 63/96 (65%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
ERDI+ A + ++V + +F+ + L MVM+Y+ GGD L+ N +P A+ Y AE
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VLAL+ +H G VHRD+KPDN+L+ GH+KL DFG
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 43/80 (53%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE--KDESPEEN 221
RLG EEIK+HPFF W NLRE PP VPELS DTSNFDD E KD S +
Sbjct: 275 RLGS--FEEIKSHPFFKGIDWE--NLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLS 330
Query: 222 FPVPKAFAGNHLPFVGFTYS 241
K G L FVGFTY
Sbjct: 331 QNSKKLNKGKQLAFVGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 43/100 (43%), Positives = 56/100 (56%), Gaps = 3/100 (3%)
Query: 56 ERDIMAHANSE---WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
E+ I ANSE ++V L FQ + VM+Y GGDL+ + E A FY A
Sbjct: 49 EKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
VVL L +H V+RD+K DN+LLD G +K+ADFG C
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC 148
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 43/99 (43%), Positives = 62/99 (62%), Gaps = 2/99 (2%)
Query: 56 ERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAE 113
E+ ++A A ++ QLH FQ L+ VM+Y+ GGDL+ + E A+FY AE
Sbjct: 45 EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE 104
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+VL L +H G ++RD+K DN+LLD GH+K+ADFG C
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 47/99 (47%), Positives = 62/99 (62%), Gaps = 4/99 (4%)
Query: 56 ERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYC 111
ER+I+ S +IV L F+FQ LY+V DYM GG+L +L E AKFY
Sbjct: 43 ERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI 102
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
AE+VLAL+ +H V+RD+KP+N+LLD GH+ L DFG
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFG 141
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-22
Identities = 46/106 (43%), Positives = 65/106 (61%), Gaps = 8/106 (7%)
Query: 55 EERDIMAHAN-------SEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKW 106
E++ IMA N ++V LH++FQ A LY V+DY+ GG+L +L PE
Sbjct: 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR 97
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
A+FY AE+ AL +H L ++RD+KP+N+LLD GH+ L DFG C
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 3/109 (2%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYC 111
E I++ IV+ + + +D +L + ++Y+ GG L +L+ + +PE + Y
Sbjct: 48 REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT 107
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+++ L +H G VHRD+K N+L+D G +KLADFG R+ T
Sbjct: 108 RQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-22
Identities = 40/97 (41%), Positives = 61/97 (62%), Gaps = 2/97 (2%)
Query: 56 ERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYCAE 113
ER ++ ++V LH+AFQ L++++DY+ GG+L +L E + Y AE
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE 113
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+VLALD +H LG ++RD+K +N+LLD GH+ L DFG
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-22
Identities = 41/117 (35%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCA 112
E+ I+ +S +IV L +AF+ L +VM M GGDL + N PE A FY A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
+++ L+ +H V+RD+KP+N+LLD HG+++++D G + + R G G
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 41/80 (51%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
RLGRNG+++ K HPFF W N+R P VPE+S DTSNFD + D E+ P
Sbjct: 254 RLGRNGLQDFKDHPFFEGIDW--DNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLP 311
Query: 224 VPK--AFAGNHLPFVGFTYS 241
AF+GNHLPFVGFTY+
Sbjct: 312 PSSHGAFSGNHLPFVGFTYT 331
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 38/96 (39%), Positives = 63/96 (65%), Gaps = 1/96 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEV 114
E+ ++ + +I++L + D + LYM+M+Y+PGG+L + L ++ FY +E+
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
V AL+ +H V+RD+KP+N+LLDK GH+KL DFG
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-21
Identities = 45/130 (34%), Positives = 72/130 (55%), Gaps = 3/130 (2%)
Query: 33 YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGD 92
Y L + + + RS+ ER ++A N +IV L F+FQ + LY+V+ ++ GG+
Sbjct: 21 YALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79
Query: 93 LV-NLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
L +L A+FY AE++ AL+ +H ++RD+KP+N+LLD GH+ L DFG
Sbjct: 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL 139
Query: 152 C-MRMNKTGT 160
C + M
Sbjct: 140 CKLNMKDDDK 149
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 37/97 (38%), Positives = 62/97 (63%), Gaps = 1/97 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYCAE 113
+E+ I+ + +IV + +FQD +Y +++++ GG+L +L P AKFY AE
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+VLA + +H ++RD+KP+N+LLD GH+K+ DFG
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163
|
Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-21
Identities = 42/101 (41%), Positives = 64/101 (63%), Gaps = 1/101 (0%)
Query: 63 ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAI 121
+N ++V LH FQ L+ V++++ GGDL+ M +PE+ A+FY AE+ LAL+ +
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 122 HCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
H G ++RD+K DN+LLD GH+KL D+G C + G T
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-20
Identities = 48/145 (33%), Positives = 78/145 (53%), Gaps = 6/145 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
KR + E+ I+ NS ++V L +A++ +L +V+ M GGDL + M
Sbjct: 40 KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF 99
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E A FY AE+ L+ +H V+RD+KP+N+LLD HGH++++D G + + + T
Sbjct: 100 EEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFS 187
R+G G A N+++TFS
Sbjct: 160 GRVGTVG---YMAPEVVKNERYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 44/106 (41%), Positives = 65/106 (61%), Gaps = 8/106 (7%)
Query: 55 EERDIMAHAN-------SEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKW 106
E++ IMA N ++V LH++FQ + LY V+D++ GG+L +L PE
Sbjct: 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR 97
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
A+FY AE+ AL +H + V+RD+KP+N+LLD GH+ L DFG C
Sbjct: 98 ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 43/99 (43%), Positives = 60/99 (60%), Gaps = 1/99 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAE 113
E+R + A ++ LH FQ L+ VM+Y+ GGDL+ + + E ++FY AE
Sbjct: 45 EKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE 104
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
V LAL +H G ++RD+K DN+LLD GH KLADFG C
Sbjct: 105 VTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-20
Identities = 48/115 (41%), Positives = 67/115 (58%), Gaps = 12/115 (10%)
Query: 55 EERDIMAHAN-------SEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKW 106
E+ IMA N ++V LH++FQ A+ LY V+DY+ GG+L +L E
Sbjct: 38 EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR 97
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
A+FY AEV A+ +H L ++RD+KP+N+LLD GH+ L DFG C K G E
Sbjct: 98 ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC----KEGVE 148
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 2/101 (1%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVL 116
IM IV + ++ L++VM+YM GG L ++++ V E + C EV+
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157
L+ +H +HRD+K DN+LL K G +KLADFG ++ K
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-20
Identities = 49/138 (35%), Positives = 79/138 (57%), Gaps = 4/138 (2%)
Query: 29 LKYRYTLYALYSRYFQIKRSDSAFFW--EERDIMAHANSE-WIVQLHFAFQDAKSLYMVM 85
LK +YA+ ++ D W E+ + A+S ++V LH FQ L++V+
Sbjct: 16 LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75
Query: 86 DYMPGGDLV-NLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144
+Y+ GGDL+ ++ +PE+ A+FY AE+ +AL+ +H G ++RD+K DN+LLD GH+
Sbjct: 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI 135
Query: 145 KLADFGTCMRMNKTGTET 162
KL D+G C G T
Sbjct: 136 KLTDYGMCKEGLGPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-20
Identities = 47/106 (44%), Positives = 64/106 (60%), Gaps = 8/106 (7%)
Query: 55 EERDIMAHAN-------SEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKW 106
EE+ IM+ N ++V LHF+FQ A LY V+DY+ GG+L +L E
Sbjct: 38 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 97
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
A+FY AE+ AL +H L V+RD+KP+N+LLD GH+ L DFG C
Sbjct: 98 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-20
Identities = 49/145 (33%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
KR A E+ I+ NS ++V L +A++ +L +V+ M GGDL + M N
Sbjct: 40 KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF 99
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ A FY AE+ L+ +H V+RD+KP+N+LLD +GH++++D G + + + T
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFS 187
R+G G A N+++TFS
Sbjct: 160 GRVGTVG---YMAPEVVKNERYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-20
Identities = 50/138 (36%), Positives = 78/138 (56%), Gaps = 4/138 (2%)
Query: 29 LKYRYTLYALYSRYFQIKRSDSAFFW--EERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85
LK +YA+ ++ D W E+ + A N ++V LH FQ L+ V+
Sbjct: 16 LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75
Query: 86 DYMPGGDLV-NLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144
+Y+ GGDL+ ++ +PE+ A+FY AE+ LAL+ +H G ++RD+K DN+LLD GH+
Sbjct: 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 135
Query: 145 KLADFGTCMRMNKTGTET 162
KL D+G C + G T
Sbjct: 136 KLTDYGMCKEGLRPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 40/97 (41%), Positives = 65/97 (67%), Gaps = 2/97 (2%)
Query: 56 ERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYCAE 113
ER+++ H S ++V LH+AFQ L++++DY+ GG++ +L + E +FY E
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++LAL+ +H LG V+RD+K +N+LLD GH+ L DFG
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFG 150
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-19
Identities = 40/97 (41%), Positives = 65/97 (67%), Gaps = 2/97 (2%)
Query: 56 ERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAE 113
ER ++ H S ++V LH+AFQ L++++DY+ GG+L +S + E+ + Y E
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+VLAL+ +H LG ++RD+K +N+LLD +GH+ L DFG
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 150
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-19
Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 1/120 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VP 103
IK +E D++ + IV+ + + + SLY++++Y G L ++ + P
Sbjct: 38 IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP 97
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
E Y +V+ L +H G +HRD+K N+L K G +KLADFG ++N +
Sbjct: 98 ESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-19
Identities = 46/145 (31%), Positives = 81/145 (55%), Gaps = 6/145 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
KR + E+ I+ NS+++V L +A++ +L +V+ M GGDL + M N
Sbjct: 40 KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF 99
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ A FY AE++ L+ +H V+RD+KP+N+LLD +GH++++D G +++ + +
Sbjct: 100 EEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFS 187
R+G G A N ++T S
Sbjct: 160 GRVGTVG---YMAPEVLNNQRYTLS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.0 bits (206), Expect = 7e-19
Identities = 46/127 (36%), Positives = 71/127 (55%), Gaps = 6/127 (4%)
Query: 43 FQIKRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ K + F E I+A N IV+L+ FQD SLY+VM+Y+ GG L +L+
Sbjct: 34 LESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIG 93
Query: 102 ----VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADFGTCMRMN 156
+ E A F A+++ AL+ +H G +HRD+KP+N+LLD+ G +KL DFG +
Sbjct: 94 RKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153
Query: 157 KTGTETK 163
G+ +
Sbjct: 154 DPGSTSS 160
|
Length = 384 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 42/99 (42%), Positives = 64/99 (64%), Gaps = 2/99 (2%)
Query: 56 ERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAE 113
ER ++A A ++ L FQ + L+ VM+Y+ GGDL+ ++ S+ E A+FY AE
Sbjct: 45 ERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE 104
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
++ L +H G ++RD+K DN+LLDK GH+K+ADFG C
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-18
Identities = 42/120 (35%), Positives = 64/120 (53%), Gaps = 1/120 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-P 103
I + + A E ++ + ++ L ++FQ L VM+Y GG+L +S V
Sbjct: 34 IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS 93
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
E A+FY AE+V AL +H V+RD+K +N++LDK GH+K+ DFG C G K
Sbjct: 94 EDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKWAKFYC 111
E+R + ++ QLH FQ LY VM+Y+ GGDL + + + P+ A FY
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ--AVFYA 107
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRN--- 168
AE+ + L +H G ++RD+K DN++LD GH+K+ADFG C G T+
Sbjct: 108 AEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDY 167
Query: 169 -GIEEIKAHPFFIN-DQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPK 226
E I P+ + D W + L + P G+D+ F I E N PK
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM-----EHNVSYPK 222
Query: 227 AFA 229
+ +
Sbjct: 223 SLS 225
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-18
Identities = 41/113 (36%), Positives = 67/113 (59%), Gaps = 5/113 (4%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKFY 110
E+ I+A +S +IV L +AFQ L +VM M GGDL + N D PE A FY
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
A+++ L+ +H ++RD+KP+N+LLD G+++++D G + + ++TK
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-18
Identities = 41/80 (51%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
RLG+NGIE+ K HPFF W N+R C P +PE+S DTSNFD + E P
Sbjct: 254 RLGQNGIEDFKQHPFFTGIDW--DNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMP 311
Query: 224 VP--KAFAGNHLPFVGFTYS 241
P AF+G+HLPFVGFTY+
Sbjct: 312 PPSHTAFSGHHLPFVGFTYT 331
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-18
Identities = 38/87 (43%), Positives = 55/87 (63%), Gaps = 1/87 (1%)
Query: 67 WIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAEVVLALDAIHCLG 125
++ QLH FQ LY VM+Y+ GGDL+ ++ E A FY AE+ + L +H G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 126 FVHRDVKPDNMLLDKHGHLKLADFGTC 152
++RD+K DN++LD GH+K+ADFG C
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMC 148
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-18
Identities = 41/99 (41%), Positives = 61/99 (61%), Gaps = 1/99 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAE 113
E+R + N ++ QL+ FQ L+ VM+++ GGDL+ ++ + E A+FY AE
Sbjct: 45 EKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 104
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+ AL +H G ++RD+K DN+LLD GH KLADFG C
Sbjct: 105 ITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 6e-18
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 4/108 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAE 113
E + ++V+L F +VM+YMP DL ++ + + +PE K Y
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM 107
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
++ + +H G +HRD+KP N+L+ G LK+ADFG R+
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA-RLFSEEEP 154
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-18
Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 11/181 (6%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAE 113
E+R + ++ QLH FQ LY VM+Y+ GGDL+ + E A FY AE
Sbjct: 50 EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAE 109
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRN----G 169
+ + L +H G ++RD+K DN++LD GH+K+ADFG C G TK
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169
Query: 170 IEEIKAHPFFIN-DQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF 228
E I P+ + D W F L + G+D+ F I E N PK+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-----EHNVAYPKSM 224
Query: 229 A 229
+
Sbjct: 225 S 225
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-18
Identities = 40/101 (39%), Positives = 63/101 (62%), Gaps = 6/101 (5%)
Query: 56 ERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKWAKFYC 111
E+ +++ A ++ L+ FQ ++L+ VM+Y+ GGDL + +D+P A FY
Sbjct: 45 EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR--ATFYA 102
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
AE++ L +H G V+RD+K DN+LLD GH+K+ADFG C
Sbjct: 103 AEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-18
Identities = 50/145 (34%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
KR A E+ I+ NS ++V L +A++ +L +V+ M GGDL + M N
Sbjct: 40 KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF 99
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ A FY AE+ L+ + V+RD+KP+N+LLD GH++++D G +++ + ET
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GET 157
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFS 187
R GR G A N+++TFS
Sbjct: 158 VR-GRVGTVGYMAPEVINNEKYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 34/82 (41%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222
+RLG NG+ EIK+HPFF W ++RE P++PEL DTSNFDD E+ +
Sbjct: 283 RRLGNNGVNEIKSHPFFKGVDW--EHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTS 340
Query: 223 PVPKA--FAGNHLPFVGFTYSG 242
P P L F+G+TY
Sbjct: 341 PGPPRGKIKSKDLAFIGYTYKR 362
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-17
Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 18/120 (15%)
Query: 45 IKRSDSAFF-WEE----------RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93
IK+ F+ WEE R + H N IV+L F++ LY V +YM G +L
Sbjct: 29 IKKMKKKFYSWEECMNLREVKSLRKLNEHPN---IVKLKEVFRENDELYFVFEYMEG-NL 84
Query: 94 VNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
LM + E + +++ L IH GF HRD+KP+N+L+ +K+ADFG
Sbjct: 85 YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG 144
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 36/109 (33%), Positives = 62/109 (56%), Gaps = 2/109 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVV 115
E ++ S +I + + +F L+++M+Y GG ++L+ + E + F EV+
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL 108
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
L L+ +H G +HRD+K N+LL + G +KLADFG ++ T T +KR
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKR 155
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-17
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEV 114
E + S ++V+ + AF + +V++YM GG L +L+ +PE + ++
Sbjct: 49 ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108
Query: 115 VLALDAIH-CLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+ LD +H +HRD+KP N+L++ G +K+ADFG
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-17
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM--SNYDVPEKWAKFYCAEVVLA 117
+ H N I++L F+ LY+V ++M DL L+ +PE K Y +++
Sbjct: 55 LNHPN---IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQG 110
Query: 118 LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
L H G +HRD+KP+N+L++ G LKLADFG
Sbjct: 111 LAFCHSHGILHRDLKPENLLINTEGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-17
Identities = 35/85 (41%), Positives = 55/85 (64%), Gaps = 1/85 (1%)
Query: 67 WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLG 125
+IV + +AF L ++D M GGDL +S + V E +FY AE++L L+ +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 126 FVHRDVKPDNMLLDKHGHLKLADFG 150
V+RD+KP N+LLD+HGH++++D G
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLG 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 43/122 (35%), Positives = 68/122 (55%), Gaps = 1/122 (0%)
Query: 32 RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG 91
RY + + I + + A E ++ + ++ L +AFQ L VM+Y GG
Sbjct: 21 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80
Query: 92 DLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+L +S V E+ A+FY AE+V AL+ +H V+RD+K +N++LDK GH+K+ DFG
Sbjct: 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 140
Query: 151 TC 152
C
Sbjct: 141 LC 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 4/114 (3%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS---NYDV-PEKWAKFY 110
+E M+ N +V+ + +F L++VM Y+ GG L+++M E
Sbjct: 48 KEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
EV+ L+ +H G +HRD+K N+LL + G +K+ADFG + G T++
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 34/80 (42%), Positives = 46/80 (57%), Gaps = 6/80 (7%)
Query: 166 GRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES-PEENFPV 224
R G E + HPFF W +N+R +PP VP L DDDTSNFD+ EK+ + ++
Sbjct: 253 ERLGYEGLCCHPFFSKIDW--NNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTT 310
Query: 225 ---PKAFAGNHLPFVGFTYS 241
P F+G LPFVGF++
Sbjct: 311 QLKPNGFSGKDLPFVGFSFI 330
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-16
Identities = 42/119 (35%), Positives = 68/119 (57%), Gaps = 7/119 (5%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAK-----FY 110
E++I+ NS +IV L +AF+ L +VM M GGDL + Y+V E+ + Y
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHI--YNVGERGLEMERVIHY 100
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
A++ + +H + V+RD+KP+N+LLD G+ +L+D G + + T T+R G NG
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 41/112 (36%), Positives = 66/112 (58%), Gaps = 3/112 (2%)
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMS 98
S+ + K+ D F ER I+ + N + V L+ +F+D LY+V++++ GG+ L
Sbjct: 67 SKIIKQKQVDHVF--SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR 124
Query: 99 NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
N P FY A++VL + + L V+RD+KP+N+LLDK G +K+ DFG
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176
|
Length = 340 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 6e-16
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 11/103 (10%)
Query: 56 ERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-----PEKWA 107
E I+ H N I++ + +F++ L +VM+Y GGDL + PE+
Sbjct: 49 EVKILKKLNHPN---IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ LAL +H +HRD+KP N+ L +G +KL DFG
Sbjct: 106 LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFG 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 37/104 (35%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKW------AK 108
E+R + + ++ L+ FQ + L+ VM+++ GGDL+ + + +K A
Sbjct: 45 EKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRAT 99
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
FY AE+V L +H G ++RD+K DN++LD+ GH+K+ADFG C
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 41/122 (33%), Positives = 67/122 (54%), Gaps = 1/122 (0%)
Query: 32 RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG 91
+Y + + I + + A E ++ + ++ L ++FQ L VM+Y+ GG
Sbjct: 21 KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80
Query: 92 DLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+L +S V E +FY AE+V ALD +H V+RD+K +N++LDK GH+K+ DFG
Sbjct: 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFG 140
Query: 151 TC 152
C
Sbjct: 141 LC 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 2/134 (1%)
Query: 32 RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG 91
RY + + + + + A E ++ ++ ++ L ++FQ L VM+Y GG
Sbjct: 21 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80
Query: 92 DLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADF 149
+L +S V E A+FY AE+V ALD +H V+RD+K +N++LDK GH+K+ DF
Sbjct: 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 140
Query: 150 GTCMRMNKTGTETK 163
G C K G K
Sbjct: 141 GLCKEGIKDGATMK 154
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 40/128 (31%), Positives = 72/128 (56%), Gaps = 3/128 (2%)
Query: 33 YTLYALYSRYFQIKRSDSAFFWEE--RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90
Y + L + ++K+ ++ E +++ + +IV + +AF L ++D M G
Sbjct: 22 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81
Query: 91 GDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149
GDL +S + V EK +FY E++L L+ +H V+RD+KP N+LLD+HGH++++D
Sbjct: 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 141
Query: 150 GTCMRMNK 157
G +K
Sbjct: 142 GLACDFSK 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 30/74 (40%), Positives = 44/74 (59%), Gaps = 3/74 (4%)
Query: 79 KSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNM 136
S+YMV +YM DL L+ + +V E K Y +++ L +H G +HRD+K N+
Sbjct: 73 GSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI 131
Query: 137 LLDKHGHLKLADFG 150
L++ G LKLADFG
Sbjct: 132 LINNDGVLKLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 36/120 (30%), Positives = 67/120 (55%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK 105
K+ + E IM E +V+++ ++ L++VM+++ GG L +++++ + E+
Sbjct: 57 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE 116
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165
C V+ AL +H G +HRD+K D++LL G +KL+DFG C +++K K L
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-15
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAE 113
+E +MA N I+++ A + + +++M GG + +L+S Y E Y +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ 111
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADFGTCMRMNKTGTET 162
++ L +H +HRDVK N+L+D G L++ADFG R+ GT
Sbjct: 112 LLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-15
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 5/110 (4%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKFYCAE 113
I+A N I+ AF D L +VM+Y P GDL +S +PE+ +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
++ L A+H +HRD+K N+LL + +K+ D G + K +T+
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ 161
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 38/84 (45%), Positives = 50/84 (59%), Gaps = 4/84 (4%)
Query: 160 TETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD-DIEKDESP 218
+ +RLG+NGIE+ K H FF W N+R P +P++S DTSNFD D + +P
Sbjct: 250 SRERRLGQNGIEDFKKHAFFEGIDW--ENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNP 307
Query: 219 EENFPVPKA-FAGNHLPFVGFTYS 241
E P F+G HLPFVGFTY+
Sbjct: 308 EIAPPSSHTGFSGLHLPFVGFTYT 331
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-14
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALD 119
H N IV+L + LY+V +Y DL + + K +++ L
Sbjct: 57 HPN---IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L+++ G LKLADFG
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFG 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 28/183 (15%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK 105
K+ + E IM + E +V ++ ++ L++VM+++ GG L +++++ + E+
Sbjct: 59 KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE 118
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT------- 158
C V+ AL +H G +HRD+K D++LL G +KL+DFG C +++K
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178
Query: 159 -----------------GTETK--RLGRNGIEEIKAHPFFINDQ--WTFSNLRECVPPVV 197
GTE LG IE I P + N+ +R+ +PP V
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV 238
Query: 198 PEL 200
+
Sbjct: 239 KDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-14
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM--SNYDVPEKWAKFYCAE 113
E I+ +S +IV+ + ++ L++VM+Y G + ++M +N + E+ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
+ L+ +H +HRD+K N+LL++ G KLADFG ++ T +
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-14
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDA 120
H N IVQ ++ +LY+ ++ +PGG L L+ Y PE + Y +++L L+
Sbjct: 61 HPN---IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 121 IHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H VHRD+K N+L+D +G +KLADFG
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFG 147
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 35/120 (29%), Positives = 68/120 (56%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK 105
K+ + E IM + +V+++ ++ + L+++M+++ GG L +++S + E+
Sbjct: 58 KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE 117
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165
C V+ AL +H G +HRD+K D++LL G +KL+DFG C +++K + K L
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-14
Identities = 33/84 (39%), Positives = 54/84 (64%), Gaps = 1/84 (1%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGF 126
+V LH S+++V+ + GG L + +S + ++PE+ K + AE+V+ALDA+H G
Sbjct: 47 MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGI 106
Query: 127 VHRDVKPDNMLLDKHGHLKLADFG 150
V RD+ P+N+LLD GH++L F
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-14
Identities = 39/102 (38%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKWAKFYCAEVVL 116
M H N IVQ +F++ +LY+VMDY GGDL +N PE + ++ L
Sbjct: 56 MKHPN---IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
AL +H +HRD+K N+ L K G +KL DFG +N T
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-14
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 2/105 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E ++ IV ++ L++VM+Y GG L ++ P E + C E
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+ L +H G +HRD+K N+LL + G +KLADFG ++ T
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-14
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 38/176 (21%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAI 121
H N IV+++ ++ L++VM+++ GG L +++++ + E+ C V+ AL +
Sbjct: 75 HPN---IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 122 HCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT----------------------- 158
H G +HRD+K D++LL G +KL+DFG C +++K
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 159 -GTETK--RLGRNGIEEIKAHPFFINDQ--WTFSNLRECVPP-------VVPELSG 202
GTE LG IE + P + N+ +R+ +PP V P L
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 30/97 (30%), Positives = 53/97 (54%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAI 121
+ I + + ++ L+++M+Y GG + LM + EK+ EV++AL I
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 122 HCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
H +G +HRD+K N+L+ G++KL DFG +N+
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWA--KFYCAEVVLALD 119
H N I+ L F ++ +V ++M DL ++ + + A K Y + L+
Sbjct: 61 HPN---IIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H +HRD+KP+N+L+ G LKLADFG
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFG 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-13
Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140
L++VM+Y+ GG L ++++ + E C E + AL+ +H +HRD+K DN+LL
Sbjct: 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 150
Query: 141 HGHLKLADFGTCMRMNKTGTETKR 164
G +KL DFG C ++ T ++KR
Sbjct: 151 DGSVKLTDFGFCAQI--TPEQSKR 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-13
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 2/116 (1%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFY 110
F EE IM + IV+L + LY+V +YMPGGDL++ + + + K
Sbjct: 48 FLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM 107
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
++ ++ + FVHRD+ N L+ ++ +K++DFG + + KR G
Sbjct: 108 ALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163
|
Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAE 113
E DI+ NS +IV + AF + + + M+YM GG L ++ +PE+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 114 VVLALDAIH-CLGFVHRDVKPDNMLLDKHGHLKLADFG 150
V+ L +H +HRDVKP N+L++ G +KL DFG
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-13
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 57 RDIMA------HANSEWIVQLHFAFQDAK--SLYMVMDYMPGGDLVNLMSN--YDVPEKW 106
R+I A H N I++L D K L +V + M +L L+ +PEK
Sbjct: 46 REIQALRRLSPHPN---ILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKR 101
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
K Y +++ +LD +H G HRD+KP+N+L+ LKLADFG+C
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSC 146
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 62 HANSEWIVQL--HFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEK--WAKFYCA 112
H N IV+ + ++LY+VM+Y GGDL L+ + E+ W
Sbjct: 58 HPN---IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL--T 112
Query: 113 EVVLALDAIHCLG-----FVHRDVKPDNMLLDKHGHLKLADFG 150
+++LAL H +HRD+KP N+ LD + ++KL DFG
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 1/81 (1%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139
+Y+ M+Y GG L L+ + + E + Y +++ L +H G VHRD+KP N+ LD
Sbjct: 74 VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD 133
Query: 140 KHGHLKLADFGTCMRMNKTGT 160
+G +KL DFG +++ T
Sbjct: 134 HNGVIKLGDFGCAVKLKNNTT 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 32/110 (29%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV 114
+E +++ +S ++ + + ++ L+++M+Y+ GG ++L+ + E E+
Sbjct: 51 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREI 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ LD +H +HRD+K N+LL +HG +KLADFG ++ T T+ KR
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 158
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 1/101 (0%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
E ++ + E IVQ + +D ++L + M+YMPGG + + + Y + E + Y ++
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI 113
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
+ ++ +H VHRD+K N+L D G++KL DFG R+
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 32/84 (38%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140
L++VM+Y+ GG L ++++ + E C E + ALD +H +HRD+K DN+LL
Sbjct: 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150
Query: 141 HGHLKLADFGTCMRMNKTGTETKR 164
G +KL DFG C ++ T ++KR
Sbjct: 151 DGSVKLTDFGFCAQI--TPEQSKR 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 3e-12
Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLAL 118
+M + IV +F L++VM+Y+ GG L ++++ + E C E + AL
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQAL 128
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ +H +HRD+K DN+LL G +KL DFG C ++ T ++KR
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKR 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-12
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F E IM + IV+L + + L +VM+YMPGGDL++ L N +
Sbjct: 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS 107
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ ++ + F+HRD+ N L+ ++ +K++DFG
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 148
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-12
Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL----MSNYDVPEKWAKFYC 111
E DI+ A S +IV + AF ++YM M+YM G L L ++ +PE +
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 112 AEVVLALDAI-HCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VV L + +HRDVKP N+L++ +G +KL DFG
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-12
Identities = 36/105 (34%), Positives = 60/105 (57%), Gaps = 2/105 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAE 113
E +I+A N +IV+L AF L++++++ PGG + +M D + E + C +
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
++ AL +H + +HRD+K N+LL G +KLADFG + KT
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 29/74 (39%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 79 KSLYMVMDYMPGGDLVNLMSNYDV--PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNM 136
S+YMV YM DL L+ N V E K Y +++ ++ +H +HRD+K N+
Sbjct: 88 GSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI 146
Query: 137 LLDKHGHLKLADFG 150
L+D G LK+ADFG
Sbjct: 147 LIDNQGILKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-12
Identities = 31/110 (28%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV 114
+E +++ +S ++ + + ++ L+++M+Y+ GG ++L+ E E+
Sbjct: 51 QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ LD +H +HRD+K N+LL + G +KLADFG ++ T T+ KR
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-12
Identities = 32/110 (29%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV 114
+E +++ +S +I + + ++ L+++M+Y+ GG ++L+ + E + E+
Sbjct: 51 QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREI 110
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ LD +H +HRD+K N+LL + G +KLADFG ++ T T+ KR
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 1e-11
Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--Y 110
F E IM + +V+L + + LY+VM+YM GGDL++ + + +
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSF 107
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ ++ + F+HRD+ N L+ ++ +K++DFG
Sbjct: 108 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 147
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 2/84 (2%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140
L++VM+Y+ GG L ++++ + E C E + AL+ +H +HRD+K DN+LL
Sbjct: 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 141 HGHLKLADFGTCMRMNKTGTETKR 164
G +KL DFG C ++ T ++KR
Sbjct: 152 DGSVKLTDFGFCAQI--TPEQSKR 173
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 32/100 (32%), Positives = 56/100 (56%), Gaps = 1/100 (1%)
Query: 66 EWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCL 124
E IVQ + DA L + ++Y+PGG + L++NY E + + +++ L+ +H
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
G +HRD+K N+L+D G +K++DFG ++ TK
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 32/86 (37%), Positives = 41/86 (47%), Gaps = 12/86 (13%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
RLGR G EIK+HPFF W +R+ P +P+L DTS F E ++ PE P
Sbjct: 293 RLGRGGAHEIKSHPFFRGVDW--DTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEA--P 348
Query: 224 VPKAFAGN--------HLPFVGFTYS 241
K A L F+G+TY
Sbjct: 349 ALKQAAPAQQEESVELDLAFIGYTYK 374
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 2/108 (1%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFY 110
F E DI++ IV L+ A+ L++++++ GG L ++M + E ++
Sbjct: 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
C +++ AL+ +H +HRD+K N+LL G +KLADFG + T
Sbjct: 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 32/96 (33%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG---DLVNLMSNYDVPEKWAKFYCAEVV 115
+++H N I++ + F + K+L +VM+Y PGG + + N + E + +++
Sbjct: 55 LLSHPN---IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADFG 150
LAL +H +HRD+K N+LLDKH +K+ DFG
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFG 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL-MSNYDVPEKWAKFYCAEVVLALDA 120
H N IV L AF+ LY+V +Y+ L L S +P + Y +++ A+
Sbjct: 59 HEN---IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 121 IHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP+N+L+ + G LKL DFG
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 37/131 (28%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCA 112
E ++ + E IVQ + +D K+L + M+YMPGG + + + Y + E + Y
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEE 172
+++ + +H VHRD+K N+L D G++KL DFG R+ +T + GI
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRS 168
Query: 173 IKAHPFFINDQ 183
+ P++++ +
Sbjct: 169 VTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKS--LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAE 113
E +I S +IV+ + AF D S + + M+Y GG L ++ V ++ + E
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK--VKKRGGR--IGE 104
Query: 114 VVL---------ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VL L +H +HRD+KP N+LL + G +KL DFG
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 4e-11
Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 2/90 (2%)
Query: 69 VQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFV 127
++L+++ K ++MDY+ GDL +L+ + E K ++V AL+ +H +
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 128 HRDVKPDNMLLDKH-GHLKLADFGTCMRMN 156
H D+K +N+L D+ + L D+G C +
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
|
Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 77 DAKSLYMVMDYMPGG---DLVN--LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDV 131
+ L++VM+ GG DLV + E+W + E + L +H +HRD+
Sbjct: 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDI 139
Query: 132 KPDNMLLDKHGHLKLADFGTCMRMNKT 158
K N+LL K+ +KL DFG +++ T
Sbjct: 140 KGQNILLTKNAEVKLVDFGVSAQLDST 166
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKWAKFYCAEVVL 116
M H N IV +FQ+ L++VM+Y GGDL +N E + ++ L
Sbjct: 56 MKHPN---IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHL-KLADFGTCMRMNKT 158
L IH +HRD+K N+ L K+G + KL DFG ++N +
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 34/121 (28%), Positives = 66/121 (54%), Gaps = 8/121 (6%)
Query: 66 EWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH 122
E IVQ + +D ++L + M++MPGG + + + +Y + E + Y +++ + +H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFIND 182
VHRD+K N+L D G++KL DFG R+ +T L G++ + P++++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSVTGTPYWMSP 178
Query: 183 Q 183
+
Sbjct: 179 E 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
E IM S +IV + AF + ++ M M++M G L + +P E+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV--------EI 104
Query: 115 V--LALDAIHCLGF-------VHRDVKPDNMLLDKHGHLKLADFG 150
+ +A+ + L + +HRD+KP N+L++ G +KL DFG
Sbjct: 105 LGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 27/81 (33%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE-----KDES 217
RLG+NG +EIKAHPFF + S +R P +P+++ DTSNFD ++ D+S
Sbjct: 288 DRLGKNGADEIKAHPFFKGIDFA-SLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDS 346
Query: 218 PEENFPVPKAFAGNHLPFVGF 238
E + F
Sbjct: 347 GESSPDRNVKPNNRKRTEHAF 367
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 34/121 (28%), Positives = 64/121 (52%), Gaps = 8/121 (6%)
Query: 66 EWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH 122
+ IVQ + +D K L + ++YMPGG + + + Y + E + Y +++ + +H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFIND 182
VHRD+K N+L D G++KL DFG R+ +T + GI+ + P++++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-----QTICMSGTGIKSVTGTPYWMSP 178
Query: 183 Q 183
+
Sbjct: 179 E 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 7/101 (6%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEK--WAKF 109
+E ++A +S +I++ + +F D L +VM+Y GDL L+ +PE W +F
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW-RF 106
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +++L L +H +HRD+K N+ LD + ++K+ D G
Sbjct: 107 FI-QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLG 146
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 32/85 (37%), Positives = 41/85 (48%), Gaps = 14/85 (16%)
Query: 168 NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP---EENFPV 224
+E+IK HPFF W + LRE PP VPEL + DT FDD E ++ ++
Sbjct: 249 GSLEDIKNHPFFKEVDW--NELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEK 306
Query: 225 PKAF---------AGNHLPFVGFTY 240
KA GN FVGFT+
Sbjct: 307 KKAAGKGGANGRDPGNRRKFVGFTF 331
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVL 116
+ H N I+ +F LY+V M G +L+ + +PE F +V+
Sbjct: 56 LQHPN---ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
ALD IH GF+HR VK ++LL G + L+ + M K G
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 7e-10
Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 1/47 (2%)
Query: 199 ELSGDDDTSNFDDIEKDESPEENFP-VPKAFAGNHLPFVGFTYSGDY 244
++ DTSNFD E P+ + P + + L F GF+Y
Sbjct: 1 KVKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-10
Identities = 25/81 (30%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 81 LYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137
L++VM++ G + +L+ N + E+W + C E++ L +H +HRD+K N+L
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143
Query: 138 LDKHGHLKLADFGTCMRMNKT 158
L ++ +KL DFG ++++T
Sbjct: 144 LTENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 24/52 (46%), Positives = 32/52 (61%), Gaps = 2/52 (3%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211
TKRLG +NG+ +IK HP+F W R+ P +P++ G DTSNFDD
Sbjct: 238 TKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 32/114 (28%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 56 ERDIMAHANSEWIVQLHFAFQ----DAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFY 110
E I+ H + I+ + + D K +Y+VMD M DL +++ S+ + E+ +++
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF 112
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+++ L IH +HRD+KP N+L+++ L++ DFG ++ + TE K
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 10/98 (10%)
Query: 77 DAKSLYMVMDYMPGGDL----------VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGF 126
+ + LY+V++YM GGDL + K + ++ ++ + F
Sbjct: 67 EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF 126
Query: 127 VHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
VHRD+ N L+ + +K++DFG + K+
Sbjct: 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 25/81 (30%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 81 LYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137
L++VM++ G + +L+ N + E W + C E++ L +H +HRD+K N+L
Sbjct: 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153
Query: 138 LDKHGHLKLADFGTCMRMNKT 158
L ++ +KL DFG ++++T
Sbjct: 154 LTENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 13/103 (12%)
Query: 57 RDIMA-----HANSEWIVQLH--FAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWA 107
R+I H N IV+L + S+++VM+Y DL +L+ N P E
Sbjct: 55 REITLLLNLRHPN---IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQV 110
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
K +++ L +H +HRD+K N+LL G LK+ADFG
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKFYCAEVVLAL 118
H N IV+L LY+V +++ DL M +P K Y +++ L
Sbjct: 58 HPN---IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L++ G +KLADFG
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E DI+A + IV+L AF +L++++++ GG + +M + P E + C +
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+ AL+ +H +HRD+K N+L G +KLADFG + +T
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVV 115
E +I+ +S +I+ + AF + + ++M GG L +PE VV
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK---IPEHVLGRIAVAVV 105
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
L + L +HRDVKP NML++ G +KL DFG
Sbjct: 106 KGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFG 140
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 13/98 (13%)
Query: 65 SEWIVQL----HFAFQDAK-SLYMVMDYMPGGDLVNLMSNY------DVPEKWAKFYCAE 113
S +IV+L H ++ K SLY+V +Y+ DL M + +P K K + +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFG 150
++ + H G +HRD+KP N+L+DK G LK+AD G
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 30/81 (37%), Positives = 41/81 (50%), Gaps = 3/81 (3%)
Query: 162 TKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
RLG +G+EEIK HPFF W RE PP P + DDT FD +P+
Sbjct: 238 ANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPK 297
Query: 220 ENFPVPKAFAGNHLPFVGFTY 240
++ +P + A H F GF++
Sbjct: 298 DSPGIPPS-ANAHQLFRGFSF 317
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-09
Identities = 19/53 (35%), Positives = 25/53 (47%), Gaps = 1/53 (1%)
Query: 190 RECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNH-LPFVGFTYS 241
+E PP VP++ DTSNFD +E+P G PF GF+Y
Sbjct: 11 KEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGFSYV 63
|
Length = 64 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 5/112 (4%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCA 112
E I++ I+ + F D +L + M+Y GG L + + E+ +Y
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN--KTGTET 162
++V A+ IH G +HRD+K N+ L K G +KL DFG + + ET
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 12/98 (12%)
Query: 61 AHANSEWIVQLH--FAFQDAK---SLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCA 112
H N IV+L L +V +++ DL +S +P + K
Sbjct: 59 EHPN---IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ +D +H VHRD+KP N+L+ G +K+ADFG
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP----EKWAKFYCAEVV 115
+ H N IVQ + + + M+ +PGG L L+ + P E+ FY +++
Sbjct: 62 LKHRN---IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRM 155
L +H VHRD+K DN+L++ + G +K++DFGT R+
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-09
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKWAKFYCAEVVL 116
M H N IV +F+ LY+VM+Y GGDL + L PE + ++ L
Sbjct: 55 MKHPN---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
+ IH +HRD+K N+ L ++G +KL DFG+
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDA 120
H N +V L F+ + L++V +Y L L N VPE K + + A++
Sbjct: 59 HPN---LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 121 IHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRDVKP+N+L+ K G +KL DFG
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAK-SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAE 113
E + + + IVQ + F+ + L + ++Y+PGG + + + Y E+ +F+ +
Sbjct: 58 EIETLKDLDHLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
V+ L +H G +HRD+K DN+L+D G K++DFG
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP----EKWAKFYC 111
E +M E IV+LH L +V +YM DL M + V K +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ + H +HRD+KP N+L++K G LKLADFG
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFG 145
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 26/55 (47%), Positives = 37/55 (67%), Gaps = 1/55 (1%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
RLGRNG ++IKAHPFF ++ S++R P VP++S DTSNFD +E++
Sbjct: 293 RLGRNGADDIKAHPFFSEVDFS-SDIRTQPAPYVPKISHPMDTSNFDPVEEESPW 346
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 26/101 (25%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQ-----DAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKF 109
E ++ H E I+ L + D +Y+V + M DL ++ S + + ++
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY 107
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +++ L +H +HRD+KP N+L++ + LK+ DFG
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG------DLVNLMSNYDVPEKWAKFYCAE 113
+ HAN IV LH KSL +V +Y+ D N+MS ++V K + +
Sbjct: 61 LKHAN---IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNV-----KIFLYQ 112
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ L H +HRD+KP N+L+++ G LKLADFG
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFG 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 26/57 (45%), Positives = 32/57 (56%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
T+RLG NG +EIK HPFF W ++ PP P +S DTSNFD+ E P
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV----PEKWAKFYCAEVVLA 117
H N IV ++ + L++ M+Y GG L ++ Y V E + C E +
Sbjct: 65 HCN---IVAYFGSYLSREKLWICMEYCGGGSLQDI---YHVTGPLSELQIAYVCRETLQG 118
Query: 118 LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
L +H G +HRD+K N+LL +G +KLADFG ++ T T KR
Sbjct: 119 LAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKR 163
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 25/53 (47%), Positives = 38/53 (71%), Gaps = 1/53 (1%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216
RLG+NG +EIKAHPFF ++ S+LR+ P +P+++ DTSNFD ++ D+
Sbjct: 293 RLGKNGADEIKAHPFFKTIDFS-SDLRQQSAPYIPKITHPTDTSNFDPVDPDK 344
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 32/83 (38%), Positives = 39/83 (46%), Gaps = 5/83 (6%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
KRLG G ++IK HPFF W +E PP P++ G D SNFDD E P
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPV 295
Query: 220 ENFPVPKAFAGNHLP--FVGFTY 240
P +A N F GF+Y
Sbjct: 296 LT-PPDEAIIRNIDQEEFRGFSY 317
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 16/98 (16%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-------NLMSNYDVPEKWAKFYCA 112
+ HAN IV LH + L +V +Y+ DL NLMS ++V K +
Sbjct: 60 LKHAN---IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNV-----KIFMF 110
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L H +HRD+KP N+L+++ G LKLADFG
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFG 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 76 QDAKSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKP 133
+D + Y+V +YM DL+ L+ + E K + +++ L+ H F+HRD+K
Sbjct: 86 KDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144
Query: 134 DNMLLDKHGHLKLADFG 150
N+LL+ G +KLADFG
Sbjct: 145 SNILLNNKGQIKLADFG 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALD 119
HAN IV LH K+L +V +Y+ DL M + + + + +++ L
Sbjct: 62 HAN---IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L+ + G LKLADFG
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFG 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 32/85 (37%), Positives = 49/85 (57%), Gaps = 3/85 (3%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGG--DLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLG 125
IV+L AF+ LY+V +Y+ +L+ M N PEK + Y +++ A+ H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKND 120
Query: 126 FVHRDVKPDNMLLDKHGHLKLADFG 150
VHRD+KP+N+L+ + LKL DFG
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 6e-08
Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 13/78 (16%)
Query: 80 SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV-------VLALDAIHCLGFVHRDVK 132
+YMVM+Y+ DL +LM P F +EV + + +H +HRD+K
Sbjct: 80 KIYMVMEYVEH-DLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWILHRDLK 133
Query: 133 PDNMLLDKHGHLKLADFG 150
N+LL+ G LK+ DFG
Sbjct: 134 TSNLLLNNRGILKICDFG 151
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 54 WEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLMSNYDVPEKWA 107
+ E ++ H E ++ L F SL Y+VM +M G DL LM + + E
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRI 120
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+F +++ L IH G +HRD+KP N+ +++ LK+ DFG
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKFYCAEVVL 116
+ H N IV+L LY+V +++ DL M + K Y +++
Sbjct: 55 LNHPN---IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ H +HRD+KP N+L+D+ G LKLADFG
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 27/101 (26%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKF 109
+E D++ N +++ + +F + L +V++ GDL ++ ++ +PEK
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y ++ AL+ +H +HRD+KP N+ + G +KL D G
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 10/88 (11%)
Query: 162 TKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE---- 216
TKRLG ++ EIK H FF + W ++ PP P +SG D +FD +E
Sbjct: 236 TKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPN 295
Query: 217 ----SPEENFPVPKAFAGNHLPFVGFTY 240
SP+ + F+GF+Y
Sbjct: 296 SVGKSPDSVLVSASVKEADD-AFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 24/52 (46%), Positives = 35/52 (67%), Gaps = 2/52 (3%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211
T+RLG +NG +++K H +F + W R+ PP+VP++S D DTSNFDD
Sbjct: 238 TRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 16/104 (15%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG--DLVNLMSNYDVPEKWAKFYCAE 113
E ++ NS +IV + AF + + M++M GG D V L +PE +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEN----ILGK 103
Query: 114 VVLA-------LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +A L H + +HRDVKP N+L++ G +KL DFG
Sbjct: 104 ISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 13/111 (11%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAK---- 108
F +E IM+ + I++L L M+ +YM GDL +S ++ +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 109 ---------FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ + + L FVHRD+ N L+ H +K+ADFG
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 54 WEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLMSNYDVPEKWA 107
+ E ++ H E ++ L F A+SL Y+V M G DL N++ + +
Sbjct: 64 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHV 122
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+F +++ L IH +HRD+KP N+ +++ LK+ DFG
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 17/29 (58%), Positives = 23/29 (79%)
Query: 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
L +HRDVKP N+LLD++G++KL DFG
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 24/57 (42%), Positives = 34/57 (59%), Gaps = 4/57 (7%)
Query: 114 VVLALDAIHCL----GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
V + A+H L G +HRDVKP N+LLD G++KL DFG R+ + +T+ G
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG 176
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLA 117
+ HAN IV LH ++L V +YM DL M + + + + +++
Sbjct: 60 LKHAN---IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRG 115
Query: 118 LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
L IH +HRD+KP N+L+ G LKLADFG
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGELKLADFG 148
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG------DLVNLMSNYDVPEKWAKFYCAE 113
+ HAN IV LH KSL +V +Y+ D N ++ ++V K + +
Sbjct: 61 LKHAN---IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV-----KLFLFQ 112
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ L+ H +HRD+KP N+L+++ G LKLADFG
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFG 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 22/59 (37%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 163 KRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
+RLG E++K PFF + W R+ PP VP + G +D SNFD+ E+P
Sbjct: 242 RRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPV 300
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 1/116 (0%)
Query: 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS-NYDVPEKWA 107
D A +E +M IV ++ L++ M++ GG L ++ + E
Sbjct: 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQI 108
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
+ E + L +H G +HRD+K N+LL +GH+KLADFG ++ T + K
Sbjct: 109 AYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 28/98 (28%), Positives = 57/98 (58%), Gaps = 2/98 (2%)
Query: 54 WEERDIMAHANSEWIVQLHFAF-QDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
+ E ++ H E I+ L F + +Y V + + G DL L+++ + +++ +++
Sbjct: 57 YRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L +H G VHRD+KP N+L++++ LK+ DFG
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 13/102 (12%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG---GDLVNLMS--NYDVPEK--WAKF 109
++ + H N IV+ + F + LY+VMD + G G+ N + E+ W F
Sbjct: 63 KEQLRHPN---IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 110 YCAEVVLALDAIHCLGF-VHRDVKPDNMLLDKHGHLKLADFG 150
++VLAL +H VHRD+ P+N++L + + + DFG
Sbjct: 120 --VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEV 114
E ++ NS +IV + AF + + M++M GG L ++ +PE+ V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 115 VLALDAI---HCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ L + H + +HRDVKP N+L++ G +KL DFG
Sbjct: 113 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG 149
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 19/38 (50%), Positives = 29/38 (76%), Gaps = 1/38 (2%)
Query: 114 VVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+V AL+ +H L +HRDVKP N+L++++G +KL DFG
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 4e-07
Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 24/108 (22%)
Query: 57 RDIM------AHANSEWIVQL---HFAFQDAKSLYMVMDYMPGGDL-----VNLMSNYDV 102
R+IM H N IV+L A D K +Y+V +YM DL N++ DV
Sbjct: 55 REIMFLQELGDHPN---IVKLLNVIKAEND-KDIYLVFEYMET-DLHAVIRANILE--DV 107
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ Y +++ AL IH +HRD+KP N+LL+ +KLADFG
Sbjct: 108 HKRYI-MY--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 56 ERDIMAHANSEWIVQLH-----FAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFY 110
E I+ E I+ + +F+ +Y+V + M DL L+ + +++
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF 111
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L IH +HRD+KP N+LL+ + LK+ DFG
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV- 114
E +I+ N +V+ H F + +++++M GG L + + + A+V
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVA 174
Query: 115 --VLA-LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+L+ + +H VHRD+KP N+L++ ++K+ADFG + +T
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 26/103 (25%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEK--WA 107
+E D++ + +++ +F + L +V++ GDL ++ ++ +PE+ W
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
F ++ AL+ +H +HRD+KP N+ + G +KL D G
Sbjct: 111 YFV--QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 80 SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV-------VLALDAIHCLGFVHRDVK 132
S Y+V ++ DL L+SN +V KF +E+ + L IH +HRD+K
Sbjct: 93 SFYLVFEFCEH-DLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146
Query: 133 PDNMLLDKHGHLKLADFG 150
N+L+ K G LKLADFG
Sbjct: 147 AANILITKDGILKLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 2/71 (2%)
Query: 171 EEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAG 230
E+++HPFF + W R+ PP P L ++D S FD ++P ++ P +
Sbjct: 251 AEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDS-PDDSTLSE 309
Query: 231 N-HLPFVGFTY 240
+ + F+GFTY
Sbjct: 310 SANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 28/87 (32%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 158 TGTETKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215
T KRLG G +I+ H FF W RE PP P++ G NFD
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTR 296
Query: 216 ESPEENFPVPKAFAGN--HLPFVGFTY 240
E P P K N F GF++
Sbjct: 297 EPPVLT-PPDKLVIANIDQSEFQGFSF 322
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 54 WEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLMSNYDVPEKWA 107
+ E ++ H E ++ L F A S+ Y+V + M G DL N++ + ++
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHV 120
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+F +++ L IH G +HRD+KP N+ +++ L++ DFG
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 30/120 (25%), Positives = 58/120 (48%), Gaps = 10/120 (8%)
Query: 76 QDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
Q K L ++M+Y+P G L + + + + + ++ + +H ++HRD+ N
Sbjct: 78 QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137
Query: 136 MLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG--------IEEIKAHPF-FINDQWTF 186
+LLD +K+ DFG + G E R+ +G +E +K + F + +D W+F
Sbjct: 138 VLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEV 114
E ++ NS +IV + AF + + M++M GG L ++ +PE+ V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 115 VLALDAI---HCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ L + H + +HRDVKP N+L++ G +KL DFG
Sbjct: 113 LRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFG 149
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 47 RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKW 106
R+D F +E IM+ I++L + L M+ +YM GDL +S ++ E
Sbjct: 63 RND---FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 107 AK------------FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
K F ++ + + L FVHRD+ N L+ K+ +K+ADFG
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 68 IVQLH--FAFQDAKS------LYMVMDYMPGGDLVNLM-----SNYDVPEKWAKFYCAEV 114
IV+ H FA +D ++ + +V+DY GDL + +N E A +V
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+LA+ +H +HRD+K N+LL +G +KL DFG
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 83 MVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141
+VMD M DL ++ + E K +++ L+ +H F+HRD+ P N+ ++
Sbjct: 97 LVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 142 GHLKLADFGTCMR 154
G K+ADFG R
Sbjct: 156 GICKIADFGLARR 168
|
Length = 335 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI-EKDESPEENF 222
R+G NG+EEIK+HPFF W ++RE + E+ DDTSNFD+ E D
Sbjct: 281 RIGSNGVEEIKSHPFFEGVDW--GHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAEN 338
Query: 223 PVPKAFAGNHLPFVGFTYSGD 243
+ + F+ +TY
Sbjct: 339 TIEPDYKSKDWVFLNYTYKRF 359
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 20/49 (40%), Positives = 27/49 (55%), Gaps = 2/49 (4%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210
+RLG G E+K H FF+ W LR+ +P+L +DDTS FD
Sbjct: 259 LERLGTGGAFEVKQHRFFLGLDWN-GLLRQ-KAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 33/91 (36%), Positives = 44/91 (48%), Gaps = 12/91 (13%)
Query: 72 HFA----FQDAKS---LYMVMDYMPGGDL-----VNLMSNYDVPEKWAKFYCAEVVLALD 119
HF F D KS L ++M+Y GGDL L + E ++VLALD
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H +HRD+K N+ L G +KL DFG
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFG 214
|
Length = 478 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVL 116
+ HAN IV LH ++L +V +Y+ DL M + PE K + +++
Sbjct: 60 LKHAN---IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPEN-VKLFLFQLLR 114
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
L IH +HRD+KP N+L+ G LKLADFG
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFG 148
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 15/124 (12%)
Query: 41 RYFQIKRSDSAFF--------WEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMD 86
R IK+ F + E ++ H + E ++ L F A SL Y+V
Sbjct: 41 RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100
Query: 87 YMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146
M G DL N++ + + +F +++ L IH G +HRD+KP N+ +++ LK+
Sbjct: 101 LM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159
Query: 147 ADFG 150
DFG
Sbjct: 160 LDFG 163
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 54 WEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLMSNYDVPEKWA 107
+ E ++ H E ++ L F A S Y+VM YM DL +M + +K
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDK-V 119
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ +++ L IH G +HRD+KP N+ +++ LK+ DFG
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
C + L +H +HRD+K N+LL + G +KLADFG+
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGS 161
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 18/43 (41%), Positives = 29/43 (67%)
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
+V+ L +H +G VHRD+KP+N+L+ G +K+ DFG + M
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 24/72 (33%), Positives = 42/72 (58%), Gaps = 2/72 (2%)
Query: 80 SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139
S+Y+V +YM DL N++ + E+ A+ + +++ L IH +HRD+KP N+ ++
Sbjct: 90 SVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 140 KHGH-LKLADFG 150
LK+ DFG
Sbjct: 149 TEDLVLKIGDFG 160
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 18/46 (39%), Positives = 23/46 (50%), Gaps = 3/46 (6%)
Query: 161 ETKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDD 205
+KRLG + G EIK HPFF W +R PP++P D
Sbjct: 273 PSKRLGSKRGAAEIKQHPFFRGVNWAL--IRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 28/81 (34%), Positives = 39/81 (48%), Gaps = 3/81 (3%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
TKRLG +G +I+ HPFF W RE PP P++ D SNFD +E +
Sbjct: 236 TKRLGVDG--DIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLS 293
Query: 222 FPVPKAFAG-NHLPFVGFTYS 241
K A + F GF+++
Sbjct: 294 PVDKKLLASMDQEQFRGFSFT 314
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--Y 110
F EE +M + E +VQL+ + +Y+V +YM G L+N + + + ++
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C +V + + F+HRD+ N L+D G +K++DFG
Sbjct: 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 62 HANSEWIVQL-HFAFQDAKSLYMVMDYMPGGDLVNLM----SNYDVPEKWAKFYCAEVVL 116
H N IV L Q+++ LY++ +++ DL + + + K Y +++
Sbjct: 58 HPN---IVCLQDVLMQESR-LYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ H +HRD+KP N+L+D G +KLADFG
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFG 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 26/86 (30%), Positives = 48/86 (55%), Gaps = 1/86 (1%)
Query: 66 EWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCL 124
E +V L F+ K LY+V +++ L +L + + E + Y +++ ++ H
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 125 GFVHRDVKPDNMLLDKHGHLKLADFG 150
+HRD+KP+N+L+ + G +KL DFG
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS---NYDVPEKWAKFYCAEVVL 116
M H N IV+L K LY+V +Y+ DL M ++ + K Y +++
Sbjct: 58 MQHGN---IVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADFG 150
+ H +HRD+KP N+L+D+ + LKLADFG
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148
|
Length = 294 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 1/102 (0%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAE 113
EE D++ IVQ D ++ + M+++PGG + ++++ + +PE Y +
Sbjct: 51 EEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ 110
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
++ + +H VHRD+K +N++L +G +KL DFG R+
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 27/91 (29%), Positives = 36/91 (39%), Gaps = 14/91 (15%)
Query: 164 RLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD-----DIEKDES 217
RLG E+K HPFF + W + ++ PP P + D+D SNFD +
Sbjct: 240 RLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAG 299
Query: 218 PEENFPVPKAFAGNHLP--------FVGFTY 240
VP N P F GFT+
Sbjct: 300 IVPWEDVPGLPGANSTPLSSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 23/124 (18%)
Query: 47 RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKW 106
R+D F +E I++ I++L D L M+ +YM GDL +S++ + +K
Sbjct: 63 RND---FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 107 AK--------------------FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146
++ + + L FVHRD+ N L+ ++ +K+
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179
Query: 147 ADFG 150
ADFG
Sbjct: 180 ADFG 183
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-06
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--- 109
F EE +M + +VQL+ K LY+V ++M G L+N + ++ K
Sbjct: 46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR-----QRQGKLSKD 100
Query: 110 ----YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C +V ++ + F+HRD+ N L+ G +K++DFG
Sbjct: 101 MLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG 145
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 81 LYMVMDYMPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
L++V++ GG + +L+ + + E + E ++ L +H +HRDVK +N
Sbjct: 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 136 MLLDKHGHLKLADFGTCMRMNKTGTETKRLGRN 168
+LL G +KL DFG ++ T RL RN
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTST-----RLRRN 182
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 25/101 (24%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKF 109
+E D++ N +++ +F + L +V++ GDL ++ + +PE+
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y ++ A++ +H +HRD+KP N+ + G +KL D G
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 30/92 (32%), Positives = 42/92 (45%), Gaps = 16/92 (17%)
Query: 162 TKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220
+RLG + EI+ HPFF + WT ++ PP P + G DD SNFD EE
Sbjct: 236 QRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFD----AVFTEE 291
Query: 221 NFPVPKAFAGNHL-----------PFVGFTYS 241
P F+ ++ FVGF+Y+
Sbjct: 292 TVPYSVCFSSDYSIVNASVLEADDAFVGFSYA 323
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK--WAKFY 110
F EE +M + +VQL+ + +++V +YM G L+N + W
Sbjct: 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM 105
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C++V A++ + GF+HRD+ N L+ + +K++DFG
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG 145
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 6/79 (7%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
TKRLG + G+ ++K HP+F W R P+ + DTSNF+ + +SP
Sbjct: 255 TKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFE--KYPDSPV 312
Query: 220 ENFPVPKAFAGNHLPFVGF 238
+ +P A F GF
Sbjct: 313 D--RLPPLTAAQQAEFAGF 329
|
Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 25/68 (36%), Positives = 34/68 (50%), Gaps = 5/68 (7%)
Query: 155 MNKTGTETKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211
+NK E RLG + G +IK+HPFF N W ++ +PP P + D D NFD
Sbjct: 240 LNKDPKE--RLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
Query: 212 IEKDESPE 219
DE +
Sbjct: 298 QFTDEPVQ 305
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 12/124 (9%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVM-----DYMPGGDLVNLMSNYDVPEKWAKFY 110
E DI+ + I+ L A++ ++ MVM D D +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQA------IT 189
Query: 111 CAEVVL-ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
+L AL +H G +HRDVK +N+ LD+ + L DFG +++ + G +G
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 170 IEEI 173
E
Sbjct: 250 TLET 253
|
Length = 392 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 21/49 (42%), Positives = 30/49 (61%)
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
VP + K +++ LD +H VHRD+KP N+L+ G +KLADFG
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 5/116 (4%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKF 109
F EE +M + + +V+L LY+VM+ M G+LVN + V
Sbjct: 46 FLEETAVMTKLHHKNLVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165
+ +V ++ + VHRD+ N+L+ + G K++DFG R+ G + +L
Sbjct: 105 FSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDNSKL 159
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALD 119
H N IV+L+ K L +V +Y DL N D+ + K + +++ L
Sbjct: 58 HKN---IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L++K+G LKLADFG
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 25/63 (39%), Positives = 30/63 (47%), Gaps = 4/63 (6%)
Query: 158 TGTETKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD-DIE 213
T T RLG G E I HPFF W N R+ PP P + +D SNFD D
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFI 291
Query: 214 KDE 216
K++
Sbjct: 292 KED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 24/61 (39%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
T+RLG G I+ HPFF WT RE PP P++ D SNFD E P +
Sbjct: 236 TRRLGVVG--NIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLS 293
Query: 222 F 222
+
Sbjct: 294 Y 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 2/76 (2%)
Query: 76 QDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
++ K +Y+V + M DL ++ +N D+ + +F+ +++ AL IH HRD+KP
Sbjct: 74 REFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPK 132
Query: 135 NMLLDKHGHLKLADFG 150
N+L + LK+ DFG
Sbjct: 133 NILANADCKLKICDFG 148
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKF 109
F E +M +VQL LY+V +YM G LV+ + + +
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V ++ + FVHRD+ N+L+ + K++DFG
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFG 147
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 9/119 (7%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--- 109
F EE IM + +VQL +A + +Y+V +YM G L++ + + + + K
Sbjct: 48 FLEEAQIMKKLRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGE--GRALKLPNL 104
Query: 110 --YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
A+V + I + ++HRD++ N+L+ K+ADFG R+ + T R G
Sbjct: 105 VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 28/77 (36%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 81 LYMVMDYMPGGDLVNLM-----SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
L +VM+++P + M +N+ +P K Y ++ AL IH HRD+KP N
Sbjct: 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQN 200
Query: 136 MLLDKHGH-LKLADFGT 151
+L+D + H LKL DFG+
Sbjct: 201 LLIDPNTHTLKLCDFGS 217
|
Length = 440 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 12/112 (10%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFY-- 110
F +E I++ + I +L L M+M+YM GDL + +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 111 ----------CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
++ + + L FVHRD+ N L+ K+ +K+ADFG
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-05
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES-- 217
+RLG +EI H FF + W ++ PP P+++ + DT FD+ +S
Sbjct: 235 KQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSIT 294
Query: 218 ---PEENFPVPKAFAGNHLPFVGFTYSGD 243
P+ + F F+YS
Sbjct: 295 ITPPDRYDSLGLLQLEERPHFPQFSYSAS 323
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 26/103 (25%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM--SNYDVPEKWAKFY 110
F +E +I+ + IV+L + +Y+VM+ +PGG L+ + + K
Sbjct: 39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM 98
Query: 111 CAEV---VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ + L++ +C +HRD+ N L+ ++ LK++DFG
Sbjct: 99 SLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFG 138
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 10/85 (11%)
Query: 163 KRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES-- 217
+RLG + G +I+ HPFF N W ++ VPP P +SG+ NFD +E
Sbjct: 246 ERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQ 305
Query: 218 --PEENFPVPKAFAGNHLPFVGFTY 240
P+++ V K + F GF Y
Sbjct: 306 LTPDDDDIVRKI---DQSEFEGFEY 327
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 13/110 (11%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM----------SNYDV 102
F E +M N +V+L + +VM+ M GDL + +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 103 PEKWAKFY--CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
P KF AE+ + + FVHRD+ N ++ + +K+ DFG
Sbjct: 116 PTL-QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-05
Identities = 19/104 (18%), Positives = 43/104 (41%), Gaps = 11/104 (10%)
Query: 56 ERDIMAHANSEWIV--QLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAE 113
E I+ + + ++ + + Y++M+++ G L + + + E A+ +
Sbjct: 41 EVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--SEEEKEDIAE----Q 94
Query: 114 VVLALDAIHCL---GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154
+ L +H L H D+ P N+L+D L + D+
Sbjct: 95 LAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 2/99 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYC 111
F E +MA + IV+L + L +VM+ P G L+ L ++P K
Sbjct: 43 FLREASVMAQLDHPCIVRL-IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA 101
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+V + + + FVHRD+ N+LL K++DFG
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG 140
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 17/39 (43%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFG 150
+++ ALD +H G VHRDVKP N++ G K+ D G
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 22/173 (12%)
Query: 37 ALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN- 95
A+ + D + F E IM+ N + IV+L + +++++ M GGDL +
Sbjct: 40 AVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF 99
Query: 96 LMSNYDVPEKWAKFYCAEVV-LALD---AIHCL---GFVHRDVKPDNMLLDKHGH---LK 145
L N PE+ + +++ A D L F+HRD+ N LL G K
Sbjct: 100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159
Query: 146 LADFGTCMRMNKTGTETKRLGRNGIEEIKAHP--FFIN-------DQWTFSNL 189
+ADFG M + R G + IK P F++ D W+F L
Sbjct: 160 IADFG--MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 21/49 (42%), Positives = 24/49 (48%), Gaps = 2/49 (4%)
Query: 163 KRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209
KRLG G EIK HPFF W LR+ PP P + + D NF
Sbjct: 252 KRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNF 300
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 81 LYMVMDYMPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
L++V++ GG + L+ + E + +L L +H +HRDVK +N
Sbjct: 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158
Query: 136 MLLDKHGHLKLADFGTCMRMNKTGTETKRLGRN 168
+LL G +KL DFG ++ T RL RN
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTST-----RLRRN 186
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 18/33 (54%), Positives = 24/33 (72%)
Query: 118 LDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
LD +H VHRD+KP+N+L+ G +KLADFG
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 27/117 (23%), Positives = 53/117 (45%), Gaps = 4/117 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKF 109
F +E +M +VQL Y++ ++M G+L++ + + V +
Sbjct: 49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 108
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
++ A++ + F+HRD+ N L+ ++ +K+ADFG R+ T T G
Sbjct: 109 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAG 164
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 1e-04
Identities = 31/117 (26%), Positives = 58/117 (49%), Gaps = 5/117 (4%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F +E +M E +VQL +A + +Y+V +YM G L++ L + +
Sbjct: 48 FLQEAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
A++ + + + +VHRD++ N+L+ ++ K+ADFG R+ + T R G
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 24/101 (23%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKF 109
F E ++M +V+L+ A + +Y++ +YM G LV+ + +
Sbjct: 48 FLAEANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A++ + I ++HRD++ N+L+ + K+ADFG
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG 147
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 16/86 (18%)
Query: 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223
R+G G+EEIK +PFF W ++RE + E+ DDTSNF DE P+ +
Sbjct: 281 RIGAPGVEEIKTNPFFEGVDW--EHIRERPAAIPIEIKSIDDTSNF-----DEFPDSDIL 333
Query: 224 VPKAFAGNHLP---------FVGFTY 240
P NH F+ +TY
Sbjct: 334 KPTVATSNHPETDYKNKDWVFINYTY 359
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 22/60 (36%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 163 KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222
+RLG G +I+ HPFF W+ RE PP P++ +D SNFD +E P +
Sbjct: 237 RRLGVKG--DIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSV 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 4/74 (5%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139
L+ V +Y+PG L +++ P +V+ AL H G VHRD+KP N+++
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 140 KHG---HLKLADFG 150
+ G H K+ DFG
Sbjct: 114 QTGVRPHAKVLDFG 127
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 21/116 (18%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL----------VNLMSNYDV 102
F E +++ + E IV+ + + MV +YM GDL + + D
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 103 PEK--------WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
P A ++ L + H FVHRD+ N L+ +K+ DFG
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFG 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 42 YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
Y + +R D F E IM + I+ L +K + +V +YM G L + +D
Sbjct: 44 YTEKQRRD---FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD 100
Query: 102 VPEKWAKFYCAEVVLALDAIHC-------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+F ++V L I +G+VHRD+ N+L++ + K++DFG
Sbjct: 101 -----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG 151
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 22/73 (30%), Positives = 38/73 (52%), Gaps = 3/73 (4%)
Query: 81 LYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137
LY+VM + GGDL + + +PE + ++ +AL +H +HRD+K N+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 138 LDKHGHLKLADFG 150
L + +K+ D G
Sbjct: 135 LTRTNIIKVGDLG 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVV 115
+DIM + E AF D +Y +MD DL ++ S+ + + +++ +++
Sbjct: 70 KDIMPPPHRE-------AFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
L IH +HRD+KP N+LL+ + LK+ DFG
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 153
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 14/22 (63%), Positives = 17/22 (77%)
Query: 163 KRLGRNGIEEIKAHPFFINDQW 184
KRLG NG +EIK+HPFF + W
Sbjct: 238 KRLGANGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 30/91 (32%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 158 TGTETKRLG----RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213
T KRLG + G + IK HPFF W R+ PP P++ D +NFD
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDF 291
Query: 214 KDESPEENFPVPKAF--AGNHLPFVGFTYSG 242
E P PV A N F GF++
Sbjct: 292 TKEEPVLT-PVDPAVIKQINQEEFRGFSFFN 321
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 7/67 (10%)
Query: 162 TKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220
TKRLG ++ EIK H FF W ++ PP P +SG +D +FD +E
Sbjct: 236 TKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEE---- 291
Query: 221 NFPVPKA 227
PVP +
Sbjct: 292 --PVPNS 296
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 24/101 (23%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKF 109
F E ++M + +V+LH A + +Y++ ++M G L++ + + + P
Sbjct: 48 FLAEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ A++ + I ++HRD++ N+L+ K+ADFG
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 147
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 24/101 (23%), Positives = 50/101 (49%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKF 109
F +E IM + +VQL+ + + +Y+V +YM G L++ + + +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A++ + + ++HRD+ N+L+ ++ K+ADFG
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-----SNYDVPEKWA 107
F EE ++M + +V+L+ + +Y++ +YM G L++ + +P+
Sbjct: 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGR 167
+ A++ + I ++HRD++ N+L+ + K+ADFG R+ + T R G
Sbjct: 108 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGA 164
Query: 168 ------NGIEEIKAHPFFI-NDQWTFSNL 189
E I F I +D W+F L
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 30/117 (25%), Positives = 59/117 (50%), Gaps = 9/117 (7%)
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDL 93
SR FQ ++ + + E ++ N + I+ L F KSL Y+VM+ M +L
Sbjct: 55 SRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANL 112
Query: 94 VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ + ++ + + +++ + +H G +HRD+KP N+++ LK+ DFG
Sbjct: 113 CQVI-HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 24/107 (22%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF- 109
F E +I+ + E IV+ + +SL ++M+Y+P G L +Y + +
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL----RDY-LQRHRDQIN 107
Query: 110 ------YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +++ +D + ++HRD+ N+L++ +K++DFG
Sbjct: 108 LKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 18/74 (24%), Positives = 41/74 (55%), Gaps = 2/74 (2%)
Query: 79 KSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNM 136
++L +VM+Y+P G L + + + + + Y +++ ++ + +VHRD+ N+
Sbjct: 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139
Query: 137 LLDKHGHLKLADFG 150
L++ +K+ DFG
Sbjct: 140 LVESENRVKIGDFG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 6e-04
Identities = 31/119 (26%), Positives = 58/119 (48%), Gaps = 9/119 (7%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--- 109
F +E IM + +V L +A + +Y+V ++M G L++ + D K+ K
Sbjct: 48 FLQEAQIMKKLRHDKLVPL-YAVVSEEPIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQL 104
Query: 110 --YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
A++ + I + ++HRD++ N+L+ + K+ADFG R+ + T R G
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
F E I+ + IV+L + +Y+VM+ +PGGD ++ + K +
Sbjct: 39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL--- 95
Query: 113 EVVLALDAIHCLGF------VHRDVKPDNMLLDKHGHLKLADFG 150
V ALDA + + +HRD+ N L+ ++ LK++DFG
Sbjct: 96 -VKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFG 138
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 24/91 (26%), Positives = 43/91 (47%), Gaps = 3/91 (3%)
Query: 62 HANSEWIVQLHFAFQDA-KSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALD 119
H N + + F LY+ + M DL ++ S + + + + +++ L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
IH +HRD+KP N+L++ LK+ DFG
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFG 150
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 16/37 (43%), Positives = 18/37 (48%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVP 198
KRLG NG +EIK HPFF W + P P
Sbjct: 252 KKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 31/117 (26%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDL 93
SR FQ ++ + + E +M N + I+ L F KSL Y+VM+ M +L
Sbjct: 58 SRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 94 VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ ++ + + +++ + +H G +HRD+KP N+++ LK+ DFG
Sbjct: 116 CQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 8e-04
Identities = 31/117 (26%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDL 93
SR FQ ++ + + E +M N + I+ L F KSL Y+VM+ M +L
Sbjct: 51 SRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANL 108
Query: 94 VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ ++ + + +++ + +H G +HRD+KP N+++ LK+ DFG
Sbjct: 109 CQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 14/23 (60%), Positives = 14/23 (60%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQW 184
KRLG IEEIK HPFF W
Sbjct: 243 EKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKFYCAEVVLALDAIH 122
IV+ H +F + + ++ +Y G DL + + E + +++L + +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFG-TCMRM 155
+HRD+K N+ L K+ LK+ DFG + + M
Sbjct: 124 QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLM 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 6/103 (5%)
Query: 53 FWEERDIMAHANSEWIVQL-HFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP----EKWA 107
F E +M +VQL ++ LY+V +YM G LV+ + + +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
KF +V A++ + FVHRD+ N+L+ + K++DFG
Sbjct: 106 KF-SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFG 147
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 48 SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWA 107
+ F +E +M++ N IV+L + Y++M+ M GGDL++ + + +
Sbjct: 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD----ARVE 96
Query: 108 KFYCAEVVL------ALD-AIHC-----LGFVHRDVKPDNMLLDKHGH-----LKLADFG 150
+F + L LD A C + F+HRD+ N L+ + G+ +K+ DFG
Sbjct: 97 RFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAE 113
E +IM ++ +IV++ +A++L +VM+ GG L +S ++ +
Sbjct: 45 EAEIMHQLDNPYIVRM-IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ 103
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
V + + + FVHRD+ N+LL + K++DFG
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 15/34 (44%), Positives = 23/34 (67%)
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A+D IH G +HRD+K +N+L++ + L DFG
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
|
Length = 461 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 48 SDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYDVPEK 105
+ A +E +I+ + E IV+ + + ++M+++P G L + P
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PRN 102
Query: 106 WAKF-------YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
K Y ++ +D + +VHRD+ N+L++ +K+ DFG
Sbjct: 103 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.003
Identities = 15/18 (83%), Positives = 15/18 (83%)
Query: 162 TKRLGRNGIEEIKAHPFF 179
TKRLG G EEIKAHPFF
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 8/105 (7%)
Query: 51 AFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFY 110
A F +E I+ + IV+L + +Y+VM+ + GGD + + K +
Sbjct: 38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI 97
Query: 111 -----CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A + L++ HC +HRD+ N L+ + LK++DFG
Sbjct: 98 QMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFG 139
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 37.8 bits (87), Expect = 0.003
Identities = 16/35 (45%), Positives = 23/35 (65%)
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
L +H +HRD+K N+LL + G +KLADFG+
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 14/46 (30%), Positives = 26/46 (56%)
Query: 166 GRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211
G + +E+ H FF++ W ++ +PP P+++ + DT FDD
Sbjct: 241 GPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 16/35 (45%), Positives = 23/35 (65%)
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
L +H +HRD+K N+LL + G +KLADFG+
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0984|consensus | 282 | 99.98 | ||
| KOG0194|consensus | 474 | 99.98 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| KOG0983|consensus | 391 | 99.98 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579|consensus | 1187 | 99.98 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607|consensus | 463 | 99.97 | ||
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| KOG1989|consensus | 738 | 99.97 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1006|consensus | 361 | 99.97 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0193|consensus | 678 | 99.97 | ||
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0584|consensus | 632 | 99.97 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0662|consensus | 292 | 99.97 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG1026|consensus | 774 | 99.97 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0604|consensus | 400 | 99.97 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4645|consensus | 1509 | 99.96 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG4257|consensus | 974 | 99.96 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG1095|consensus | 1025 | 99.96 | ||
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0671|consensus | 415 | 99.96 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0196|consensus | 996 | 99.96 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0577|consensus | 948 | 99.96 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0587|consensus | 953 | 99.96 | ||
| KOG0666|consensus | 438 | 99.96 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG2345|consensus | 302 | 99.96 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG1152|consensus | 772 | 99.95 | ||
| KOG1094|consensus | 807 | 99.95 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0669|consensus | 376 | 99.95 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| KOG0603|consensus | 612 | 99.95 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG1151|consensus | 775 | 99.95 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0670|consensus | 752 | 99.94 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG2052|consensus | 513 | 99.94 | ||
| KOG0665|consensus | 369 | 99.94 | ||
| KOG1035|consensus | 1351 | 99.94 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG0668|consensus | 338 | 99.94 | ||
| KOG4278|consensus | 1157 | 99.93 | ||
| KOG3653|consensus | 534 | 99.93 | ||
| KOG1345|consensus | 378 | 99.93 | ||
| KOG0199|consensus | 1039 | 99.93 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1025|consensus | 1177 | 99.93 | ||
| KOG0664|consensus | 449 | 99.92 | ||
| KOG0200|consensus | 609 | 99.92 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG1027|consensus | 903 | 99.9 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1167|consensus | 418 | 99.89 | ||
| KOG1290|consensus | 590 | 99.89 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG0576|consensus | 829 | 99.87 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1163|consensus | 341 | 99.82 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG0603|consensus | 612 | 99.82 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1024|consensus | 563 | 99.8 | ||
| KOG1164|consensus | 322 | 99.8 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1165|consensus | 449 | 99.79 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| KOG0590|consensus | 601 | 99.73 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG1166|consensus | 974 | 99.63 | ||
| KOG4158|consensus | 598 | 99.62 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG0195|consensus | 448 | 99.56 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG1240|consensus | 1431 | 99.5 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.48 | |
| KOG1023|consensus | 484 | 99.44 | ||
| KOG0606|consensus | 1205 | 99.43 | ||
| KOG0590|consensus | 601 | 99.32 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG1033|consensus | 516 | 99.26 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1243|consensus | 690 | 99.17 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0606|consensus | 1205 | 99.09 | ||
| KOG3087|consensus | 229 | 99.01 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG0601|consensus | 524 | 98.91 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 | |
| KOG1266|consensus | 458 | 98.63 | ||
| KOG0601|consensus | 524 | 98.61 | ||
| KOG3741|consensus | 655 | 98.57 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.33 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| KOG2137|consensus | 700 | 97.65 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.49 | |
| KOG0694|consensus | 694 | 97.43 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.36 | |
| KOG0576|consensus | 829 | 97.36 | ||
| KOG1235|consensus | 538 | 97.14 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.03 | |
| KOG2268|consensus | 465 | 96.82 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.67 | |
| KOG0605|consensus | 550 | 96.4 | ||
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 96.39 | |
| KOG0696|consensus | 683 | 96.13 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 96.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 95.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.72 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 95.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.52 | |
| KOG2270|consensus | 520 | 95.52 | ||
| KOG1035|consensus | 1351 | 95.45 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.73 | |
| KOG0612|consensus | 1317 | 94.34 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.04 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.98 | |
| KOG0598|consensus | 357 | 93.87 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.7 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.64 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.46 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.27 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.09 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 92.92 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.17 |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=312.28 Aligned_cols=214 Identities=28% Similarity=0.474 Sum_probs=194.7
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
-++++|.---.+|+|+||+| ++|+++ ++.|| +++|....+..+.++...|..||..++||+||+++..|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV-----~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKV-----FQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceE-----EEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 46788988888999999999 688887 99999 8889888888899999999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
.+++|+|+||++||.|..+++ ++.+++..+++++.+|+.||.|||+.||+||||||+|||+|.+|.++|+|||+|+...
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999999999998 5569999999999999999999999999999999999999999999999999999644
Q ss_pred CC-CCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 157 KT-GTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 157 ~~-~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
.. ....+.+| |+|||.+...++ ..+|-||+|+++|+|++|.|||.+++.....++|..++.+.+
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP 245 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC
Confidence 33 33344566 789999999998 667999999999999999999999999999999999874433
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=305.37 Aligned_cols=230 Identities=20% Similarity=0.265 Sum_probs=188.0
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccC----chHHHHHHHHHHHhcCCccceeee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRS----DSAFFWEERDIMAHANSEWIVQLH 72 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~ 72 (245)
+.|.+.|. +|.|+||.|+ +|.++ |+.|| +++|......+ ....+.+|++||++|+|||||+++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vk-----la~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVK-----LAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred chhcceeEeeeeecCCceeEEE-----EEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 34555554 7888999996 55555 99999 66666554322 445578999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEe
Q psy16292 73 FAFQDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLAD 148 (245)
Q Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~D 148 (245)
++|...++.|+||||+.||+|.+.+-. +.+.+..-..++.|++.|+.|||++||+||||||+|||+..+ ..+||+|
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999999997654 457788888999999999999999999999999999999876 6789999
Q ss_pred eCceeecCCCCCccccCC---CCchhhhhcCCC----cccCCCcccccceecCCccCCCCCCCCCC-CCcccCcCCCCCC
Q psy16292 149 FGTCMRMNKTGTETKRLG---RNGIEEIKAHPF----FINDQWTFSNLRECVPPVVPELSGDDDTS-NFDDIEKDESPEE 220 (245)
Q Consensus 149 fg~a~~~~~~~~~~~~~~---~~~~e~i~~~~~----~~~Diws~g~~~~~~~~~~~pf~~~~~~~-~~~~~~~~~~~~~ 220 (245)
||+|+......-..+.+| |.+||.+..... .+.|+||+||++|.+++|.|||++..... .-..|.++..+.-
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 999999876655556666 678999877654 24599999999999999999999997555 6777889888877
Q ss_pred CCCCCccccCCCCCccccee
Q psy16292 221 NFPVPKAFAGNHLPFVGFTY 240 (245)
Q Consensus 221 ~~~~~~~~~~~~~~f~~f~~ 240 (245)
++.+.++ +.+.+.++++..
T Consensus 403 p~~w~~I-seea~dlI~~mL 421 (475)
T KOG0615|consen 403 PLQWDRI-SEEALDLINWML 421 (475)
T ss_pred Chhhhhh-hHHHHHHHHHhh
Confidence 6666555 556777776654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=304.54 Aligned_cols=210 Identities=22% Similarity=0.301 Sum_probs=183.0
Q ss_pred CcchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehh-hhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 1 MKNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRY-FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 1 ~~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~-~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
|..+++|.-.-++|+|+|+.|| +++++ +..+||+.-. .......++.+..|+.+|+.++|||||.++++.++
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVy-----kg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVY-----KGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred ccccccceehhhccCcceEEEE-----EeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 3456788877789999999994 77777 8888832222 21245678889999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC------CcEEEEeeC
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH------GHLKLADFG 150 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~------~~i~l~Dfg 150 (245)
++++|+|||||.||+|.++++.+ ++++..++.++.|++.||++||+++|+||||||+|||+... -.+||+|||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999999876 69999999999999999999999999999999999999875 357999999
Q ss_pred ceeecCCCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 151 TCMRMNKTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 151 ~a~~~~~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
+|+.+.......+.+| |++||.++...| -++|+||+|+++|++++|++||...+..+.+..+..+
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 9999998877777888 799999988877 8899999999999999999999988877777655444
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=292.50 Aligned_cols=214 Identities=27% Similarity=0.457 Sum_probs=197.6
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
++++|...-.+|.|+||.| .||+++ |..|| +++|..+.+-.++++..+|..+|+.+.||+++++++.|.+.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV-----~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRV-----HLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred chhhhhheeeeccCccceE-----EEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence 4678888888999999999 899999 99999 88898888889999999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.++|+||||++||.|.+++++ +++++..+++++.+|++||+|||+++|++|||||+||++|++|.+|++|||+|+....
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCC
Q psy16292 158 TGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223 (245)
Q Consensus 158 ~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (245)
. ..+-+| |.+||.+...++ ...|=||+||+.|+|+.|.|||.+.++...+.+|+.++...|+.-
T Consensus 197 r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f 264 (355)
T KOG0616|consen 197 R--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF 264 (355)
T ss_pred c--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc
Confidence 3 344445 789999999999 778999999999999999999999999999999999988766543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=309.02 Aligned_cols=217 Identities=29% Similarity=0.489 Sum_probs=195.4
Q ss_pred CcchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEE
Q psy16292 1 MKNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAF 75 (245)
Q Consensus 1 ~~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 75 (245)
+|.+.||.---.+|.|+|++| ++|+.+ ++.|| |+.|..++++..+..+.+|..+|.+| .||.|++|+..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV-----~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTV-----VLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeE-----EEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 467899999999999999999 688877 99999 99999999999999999999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
++...+|+|+||+++|+|.++|+.. .+.+..++.++.+|+.||+|||++|||||||||+|||+|.+|+++|+|||.|+.
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999999999865 599999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCc--------------cccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 155 MNKTGTE--------------TKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 155 ~~~~~~~--------------~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+...... .+..| |.+||.+...+- +.+|+|+|||++|.|+.|.|||.+.++--.|.+|+.-+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 7543221 33455 577888877665 88999999999999999999999999999999998776
Q ss_pred CCCCCC
Q psy16292 217 SPEENF 222 (245)
Q Consensus 217 ~~~~~~ 222 (245)
...|..
T Consensus 304 y~fp~~ 309 (604)
T KOG0592|consen 304 YEFPEG 309 (604)
T ss_pred ccCCCC
Confidence 654433
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=296.39 Aligned_cols=225 Identities=21% Similarity=0.304 Sum_probs=190.1
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+..+...--.+|.|..|+| ++|+|+ ++.||.+.-....+....+++.+|+++++.++||+||++|++|..++.
T Consensus 77 ~~~dle~~~~lG~G~gG~V-----~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTV-----YKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred CHHHhhhhhhcccCCCcEE-----EEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 3456777778999999999 699999 999992222334455677889999999999999999999999999994
Q ss_pred -EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 81 -LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 81 -~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+.|+||||.+|||.++++. ++++|..+..++.+++.||.|||. ++|+||||||+|+|+++.|.|||+|||.++.+..
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999998875 569999999999999999999995 9999999999999999999999999999998876
Q ss_pred CCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC-----CCCCCCcccCcCCCCCCCCCCCc-c
Q psy16292 158 TGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD-----DDTSNFDDIEKDESPEENFPVPK-A 227 (245)
Q Consensus 158 ~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~-~ 227 (245)
+ ...+..| |++||.|.+..| .++||||||+.+.|+++|+.|+..+ ...+.+..|..+++|.. |. .
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l----P~~~ 306 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL----PEGE 306 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC----Cccc
Confidence 5 4555666 799999999888 8999999999999999999999886 34455666777766633 33 4
Q ss_pred ccCCCCCccc
Q psy16292 228 FAGNHLPFVG 237 (245)
Q Consensus 228 ~~~~~~~f~~ 237 (245)
+|.+...|++
T Consensus 307 fS~ef~~FV~ 316 (364)
T KOG0581|consen 307 FSPEFRSFVS 316 (364)
T ss_pred CCHHHHHHHH
Confidence 6666666654
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=308.84 Aligned_cols=210 Identities=31% Similarity=0.595 Sum_probs=188.0
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
++||.---.||+|+||.| .||+++ |.+|| +++|....+..++++++.|..||...++|+||+||.+|++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeV-----rLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEV-----RLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccchhheeeccccceeE-----EEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 567777778999999999 599999 99999 889999999999999999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
++||||||+|||++..+|.. ..+++.++++++.+++.|+..+|+.|++||||||+|+|+|..|.+||+|||+|..+...
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999999998765 45999999999999999999999999999999999999999999999999999643210
Q ss_pred CC------------------------------------------------ccccCC---CCchhhhhcCCC-cccCCCcc
Q psy16292 159 GT------------------------------------------------ETKRLG---RNGIEEIKAHPF-FINDQWTF 186 (245)
Q Consensus 159 ~~------------------------------------------------~~~~~~---~~~~e~i~~~~~-~~~Diws~ 186 (245)
.. .....| |.|||.+.+..| ..+|-||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 112233 789999999998 78899999
Q ss_pred cccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 187 SNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 187 g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
||++|+|+.|.|||.++++.+.+.+|..-...
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 99999999999999999999999999776543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=305.44 Aligned_cols=204 Identities=20% Similarity=0.328 Sum_probs=184.2
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+|+|+|.++ +.++.. |+.|| ++.|....+....+.+.+|++|.++|+|||||+++++|++..++|||+|+|
T Consensus 26 LGkGgFA~c-----Ye~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 26 LGKGGFARC-----YEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eccCcceEE-----EEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 899999999 355553 99999 888888888999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCccccCC
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTETKRLG 166 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~~~~~ 166 (245)
..++|..+++.+ .++|..++.++.||+.||.|||+++|+|||||..|++++.+.++||+|||+|..+..+ +...+.+|
T Consensus 101 ~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCG 180 (592)
T KOG0575|consen 101 HRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCG 180 (592)
T ss_pred CCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecC
Confidence 999999998854 5999999999999999999999999999999999999999999999999999998755 55555666
Q ss_pred ---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 167 ---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 167 ---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
|.+||.+..... |.+||||+||++|.|+.|+|||...+-.+.+.+|...+...|+
T Consensus 181 TPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 181 TPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred CCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence 688999876555 8999999999999999999999999888888888877776654
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=308.61 Aligned_cols=217 Identities=29% Similarity=0.447 Sum_probs=196.8
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD 77 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~ 77 (245)
++++|.---.+|||+||+| +||+.+ ++.|| +++|..+..++++++.+.|.+|+..+ +||+++.++++|++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV-----~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKV-----LLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccceEEEEEeccCcCceE-----EEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 5677777777999999999 799988 99999 88899999999999999999999998 59999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC-
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN- 156 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~- 156 (245)
..++|+||||+.||++..+++...+++..+++++..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+|+...
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999999996666666789999999999999999999999999999999999999999999999999999755
Q ss_pred CCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCC
Q psy16292 157 KTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPV 224 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (245)
.+....+.+| +.+||.+....| ...|=||+||++|+|+.|.+||.|++..+.|++|+..++..|....
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 4445566777 689999999999 4569999999999999999999999999999999999888665443
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=282.16 Aligned_cols=228 Identities=24% Similarity=0.334 Sum_probs=188.5
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeE-EEEe
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHF-AFQD 77 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~ 77 (245)
+++.+|.---++|+|+||+|+ +|... |+.+| +..+-...+....+.+..|+.+|++|+|||||++++ .|..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vy-----kv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVY-----KVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred ccHHHHHHHHHHcCCcchheE-----EeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 467889888899999999994 55444 88888 433455556667788999999999999999999998 5655
Q ss_pred CCE-EEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCceEecCCCcEEEE
Q psy16292 78 AKS-LYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHC--LG--FVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 78 ~~~-~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~--iih~dlkp~nil~~~~~~i~l~ 147 (245)
+.. ++||||+|.+|+|...++. ..+++..++.++.|++.||.++|. .+ |+||||||.||+++..|.+||.
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 555 8999999999999998863 249999999999999999999998 55 9999999999999999999999
Q ss_pred eeCceeecCCCCCc-cccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCC
Q psy16292 148 DFGTCMRMNKTGTE-TKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222 (245)
Q Consensus 148 Dfg~a~~~~~~~~~-~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (245)
|||+++.+...... .+..| |++||.|...+| +++||||+||++|+|+.-.+||.|.+-.+.-.+|..++.|
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~---- 246 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP---- 246 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC----
Confidence 99999988755442 33444 789999999999 9999999999999999999999999877778888888665
Q ss_pred CCC-ccccCCCCCcccc
Q psy16292 223 PVP-KAFAGNHLPFVGF 238 (245)
Q Consensus 223 ~~~-~~~~~~~~~f~~f 238 (245)
|.| ..+|......+++
T Consensus 247 ~~p~~~YS~~l~~li~~ 263 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINM 263 (375)
T ss_pred CCcHHHhhhHHHHHHHH
Confidence 333 4445444433433
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=283.27 Aligned_cols=214 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|.-.-.+|+|.||+|. +|... |+.+| .++|....++.+.-++.+|++||..|+||||+++|.+|+..+.+.
T Consensus 55 yE~~etLGkGTYGKVk-----~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVK-----LAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred HHHHHHhcCCccccee-----ehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3444458999999995 55554 99999 666777777889999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|||||..+|.|++++.+. .+++..++.+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+....-.
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 999999999999999865 5999999999999999999999999999999999999999999999999999988877777
Q ss_pred cccCC---CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC
Q psy16292 162 TKRLG---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP 225 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (245)
.+.+| |.+||.+.+.|| ...|.||+||++|.++.|..||.|.+..-....|.++..-.|..|.+
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSd 278 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSD 278 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCch
Confidence 77888 788999999999 67899999999999999999999999888888899988877766553
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=289.68 Aligned_cols=208 Identities=21% Similarity=0.289 Sum_probs=186.8
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+|.|+-|.| -+|++. |+..| ++.|.....+.....+.+|+-||+.+.|||++++|++|+.+.++|+|.||+
T Consensus 20 LG~Gstg~v-----rlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 20 LGKGSTGCV-----RLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccCCCCcee-----hhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 566788888 589888 99988 666665666777888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCC-
Q psy16292 89 PGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG- 166 (245)
Q Consensus 89 ~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~- 166 (245)
+||.|.+++- .+++++..++.++.||+.|+.|+|..+|+|||+||+|+++|..++|||+|||+|..-.++....+.||
T Consensus 95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGS 174 (786)
T KOG0588|consen 95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGS 174 (786)
T ss_pred CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCC
Confidence 9999999765 56799999999999999999999999999999999999999999999999999998776666666666
Q ss_pred --CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC
Q psy16292 167 --RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP 225 (245)
Q Consensus 167 --~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (245)
|.+||.+++.+| .++||||+||++|.+++|+.||.+++-...+.++..|....|+...+
T Consensus 175 PHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~ 237 (786)
T KOG0588|consen 175 PHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISS 237 (786)
T ss_pred cccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCH
Confidence 899999999999 89999999999999999999999888888889999998887766543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.25 Aligned_cols=206 Identities=25% Similarity=0.353 Sum_probs=177.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc--CchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR--SDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~--~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv 84 (245)
.++.|.||+|+ ++++. |..+| ++++...... ...+.+.+|+.+++.++ ||||+++++++.....+++|
T Consensus 24 ~lG~GsfgkV~-----~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 24 TLGSGSFGKVK-----LAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eecCCCCeeEE-----EeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 37788999994 66665 88889 4444432212 34667789999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeec-CCCCCc
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRM-NKTGTE 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~-~~~~~~ 161 (245)
|||+.||+|.+.+.+ +.+.+..++.++.|+++||.|||++||+||||||+|++++.+ +++||+|||++... ......
T Consensus 99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l 178 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLL 178 (370)
T ss_pred EEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcc
Confidence 999999999998876 569999999999999999999999999999999999999999 99999999999987 455556
Q ss_pred cccCC---CCchhhhhcCC-C--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCC
Q psy16292 162 TKRLG---RNGIEEIKAHP-F--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~-~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (245)
.+.+| |.+||.+.+.+ | .++|+||+||++|.|++|..||.+++....+.+|..+....|..
T Consensus 179 ~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 179 KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC
Confidence 66666 78899999888 6 67899999999999999999999998888888888887765554
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=277.68 Aligned_cols=206 Identities=25% Similarity=0.314 Sum_probs=178.6
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-- 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 78 (245)
.+.|...-+||+|.||.| ++|++. |++|| +..+....+........+||.||++|+||||++|.+...+.
T Consensus 116 ~~~feki~kIGeGTyg~V-----YkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQV-----YKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred hHHHHHHHHhcCcchhhe-----eEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 567888889999999999 688877 99999 43344444567788899999999999999999999998776
Q ss_pred CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+.+|+|+||| ..+|.-++... ++++.++..++.|++.||.|||++||+|||||..|||+|.+|.+||+|||+|+.+.
T Consensus 191 ~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 191 GSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 7899999999 77998888875 59999999999999999999999999999999999999999999999999999776
Q ss_pred CCCCc--cc---cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 157 KTGTE--TK---RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 157 ~~~~~--~~---~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
..... +. ++-|++||.+.+..- ...|+||+||++.+|..|+|+|.|.++.+++.+|.+-
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 55432 22 233789999887654 5679999999999999999999999999999888554
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.99 Aligned_cols=231 Identities=60% Similarity=1.079 Sum_probs=205.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+||.---.||||+||.| .+|+++ +++|| +++|....++.+..+|++|.++|...+.+-|++++-+|++..+
T Consensus 75 ~DfeilKvIGrGaFGEV-----~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEV-----ALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhhHHHHHhccccccee-----EEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 34444445899999999 699998 99999 8889888999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||++||+|..+++... +|+.+++++...|+.||.-+|+.|+|||||||+|||+|..|.++|+|||.|-.+...+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999999999999999887 9999999999999999999999999999999999999999999999999988776544
Q ss_pred C-------------------------------------------------------------------------------
Q psy16292 160 T------------------------------------------------------------------------------- 160 (245)
Q Consensus 160 ~------------------------------------------------------------------------------- 160 (245)
.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 4
Q ss_pred -------------ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCC--CC
Q psy16292 161 -------------ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP--VP 225 (245)
Q Consensus 161 -------------~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 225 (245)
+..++|..+.|.|+.||||..|-| +-+....+|..|-+++++|.++|+-......+....| .|
T Consensus 310 eeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W--~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~ 387 (1317)
T KOG0612|consen 310 EEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDW--DNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRIP 387 (1317)
T ss_pred HHHHHHHHHHhcChhhhcccccHHHHHhCccccCCCh--hhhhhcCCCCCCcCCCCCccccccccccccchhhccCCCCC
Confidence 455677777788888888888888 6667777777788899999999987777777777777 68
Q ss_pred ccccCCCCCcccceeec
Q psy16292 226 KAFAGNHLPFVGFTYSG 242 (245)
Q Consensus 226 ~~~~~~~~~f~~f~~~~ 242 (245)
..|++++..|+||||..
T Consensus 388 ~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 388 KAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred CCCcCCcCCeeeeeecc
Confidence 88999999999999986
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=254.81 Aligned_cols=219 Identities=19% Similarity=0.218 Sum_probs=185.7
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++...-++|+|.||.| ++|++. |+.+|+.+ |....+++--....+|+..|+.++||||+.+.++|...+.+.
T Consensus 3 rY~~~~~lGEG~~gvV-----yka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVV-----YKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEE-----EEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 5566678999999999 466655 99999333 333334444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|+||+ ..+|..+++... ++.+.+..++.+++.||+|||++.|+||||||.|+|++++|.+|++|||+|+.+.....
T Consensus 78 lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 78 LVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 999999 679999998664 78899999999999999999999999999999999999999999999999998876554
Q ss_pred ccc----cCCCCchhhhhcCCCc--ccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccC
Q psy16292 161 ETK----RLGRNGIEEIKAHPFF--INDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAG 230 (245)
Q Consensus 161 ~~~----~~~~~~~e~i~~~~~~--~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (245)
... ..-|++||.+.+-..| ..|+||.||++.|++-+.|.|.|.+|.+++..|....+.+....+|...+.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 333 1227889988776554 459999999999999999999999999999999988888777788876443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=259.89 Aligned_cols=220 Identities=23% Similarity=0.258 Sum_probs=189.6
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+++++|..-.+|..|+||.| |.|+++ +++|| +..|....+.+..-.-++||.+|.+++|||||.+-.+....
T Consensus 73 rsv~efe~lnrI~EGtyGiV-----YRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVV-----YRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred ccHHHHHHHhhcccCcceeE-----EEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 57899999999999999999 588777 99999 44455555566777789999999999999999998888654
Q ss_pred --CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 79 --KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 79 --~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
+.+|+||||| ..+|.+++..- .+....+..++.|++.|++|||.+.|+||||||+|+|+...|.+|++|||+|+.
T Consensus 148 ~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 148 NMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 5799999999 78999998753 588999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCccc----cCCCCchhhhhcCCCc--ccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCcc
Q psy16292 155 MNKTGTETK----RLGRNGIEEIKAHPFF--INDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKA 227 (245)
Q Consensus 155 ~~~~~~~~~----~~~~~~~e~i~~~~~~--~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (245)
+.++..+.+ ..-|++||.+.+.+.+ ..|+||+||++.++++++|.|.|.+..++.++|....+.+....+|..
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 987755444 3348999999887764 459999999999999999999999999999999887666555555533
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.15 Aligned_cols=216 Identities=23% Similarity=0.336 Sum_probs=180.0
Q ss_pred chHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeE
Q psy16292 3 NVEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHF 73 (245)
Q Consensus 3 ~~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~ 73 (245)
..-+|++||. +|.|.||.| ++|+.+ |+.|| .++++.. ...+ -.-+||++-|++|+ ||||+++.+
T Consensus 4 ~~~~~m~RY~~i~klGDGTfGsV-----~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~E 76 (538)
T KOG0661|consen 4 TQVIFMDRYTVIRKLGDGTFGSV-----YLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKE 76 (538)
T ss_pred eehhHHHHHHHHHHhcCCcceeE-----EEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHH
Confidence 4557788886 778899999 688777 99999 3333332 2222 22478999999998 999999999
Q ss_pred EEEeCC-EEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 74 AFQDAK-SLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 74 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
++.+.+ .+++||||| ..+|+++++.+ .++++.++.|+.||+.||+|+|.+|+.|||+||+|||+.....+||+|||
T Consensus 77 vi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 77 VIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred HhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence 999888 999999999 78999999865 49999999999999999999999999999999999999988999999999
Q ss_pred ceeecCCCCCccccCC---CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC
Q psy16292 151 TCMRMNKTGTETKRLG---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP 225 (245)
Q Consensus 151 ~a~~~~~~~~~~~~~~---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (245)
+||.+.+....+.... |++||.+..-.+ .+.|+|++||+++++.+.+|.|.|.++.+++.+|..-.+.+....++
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 9999887666555444 689999877666 55699999999999999999999999999999987665554433444
Q ss_pred c
Q psy16292 226 K 226 (245)
Q Consensus 226 ~ 226 (245)
.
T Consensus 236 e 236 (538)
T KOG0661|consen 236 E 236 (538)
T ss_pred h
Confidence 4
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=260.72 Aligned_cols=205 Identities=19% Similarity=0.248 Sum_probs=169.8
Q ss_pred HHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCc-hHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSD-SAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~-~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.--++|.|+||.| ++|+++ |++|||.+=....++.. .+-.++|+++|++++|||+|.++.+|...+.+++|+
T Consensus 6 ~LgkvGEGSYGvV-----~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 6 KLGKVGEGSYGVV-----MKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred hhhccccCcceEE-----EEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 3345899999999 688888 99999644222112122 345899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCcc
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~ 162 (245)
||| ..++.+-+.. ++++...+..++.|++.|+.|+|+++++||||||+||++...|.+||+|||+|+.+..+ ...+
T Consensus 81 E~~-dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 81 EYC-DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eec-chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 999 5566666654 47999999999999999999999999999999999999999999999999999998744 3333
Q ss_pred ccCC---CCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 163 KRLG---RNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 163 ~~~~---~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
.... |++||.+.+ .+| ...||||.||++.+|++|.|.|.|.+|.+++-.|..-.++.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 3333 689999877 556 66799999999999999999999999998877776555543
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.52 Aligned_cols=216 Identities=28% Similarity=0.407 Sum_probs=187.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
++.+|.---++|.|..|+| +||+.+ +..+| |+.|.....+....++..|.+||+.++||+++.||..|+++
T Consensus 75 ~l~~f~llk~LG~GdiG~V-----yL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTV-----YLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeE-----EEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4678888889999999999 699998 68999 88999998889999999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
++.|++||||+||+|..+.+.. .++++.+++++.+++.||+|||..|||.|||||+|||+.++|.|.|+||-++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999988754 4999999999999999999999999999999999999999999999999887542
Q ss_pred CCCC---------------------------------C------------------------ccccCC---CCchhhhhc
Q psy16292 156 NKTG---------------------------------T------------------------ETKRLG---RNGIEEIKA 175 (245)
Q Consensus 156 ~~~~---------------------------------~------------------------~~~~~~---~~~~e~i~~ 175 (245)
.... . .....| |.+||.|++
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 1100 0 001122 456777776
Q ss_pred CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCC
Q psy16292 176 HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223 (245)
Q Consensus 176 ~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (245)
..- .+.|=|+||+.+|+|+.|.-||+|.+..+.|.+|+..+...|..|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~ 358 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP 358 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC
Confidence 655 677999999999999999999999999999999988766655444
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=277.18 Aligned_cols=202 Identities=23% Similarity=0.320 Sum_probs=175.0
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+|+|+||.| |+++.| .++|| +...+....+.+.+.+.+|++|++.++||||+.++++|++..++|+|.||+.
T Consensus 10 iG~Gsfg~V-----YKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 10 IGEGSFGRV-----YKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hcCCcccee-----eecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 899999999 688877 88888 2222233445678899999999999999999999999999999999999996
Q ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----ccc
Q psy16292 90 GGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----TKR 164 (245)
Q Consensus 90 ~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----~~~ 164 (245)
| +|..++.. +.++|+.+..++.++++||.|||+++|+|||+||.||+++..|.+|++|||+|+.+.....- ...
T Consensus 85 g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGt 163 (808)
T KOG0597|consen 85 G-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGT 163 (808)
T ss_pred h-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCc
Confidence 5 99998875 56999999999999999999999999999999999999999999999999999976543221 223
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
+-|++||.+...+| ..+|.||+||++|++..|.|||-..+-......|..++.+.|
T Consensus 164 PlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 164 PLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP 220 (808)
T ss_pred ccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc
Confidence 33899999999999 788999999999999999999998888888888888766533
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.94 Aligned_cols=222 Identities=25% Similarity=0.336 Sum_probs=193.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
++|+|.||.| ++|+++ |+.+| +++|.........+.+.+|+.+|+++. ||||+.++++|++...+++|||
T Consensus 42 ~lG~G~Fg~v-----~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 42 ELGRGQFGVV-----YLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred hhCCCCceEE-----EEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 4789999999 577666 99999 666666655567789999999999997 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC----CcEEEEeeCceeecCCCCCcc
Q psy16292 87 YMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH----GHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~----~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
++.||.|.+.+....+++..+..++.|++.++.|||+.|++|||+||+|+++... +.++++|||++..........
T Consensus 117 L~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~ 196 (382)
T KOG0032|consen 117 LCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLH 196 (382)
T ss_pred ecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEe
Confidence 9999999998866458999999999999999999999999999999999998654 479999999999988754555
Q ss_pred ccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccc
Q psy16292 163 KRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGF 238 (245)
Q Consensus 163 ~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f 238 (245)
..+| |.+||.+...++ ...|+||+||++|.|+.|.+||.+++....+.++..+....+..+++.. +..+++|+.-
T Consensus 197 ~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i-s~~akd~i~~ 275 (382)
T KOG0032|consen 197 TIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI-SESAKDFIRK 275 (382)
T ss_pred eecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc-CHHHHHHHHH
Confidence 5555 789999997777 7889999999999999999999999999999999999988887787776 5567777654
Q ss_pred e
Q psy16292 239 T 239 (245)
Q Consensus 239 ~ 239 (245)
.
T Consensus 276 l 276 (382)
T KOG0032|consen 276 L 276 (382)
T ss_pred h
Confidence 3
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.76 Aligned_cols=204 Identities=31% Similarity=0.587 Sum_probs=171.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+|...-.+|+|+||+|+ +|+++ |+.|| ++++...........+.+|+.++..++||||+++++++.+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVR-----LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEE-----EEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE
Confidence 34555569999999994 67665 88899 55555544555677899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999998865 4689999999999999999999999999999999999999999999999999875432110
Q ss_pred ---------------------------------------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCC
Q psy16292 161 ---------------------------------------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 161 ---------------------------------------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf 200 (245)
.....+|.+||.+.+..+ .++|+||+||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 112334789999887776 7889999999999999999999
Q ss_pred CCCCCCCCCcccCc
Q psy16292 201 SGDDDTSNFDDIEK 214 (245)
Q Consensus 201 ~~~~~~~~~~~~~~ 214 (245)
.+.+....+.++..
T Consensus 237 ~~~~~~~~~~~i~~ 250 (363)
T cd05628 237 CSETPQETYKKVMN 250 (363)
T ss_pred CCCCHHHHHHHHHc
Confidence 98887776666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=248.62 Aligned_cols=212 Identities=23% Similarity=0.270 Sum_probs=181.2
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+-.+++|.|+.|+ .+-++ |+.|| +++- ......+.+.+.+|+.|.+.|+||||+++++.....+..|+|+
T Consensus 16 ~e~igkG~FSvVr-----Rc~~~~tg~~fa~kiin~-~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 16 KEELGKGAFSVVR-----RCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred HHHHccCchHHHH-----HHHhccchHHHHHHHhhh-hhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4458999999993 44444 99999 4333 3344568899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEEeeCceeecCCCCCc
Q psy16292 86 DYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 86 e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~a~~~~~~~~~ 161 (245)
|++.|++|..-| ...-.++..+..++.||+.+|.|+|.++|+|||+||+|+++.+.. -+||+|||+|..+......
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 999999997644 333468889999999999999999999999999999999997653 4899999999998865555
Q ss_pred cccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCcc
Q psy16292 162 TKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKA 227 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (245)
..+.| +.+||.++..|+ ..+|||+.||++|.++.|.+||.|++....+..|..+....+++.++..
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC
Confidence 55544 789999999999 6779999999999999999999999999999999999888888777766
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=263.97 Aligned_cols=211 Identities=22% Similarity=0.260 Sum_probs=172.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeE-EEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-E
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTL-YAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-S 80 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~-~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~ 80 (245)
..++...-++++|+||+| +.+.++|.. +|+ ............+.+.+|+.+|.+++|||||++++++.... .
T Consensus 40 ~~~l~~~~~iG~G~~g~V-----~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTV-----YKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred hHHhhhhhhcccCCceeE-----EEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 445555556999999999 577778888 772 22222222223678999999999999999999999999887 7
Q ss_pred EEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCceEecCCC-cEEEEeeCceeec
Q psy16292 81 LYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLG-FVHRDVKPDNMLLDKHG-HLKLADFGTCMRM 155 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~ 155 (245)
+++||||+++|+|.+++.. ..++...+..++.+|+.|+.|||+++ ||||||||+|+|++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999965 46999999999999999999999999 99999999999999998 9999999999876
Q ss_pred CCC-CCc---cccCCCCchhhhh--cCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc-CcCCCCC
Q psy16292 156 NKT-GTE---TKRLGRNGIEEIK--AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI-EKDESPE 219 (245)
Q Consensus 156 ~~~-~~~---~~~~~~~~~e~i~--~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~-~~~~~~~ 219 (245)
... ... .....+++||.++ ..+| .++|+||||+++|+++|+..||.+..+......+ ..+..|.
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 643 222 2334479999999 4566 7899999999999999999999999885554444 3444443
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.04 Aligned_cols=217 Identities=24% Similarity=0.351 Sum_probs=179.0
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccC-----------chHHHHHHHHHHHhcCCc
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRS-----------DSAFFWEERDIMAHANSE 66 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~-----------~~~~~~~E~~il~~l~hp 66 (245)
|.++.|.-.-++|.|.||+|. ||+.. ++.|| |+.|....... ..+.+.+||.||+++.||
T Consensus 94 k~lNqy~l~~eiG~G~yGkVk-----Lar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVK-----LARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred eehhheehhhhhcCCccceEE-----EEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 567788888889999999995 67666 99999 66665543321 236899999999999999
Q ss_pred cceeeeEEEEeC--CEEEEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 67 WIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 67 ~Iv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
|||+|+.+.-+. .++|||+|||..|.+...-.... +.+.+++.+++.++.||+|||.+||+||||||.|+|++++|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 999999999765 58999999999888766544444 789999999999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCC------ccccCC---CCchhhhhc---CCC--cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 144 LKLADFGTCMRMNKTGT------ETKRLG---RNGIEEIKA---HPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~------~~~~~~---~~~~e~i~~---~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
+||+|||.+.....+.. .....| ..+||.... +.+ ++.||||+||.||.++.|..||-++.....|
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999986632211 223455 467888766 333 5679999999999999999999999999999
Q ss_pred cccCcCCCCCCCCC
Q psy16292 210 DDIEKDESPEENFP 223 (245)
Q Consensus 210 ~~~~~~~~~~~~~~ 223 (245)
++|.......|..|
T Consensus 329 ~KIvn~pL~fP~~p 342 (576)
T KOG0585|consen 329 DKIVNDPLEFPENP 342 (576)
T ss_pred HHHhcCcccCCCcc
Confidence 99998876666554
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=266.44 Aligned_cols=198 Identities=57% Similarity=0.886 Sum_probs=168.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.| ++|+++ ++.+| ++++...........+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 50 ~lG~G~fg~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 50 VIGRGAFGEV-----QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred EEEecCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 4788999999 477766 88888 45554544555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----cc
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~~ 162 (245)
+++|+|.+++....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+|........ ..
T Consensus 125 ~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~ 204 (370)
T cd05621 125 MPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204 (370)
T ss_pred CCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCC
Confidence 9999999999888899999999999999999999999999999999999999999999999999987653322 22
Q ss_pred ccCCCCchhhhhcCC----C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 163 KRLGRNGIEEIKAHP----F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~----~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
...+|.+||.+...+ + .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 205 gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred CCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 344578999987643 3 678999999999999999999998876666665554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.51 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=167.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|+|+||+| ++|+++ |+.|| ++++...........+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~lG~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 2 LLGKGTFGKV-----ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred eeeeCCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence 3789999999 466665 88899 55555444556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----cc
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~ 162 (245)
+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....... ..
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 999999988865 4589999999999999999999999999999999999999999999999999886432221 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+..+..+..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 212 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 3445789999987776 789999999999999999999988766555555554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=256.33 Aligned_cols=223 Identities=24% Similarity=0.366 Sum_probs=171.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC--EE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK--SL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~ 81 (245)
++...--+|+|+||+| +++.+. |..+||..-... +....+.+.+|+.+|.+++|||||++++...... .+
T Consensus 18 ~~~~~~~lG~Gs~G~V-----~l~~~~~~g~~~AvK~v~~~-~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSV-----YLATNKKTGELMAVKSVELE-DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred hhhhhccccCccceEE-----EEEEecCCCcceeeeeeecc-cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 3445556999999999 577666 788884332222 2223778999999999999999999999755444 69
Q ss_pred EEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCC-
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNK- 157 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~- 157 (245)
+++|||+++|+|.+++... ++++..++.+..||+.||.|||++|++||||||+|||++. ++.+||+|||+++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999999999865 4899999999999999999999999999999999999999 69999999999987663
Q ss_pred ---CCC---ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC-CCCCCCcccCcCC-CCCCCCCCCcc
Q psy16292 158 ---TGT---ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD-DDTSNFDDIEKDE-SPEENFPVPKA 227 (245)
Q Consensus 158 ---~~~---~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 227 (245)
... ...+..+++||.+..... .++||||+||+..+|+||.+|+..- ......-.+..+. .| ++|..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P----~ip~~ 247 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP----EIPDS 247 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC----CCCcc
Confidence 111 222333789999985333 4899999999999999999999873 2222222222222 22 55666
Q ss_pred ccCCCCCcccc
Q psy16292 228 FAGNHLPFVGF 238 (245)
Q Consensus 228 ~~~~~~~f~~f 238 (245)
++..+++|+.-
T Consensus 248 ls~~a~~Fl~~ 258 (313)
T KOG0198|consen 248 LSDEAKDFLRK 258 (313)
T ss_pred cCHHHHHHHHH
Confidence 67777777653
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.60 Aligned_cols=201 Identities=56% Similarity=0.877 Sum_probs=169.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||.| ++|+++ ++.+| ++.+...........+.+|+.+++.++||||+++++++.++.++|+||
T Consensus 48 ~~~lG~G~fg~V-----y~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 48 VKVIGRGAFGEV-----QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred EEEEeecCCeEE-----EEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 334788999999 467776 88888 445545455556677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----- 160 (245)
||+++|+|.+++....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.......
T Consensus 123 Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~ 202 (371)
T cd05622 123 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202 (371)
T ss_pred cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccC
Confidence 999999999999888899999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccCCCCchhhhhcCC----C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHP----F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~----~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+|.+||.+...+ + .++|+||+||++|+|++|.+||.+.+....+.++...
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 12334478999987543 3 6789999999999999999999988776666666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.13 Aligned_cols=209 Identities=23% Similarity=0.371 Sum_probs=173.5
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc---CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR---YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~---~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+++|.-.-.+++|+||.|+ +|+.+ +..+| ++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy-----~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVI-----LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEE-----EEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 4555555668999999994 66544 36777 44455555556677899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+.+|+||||+++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999999988654 589999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 158 TGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 158 ~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
... .....+|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.++.....++..+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 321 223345789999877666 788999999999999999999998877666666665543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=262.43 Aligned_cols=209 Identities=24% Similarity=0.374 Sum_probs=173.9
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.+++|+||.|+ +|+.+ |+.|| ++++.........+.+.+|+.++++++||||+++++++.+++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVR-----IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEE-----EEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 444445568999999994 66666 88888 4555444455667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||+++++|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++......
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999999988654 58999999999999999999999999999999999999999999999999998765432
Q ss_pred C-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 160 T-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 160 ~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. ......|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.++...+.++..+..+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 233 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC
Confidence 2 223344789999987766 7899999999999999999999887766666666555443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=264.93 Aligned_cols=206 Identities=56% Similarity=0.883 Sum_probs=171.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|...-.+++|+||+| ++|+++ |+.|| ++++....+......+.+|+.+++.++||||+++++++.++.+
T Consensus 43 ~~y~~~~~lg~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 43 EDFDVIKVIGRGAFGEV-----QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred HHcEEEEEEeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 33444445889999999 477766 88888 4555444555666778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|+||||+++|+|.+++....+++.++..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++........
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987653322
Q ss_pred -----ccccCCCCchhhhhcCC----C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 -----ETKRLGRNGIEEIKAHP----F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~----~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
......|.+||.+...+ + .++|+||+||++|+|++|.+||.+.+....+.++...
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 12234478899886532 3 6789999999999999999999988776666666543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=267.77 Aligned_cols=224 Identities=21% Similarity=0.359 Sum_probs=186.0
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
|..--++|+|+-|.| +.|+.. ++.+|+ ++....+....+-+++|+.+|+..+|+|||.+++.|...+.+|.|
T Consensus 275 y~~~~kigqgaSG~v-----y~A~~~~~~~~Vai-K~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGV-----YVARKISTKQEVAI-KRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hcchhhhccccccce-----eeeeeccCCceEEE-EEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 334455999999999 577666 776763 233334456667799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cccc
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TETK 163 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~~~ 163 (245)
||||+||+|.+++....++|.+++.++++++.||.|||.+||+|||||.+||+++.+|.+||+|||+|..+.... .+.+
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999987765 4455
Q ss_pred cCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccc
Q psy16292 164 RLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGF 238 (245)
Q Consensus 164 ~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f 238 (245)
-.| +++||.+...+| ++.||||||++..+|+-|-|||-.+++...+.-|-..-.|.. .-++.+|...++|.+-
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l--k~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL--KNPEKLSPELKDFLDR 505 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc--CCccccCHHHHHHHHH
Confidence 555 689999999998 999999999999999999999998877766665555444322 3344445556666543
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=262.62 Aligned_cols=202 Identities=21% Similarity=0.327 Sum_probs=176.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE-EEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS-LYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~lv~e~ 87 (245)
.+|+|+||.+ ++++++ ++.|+ +............+....|+.++++++|||||.+.+.|+.++. ++|||+|
T Consensus 11 ~iG~GafG~a-----~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 11 QVGRGAFGSA-----LLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hcCccccchh-----hhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 4899999999 688888 77776 3333333334556678999999999999999999999998887 9999999
Q ss_pred cCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cccc
Q psy16292 88 MPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~~~ 163 (245)
|+||++.+.+... .+++..+..++.|++.|+.|||+++|+|||||+.||++..++.|+|.|||+|+.+.... ...+
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~t 165 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAST 165 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhhe
Confidence 9999999988754 38999999999999999999999999999999999999999999999999999987765 4455
Q ss_pred cCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 RLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 ~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
..| |..||.+.+.|| +++||||+||++|+|++-+++|++.+-.....+|..+...
T Consensus 166 vvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~ 224 (426)
T KOG0589|consen 166 VVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS 224 (426)
T ss_pred ecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC
Confidence 555 688999999999 9999999999999999999999999988888888888743
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=262.61 Aligned_cols=203 Identities=32% Similarity=0.605 Sum_probs=169.8
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|...-.+++|+||+| ++|+.+ |+.|| ++++...........+.+|+.++..++||||+++++++.+.+++|
T Consensus 3 f~~~~~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 77 (360)
T cd05627 3 FESLKVIGRGAFGEV-----RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLY 77 (360)
T ss_pred ceEEEEEeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 444456899999999 466665 88888 455555555567788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999998865 4589999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 161 --------------------------------------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 161 --------------------------------------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
.....+|.+||.+.+..+ .++|+||+||++|+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 112344789999987777 78899999999999999999999
Q ss_pred CCCCCCCCcccCc
Q psy16292 202 GDDDTSNFDDIEK 214 (245)
Q Consensus 202 ~~~~~~~~~~~~~ 214 (245)
+.++...+.++..
T Consensus 238 ~~~~~~~~~~i~~ 250 (360)
T cd05627 238 SETPQETYRKVMN 250 (360)
T ss_pred CCCHHHHHHHHHc
Confidence 8877666555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.42 Aligned_cols=199 Identities=31% Similarity=0.559 Sum_probs=165.1
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.++.|+||+|+ +++.+ |+.|| ++.+....+......+.+|+.+++.++||||+++++++.+..++|+||
T Consensus 6 ~~~lG~G~~g~Vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 6 VKVIGKGAFGEVR-----LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred eEEEeecCCEEEE-----EEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3458999999994 66665 88899 444544444556778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-----
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG----- 159 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~----- 159 (245)
||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999998865 458899999999999999999999999999999999999999999999999986322100
Q ss_pred ----------------------------------------------CccccCCCCchhhhhcCCC-cccCCCccccccee
Q psy16292 160 ----------------------------------------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLREC 192 (245)
Q Consensus 160 ----------------------------------------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~ 192 (245)
......+|.+||.+....+ .++|+||+||++|+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012334789999877766 78999999999999
Q ss_pred cCCccCCCCCCCCCCCCcccC
Q psy16292 193 VPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 193 ~~~~~~pf~~~~~~~~~~~~~ 213 (245)
|++|.+||.+.+....+..+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHH
Confidence 999999998877655555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=261.17 Aligned_cols=198 Identities=33% Similarity=0.559 Sum_probs=163.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.||+|+||.|+ +|+.+ |+.|| ++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 6 ~~~lG~G~~g~V~-----~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 6 IKTIGIGAFGEVC-----LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred EEEEEeCCCeEEE-----EEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3458999999994 67666 88899 444444444556778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC------
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT------ 158 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~------ 158 (245)
||+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999988754 4788999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------CCccccCCCCchhhhhcCCC-cccCCCcccccceecCCc
Q psy16292 159 -----------------------------------------GTETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV 196 (245)
Q Consensus 159 -----------------------------------------~~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~ 196 (245)
.......+|.+||.+.+..+ .++|+||+||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00112344788999887776 788999999999999999
Q ss_pred cCCCCCCCCCCCCccc
Q psy16292 197 VPELSGDDDTSNFDDI 212 (245)
Q Consensus 197 ~~pf~~~~~~~~~~~~ 212 (245)
.+||.+..+.....++
T Consensus 241 ~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 241 QPPFLADTPAETQLKV 256 (376)
T ss_pred CCCCCCCCHHHHHHHH
Confidence 9999988765443333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=250.26 Aligned_cols=218 Identities=21% Similarity=0.287 Sum_probs=178.8
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCcc-ceeeeEEEEeCC-
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAK- 79 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~- 79 (245)
..|..--++|.|+||+| +.|+.+ |+.|| +..+.....++-.....+|+.+|+.++|+| |+.+++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~V-----ykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVV-----YKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEE-----EEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 34666667999999999 577777 98999 333333232456677899999999999999 999999999877
Q ss_pred -----EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 80 -----SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 80 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
.+++|+|++ ..+|.+++.. .+++...++.++.|++.||.|||+++|+||||||+||+++..|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 899999999 7899998875 34777899999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCc-cc---cCCCCchhhhhcCCCcc--cCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCC
Q psy16292 150 GTCMRMNKTGTE-TK---RLGRNGIEEIKAHPFFI--NDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFP 223 (245)
Q Consensus 150 g~a~~~~~~~~~-~~---~~~~~~~e~i~~~~~~~--~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (245)
|+|+...-+... +. ..-|++||.+.+..++. .|+||+||++.+|+++.+-|.|.++.++...|..-...+....
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999976533332 11 22379999998886644 5999999999999999999999999888888766655555555
Q ss_pred CCccc
Q psy16292 224 VPKAF 228 (245)
Q Consensus 224 ~~~~~ 228 (245)
+|...
T Consensus 245 Wp~v~ 249 (323)
T KOG0594|consen 245 WPGVS 249 (323)
T ss_pred CCCcc
Confidence 66554
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=256.09 Aligned_cols=200 Identities=27% Similarity=0.462 Sum_probs=167.8
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||+|+ +|+++ ++.|| ++++...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 lg~G~~g~Vy-----~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVM-----QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEE-----EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 5889999994 66665 88888 444544445566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---cc
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E---TK 163 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~---~~ 163 (245)
++|+|.+.+.. +.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... . ..
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 99999998864 4589999999999999999999999999999999999999999999999999886432211 1 23
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
..++.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+.++..+..
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~ 210 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 445789999988776 778999999999999999999988776666666555433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=263.11 Aligned_cols=201 Identities=32% Similarity=0.544 Sum_probs=165.6
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
...-.||+|+||+|+ +|+++ ++.|| ++.+...........+.+|+.++++++||||+++++++.+++++|+
T Consensus 4 ~~~~~LG~G~~g~Vy-----~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 4 VKIKTLGIGAFGEVC-----LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred EEEEEEEeCCCEEEE-----EEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 334468999999994 67665 88888 4445444445667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG--- 159 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~--- 159 (245)
||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.+|.++|+|||+|+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999988654 58899999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------------CccccCCCCchhhhhcCCC-cccCCCcccccc
Q psy16292 160 ------------------------------------------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLR 190 (245)
Q Consensus 160 ------------------------------------------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~ 190 (245)
.......|.+||.+.+..+ .++|+||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0012334789999887776 789999999999
Q ss_pred eecCCccCCCCCCCCCCCCcccC
Q psy16292 191 ECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 191 ~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
|+|++|.+||.+.++.....++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999877655444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=262.08 Aligned_cols=199 Identities=34% Similarity=0.549 Sum_probs=164.8
Q ss_pred HHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
..-.||+|+||+|+ +|+++ ++.|| ++++....+......+.+|+.+++.++||||+++++++.+..++|+|
T Consensus 5 ~~~~LG~G~~g~Vy-----~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 5 KIKTLGIGAFGEVC-----LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred EEEEEeecCCEEEE-----EEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 34468999999994 66665 88899 45554555556678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---- 159 (245)
|||+++|+|.+++... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999999988654 58999999999999999999999999999999999999999999999999975431100
Q ss_pred -----------------------------------------------CccccCCCCchhhhhcCCC-cccCCCcccccce
Q psy16292 160 -----------------------------------------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRE 191 (245)
Q Consensus 160 -----------------------------------------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~ 191 (245)
.......|.+||.+.+..+ .++|+||+||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0112334788999887766 7899999999999
Q ss_pred ecCCccCCCCCCCCCCCCccc
Q psy16292 192 CVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 192 ~~~~~~~pf~~~~~~~~~~~~ 212 (245)
+|++|.+||.+.++.....++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHH
Confidence 999999999887665443333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=244.77 Aligned_cols=211 Identities=23% Similarity=0.341 Sum_probs=186.9
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+++|.---.+++|.||.| ++++.+ +-++| |+-|....+..-..++.+|++|...|+||||+++|++|.+..
T Consensus 21 l~dfeigr~LgkgkFG~v-----Ylarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNV-----YLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred hhhccccccccCCccccE-----eEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 566766667999999999 588877 77888 777888777777788999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
.+|+++||.++|++...+..+ .+.+.....+..|++.|+.|+|.++++||||||+|+|++..|.+|++|||.+....
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999999988743 48999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 157 KTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
...+.+-+| |.+||.+.+.+. ...|+|++|++.|+++.|.|||.+.+..+.+.+|.+.....|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC
Confidence 444555555 688999988887 677999999999999999999999999999999887766544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.21 Aligned_cols=199 Identities=33% Similarity=0.592 Sum_probs=165.8
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.||+|+||+| ++|+.+ |+.|| ++++...........+.+|+.+++.++||||+++++++.++.++|+||
T Consensus 6 ~~~lG~G~~g~V-----~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 6 IKVIGRGAFGEV-----RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred EEEEEecCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 345899999999 467666 88898 445444444556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
||+++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999988654 589999999999999999999999999999999999999999999999999876532211
Q ss_pred --------------------------------------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 161 --------------------------------------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 161 --------------------------------------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
.....++.+||.+....+ .++|+||+||++|+|++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 012334788998877766 78899999999999999999998
Q ss_pred CCCCCCCCcccC
Q psy16292 202 GDDDTSNFDDIE 213 (245)
Q Consensus 202 ~~~~~~~~~~~~ 213 (245)
+.+....+..+.
T Consensus 241 ~~~~~~~~~~i~ 252 (364)
T cd05599 241 SDNPQETYRKII 252 (364)
T ss_pred CCCHHHHHHHHH
Confidence 876655444443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=252.49 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=166.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||+| ++|+++ |+.|| ++++...........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~lG~G~~g~V-----~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 2 LLGKGTFGKV-----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred eeeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence 4789999999 466665 88898 55554444455667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----c
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~ 161 (245)
+++|+|...+... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... .
T Consensus 77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999887654 58999999999999999999997 7999999999999999999999999999886432221 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+..+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC
Confidence 23445789999987776 78999999999999999999998877655555554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.63 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=167.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.| ++++.+ |+.|| ++++...........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~lG~G~~g~V-----y~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 2 LLGKGTFGKV-----ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred eeeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence 4789999999 477665 88888 55555444556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-C---cc
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-T---ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~---~~ 162 (245)
+++|+|...+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++...... . ..
T Consensus 77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 9999998887654 58999999999999999999999999999999999999999999999999987643221 1 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
...+|.+||.+.+..+ .++|+||+||++|++++|.+||.+.+....+..+..+..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 212 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc
Confidence 3445789999877666 788999999999999999999988766655555554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.53 Aligned_cols=207 Identities=25% Similarity=0.395 Sum_probs=171.0
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|.-.-.+++|+||.|+ +|+.+ |+.+| ++.+.........+.+.+|+.+++.++||||+++++++.+...++
T Consensus 3 y~~~~~lg~G~~g~Vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 77 (291)
T cd05612 3 LERIKTVGTGTFGRVH-----LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY 77 (291)
T ss_pred ceeeeeeecCCCeEEE-----EEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEE
Confidence 3344568999999994 66665 88888 444433333445677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence 999999999999988654 588999999999999999999999999999999999999999999999999987643321
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
......+.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+.++..+...
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 216 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC
Confidence 223445789999887766 7789999999999999999999988776666666555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.31 Aligned_cols=213 Identities=19% Similarity=0.217 Sum_probs=175.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhcCe-EEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYRYT-LYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~~~-~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
.+.---+||+|.||+|+ +.+.+|. .+| +..|.. .-..+.+.+|+.+|++|+|+|||++++++..++.++|
T Consensus 207 ~l~l~~~LG~G~FG~V~-----~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVW-----LGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred HHHHHHHhcCCccceEE-----EEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 34445679999999995 7777744 667 222221 2344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|||||+.|+|.++++. ..+.....+.++.||+.|++||.++++|||||..+|||++.+..+||+|||+|+.+..+..
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999999986 3488899999999999999999999999999999999999999999999999996554433
Q ss_pred ccccCC-----CCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcCC-CCCCCCCCCc
Q psy16292 161 ETKRLG-----RNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKDE-SPEENFPVPK 226 (245)
Q Consensus 161 ~~~~~~-----~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (245)
.....+ +.+||.+....| .+||+|||||+|+++. .|..|+.+.+..+....+.++. .|.|...++.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence 222222 689999998888 7999999999999888 5789999999998888888873 3444444433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.40 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=167.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|+|+||.| ++++.+ |+.|| ++++...........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~lG~G~~g~V-----y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 2 LLGKGTFGKV-----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred eeeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence 4789999999 477665 88888 45554444455677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----cc
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~ 162 (245)
+++++|...+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ..
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 9999998887654 589999999999999999999999999999999999999999999999999876432211 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....|.+||.+.+..+ .++|+||+||++|++++|..||.+.+....+..+....
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 3345789999877766 78899999999999999999998877666555554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=251.49 Aligned_cols=202 Identities=30% Similarity=0.456 Sum_probs=169.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||.|+ +++.+ |+.|| ++++.........+.+..|..+++.+ +||||+++++++.+.+.+|+|||
T Consensus 2 ~lG~G~~g~Vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 2 VLGKGSFGKVM-----LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred ccccCCCeEEE-----EEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence 47899999994 66665 78888 55555444556677888999999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cc--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~-- 162 (245)
|+++++|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ..
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 9999999988764 4588999999999999999999999999999999999999999999999999886432221 22
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
....|.+||.+...++ .++|+||+||++|+|++|.+||.+.++...+.++..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~ 214 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL 214 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2345789999887777 7889999999999999999999998877777777666544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=265.11 Aligned_cols=199 Identities=19% Similarity=0.233 Sum_probs=168.5
Q ss_pred hccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-Cc-----cceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-SE-----WIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~~~~~~~~~~lv~ 85 (245)
||+|.||.|-+|++... ++.|| ++.|.. ....++...|+.||..|+ |. |+|+++++|...+++|||+
T Consensus 194 LGkGtFGQVvk~~d~~T---~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 194 LGKGSFGQVVKAYDHKT---GEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred ecccccceeEEEEecCC---CcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 89999999954444333 99999 444432 466778899999999996 43 8999999999999999999
Q ss_pred eccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC--cEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG--HLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~--~i~l~Dfg~a~~~~~~~~ 160 (245)
|++ +.+|.++++.+ +++...++.++.||+.||.+||+.+|||+||||+|||+...+ .||++|||.|........
T Consensus 268 ELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 268 ELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred hhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 999 88999999865 589999999999999999999999999999999999997654 589999999998665443
Q ss_pred cccc-CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETKR-LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~~-~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
..-. .-|++||.|.+.|| .+.|+|||||++.||.+|.|.|.|++..+++..|..-.+.
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 2211 22799999999999 6779999999999999999999999999999988665553
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.24 Aligned_cols=198 Identities=32% Similarity=0.584 Sum_probs=167.3
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-+++.|+||.| ++|+.+ |+.|| ++++...........+.+|+.++..++||||+++++++...+++|+||
T Consensus 6 ~~~ig~G~~g~V-----y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 6 LTQVGQGGYGQV-----FLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred EEEEeecCCeEE-----EEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 345889999999 467665 78888 555554444456778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCccc
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~~ 163 (245)
||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 999999999998754 5889999999999999999999999999999999999999999999999999875432 12233
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
..+|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+..+
T Consensus 161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 455889999987776 7899999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=246.25 Aligned_cols=192 Identities=30% Similarity=0.526 Sum_probs=171.8
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
+++|.---.++||+|.+| .+|+++ .++|| +++|...+++.+.+.++.|.++..+. +||++|.++.+|++.
T Consensus 249 l~df~ll~vigrgsyakv-----l~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKV-----LLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhh-----hheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 456665566899999999 788888 99999 77777788888999999999999987 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee-cC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR-MN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~-~~ 156 (245)
..+++|.||++||+|.-+++. +++|++.++++...|+.||.|||++||+.||||.+|+++|..|.+||+|+|.++. +.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999999999987764 5799999999999999999999999999999999999999999999999999986 44
Q ss_pred CCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCC
Q psy16292 157 KTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf 200 (245)
......+.+| |.+||.+++..| |..|-|++||++++|+.|+.||
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 4455555566 678899999998 9999999999999999999998
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=250.75 Aligned_cols=207 Identities=27% Similarity=0.424 Sum_probs=165.4
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhh-hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQ-IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||.|+.+........++.|| ++++... ........+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 47899999995322211112378888 4444332 22345567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---cc
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E---TK 163 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~---~~ 163 (245)
++++|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... . ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 162 (323)
T cd05584 83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG 162 (323)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCC
Confidence 999999988654 478888999999999999999999999999999999999999999999999876432222 1 23
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
..+|.+||.+....+ .++|+||+||++|+|++|.+||.+........++..+..+
T Consensus 163 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 218 (323)
T cd05584 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218 (323)
T ss_pred CccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 345789999877766 7899999999999999999999887766655665555443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.40 Aligned_cols=200 Identities=37% Similarity=0.650 Sum_probs=166.3
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-++++|+||+| ++++.+ ++.|| ++++...........+.+|+.++..++|++|+++++++.+.++.|+||
T Consensus 6 ~~~lG~G~fg~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 6 IKVIGRGAFGEV-----AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred EEEEeeCCCeEE-----EEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 345899999999 466665 78888 444444445556777899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
||+++|+|.+++.. ..+++..+..++.|++.||.|+|+++++||||||+||+++.++.++|+|||+++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999875 45899999999999999999999999999999999999999999999999999876543321
Q ss_pred ---cccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 ---TKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
....++.+||.+.. ..+ .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence 23445789998865 223 678999999999999999999988776555555544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=250.66 Aligned_cols=203 Identities=29% Similarity=0.409 Sum_probs=169.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ +|+.+ ++.|| ++++.........+.+..|..++..+ +||||+++++++.+.+.+|+|||
T Consensus 2 ~lg~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 2 VLGKGSFGKVM-----LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred eeeeCCCeEEE-----EEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence 47899999994 66665 88888 45555444556677888999999877 79999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~--- 161 (245)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++...... ..
T Consensus 77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 9999999988864 468999999999999999999999999999999999999999999999999988643221 11
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
....++.+||.+.+..+ .++|+||+||++|++++|.+||.+.+....+..+..+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 215 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 23445789999887766 67899999999999999999999887776666666654443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=252.11 Aligned_cols=210 Identities=25% Similarity=0.344 Sum_probs=174.8
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+++.-.-.+|+|.-.+| ++|+.+ +++|||..-.......+.+.+.+|++.+..++||||++++.+|..+..+|
T Consensus 26 ~~YeL~e~IG~G~sa~V-----~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVV-----YLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred cceeEEEEEeccceeEe-----eeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 33333445777777777 566655 99999544444444566899999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+||.+|.+||+.++++.. +++|..++.+.++++.||.|||.+|-||||+|+.|||++.+|.|+|+|||.+..+...+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999999853 69999999999999999999999999999999999999999999999999988766554
Q ss_pred Ccc-----ccCC---CCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 160 TET-----KRLG---RNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 160 ~~~-----~~~~---~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
.+. ...| +++||.++. +.| +++||||+|+...++++|..||+.-.+...+-.-+.+.+|.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 322 2233 678888543 455 89999999999999999999999988888777777776663
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=249.34 Aligned_cols=200 Identities=28% Similarity=0.493 Sum_probs=162.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHH-HHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERD-IMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||.| ++|+++ |+.|| ++.+...........+..|.. +++.++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 2 VIGKGSFGKV-----LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred eeeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence 4789999999 477766 88888 444544444445556666655 5788999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCcc--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~-- 162 (245)
|+++++|...+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..... ....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 9999999887764 45889999999999999999999999999999999999999999999999998753222 1112
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
...+|.+||.+...++ .++|+||+||++|+|++|.+||.+.+....+..+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Confidence 2345789999887776 68999999999999999999998887655556555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=248.58 Aligned_cols=205 Identities=31% Similarity=0.440 Sum_probs=165.1
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||+|+.+.....+..|+.|| ++++.. ....+..++.+|+.++++++||||+++++++.+++.+|+||||++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 47899999996332222222388888 444433 233455678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---ccc
Q psy16292 90 GGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E---TKR 164 (245)
Q Consensus 90 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~---~~~ 164 (245)
+++|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... . ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~ 161 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence 99999988654 589999999999999999999999999999999999999999999999999886543322 1 123
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
..+.+||.+....+ .++|+||+||++|+|++|..||.+.........+.....
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~ 215 (318)
T cd05582 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL 215 (318)
T ss_pred hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 44788998877666 789999999999999999999988776655555544433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=253.73 Aligned_cols=198 Identities=38% Similarity=0.674 Sum_probs=165.3
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||+| ++++.+ ++.|| ++++....+....+.+.+|+.+++.++||||+++++++.+++++|+||
T Consensus 6 ~~~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 6 LKVIGRGAFGEV-----AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred EEEEEecCCeEE-----EEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 345899999999 466665 88888 555555555667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999865 35899999999999999999999999999999999999999999999999999876543321
Q ss_pred ---cccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 162 ---TKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
....++.+||.+.. ..+ .++|+||+||++|+|++|..||.+.+....+.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 23445789999863 222 5789999999999999999999887654444444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=249.31 Aligned_cols=200 Identities=29% Similarity=0.458 Sum_probs=165.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+|+ +|+.+ ++.|| ++++.........+....|..++..+ +||||+++++++..++.+++|||
T Consensus 2 ~lG~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 2 VLGKGSFGKVM-----LAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred eeeeCCCeEEE-----EEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 47899999994 66665 78888 44554444556677778888888765 89999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~--- 161 (245)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++....... .
T Consensus 77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 9999999998865 4589999999999999999999999999999999999999999999999999986532221 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.....|.+||.+.+.++ .++|+||+||++++|++|..||.+.++...+..+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 22445789999987776 78999999999999999999999887666555554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=250.44 Aligned_cols=201 Identities=30% Similarity=0.405 Sum_probs=166.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHH---hcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMA---HANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+++|+||+| ++++.+ |+.|| ++++.........+.+.+|+.++. .++||||+++++++.+++++|+|
T Consensus 6 ~lg~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 6 VLGRGHFGKV-----LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred EEeecCCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4889999999 466655 88888 555544444556778888887765 45799999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
|||+++++|...+....+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccc
Confidence 9999999999988887899999999999999999999999999999999999999999999999999875432221
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....++.+||.+.+..+ .++|+||+||++|++++|.+||.+.+....+.++.....
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T cd05589 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV 218 (324)
T ss_pred cccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 123445789999887766 678999999999999999999998876666665555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=244.69 Aligned_cols=192 Identities=27% Similarity=0.411 Sum_probs=160.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
...+++|+||+| ++++.+ |+.|| ++.+...........+.+|+.++++++|++|+++++++.+.+.+++||
T Consensus 5 ~~~lg~G~~g~V-----~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 5 YRVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred EEEEecCCCEEE-----EEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 345899999999 477665 88888 334433333344566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 86 DYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
||+++|+|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99999999887643 25889999999999999999999999999999999999999999999999999876443322
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
....+|.+||.+.+..+ .++|+||+||+++++++|.+||.+....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 23445789999987776 7789999999999999999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.71 Aligned_cols=200 Identities=29% Similarity=0.505 Sum_probs=163.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHH-HHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERD-IMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+| ++|+.+ |+.|| ++.+...........+..|.. +++.++||||+++++++...+..|+|||
T Consensus 2 ~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 2 VIGKGSFGKV-----LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred ceeeCCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence 4789999999 466655 88888 444444444455566666665 4677899999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCcc--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~-- 162 (245)
|+++++|...+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++..... ....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 9999999887764 45899999999999999999999999999999999999999999999999998764322 2222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 2344789999887776 78999999999999999999999887666666665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=249.62 Aligned_cols=203 Identities=33% Similarity=0.621 Sum_probs=167.7
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|.-...+++|+||+| ++|+.+ |+.|| ++++...........+.+|+.+++.++||||+++++++.+...++
T Consensus 3 y~~~~~lg~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 3 FDVKSLVGRGHFGEV-----QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred ceEEEEEEeccCEEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 334456899999999 466665 88888 445544444556777899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999998764 589999999999999999999999999999999999999999999999999987654332
Q ss_pred c-----cccCCCCchhhhhc------CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 161 E-----TKRLGRNGIEEIKA------HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 161 ~-----~~~~~~~~~e~i~~------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
. .....|.+||.+.. ..+ .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 1 22344788998863 333 678999999999999999999988776555555443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=253.80 Aligned_cols=199 Identities=41% Similarity=0.697 Sum_probs=168.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.+++|+||+| ++|+.+ |+.|| ++++...........+.+|+.++..++||||+++++++.+++++|+|||
T Consensus 7 ~~lg~G~~g~V-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 7 KVIGRGAFGEV-----WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred EEEEeCCcEEE-----EEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 45899999999 477666 88899 5555554455677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC------
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG------ 159 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~------ 159 (245)
|+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 99999999988754 68999999999999999999999999999999999999999999999999998765433
Q ss_pred ---------------------------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 160 ---------------------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 160 ---------------------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.......|.+||.+.+..+ .++|+||+||++|+|++|.+||.+........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 241 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHH
Confidence 1122344788999887766 789999999999999999999988876555444
Q ss_pred cCc
Q psy16292 212 IEK 214 (245)
Q Consensus 212 ~~~ 214 (245)
+..
T Consensus 242 i~~ 244 (350)
T cd05573 242 IIN 244 (350)
T ss_pred Hhc
Confidence 443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.69 Aligned_cols=199 Identities=28% Similarity=0.514 Sum_probs=162.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHH-HHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERD-IMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ +++.+ |+.|| ++.+...........+.+|.. +++.++||||+++++++...+.+++|||
T Consensus 2 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 2 VIGKGSFGKVL-----LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred eeeeCCCeEEE-----EEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence 47899999994 66665 88888 444544444445566666665 4577899999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cc--
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~-- 162 (245)
|+++|+|...+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ..
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999887654 589999999999999999999999999999999999999999999999999876432221 12
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 2344789999888777 7799999999999999999999887666555555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=251.97 Aligned_cols=201 Identities=35% Similarity=0.646 Sum_probs=166.2
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+|+|+||.|+ +++.+ ++.+| ++.+....+......+.+|+.++..++|++|+++++++.+...+|+||
T Consensus 6 ~~~lG~G~fg~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 6 LKVIGRGAFGEVA-----VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred EEEEEeCCCeEEE-----EEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3458999999994 66655 77888 444544445556677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999875 45899999999999999999999999999999999999999999999999999865433221
Q ss_pred ---cccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 162 ---TKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+|.+||.+.. ..+ .++|+||+||++|++++|.+||.+.+....+.++...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 23445789998863 223 6789999999999999999999988766666655443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.26 Aligned_cols=199 Identities=28% Similarity=0.500 Sum_probs=161.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHH-HHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERD-IMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ +|+++ ++.|| ++.+...........+..|.. +++.++||||+++++++...+.+|+|||
T Consensus 2 ~lg~G~fg~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 2 VIGKGSFGKVL-----LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred eeeeCCCeEEE-----EEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence 47899999994 66665 77788 444444333344445555554 5677899999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~--- 161 (245)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...... ..
T Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 9999999998865 458888999999999999999999999999999999999999999999999997643222 12
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 23345789999988777 7899999999999999999999887766655555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=249.50 Aligned_cols=204 Identities=29% Similarity=0.460 Sum_probs=168.5
Q ss_pred HHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEE
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 83 (245)
-.-.+++|+||+|+ +++.+ ++.|| ++++.........+....|..++..+ +||+|+++++++.+.+.+++
T Consensus 4 ~~~~lg~G~~g~Vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 4 FLMVLGKGSFGKVM-----LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred EEEEEeeCCCeEEE-----EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 34468999999994 66655 77888 55555444455667788899999887 68999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~ 161 (245)
||||+++|+|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++...... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 9999999999988865 458999999999999999999999999999999999999999999999999998643222 11
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....|.+||.+...++ .++|+||+||++|+|++|.+||.+.+....+..+.....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 218 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 218 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 22345789999988777 788999999999999999999998877666666555443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=244.46 Aligned_cols=203 Identities=22% Similarity=0.285 Sum_probs=167.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehh-hhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-----CCEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRY-FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-----AKSL 81 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~-~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~~ 81 (245)
.-.+|+|+||.| +.|.++ |+.||+.|-. ...+....++..+|+.+|+.++|+||+.+.+.+.. -..+
T Consensus 27 ~~~iG~GAyGvV-----csA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 27 IEPIGRGAYGVV-----CSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred cccccCcceeeE-----EEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 445899999999 455555 8888843333 23445678999999999999999999999999965 2479
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC--
Q psy16292 82 YMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-- 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-- 158 (245)
|+|+|+| +.+|.+.++.+. ++......++.|++.||.|+|+.+++||||||.|++++.++.+|++|||+|+.....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 9999999 889999999887 999999999999999999999999999999999999999999999999999988642
Q ss_pred -CCccccCC---CCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 -GTETKRLG---RNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 -~~~~~~~~---~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+..+.... |++||.+.. ..| ...||||+||++.+|++|+|.|.|.+...++..|..-.+.
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 21222222 688888744 445 3459999999999999999999999988888877655443
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.88 Aligned_cols=206 Identities=22% Similarity=0.299 Sum_probs=182.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+|+|.|..| .||++- |+.|| |+.|.. .+.-...+++.|++-|+.++|||||++|.+.-++..+|+|+
T Consensus 23 ekTlG~GHFAVV-----KLArHVFTGekVAVKviDKTK-lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 23 EKTLGRGHFAVV-----KLARHVFTGEKVAVKVIDKTK-LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred hhhhcCCceehh-----hhhhhhcccceeEEEEecccc-cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345899999999 599988 99999 555544 34456778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-CCCcEEEEeeCceeecCCCCCcc
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
|+=.+|+|.++|-. .++.+.....++.||+.|+.|+|...++||||||+|+++- .-|.+||.|||++..+.+++..+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999998854 4799999999999999999999999999999999999765 45999999999999998888777
Q ss_pred ccCC---CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 163 KRLG---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 163 ~~~~---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
+.+| |.+||.+.+..| .+.||||+||++|+++.|.+||+-.+|.+.+.+|+.-+...|+
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch
Confidence 7777 788999999998 5679999999999999999999999999999999887776554
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=237.31 Aligned_cols=218 Identities=19% Similarity=0.268 Sum_probs=179.3
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc-----CchHHHHHHHHHHHhc-CCcccee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR-----SDSAFFWEERDIMAHA-NSEWIVQ 70 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~-----~~~~~~~~E~~il~~l-~hp~Iv~ 70 (245)
+.|.++|. ++||..+.|. .+-++ |+.+| ++......+. ...+....|++||+++ .||+|++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vr-----Rci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVR-----RCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred hhHHhhcChHHHhcccchhhhh-----hhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 45666554 7888777773 33333 77777 3332221111 1245567899999998 8999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 71 LHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 71 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
+.++++++..+++|+|.|+.|.|.+++.+. .+++...+.+++|++.|+.|+|.++|+||||||+||+++.+.+++|+||
T Consensus 88 l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred eeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999999999765 5899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCcc---ccCCCCchhhhhcCCC-------cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 150 GTCMRMNKTGTET---KRLGRNGIEEIKAHPF-------FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 150 g~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-------~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
|+|..+..+.... ..+||.+||.|++..+ ...|.|++||++|.++.|.|||-.....-++..|..++...
T Consensus 168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 9999988776544 4556788999875433 34699999999999999999999988888889999999888
Q ss_pred CCCCCCcc
Q psy16292 220 ENFPVPKA 227 (245)
Q Consensus 220 ~~~~~~~~ 227 (245)
-++.+...
T Consensus 248 ~speWadi 255 (411)
T KOG0599|consen 248 RSPEWADI 255 (411)
T ss_pred CCcchhhc
Confidence 88887665
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.47 Aligned_cols=199 Identities=27% Similarity=0.439 Sum_probs=164.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||.| ++|+.+ |+.|| ++++..............|..++..+ +||||+++++++.+.+++|+|||
T Consensus 2 ~lg~G~~g~V-----~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 2 VLGKGSFGKV-----LLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred eeeeCCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC
Confidence 4789999999 467666 88888 44554444455677788899988765 99999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc---
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~--- 161 (245)
|+++++|.+.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...... ..
T Consensus 77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 99999999888654 58999999999999999999999999999999999999999999999999987542221 11
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....++.+||.+.+..+ .++|+||+||++|+|++|.+||.+.++...+..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 23445789999987776 6899999999999999999999887765555544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.38 Aligned_cols=202 Identities=30% Similarity=0.467 Sum_probs=167.0
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCc-cceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~ 85 (245)
-.+++|+||.|+ +|+.+ ++.|| ++++.........+.+..|+.++..++|+ +|+.+++++...+.+|+||
T Consensus 6 ~~lg~G~~g~Vy-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 6 MVLGKGSFGKVM-----LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred EEEeeccCeEEE-----EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 358999999994 66665 77888 55555444556778899999999999764 6889999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCc--
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~-- 161 (245)
||+++|+|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999988654 5899999999999999999999999999999999999999999999999998754322 111
Q ss_pred -cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 -TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+.....
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218 (324)
T ss_pred ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 23445889999988777 778999999999999999999998876666665555443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=245.70 Aligned_cols=185 Identities=30% Similarity=0.514 Sum_probs=157.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+| ++|+++ ++.|| ++++...........+.+|..+++.+ +||||+++++++.+...+|+|||
T Consensus 2 ~lG~G~~g~V-----~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 2 VIGRGSYAKV-----LLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred eEeeCCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence 3789999999 466665 88888 55555544555677889999999998 79999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC-CCCcc--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK-TGTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~-~~~~~-- 162 (245)
|+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.... .....
T Consensus 77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 9999999988754 4699999999999999999999999999999999999999999999999999875322 22222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
....|.+||.+.+..+ .++|+||+||++|++++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 2344789999987776 78999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=244.42 Aligned_cols=199 Identities=29% Similarity=0.449 Sum_probs=161.8
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+|+|+||+| ++|+++ |+.|| ++.+..............|..++... +||||+++++++.+...+|+||
T Consensus 1 lG~G~~g~V-----y~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQV-----YQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEE-----EEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 588999999 466666 88888 44454444445566677788888765 7999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c--
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~-- 161 (245)
||+++|+|.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 99999999988764 4589999999999999999999999999999999999999999999999999876432221 1
Q ss_pred -cccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 162 -TKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+|.+||.+.... + .++|+||+||++|+|++|..||.+.+....+..+..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 2344578999886543 3 77999999999999999999998877665555554443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=248.22 Aligned_cols=201 Identities=29% Similarity=0.471 Sum_probs=167.1
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
-.+++|+||+| ++|+.+ |+.|| ++++.........+.+..|..+++.+. |++|+++++++.+.+.+|+||
T Consensus 6 ~~lg~G~~g~V-----y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 6 MVLGKGSFGKV-----MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred EEEEecCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 45899999999 577766 88899 555554445566788899999998885 578889999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999998875 4589999999999999999999999999999999999999999999999999886432221
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.....++.+||.+.+.++ .++|+||+||++++|++|.+||.+.........+....
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 123445789999987776 77899999999999999999999887665555554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=243.48 Aligned_cols=187 Identities=29% Similarity=0.496 Sum_probs=159.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+| ++|+.+ ++.|| ++++.........+.+.+|+.++.++ +||||+.+++++.+...+|+|||
T Consensus 2 ~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 2 VIGRGSYAKV-----LLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred eeeeCCCeEE-----EEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEe
Confidence 4789999999 466665 78888 55554444556677899999999988 79999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCcc--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~-- 162 (245)
|+++++|...+.. +.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..... ....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 9999999987764 46999999999999999999999999999999999999999999999999999863322 2222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
...++.+||.+.+.++ .++|+||+||++|+|++|.+||...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 2345789999987777 7899999999999999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.64 Aligned_cols=196 Identities=24% Similarity=0.307 Sum_probs=158.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-----EEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-----SLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv 84 (245)
.+|.|+||.|+ .+.-. ++.+||++-.. ++. --.+|+.+|+.++|||||+|.-+|.... ++.+|
T Consensus 31 liG~GsFg~Vy-----q~~~~e~~~~vAIKKv~~--d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 31 LIGSGSFGVVY-----QAKLRETEEEVAIKKVLQ--DKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeecccceEE-----EEEEcCCCceeEEEEecC--CCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 47899999994 44333 78888644322 122 2356999999999999999988886432 56799
Q ss_pred EeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCC
Q psy16292 85 MDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKT 158 (245)
Q Consensus 85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~ 158 (245)
|||+ ..+|...++ +.+++.-.++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||+|||.|+.+...
T Consensus 101 leym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 9999 569999887 3568888999999999999999999999999999999999987 88999999999987655
Q ss_pred CCccc---cCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GTETK---RLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~~~~---~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+...+ ..-|++||.+.+- .| .+-|+||.||++.||+-|.|.|.|++..++...|.+-.+.
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 43322 2227899998664 44 5569999999999999999999999999998888766555
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=252.19 Aligned_cols=214 Identities=21% Similarity=0.264 Sum_probs=186.1
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.|...-.++||.||.|+.+++..+ ++.+|+..-.....+.+.+.+..|+.+|.++++|||.++|+++..+..+|++|
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t---~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKT---KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccchhccccccceeeeeeeccc---cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 466667899999999975555554 89999433334445677889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-cc
Q psy16292 86 DYMPGGDLVNLMSNYDV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-TK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-~~ 163 (245)
|||.||++.++++.+.+ .+..+..++++++.|+.|+|..+.+|||||+.||++..+|.++|+|||.+..+...... .+
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 99999999999998775 88888999999999999999999999999999999999999999999999987765443 56
Q ss_pred cCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCC
Q psy16292 164 RLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222 (245)
Q Consensus 164 ~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (245)
..| +++||.|++..| .++||||||+..++|++|.||+++-.+....-.|.+..||..+.
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG 233 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc
Confidence 666 689999998788 89999999999999999999999999988877787777765544
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=243.74 Aligned_cols=185 Identities=31% Similarity=0.531 Sum_probs=157.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+| ++|+.+ ++.|| ++++...........+.+|+.++.++ +||||+++++++.+...+++|||
T Consensus 2 ~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 2 VIGRGSYAKV-----LLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred eeeeCCCeEE-----EEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe
Confidence 4789999999 466665 78888 55555444455667788999999877 89999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~--- 161 (245)
|+++++|...+.. +.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++...... ..
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 9999999887764 468999999999999999999999999999999999999999999999999987643221 11
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
....++.+||.+.+..+ .++|+||+||++|+|++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 22345789999987776 78999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=254.59 Aligned_cols=210 Identities=30% Similarity=0.468 Sum_probs=185.9
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
+.||----.+|+|+||+| +|++.+ .+.|| |++|..++.++++++-+.|.++|... +-|++++++.+|++-
T Consensus 348 ~tDFnFl~VlGKGSFGKV-----lLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKV-----LLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ecccceEEEeccCcccee-----eeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 344544456899999999 799888 88999 88888899999999999999999888 678999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec-C
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM-N 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~-~ 156 (245)
+.+|+||||+.||+|...++. +++.+..+.+++..|+.||-+||++||+.||||.+|++++.+|.+||+|||+++.- .
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999999999876 46999999999999999999999999999999999999999999999999999863 3
Q ss_pred CCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 157 KTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...+..+.+| |.+||.|.-.|| ...|-||+||++|+|+.|.|||.|++..+.|.+|..-...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs 568 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS 568 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc
Confidence 3344445555 789999999999 5569999999999999999999999999999988665444
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.84 Aligned_cols=207 Identities=27% Similarity=0.394 Sum_probs=187.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhcCe--EEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYRYT--LYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~--~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
.++...-.+|-|+||.| -||+..++ .+| +++|..+.+..+.+++..|.+||..++.|+||++|..|.++++
T Consensus 420 ~dl~~iaTLGvGgFGRV-----ELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRV-----ELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceE-----EEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 44455556899999999 67776633 377 8888888888999999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|++||-|-||.|+..++.+ .+.+...++++..++.|+.|||++||+.|||||+|++++.+|.+||.|||+|+.+..+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999999988765 59999999999999999999999999999999999999999999999999999999888
Q ss_pred CccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 160 TETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 160 ~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
...+.+| |.+||.|.+... ...|.||+|+++|++++|.|||+|.++...+..|+++.
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 8778888 578999987766 67899999999999999999999999999999998873
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=244.61 Aligned_cols=200 Identities=31% Similarity=0.491 Sum_probs=167.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ +|+.+ ++.|| ++++...........+.+|+.+++.+ +||||+++++++.+.+++|+|||
T Consensus 2 ~lG~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 2 VLGKGSFGKVL-----LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred eeeeCCCeEEE-----EEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 47899999994 66655 77888 55655555566778889999999888 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~--- 161 (245)
|+++++|...+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... .
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 99999999888755 689999999999999999999999999999999999999999999999999876322221 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.....|.+||.+.+.++ .++|+||+||++|++++|.+||.+.++...+..+....
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 12345789999987777 78899999999999999999998877666555554443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=243.94 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=163.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+|+ +++.+ ++.|| ++++..............|..++..+ +||||+++++++.+.+.+++|||
T Consensus 2 ~lG~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 2 MLGKGSFGKVF-----LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred eeeeCCCEEEE-----EEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe
Confidence 47999999994 66665 78888 44444444455667788888888865 99999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~--- 161 (245)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... .
T Consensus 77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 9999999998875 4688999999999999999999999999999999999999999999999999886432211 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
.....+.+||.+.+..+ .++|+||+||++|++++|.+||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 210 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 22345789999887766 788999999999999999999988765555544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=237.82 Aligned_cols=188 Identities=27% Similarity=0.401 Sum_probs=157.4
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||+|+ +++.+ |+.|| ++.+.........+.+..|+.+++.++||||+++.+++.....+++||||+
T Consensus 1 lg~G~~g~Vy-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVS-----ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEE-----EEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 5789999994 66555 88888 344443333445677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 89 PGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 89 ~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
++|+|.+.+. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+......
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9999988763 234889999999999999999999999999999999999999999999999999876543222
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....++.+||.+.+.++ .++|+||+|+++|++++|..||.+...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22345789999987776 789999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=241.33 Aligned_cols=218 Identities=25% Similarity=0.370 Sum_probs=193.2
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+.++|.----+|+|.||+| +||+.+ |+.|| |++|..+..++++.+.+.|-++|+..+||++..+--.|+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKV-----IL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKV-----ILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceE-----EEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 4567776677999999999 799988 99999 88888888899999999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec-C
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM-N 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~-~ 156 (245)
+.+|+||||..||.|..+++. ..+++...+++-..|++||.|||+++|+.||+|.+|+++|.+|.+||.|||+|+.- .
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999999999988765 45999999999999999999999999999999999999999999999999999864 3
Q ss_pred CCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC
Q psy16292 157 KTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP 225 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (245)
......+.+| |.+||.+...-| -..|-|.+||++|+|+.|+.||...+....|.-|+.++...|....|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP 393 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH
Confidence 4444556667 678899888888 56699999999999999999999999999999888887665554433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.45 Aligned_cols=202 Identities=21% Similarity=0.280 Sum_probs=160.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|...-+++.|+||+|+ +++.+ ++.||+..-...........+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVF-----KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEE-----EEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 445555668999999994 56555 78888322111122334557889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|||+++ ++|.+.+... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9999995 5898887643 378889999999999999999999999999999999999999999999999986543221
Q ss_pred ----ccccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 161 ----ETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
......+.+||.+.+ .++ .++|+||+||++|++++|.+||.+.+..+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 122344788998865 334 6789999999999999999999887655544444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=234.14 Aligned_cols=187 Identities=25% Similarity=0.384 Sum_probs=156.2
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||+| ++++.+ |+.|| ++.+...........+..|+.++++++||||+++++++.++.++++||||+
T Consensus 1 lg~G~~g~V-----y~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEV-----CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEE-----EEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 578999999 466655 88999 344433333334556677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---c
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---T 162 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---~ 162 (245)
++++|.+++... .+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......... .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 999998877532 4788888999999999999999999999999999999999999999999999876543322 2
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
...++.+||.+.+..+ .++|+||+||++|++++|.+||.+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3345789999877776 78899999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=233.23 Aligned_cols=220 Identities=22% Similarity=0.293 Sum_probs=186.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
|.---++|.|+||+| ++|-++ |.++|+.+. .-+.+.+.+..|+.|+++++.|.+|++|+.+-....+|+|
T Consensus 35 FDi~~KLGEGSYGSV-----~KAIH~EsG~v~AIK~V---PV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSV-----HKAIHRESGHVLAIKKV---PVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHhcCCcchHH-----HHHHHhccCcEEEEEec---CccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 555667999999999 566666 999996443 2357899999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCc
Q psy16292 85 MDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTE 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~ 161 (245)
||||..|+..+.++. ..+.+..+..+....+.||+|||..+-+|||||..|||++.+|..||.|||.|..+... ..+
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999999998864 45899999999999999999999999999999999999999999999999999987654 234
Q ss_pred cccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcc
Q psy16292 162 TKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFV 236 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~ 236 (245)
.+..| +++||.|..-.| ..+||||+|+...+|+.|+||+++-.+....-.|... |+|+...|+.-|.+..+|+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~--PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK--PPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--CCCCCCChHhhhhHHHHHH
Confidence 45555 689999988887 8899999999999999999999988887776666654 3346666777777666665
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=238.85 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=157.5
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE--EEehhhhh-ccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQI-KRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.+++|+||+|+.+........|+.|| ++++.... .....+.+.+|+.+++.+ +||+|+++++++...+.+++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 358999999996332222222388888 44444332 234567788999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----- 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----- 160 (245)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 86 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~ 165 (332)
T cd05614 86 YVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165 (332)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCcccc
Confidence 9999999998865 4589999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+|.+||.+.+.. + .++|+||+||++|+|++|.+||.....
T Consensus 166 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred ccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 12344578999987654 3 678999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=246.17 Aligned_cols=200 Identities=25% Similarity=0.400 Sum_probs=174.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|..-..+|+|+||.|+ -+.++..|+-|| .+.|+.+.++....-.++|..||.+++.++||.+--+|++.+.+|+
T Consensus 186 ~F~~~RvlGkGGFGEV~---acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVC---ACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ceeeeEEEeccccccee---EEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 45544459999999993 223333399999 6777777777778889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|+..|+||+|..+|.+. +++++.+.+++.+|+.||.+||..+||.||+||+|||+|..|+++|+|+|+|..+.....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 99999999999888653 599999999999999999999999999999999999999999999999999999987766
Q ss_pred ccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 ETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 ~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
... +.||++||.+.+..| +..|=||+||++|+|+.|..||..-....-
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk 394 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK 394 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence 555 455899999999988 888999999999999999999987654443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=244.40 Aligned_cols=201 Identities=17% Similarity=0.186 Sum_probs=153.3
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC-CEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA-KSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-~~~ 81 (245)
+|.-.-++++|+||.|+.+.......+ ++.||+..-...........+.+|+.+++++ +||||+++++++... +.+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 344444589999999964433222222 5667732211112233456799999999999 899999999988764 468
Q ss_pred EEEEeccCCCCHHHHHhcC-------------------------------------------------------------
Q psy16292 82 YMVMDYMPGGDLVNLMSNY------------------------------------------------------------- 100 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~------------------------------------------------------------- 100 (245)
+++|||+++|+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 9999999999999888632
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhh
Q psy16292 101 --DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEE 172 (245)
Q Consensus 101 --~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~ 172 (245)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... ......|.+||.
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 255677888999999999999999999999999999999999999999999986543211 111245789999
Q ss_pred hhcCCC-cccCCCcccccceecCC-ccCCCCCCCCC
Q psy16292 173 IKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDT 206 (245)
Q Consensus 173 i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~ 206 (245)
+....+ .++|+||+||++|++++ |.+||.+....
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~ 283 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 877766 78999999999999986 99999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=244.91 Aligned_cols=203 Identities=23% Similarity=0.289 Sum_probs=178.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|.|++| .++++. |..+| ++.|. ..+....+.+.+|+++|+.++|||||+++.+.++...+|+||||
T Consensus 63 tig~g~f~~V-----~La~~~~t~~~VaiK~idkt-~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 63 TIGKGNFAKV-----KLARHILTGTEVAIKIIDKT-QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred eeccceeEEE-----EeeEecCCCceEEEEEehhc-ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 4788899999 577777 88888 44444 45556667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCC
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~ 166 (245)
+.+|.+.+++..+ .+.+..++.++.|+++|++|||+++|+|||||.+|++++.+.++||+|||++..+.......+.+|
T Consensus 137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cg 216 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCG 216 (596)
T ss_pred ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCC
Confidence 9999999988765 477789999999999999999999999999999999999999999999999999887666666666
Q ss_pred ---CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 167 ---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 167 ---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
+.+||...+.++ .+.|+||+|+++|.++.|..||.|.+-.+.-..++.++...|
T Consensus 217 sppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp 275 (596)
T KOG0586|consen 217 SPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP 275 (596)
T ss_pred CCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc
Confidence 788899988888 788999999999999999999999988888788877766533
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=238.74 Aligned_cols=195 Identities=23% Similarity=0.270 Sum_probs=156.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|...-+++.|+||+|+ +|+.+ |+.||+..-...........+.+|+.+++.++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVY-----KGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEE-----EEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 445555668999999994 66665 88888322111122334456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||+ +++|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 999999 5688877764 3488899999999999999999999999999999999999999999999999876432221
Q ss_pred ----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
......+.+||.+.+.. + .++|+||+||++++|++|.+||.+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 12234478899886543 4 578999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=252.70 Aligned_cols=200 Identities=19% Similarity=0.212 Sum_probs=160.9
Q ss_pred hhccccccchhhhHHHHHhhc---CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|++|.|+ +|... +..+|+ ++...........+.+|+.+++.++||||+++++++..++++|+||||+
T Consensus 74 ~lg~G~~g~vy-----~a~~~~~~~~~vv~-K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 74 LVGRNPTTAAF-----VATRGSDPKEKVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEeCCCcEEE-----EEEEcCCCCeEEEE-EEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 47889999994 55443 344442 2222233344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 89 PGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 89 ~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
++|+|.+.+.. ..+++..+..++.|++.||.|+|+++|+||||||+||+++.++.++|+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 99999987643 2478889999999999999999999999999999999999999999999999987653321
Q ss_pred ---ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 ---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....+|.+||.+....+ .++|+||+||++++|++|.+||.+.+....+..+..+..
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 288 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 123445789998877766 678999999999999999999988776655555555433
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=253.04 Aligned_cols=224 Identities=22% Similarity=0.279 Sum_probs=180.2
Q ss_pred HhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
|-.+|+|.||+| +-++++..++- ++|.....+....+-+.+|+.+-++|+|.|||++.+++..++++-|.||-+
T Consensus 580 rvVLGKGTYG~V-----YA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 580 RVVLGKGTYGTV-----YAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred eEEeecCceeEE-----EeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 445899999999 57887744444 666666666678888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCCC----C
Q psy16292 89 PGGDLVNLMSNY--DV--PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKT----G 159 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~--~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~----~ 159 (245)
|||+|.++++.. .+ .++.+.++..||+.||.|||++.|+|||||.+|++++. .|.+||+|||.++++..- +
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 999999999864 23 78899999999999999999999999999999999976 588999999999886532 3
Q ss_pred CccccCCCCchhhhhcCCC---cccCCCcccccceecCCccCCCCCC--CCCCCCcccCcCCCCCCCCCCCccccCCCCC
Q psy16292 160 TETKRLGRNGIEEIKAHPF---FINDQWTFSNLRECVPPVVPELSGD--DDTSNFDDIEKDESPEENFPVPKAFAGNHLP 234 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~~~~---~~~Diws~g~~~~~~~~~~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (245)
+.+..+.|++||.|...+. .++||||+||...+|+||+|||--- ....+|.--.-.. .+|+|++++.++++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv----HP~iPeelsaeak~ 810 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV----HPPIPEELSAEAKN 810 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec----CCCCcHHHHHHHHH
Confidence 3445556899999976654 5679999999999999999999733 3333343211111 23678888888888
Q ss_pred cccceeec
Q psy16292 235 FVGFTYSG 242 (245)
Q Consensus 235 f~~f~~~~ 242 (245)
|+-=.|.+
T Consensus 811 FilrcFep 818 (1226)
T KOG4279|consen 811 FILRCFEP 818 (1226)
T ss_pred HHHHHcCC
Confidence 87555443
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=248.86 Aligned_cols=199 Identities=33% Similarity=0.571 Sum_probs=171.9
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.||-|+||+| +||++. .+.|| .+.|..+..+.++.++..|.+||...+.+-||+||-.|++.+.+|+||+
T Consensus 635 k~iGvGAFGeV-----~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 635 KTIGVGAFGEV-----CLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eeeccccccee-----EEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 34788899999 788777 88899 7788888999999999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-------
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT------- 158 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~------- 158 (245)
|++||++..++-. +-|+|..+++++.++.+|+++.|..|+|||||||+|||+|.+|.|||+|||+|.-+.=.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999997654 45899999999999999999999999999999999999999999999999999643211
Q ss_pred -CC-----------------------------------ccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccC
Q psy16292 159 -GT-----------------------------------ETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVP 198 (245)
Q Consensus 159 -~~-----------------------------------~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~ 198 (245)
+. ... ...|.+||.+....+ -.+|-||.||+||+|+.|.+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 00 111 222688899877776 55799999999999999999
Q ss_pred CCCCCCCCCCCcccCc
Q psy16292 199 ELSGDDDTSNFDDIEK 214 (245)
Q Consensus 199 pf~~~~~~~~~~~~~~ 214 (245)
||.+.++.+.-.++..
T Consensus 870 pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 870 PFLADTPGETQYKVIN 885 (1034)
T ss_pred CccCCCCCcceeeeee
Confidence 9999998877666543
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=241.48 Aligned_cols=195 Identities=18% Similarity=0.148 Sum_probs=161.1
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-E
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-S 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~ 80 (245)
..++|.....+++|+||.| +.+... |..+||.+-....... ...|.+|+.++.+++|||+|+|+++|.+.+ .
T Consensus 73 AT~~Fs~~~~ig~Ggfg~V-----YkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTV-----YKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHhCCchhcceecCCCeEE-----EEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 4568888899999999999 466555 5777854322211111 445999999999999999999999999998 5
Q ss_pred EEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCL---GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++|+||+++|+|.+++... .++|.....|+.+++.||.|||.. .|+|||||++|||+|.+.+.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 99999999999999998754 569999999999999999999984 399999999999999999999999999976
Q ss_pred cCC-CCCc----cccCCCCchhhhhc-CCCcccCCCcccccceecCCccCCCCCC
Q psy16292 155 MNK-TGTE----TKRLGRNGIEEIKA-HPFFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 155 ~~~-~~~~----~~~~~~~~~e~i~~-~~~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
... .... ....||.+||.+.. .-..++|+|||||++-++++|+++....
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 654 3222 45667888999865 3447999999999999999999887644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=238.37 Aligned_cols=192 Identities=21% Similarity=0.271 Sum_probs=156.9
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.+++|+||+|+ +++.+ ++.+| +..+.........+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 7 ~~lg~g~~~~v~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 7 GVVGEGAYGVVL-----KCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred EEecccCCEEEE-----EEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 347889999994 66666 77888 22222222334567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
++++.+..+... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccc
Confidence 988766655543 3589999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
....++.+||.+.+.++ .++|+||+||++|++++|.+||.+.++.+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred ccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 22345788999877666 67899999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=236.14 Aligned_cols=201 Identities=21% Similarity=0.208 Sum_probs=157.6
Q ss_pred HHHhhhccccccchhhhHHHHHhhc---CeEEE-EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEE----
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR---YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQ---- 76 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~---~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~---- 76 (245)
.-...+++|+||+|+ +|++. |+.+| +..+...........+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~~~~~lg~G~~g~Vy-----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 4 ECVAEIGEGAYGKVF-----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred ceeeEeccCCCeEEE-----EEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 334458999999994 66553 66777 32222222334455677888888776 6999999999985
Q ss_pred -eCCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 77 -DAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 77 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
....+++|||+++ ++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 3457999999994 689888764 34889999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 153 MRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 153 ~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
+......... ....|.+||.+...++ .++|+||+||++|++++|.+||.+..+.+...++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 8765432222 2344789999877766 789999999999999999999998877665555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=233.45 Aligned_cols=191 Identities=27% Similarity=0.420 Sum_probs=158.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||+|+ +++.. ++.|| ++.+...........+.+|+.+++.++||||+++++++.++.++++||||
T Consensus 7 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 7 VLGKGGFGEVC-----ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred EEecCCCeEEE-----EEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 48999999994 55554 88888 34443333334456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccc
Confidence 999999987743 348999999999999999999999999999999999999999999999999998764333222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
....+.+||.+....+ .++|+||+||++|++++|.+||.+.....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred cCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 2345788999877666 67899999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=238.96 Aligned_cols=214 Identities=20% Similarity=0.295 Sum_probs=177.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|-|.||+| +-+++| |+-+| ++.|..-.. .+...+++|+.||+++.||.||.+...|++.+.++.|||-
T Consensus 571 vLGSGQFG~V-----Ygg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 571 VLGSGQFGTV-----YGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred hccCCcceee-----ecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 4788899999 466666 99999 666655443 3447899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCceeecCCCCCc
Q psy16292 88 MPGGDLVNLMS---NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 88 ~~~g~L~~~l~---~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a~~~~~~~~~ 161 (245)
+ .|+....|. .+++++....++..||+.||.|||-++|+|+||||+|+|+.+. ..+||+|||+|+.+.+..-+
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 9 566666553 3469999999999999999999999999999999999999765 56899999999999887766
Q ss_pred cccCC---CCchhhhhcCCCccc-CCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCc
Q psy16292 162 TKRLG---RNGIEEIKAHPFFIN-DQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPF 235 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~~~~~-Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f 235 (245)
.+..| |.+||.++...|-++ |+||.||++|.-++|..||.-.. ++-+.|.++..-.|+.|+.++ +..+-+|
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~ei-s~~Aidl 798 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEI-SPEAIDL 798 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhc-CHHHHHH
Confidence 66666 578899999998665 99999999999999999996543 445777777777777777665 4444443
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=247.09 Aligned_cols=191 Identities=23% Similarity=0.275 Sum_probs=160.3
Q ss_pred HHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC------E
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK------S 80 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~ 80 (245)
..-++|+|+||.| +..+++ |+.+||+.-........++++.+|+++|++++|||||+++++=++.. .
T Consensus 17 ~~e~LG~Ga~g~V-----~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 17 MDERLGKGAFGNV-----YRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ehhhhcCCcccee-----eeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4567999999999 677766 99999433223235678899999999999999999999998876543 5
Q ss_pred EEEEEeccCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec--CCCc--EEEEeeCce
Q psy16292 81 LYMVMDYMPGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD--KHGH--LKLADFGTC 152 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~--~~~~--i~l~Dfg~a 152 (245)
..++||||+||||...+++ .++++..++.+...+..|+.|||++||+||||||.||++. .+|. .||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 7899999999999999974 4799999999999999999999999999999999999873 3344 599999999
Q ss_pred eecCCCCCccccCC---CCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 153 MRMNKTGTETKRLG---RNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 153 ~~~~~~~~~~~~~~---~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
+.+.......+..| |.+|+.+-. ..| ...|.||+||++|+.+||..||-.-.
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99988887777777 577888764 444 34599999999999999999987554
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=241.72 Aligned_cols=199 Identities=15% Similarity=0.177 Sum_probs=171.4
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
++...+=.++|-|+=|.| ++.+.+++.|||.|...+ + ..+|+.|++|+||||+.+.++|...-.+||
T Consensus 123 Fe~IsELeWlGSGaQGAV-----F~Grl~netVAVKKV~el-k-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAV-----FLGRLHNETVAVKKVREL-K-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred HHHhhhhhhhccCcccce-----eeeeccCceehhHHHhhh-h-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 455556667888888888 577777888886443332 2 237888999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
|||||+.|-|..+++.+ .++......|..+|+.|+.|||.+.|||||||.-|||+..+..|||+|||.++......+..
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence 99999999999999876 48889999999999999999999999999999999999999999999999999877666666
Q ss_pred ccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 163 KRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 ~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
..+| +++||.|++.|. .+.|||||||+||+|+|+..|+++-+...++.-+-+.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN 326 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN 326 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence 6666 689999999998 7899999999999999999999988777766666554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=237.77 Aligned_cols=195 Identities=20% Similarity=0.234 Sum_probs=161.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++|...-++++|+||.| ++++++ |..+| ++.+.. ......+++.+|+.++++++||||+++++++..++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V-----~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 5 DDFERISELGAGNGGVV-----TKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred ccceEEEeecCCCCEEE-----EEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 45555567899999999 466666 88888 322221 2233456799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++||||+++++|.+++... .+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999999988754 589999999999999999999985 69999999999999999999999999998664332
Q ss_pred C--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 160 T--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 160 ~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
. ......+.+||.+.+..+ .++|+||+||++|++++|..||.+...
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 123345789999877666 778999999999999999999976543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=214.34 Aligned_cols=210 Identities=20% Similarity=0.276 Sum_probs=172.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
++...--++|+|+||.| ...++. |.+.|+..-....+.+...+.++|+++.... ..|++|++|+...+.+.+
T Consensus 46 d~L~~i~elGrGayG~v-----ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVV-----EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchh-----hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34455678999999999 677777 9999955544444566778889999988765 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 82 YMVMDYMPGGDLVNLMS----N-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~----~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
|+.||.| ..||..+.+ . ..++|..+.+++..++.||.|||+ ..++|||+||.|||++.+|.+|++|||++..+
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999999 778876543 3 358999999999999999999998 57999999999999999999999999999987
Q ss_pred CCCCCccccCC---CCchhhhhcC----CC-cccCCCcccccceecCCccCCCC-CCCCCCCCcccCcCCCCCC
Q psy16292 156 NKTGTETKRLG---RNGIEEIKAH----PF-FINDQWTFSNLRECVPPVVPELS-GDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 156 ~~~~~~~~~~~---~~~~e~i~~~----~~-~~~Diws~g~~~~~~~~~~~pf~-~~~~~~~~~~~~~~~~~~~ 220 (245)
..+-..+...| |++||.+... .| .++|+||+|+.+.+|++++.|+. +.++.+++.++..+++|..
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 65544333333 8889887432 33 68999999999999999999987 5578888888888766644
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=242.95 Aligned_cols=204 Identities=20% Similarity=0.243 Sum_probs=169.1
Q ss_pred hhhccccccchhhhHHHHHhhc---C--eE-EEEEehh--hhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR---Y--TL-YALYSRY--FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~---~--~~-~av~~k~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
-++|+|+||.|+ .++.+ + .. ||++... ....+.....+++|++++++++|||||++||+......++
T Consensus 163 kkLGeGaFGeV~-----~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 163 KKLGEGAFGEVF-----KGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred ceeecccccEEE-----EEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 469999999994 44444 1 12 6633332 2344567888999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG- 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~- 159 (245)
+|||+|+||+|.++++..+ ++......++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.-....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999999998754 8999999999999999999999999999999999999999999999999988653111
Q ss_pred ---CccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 160 ---TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 160 ---~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
.......+.+||.+...-| +++||||+||++|+..+ |..|+.|....+.-.+|..+..+.
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 1223345889999988887 89999999999999887 889999999888888785543333
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=232.53 Aligned_cols=199 Identities=10% Similarity=0.061 Sum_probs=158.9
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~ 85 (245)
.+++|+++.| ++++..|+.+|+ +++.........+.+.+|+.+|++++||||+++++++.+ ...+++||
T Consensus 27 ~i~~g~~~~v-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 27 LIKENDQNSI-----YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred EEeeCCceEE-----EEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 4678888888 466666888883 222221112225778899999999999999999999977 45789999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cc
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~ 162 (245)
||+++|+|.+++... .+++.....++.+++.|+.++|+ .+++||||||+||+++.++.++++|||+++....... ..
T Consensus 102 Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 181 (283)
T PHA02988 102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181 (283)
T ss_pred EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccccccc
Confidence 999999999998754 47888899999999999999998 5899999999999999999999999999886543321 22
Q ss_pred ccCCCCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 163 KRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 ~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+.+||.+.. ..+ .++|+||+||++|++++|..||.+.+..+.+..+...
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 237 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 3345788888865 233 7899999999999999999999988766666665443
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=226.25 Aligned_cols=226 Identities=21% Similarity=0.313 Sum_probs=184.5
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 79 (245)
++++...--.+|-|+.|.|+ .++.+ |.+.||.....-.+..+.++++..++++... +.|.||+.+++|..+.
T Consensus 90 dindl~~l~dlGsGtcG~V~-----k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVW-----KMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ChHHhhhHHhhcCCCccceE-----EEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 35566666678889999995 66666 8999955544445566788899999988776 5999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 80 SLYMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
.+++.||.| +..+..+++ .+.+||..+..+...++.||.||-+ ++|+|||+||+|||+|..|++||+|||++..+.
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 999999999 667777665 3469999999999999999999986 789999999999999999999999999999887
Q ss_pred CCCCccccCC---CCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCC-CCCCCCcccCcCCCCCCCCCCCccc
Q psy16292 157 KTGTETKRLG---RNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGD-DDTSNFDDIEKDESPEENFPVPKAF 228 (245)
Q Consensus 157 ~~~~~~~~~~---~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (245)
.+...+...| |++||.|.-. .| .++|+||+|+.+++++||..||.+- .+.+.+.+++.++||. .|.-..|
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~--L~~~~gF 321 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL--LPGHMGF 321 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC--CCcccCc
Confidence 7766555555 8999998543 33 6899999999999999999999984 6888899999987753 3444556
Q ss_pred cCCCCCcc
Q psy16292 229 AGNHLPFV 236 (245)
Q Consensus 229 ~~~~~~f~ 236 (245)
|.....|+
T Consensus 322 Sp~F~~fv 329 (391)
T KOG0983|consen 322 SPDFQSFV 329 (391)
T ss_pred CHHHHHHH
Confidence 66555554
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=235.07 Aligned_cols=189 Identities=20% Similarity=0.223 Sum_probs=150.9
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLY 82 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~ 82 (245)
-.+++|+||.|+ +++++ |+.||+ ..+..........++.+|+.+++.++||||+++++++... ..+|
T Consensus 6 ~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 6 EVIGKGSYGVVC-----SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred EEEeecCCeEEE-----EEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 358899999994 66554 888883 2222222334556789999999999999999999988543 3589
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+||||+ +++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 57898888654 589999999999999999999999999999999999999999999999999986432211
Q ss_pred ------ccccCCCCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ------ETKRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ------~~~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
......|.+||.+.+ ..+ .++|+||+||++|++++|.+||.+.+.
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 112334688888765 333 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=240.39 Aligned_cols=203 Identities=17% Similarity=0.145 Sum_probs=157.8
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
++|.-.-.+++|+||+|+.+..+..... +..+|++.-.........+.+.+|+.+++.+ +||||+++++++..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3555566689999999964432222122 6677732211112234556789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-------------------------------------------------------------
Q psy16292 82 YMVMDYMPGGDLVNLMSNY------------------------------------------------------------- 100 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~------------------------------------------------------------- 100 (245)
++||||+++|+|.+++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999887532
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 101 ---------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 101 ---------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 2566778889999999999999999999999999999999999999999999876433221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
....++.+||.+.+.++ .++|+||+||+++++++ |.+||.+.....
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 11234788999877666 78999999999999987 889997765433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=229.07 Aligned_cols=191 Identities=27% Similarity=0.426 Sum_probs=157.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||+| +++..+ ++.|| .+.+...........+.+|+.+++.++|++|+.+++.+.+.+.+++||
T Consensus 5 ~~~ig~G~~g~v-----~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 5 YRVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eEEeecCCCeEE-----EEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 334899999999 466655 88888 333332222333456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 86 DYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
||+++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999988743 24889999999999999999999999999999999999999999999999999875433322
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....++.+||.+....+ .++|+||+|++++++++|.+||.+..+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 22345788999877666 778999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=247.18 Aligned_cols=214 Identities=21% Similarity=0.309 Sum_probs=178.6
Q ss_pred chHHHHH-HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMH-RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~-~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
|..+|-+ .-++|.|+||+| ++|..+ -+..|+-+........+.+.++.||+||..++||+||+++++|...+.
T Consensus 29 nP~d~WeIiGELGDGAFGKV-----yKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKV-----YKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred CHHHHHHHHhhhcCccchhh-----hhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 4455554 345999999999 688777 555553333344456788899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+||+.|||.||....++- .+.+++..+..+++|++.||.|||+++|||||||..|||+..+|.++|+|||.+......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 999999999888877665 356999999999999999999999999999999999999999999999999998765433
Q ss_pred -CCccccCC---CCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 159 -GTETKRLG---RNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 159 -~~~~~~~~---~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
....+..| +++||.++ ..|| |++||||||+.+.+|+.+.||-..-++...+-+|-+.+||...
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 33445555 57887664 4677 8999999999999999999999999999999999888777543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=230.25 Aligned_cols=210 Identities=14% Similarity=0.123 Sum_probs=160.6
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+|.-.-.+++|+||.|+.+........+..+|+..............+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 34444568999999995322111111256666322222222334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
||+++|+|.+++... .+++..+..++.+++.||.|||+++++||||||+||+++.++.++++|||.+.........
T Consensus 86 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 165 (266)
T cd05064 86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165 (266)
T ss_pred EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcc
Confidence 999999999988653 5789999999999999999999999999999999999999999999999987654322111
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+...++ .++|+||+||++++++ +|.+||.+..+......+..+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05064 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224 (266)
T ss_pred cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 11234788998877776 7899999999999965 599999887665544444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=240.46 Aligned_cols=205 Identities=18% Similarity=0.178 Sum_probs=157.7
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
++|.-.-.+++|+||.|+.+........ ++.||+..-...........+.+|+.+++.+ +||||+++++++...+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3555556699999999953332211111 4567732211111223456789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-------------------------------------------------------------
Q psy16292 82 YMVMDYMPGGDLVNLMSNY------------------------------------------------------------- 100 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~------------------------------------------------------------- 100 (245)
++||||+++|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999887431
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc------ccc
Q psy16292 101 ----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE------TKR 164 (245)
Q Consensus 101 ----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~------~~~ 164 (245)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++........ ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 2566788999999999999999999999999999999999999999999999875433221 112
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNF 209 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~ 209 (245)
.+|.+||.+....+ .++|+||+||++|++++ |.+||.+......+
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 34788998876665 78999999999999996 99999876554433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=240.20 Aligned_cols=196 Identities=17% Similarity=0.213 Sum_probs=155.5
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
..++|+ +++|+||.|+ +++++ |+.+| +..+...........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVC-----AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEE-----EEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 345554 7889999994 66555 88888 322222233345677889999999999999999999986543
Q ss_pred ------EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 80 ------SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 80 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
.+|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 5799999995 567666543 47888899999999999999999999999999999999999999999999998
Q ss_pred ecCCCCCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 154 RMNKTGTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 154 ~~~~~~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
........ .....|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 65433222 22344789999887776 6789999999999999999999987654433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=227.37 Aligned_cols=216 Identities=17% Similarity=0.162 Sum_probs=168.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHh--hcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLK--YRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~--~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+.++|.-...+++|+||.|+.+...... ..++.+|+..-.........+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4577888888999999999533221111 11466663221111222245789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEE
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY---------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLK 145 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~ 145 (245)
.+++|||+++++|.+++... .+++..+..++.+++.|+.++|+++++|+||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 99999999999999988642 267788899999999999999999999999999999999999999
Q ss_pred EEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 146 LADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 146 l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
|+|||+++....... ......+.+||.+...++ .++|+||+|++++++++ |..||.+.+.....+.+..+..
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999986533221 111234789999887776 67999999999999998 9999987776665555555444
Q ss_pred C
Q psy16292 218 P 218 (245)
Q Consensus 218 ~ 218 (245)
+
T Consensus 243 ~ 243 (280)
T cd05049 243 L 243 (280)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=226.59 Aligned_cols=215 Identities=20% Similarity=0.295 Sum_probs=167.3
Q ss_pred HHHHHHhh-----hccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEE
Q psy16292 5 EAFMHRYR-----RYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~-----~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 76 (245)
++|.+-|+ +|.|+|++|..|-.+.. |+.|| |+.|. ......++.+|++++.++ .|+||++++++|+
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t---~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQT---GKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeecc---chhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 35676665 68889999953322222 89999 44443 245678899999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~Dfg~a 152 (245)
++..+|+|||-|.||+|.++|.+++ +++..+..+...|++||.+||.+||.|||+||+|||-...+. +||+||.+.
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999999998764 999999999999999999999999999999999999876544 799999887
Q ss_pred eecCCCCC--------ccccCC---CCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCC--------
Q psy16292 153 MRMNKTGT--------ETKRLG---RNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS-------- 207 (245)
Q Consensus 153 ~~~~~~~~--------~~~~~~---~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~-------- 207 (245)
..+..... ..+.+| +++||.+.. +-| .+.|.||+||++|.|+.|+|||.|.=+.+
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 65432221 123344 577877632 333 56899999999999999999999864322
Q ss_pred -------CCcccCcCCCCCCCCCCC
Q psy16292 208 -------NFDDIEKDESPEENFPVP 225 (245)
Q Consensus 208 -------~~~~~~~~~~~~~~~~~~ 225 (245)
.|..|..+..-.|.-.+-
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkdWa 331 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKDWA 331 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhhhH
Confidence 355667776666655553
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=225.76 Aligned_cols=208 Identities=20% Similarity=0.232 Sum_probs=167.9
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
|.++|.-.-++++|+||.|+ +++.+ +..+|+.. .. ........+.+|+.+++.++||||+++++++.....+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy-----~~~~~~~~~~a~K~-~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVH-----LGKWRAQIKVAIKA-IN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEE-----EEEeccCceEEEEe-cc-cCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 56777777779999999994 56555 55666321 11 1223346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++||||+++|+|.+.+.. ..+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++++|||.++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999999998864 347889999999999999999999999999999999999999999999999988654322
Q ss_pred Ccc-----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 160 TET-----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 160 ~~~-----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
... ....+.+||.+...++ .++|+||+|++++++++ |.+||.+.+......++..+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 219 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR 219 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence 211 1234788898876666 78999999999999998 8999988876666666655433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=227.89 Aligned_cols=215 Identities=16% Similarity=0.136 Sum_probs=166.4
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++++|.-.-.+++|+||.|+.+.......+ ++.+|+..............+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 567888888899999999952221111101 345552221111222345668999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-----------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
.+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 9999999999999998864 23677888999999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 144 LKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
++|+|||+++....... ......+.+||.+....+ .++|+||+||++|++++ |..||.+.+..+....+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986543221 112344788998876666 67899999999999997 99999887776666555544
Q ss_pred CC
Q psy16292 216 ES 217 (245)
Q Consensus 216 ~~ 217 (245)
..
T Consensus 243 ~~ 244 (283)
T cd05048 243 QL 244 (283)
T ss_pred Cc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=231.31 Aligned_cols=205 Identities=17% Similarity=0.232 Sum_probs=161.7
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEeh-hhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSR-YFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k-~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
+++|.-.-.+++|+||.|+ +|+.+ |..++ ++++ ...........+.+|+.++.++ +||||+++++++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~-----~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVL-----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEE-----EEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 4566666679999999994 66544 55444 3322 2222334556788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~ 141 (245)
+.+|+||||+++++|.+++... .+++..+..++.|++.|+.|||++|++||||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 9999999999999999988632 36788999999999999999999999999999999999999
Q ss_pred CcEEEEeeCceeecCCCCCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 142 GHLKLADFGTCMRMNKTGTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 142 ~~i~l~Dfg~a~~~~~~~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
+.++|+|||++......... .....+.+||.+...++ .++|+||+||+++++++ |.+||.+.+..+.+..+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999998643211111 11234788998877665 78999999999999997 999998776555555443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=233.11 Aligned_cols=196 Identities=20% Similarity=0.226 Sum_probs=160.8
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
-++|.-..++++|+||.|+ +++++ |..+| ++.+.. .+......+.+|+.++++++||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~-----~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVF-----KVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEE-----EEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 3567767779999999994 56665 77777 222221 123345678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++||||+++++|.+++... .+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999988754 48889999999999999999997 47999999999999999999999999998765332
Q ss_pred C--CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 159 G--TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 159 ~--~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
. .......+.+||.+.+..+ .++|+||+||++|++++|..||.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 1 1223345789999877655 678999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=234.98 Aligned_cols=193 Identities=20% Similarity=0.254 Sum_probs=155.0
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++.+|....+|++|+||+|+ +++++ |+.||++.-...........+.+|+.+++.++|+||+++++++...+.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVY-----KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEE-----EEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 56778877889999999995 56555 888883221111122345678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+++||||+.+++|... ....+..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.....
T Consensus 147 ~~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999999988653 2346778888999999999999999999999999999999999999999999987653322
Q ss_pred ----ccccCCCCchhhhhcC----CC--cccCCCcccccceecCCccCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAH----PF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~----~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
......|.+||.+... .+ .++|+||+||++|++++|..||...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1223447888877432 12 5789999999999999999999743
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=248.22 Aligned_cols=200 Identities=24% Similarity=0.273 Sum_probs=161.5
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe-------CCEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD-------AKSLY 82 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-------~~~~~ 82 (245)
|..|+|+.| ++|+.. |+.||. ++....++...+.+.+|+.+|++| .|+|||.+++.... ...++
T Consensus 45 LAEGGFa~V-----Yla~~~~~~~~~Al-Krm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 45 LAEGGFAQV-----YLAQDVKGGKKYAL-KRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EccCCcEEE-----EEEEecCCCceeee-eeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 677899999 688877 466664 444555778899999999999999 59999999994321 13588
Q ss_pred EEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 83 MVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
|+||||.||+|.+++.. .++++..++.|+.+++.||.+||... |||||||-||+|++.+|..||||||.+.....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999874 35999999999999999999999987 99999999999999999999999998865322
Q ss_pred CC-C------------ccccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 158 TG-T------------ETKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 158 ~~-~------------~~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
.. . ..+..-|++||.|-- .+- .++|||+|||+||-++.+..||.+.... +|+.+....|
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P 274 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFP 274 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCC
Confidence 21 1 345666899999843 333 7899999999999999999999655443 4666666555
Q ss_pred CC
Q psy16292 221 NF 222 (245)
Q Consensus 221 ~~ 222 (245)
+.
T Consensus 275 ~~ 276 (738)
T KOG1989|consen 275 PF 276 (738)
T ss_pred CC
Confidence 44
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=224.97 Aligned_cols=189 Identities=26% Similarity=0.431 Sum_probs=157.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.++.|+||+|+ +++.. |+.+| ++.+...........+.+|+.+++.++|+||+.+++++..++..+++|||
T Consensus 7 ~lg~G~~g~vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 7 VLGKGGFGEVC-----ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred EEecCCCeEEE-----EEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 38899999994 65555 88888 34343333334455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
+++++|.+.+.. ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 999999887753 25899999999999999999999999999999999999999999999999999765433222
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.+..+ .++|+||+|++++++++|.+||.+..+
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 23445788999877666 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=229.08 Aligned_cols=213 Identities=17% Similarity=0.185 Sum_probs=165.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
-.+|.-...+++|+||+|+.+........ +..+|+ +............+.+|+.++++++||||+++++++...+.+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~i-k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAV-KTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEE-EecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35677778899999999952211111011 344552 222222234566799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 9999999999999988643 27889999999999999999999999999999999999999999999
Q ss_pred eeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 148 DFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 148 Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
|||+++....... .....++.+||.+....+ .++|+||+||++++|++ |.+||.+........++..+..
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999986543221 111235788998876655 78999999999999998 9999987766555555555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=226.01 Aligned_cols=213 Identities=23% Similarity=0.249 Sum_probs=171.6
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 82 (245)
+.++--.+|+|+||+| .+..++ |+..||.+-.......+..+++.|.+...+- +.||||++|++.-.++..|
T Consensus 65 ~Lqdlg~iG~G~fG~V-----~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTV-----NKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhh-----hhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 3445567999999999 577777 9999965555545567788889998877665 8999999999999999999
Q ss_pred EEEeccCCCCHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 83 MVMDYMPGGDLVNLM------SNYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 83 lv~e~~~~g~L~~~l------~~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+.||+| ..||..+. +...++|+.+..+...++.||.||-. .+|+|||+||+|||++..|.+||+|||+|..+
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999999 77776653 24468999999999999999999986 68999999999999999999999999999987
Q ss_pred CCCCCccccCC---CCchhhhhcC--CC-cccCCCcccccceecCCccCCCCCCC-CCCCCcccCcCCCCCCCCCC
Q psy16292 156 NKTGTETKRLG---RNGIEEIKAH--PF-FINDQWTFSNLRECVPPVVPELSGDD-DTSNFDDIEKDESPEENFPV 224 (245)
Q Consensus 156 ~~~~~~~~~~~---~~~~e~i~~~--~~-~~~Diws~g~~~~~~~~~~~pf~~~~-~~~~~~~~~~~~~~~~~~~~ 224 (245)
-.+-..+...| |.+||.|... .| .++|+||+|+.+++.+||..|+.+=+ -.++...+..+.+|....+.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 65544444444 8999998543 24 78999999999999999999997654 33444556778777665543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=236.24 Aligned_cols=180 Identities=16% Similarity=0.122 Sum_probs=148.7
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.++++|+||.|+ +|.++ ++.+|+... ....+.+|+.++++++||||++++++|......++|+|++
T Consensus 98 ~~lg~G~~g~V~-----~~~d~~~~~~vaiK~~-------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 98 ETFTPGAEGFAF-----ACIDNKTCEHVVIKAG-------QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred EEEcCCCCeEEE-----EEEECCCCCEEEEech-------hhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 357889999994 66555 777774321 1235789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC--C---cc
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG--T---ET 162 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~--~---~~ 162 (245)
+++|..++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++...... . ..
T Consensus 166 -~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 166 -KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred -CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 5788887754 468899999999999999999999999999999999999999999999999987532211 1 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
...++.+||.+...++ .++|+||+||++|++++|.+||.+.
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 3445788999887777 6789999999999999999877544
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=228.38 Aligned_cols=204 Identities=28% Similarity=0.435 Sum_probs=167.3
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
...+++|++|.|+ +++.. ++.+| ++++....+......+.+|+.+++.++||||+++++++..+..+++||
T Consensus 6 ~~~ig~g~~~~vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 6 IKTLGTGSFGRVM-----LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred EEEeecCCCeEEE-----EEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3458899999994 55554 78888 444444444556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccc
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~ 163 (245)
||+++++|.+.+.. ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence 99999999998865 4589999999999999999999999999999999999999999999999999987654421 123
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
..++.+||.+.+.++ .++|+||+|++++++++|.+||.+.........+..+..+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 216 (290)
T cd05580 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR 216 (290)
T ss_pred CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc
Confidence 345788998876665 6789999999999999999999877654444444444333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=237.78 Aligned_cols=207 Identities=15% Similarity=0.168 Sum_probs=174.8
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
.+++++--++||+|+||+| +.+++=|.+-.++-+.......+.+.|.+|+..+++-+|.||+-+.+++..+.. -
T Consensus 390 p~~ev~l~~rIGsGsFGtV-----~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTV-----YRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred CHHHhhccceeccccccce-----eecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 4567788899999999999 566666765554444455556689999999999999999999999999998887 9
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC---
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK--- 157 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~--- 157 (245)
||+.+|+|.+|+.+++.. ++....++.|+.||+.|+.|||.++|||||||..||++.+++.|+|.|||++..-..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999988744 588889999999999999999999999999999999999999999999999864321
Q ss_pred CCC---ccccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 158 TGT---ETKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 158 ~~~---~~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
... ++...-|++||.|+. .|| +.+|+||||+++|||++|..||+.....+.+.++-+|
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 111 233334899999974 355 7899999999999999999999988877777778777
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=221.87 Aligned_cols=205 Identities=20% Similarity=0.271 Sum_probs=165.2
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+..+|...-.+++|.+|.|+ +++.+ +..+|+ +.+ ........+.+|+.++++++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~-----~~~~~~~~~~~iK~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVH-----LGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred ChHHcchhhhhccCCCceEE-----EeEecCCccEEEEEec---cCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 45678888889999999994 55555 555662 221 112234568889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++|||++++++|.+++... .+++..+..++.|++.|+.|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999988643 4788999999999999999999999999999999999999999999999999865432
Q ss_pred CCcc-----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 159 GTET-----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 ~~~~-----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.... ...++.+||.+....+ .++|+||+|+++|++++ |.+||.+..+.....++...
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC
Confidence 2111 1234788888876665 67999999999999998 89999877666655555444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=237.76 Aligned_cols=196 Identities=16% Similarity=0.199 Sum_probs=156.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~ 82 (245)
.+++|+||.|+ ++.++ ++.+|++ .+...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 31 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 31 PIGSGAQGIVC-----AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred EeecCCCeEEE-----EEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 48899999995 55444 7778832 222222334566788999999999999999999988643 3689
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++........
T Consensus 106 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 183 (364)
T cd07875 106 IVMELMD-ANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 183 (364)
T ss_pred EEEeCCC-CCHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCccc
Confidence 9999994 577776653 4788889999999999999999999999999999999999999999999999876543222
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
....+|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred CCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 23445789999988777 678999999999999999999988776655555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=233.01 Aligned_cols=201 Identities=21% Similarity=0.273 Sum_probs=156.8
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|...-++++|+||+|+ +++.+ ++.+|+..-...........+.+|+.+++.++||||+++++++..++..++
T Consensus 7 ~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 7 TYIKLEKLGEGTYATVF-----KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred ceEEEEEecccCCEEEE-----EEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 34334458899999995 55544 777772221111223344567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
||||++ ++|.+.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 999995 5888877543 378889999999999999999999999999999999999999999999999986543221
Q ss_pred ---ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 161 ---ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
......+.+||.+.+. .+ .++|+||+||++++|++|.+||.+.+..+.+..+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1223447888887653 33 6789999999999999999999887655444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=226.08 Aligned_cols=195 Identities=20% Similarity=0.220 Sum_probs=153.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEEe-----CC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQD-----AK 79 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-----~~ 79 (245)
..+++|+||+| ++|+++ |+.+| +..+.............+|+.+++.+ +||||+++++++.. ..
T Consensus 6 ~~lg~g~~g~v-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 6 AEIGVGAYGTV-----YKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred eEEeecCCeEE-----EEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 45899999999 467666 88888 32222222233344567788888766 79999999999864 34
Q ss_pred EEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
.++++||+++ ++|.+++.. ..+++..+..++.|++.||.|+|+.|++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999995 588887764 248999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 157 KTGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 157 ~~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
....... ...+.+||.+.+..+ .++|+||+||++|+|++|.+||.+..+...+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 4332222 344789999877666 788999999999999999999987765544333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=252.89 Aligned_cols=197 Identities=18% Similarity=0.154 Sum_probs=157.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+|.-.-.+|+|+||.|+ +|.++ |+.||+ +++.........+++.+|+.+++.++||||+++++++.+++..
T Consensus 3 rYeIi~~LGkGgfG~VY-----lA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVY-----LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPV 77 (932)
T ss_pred CeEEEEEEecCCCEEEE-----EEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEE
Confidence 34444568999999995 55555 888882 2222222223456799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 82 YMVMDYMPGGDLVNLMSNY------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
+++|||++|++|.+++... ..+...+..++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999999987531 2345567888999999999999999999999999999999999999999
Q ss_pred CceeecCCCC----------------------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 150 GTCMRMNKTG----------------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 150 g~a~~~~~~~----------------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
|+++...... ......++.+||.+.+.++ .++|+||+||++++|++|.+||.+....
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762110 0112345789999887776 7789999999999999999999876544
Q ss_pred C
Q psy16292 207 S 207 (245)
Q Consensus 207 ~ 207 (245)
.
T Consensus 238 k 238 (932)
T PRK13184 238 K 238 (932)
T ss_pred h
Confidence 3
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=224.96 Aligned_cols=214 Identities=14% Similarity=0.119 Sum_probs=166.4
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhh--cCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKY--RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~--~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++.+|.-.-+++.|+||+|+.+...-... .++.+|+.......+....+.+.+|+.++..++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 56788888889999999996433222111 1566663222221222335678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-----------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
.++++||+++++|.+++.. ..+++..+..++.|++.||.|+|+++++||||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 9999999999999998742 23677788999999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 144 LKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
++|+|||+++....... ......|.+||.+....+ .++|+||+|++++++++ |.+||.+.........+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999886543221 112345789999876655 67899999999999997 88999887776666665554
Q ss_pred C
Q psy16292 216 E 216 (245)
Q Consensus 216 ~ 216 (245)
.
T Consensus 243 ~ 243 (283)
T cd05091 243 Q 243 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=238.07 Aligned_cols=200 Identities=16% Similarity=0.185 Sum_probs=158.7
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEeh-hhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC----
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSR-YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK---- 79 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k-~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---- 79 (245)
|.-.-.+++|+||.|+ +++.+ |+.||+++- ..........++.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 2 VEPDRPIGYGAFGVVW-----SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CcccceeeeCCCEEEE-----EEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 4445569999999995 56554 888883322 11122234567899999999999999999999998776
Q ss_pred -EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 -SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 -~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.+|+|+||+. ++|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 8999999995 678777754 4589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCc-----cccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 158 TGTE-----TKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 158 ~~~~-----~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.... .....|.+||.+.+.. + .++|+||+||++++|++|.+||.+.++...+..+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2211 1233478899887643 3 6789999999999999999999887765544433
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=224.94 Aligned_cols=200 Identities=20% Similarity=0.197 Sum_probs=158.7
Q ss_pred hhccccccchhhhHHHHHhh----cCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY----RYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~----~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
++++|+||+|+ ++.. .++.+| ++.+.........+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~-----~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVK-----KGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceE-----EeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 58999999995 4321 267777 332322222334667899999999999999999999875 456789999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
|+++++|.+++... .+++..+..++.|++.||.++|+++++|+||||.||+++.++.++|+|||+++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999999988653 5899999999999999999999999999999999999999999999999999876543321
Q ss_pred cc---cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 TK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.. ...+.+||.+....+ .++|+||+|+++|++++ |.+||.+.........+..+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~ 216 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC
Confidence 11 134678888766555 67999999999999997 9999988777666666655543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=227.08 Aligned_cols=203 Identities=19% Similarity=0.217 Sum_probs=154.4
Q ss_pred HHHHHHhhhccccccchhhhHHHH------------Hhh-cCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceee
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYL------------LKY-RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQL 71 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l------------~~~-~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 71 (245)
++|.-.-++++|+||.|+.+..-. .+. .+..+|+..............+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 344445568999999996432110 011 1456773221111123345678999999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCCCHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q psy16292 72 HFAFQDAKSLYMVMDYMPGGDLVNLMSNY--------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDV 131 (245)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl 131 (245)
++++.+....++||||+++++|.+++... .+++..+..++.|++.||.|||+++++||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 99999999999999999999999988542 2466778899999999999999999999999
Q ss_pred CCCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC--ccCCCCC
Q psy16292 132 KPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP--VVPELSG 202 (245)
Q Consensus 132 kp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~--~~~pf~~ 202 (245)
||+||+++.++.++|+|||+++....... ......+.+||.+....+ .++|+||+|+++|++++ +..||.+
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 99999999999999999999987543321 111334788998876666 78999999999999875 5678876
Q ss_pred CCCCC
Q psy16292 203 DDDTS 207 (245)
Q Consensus 203 ~~~~~ 207 (245)
.++..
T Consensus 245 ~~~~~ 249 (304)
T cd05096 245 LTDEQ 249 (304)
T ss_pred CCHHH
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=221.75 Aligned_cols=199 Identities=19% Similarity=0.202 Sum_probs=155.5
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
++++|+||.|+ ++..+ +..+|+............+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~-----~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVK-----KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEE-----EEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 47899999995 43322 455663222222223345678999999999999999999998864 578999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--c
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET--K 163 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~--~ 163 (245)
+++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||+++......... .
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999998864 358999999999999999999999999999999999999999999999999998654332211 1
Q ss_pred -----cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 164 -----RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 164 -----~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
...+.+||.+....+ .++|+||+|+++|++++ |.+||.+..+.+....+..+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 215 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK 215 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence 234788898876655 68899999999999885 999998877665555454443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=231.16 Aligned_cols=193 Identities=19% Similarity=0.250 Sum_probs=154.0
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA----- 78 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 78 (245)
|...-.+++|+||+|+ +|... ++.||++ .+...........+.+|+.++++++||||+++++++...
T Consensus 17 y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 17 YQNLTPVGSGAYGSVC-----SAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhheecccCCCeEEE-----EEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3333447889999994 55544 7778832 222222223456688999999999999999999988643
Q ss_pred -CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 -KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
...|++++++ +++|.+++....+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 88999988887899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 158 TGT-ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 158 ~~~-~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
... ......|.+||.+.+. .+ .++|+||+||++|+|++|.+||.+...
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 321 1223447889988763 33 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=221.85 Aligned_cols=207 Identities=19% Similarity=0.270 Sum_probs=166.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-...+++|.+|+|+ ++..+ |+.|+ +..+...........+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~~~l~~g~~~~v~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 2 FEILNKIGKGSFGVVF-----KVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred ceEeEEecCCCCeEEE-----EEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 3345568999999994 55554 77788 3222222334567788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
||||+++++|.+++... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||+++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999988653 478889999999999999999999999999999999999999999999999887654332
Q ss_pred c----cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 E----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. .....+.+||.....++ .++|+||+|++++++++|.+||.+.++.....++..+..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP 219 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2 22344778888876665 6799999999999999999999887755555555554433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=233.92 Aligned_cols=187 Identities=17% Similarity=0.194 Sum_probs=150.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~ 82 (245)
.+++|+||.|+ +|.++ ++.+|+. .+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 24 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 24 PIGSGAQGIVC-----AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred EeeecCCEEEE-----EEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 48899999995 55444 7888832 222222334456788999999999999999999998644 3579
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
+||||+. +++.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 99 lv~e~~~-~~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (355)
T cd07874 99 LVMELMD-ANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176 (355)
T ss_pred EEhhhhc-ccHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccC
Confidence 9999995 577776653 4788889999999999999999999999999999999999999999999999876543222
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.+..+ .++|+||+||++++|++|.+||.+...
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22344789999887776 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=246.40 Aligned_cols=201 Identities=20% Similarity=0.184 Sum_probs=161.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC--------
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-------- 79 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-------- 79 (245)
..+|+|+||+| ++++.+ |+.|| ++.+...........+.+|+.++..++|+||++++..+....
T Consensus 38 ~~LG~G~fG~V-----y~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 38 RVLGSGATGTV-----LCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred EEEecCCCEEE-----EEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 34889999999 466655 88899 322222233455677899999999999999999988875432
Q ss_pred EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++||||+++|+|.+.+.. ..+++..+..++.|++.||.|+|+++++||||||+||+++.++.++|+|||+++.
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 47899999999999998864 2488899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 155 MNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 155 ~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
...... .....+|.+||.+...++ .++|+||+||++|++++|.+||.+.+....+.++..+.
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 543211 123345789999887766 78999999999999999999998876655555555443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=229.49 Aligned_cols=198 Identities=15% Similarity=0.191 Sum_probs=157.3
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--Ce----EEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YT----LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~----~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
..+|.....+++|+||+|+ +++.+ |+ .+|+..-.........+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy-----~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVY-----KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEE-----EEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 3567778889999999995 55432 33 3552221112223345678899999999999999999999876
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
. ..++++|++++|+|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5 577999999999999988754 4788889999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcc------ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 156 NKTGTET------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 156 ~~~~~~~------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
....... ....+.+||.+....+ .++|+||+|+++|++++ |.+||.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 5433221 1234788998877666 78899999999999887 999998765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=220.81 Aligned_cols=205 Identities=23% Similarity=0.283 Sum_probs=167.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|.....++.|++|.|+ +++.+ |+.+|+..-...........+.+|+.+++.++||||+++++++.++..+++
T Consensus 2 ~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVY-----KAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEE-----EEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 46666778999999994 55554 788882221111223456678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
|+|++++++|.+++....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999987754321
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....++.+||.+.+..+ .++|+||+|++++++++|.+||.+..+......+...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 213 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence 122334788998877665 7899999999999999999999876655444444444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=221.36 Aligned_cols=188 Identities=26% Similarity=0.407 Sum_probs=156.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
++.|+||+|+ +|..+ |+.|| ++.+...........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 1 lg~g~~g~vy-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVC-----ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEE-----EEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 5789999994 56544 88888 444443333445667789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---c
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---T 162 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---~ 162 (245)
++++|.+.+... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 999999988643 4899999999999999999999999999999999999999999999999998765432222 2
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....+.+||.+.+..+ .++|+||+|++++++++|.+||.+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 2344788998877666 689999999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=239.35 Aligned_cols=190 Identities=23% Similarity=0.244 Sum_probs=147.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--------CEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--------KSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--------~~~ 81 (245)
.+|+|+||.|+ +|..+ ++.||+.+.. .......+|+.+++.++||||+++++++... ..+
T Consensus 73 ~LG~G~fg~Vy-----~~~~~~~~~~vAiK~i~-----~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 73 IIGNGSFGVVY-----EAICIDTSEKVAIKKVL-----QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeCCCEEEE-----EEEECCCCCEEEEEEEe-----cCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 47899999995 55554 7888843221 1122345799999999999999999887542 257
Q ss_pred EEEEeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeec
Q psy16292 82 YMVMDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRM 155 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~ 155 (245)
++||||++ ++|.+.+. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+|+.+
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 89999995 57766654 23589999999999999999999999999999999999998765 6999999999876
Q ss_pred CCCCCccc---cCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 156 NKTGTETK---RLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 156 ~~~~~~~~---~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
........ ...|.+||.+.+. .+ .++|+||+||++|+|++|.+||.+.+..+.+.++
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 54433322 3347899988654 34 6789999999999999999999988765444433
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=220.89 Aligned_cols=191 Identities=17% Similarity=0.256 Sum_probs=151.1
Q ss_pred hhccccccchhhh-HHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEEEEEe
Q psy16292 12 RRYRQKYSEVPRL-FEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~-~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e 86 (245)
.+++|+||+|+.+ ++ ..... +..+| +..+.. ........+.+|+.+++.++||||+++++++... ..++++||
T Consensus 11 ~lg~g~~g~v~~~~~~-~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 11 VLGEGHFGKVSLYCYD-PANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ecccCCCcEEEEeeEc-cccCCCCceEEEEEeccc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 4899999999421 11 11222 77777 322221 1223456788999999999999999999988653 46899999
Q ss_pred ccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 87 YMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
|+++++|.+++....+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 89 ~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 168 (283)
T cd05080 89 YVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168 (283)
T ss_pred CCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCC
Confidence 999999999998888999999999999999999999999999999999999999999999999999876433211
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+.+||.+....+ .++|+||+|++++++++|..|+....
T Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred CCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 11222578888766555 78999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=225.23 Aligned_cols=186 Identities=19% Similarity=0.249 Sum_probs=146.2
Q ss_pred hhhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv 84 (245)
-++|+|+||+|+ +|+.+ ++.+|+.... .......+.+|+.++++++||||+++++++.. +..+|++
T Consensus 7 ~~lG~G~~g~Vy-----~~~~~~~~~~~~~aiK~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 7 CKVGRGTYGHVY-----KAKRKDGKDDRDYALKQIE---GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred cccccCCCeEEE-----EEEEccCCCCceEEEEEEC---CCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 369999999995 55533 5667732211 12234557899999999999999999999854 4678999
Q ss_pred EeccCCCCHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe----cCCCcEEEEeeC
Q psy16292 85 MDYMPGGDLVNLMSN----------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFG 150 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~----~~~~~i~l~Dfg 150 (245)
|||+ +++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||++ +..+.++|+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 5688887642 137888999999999999999999999999999999999 456789999999
Q ss_pred ceeecCCCCC-------ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 151 TCMRMNKTGT-------ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 151 ~a~~~~~~~~-------~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
+++....... ......|.+||.+.+.. + .++|+||+||+++++++|.+||.+...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 9987643321 12234478999987643 4 678999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=221.16 Aligned_cols=197 Identities=20% Similarity=0.243 Sum_probs=158.7
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
..+|.-.-.+++|+||.|+ +++.+ |+.+| ++.+. ........+.+|+.++++++||||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy-----~~~~~~~~~~~aik~~~~--~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVY-----KARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEE-----EEEECCCCeEEEEEEEec--CccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 3456667779999999994 56554 77777 22221 122445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+|++|+||+++.++.++|+|||++.......
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999999999998764 458999999999999999999999999999999999999999999999999998764332
Q ss_pred C----ccccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 160 T----ETKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
. ......+.+||.+.. ..+ .++|+||+||+++++++|.+||....+..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 1 122334778887742 223 57899999999999999999997655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=239.69 Aligned_cols=207 Identities=16% Similarity=0.223 Sum_probs=172.1
Q ss_pred HhhhccccccchhhhHHHHHhhcCeEEE---EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE--EEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYRYTLYA---LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS--LYMV 84 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~~~~~a---v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--~~lv 84 (245)
...+|+|+|.+||.+|+ +..|..|| +.......+....+++..|+++|+.|+||||+++|++|.+..+ +.+|
T Consensus 45 ~evLGrGafKtVYka~D---e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFD---EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred hhhcccccceeeeeccc---cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 45699999999987777 33388888 3333333444567999999999999999999999999987765 8899
Q ss_pred EeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCceEecCC-CcEEEEeeCceeecCCCCC
Q psy16292 85 MDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCL--GFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|++.+|+|..+++++ .+....+..|++||+.||.|||++ .|+|||||-+||+++.+ |.|||.|+|+|.....+..
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999998876 488899999999999999999986 49999999999999865 8999999999998765543
Q ss_pred ccccCC---CCchhhhhcCCCcccCCCcccccceecCCccCCCC-CCCCCCCCcccCcCCCCCC
Q psy16292 161 ETKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELS-GDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 161 ~~~~~~---~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~-~~~~~~~~~~~~~~~~~~~ 220 (245)
.. ..| .++||.+..+.--..||||||.++-+|+|+..|++ ..++++++.++.+|..|..
T Consensus 202 ks-vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 202 KS-VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred ce-eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 33 445 57888887443366799999999999999999987 6778888999999966643
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=218.72 Aligned_cols=196 Identities=22% Similarity=0.224 Sum_probs=160.0
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
..++|.....+++|+||.|+ +|+.. ++.|| +..+.. .......+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVY-----KARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEE-----EEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 34688888889999999995 55554 77777 222211 2234566888999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++++|||+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999999999988644 5899999999999999999999999999999999999999999999999998765432
Q ss_pred CC----ccccCCCCchhhhh---cC-CCcccCCCcccccceecCCccCCCCCCCC
Q psy16292 159 GT----ETKRLGRNGIEEIK---AH-PFFINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 159 ~~----~~~~~~~~~~e~i~---~~-~~~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.. ......+.+||.+. .. ...++|+||+||+++++++|.+||....+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 21 12334578888863 22 23678999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=224.29 Aligned_cols=211 Identities=17% Similarity=0.179 Sum_probs=160.4
Q ss_pred hHHHHHHhhhccccccchhhhHHHH-Hhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYL-LKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l-~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
.++|.-.-++++|+||.|+.+.... .+.. +..+|+..-...........+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4566666679999999996332211 1111 5566632211111223445688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
++||||+++++|.+++... .++...+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 9999999999999988642 14566788899999999999999999999999999999999999999999
Q ss_pred ceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 151 TCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 151 ~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
+++....... .....+|.+||.+....+ .++|+||+||+++++++ +.+||.+.........+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9876543221 112345889999877665 77899999999999998 7899987765554444333
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=206.20 Aligned_cols=205 Identities=20% Similarity=0.268 Sum_probs=168.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+..-.++|+|.||+| .+++++ ++++| +-.+....+++-....++|+-+|+.++|.|||+++++...++.+-+
T Consensus 4 ydkmekigegtygtv-----fkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTV-----FKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred hHHHHhhcCCcceee-----EecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 344457999999999 577777 99999 4445555555667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|+|+| ..+|..+..+ +.+..+.++.++.|++.||.++|+++++|||+||.|++++.+|.+|+.|||+++-+.-+..+
T Consensus 79 vfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred eHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 99999 7788887764 45888999999999999999999999999999999999999999999999999987665543
Q ss_pred cc----cCCCCchhhhhcCCCc--ccCCCcccccceecC-CccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 TK----RLGRNGIEEIKAHPFF--INDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ~~----~~~~~~~e~i~~~~~~--~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.. ..-|++|..+-+-..+ .-|+||.||++.++. .|.|.|.|.+-.++..+|..-..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg 220 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence 32 2335666666554443 449999999999888 78899999887777666654433
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=220.27 Aligned_cols=191 Identities=19% Similarity=0.234 Sum_probs=154.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
++++|+||.| ++++.+ |+.+|+..-...........+.+|+.+++.++||||+++++++......++||||++
T Consensus 2 ~lg~g~~g~v-----y~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEV-----FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred ccCcccCccE-----EEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 4789999999 466554 888883321111223345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc------
Q psy16292 90 GGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE------ 161 (245)
Q Consensus 90 ~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~------ 161 (245)
+++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999988653 4788999999999999999999999999999999999999999999999998764422111
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
.....+.+||.+....+ .++|+||+|+++|++++ |.+||....+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 11123778888876665 67899999999999996 889997655443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=225.17 Aligned_cols=194 Identities=21% Similarity=0.224 Sum_probs=158.5
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|...-+++.|+||.| ++++++ |..+| ++.+.. .+......+.+|++++++++||||+++++++.+++.++
T Consensus 2 ~~~~~~~lg~G~~g~v-----~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (308)
T cd06615 2 DFEKLGELGAGNGGVV-----TKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS 75 (308)
T ss_pred CceEEeeccCCCCeEE-----EEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEE
Confidence 3555567899999999 466665 77777 322221 12334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||+++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence 999999999999998654 58999999999999999999997 6999999999999999999999999999876543221
Q ss_pred --ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
......+.+||.+.+..+ .++|+||+|++++++++|.+||.+.+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 223345788998866555 678999999999999999999976553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=221.97 Aligned_cols=198 Identities=14% Similarity=0.131 Sum_probs=149.9
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
++++|+||+|+ +++.. ...+|+..............+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~fg~v~-----~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVL-----LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEE-----EEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 58999999995 33222 3333322111111223345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 88 MPGGDLVNLMSNYD------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+++|+|.+++.... .++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999999886532 35677889999999999999999999999999999999999999999999875432211
Q ss_pred -----ccccCCCCchhhhhcC-------CC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 161 -----ETKRLGRNGIEEIKAH-------PF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~-------~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
......+.+||.+... .+ .++|+||+||+++++++ |.+||....+...+.++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 224 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh
Confidence 1122347888887532 22 57899999999999998 7889987765554444433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=219.44 Aligned_cols=206 Identities=22% Similarity=0.270 Sum_probs=161.2
Q ss_pred chHHH-HHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 3 NVEAF-MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f-~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+.++| .-.-+++.|+||.|+ +++.. +..+|+.. .........+.+.+|+.+++.++||||+++++.+..++
T Consensus 2 ~~~~~~~i~~~lg~g~~g~v~-----~~~~~~~~~~~~~k~-~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 75 (282)
T cd06643 2 NPEEFWEIIGELGDGAFGKVY-----KAQNKETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75 (282)
T ss_pred CHHHHHHHHhhcccCCCeEEE-----EEEECCCCeEEEEEE-eCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence 34555 344558999999994 55555 66666221 11122345677899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
..++|+||+++++|..++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++++|||++.....
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc
Confidence 99999999999999887753 4589999999999999999999999999999999999999999999999999876532
Q ss_pred CCC----ccccCCCCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 158 TGT----ETKRLGRNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 158 ~~~----~~~~~~~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
... ......+.+||.+. ..++ .++|+||+||+++++++|.+||.+.++.....++..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 222 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh
Confidence 211 12334578888874 2233 678999999999999999999987765544444433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=226.48 Aligned_cols=191 Identities=20% Similarity=0.231 Sum_probs=152.7
Q ss_pred hhccc--cccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQ--KYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~--~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+| .+++| ++++.+ |+.||+. .+.........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~ig~G~~~~~~v-----~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 5 VIGRGFEDLMTV-----NLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hccccccceEEE-----EEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 47788 56788 566666 8888832 22222223445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 87 YMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999998864 2488999999999999999999999999999999999999999999999986544322111
Q ss_pred --------ccccCCCCchhhhhcC--CC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 --------ETKRLGRNGIEEIKAH--PF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 --------~~~~~~~~~~e~i~~~--~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
......+.+||.+... .+ .++|+||+||+++++++|.+||.+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 1122337889988652 34 78899999999999999999998655433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=217.48 Aligned_cols=200 Identities=20% Similarity=0.259 Sum_probs=159.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.+++|+||.|+ +++.+ ++.+|+..-.........+.+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 5 ~~~lg~g~~g~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 5 LRVVGEGSFGRAL-----LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred EEEeeccCCeEEE-----EEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3458899999994 55555 7788822211112234567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+++++|.+++.. ..+++..+..++.+++.||.+||+++++|+||+|+||+++.++.++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999998754 2478999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
......+.+||.+.+..+ .++|+||+|+++++|++|.+||.+.+.......+..
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence 122334788998876655 678999999999999999999987654443333333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=227.73 Aligned_cols=195 Identities=22% Similarity=0.292 Sum_probs=155.9
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|...-+++.|+||.|+ +++.+ ++.+|+..-...........+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~g~~g~vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVY-----KGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEE-----EEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 445555668999999994 55555 77788322111122344556789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||++ ++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9999995 688887764 3488899999999999999999999999999999999999999999999999876543221
Q ss_pred ----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
......+.+||.+.+.. + .++|+||+|+++++|++|.+||.+.+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12234478888876543 3 578999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=223.89 Aligned_cols=209 Identities=16% Similarity=0.171 Sum_probs=158.0
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+.+|.-.-++++|+||+|+.+-....... ++.+|+..-...........+.+|+.+++.++||||+++++++..+...|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 34555556689999999952211111111 55666322211222234467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 83 MVMDYMPGGDLVNLMSN------------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~------------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
++|||+++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 99999999999998742 136778888999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 145 KLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
+|+|||+++....... ......|.+||.+.+..+ .++|+||+|++++++++ |.+||.+..+......+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543221 111234788888866555 67899999999999998 99999876654433333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=219.20 Aligned_cols=205 Identities=19% Similarity=0.257 Sum_probs=164.1
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
..++|+-..++++|++|.|+ ++... +..+|++.- . ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~v~iK~~-~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVW-----MGYYNNSTKVAVKTL-K-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEE-----EEEecCCceEEEEEc-c-CCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 44667767789999999995 55544 555663221 1 1223457889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++||++++++|.+++.. ..+++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999998864 34788888999999999999999999999999999999999999999999999876533
Q ss_pred CCc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 159 GTE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 159 ~~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
... ....++.+||.+....+ .++|+||+|+++|++++ |.+||.+..+......+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 221 11234788998876655 67899999999999998 9999987766554444433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=219.01 Aligned_cols=200 Identities=20% Similarity=0.263 Sum_probs=164.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+.|....+++.|+||.| +++.++ +..+|+ ..+.. ........+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~y~~~~~lg~g~~~~v-----y~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEV-----FKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEE-----EEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 35666777999999999 466554 777882 22211 1124467789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
++||||+++++|.+++..+.+++..+..++.+++.||.++|+.+++|+||+|+||+++.++.++++|||++.........
T Consensus 78 ~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543221
Q ss_pred ----cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 162 ----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
.....+.+||.+.+..+ .++|+||+|++++++++|.+||.+..+.....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 12334688898876655 78999999999999999999998766554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=233.43 Aligned_cols=199 Identities=19% Similarity=0.176 Sum_probs=153.3
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-.-.|++|+||.|+.+.......+ +..||+..-.........+.+.+|+.++++++ ||||+++++++.....+|+
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 33344589999999964443322222 45677322111222344567999999999995 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---------------------------------------------------------------
Q psy16292 84 VMDYMPGGDLVNLMSNY--------------------------------------------------------------- 100 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--------------------------------------------------------------- 100 (245)
||||+++|+|.+++...
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999998876431
Q ss_pred ----------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEE
Q psy16292 101 ----------------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146 (245)
Q Consensus 101 ----------------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l 146 (245)
.+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEE
Confidence 2566777889999999999999999999999999999999999999
Q ss_pred EeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCC
Q psy16292 147 ADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDD 205 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~ 205 (245)
+|||+++........ .....+.+||.+.+..+ .++|+||+||+++++++ |..||.+...
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 999999875432211 11234788998877666 78999999999999985 8889876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=220.40 Aligned_cols=208 Identities=15% Similarity=0.179 Sum_probs=163.5
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
+.++|...-.+++|+||+|+ +++.+ ...+|+..............+.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVC-----RGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEE-----EEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 45677777789999999995 44432 334553222122223345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.+..+++||++++++|.+++... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999999988653 5889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 156 NKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 156 ~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
...... .....+.+||.+....+ .++|+||+|++++++++ |..||....+......+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 422111 11234778888876555 67899999999999887 99999766655555555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=220.22 Aligned_cols=205 Identities=18% Similarity=0.195 Sum_probs=163.6
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
-++|.-.-++++|.+|.|+ ++... ++.+|+..- . ......+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~-----~~~~~~~~~v~iK~~-~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVW-----EGLWNNTTPVAVKTL-K-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEE-----EEEecCCeEEEEEee-C-CCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3455556679999999995 44444 566663221 1 12234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++||++++++|.+++... .+++..+..++.+++.||.+||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999999998653 48899999999999999999999999999999999999999999999999998765332
Q ss_pred Ccc-----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 TET-----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~~~-----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
... ...++.+||.+....+ .++|+||+|++++++++ |.+||.+..+...+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 111 1134778888776665 68899999999999998 99999887766555554433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=240.07 Aligned_cols=204 Identities=19% Similarity=0.209 Sum_probs=168.2
Q ss_pred HHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
-+.++|+|+||+|+ +++.- -..|||+.-+...+.+....|++|++++..++|||||+++++|..++.+
T Consensus 490 ~~~eLGegaFGkVf-----~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 490 FKEELGEGAFGKVF-----LAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred ehhhhcCchhhhhh-----hhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45679999999994 44433 3334432222222333677899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------C----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------D----VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------~----~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l 146 (245)
|+|+|||..|+|.++++.. . ++..+.+.++.||+.|+.||-++.++||||-.+|+|++..-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 9999999999999998531 1 667889999999999999999999999999999999999999999
Q ss_pred EeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcCCC
Q psy16292 147 ADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
+|||+++.+...+.. .-...+++||.|....| .+|||||+||++||+. .|+-|+.|-++.+...-+-.+..
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999999987654432 22345799999999998 8999999999999888 67899999999988887766643
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=226.04 Aligned_cols=204 Identities=16% Similarity=0.200 Sum_probs=157.7
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeE--EEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTL--YALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~--~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
|.-.-.+++|+||.|+ ++..+ +.. +|+............+.+.+|+.++.++ +||||+++++++...+.+
T Consensus 4 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 4 IKFEDVIGEGNFGQVI-----RAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ceeeeeecCCCcceEE-----EEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3334458999999994 55433 332 3322222222233456789999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
++++||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999999999988642 36788899999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCC---ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 145 KLADFGTCMRMNKTGT---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
+|+|||++........ ......+.+||.+...++ .++|+||+||++|+|++ |.+||.+......+.++..+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999864322111 111234788998877766 78999999999999996 99999887665555554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=221.31 Aligned_cols=208 Identities=17% Similarity=0.190 Sum_probs=162.0
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
+.++|.-.-.+++|+||.|+ +++.+ +..+|+..............+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVC-----SGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceE-----EEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34566666679999999994 44432 335662221111222345678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
++.+++||||+++++|.+++... .+++..+..++.|++.|+.+||+.+++|+||||+||+++.++.++++|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999999998753 4788899999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc--cc-----cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 156 NKTGTE--TK-----RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 156 ~~~~~~--~~-----~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
...... .. ...+.+||.+....+ .++|+||+|++++++++ |..||.+....+....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence 433221 11 123678888876555 78899999999999775 99999877655544544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=222.07 Aligned_cols=208 Identities=18% Similarity=0.221 Sum_probs=164.0
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhh-------cCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKY-------RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~-------~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
-.++.-..++++|+||.|+ +++. .+..+|+.. ...........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVF-----LAECHNLLPEQDKMLVAVKA-LKEASESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEE-----EeEEecCCCCCCceEEEEEe-cCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 3456667889999999995 3321 155555222 22223345667999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~ 140 (245)
.....+++|||+++++|.+++... .+++..+..++.|++.|+.|||+++++|+||||+||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 999999999999999999988643 3678889999999999999999999999999999999999
Q ss_pred CCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 141 HGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
++.++|+|||+++....... ......+.+||.+.+..+ .++|+||+||+++++++ |.+||....+......+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999976533221 111234788998876655 77999999999999997 99999877666555555
Q ss_pred CcCCC
Q psy16292 213 EKDES 217 (245)
Q Consensus 213 ~~~~~ 217 (245)
.....
T Consensus 238 ~~~~~ 242 (280)
T cd05092 238 TQGRE 242 (280)
T ss_pred HcCcc
Confidence 55433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=223.42 Aligned_cols=206 Identities=18% Similarity=0.196 Sum_probs=160.7
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
..+|.-.-.+++|+||.|+ +++.. +..+| ++............+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~~~~~-~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVF-----LAECYNLSPTKDKMLVA-VKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred hHHeEEeeeecccCCCeEE-----EeEeeccCCCCcceeeE-EEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 3456666679999999995 44321 33344 22222222234467889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~ 139 (245)
.....++||||+++++|.+++..+ .+++..+..++.+++.|+.|||+++++|+||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 999999999999999999998643 267888999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 140 KHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.++.++|+|||++........ ......+.+||.+.+..+ .++|+||+|++++++++ |.+||...++......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999976543321 111234788998877665 67999999999999998 9999977665544444
Q ss_pred cCcC
Q psy16292 212 IEKD 215 (245)
Q Consensus 212 ~~~~ 215 (245)
+..+
T Consensus 238 ~~~~ 241 (291)
T cd05094 238 ITQG 241 (291)
T ss_pred HhCC
Confidence 4333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=220.74 Aligned_cols=205 Identities=19% Similarity=0.270 Sum_probs=164.0
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
..+|...-++++|++|.|+ ++..+ ++.+|+..- ..+......+.+|+.+++.++||||+++++++.....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~-----~~~~~~~~~~~~~K~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVY-----EGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred hHHeEEeeecCCcccceEE-----EEEEecCCceEEEEEe--cCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 3455556679999999994 44444 777773211 12233456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++|||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999988642 4788899999999999999999999999999999999999999999999999876533
Q ss_pred CCc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 159 GTE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 ~~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
... ....++.+||.+.+.++ .++|+||+||++|++++ |.+||.+......+..+..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 211 11235788998876666 67899999999999998 99999877655555555443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=225.71 Aligned_cols=205 Identities=20% Similarity=0.186 Sum_probs=159.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
++|...-.+++|+||.|+.+.......+ +..+|+............+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3555556689999999964333222222 5566632211112233456789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++|||+++++|.+++... .+++..+..++.+++.||.|||+++++|+||||+||+++.++.++++|||+++.....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 9999999999999988643 2789999999999999999999999999999999999999999999999999865433
Q ss_pred CCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCC
Q psy16292 159 GTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNF 209 (245)
Q Consensus 159 ~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~ 209 (245)
... .....+.+||.+....+ .++|+||+||+++++++ |.+||.+......+
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 221 11234788998866655 78899999999999997 99999876654444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=219.19 Aligned_cols=205 Identities=16% Similarity=0.160 Sum_probs=157.1
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE------EEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS------LYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~------~~l 83 (245)
..+++|+||.|+.+........+..+| +..+...........+.+|+.+++.++||||+++++++..... .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 358999999995222111111146677 3223222333456789999999999999999999998865543 899
Q ss_pred EEeccCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 84 VMDYMPGGDLVNLMSN-------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++||+++++|...+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++...
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY 164 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecc
Confidence 9999999999988742 247889999999999999999999999999999999999999999999999998764
Q ss_pred CCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 157 KTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 157 ~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
..... .....+.+||.+....+ .++|+||+|++++++++ |.+||.+..+...++.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05035 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231 (273)
T ss_pred ccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 33221 11234678888766555 78999999999999998 99999887766666555544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=217.71 Aligned_cols=195 Identities=23% Similarity=0.306 Sum_probs=160.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
.+|.-.-.+++|.+|.|+ +++.+ |+.+|+ +.+...........+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~-----~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVY-----RATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEE-----EEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 567777779999999994 65544 778883 223222333455678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.+++||++++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++++|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999999998752 34788999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 156 NKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 156 ~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
..... .....++.+||.+....+ .++|+||+|++++++++|.+||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 43322 123344678898866655 67899999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=218.98 Aligned_cols=198 Identities=21% Similarity=0.252 Sum_probs=159.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-E-Eehhhh--hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-L-YSRYFQ--IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v-~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+|...-.++.|++|.|+ .+... ++.+| + +.+... ........+.+|+.++++++||||+++++++..+.
T Consensus 3 ~~~~~~~lg~g~~~~vy-----~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVY-----LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred cccccceecCCCceEEE-----EEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 45556678999999995 44333 77888 2 222211 11224567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+++++|++++++|.+.+... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999999988654 4788999999999999999999999999999999999999999999999999865432
Q ss_pred CC-------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 159 GT-------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 159 ~~-------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.. ......+.+||.+.+... .++|+||+|+++|++++|.+||.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 11 112334788888877665 788999999999999999999987654433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=220.79 Aligned_cols=211 Identities=17% Similarity=0.157 Sum_probs=160.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHh-hc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLK-YR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~-~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|.-...+++|+||.|+.+...... .. ++.+|+..-...........+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 44555556899999999522222111 11 45666322111112233457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCc
Q psy16292 83 MVMDYMPGGDLVNLMSNY-----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
+||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 999999999999988532 256778899999999999999999999999999999999999999999999
Q ss_pred eeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 152 CMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 152 a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
++.+..... .....++.+||.+....+ .++|+||+||+++++++ |.+||.+.+....+..+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 886543321 112345788998876555 78999999999999998 99999877665555544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=249.06 Aligned_cols=197 Identities=19% Similarity=0.266 Sum_probs=154.7
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-- 77 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 77 (245)
+.++|+ |++|+||+|| +|+++ ++.+| ++.+...........+..|+.++++++||||++++++|..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVY-----LAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVF-----LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEE-----EEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 444554 6789999994 67666 77777 3323222334456778999999999999999999999864
Q ss_pred CCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCceEecC-----
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCL-------GFVHRDVKPDNMLLDK----- 140 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~-------~iih~dlkp~nil~~~----- 140 (245)
...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999998864 3589999999999999999999984 4999999999999964
Q ss_pred ------------CCcEEEEeeCceeecCCCCCc---cccCCCCchhhhhcC--CC-cccCCCcccccceecCCccCCCCC
Q psy16292 141 ------------HGHLKLADFGTCMRMNKTGTE---TKRLGRNGIEEIKAH--PF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 141 ------------~~~i~l~Dfg~a~~~~~~~~~---~~~~~~~~~e~i~~~--~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
.+.++|+|||++..+...... .....|.+||.+... .+ .++|+|||||++|+|++|.+||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 234899999999876433222 234457899988643 23 678999999999999999999986
Q ss_pred CCCCCC
Q psy16292 203 DDDTSN 208 (245)
Q Consensus 203 ~~~~~~ 208 (245)
......
T Consensus 246 ~~~~~q 251 (1021)
T PTZ00266 246 ANNFSQ 251 (1021)
T ss_pred CCcHHH
Confidence 654433
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=224.61 Aligned_cols=204 Identities=28% Similarity=0.407 Sum_probs=163.2
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
...-.++.|.||.|+ +++++ ++.+| .+++...........+.+|+.+++.++||||+++++.+..++++++
T Consensus 4 ~~~~~l~~g~~~~v~-----~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 4 ETIKLISNGAYGAVY-----LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred eEeeEeecCCCeeEE-----EEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 334458899999994 66666 77788 3333333233456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG--- 159 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~--- 159 (245)
|||++++++|.+++... .+++..+..++.+++.|+.|+|+++++|+||+|+||+++..+.++|+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999999998654 47889999999999999999999999999999999999999999999999886421100
Q ss_pred ----------------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 160 ----------------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 160 ----------------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
......++.+||.+....+ .++|+||+|++++++++|..||.+......+..+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 0112334788888876665 67899999999999999999998876665555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=219.05 Aligned_cols=208 Identities=19% Similarity=0.231 Sum_probs=164.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+.++|.-.-++++|.+|+|+ +++.+ +..+|+.. .. ......+.+.+|+.+++.++||||+++++++.....+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy-----~~~~~~~~~~aik~-~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVK-----YGKWRGQYDVAIKM-IK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEE-----EEEecCCCcEEEEE-cC-CCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45566656679999999994 56555 33466321 11 1123346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+++|||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.++......
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999999988653 48899999999999999999999999999999999999999999999999988654332
Q ss_pred Ccc-----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 160 TET-----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 160 ~~~-----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
... ....+.+||.+.+.++ .++|+||+|++++++++ |..||...........+..+..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC
Confidence 211 1234778898876655 67999999999999998 9999987665555555555433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=221.47 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=163.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|....+++.|++|.|+ ++..+ |+.+|+..- ........+.+.+|+.+++.++||||+++++++..+++.++
T Consensus 20 ~y~~~~~lg~g~~g~v~-----~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 20 KYTRFEKIGQGASGTVY-----TAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hceeeeeeccCCCeEEE-----EEEECCCCCEEEEEEE-ecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 33334458888999994 55543 788883221 11223445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||||+++++|.+++.+..+++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99999999999999887789999999999999999999999999999999999999999999999999887643322
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
......+.+||.+.+..+ .++|+||+||+++++++|.+||.+.++......+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~ 227 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee
Confidence 122334778998877666 7789999999999999999999887665443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=219.46 Aligned_cols=198 Identities=17% Similarity=0.248 Sum_probs=155.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehh-hhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRY-FQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~-~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||.|+ +++.+ |..+. +++.. ........+.+.+|+.+++++ +||||+++++++...+.++++||
T Consensus 2 ~lg~g~~g~v~-----~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVL-----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEE-----EEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 37899999994 55544 44443 22222 222234456788999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 87 YMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
|+++++|.+++... .+++..+..++.+++.||.|||+++++|+||||+||+++.++.++++||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 99999999988642 2678889999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCC---ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 150 GTCMRMNKTGT---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 150 g~a~~~~~~~~---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
|++........ ......+.+||.+....+ .++|+||+|++++++++ |.+||.+.+....+..+..
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 99864321111 111234788998876666 68899999999999996 9999987765555555443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=219.09 Aligned_cols=206 Identities=20% Similarity=0.261 Sum_probs=165.6
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
..++|.-..+++.|+||+|+ ++..+ ++.+| +..+ .......+.+.+|+.++++++||||+++++.+..+.
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVY-----KAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred chhHHHHHHHhcCCCCceEE-----EEEEcCCCcEEEEEEEe--eCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 45678888889999999995 55554 67777 2222 223345667889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999999998865 3589999999999999999999999999999999999999999999999998876543
Q ss_pred CCC----ccccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 158 TGT----ETKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 158 ~~~----~~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
... ......+.+||.+.. .++ .++|+||+|+++|++++|.+||.+........++...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence 221 122334678888752 223 5789999999999999999999877655444444444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=219.35 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=163.7
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+.|...-.++.|.||.|+ ++... ++.+|+ ..+.. ......+.+.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~y~~~~~l~~g~~~~vy-----~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVY-----KGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEE-----EEEEcCCCeEEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 345566669999999995 55433 777773 22211 1223456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
++|+||+++++|.+.+..+.+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++++|||++..+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 78 WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876533221
Q ss_pred ----cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 162 ----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....+.+||.+.+..+ .++|+||+|++++++++|.+|+.+..+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence 12334788998877665 689999999999999999999976655444433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=218.09 Aligned_cols=203 Identities=20% Similarity=0.238 Sum_probs=163.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
..++.|+||.| ++++.. |+.++ +.......+......+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 6 ~~ig~g~~g~v-----~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 6 RVLGKGAFGEA-----TLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred eEecccCCceE-----EEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 34788999988 355544 77777 22222223345567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----C
Q psy16292 88 MPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG----T 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~----~ 160 (245)
+++++|.+.+... .+++..+..++.+++.+|.|||+.+++|+||+|+||+++.++.++++|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999988754 47889999999999999999999999999999999999999999999999998764433 1
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
......+.+||.+.+..+ .++|+||+|++++++++|..||.+.........+..+..+
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 222334678888766555 7899999999999999999999887766655555554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=220.10 Aligned_cols=204 Identities=15% Similarity=0.183 Sum_probs=159.4
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--C---eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--Y---TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~---~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
++++.-.-.+++|+||.|+ +++.+ + ..||+..-...........+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVC-----RGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEE-----EEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4455555568999999994 55544 3 346632211112234567799999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
...++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999999998864 347889999999999999999999999999999999999999999999999987654
Q ss_pred CCCCc---cc------cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 157 KTGTE---TK------RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 157 ~~~~~---~~------~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
..... .. ...+.+||.+...++ .++|+||+||+++++++ |.+||.+.........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 32211 11 124678898876666 67899999999999775 99999776555444444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=216.65 Aligned_cols=187 Identities=29% Similarity=0.462 Sum_probs=157.7
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
++.|++|.|+ +|+.. ++.+| ++.+.........+.+.+|+.+++.++||||+++++.+.++..+++++||+
T Consensus 1 lg~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVE-----LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEE-----EEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 5788999994 55555 77888 444444333455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---cccc
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---ETKR 164 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---~~~~ 164 (245)
++++|.+++... .+++..+..++.+++.||.|+|+++++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 999999998764 578999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
..+.+||.+....+ .++|+||+|+++|++++|.+||.+..
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 44788998876665 77899999999999999999998776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=216.69 Aligned_cols=206 Identities=16% Similarity=0.164 Sum_probs=166.6
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
-.+|.-.-.++.|++|+|+ +++.+ +..+|+.. ...........+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy-----~~~~~~~~~~~~k~-~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVW-----EGLWKNRVRVAIKI-LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEE-----EeEecCCCcEEEEe-ccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 3567777779999999994 66666 56666211 11122334667899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+||||+++++|.+++... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999998742 47888999999999999999999999999999999999999999999999998764332
Q ss_pred Cc----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 TE----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~~----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.. ....++.+||.+...++ .++|+||+|++++++++ |.+||.+..+.+.+..+..+
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 11 11234678898876666 68899999999999997 89999888776666666544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=217.99 Aligned_cols=195 Identities=22% Similarity=0.239 Sum_probs=156.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-...++.|.+|.|+ +++.+ |+.+|+. .+.........+.+.+|+.++++++||||+++++++......++
T Consensus 3 y~~~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 3 YEKLSKIGEGSYGVVF-----KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred eeeeeeecccCCeEEE-----EEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 3344568899999994 56555 7888822 22111122334567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
||||+++++|..++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99999988888776543 589999999999999999999999999999999999999999999999999987654431
Q ss_pred --ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
......+.+||.+.+. .+ .++|+||+|++++++++|.+||.+..+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 1223447889988653 33 6789999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=220.94 Aligned_cols=205 Identities=20% Similarity=0.244 Sum_probs=165.4
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+++++|.....++.|.+|.|+ +|+.+ ++.+| +..+...........+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVY-----RARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEE-----EEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 478899999999999999994 56655 77777 22222222233445678899999999999999999999877
Q ss_pred --CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 79 --KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 79 --~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
...|+|+||++ ++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 77 NLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred CCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 89999999995 5998887643 489999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----ccccCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 155 MNKTGT----ETKRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 155 ~~~~~~----~~~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...... ......+.+||.+.+.. ..++|+||+|++++++++|.+||.+..+...+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 654421 12233478888876543 26789999999999999999999887665444443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=217.57 Aligned_cols=191 Identities=26% Similarity=0.458 Sum_probs=161.7
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
...++.|+||.|+ +|+.+ ++.|| ++.+.........+.+.+|+.++++++||||+++++++..+...++|+
T Consensus 5 ~~~i~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 5 LRVIGKGAFGKVC-----IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred EEEeccCCCceEE-----EEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 3458899999995 55555 88888 444444444456788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
||+.+++|.+.+... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 999999999998765 78999999999999999999999999999999999999999999999999988765442222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....+.+||.+....+ .++|+||+|+++|++++|..||.....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2233678888876665 789999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=214.78 Aligned_cols=205 Identities=20% Similarity=0.220 Sum_probs=163.7
Q ss_pred CcchHHHHHHhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 1 MKNVEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 1 ~~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
|.++++|.-.-.+++|+||.|+ +++..++.+| +..+. ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~iK~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred cccHHHceeeeeeccCCCCceE-----ecccCCCceEEEeecC----cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 4577888888889999999995 5555577787 32221 22346789999999999999999999998765
Q ss_pred EEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
..+++|||+++++|.+++... .+++..+..++.|++.||.++|++|++||||||+||+++.++.++|+|||++....
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 479999999999999988643 37888999999999999999999999999999999999999999999999998654
Q ss_pred CCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 157 KTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 157 ~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.... ......+.+||.+....+ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 152 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 213 (254)
T cd05083 152 MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213 (254)
T ss_pred ccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence 3211 122334788998876666 67899999999999986 99999877654444444433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=215.46 Aligned_cols=197 Identities=31% Similarity=0.503 Sum_probs=157.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHH-hcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMA-HANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.++.|+||.| ++|..+ |+.+| ++++...........+..|..++. ..+||||+++++++..++.+++++|
T Consensus 3 ~l~~g~~~~v-----~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (260)
T cd05611 3 PISKGAFGSV-----YLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME 77 (260)
T ss_pred cCCcCCCeeE-----EEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence 3788999999 466554 78888 333333222233344555655544 4589999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccC
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~ 165 (245)
|+++++|.++++.. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (260)
T cd05611 78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP 157 (260)
T ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCc
Confidence 99999999998764 58999999999999999999999999999999999999999999999999988765443344455
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
.+.+||.+.+... .++|+||+|++++++++|.+||.+.+....+..+.
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 6788998876654 78899999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=215.19 Aligned_cols=200 Identities=19% Similarity=0.209 Sum_probs=154.6
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
++++|+||.|+.+........+..+|+ ..+... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 588999999963332111111355662 222111 1135567899999999999999999999876 4468999999999
Q ss_pred CCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc------
Q psy16292 91 GDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK------ 163 (245)
Q Consensus 91 g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~------ 163 (245)
++|.+++... .+++..+..++.|++.||.+||..+++|+||||+||+++.++.++|+|||+++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 9999998765 489999999999999999999999999999999999999999999999999987654332111
Q ss_pred -cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 164 -RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 164 -~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
...+.+||.+....+ .++|+||+|++++++++ |.+||...++......+.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 124788998876666 68999999999999997 999998776554444443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=217.08 Aligned_cols=195 Identities=21% Similarity=0.294 Sum_probs=158.2
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEE--ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY--SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~--~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.+++|.||.|+ +++.+ ++.+|+. ++....+......+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVY-----RATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEE-----EEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 345555668999999994 66554 7888832 22222333445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.++++||+++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999999988742 23788899999999999999999999999999999999999999999999998876
Q ss_pred CCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 156 NKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 156 ~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
..... ......+.+||.+....+ .++|+||+|++++++++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 53322 122334778998876555 78899999999999999999986553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=218.70 Aligned_cols=207 Identities=16% Similarity=0.167 Sum_probs=162.5
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--C---eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--Y---TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~---~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
..++|...-.+++|++|.|+ +++.+ + ..+|+............+.+..|+.+++.++||||+++.+++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVF-----RGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred ChHHceEeeEecCCCCccEE-----EEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 34577777789999999994 55443 2 24553221111123345678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.+..++|||++++++|.+++... .+++..+..++.+++.|+.|||+.+++|+||||+||+++.++.++++|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999999988653 4788999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCcc-------ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 156 NKTGTET-------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 156 ~~~~~~~-------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
....... ....+.+||.+....+ .++|+||+|+++|++++ |..||...++......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence 4332211 1123678888876555 67899999999999886 9999987765555454443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=220.14 Aligned_cols=206 Identities=20% Similarity=0.201 Sum_probs=159.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
.++|.-.-.+++|++|.|+ +|..+ +..+|++.............+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVY-----EGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEE-----EEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3445555568999999995 44443 34444322222222233456899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEE
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY--------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLK 145 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~ 145 (245)
+....++||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 999999999999999999988643 378888999999999999999999999999999999998765 589
Q ss_pred EEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 146 LADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 146 l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
|+|||+++.+..... ......+.+||.+.+..+ .++|+||+||+++++++ |..||.+.+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999987632221 111235788999877666 78999999999999885 9999988766555544443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=218.74 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=161.3
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+.|.-..+++.|+||.|+ +++.. ++.+| ++.+ .........+.+|+.+++.++||||+++++++..++.+
T Consensus 12 ~~y~i~~~lg~g~~g~vy-----~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 12 EVWEIIGELGDGAFGKVY-----KAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred hhhhhhheecCCCCeEEE-----EEEECCCCceEEEEEec--cCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 446666779999999994 66655 77777 2222 12234567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++||||+++++|..++.+ ..+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999999999887753 458999999999999999999999999999999999999999999999999987643321
Q ss_pred C----ccccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 160 T----ETKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
. ......|.+||.+.. .++ .++|+||+||++|++++|.+||.+.+......++..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 229 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc
Confidence 1 122344788887742 233 578999999999999999999987665444444433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=221.34 Aligned_cols=191 Identities=20% Similarity=0.269 Sum_probs=157.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
++++|.+|.|+ ++..+ ++.+|+..- ........+.+.+|+.+++.++||||+++++.+..+.+.|+||||++
T Consensus 27 ~lg~g~~~~v~-----~~~~~~~~~~v~ik~~-~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 27 KIGQGASGTVY-----TAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred EecCCCCeEEE-----EEEECCCCcEEEEEEE-ecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 47888999994 55443 777773221 11223345778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccccC
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~~~ 165 (245)
+++|.+++....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........ .....
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 180 (296)
T cd06654 101 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180 (296)
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCc
Confidence 99999999877789999999999999999999999999999999999999999999999999886543321 12233
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.+.+||.+....+ .++|+||+||+++++++|.+||.+..+...
T Consensus 181 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 4778888876655 789999999999999999999987765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=223.97 Aligned_cols=202 Identities=30% Similarity=0.426 Sum_probs=163.0
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.++.|++|+|+ +|... ++.|| .+.+...........+.+|+.+++.++||||+++++.+..+...|++|
T Consensus 6 ~~~ig~g~~g~vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 6 IKLLGKGDVGRVF-----LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred eeeecCCccEEEE-----EEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3458899999994 55554 78888 333332222345677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 86 DYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
|++.+++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998864 35899999999999999999999999999999999999999999999999998764322110
Q ss_pred --------------------------------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 162 --------------------------------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 162 --------------------------------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.....+.+||.+.+..+ .++|+||+|+++|++++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 11223678888876655 678999999999999999999988876666
Q ss_pred CcccCcCC
Q psy16292 209 FDDIEKDE 216 (245)
Q Consensus 209 ~~~~~~~~ 216 (245)
+.++....
T Consensus 241 ~~~~~~~~ 248 (316)
T cd05574 241 FSNILKKE 248 (316)
T ss_pred HHHHhcCC
Confidence 65555433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=219.73 Aligned_cols=199 Identities=24% Similarity=0.254 Sum_probs=159.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|.-.-.++.|+||.|+ +++.+ |+.||+..-...........+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~ig~g~~g~v~-----~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVY-----KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEE-----EEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 44555668999999994 66655 888883221111233445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 84 VMDYMPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
||||+++++|..++... .+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..+...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999888764 68999999999999999999997 69999999999999999999999999999865433
Q ss_pred CC--ccccCCCCchhhhhcCC-------CcccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 159 GT--ETKRLGRNGIEEIKAHP-------FFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 159 ~~--~~~~~~~~~~e~i~~~~-------~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
.. .....++.+||.+.+.. ..++|+||+||+++++++|..||........+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence 22 22334577888874322 25789999999999999999999776554433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=219.26 Aligned_cols=206 Identities=16% Similarity=0.176 Sum_probs=159.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 76 (245)
++|.-...+++|+||.|+ ++..+ ...+|+..............+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~-----~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVV-----KAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred hHeEEeeEecccccccEE-----EEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 344444567999999995 44332 3556622211112223456788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-----------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~ 139 (245)
.++.++++|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999998853 2377888999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 140 KHGHLKLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.++.++|+|||+++.+...... ....++.+||.+....+ .++|+||+||++|++++ |..||.+......+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999875433211 11234788998876666 78899999999999886 8999987765555554
Q ss_pred cCcC
Q psy16292 212 IEKD 215 (245)
Q Consensus 212 ~~~~ 215 (245)
+...
T Consensus 247 ~~~~ 250 (293)
T cd05053 247 LKEG 250 (293)
T ss_pred HHcC
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=214.26 Aligned_cols=203 Identities=19% Similarity=0.233 Sum_probs=161.1
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
.+++|+||.|+.+........+..+| +..+.. ......+.+.+|+.+++.++|+||+++++++.....++++|||+++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccc-cchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47889999995222211111155666 222222 2222478899999999999999999999999999999999999999
Q ss_pred CCHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-
Q psy16292 91 GDLVNLMSN----------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG- 159 (245)
Q Consensus 91 g~L~~~l~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~- 159 (245)
++|.+++.. ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 999999875 458999999999999999999999999999999999999999999999999998765432
Q ss_pred -----CccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 -----TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 -----~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.......+.+||.+....+ .++|+||+|++++++++ |.+||.+..+...+..+..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 223 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 1222344788998876555 78899999999999998 69999888766666655543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=213.43 Aligned_cols=196 Identities=17% Similarity=0.242 Sum_probs=155.2
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
.++.|+||.|+ ++..+ +..+|+..-...........+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~ig~g~~g~vy-----~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 2 LLGKGNFGEVF-----KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred ccCCCCCceEE-----EEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 47889999994 55545 6777732211111222345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----cc
Q psy16292 91 GDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-----TK 163 (245)
Q Consensus 91 g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-----~~ 163 (245)
++|.+.+... .+.+.....++.+++.+|.|+|+++++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999988643 4788899999999999999999999999999999999999999999999999765432211 12
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
..++.+||.+....+ .++|+||+|++++++++ |.+||.+.........+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 334788998876555 67999999999999997 99999876554433333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=221.03 Aligned_cols=206 Identities=17% Similarity=0.223 Sum_probs=157.6
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
|.-...+++|.||.|+.+........ +..+|+..-...........+.+|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 34456789999999964433222111 2344421111111223456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec
Q psy16292 85 MDYMPGGDLVNLMSNY-------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~-------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~ 139 (245)
+||+++++|.+++... .+++..+..++.+++.||.|||+++++|+||||+||+++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 9999999999987532 266788899999999999999999999999999999999
Q ss_pred CCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 140 KHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.++.++|+|||+++....... ......+.+||.+.+..+ .++|+||+|+++++|++ |.+||.+..+...+..
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 241 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986533221 112234788888876665 67899999999999998 9999987766555444
Q ss_pred c
Q psy16292 212 I 212 (245)
Q Consensus 212 ~ 212 (245)
+
T Consensus 242 ~ 242 (290)
T cd05045 242 L 242 (290)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.10 Aligned_cols=199 Identities=14% Similarity=0.134 Sum_probs=154.9
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE---EEehhhhh-ccCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA---LYSRYFQI-KRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a---v~~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
.++|...-.+++|+||+|+ ++... |..++ +++..... .......+..|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy-----~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVH-----KGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred HhhceeccccCccCCcceE-----EEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 3566666779999999995 55443 44333 22222211 1223456778888999999999999999875
Q ss_pred CCEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+...++++|++++|+|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 4567899999999999999864 34789999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCC
Q psy16292 156 NKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSN 208 (245)
Q Consensus 156 ~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~ 208 (245)
..... .....++.+||.+.+.++ .++|+||+|+++|++++ |.+||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 43321 112234778898876666 78899999999999997 9999987765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=222.93 Aligned_cols=203 Identities=18% Similarity=0.181 Sum_probs=156.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC-CE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA-KS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-~~ 80 (245)
.+|.-.-.+++|+||.|+.+.......+ ++.||+..-.........+.+..|+.+++++ +||||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 3566666799999999963332221111 5677732211111223456788999999999 899999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHhc-------------------------------------------------------------
Q psy16292 81 LYMVMDYMPGGDLVNLMSN------------------------------------------------------------- 99 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~------------------------------------------------------------- 99 (245)
++++|||+++++|.+++..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8999999999999988743
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhh
Q psy16292 100 -YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEE 172 (245)
Q Consensus 100 -~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~ 172 (245)
..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+..... ......|.+||.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 1467888999999999999999999999999999999999999999999999987543221 112234789998
Q ss_pred hhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 173 IKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 173 i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
+.+.++ .++|+||+||+++++++ |.+||.+.....
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~ 283 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence 877776 78999999999999996 999998754433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=213.93 Aligned_cols=204 Identities=20% Similarity=0.270 Sum_probs=162.2
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+.++|.-.-++++|++|.|+ ++... +..+|+ ..+. .....+.+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~-----~~~~~~~~~~~~k~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVW-----MGTWNGNTKVAVKTLKP---GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP 74 (260)
T ss_pred chHHhhhhheeccccCceEE-----EEEecCCceeEEEEecC---CCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence 45667777779999999995 55544 555662 2221 1233467899999999999999999999885 456
Q ss_pred EEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.+++||++++++|.+++... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 89999999999999988642 478899999999999999999999999999999999999999999999999987643
Q ss_pred CCCc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 158 TGTE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 158 ~~~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.... .....+.+||.+...+. .++|+||+|++++++++ |.+||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 3221 11235788998876655 78999999999999998 99999887766655555443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=214.30 Aligned_cols=203 Identities=20% Similarity=0.272 Sum_probs=160.6
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE-EeCCEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF-QDAKSL 81 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~~ 81 (245)
..+|.-.-.+++|++|.|+ +++.+|..+| +..+ .....+.+.+|+.+++.++|||++++++++ ..+...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~-----~~~~~~~~~~~k~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred HHhCeeeeeecccCCCeEE-----EEEEcCCcEEEEEeC----CCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4455556668999999994 5666687777 3222 123456789999999999999999999875 455679
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
++++||+++++|.+++... .+++..+..++.+++.||.+||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999988753 2788899999999999999999999999999999999999999999999999875433
Q ss_pred CC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 159 GT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 ~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.. .....++.+||.+..... .++|+||+|+++|++++ |.+||...........+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 22 222345888998876555 67899999999999996 99999776554444444333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=215.63 Aligned_cols=196 Identities=20% Similarity=0.261 Sum_probs=160.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
-|....+++.|+||.|+ ++... ++.+|+..............+.+|+.+++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVF-----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEE-----EEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 35566679999999995 55443 778883221111122345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||||+++++|.+++....+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++++|||++..+.....
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999887643321
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....++.+||.+....+ .++|+||+||+++++++|.+||.+....
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 207 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM 207 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH
Confidence 122334678888766555 6789999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=217.10 Aligned_cols=211 Identities=18% Similarity=0.210 Sum_probs=160.8
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhh-c-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKY-R-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~-~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+-++|.....+++|+||+|+.+....... . .+.+|+..............+.+|+.++++++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 34678888889999999995222211101 1 344442211111111235678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
.++||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 99999999999999988643 37899999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCC-----ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 151 TCMRMNKTGT-----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 151 ~a~~~~~~~~-----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
+++....... ......+.+||.+....+ .++|+||+|++++++++ |.+||.+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 9875432211 111233788898876655 77899999999999997 888998766655444443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=221.73 Aligned_cols=211 Identities=16% Similarity=0.155 Sum_probs=160.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhh---c-CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKY---R-YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK 79 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~---~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 79 (245)
.+|.-...++.|+||.|+.+....... . +..+|+..............+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 345555668899999995222111111 1 4456622221122234567799999999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG 142 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~ 142 (245)
..+++|||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 999999999999999988642 256677888999999999999999999999999999999999
Q ss_pred cEEEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 143 HLKLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 143 ~i~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
.++|+|||+++........ .....+.+||.+.+..+ .++|+||+|++++++++ |.+||.+.+....+..+..
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 254 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 9999999999876432211 11234788998877665 78999999999999987 7889987766555555443
Q ss_pred C
Q psy16292 215 D 215 (245)
Q Consensus 215 ~ 215 (245)
+
T Consensus 255 ~ 255 (304)
T cd05101 255 G 255 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=218.26 Aligned_cols=198 Identities=17% Similarity=0.201 Sum_probs=156.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--Ce----EEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YT----LYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF 75 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~----~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 75 (245)
+..+|...-.++.|+||.|+ ++++. |. .|| ++.+. .........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy-----~~~~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVY-----KGIWIPDGENVKIPVAIKVLRE-NTSPKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred chhheeeeeecCCCCCceEE-----EEEEecCCCccceEEEEEEecC-CCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 45667777789999999994 65543 44 356 22221 12223456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
... ..++++|++++|+|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++
T Consensus 79 ~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 79 LTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 754 578999999999999988753 48999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 154 RMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 154 ~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
........ .....+.+||.+....+ .++|+||+||++|++++ |.+||.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 76533221 11234788998876655 78899999999999987 899997655433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=213.34 Aligned_cols=203 Identities=20% Similarity=0.212 Sum_probs=153.4
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe----CCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD----AKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~~~~~lv~ 85 (245)
.+|-|.-|+|-+||.-.. |+.+| ++- .+....++|+++--.. .|||||+++++|+. ...+.+||
T Consensus 69 vLG~GinGkV~~C~~k~T---~ekfALKvL-------~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRT---QEKFALKVL-------LDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhccccCCceEEEEeccc---hhhhHHHHH-------hcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 366667777743332222 66666 211 2344567888876555 79999999999864 35789999
Q ss_pred eccCCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCceeecCCCC
Q psy16292 86 DYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a~~~~~~~ 159 (245)
|.|+||.|.+.++.++ ++|..+..++.||..|+.|||+.+|.||||||+|+|.... ..+||+|||+|+......
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999999998653 9999999999999999999999999999999999998654 458999999999876544
Q ss_pred Cccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC----CcccCcCCCCCCCCCC
Q psy16292 160 TETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN----FDDIEKDESPEENFPV 224 (245)
Q Consensus 160 ~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~----~~~~~~~~~~~~~~~~ 224 (245)
...+ ..-|.+||.+..+.| ...|+||+||++|.|+.|+|||-+...... -.+|..+....|...+
T Consensus 219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 3333 333677877776777 456999999999999999999988766433 2345666665555554
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=220.71 Aligned_cols=205 Identities=16% Similarity=0.166 Sum_probs=158.3
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc---------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR---------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFA 74 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~---------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 74 (245)
++|.-.-.+++|+||.|+ +++.. +..+|+..-...........+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy-----~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVV-----RAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred HHeeeeeeecCCCcccEE-----EeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 455555678999999995 44321 3455522111112233456788999999999 69999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceE
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil 137 (245)
+...+.++++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999988542 3677888999999999999999999999999999999
Q ss_pred ecCCCcEEEEeeCceeecCCCCC----cc--ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCC
Q psy16292 138 LDKHGHLKLADFGTCMRMNKTGT----ET--KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNF 209 (245)
Q Consensus 138 ~~~~~~i~l~Dfg~a~~~~~~~~----~~--~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~ 209 (245)
++.++.++|+|||+++....... .. ....+.+||.+....+ .++|+||+|+++|++++ |..||.+......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986543211 11 1124788998876665 68899999999999998 88999776655555
Q ss_pred cccCc
Q psy16292 210 DDIEK 214 (245)
Q Consensus 210 ~~~~~ 214 (245)
..+..
T Consensus 247 ~~~~~ 251 (314)
T cd05099 247 KLLRE 251 (314)
T ss_pred HHHHc
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=216.85 Aligned_cols=187 Identities=20% Similarity=0.217 Sum_probs=151.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.+++|++|+|+ ++.+. ++.+|+............+.+.+|+.++++++||||+++++.+......++||||
T Consensus 6 ~~~lg~g~~~~v~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 6 QEILGHGNGGTVY-----KAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred eeeeccCCCeEEE-----EEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3458999999995 55544 7778822211111223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--ccccC
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--ETKRL 165 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--~~~~~ 165 (245)
+++++|... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..+..... .....
T Consensus 81 ~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (279)
T cd06619 81 MDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN 157 (279)
T ss_pred CCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCCh
Confidence 999988654 2468889999999999999999999999999999999999999999999999987643321 12233
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.+.+||.+.+..+ .++|+||+|++++++++|..||....
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred hhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 4788998877666 78999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=217.59 Aligned_cols=188 Identities=20% Similarity=0.275 Sum_probs=152.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.++.|.+|.|+ +++.+ |+.||+ ..+...........+.+|+.+++.++||||+++++++..+..+++||||+
T Consensus 7 ~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 7 KIGEGTYGVVY-----KGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred EecccCceEEE-----EEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 47889999995 55554 777883 22222223344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 89 PGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 89 ~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
+ ++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 6 688887753 34889999999999999999999999999999999999999999999999999865433211
Q ss_pred -cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 -TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.+. ++ .++|+||+|++++++++|.+||.+..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 123447889887653 33 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=215.89 Aligned_cols=205 Identities=16% Similarity=0.194 Sum_probs=160.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--Ce----EEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YT----LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~----~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
.+|.-...++.|+||+|+ ++..+ |+ .+|+..............+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~-----~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVY-----KGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEE-----EEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345455668999999994 44433 32 3442111111112345678899999999999999999999987
Q ss_pred CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
...++++||+++|+|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999988753 48899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccc------cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 157 KTGTETK------RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 157 ~~~~~~~------~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
....... ...+.+||.+....+ .++|+||+|++++++++ |.+||.+....+....+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 3332111 234788898876655 78999999999999998 99999887665555555444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=223.79 Aligned_cols=187 Identities=23% Similarity=0.278 Sum_probs=155.4
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
--.||+|+-++| ++|... ...|| +..+....+.....-+.+|+.+|.+| .|.+|++++++-..++++|+|||
T Consensus 366 lk~iG~GGSSkV-----~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 366 LKQIGSGGSSKV-----FKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred HHhhcCCCccee-----eeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 345899999999 677766 67777 33334445556678899999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 87 YMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+= ..+|.+.++.++ .+...++++..|++.++.++|.+||||.||||.|+|+ -.|.+||+|||+|..+....+
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceee
Confidence 75 789999998765 4445899999999999999999999999999999998 678999999999998775543
Q ss_pred --ccccCCCCchhhhhcCCC------------cccCCCcccccceecCCccCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF------------FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~------------~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
......|++||.+....+ .++||||+||++|.|+.|++||..-
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 233444899999876443 3579999999999999999999654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=215.02 Aligned_cols=203 Identities=19% Similarity=0.152 Sum_probs=150.5
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE-eCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ-DAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+.+.... ... +..+|++.-.........+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLID-SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEec-CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47899999995222111 111 33445322112222345678889999999999999999999765 4556899999999
Q ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-------
Q psy16292 90 GGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------- 160 (245)
Q Consensus 90 ~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------- 160 (245)
+++|.+++... ..++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999998753 356677788999999999999999999999999999999999999999999986543211
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+...++ .++|+||+|++++++++ +.+||.+.........+..+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 111234778898876666 78999999999999998 57888765544433334443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=213.60 Aligned_cols=194 Identities=20% Similarity=0.284 Sum_probs=158.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-E-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-L-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+|.-.-.++.|.+|.|+ ++..+ |+.+| + +++..........++.+|+.++++++|+||+++++++...+..
T Consensus 3 ~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 3 NFKIEKKIGKGQFSVVY-----KAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNEL 77 (267)
T ss_pred ceeeeeeeccCCceEEE-----EEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 44445568999999995 44444 88888 3 2222333334577899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+++|||+++++|.+++.. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999999998853 237889999999999999999999999999999999999999999999999988654
Q ss_pred CCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 157 KTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 157 ~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.... ......+.+||.+.+..+ .++|+||+|++++++++|..||.+..
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 3221 122334678898876666 68899999999999999999996553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=213.90 Aligned_cols=183 Identities=22% Similarity=0.361 Sum_probs=149.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.+++.|+||.|+ ++..+ |+.+| +..+.. .. . .|+.....+ +||||+++++++...+.+++||
T Consensus 22 ~~lg~g~~g~v~-----~~~~~~~~~~~~~k~~~~~~-~~--~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 22 LKLIDGKFGKVS-----VLKHKPTQKLFVQKIIKAKN-FN--A-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred eeecCCCceEEE-----EEEEcCCCcEEEEEEEehhh-cc--h-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 335899999994 56555 77788 322221 11 1 133333323 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCCCccc
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
||+++++|.+++... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++++|||+++..........
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 168 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG 168 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCC
Confidence 999999999998765 689999999999999999999999999999999999999998 999999999988765554555
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
...+.+||.+.+.++ .++|+||+|++++++++|.+||.+..+.
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 666889999877666 6789999999999999999999866543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=213.49 Aligned_cols=200 Identities=19% Similarity=0.272 Sum_probs=158.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
++|.-.-+++.|+||.|+ +|..+ ++.+|+..-. ........+.+|+.+++.++||||+++++++. .+..++
T Consensus 6 ~~~~~~~~ig~G~~g~v~-----~~~~~~~~~~a~K~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVW-----MGYYNGHTKVAIKSLK--QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred HHceeeeeeccCccceEE-----eeecCCCceEEEEEec--CCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 445555568999999995 55555 7777732211 12234567899999999999999999998874 457899
Q ss_pred EEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||++++++|.+++.. ..+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999998764 2478889999999999999999999999999999999999999999999999987653221
Q ss_pred c-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 161 E-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 ~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
. .....+.+||.+....+ .++|+||+|++++++++ |.+||.+.++......+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 1 12235788888866655 68899999999999998 99999877655444433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=219.11 Aligned_cols=191 Identities=21% Similarity=0.277 Sum_probs=158.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.++.|.+|+|+ ++... |+.+|+..- ........+.+.+|+.+++.++||||+++++.+.....+++|+||++
T Consensus 26 ~lg~g~~g~vy-----~~~~~~~~~~v~iK~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 26 KIGQGASGTVF-----TAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEecCCCeEEE-----EEEEcCCCcEEEEEEE-ecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 47888999995 44433 777773221 11233456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccccC
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~~~ 165 (245)
+++|..++....+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 100 ~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (296)
T cd06655 100 GGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179 (296)
T ss_pred CCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCc
Confidence 99999999887889999999999999999999999999999999999999999999999999886543322 12233
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.|.+||.+....+ .++|+||+||++|++++|.+||.+.++...
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred cccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4788898876655 789999999999999999999988765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=220.11 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=159.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-++++|+||.|+ +++.. ++.+| +..+. ......+.+.+|+.+++.++||||+++++.+..++..++++||
T Consensus 27 ~~ig~g~~g~v~-----~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 27 IKIGEGSTGIVC-----IAREKHSGRQVAVKMMDL--RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhcCCCCceeEE-----EEEEcCCCCEEEEEEEEe--cccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 358999999994 55544 77777 22211 1234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccc
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~ 163 (245)
+++++|..++....+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 9999999988877789999999999999999999999999999999999999999999999999875543221 123
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
..++.+||.+...++ .++|+||+|++++++++|.+||.+..+.....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 345788998877665 77899999999999999999998765544333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=219.66 Aligned_cols=185 Identities=19% Similarity=0.251 Sum_probs=144.6
Q ss_pred hhhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv 84 (245)
-++++|+||+|+ +|+.+ ++.+|+.... .......+.+|+.++++++||||+++++++.. +..++++
T Consensus 7 ~~lG~G~~g~Vy-----~~~~~~~~~~~~~a~k~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 7 CKVGRGTYGHVY-----KAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eEeccCCCeeEE-----EEEecCCCccceEEEEEec---CCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 369999999995 55543 4566632211 12334567899999999999999999999853 5688999
Q ss_pred EeccCCCCHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe----cCCCcEEEEeeC
Q psy16292 85 MDYMPGGDLVNLMSN----------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFG 150 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~----~~~~~i~l~Dfg 150 (245)
+||+ +++|.+.+.. ..+++..+..++.|++.||.|||+.+++||||||+||++ +..+.++|+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9998 5678777642 137888899999999999999999999999999999999 456789999999
Q ss_pred ceeecCCCCC-------ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCC
Q psy16292 151 TCMRMNKTGT-------ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 151 ~a~~~~~~~~-------~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
+++....... .....+|.+||.+.+.. + .++|+||+||+++++++|.+||.+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9987643322 12234478899886643 3 67899999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=217.95 Aligned_cols=196 Identities=21% Similarity=0.247 Sum_probs=159.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|.....++.|.+|.|+ +|+.. ++.+| ++.+. ......+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 4 ~~~~~~~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 4 DYELIQRIGSGTYGDVY-----KARDIATGELVAIKVIKL--EPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ceEEEEEecCCCceEEE-----EeEecCCCCEEEEEEEEc--CchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 44445568899999994 55554 66677 22221 12235678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999999998865 4689999999999999999999999999999999999999999999999999887553321
Q ss_pred ----ccccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
......+.+||.+... .+ .++|+||+|+++++|++|.+||.+..+...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1223347888887654 44 678999999999999999999987654433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=214.00 Aligned_cols=197 Identities=21% Similarity=0.205 Sum_probs=162.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+..+|.-.-.+++|.||+|+ +++.. |+.|| ++... .......+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~-----~~~~~~~~~~~a~k~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVS-----KVKHIPTGTVMAKKVVHI-GAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEE-----EEEEcCCCcEEEEEEEEe-cCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 34677777889999999994 66655 88888 22221 122344678899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.+++||||+++++|.+++... .+++..+..++.+++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999999988764 58899999999999999999997 6899999999999999999999999999876532
Q ss_pred CCC--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 158 TGT--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 158 ~~~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
... ......+.+||.+....+ .++|+||+||+++++++|.+||.+..+
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 221 223445788998866555 789999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=215.85 Aligned_cols=199 Identities=20% Similarity=0.247 Sum_probs=157.1
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhh---ccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQI---KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA- 78 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~- 78 (245)
+|.-...+++|+||+|+ .++.+ |+.+|++. +.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~l~~g~~g~v~-----~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 3 NWRLGKLLGQGAFGRVY-----LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred cceEeeEEecCCceEEE-----EEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 34445668899999994 55544 78888322 11111 112356788999999999999999999998764
Q ss_pred -CEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 -KSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
..++++||++++++|.+++... .+++.....++.+++.||.+||+++++|+||+|+||+++.++.++|+|||+++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 5788999999999999988654 47888999999999999999999999999999999999999999999999988653
Q ss_pred CCC-------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 157 KTG-------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 157 ~~~-------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
... .......+.+||.+.+..+ .++|+||+|+++|++++|.+||.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 218 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence 211 1123345788998876665 7789999999999999999999876444333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=220.35 Aligned_cols=194 Identities=22% Similarity=0.311 Sum_probs=158.8
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++.|+||.|+ ++... ++.+|+..- ........+.+.+|+.+++.++||||+++++.+..+++.++||||+
T Consensus 28 ~~lg~g~~g~v~-----~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 28 IKIGEGSTGIVC-----IATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred hcccCCCCeEEE-----EEEECCCCCEEEEEEE-ecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 348899999994 55544 777773221 1122344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----cccc
Q psy16292 89 PGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETKR 164 (245)
Q Consensus 89 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~~ 164 (245)
++++|.+++....+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT 181 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence 999999998877789999999999999999999999999999999999999999999999999876532221 1223
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
..+.+||...+..+ .++|+||+|++++++++|..||.+..+...+.
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 34788998866555 67999999999999999999998776554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=211.68 Aligned_cols=201 Identities=23% Similarity=0.271 Sum_probs=162.3
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC---CccceeeeEEEEeCCEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN---SEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~ 81 (245)
|.....++.|+||.|+ ++... |+.+|+..-...........+.+|+.+++.++ |||++++++++..+...
T Consensus 3 y~~~~~l~~g~~g~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 3 YQRLELIGRGAYGAVY-----RGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhheeccCCceEE-----EEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 4556678999999994 55544 78888322111123345677889999999996 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+++|||+++++|.+++..+.+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987654332
Q ss_pred cc---ccCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 161 ET---KRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 ~~---~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.. ....+.+||.+.... ..++|+||+|+++|++++|.+||.+.........+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 11 222367888875432 36899999999999999999999877655444333
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=214.56 Aligned_cols=189 Identities=19% Similarity=0.185 Sum_probs=149.1
Q ss_pred hhccccccchhhhHHHHHhhc--C---eEEE--EEehhh-hhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y---TLYA--LYSRYF-QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~---~~~a--v~~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
.+++|+||.|+ ++..+ + ...+ +..|.. .......+.+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~Vy-----~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIF-----KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCcccchhhe-----eeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 47899999995 44333 1 1112 111211 1122345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc--------EEEEeeCcee
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH--------LKLADFGTCM 153 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~--------i~l~Dfg~a~ 153 (245)
||||+++|+|.+++... .+++.....++.|++.||.|||+++++||||||+||+++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999998754 3788999999999999999999999999999999999987764 6999999987
Q ss_pred ecCCCCCccccCCCCchhhhhcCC--CcccCCCcccccceecCCc-cCCCCCCCC
Q psy16292 154 RMNKTGTETKRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPV-VPELSGDDD 205 (245)
Q Consensus 154 ~~~~~~~~~~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~-~~pf~~~~~ 205 (245)
............++.+||.+.... ..++|+||+|+++|++++| .+|+.....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 157 TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 765544444556688999887643 3678999999999999998 466655444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=221.15 Aligned_cols=199 Identities=17% Similarity=0.188 Sum_probs=154.5
Q ss_pred HhhhccccccchhhhHHHHHhhc---------CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR---------YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~---------~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
.-++++|+||.|+ +++.. +..+| ++.+. .........+.+|+.+++.+ +||||+++++++...
T Consensus 23 ~~~lg~G~~g~V~-----~~~~~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 23 GKPLGEGCFGQVV-----MAEAIGLDKEKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred eeeeccCCCeeEE-----EeEEeccCCcccCccceEEEEeccC-CCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3446799999995 44322 34566 22221 12234456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~ 141 (245)
+..|+||||+++++|.+++... .++...+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 9999999999999999998642 36778899999999999999999999999999999999999
Q ss_pred CcEEEEeeCceeecCCCCC----c--cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 142 GHLKLADFGTCMRMNKTGT----E--TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 142 ~~i~l~Dfg~a~~~~~~~~----~--~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
+.++|+|||.++....... . .....+.+||.+.+..+ .++|+||+||++|+|++ |.+||.+......+..+.
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 9999999999876543211 1 11134788898876555 67899999999999997 889997765544444443
Q ss_pred c
Q psy16292 214 K 214 (245)
Q Consensus 214 ~ 214 (245)
.
T Consensus 257 ~ 257 (307)
T cd05098 257 E 257 (307)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=213.91 Aligned_cols=198 Identities=19% Similarity=0.230 Sum_probs=161.7
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhcCeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+.++|.-...+++|.+|.|+ ++...|+.+|+ ..+.. ....+++.+|+.+++.++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~-----~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVM-----LGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ChhhccceeeeecCCCceEE-----EEEecCcEEEEEEeccc---hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 34566667779999999994 55556888883 22221 12567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
++|||++++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999999999998654 4889999999999999999999999999999999999999999999999999876433
Q ss_pred CCc-cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCC
Q psy16292 159 GTE-TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSN 208 (245)
Q Consensus 159 ~~~-~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~ 208 (245)
... ....++.+||.+....+ .++|+||+|++++++++ |.+||........
T Consensus 156 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05039 156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 221 22334788888866555 57899999999999986 9999876654443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=213.42 Aligned_cols=187 Identities=24% Similarity=0.367 Sum_probs=148.4
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHh---cCCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAH---ANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~---l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
++.|+||.|+ +++.. |+.+| ++.+.............+|..+++. .+||||+.+++++...+..++||
T Consensus 2 lg~G~~g~Vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (279)
T cd05633 2 IGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL 76 (279)
T ss_pred cccCCCeEEE-----EEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence 6889999994 66554 88888 3333333222333344555554444 47999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--cc
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--ET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--~~ 162 (245)
||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........ ..
T Consensus 77 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcC
Confidence 999999999888654 589999999999999999999999999999999999999999999999999876543222 22
Q ss_pred ccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 163 KRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 163 ~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
...++.+||.+.. ..+ .++|+||+||+++++++|..||.+..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 3445788998753 333 67899999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=214.30 Aligned_cols=188 Identities=25% Similarity=0.353 Sum_probs=154.4
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
..|++|+||+| ++++.+ ++.|| +.-..............+|+.++++++||||+++++++......+++||+
T Consensus 5 ~~lg~G~~g~v-----~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 5 KKLGSGGFGTV-----YKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEESSEEE-----EEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred EEEEeCCCEEE-----EEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 35899999999 577777 77788 32222222233333456699999999999999999999999999999999
Q ss_pred cCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC-CCCc---c
Q psy16292 88 MPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK-TGTE---T 162 (245)
Q Consensus 88 ~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~-~~~~---~ 162 (245)
+++++|.+++. ...+++..+..++.|++.||.+||+++++|+||||+||+++.++.++|+|||.+..... .... .
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 98889999987 66789999999999999999999999999999999999999999999999999986421 1111 2
Q ss_pred ccCCCCchhhhh-cCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 163 KRLGRNGIEEIK-AHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 163 ~~~~~~~~e~i~-~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
....+.+||.+. ...+ .++|+||+|+++++|++|..|+.+.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 223368888887 4444 7889999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=226.31 Aligned_cols=182 Identities=21% Similarity=0.220 Sum_probs=147.7
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ ++..+ ++.+|+ +... . .....+|+.+++.++||||+++++++.....+|++||+
T Consensus 99 ~Lg~G~~g~Vy-----~~~~~~~~~~~~v~v-K~~~--~---~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 99 SLTPGSEGEVF-----VCTKHGDEQRKKVIV-KAVT--G---GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred eecCCCCeEEE-----EEEEcCCccceeEEE-Eecc--c---cccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 36889999995 44332 444442 1111 1 12356899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus 168 ~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~ 246 (392)
T PHA03207 168 Y-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246 (392)
T ss_pred c-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence 9 5788887754 4589999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+|.+||.+...++ .++|+||+||++|+|++|.+||.+...
T Consensus 247 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 123345788999887776 678999999999999999999987654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=220.66 Aligned_cols=204 Identities=20% Similarity=0.253 Sum_probs=155.5
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
.||.|.||.|+.+......+. +..+++..-.........+.+.+|++.+++++||||+++++++...+..++|+||+++
T Consensus 6 ~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~ 85 (259)
T PF07714_consen 6 QIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPG 85 (259)
T ss_dssp EEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred EEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccc
Confidence 589999999953222211111 5555521111122233478899999999999999999999999988889999999999
Q ss_pred CCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------c
Q psy16292 91 GDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------E 161 (245)
Q Consensus 91 g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~ 161 (245)
|+|.+++... .+++.....++.|++.||.|||+++++|++|+++||+++.++.+||+|||++........ .
T Consensus 86 g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~ 165 (259)
T PF07714_consen 86 GSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQ 165 (259)
T ss_dssp EBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998875 589999999999999999999999999999999999999999999999999988732211 2
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+....+ .++||||||++++++++ +..|+.+........++..+
T Consensus 166 ~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~ 221 (259)
T PF07714_consen 166 QLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG 221 (259)
T ss_dssp ESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 23344788999877765 78999999999999999 78998877655544555443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=217.88 Aligned_cols=211 Identities=17% Similarity=0.157 Sum_probs=158.5
Q ss_pred chHHHHHHhhhccccccchhhhHHHH-Hhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYL-LKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l-~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+.++|.-.-.+++|+||.|+.+...- .+.. +..+|++.............+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45667767779999999995332110 0111 446663221111112234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
.++||||+++|+|.+++... ..+...+..++.+++.||.|||+++++||||||+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999998642 1345678889999999999999999999999999999999999999999
Q ss_pred CceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 150 GTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 150 g~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
|+++....... ......+.+||.+....+ .++|+||+||+++++++ +.+||.+....+....+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99886533221 111234788888876555 67899999999999997 788998766554444443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=217.10 Aligned_cols=194 Identities=21% Similarity=0.276 Sum_probs=153.5
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|...-.++.|.+|+|+ +++.+ |+.||+..-...........+.+|+.+++.++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVY-----KGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEE-----EEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 445555668999999995 55444 78888322111122233455788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||++ ++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.......
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9999996 5898887643 478899999999999999999999999999999999999999999999999876432211
Q ss_pred c----cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 E----TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ~----~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
. .....+.+||.+.+. ++ .++|+||+|+++++|++|.+||.+..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 122346788877653 34 67899999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=213.30 Aligned_cols=191 Identities=22% Similarity=0.290 Sum_probs=154.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE--Eehhhhhc------cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIK------RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
.++.|++|.|+ .|... ++.+|+ +.+..... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 7 ~ig~g~~~~v~-----~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 7 LIGSGSFGSVY-----LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred eeecCCCeEEE-----EEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 47888999995 55443 677772 22211111 12336788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++++||+++++|.+++... .+++..+..++.+++.||.+||+++++|+||+|+||+++.++.++|+|||.++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 9999999999999998764 578899999999999999999999999999999999999999999999999887652211
Q ss_pred ----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 ----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 ----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
......+.+||.+....+ .++|+||+|++++++++|..||.+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 112334678888876665 67899999999999999999998765543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=221.10 Aligned_cols=206 Identities=22% Similarity=0.256 Sum_probs=162.4
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
.++++|...-.+++|.||.|+ ++..+ |+.|| +..+.............+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVY-----RARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred ccccceeEeeeeeecCCEEEE-----EEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 456677777779999999995 55554 88888 32222222233344567899999999999999999999765
Q ss_pred --CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 79 --KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 79 --~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
+.+++|||++. ++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 57899999995 588887764 3588999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc----cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 155 MNKTGTE----TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 155 ~~~~~~~----~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
....... .....+.+||.+.+. .+ .++|+||+|+++|++++|.+||.+.++...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6543211 123347888887653 33 78899999999999999999998887765555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=213.42 Aligned_cols=191 Identities=16% Similarity=0.108 Sum_probs=147.0
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ +++.. +..+|+..............+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~lg~G~~g~Vy-----~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVI-----LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred cccccCCceEE-----EEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 47999999995 44322 4455532221111223345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 88 MPGGDLVNLMSNY------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+++|+|.+++... ..++..+..++.|++.|+.|||+.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999988642 245667788999999999999999999999999999999999999999999875432221
Q ss_pred -----ccccCCCCchhhhhcCC--------CcccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 161 -----ETKRLGRNGIEEIKAHP--------FFINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~--------~~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
.....++.+||.+.... -.++|+||+|++++++++ |.+||....+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 11123478888875321 257899999999999985 999997665443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=215.10 Aligned_cols=201 Identities=15% Similarity=0.220 Sum_probs=153.2
Q ss_pred hhhccccccchhhhHHHHHhhc--Ce--EEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------C
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YT--LYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------K 79 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~--~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~ 79 (245)
-.+++|+||.|+ +++.. +. .+| +..+.........+.+.+|+.+++.++||||+++++.+... .
T Consensus 5 ~~ig~G~~g~V~-----~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 5 KTLGEGEFGSVM-----EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred cccCcccCceEE-----EeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 358999999995 55444 33 355 22222223345577889999999999999999999876432 2
Q ss_pred EEEEEEeccCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
..+++|||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887631 23788899999999999999999999999999999999999999999999999
Q ss_pred eecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 153 MRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 153 ~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+....... ......+.+||......+ .++|+||+|++++++++ |.+||.+..+......+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 87643321 111223567777766555 67899999999999998 899998876655555444443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=213.63 Aligned_cols=198 Identities=33% Similarity=0.529 Sum_probs=162.6
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
++.|++|.|+ +++.+ |+.+| ++.+...........+.+|+.+++.++||||+++++.+..+...|+++|++
T Consensus 1 lg~g~~~~vy-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVF-----LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEE-----EEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 4778999994 66665 88888 333333333456778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-------
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------- 160 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------- 160 (245)
++++|.+++.. +.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999998875 4689999999999999999999999999999999999999999999999999876433211
Q ss_pred -----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||....... .++|+||+|++++++++|.+||........+..+..+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 112234678888766655 6889999999999999999999877766666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=215.05 Aligned_cols=203 Identities=20% Similarity=0.232 Sum_probs=153.5
Q ss_pred HHHHHhhhccccccchhhhHHHH------------Hhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeee
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYL------------LKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH 72 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l------------~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 72 (245)
+|.-.-++++|+||+|+.+...- .... +..+|+..-...........+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 44445568999999996321110 1111 3345522211112233456789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHhcCC------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC
Q psy16292 73 FAFQDAKSLYMVMDYMPGGDLVNLMSNYD------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140 (245)
Q Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~ 140 (245)
+++..++..+++|||+++++|.+++.... +++..+..++.+++.||.|||+++++|+||||+||+++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~ 165 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC
Confidence 99999999999999999999999886532 556789999999999999999999999999999999999
Q ss_pred CCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC--ccCCCCCCCCCCC
Q psy16292 141 HGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP--VVPELSGDDDTSN 208 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~--~~~pf~~~~~~~~ 208 (245)
++.++|+|||+++.+..... ......+.+||.....++ .++|+||+||++|++++ +..||.+.++...
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999986543221 111234677887766666 78999999999999997 7788877655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=211.54 Aligned_cols=193 Identities=18% Similarity=0.158 Sum_probs=149.2
Q ss_pred hhccccccchhhhHHHHH--------hhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLL--------KYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~--------~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
.+++|.+|.|+.+..... ... ...+| ++............+.+|+.+++.++||||+++++++..+...+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~-~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVI-LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEE-EeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 478999999974432100 001 22233 22222222344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc-------EEEEeeCcee
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-------LKLADFGTCM 153 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~-------i~l~Dfg~a~ 153 (245)
++|||+++++|..++... .+++..+..++.|++.||.|||+++++||||||+||+++.++. ++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999998887643 4889999999999999999999999999999999999987664 8999999988
Q ss_pred ecCCCCCccccCCCCchhhhhc-CCC-cccCCCcccccceecC-CccCCCCCCCC
Q psy16292 154 RMNKTGTETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVP-PVVPELSGDDD 205 (245)
Q Consensus 154 ~~~~~~~~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~ 205 (245)
............++.+||.+.. ..+ .++|+||+||++|+++ .|.+|+.+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred cccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 7654444444566889998763 333 6789999999999987 68888876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=211.43 Aligned_cols=200 Identities=20% Similarity=0.283 Sum_probs=158.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~ 87 (245)
.+++|.+|+|+ +++.+ ++.+| +..+.........+.+.+|+.+++.++|||++++++.+.. +..++++||+
T Consensus 7 ~lg~g~~~~v~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 7 VVGKGSYGEVS-----LVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred EecCCCCeEEE-----EEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 47888999994 56555 77777 2222222333456678999999999999999999998864 4578999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+++++|.+.+.. ..+++..+..++.+++.|+.++|+++++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccc
Confidence 999999998864 2479999999999999999999999999999999999999999999999999987643322
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
......+.+||.+.+..+ .++|+||+|++++++++|..||.+.+.......+..+.
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd08223 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218 (257)
T ss_pred ccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 122344788998877665 67899999999999999999998765544433444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=208.36 Aligned_cols=196 Identities=21% Similarity=0.225 Sum_probs=162.5
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++|.-...++.|++|.|+ ++..+ ++.+| +.-+.. ...+.+.+|+++++.++||||+++++.+.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~-----~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVY-----KAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEE-----EEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 456777789999999994 55555 67777 222211 1167899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
|+++|++++++|.+++.. ..+++..+..++.+++.|+.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999999998864 357899999999999999999999999999999999999999999999999988765433
Q ss_pred C----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 160 T----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
. .....++.+||.+.+..+ .++|+||+|++++++++|.+||....+....
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 1 122345788998877666 6799999999999999999999877655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=215.43 Aligned_cols=199 Identities=17% Similarity=0.126 Sum_probs=150.6
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE--EEehhhh-hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA--LYSRYFQ-IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a--v~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
++++|+||+|+ +++.. +..++ +++.... ......+.+.+|+.+++.++||||+++++.+.+....++||||
T Consensus 2 ~lg~G~~g~v~-----~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVL-----LSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEE-----EEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 58999999995 44432 22222 2222221 1123467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC----
Q psy16292 88 MPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT---- 158 (245)
Q Consensus 88 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~---- 158 (245)
+++|+|.+++... ..++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999988643 2566677889999999999999999999999999999999999999999987643211
Q ss_pred --CCccccCCCCchhhhhcC-------C-CcccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 159 --GTETKRLGRNGIEEIKAH-------P-FFINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 --~~~~~~~~~~~~e~i~~~-------~-~~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
........+.+||.+... + ..++|+||+|++++++++ +.+||.+..+...+.++..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence 112223446788876431 1 257899999999999985 67888776666555555444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=214.11 Aligned_cols=208 Identities=18% Similarity=0.187 Sum_probs=159.6
Q ss_pred chHHHHHHhhhccccccchhhhHHHH-----------Hhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccce
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYL-----------LKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIV 69 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l-----------~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 69 (245)
+.++|.-.-++++|+||.|+.+.... +... +..+|+..-.........+.+.+|+.++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45667777789999999996322110 1111 3445521111111224567789999999999999999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceE
Q psy16292 70 QLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137 (245)
Q Consensus 70 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil 137 (245)
++++++..++..+++||++++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999999999988653 3788999999999999999999999999999999999
Q ss_pred ecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC--ccCCCCCCCCCCC
Q psy16292 138 LDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP--VVPELSGDDDTSN 208 (245)
Q Consensus 138 ~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~--~~~pf~~~~~~~~ 208 (245)
++.++.++|+|||+++....... .....++.+||.+....+ .++|+||+|+++|++++ +.+||...++...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 99999999999999987543321 112234788998876544 78999999999999987 6788876655443
Q ss_pred Cc
Q psy16292 209 FD 210 (245)
Q Consensus 209 ~~ 210 (245)
+.
T Consensus 243 ~~ 244 (296)
T cd05051 243 IE 244 (296)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=212.06 Aligned_cols=203 Identities=22% Similarity=0.290 Sum_probs=162.7
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.-++++|.||++ ++++.+ |+.|| +..+...........+.+|+.+++.++||||+++++++...++.++|+|
T Consensus 5 ~~~lg~g~~g~~-----~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 5 VKKIGEGSFGKA-----ILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred EEEeccCCceEE-----EEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 346889999999 455555 78888 2222222233456678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 87 YMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
|+++++|.+.+... .+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++++|||.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999988643 4788999999999999999999999999999999999999999999999999876543221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....+.+||...+..+ .++|+||+|++++++++|..||......+...++..+..
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY 218 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC
Confidence 22344778888766555 678999999999999999999976655555555544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=221.18 Aligned_cols=209 Identities=16% Similarity=0.155 Sum_probs=157.6
Q ss_pred HHHHhhhccccccchhhhHHHHH-hhc---CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLL-KYR---YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~-~~~---~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
|+-...+++|+||.|+.+...-. +.. +..+|+............+.+.+|+.+++++ +||||+++++++...+.+
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 33344589999999953322111 111 2345522111112233467789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
++++||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~ 173 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVM 173 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcE
Confidence 9999999999999988642 25667788899999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCCc---cc---cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 145 KLADFGTCMRMNKTGTE---TK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~---~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
+|+|||+++........ .. ...+.+||.+....+ .++|+||+|++++++++ |.+||.+.+....+..+...
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252 (334)
T ss_pred EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11 123788998877666 67899999999999997 88999877655555555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=213.30 Aligned_cols=201 Identities=19% Similarity=0.267 Sum_probs=155.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
+|.-.-+++.|+||.|+ +++.. ...+|+ ++.. ......+.+.+|+.+++.++||||+++++.+.. ...++|
T Consensus 7 ~~~~~~~lg~g~~~~v~-----~~~~~~~~~val-K~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 7 SLRLEVKLGQGCFGEVW-----MGTWNGTTRVAI-KTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred HeeEeeecCCCCCCcEE-----EEEecCCceEEE-Eecc-cCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 34444458889999995 55444 334552 2111 122334678999999999999999999998754 568999
Q ss_pred EeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 85 MDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|||+++++|.+++... .+++..+..++.+++.||.++|+.+++|+||+|+||+++.++.++|+|||.++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999998752 4788899999999999999999999999999999999999999999999999876433221
Q ss_pred -----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 162 -----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 -----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
.....+.+||.+...++ .++|+||+|+++|++++ |.+||.+..+......+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~ 218 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc
Confidence 12234788898766555 68899999999999998 8999988766555554433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=210.62 Aligned_cols=206 Identities=20% Similarity=0.239 Sum_probs=163.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
|.-...++.|++|+|+ .+... +..+|+..-...........+.+|+.+++.++||||+++++.+......+++
T Consensus 3 y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 3 YELIEVIGVGATAVVY-----AAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred ceeeeeecCCCCeEEE-----EEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 3344568889999995 44433 6677722211111122567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 85 MDYMPGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|++++++|.+.+.. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999998864 3478999999999999999999999999999999999999999999999999876654322
Q ss_pred c--------cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 E--------TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 ~--------~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
. ....++.+||.+... .+ .++|+||+|++++++++|.+||...+....+.+.....+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC
Confidence 2 123346788887665 33 789999999999999999999988777666666555533
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=212.12 Aligned_cols=158 Identities=19% Similarity=0.250 Sum_probs=132.5
Q ss_pred chHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy16292 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGF 126 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (245)
....+.+|+.+++.++||||+++++++..+...++||||+++++|..++.. +.+++.++..++.|++.||.|||++++
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL 138 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 345788899999999999999999999999999999999999999988864 358899999999999999999999999
Q ss_pred eeCCCCCCceEecCCC-------cEEEEeeCceeecCCCCCccccCCCCchhhhhcC-CC-cccCCCcccccceec-CCc
Q psy16292 127 VHRDVKPDNMLLDKHG-------HLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECV-PPV 196 (245)
Q Consensus 127 ih~dlkp~nil~~~~~-------~i~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~-~~~ 196 (245)
+||||||+||+++..+ .++++|||.+..............+.+||.+... .+ .++|+||+|++++++ .+|
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999997643 4799999988765433333344557888888653 23 678999999999988 589
Q ss_pred cCCCCCCCCC
Q psy16292 197 VPELSGDDDT 206 (245)
Q Consensus 197 ~~pf~~~~~~ 206 (245)
.+||.+..+.
T Consensus 219 ~~p~~~~~~~ 228 (274)
T cd05076 219 EVPLKERTPS 228 (274)
T ss_pred CCCccccChH
Confidence 9999876544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=215.28 Aligned_cols=194 Identities=22% Similarity=0.333 Sum_probs=159.3
Q ss_pred HHHhh-hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 8 MHRYR-RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 8 ~~~y~-~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+.+. +++|++|.|+ ++..+ |+.+|+++- ..........+.+|+.+++.++||||+++++.+...++.+++
T Consensus 22 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~v~iK~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 22 LDNFIKIGEGSTGIVC-----IATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred hhhHHHcCCCCCeEEE-----EEEEcCCCeEEEEEEe-cccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 33444 8999999994 55554 777774322 222234556789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
|||+++++|.+++....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 96 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9999999999988877889999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.....++.+||.+...++ .++|+||+|++++++++|.+||.+.....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 122344788898866555 78899999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=224.55 Aligned_cols=192 Identities=17% Similarity=0.197 Sum_probs=153.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~ 82 (245)
.+++|+||.|+ ++.++ |+.+|+.. +....+......+.+|+.+++.++||||+++++++... ...|
T Consensus 23 ~lg~g~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 23 PIGSGAQGIVC-----AAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred EeccCCCEEEE-----EEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 38899999994 66655 88888322 21122234456788999999999999999999998644 3579
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
+||||+ .++|.+.+... +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.........
T Consensus 98 lv~e~~-~~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 175 (353)
T cd07850 98 LVMELM-DANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175 (353)
T ss_pred EEEecc-CCCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCC
Confidence 999999 56888877654 8888999999999999999999999999999999999999999999999998765433222
Q ss_pred ---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 163 ---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 163 ---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
....+.+||.+.+..+ .++|+||+||++++|++|..||.+.+....+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred CCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 2344788999887776 77899999999999999999998765433333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=248.63 Aligned_cols=224 Identities=19% Similarity=0.268 Sum_probs=175.7
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.++.|.||+|+ ..+... |...| +-.+.......-...+.+|..++..++|||+|++|++=...+.++|.|||
T Consensus 1240 g~~Ig~G~fG~VY----tavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVY----TAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred ccccCCcceeeeE----EeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 3458888999995 223223 88778 43344444456677799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-C----c
Q psy16292 88 MPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-T----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~----~ 161 (245)
|.+|+|.+++..++ .++.....+..|++.|+.|||++|||||||||.||+++..|.+|++|||.|..+...- + -
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99999999998765 6777888889999999999999999999999999999999999999999999876442 1 1
Q ss_pred cccCC---CCchhhhhcCCC----cccCCCcccccceecCCccCCCCCC-CCCCCCcccCcCCCCCCCCCCCccccCCCC
Q psy16292 162 TKRLG---RNGIEEIKAHPF----FINDQWTFSNLRECVPPVVPELSGD-DDTSNFDDIEKDESPEENFPVPKAFAGNHL 233 (245)
Q Consensus 162 ~~~~~---~~~~e~i~~~~~----~~~Diws~g~~~~~~~~~~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (245)
....| |++||.|.+... -++||||+||+.-+|+||+.|++.- +...++-++-.+..| +.|..++...+
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P----q~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP----QIPERLSSEGR 1471 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC----CCchhhhHhHH
Confidence 22333 789999976543 4679999999999999999998754 344444445555443 45555677777
Q ss_pred Ccccceee
Q psy16292 234 PFVGFTYS 241 (245)
Q Consensus 234 ~f~~f~~~ 241 (245)
+|...=+.
T Consensus 1472 dFle~Cl~ 1479 (1509)
T KOG4645|consen 1472 DFLEHCLE 1479 (1509)
T ss_pred HHHHHHHh
Confidence 77765443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=231.55 Aligned_cols=196 Identities=18% Similarity=0.217 Sum_probs=146.1
Q ss_pred HHHHHHhh----hccccccchhhhHH------HHHhh---c---CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCc
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFE------YLLKY---R---YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSE 66 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~------~l~~~---~---~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp 66 (245)
+.|.++|+ |++|+||+|+.+-. ..+.. . +...+ ++.|...........+.+|+.+|++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 45677775 78899999962210 00000 0 12222 11222222233456788999999999999
Q ss_pred cceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC
Q psy16292 67 WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140 (245)
Q Consensus 67 ~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~ 140 (245)
||+++++++...+..|++++++ +++|..++.... .....+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999999999999999999999 567777664322 335567789999999999999999999999999999999
Q ss_pred CCcEEEEeeCceeecCCCCC-----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccC-CCC
Q psy16292 141 HGHLKLADFGTCMRMNKTGT-----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVP-ELS 201 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~-----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~-pf~ 201 (245)
++.++|+|||+++.+..... ......|.+||.+.+..+ .++|+||+||++++|+++.. |+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999987654322 123344788999888777 77899999999999998764 444
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=212.99 Aligned_cols=192 Identities=21% Similarity=0.243 Sum_probs=154.5
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEE-Eehhh----hhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYF----QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
-.++.|+||+|+ ++... |..+|+ ..+.. ........++.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 6 ~~ig~g~~~~v~-----~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 6 EVLGKGAYGTVY-----CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ceEeccCCeEEE-----EEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 357899999995 44444 777772 22211 11123456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---- 159 (245)
+||+++++|.+++.. ..+++..+..++.|++.||.|+|+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999998876 458899999999999999999999999999999999999999999999999987643211
Q ss_pred ------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 160 ------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 160 ------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.......+.+||.+....+ .++|+||+|++++++++|.+||.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 1122344778888876655 77899999999999999999997654433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=216.19 Aligned_cols=196 Identities=18% Similarity=0.199 Sum_probs=156.6
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
.|...-.+++|++|+|+ +++.+ |+.||+ +.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 16 ~y~~~~~lg~g~~g~vy-----~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVY-----FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred hhhhheeecCCCCeEEE-----EEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 35555568899999994 65554 888882 2222222223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++|+||++ |++.+.+. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 99999995 67777664 3358899999999999999999999999999999999999999999999999998765444
Q ss_pred CccccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 160 TETKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.......+.+||.+.+ ..+ .++|+||+|++++++++|.+||.+..+..
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 4444455788887742 223 68999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=210.65 Aligned_cols=187 Identities=19% Similarity=0.217 Sum_probs=148.5
Q ss_pred hhccccccchhhhHHHHHhhc--C------eEE--EEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y------TLY--ALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~------~~~--av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
.+++|+||.|+ ++..+ + +.+ .+..|...........+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~lg~G~~~~v~-----~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 2 HLGQGTFTNIY-----KGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred cccccccceEE-----EEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47899999995 44443 2 111 12222222222226788999999999999999999999988 778
Q ss_pred EEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-------cEEEEeeCce
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-------HLKLADFGTC 152 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-------~i~l~Dfg~a 152 (245)
++||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999988754 488899999999999999999999999999999999999887 7999999999
Q ss_pred eecCCCCCccccCCCCchhhhhcC--CC-cccCCCcccccceecCC-ccCCCCCCC
Q psy16292 153 MRMNKTGTETKRLGRNGIEEIKAH--PF-FINDQWTFSNLRECVPP-VVPELSGDD 204 (245)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~e~i~~~--~~-~~~Diws~g~~~~~~~~-~~~pf~~~~ 204 (245)
..............+.+||.+... .+ .++|+||+|++++++++ +.+|+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 876554333444567889988665 33 77899999999999988 578887664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=214.56 Aligned_cols=194 Identities=21% Similarity=0.310 Sum_probs=155.2
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc---cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK---RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+..-.+++|++|.|+ +++.+ |+.+| ++++..... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~lg~g~~~~v~-----~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 3 LKGQQLGTGAFSSCY-----QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred cccceecCcCceEEE-----EEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 334458899999995 45443 77888 222221111 1235678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~ 158 (245)
.++|+||+++++|.+++... .+++..+..++.|++.||.+||+++++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999988754 578999999999999999999999999999999999998776 5899999998876533
Q ss_pred CC--------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 159 GT--------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 159 ~~--------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.. .....++.+||.+.+..+ .++|+||+|++++++++|.+||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 11 112334778888876655 7889999999999999999999765443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=209.69 Aligned_cols=196 Identities=17% Similarity=0.226 Sum_probs=156.2
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
.++.|++|.|+ ++... ++.+|+..-...........+.+|+.++++++||||+++++++......++|||++++
T Consensus 2 ~lg~g~~g~v~-----~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 2 KIGKGNFGDVY-----KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred ccccCCCceEE-----EEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 47889999995 55444 7777732211111113456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------cc
Q psy16292 91 GDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ET 162 (245)
Q Consensus 91 g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~ 162 (245)
++|.+++.. ..+++..+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999998864 3478888999999999999999999999999999999999999999999999886542111 11
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
....+.+||.+.+.++ .++|+||+|++++++++ |.+||.+.........+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 1234788998876655 78999999999999998 89999877655444444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=210.15 Aligned_cols=191 Identities=17% Similarity=0.221 Sum_probs=151.1
Q ss_pred HHHHhhhccccccchhhhHHHHHh----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLK----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-- 78 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 78 (245)
|+....+++|+||.|+ +|+ .+ ++.+|++.-...........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 6 LKRIRDLGEGHFGKVE-----LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhceecCCCCceeEE-----EEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4556669999999995 443 22 7777732221122234456789999999999999999999998875
Q ss_pred CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
...++||||+++++|.+++... .+++..+..++.+++.||.|+|++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 5789999999999999988653 47889999999999999999999999999999999999999999999999998764
Q ss_pred CCCCc-------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 157 KTGTE-------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 157 ~~~~~-------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
..... .....+.+||.+.+..+ .++|+||+|+++++++++..|...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcc
Confidence 33221 11223678888766555 679999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=214.24 Aligned_cols=203 Identities=21% Similarity=0.305 Sum_probs=162.2
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
+...-.++.|.+|.|+ ++..+ ++.+|++. .........+.+.+|+.+++.++||||+++++++...++.+++
T Consensus 21 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~iK~-~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVC-----IATDKSTGRQVAVKK-MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEE-----EEEECCCCCEEEEEE-EeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 3333358999999994 55544 66666322 1222234456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+||+++++|.+++....+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9999999999999887789999999999999999999999999999999999999999999999998875432211
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+.+.++ .++|+||+|++++++++|.+||.+.++......+...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence 122345788998877666 7899999999999999999999876554444433333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=211.11 Aligned_cols=187 Identities=24% Similarity=0.360 Sum_probs=146.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHH---HHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDI---MAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~i---l~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
++.|+||.|+ ++++. ++.|| ++.+..............|..+ ++..+||+|+++++++.+.+.+++||
T Consensus 2 ig~g~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 2 IGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred cccCCCeEEE-----EEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEE
Confidence 6889999994 55554 78888 3333322222222234444443 44458999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--cc
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--ET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--~~ 162 (245)
||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 77 e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcC
Confidence 999999999888654 489999999999999999999999999999999999999999999999999876543221 22
Q ss_pred ccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 163 KRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 163 ~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
....+.+||.+... .+ .++|+||+|++++++++|.+||.+..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 33447788988643 34 67899999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=225.16 Aligned_cols=217 Identities=21% Similarity=0.279 Sum_probs=176.8
Q ss_pred HhhhccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.+|.|.||.|+++....-+ +|+..| |..-+.....++.+.|+.|+.+|++++||||+++++++.+. ..|||||+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 445888999999855544443 344444 32222334456688999999999999999999999999865 69999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccC
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~ 165 (245)
++-|.|..+++.. .++......++.||+.||.|||+.+++||||..+||++.+...+||.|||+++.+..+.......
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 9999999999865 48888999999999999999999999999999999999999999999999999887665443333
Q ss_pred C-----CCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcCCCCC-CCCCCCccc
Q psy16292 166 G-----RNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKDESPE-ENFPVPKAF 228 (245)
Q Consensus 166 ~-----~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (245)
| +++||.|.-..| .++|+|-|||++|+++ .|+-||.|-...+....+..|+.++ |+..+|..+
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 3 689999988888 7889999999998655 8999999999999999999886544 444555443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=219.88 Aligned_cols=191 Identities=16% Similarity=0.186 Sum_probs=152.0
Q ss_pred hhccc--cccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQ--KYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~--~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
++++| +|++| ++|+++ |+.|| ++.+.........+.+.+|+.+++.++||||++++++|..++..++|+|
T Consensus 5 ~ig~g~~~~~~v-----~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 5 EIGRGFCNLTSV-----YLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HhCCcccCceeE-----EEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 45556 88889 477765 89999 3333222223345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 87 YMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
|+.+++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999988753 488899999999999999999999999999999999999999999999986543221111
Q ss_pred --------ccccCCCCchhhhhcCC--C-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 --------ETKRLGRNGIEEIKAHP--F-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 --------~~~~~~~~~~e~i~~~~--~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
......+.+||.+.+.. + .++|+||+||+++++++|.+||.+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 11123378888886532 3 67899999999999999999998765433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=240.04 Aligned_cols=200 Identities=20% Similarity=0.223 Sum_probs=167.5
Q ss_pred hccccccchhhhHHHHHhhc-Ce----EEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR-YT----LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~-~~----~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
||+|.||.|+.+ .++.. |. .||+++.....+.++...|++|+.+|++++|||||++++++.+....+|++||
T Consensus 700 lG~G~FG~VY~g---~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 700 LGKGAFGEVYEG---TYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eccccccceEEE---EEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 899999999521 22222 43 35666666666778899999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 88 MPGGDLVNLMSNY--------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 88 ~~~g~L~~~l~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
|.+|+|..+|++. .++......++.+|+.|+.||+++++|||||..+|+|++....+|+.|||+|+.+....
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~ 856 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKD 856 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhch
Confidence 9999999999864 37778899999999999999999999999999999999999999999999999543221
Q ss_pred C------ccccCCCCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcC
Q psy16292 160 T------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~ 215 (245)
. ......+++||.++...| .++|+|||||++||++ -|..||.+.+..+.+.-+..+
T Consensus 857 yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 857 YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 1 122344789999998887 7899999999999887 588999999888888765555
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=215.12 Aligned_cols=203 Identities=18% Similarity=0.165 Sum_probs=160.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
.|...-.++.|+||.|+ +++.. |..+|+ +.+...........+.+|+.+++.++|||++++++++.++...
T Consensus 26 ~f~~~~~lg~G~~~~v~-----~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVY-----FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEE-----EEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 46667779999999994 66554 777873 2222222233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++||||++ |++.+.+.. ..+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 99999995 577776643 357889999999999999999999999999999999999999999999999988765444
Q ss_pred CccccCCCCchhhhhc---C-CCcccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 160 TETKRLGRNGIEEIKA---H-PFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~---~-~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
.......+.+||.+.. . ...++|+||+||+++++++|.+||.+.........+..
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 4444556788988742 2 23678999999999999999999987655444344433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=213.84 Aligned_cols=205 Identities=20% Similarity=0.221 Sum_probs=157.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+|.-.-.+++|+||.|+ ++... ...+|+............+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 7 ~~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 7 DITLGRCIGEGQFGDVY-----QGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hceeeeeeCCccceeEE-----EEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 34444568999999995 44332 123442222221213455678999999999999999999998875 45
Q ss_pred EEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++|||++++++|.+++... .+++..+..++.+++.||.|+|+++++|+||||+||+++..+.++++|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999999999998753 4789999999999999999999999999999999999999999999999999875433
Q ss_pred CCc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 159 GTE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 159 ~~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
... .....+.+||.+....+ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 211 11234788998876665 78899999999999885 999998877665555554443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=208.35 Aligned_cols=193 Identities=17% Similarity=0.202 Sum_probs=153.6
Q ss_pred hhccccccchhhhHHHHHhhc---C--eEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---Y--TLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~--~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.+++|++|.|+ +++.. + ..+|+ ..+..... ...+.+.+|+.++++++||||+++++.+.. ...++++
T Consensus 2 ~ig~g~~~~v~-----~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 2 KLGDGSFGVVR-----RGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred cCCccCcccEE-----eeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 47899999995 44322 3 34562 21111111 556789999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 86 DYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
|++++++|.+.+... .+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999988654 478899999999999999999999999999999999999999999999999987654221
Q ss_pred -----ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.....++.+||.+....+ .++|+||+|+++++|++ |.+||.+.+.......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 212 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 122345788898876555 67899999999999998 9999976655444333
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=208.78 Aligned_cols=200 Identities=19% Similarity=0.248 Sum_probs=158.9
Q ss_pred hhccccccchhhhHHHHHhhc--C----eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y----TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~----~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.+++|+||.|+ .++.. + ..+|+..-...........+..|+.+++.++||||+++++++.+.+..+++|
T Consensus 6 ~lg~g~~g~v~-----~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 6 KLGEGAFGEVY-----KGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred eeccCCCcceE-----EEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 57899999995 44444 2 6666322212122225678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 86 DYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
|++++++|.+++.... +++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 9999999999886542 8999999999999999999999999999999999999999999999999998765432211
Q ss_pred -----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 163 -----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 -----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+.+||.+....+ .++|+||+|++++++++ |.+||.+.+.......+....
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 221 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY 221 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 2244778888855444 78999999999999987 889998765555444444443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=218.03 Aligned_cols=196 Identities=21% Similarity=0.265 Sum_probs=157.2
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEE-Eehhhhhc---cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIK---RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
-.+++|.+|.|+ ++..+ |+.||+ ..+..... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 6 ~~lg~g~~~~vy-----~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 6 KKLGEGTYAVVY-----KARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred eeeeeccccEEE-----EEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 358899999994 66554 788882 22222111 22345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 85 MDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
|||+ +++|.+++.... +++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 999999987654 8999999999999999999999999999999999999999999999999998765432211
Q ss_pred ----ccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 163 ----KRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 163 ----~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
....+.+||.+.+. .+ .++|+||+||+++++++|.+||.+..+...+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 12336788887543 33 6789999999999999999999887765544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=211.79 Aligned_cols=204 Identities=18% Similarity=0.234 Sum_probs=158.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
-++|.-.-.++.|++|.|+ ++... +..+|+ +... ......+.+.+|+.+++.++|||++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~-----~~~~~~~~~~~l-K~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVW-----MGTWNGTTKVAI-KTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEE-----EEEEcCCceEEE-EEcc-cCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3455555568999999995 56555 434552 2111 12233467889999999999999999998875 45688
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++|||+++++|.+++... .+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999988653 36888899999999999999999999999999999999999999999999998754332
Q ss_pred Cc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 TE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.. ....++.+||.+..... .++|+||+|+++|++++ |.+||.+..+......+...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 11 12234788888765554 67899999999999998 99999887766555544433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=211.61 Aligned_cols=200 Identities=19% Similarity=0.285 Sum_probs=156.3
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+++.-.-++++|+||.|+ ++... +..+|+.. .. ........+.+|+.+++.++|+||+++++.+.. ...++
T Consensus 6 ~~~~~~~~lg~g~~~~vy-----~~~~~~~~~~~iK~-~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVW-----MATYNKHTKVAVKT-MK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cceeEEeEecCccceEEE-----EEEecCCccEEEEe-cC-CChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 444445568999999995 55444 55566311 11 112345678999999999999999999999887 77899
Q ss_pred EEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+|||+++++|.+++... ..++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999998653 367788899999999999999999999999999999999999999999999986643222
Q ss_pred c-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 161 E-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 161 ~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
. .....+.+||.+....+ .++|+||+|++++++++ |.+||.+.++......+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 1 11234788898876555 67899999999999998 99999877654444433
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=219.36 Aligned_cols=201 Identities=17% Similarity=0.183 Sum_probs=152.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC-CE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA-KS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-~~ 80 (245)
++|.-.-.||+|+||.|+.+....+... ++.||++.............+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3444455599999999964443333222 7788832211111233456789999999999 789999999988654 56
Q ss_pred EEEEEeccCCCCHHHHHhcC------------------------------------------------------------
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY------------------------------------------------------------ 100 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------ 100 (245)
++++|||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999999999887532
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------ccccCC
Q psy16292 101 --------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLG 166 (245)
Q Consensus 101 --------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~ 166 (245)
.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++........ ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 146667788999999999999999999999999999999999999999999986532211 111233
Q ss_pred CCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCC
Q psy16292 167 RNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDD 205 (245)
Q Consensus 167 ~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~ 205 (245)
+.+||.+....+ .++|+||+|++++++++ |.+|+.+...
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 678888866655 67899999999999985 9999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=212.08 Aligned_cols=203 Identities=18% Similarity=0.263 Sum_probs=161.7
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
+|.-.-.++.|++|+|+ ++..+ +..+|++. .. ......+.+.+|+.++++++||||+++++++......+++
T Consensus 7 ~~~i~~~ig~g~~~~v~-----~~~~~~~~~~~vK~-~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 7 SLKLERKLGAGQFGEVW-----MGTWNGTTKVAVKT-LK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred heeeeeeeccCcceEEE-----EEEEcCCceEEEEE-ec-CCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 34444457899999995 45444 55566321 11 2223456789999999999999999999999998999999
Q ss_pred EeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 85 MDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
||++++++|.+++... .+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999998653 478899999999999999999999999999999999999999999999999987653211
Q ss_pred ----ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+.+... .++|+||+|++++++++ |.+||.+..+.....++..+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 111234788998876555 67899999999999998 99999887766666655443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=225.48 Aligned_cols=177 Identities=16% Similarity=0.106 Sum_probs=145.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+ ++++. ++.+|++. .....+.+|+.+|++++||||+++++++..++..++|||++
T Consensus 176 ~Lg~G~~G~Vy-----~a~~~~~~~~vavK~-------~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 176 ALTPGSEGCVF-----ESSHPDYPQRVVVKA-------GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred EEccCCCeEEE-----EEEECCCCCEEEEec-------ccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 47889999994 66665 66666432 12234678999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------c
Q psy16292 90 GGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------E 161 (245)
Q Consensus 90 ~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~ 161 (245)
.++|..++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....... .
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 57888877543 589999999999999999999999999999999999999999999999999986543221 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
....+|.+||.+.+..+ .++|+||+||++|+++++..|+.
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 23445789999987776 67899999999999988775543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=214.12 Aligned_cols=184 Identities=22% Similarity=0.239 Sum_probs=148.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|.+|+|+ +|+.+ |+.+| +..+...........+.+|+.+++.++||||+++++++.+...+++++||+
T Consensus 7 ~l~~g~~~~vy-----~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 7 KIGEGTYGTVF-----KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred EecccCCeEEE-----EEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 47889999994 56655 88888 222222223344566888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----c
Q psy16292 89 PGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----T 162 (245)
Q Consensus 89 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----~ 162 (245)
. ++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++........ .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 5 678777653 45899999999999999999999999999999999999999999999999999865433221 1
Q ss_pred ccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCC
Q psy16292 163 KRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
....+.+||.+.+.. + .++|+||+||++++|++|..|+.
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 234478899886643 3 67899999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=214.93 Aligned_cols=208 Identities=17% Similarity=0.161 Sum_probs=160.8
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhh-------cCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKY-------RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF 75 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~-------~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 75 (245)
+-.+|...-++++|+||.|+ +|+. .+..+|+..-...........+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVF-----QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred ChHhceecccccccccccEE-----EEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 34677777789999999995 4433 15666622111111123346688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSNY-----------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVK 132 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlk 132 (245)
..+...++++||+++++|.+++... .+++..+..++.+++.||.++|+++++|+||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9999999999999999999988632 25677888999999999999999999999999
Q ss_pred CCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCC
Q psy16292 133 PDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDD 204 (245)
Q Consensus 133 p~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~ 204 (245)
|+||+++.++.++|+|||+++....... ......+.+||.+....+ .++|+||+||+++++++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999886543321 112234788998876665 78999999999999997 888887665
Q ss_pred CCCCCcccCcC
Q psy16292 205 DTSNFDDIEKD 215 (245)
Q Consensus 205 ~~~~~~~~~~~ 215 (245)
.......+..+
T Consensus 238 ~~~~~~~~~~~ 248 (288)
T cd05050 238 HEEVIYYVRDG 248 (288)
T ss_pred HHHHHHHHhcC
Confidence 54444444333
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=209.45 Aligned_cols=196 Identities=21% Similarity=0.306 Sum_probs=155.8
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC--
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA-- 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-- 78 (245)
-+.|.-...+++|+||.|+ +++.+ ++.+|+.... ........+..|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy-----~~~~~~~~~~~aik~~~--~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 5 AGIFELVELVGNGTYGQVY-----KGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhHHHheeecCCeEEE-----EEEEcCCCcEEEEEEEE--cCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 3457777779999999994 55554 7777732211 1234456788999999998 799999999998753
Q ss_pred ----CEEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCc
Q psy16292 79 ----KSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 79 ----~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
..+|++|||+++++|.+++... .+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999988752 478999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCC----ccccCCCCchhhhhcC-----CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 152 CMRMNKTGT----ETKRLGRNGIEEIKAH-----PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 152 a~~~~~~~~----~~~~~~~~~~e~i~~~-----~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
+........ ......+.+||.+... .+ .++|+||+||+++++++|.+||....+.
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 986543221 1223347888987532 23 5789999999999999999999765443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=214.30 Aligned_cols=208 Identities=14% Similarity=0.180 Sum_probs=167.6
Q ss_pred HHHhh----hccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcC--Cc----cceeeeEEEE
Q psy16292 8 MHRYR----RYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN--SE----WIVQLHFAFQ 76 (245)
Q Consensus 8 ~~~y~----~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~--hp----~Iv~l~~~~~ 76 (245)
.+||. +|.|.||+|-+|++-.. +..+| ++.|.. ..-.+..+-|+++|+++. .| .++++.++|.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~---~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET---KEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC---CceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 45665 78899999966555444 77888 444433 245567888999999993 23 3888999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC------------
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH------------ 141 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~------------ 141 (245)
-.++.|||+|.+ |.|+.++++++ .++...++.++.|++.++.+||+.+++|.||||+||++-+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999999 88999999875 48999999999999999999999999999999999998321
Q ss_pred --------CcEEEEeeCceeecCCCCCc-cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 142 --------GHLKLADFGTCMRMNKTGTE-TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 142 --------~~i~l~Dfg~a~~~~~~~~~-~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
..|+++|||.|+...+.... -.+..|++||.|.+.+| +++|+||+||+|.++.+|...|.+-.+.+-+..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 24899999999987655433 23445899999999999 899999999999999999999998887775555
Q ss_pred cCcCCCCCCCC
Q psy16292 212 IEKDESPEENF 222 (245)
Q Consensus 212 ~~~~~~~~~~~ 222 (245)
+..-.+|.|+.
T Consensus 321 MerIlGp~P~~ 331 (415)
T KOG0671|consen 321 MERILGPIPSR 331 (415)
T ss_pred HHHhhCCCcHH
Confidence 55444554443
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=209.98 Aligned_cols=204 Identities=16% Similarity=0.163 Sum_probs=162.3
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++.+|.-...+++|+||.|+ ++... +..+|+.... ........+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~-----~~~~~~~~~~~~k~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVW-----LGYWLEKRKVAIKTIR--EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEE-----EEEEeCCCeEEEEECC--CCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 45567777789999999995 55444 6666732111 1122345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++++||+++++|.+++... .+++..+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999999999988643 47888999999999999999999999999999999999999999999999998654322
Q ss_pred Cc-----cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 160 TE-----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 160 ~~-----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
.. ....++.+||.+.+..+ .++|+||+|+++|++++ |.+||...........+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence 11 11245788998876555 67899999999999997 999998766555444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=214.97 Aligned_cols=194 Identities=21% Similarity=0.256 Sum_probs=156.3
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-...+++|.+|.|+ ++..+ |+.+|+.. +.........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 3 y~~~~~lg~g~~~~vy-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 3 YENLGLVGEGSYGMVM-----KCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred eeEeeeeccCCCeEEE-----EEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 3344568999999994 56655 78888322 2222222345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
|+||+++++|..+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999988888876543 5899999999999999999999999999999999999999999999999999876443221
Q ss_pred ---cccCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.+.. ..++|+||+|++++++++|.+||.+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 1233467888876533 2679999999999999999999976653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=213.13 Aligned_cols=196 Identities=20% Similarity=0.244 Sum_probs=155.2
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 79 (245)
+..+|...-.+++|+||.|+ +++++ |+.+|+..-...........+.+|+.++.++. ||||+++++++..+.
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVN-----KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred cHHHhHHHHHhCCCCceEEE-----EEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 35678888889999999994 55555 78888332211112244567889999999995 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 80 SLYMVMDYMPGGDLVNLMS------NYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
..+++||++ ++++.++.. ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 77 DCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 999999998 456655332 2458999999999999999999997 59999999999999999999999999999
Q ss_pred eecCCCCCc---cccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 153 MRMNKTGTE---TKRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 153 ~~~~~~~~~---~~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
+........ .....+.+||.+... .+ .++|+||+|++++++++|.+||....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 765433222 223447889988765 23 67899999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=209.50 Aligned_cols=197 Identities=21% Similarity=0.257 Sum_probs=157.3
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEE--ehhh--hhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY--SRYF--QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-- 77 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~--~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 77 (245)
+|...-.++.|+||.|+ ++... |+.||+. ++.. .........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~lg~g~~g~vy-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVY-----LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEE-----EEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 35555668999999995 55544 7788832 2211 1112345678899999999999999999999875
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
...+++++|++++++|.+.+... .+++.....++.|++.||.+||+++++|+||+|+||+++.++.++|+|||+++...
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 36789999999999999988754 57888999999999999999999999999999999999999999999999987653
Q ss_pred CCC-------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 157 KTG-------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 157 ~~~-------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
... ......++.+||.+.+..+ .++|+||+||+++++++|.+||.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 211 1123445789999877666 78899999999999999999998665443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=222.65 Aligned_cols=197 Identities=18% Similarity=0.169 Sum_probs=153.2
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~ 76 (245)
+++.-.-.+|+|+||.|+ +++++ ++.+|+............+.+.+|+.++..+. ||||+++++++.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy-----~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVV-----EATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred HHeehhhhccCCCceeEE-----EEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 344445679999999995 45422 56677222222222334567899999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC--------------------------------------------------------
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY-------------------------------------------------------- 100 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~-------------------------------------------------------- 100 (245)
..+.+++||||+++|+|.+++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999999999988532
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceE
Q psy16292 101 -------------------------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML 137 (245)
Q Consensus 101 -------------------------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil 137 (245)
.+++..+..++.|++.||.|||+.+++||||||+||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 1345567788999999999999999999999999999
Q ss_pred ecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCC
Q psy16292 138 LDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDT 206 (245)
Q Consensus 138 ~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~ 206 (245)
++..+.++|+|||+++....... ......+.+||.+....+ .++|+||+|++++++++ |.+||......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999986533221 111234788998877666 67899999999999997 88888765433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=212.46 Aligned_cols=197 Identities=21% Similarity=0.257 Sum_probs=152.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc----------------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccc
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR----------------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWI 68 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~----------------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~I 68 (245)
.+|.-.-++++|+||.|+ +|+.. ...+|+..-...........+.+|++++++++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~-----~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVH-----LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred HhCeehhccCCCCCceEE-----ecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 355555668999999996 33322 223552211111123345678999999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q psy16292 69 VQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135 (245)
Q Consensus 69 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~n 135 (245)
+++++++......++||||+++++|.+++... .+++..+..++.+++.||.|||+++++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999999999988542 25777889999999999999999999999999999
Q ss_pred eEecCCCcEEEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC--ccCCCCCCCCC
Q psy16292 136 MLLDKHGHLKLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP--VVPELSGDDDT 206 (245)
Q Consensus 136 il~~~~~~i~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~--~~~pf~~~~~~ 206 (245)
|+++.++.++|+|||++......... .....+.+||.+....+ .++|+||+|++++++++ +.+||...+..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999865432211 11234778888766655 78899999999999977 66788765443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=220.57 Aligned_cols=179 Identities=13% Similarity=0.134 Sum_probs=143.9
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|+||.|+ +++.+ ++.+|+... .......|+.+++.++||||+++++++......++|+|++
T Consensus 72 ~~lg~G~~g~Vy-----~~~~~~~~~~valK~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 72 KTLTPGSEGRVF-----VATKPGQPDPVVLKIG-------QKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred EEecCCCCeEEE-----EEEECCCCceEEEEeC-------CccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 357889999994 66666 566663211 1123467999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---ccc
Q psy16292 89 PGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---ETK 163 (245)
Q Consensus 89 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---~~~ 163 (245)
.++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++....... ...
T Consensus 140 -~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g 218 (357)
T PHA03209 140 -SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218 (357)
T ss_pred -CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence 5688887754 3588999999999999999999999999999999999999999999999999875432222 223
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCcc-CCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVV-PELSG 202 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~-~pf~~ 202 (245)
...+.+||.+.+..+ .++|+||+||++|+++++. ++|.+
T Consensus 219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 345788999877776 7889999999999998754 44444
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=231.59 Aligned_cols=188 Identities=16% Similarity=0.185 Sum_probs=146.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC------CccceeeeEEEEeC-CEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN------SEWIVQLHFAFQDA-KSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~~-~~~ 81 (245)
.||+|+||+|+ +|.++ ++.|| ++.+.. .........|+.+++.++ |++++++++++... .++
T Consensus 136 ~lG~G~fg~V~-----~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 136 LLGEGTFGKVV-----EAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred EEEeccCEEEE-----EEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 48999999995 66554 78888 322211 122334566777777764 44588899988765 589
Q ss_pred EEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCC----------------c
Q psy16292 82 YMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHG----------------H 143 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~----------------~ 143 (245)
|+|||++ +++|.+++.. +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 9999998 8888887764 468999999999999999999998 6999999999999998765 4
Q ss_pred EEEEeeCceeecCCCC-CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 144 LKLADFGTCMRMNKTG-TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~-~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
+||+|||.+....... ......+|.+||.+.+.++ .++|+||+||++|+|++|++||.+.++.+.
T Consensus 287 vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 287 VRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred EEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 8999999886533221 1223455899999988887 778999999999999999999988765443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=213.58 Aligned_cols=194 Identities=21% Similarity=0.272 Sum_probs=156.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.++.|.+|.|+ +|+.+ |+.+| +.-+...........+.+|+.+++.++||||+++++++..+...++|+|++
T Consensus 7 ~l~~g~~~~v~-----~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 7 RIGEGAHGIVF-----KAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ecccCCCcEEE-----EEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 47889999994 66554 77777 222222222344677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 89 PGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 89 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 9999998864 3589999999999999999999999999999999999999999999999999987654321 1
Q ss_pred cccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 162 TKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....+.+||.+.... + .++|+||+|++++++++|.+||.+..+...+..
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 2233467888775433 2 678999999999999999999988766544433
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=212.18 Aligned_cols=202 Identities=19% Similarity=0.254 Sum_probs=161.8
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|...-.++.|+||.|+ ++..+ ++.+|+..- ........+.+.+|+.+++.++||||+++++.+......|+
T Consensus 20 ~~~~~~~lg~g~~g~v~-----~~~~~~~~~~v~iK~~-~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 20 KYTRFEKIGQGASGTVY-----TAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hceeeeEecCCCCeEEE-----EEEEcCCCCEEEEEEe-ccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 33333447888999995 44333 677773221 12223445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
|+||+++++|.+++.+..+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 999999999999998878889999999999999999999999999999999999999999999999998765433221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
.....+.+||.+....+ .++|+||+|++++++++|.+||.+..+......+.
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~ 228 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh
Confidence 12233678888766655 67899999999999999999998876655544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=228.65 Aligned_cols=211 Identities=17% Similarity=0.187 Sum_probs=173.7
Q ss_pred hhccccccchhhhHHHHHhhc--C---eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y---TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~---~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.||.|.||.| +..+.+ | ..|||+.-+..-.+++...|+.|+.||.+.+||||++|.++......+.||+|
T Consensus 636 VIGaGEFGEV-----c~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 636 VIGAGEFGEV-----CSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred EEecccccce-----ecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3788999999 555555 4 33444333333445677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc-c
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE-T 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~-~ 162 (245)
||++|+|..+++.+ .++..++..+.+.|+.|+.||.+++.+||||..+|||++++-.+|++|||+++.+..+. .. +
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 99999999999854 58888888999999999999999999999999999999999999999999999764432 22 2
Q ss_pred cc-----CCCCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCCCCCCCCcccCcCCCCCCCCCCCcc
Q psy16292 163 KR-----LGRNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGDDDTSNFDDIEKDESPEENFPVPKA 227 (245)
Q Consensus 163 ~~-----~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (245)
+. ..+.+||.|....| .++|+||+|+++|+.+ .|..|+-+.+.++.+.+|..+-.-+|+.+.|..
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~a 862 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAA 862 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHH
Confidence 33 22689999988888 6789999999997655 788999999999999999888555555555543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=207.98 Aligned_cols=193 Identities=17% Similarity=0.262 Sum_probs=155.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhh-----c-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKY-----R-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD- 77 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~-----~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 77 (245)
+|.-.-.+++|+||.|+ +++. . ++.+|+ .-+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~ig~g~~~~v~-----~~~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 5 HLKFIKQLGEGHFGKVE-----LCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hchhheeeccCCCeeEE-----EeeecCCCCCCceEEEEEEecccc-chHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 44555668999999995 4432 2 677773 222111 11246789999999999999999999999887
Q ss_pred -CCEEEEEEeccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 78 -AKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 78 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
....+++|||+++++|.+++.... +++..+..++.+++.||.+||+++++|+||||+||+++.++.++|+|||.+..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 568999999999999999987654 89999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc-------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 155 MNKTGTE-------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 155 ~~~~~~~-------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
....... .....+.+||.+...++ .++|+||+|++++++++|..|+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 6532211 11223678888876665 78999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=210.99 Aligned_cols=201 Identities=19% Similarity=0.198 Sum_probs=153.5
Q ss_pred hhccccccchhhhHHHHHh--hc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLK--YR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~--~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||.|+.+...-.. .. ++.+|+..-...........+.+|+.+++.++||||+++++++...+..+++||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 4789999999532221111 11 24555211111122245667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-----cEEEEeeCceeec
Q psy16292 89 PGGDLVNLMSN--------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-----HLKLADFGTCMRM 155 (245)
Q Consensus 89 ~~g~L~~~l~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-----~i~l~Dfg~a~~~ 155 (245)
++++|.+++.. ..+++..+..++.+++.|+.|||+.+++|+||+|+||+++.++ .++++|||+++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 99999998853 2367788899999999999999999999999999999999877 8999999999865
Q ss_pred CCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 156 NKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 156 ~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
..... ......+.+||.+....+ .++|+||+|+++|++++ |.+||...++......+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 43221 112345788998876665 77899999999999997 99999876655444443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=207.39 Aligned_cols=198 Identities=34% Similarity=0.575 Sum_probs=163.1
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||.|+ .+... ++.+| ++++....+......+.+|+.+++.++||||+++++.+..+...+++||++
T Consensus 1 lg~G~~~~v~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVL-----LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEE-----EEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 5789999994 45444 77788 444444444456778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----Cccc
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG----TETK 163 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~----~~~~ 163 (245)
++++|.+++... .+++..+..++.|++.|+.++|+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 999999988765 57999999999999999999999999999999999999999999999999998765431 1223
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
..++.+||.+.+..+ .++|+||+|++++++++|..||...........+...
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 445788888876655 6789999999999999999999877654444444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=225.33 Aligned_cols=208 Identities=20% Similarity=0.224 Sum_probs=172.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhcc--CchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKR--SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
+.|.+=-+||-|+||.| |.|+.. .++|||.+.+...+. ..++.++.|+..|++++|||++.+-+||.....
T Consensus 26 klf~dLrEIGHGSFGAV-----YfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAV-----YFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHhcCCcccee-----EEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 35667778999999999 456555 777776555554443 356779999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.|+||||| -||-.+++.- .++.+-.+..++.+.+.||.|||+++.||||||..|||+...|.|||.|||.|....+.
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99999999 6788888763 45788899999999999999999999999999999999999999999999999887766
Q ss_pred CCccccCCCCchhhhhcC--C-C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GTETKRLGRNGIEEIKAH--P-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~~~~~~~~~~~e~i~~~--~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.+.-..+-+++||.|.+. . | -+.||||+|+...+++..+||+...+-.+.+--|-..++|
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC
Confidence 555555557999999653 2 2 5779999999999999999999888877766555444444
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=210.26 Aligned_cols=193 Identities=22% Similarity=0.285 Sum_probs=159.8
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|.-...+++|++|.|+ ++..+ ++.+|+..-...........+.+|+.+++.++||||+++++.+..+..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVS-----KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEE-----EEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 56777889999999994 56555 777773221111122455678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++|++++++|.+++.. ..+++..+..++.+++.|+.++|+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999999875 458899999999999999999999 9999999999999999999999999999876543222
Q ss_pred --ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....++.+||.+.+..+ .++|+||+|++++++++|.+||...
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 223344788998877665 7899999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=217.64 Aligned_cols=195 Identities=22% Similarity=0.286 Sum_probs=155.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|....+++.|.+|.|+ +++.+ |+.+|+. .+...........+.+|+.++++++||||+++++++.+++..++
T Consensus 2 y~~~~~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 2 FQKVEKIGEGTYGVVY-----KARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred ceeeeeecCCCceEEE-----EEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 3444568899999994 56554 7888832 22222223345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
||||+. ++|.+++.. ..+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 999995 688887754 3578999999999999999999999999999999999999999999999999876543322
Q ss_pred c----cccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 E----TKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 ~----~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
. ....++.+||.+.+... .++|+||+|++++++++|.+||.+.++..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1 12334678887765442 57899999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=208.90 Aligned_cols=200 Identities=21% Similarity=0.290 Sum_probs=159.7
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.+++|.+|.|+ +|... ++.+|+ ..............+.+|+.+++.++||||+++++.+...+..++|||+
T Consensus 6 ~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 6 RVVGRGAFGIVH-----LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred EEecccCceEEE-----EEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 457899999995 44443 677772 2222222344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCCCc--
Q psy16292 88 MPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~~~-- 161 (245)
+++++|.+++... .+++..+..++.+++.++.+||+++++|+||+|+||+++.++ .++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999998753 378899999999999999999999999999999999998654 5799999999876543322
Q ss_pred -cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 162 -TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....++.+||.+....+ .++|+||+|++++++++|..||.+.+......++..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 22345788998876554 6789999999999999999999877655554444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=212.59 Aligned_cols=205 Identities=11% Similarity=0.107 Sum_probs=156.2
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~ 82 (245)
++|.-...+++|.||.|+.+........ +..+|+..-....+......+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 3444455689999999953322221111 344552221122233456778999999999999999999998765 56789
Q ss_pred EEEeccCCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 83 MVMDYMPGGDLVNLMSN---------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
+++|++++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.++++|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999999998854 347889999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCC
Q psy16292 154 RMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNF 209 (245)
Q Consensus 154 ~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~ 209 (245)
.+..... ......+.+||.+....+ .++|+||+|++++++++ |.+||.+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 229 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 6543321 112334788998876655 78999999999999998 99999876554433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=210.12 Aligned_cols=204 Identities=14% Similarity=0.190 Sum_probs=153.5
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC------EEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK------SLYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~~~l 83 (245)
-.+++|+||.|+.+........++.+| ++.+.........+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 358999999995333222222267777 333333333345677899999999999999999999886542 3478
Q ss_pred EEeccCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 84 VMDYMPGGDLVNLMSN-------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||+++...
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccccc
Confidence 8999999999887632 136888899999999999999999999999999999999999999999999998764
Q ss_pred CCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCc
Q psy16292 157 KTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 157 ~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~ 214 (245)
..... .....+.+||.+....+ .++|+||+|++++++++ |.+||.+......+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05074 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230 (273)
T ss_pred CCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 32211 11123567888766655 67899999999999998 8999987765444444433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=211.48 Aligned_cols=194 Identities=23% Similarity=0.283 Sum_probs=151.7
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|...-++++|.+|+|+ +++.+ |+.||+.. +.........+.+.+|+.+++.++||||+++++++.++.+.+
T Consensus 3 ~y~~~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVY-----KARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred ceEEEEEecCCCCEEEE-----EEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 44455568999999994 55554 78888322 222222344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~ 158 (245)
+||||++ ++|.+.+... .+++..+..++.|++.||.|||+++++|+||+|+||+++. ++.++++|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999994 6887776543 2577888899999999999999999999999999999985 457899999999765432
Q ss_pred CCc----cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 159 GTE----TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 159 ~~~----~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
... .....+.+||.+.+. .+ .++|+||+|++++++++|.+||.+..+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 211 123447888887653 23 678999999999999999999987654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=209.88 Aligned_cols=197 Identities=21% Similarity=0.245 Sum_probs=156.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-e-hh--hhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-S-RY--FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-- 78 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~-k~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 78 (245)
|.-...+++|.+|.|+ +++.+ |+.+|+. . .. ..........+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 4 WRLGKLLGRGAFGEVY-----LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred eeeeeeEccCCCeEEE-----EEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4444568899999995 55544 7888832 1 11 111233556889999999999999999999998764
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
..+++++|++++++|.+.+.. ..+++..+..++.+++.||.+||+++++|+||+|+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 568999999999999998875 4578899999999999999999999999999999999999999999999999986532
Q ss_pred CC-------CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 158 TG-------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 158 ~~-------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.. .......+.+||.+.+..+ .++|+||+||+++++++|.+||.+......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 11 1122344788898877655 788999999999999999999986644433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=214.63 Aligned_cols=197 Identities=17% Similarity=0.191 Sum_probs=153.0
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeE----EEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTL----YALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~----~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
..++|...-.+++|+||.|+ ++..+ |.. +|+..-...........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy-----~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVY-----KGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEE-----EEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 34667766779999999994 55443 443 34211111111222346889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.. ..++++|++++|+|.+.+... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 54 467999999999999988754 478889999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCC
Q psy16292 155 MNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDD 205 (245)
Q Consensus 155 ~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~ 205 (245)
....... .....+.+||.+.+.++ .++|+||+|+++|++++ |..||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6433221 11234788998877666 67899999999999886 8899977643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=211.92 Aligned_cols=194 Identities=23% Similarity=0.267 Sum_probs=151.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++|.....++.|+||.| +++..+ |+.||+ ..+.. ........+.+|+.+++.++|+||+++++++..++..
T Consensus 5 ~~y~~~~~ig~g~~~~v-----~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATV-----YKGISRINGQLVALKVISMK-TEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEE-----EEEEEcCCCcEEEEEEeccc-CcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 34554556899999999 455544 777772 22211 1233345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
|+|+||+. +++.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 99999994 677766543 347788889999999999999999999999999999999999999999999987643221
Q ss_pred C----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 160 T----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
. ......+.+||.+.+.. + .++|+||+|++++++++|.+||.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 1 12234477888775432 3 678999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=212.30 Aligned_cols=197 Identities=18% Similarity=0.182 Sum_probs=156.2
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
..+++.|+||+|+ +++.. |+.+| ++.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 26 ~~~lg~g~~g~v~-----~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 26 LHEIGHGSFGAVY-----FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred ceeeccCCCeEEE-----EEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3458999999995 55544 77888 332222222334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
||++ +++.+.+.. ..+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~ 179 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG 179 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccc
Confidence 9995 677776653 3478889999999999999999999999999999999999999999999999876543333334
Q ss_pred cCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 164 RLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 164 ~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...+.+||.+.. ..+ .++|+||+|++++++++|.+||.+..+......+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~ 232 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 445788888742 223 6789999999999999999999887655544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=223.97 Aligned_cols=201 Identities=21% Similarity=0.329 Sum_probs=168.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe-----CCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD-----AKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-----~~~~~l 83 (245)
.++.|.||+| +.++++ |+..|+.. .....+..+.+..|.++|+.. +|||++.++++|.. ++.+|+
T Consensus 26 vig~Gtygkv-----~k~k~~~~~~~aa~kI--~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 26 VIGNGTYGKV-----YKGRHVKTGQLAAIKI--MDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred EEeeccceeE-----EEEeeeecCceeeeEe--ecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 4788999999 466666 66666322 223345556688899999988 89999999999953 468999
Q ss_pred EEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|||||.+||..+++++ .++.|.++..+++.++.|+.+||.+.++|||+|-.||++..++.+||+|||.+..+..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 9999999999999874 4589999999999999999999999999999999999999999999999999999887643
Q ss_pred -ccccCC---CCchhhhhcCCC------cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 161 -ETKRLG---RNGIEEIKAHPF------FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 161 -~~~~~~---~~~~e~i~~~~~------~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
..+..| +++||.|.+.+. .++|+||+|++..+|.-|.||+.+..+...+-.|.+.+||-
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 455555 588999977654 46799999999999999999999999998877777775543
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=210.43 Aligned_cols=191 Identities=18% Similarity=0.259 Sum_probs=150.4
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhh--ccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQI--KRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~ 87 (245)
.+++|.||.|+.+-......+ .+.||+ +|.... ..+-.....+|+.+++.++|||++++..+|.. +..+|+++||
T Consensus 31 ~Ig~GTYG~VykA~~~~~n~kr~k~yAi-Kkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 31 KIGRGTYGKVYKAVRKNTNDKRTKEYAI-KKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred eecccccceeeEeeeccCCcccchhhHH-HHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 478899999953311111111 334552 232222 12345678999999999999999999999987 7899999999
Q ss_pred cCCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC----CcEEEEeeCceeecCC
Q psy16292 88 MPGGDLVNLMSNY------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH----GHLKLADFGTCMRMNK 157 (245)
Q Consensus 88 ~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~----~~i~l~Dfg~a~~~~~ 157 (245)
. ..+|...|+-+ .++...+..++.||+.|+.|||++-|+||||||.||++-.+ |++||.|+|+++.+..
T Consensus 110 A-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~ 188 (438)
T KOG0666|consen 110 A-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNN 188 (438)
T ss_pred h-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhc
Confidence 9 67999988632 48889999999999999999999999999999999999877 8999999999998776
Q ss_pred CCCccc-------cCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCC
Q psy16292 158 TGTETK-------RLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 158 ~~~~~~-------~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
+-.+.. ..-|++||.+.+-. | .+.|+|+.||++.+|++..|.|.|..
T Consensus 189 plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 189 PLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 544331 22379999987644 3 45599999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=210.16 Aligned_cols=197 Identities=22% Similarity=0.284 Sum_probs=156.0
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
....+++.|.+|+|+ +++.+ |+.+|+..-...........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVY-----KGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEE-----EEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 334568899999994 66665 77787322112122344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 86 DYMPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
||++ ++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 78 EYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred ecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 9996 5888877643 478999999999999999999999999999999999999999999999999976543221
Q ss_pred ---ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 161 ---ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
......+.+||.+.+.. + .++|+||+|++++++++|.+||.+.+....+.
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 11233477888775543 2 67899999999999999999998876544333
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=211.73 Aligned_cols=174 Identities=22% Similarity=0.245 Sum_probs=143.6
Q ss_pred cCeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhc---CCCCHHHH
Q psy16292 32 RYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWA 107 (245)
Q Consensus 32 ~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~ 107 (245)
.|+.||+ ..+...........+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.. ..+++..+
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 3888883 2222223345678899999999999999999999999999999999999999999998875 35889999
Q ss_pred HHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----------ccccCCCCchhhhhcC
Q psy16292 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----------ETKRLGRNGIEEIKAH 176 (245)
Q Consensus 108 ~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----------~~~~~~~~~~e~i~~~ 176 (245)
..++.|++.||.|||+++|+|+||||+||+++.++.++++|||.+........ .....++.+||.+...
T Consensus 104 ~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC
Confidence 99999999999999999999999999999999999999999998876542211 1122346788887653
Q ss_pred --CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 177 --PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 177 --~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.+ .++|+||+||+++++++|.+||.+..+
T Consensus 184 ~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23 678999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=209.33 Aligned_cols=192 Identities=24% Similarity=0.321 Sum_probs=158.6
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|.....++.|.+|.|+ .+..+ ++.+| +++.. ......+.+|+.+++.++|+||+++++++......|
T Consensus 21 ~~~~~~l~~g~~~~v~-----~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 21 YKNLEKIGEGASGEVY-----KATDRATGKEVAIKKMRLR----KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred chHhHhccCCCCeEEE-----EEEEccCCcEEEEEEEecC----chhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4445568888999984 55555 66666 22211 114677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG- 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~- 159 (245)
+++||+++++|.+++... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999999876 68999999999999999999999999999999999999999999999999887654331
Q ss_pred ---CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 160 ---TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 160 ---~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
......++.+||.+.+.++ .++|+||+|+++|++++|.+||.+..+..
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1223345788998877766 77999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=207.79 Aligned_cols=201 Identities=18% Similarity=0.227 Sum_probs=155.7
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEE-----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQ----- 76 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~----- 76 (245)
++|.-...+++|+||.| ++|+.+ ++.+|+..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~~~~~~~~lg~g~~~~v-----y~~~~~~~~~~~~ik~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 18 DTWEIIETIGKGTYGKV-----FKVLNKKNGSKAAVKILDP--IHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cceeeeeeeccCCCcEE-----EEEEECCCCceeEEEeecc--ccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45555566899999999 466555 77787322111 122345678899999999 7999999999884
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCc
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
.+..+++||||+++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 45679999999999999987642 3478888999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCC----ccccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 152 CMRMNKTGT----ETKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 152 a~~~~~~~~----~~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
++....... .....++.+||.+.. ..+ .++|+||+||+++++++|.+||.+........++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 987643321 123344788888743 223 5789999999999999999999876654444333
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=210.65 Aligned_cols=191 Identities=21% Similarity=0.260 Sum_probs=154.8
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
...+++|.+|.|+ ++..+ ++.||+. -+.........+.+.+|+.+++.++||||+++++++..++..+++||
T Consensus 6 ~~~i~~g~~~~v~-----~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 6 LGVVGEGAYGVVL-----KCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred EEEecccCCeeEE-----EEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3457889999994 55555 7777732 22222334456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--c--
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--E-- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--~-- 161 (245)
|++++.+..+... ..+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 9987766665554 3588999999999999999999999999999999999999999999999999887654432 1
Q ss_pred -cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 -TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+... .+ .++|+||+|++++++++|.+||.+..+
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 123347888988776 44 788999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=209.07 Aligned_cols=194 Identities=26% Similarity=0.407 Sum_probs=154.3
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhhh-ccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQI-KRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.++.|+||.|+.+........|+.|| ++++.... .....+++.+|+.+++.+ +||||+++++++..+..+++|+||
T Consensus 7 ~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (290)
T cd05613 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86 (290)
T ss_pred eeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEec
Confidence 47899999996433332223478888 33333222 234457788999999999 699999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+++++|.+.+... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 87 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (290)
T cd05613 87 INGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166 (290)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccc
Confidence 9999999988654 578999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccCCCCchhhhhcCC--C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHP--F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~--~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.... + .++|+||+|++++++++|.+||....+
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred cCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 1234478888876422 2 578999999999999999999975443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=206.57 Aligned_cols=190 Identities=24% Similarity=0.306 Sum_probs=149.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC--CEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA--KSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~~lv~e 86 (245)
+++.|.+|.|+ +++.+ ++.+|+..-.............+|+.++.++ +||||+++++++.++ +.+++|||
T Consensus 6 ~lg~g~~~~v~-----~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 6 KIGEGTFSEVL-----KAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred eccccccceEE-----EEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 57889999994 66554 7888832211111222333456789999888 599999999999988 89999999
Q ss_pred ccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc-
Q psy16292 87 YMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK- 163 (245)
Q Consensus 87 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~- 163 (245)
|++ ++|.+.+.. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++. +.++|+|||+++..........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 995 688887764 34899999999999999999999999999999999999999 9999999999987654333222
Q ss_pred --cCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 164 --RLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 164 --~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
...+.+||.+.... ..++|+||+||+++++++|.+||.+.++.+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 33467888765433 3679999999999999999999988765443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=209.60 Aligned_cols=195 Identities=18% Similarity=0.161 Sum_probs=157.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
..|...-.++.|++|.|+ +++.+ ++.+|+ +............++.+|+.+++.++|||++++++++.....
T Consensus 15 ~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVY-----FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEE-----EEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 456666679999999995 55554 777773 222222223345678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++|+||+. +++.+.+. ...+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++++|||++......
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 999999995 67877664 334788999999999999999999999999999999999999999999999999876654
Q ss_pred CCccccCCCCchhhhhc----CCCcccCCCcccccceecCCccCCCCCCCC
Q psy16292 159 GTETKRLGRNGIEEIKA----HPFFINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 159 ~~~~~~~~~~~~e~i~~----~~~~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
........+.+||.+.. ....++|+||+||+++++++|.+||.+...
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 44444556888998752 223689999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=205.06 Aligned_cols=196 Identities=21% Similarity=0.265 Sum_probs=156.7
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhh--hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ--IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
|...-.+++|++|+|+ ++..+ ++.++ ++.+... ..+...+.+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~ig~g~~~~vy-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 2 WRKGELLGSGSFGSVY-----EGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred ccccceeeecCCceEE-----EEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 3344558999999995 44443 77777 2222111 112345678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+++++||+++++|.+++...+ +++..+..++.+++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999999999987654 8899999999999999999999999999999999999999999999999988765433
Q ss_pred Ccc---ccCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 160 TET---KRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 160 ~~~---~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
... ....+.+||.+.... ..++|+||+|++++++++|.+||....+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 212 223367888875543 378999999999999999999997665433
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=204.49 Aligned_cols=228 Identities=18% Similarity=0.158 Sum_probs=170.0
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA---- 78 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~---- 78 (245)
++|+-+-+++.|+|+-| ++|++- +..||.++ ....+..+.+..++|++..++++|||+++++++...+
T Consensus 21 ~Ryri~~~LgeGGfsfv-----~LV~~~s~~~~YAlKk-I~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFV-----DLVKGLSTGHLYALKK-ILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred ceEEEeeeecCCCceee-----eeecccCcccchhhhe-eeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34444556888999988 788866 88888322 2223357788999999999999999999998887544
Q ss_pred -CEEEEEEeccCCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 79 -KSLYMVMDYMPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 79 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
...|++++|...|+|.+.+... -+++..+..++.+++.||.++|+.. ..||||||.||++...+.++++|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 3599999999999999987632 3899999999999999999999988 9999999999999999999999999
Q ss_pred ceeecCCC---CC----------ccccCCCCchhhhhcCCC----cccCCCcccccceecCCccCCCCCCCC--CCCCcc
Q psy16292 151 TCMRMNKT---GT----------ETKRLGRNGIEEIKAHPF----FINDQWTFSNLRECVPPVVPELSGDDD--TSNFDD 211 (245)
Q Consensus 151 ~a~~~~~~---~~----------~~~~~~~~~~e~i~~~~~----~~~Diws~g~~~~~~~~~~~pf~~~~~--~~~~~~ 211 (245)
.+....-. .. ......|++||.+..... .++||||+||++|.++.|..||.-... .+.--+
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 98764321 11 223445788888755443 578999999999999999999975532 233333
Q ss_pred cCcCCCCCCCCCCCccccCCCCCcccceee
Q psy16292 212 IEKDESPEENFPVPKAFAGNHLPFVGFTYS 241 (245)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 241 (245)
+.++....|...+ ++...+.++.+..+
T Consensus 255 v~n~q~s~P~~~~---yse~l~~lik~mlq 281 (302)
T KOG2345|consen 255 VQNAQISIPNSSR---YSEALHQLIKSMLQ 281 (302)
T ss_pred eeccccccCCCCC---ccHHHHHHHHHHhc
Confidence 5554433222221 34445555555443
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=210.59 Aligned_cols=202 Identities=20% Similarity=0.210 Sum_probs=155.2
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC----
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA---- 78 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~---- 78 (245)
+|.-...++.|.||.|+ ++..+ ++.+|+..... .......+.+|+.+++.+ +|||++++++++...
T Consensus 23 ~y~~~~~l~~g~~~~vy-----~~~~~~~~~~~aik~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 23 TWEIIETIGKGTYGKVY-----KVTNKKDGSLAAVKILDP--ISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CeEEEEEeecCCCeEEE-----EEEECCCCCEEEEEEecc--cccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 34444467889999994 55554 77787322111 122345678899999998 899999999998754
Q ss_pred -CEEEEEEeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 79 -KSLYMVMDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 79 -~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
+..++||||+++++|.+++. ...+++..+..++.|++.||.+||+.+++|+||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 46899999999999998875 235889999999999999999999999999999999999999999999999998
Q ss_pred eecCCCCC----ccccCCCCchhhhhcCC------CcccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 153 MRMNKTGT----ETKRLGRNGIEEIKAHP------FFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 153 ~~~~~~~~----~~~~~~~~~~e~i~~~~------~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
........ ......+.+||.+.... ..++|+||+||+++++++|++||....+......+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 86543221 12234477888875432 2678999999999999999999987665444444433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=217.81 Aligned_cols=199 Identities=20% Similarity=0.246 Sum_probs=155.1
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
+..+.++|. +++|+||.|+ ++..+ |+.||++ .+.........+.+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVC-----AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEE-----EEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344556665 7788999994 55443 8888832 2211112233567889999999999999999999886
Q ss_pred eC------CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 77 DA------KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 77 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
.. ...+++++++ +++|.+++....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 43 3478888887 8899998887789999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCC-ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 151 TCMRMNKTGT-ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 151 ~a~~~~~~~~-~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
+++....... ......+.+||.+.+. .+ .++|+||+||+++++++|.+||.+......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred ccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9887543321 1223346788887652 33 678999999999999999999977654433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=210.20 Aligned_cols=194 Identities=23% Similarity=0.281 Sum_probs=155.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 81 (245)
+|...-+++.|.+|.|+ +++.+ ++.+|+.............++.+|+++++.++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~lg~g~~~~v~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVT-----KCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEE-----EEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 34445678999999994 55554 7888832211112224567789999999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++||||+++++|.+++.. ..+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999887642 347888999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 157 KTGT--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 157 ~~~~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.... ......+.+||.+....+ .++|+||+|+++|++++|.+||....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 3221 223344788998876665 68899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=211.34 Aligned_cols=196 Identities=22% Similarity=0.226 Sum_probs=152.0
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK- 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~- 79 (245)
+++|...-++++|+||.|+ +|+.+ |+.||+. .............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVF-----KARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEE-----EEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 3444444458889999994 66655 8888832 2222222333456678999999999999999999987654
Q ss_pred -------EEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 80 -------SLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 80 -------~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
..++||||+ +++|.+.+... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCC-CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 459999999 56888877654 58999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCCc--------cccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 151 TCMRMNKTGTE--------TKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 151 ~a~~~~~~~~~--------~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
++......... .....+.+||.+.+.. + .++|+||+|++++++++|.+||.+.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99865432211 1223467888775533 2 678999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=205.89 Aligned_cols=206 Identities=22% Similarity=0.250 Sum_probs=159.8
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 79 (245)
..++|.-.-.++.|.+|+|+ +|+.+ ++.+|+.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~-----~~~~~~~~~~~~~k~~~--~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVY-----KARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred chhheeheeeecCCCCeEEE-----EEEECCCCcEEEEEEEe--cCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 44566666678999999994 56655 6777722111 1122446789999999999 7999999999997644
Q ss_pred ------EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEe
Q psy16292 80 ------SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 80 ------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~D 148 (245)
.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 58999999999999988753 3588999999999999999999999999999999999999999999999
Q ss_pred eCceeecCCCCC----ccccCCCCchhhhhcCC------CcccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 149 FGTCMRMNKTGT----ETKRLGRNGIEEIKAHP------FFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 149 fg~a~~~~~~~~----~~~~~~~~~~e~i~~~~------~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
||++........ ......+.+||.+.... ..++|+||+|++++++++|.+||.+..+......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 999886543322 22234478888775432 25789999999999999999999876555444444443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=207.42 Aligned_cols=197 Identities=20% Similarity=0.300 Sum_probs=154.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD---- 77 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~---- 77 (245)
+.|.-.-.++.|.||.|+ +++.+ ++.+|+... .........+..|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~lg~g~~~~v~-----~~~~~~~~~~~a~K~~--~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 16 GIFELVEVVGNGTYGQVY-----KGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhheeeccCCCeEEE-----EEEEcCCCcEEEEEEE--ecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 445555568999999994 66655 777772211 11223456788899999998 79999999999853
Q ss_pred --CCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 78 --AKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 78 --~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
...+|++|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 4688999999999999998864 24788889999999999999999999999999999999999999999999998
Q ss_pred eecCCCCC----ccccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 153 MRMNKTGT----ETKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 153 ~~~~~~~~----~~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
........ ......+.+||.+.. ..+ .++|+||+||+++++++|.+||.+..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 76543211 222344788888753 222 678999999999999999999977654433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=207.63 Aligned_cols=203 Identities=22% Similarity=0.279 Sum_probs=162.6
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.-...+++|.|++|+ +++.+ ++.+| +..+...........+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~~~~i~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 3 KVLKKLGKGSYGSVY-----KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred eEeeeecCCCceeEE-----EEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 334568899999995 55444 77777 32222223344566788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 85 MDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|++++++|.+++.. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999998765 457888999999999999999999999999999999999999999999999988765432
Q ss_pred C--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 160 T--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
. ......+.+||.+.+.++ .++|+||+|++++++++|++||.+.+.......+..+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG 216 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 1 123344788888877666 6799999999999999999999877654433334333
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=207.85 Aligned_cols=200 Identities=21% Similarity=0.304 Sum_probs=158.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYMV 84 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv 84 (245)
.-.++.|++|.|+ +|... |+.+| +..+.........+++.+|+.+++.++||||+++++.+.. +..++++
T Consensus 5 ~~~lg~g~~~~v~-----~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 5 LETIGKGSFGTVR-----KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeeeccCCCeEEE-----EeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 3457889999994 55444 77777 3222222334456778899999999999999999998764 4578999
Q ss_pred EeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 85 MDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIH-----CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH-----~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
|||+++++|.+++.. ..+++..+..++.+++.||.++| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998864 35788999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 155 MNKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 155 ~~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
...... ......+.+||.+....+ .++|+||+|++++++++|.+||.+.........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 654332 122344788888877665 678999999999999999999987754333333333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=207.58 Aligned_cols=189 Identities=21% Similarity=0.254 Sum_probs=155.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.+++|+++.|+ .+... ++.+| +..+....+....+.+.+|+.+++.++|+||+++++.+.....+++|+||
T Consensus 6 ~~lg~G~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 6 NKIGGGTFGKVY-----TAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred eEeecCCCcEEE-----EEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 358899999994 55433 77777 32222222234678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
+++++|.+++... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999998765 3788899999999999999999999999999999999999999999999998876543221
Q ss_pred ---cccCCCCchhhhhcCC----CcccCCCcccccceecCCccCCCCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHP----FFINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~----~~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+.+||.+.... ..++|+||+|++++++++|.+||.+..
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1234477888876554 378899999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=217.44 Aligned_cols=198 Identities=23% Similarity=0.285 Sum_probs=157.0
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
+.++.++|. ++.|.||.|+ ++..+ |+.||+. .+...........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVC-----SALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhccccceEEEEEeeecCCeEEE-----EEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 445566774 7899999994 55544 8888832 2222222233456889999999999999999999997
Q ss_pred eCC------EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 77 DAK------SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 77 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
... .+++|||++ +++|.+++....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 654 468999999 8899999887789999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCC-ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 151 TCMRMNKTGT-ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 151 ~a~~~~~~~~-~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
++........ ......+.+||.+.+.. + .++|+||+|++++++++|.+||.+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred cccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9987643322 12234467888876532 2 67899999999999999999998765433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=204.38 Aligned_cols=194 Identities=21% Similarity=0.322 Sum_probs=160.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
+|.-.-.++.|++|.| ++|..+ |+.+|+..-...........+.+|+..+..++||||+++++++......++
T Consensus 2 ~~~~~~~i~~g~~~~v-----~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVV-----YKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEE-----EEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 3444556889999999 466665 777773221111111446779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
++||+++++|.+++.. ..+++.....++.|++.|+.++|+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999875 568999999999999999999999 99999999999999999999999999999876543332
Q ss_pred ----cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 162 ----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+.+||.+....+ .++|+||+|++++++++|.+||.+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 22344678888776655 68999999999999999999997775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=214.24 Aligned_cols=198 Identities=20% Similarity=0.248 Sum_probs=155.6
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEeh-hhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC-
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSR-YFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA- 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k-~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~- 78 (245)
.++|...-.+++|.||.|+ ++..+ |+.+|+.+- ...........+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVW-----KAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEE-----EEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 4567777779999999995 44443 777773221 1112234456678899999999 999999999998654
Q ss_pred -CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 -KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
..+++|||+++ ++|...+....+++.....++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 47899999995 6999988877788888999999999999999999999999999999999999999999999986643
Q ss_pred CCCc---------cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 158 TGTE---------TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 158 ~~~~---------~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.... .....+.+||.+.+. .+ .++|+||+|++++++++|.+||.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 3211 112236778876543 23 67899999999999999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=208.15 Aligned_cols=191 Identities=20% Similarity=0.263 Sum_probs=147.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHH-HHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDI-MAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|...-.++.|+||.|+ +++++ |+.||+..-...........+..|+.+ ++.++||||+++++++..++.+|
T Consensus 2 ~~~~~~~ig~g~~g~v~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVD-----KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEE-----EEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 34445568999999994 66665 888883221111122233455566665 56679999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 83 MVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++|||++ ++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||+++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999994 788776643 2488999999999999999999997 99999999999999999999999999998764
Q ss_pred CCCCcc---ccCCCCchhhhhc----CCC-cccCCCcccccceecCCccCCCCC
Q psy16292 157 KTGTET---KRLGRNGIEEIKA----HPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 157 ~~~~~~---~~~~~~~~e~i~~----~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
...... ....+.+||.+.+ ..+ .++|+||+||+++++++|.+||..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 332222 2334778887753 223 678999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=214.92 Aligned_cols=187 Identities=19% Similarity=0.233 Sum_probs=149.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv 84 (245)
.++.|++|.|+ ++.++ |+.||+..-..........++.+|+.+++.++||||+++++++... ...+++
T Consensus 12 ~lg~G~~g~vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 12 YIGEGAYGMVC-----SATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEecCCeEEE-----EEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 48888999994 55544 7888832211112233456788999999999999999999887644 358999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
+|++ +++|.+.+....+++..+..++.|++.||.+||+++++||||||+||+++.++.++|+|||++.........
T Consensus 87 ~e~~-~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 165 (336)
T cd07849 87 QELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165 (336)
T ss_pred ehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCC
Confidence 9999 568988888888999999999999999999999999999999999999999999999999999875433211
Q ss_pred ----cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 162 ----TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+.+||.+.+. .+ .++|+||+||+++++++|.+||.+..
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122347889987543 33 67899999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=207.24 Aligned_cols=194 Identities=23% Similarity=0.300 Sum_probs=152.3
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCE--
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKS-- 80 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~-- 80 (245)
|.....+++|.||.| ++++.+ |+.|| +..+...........+.+|+.+++.+ +||||+++++++.....
T Consensus 3 y~~~~~lg~g~~g~v-----y~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 3 YEKLEKIGEGTYGKV-----YKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred ceEeeEecccCCeEE-----EEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 444556899999999 466655 88888 33233222334456788999999999 56999999999987665
Q ss_pred ---EEEEEeccCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeC
Q psy16292 81 ---LYMVMDYMPGGDLVNLMSN------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFG 150 (245)
Q Consensus 81 ---~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg 150 (245)
.|++|||++ ++|.+++.. ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||
T Consensus 78 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 899999996 478887643 23789999999999999999999999999999999999998 8899999999
Q ss_pred ceeecCCCCCc----cccCCCCchhhhhcC-C-CcccCCCcccccceecCCccCCCCCCCCC
Q psy16292 151 TCMRMNKTGTE----TKRLGRNGIEEIKAH-P-FFINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 151 ~a~~~~~~~~~----~~~~~~~~~e~i~~~-~-~~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
+++........ .....+.+||.+.+. . ..++|+||+|+++++|++|.+||.+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99865432211 123347888887543 2 36889999999999999999999876544
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=202.90 Aligned_cols=194 Identities=22% Similarity=0.242 Sum_probs=159.0
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.....++.|.+|.|+ ++..+ ++.|| +..+.....+.....+.+|++++++++|||++++++++.++...+++
T Consensus 3 ~~~~~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 3 QLGDLIGRGAFGVVY-----KGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred eeeeEEcccCCeEEE-----EEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 334568889999994 55544 77788 33332322235667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
+|++++++|.+++.. ..+++..+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998865 4689999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
......+.+||....... .++|+||+|++++++++|.+||.+..+.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~ 205 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 122334778888765544 6789999999999999999999766543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=204.82 Aligned_cols=191 Identities=23% Similarity=0.236 Sum_probs=151.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
+...-.+++|+||.|+ +++.+ +..+|++.- ........+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 10 ~~~~~~lg~g~~g~v~-----~~~~~~~~~~v~~k~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 10 NGERVVLGKGTYGIVY-----AARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred CCceEEEecCCceEEE-----EeEecCCCcEEEEEEe-cCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3344568999999995 55544 666663221 112234566789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC--CC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCCCC
Q psy16292 85 MDYMPGGDLVNLMSNY--DV--PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~--~~--~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|++++++|.+++... .+ ++..+..++.|++.||.|||+++++|+||||+||+++. .+.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999988753 34 77888899999999999999999999999999999986 6789999999988654322
Q ss_pred C----ccccCCCCchhhhhcCC--C-cccCCCcccccceecCCccCCCCCC
Q psy16292 160 T----ETKRLGRNGIEEIKAHP--F-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~~~~--~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
. .....++.+||.+...+ + .++|+||+|++++++++|.+||...
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 1 12234577888875533 2 6789999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=217.39 Aligned_cols=194 Identities=21% Similarity=0.255 Sum_probs=157.6
Q ss_pred cchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhh-----ccCchHHHHHHHHHHHhcC---Cccce
Q psy16292 2 KNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQI-----KRSDSAFFWEERDIMAHAN---SEWIV 69 (245)
Q Consensus 2 ~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~-----~~~~~~~~~~E~~il~~l~---hp~Iv 69 (245)
|++.+|.--..+|.|+||.|+ +|-++ +..|. .+.|..+. .+.+.-.+-.|+.||..++ |+||+
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~-----lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl 632 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVN-----LAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL 632 (772)
T ss_pred cccccceeeeeccccccceEE-----EeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence 566777777889999999995 77777 22222 22232221 1223344667999999997 99999
Q ss_pred eeeEEEEeCCEEEEEEeccC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEE
Q psy16292 70 QLHFAFQDAKSLYMVMDYMP-GGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 70 ~l~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
+++++|++++++|++||... +.+|.++|..+ .+.|..+..++.|++.|+++||+.||+|||||-+|++++++|-+||+
T Consensus 633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred hhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence 99999999999999999864 45899999865 59999999999999999999999999999999999999999999999
Q ss_pred eeCceeecCCC--CCccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCC
Q psy16292 148 DFGTCMRMNKT--GTETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 148 Dfg~a~~~~~~--~~~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf 200 (245)
|||.|.....+ ...-...++.+||.+.+.+| ...|||++|+++|..+.-.-||
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99998876533 22334556899999999999 5679999999999998777665
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=218.95 Aligned_cols=195 Identities=22% Similarity=0.242 Sum_probs=162.8
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.-+||.|-||.| .+|+-. +..+|+..-.........+.|.+|+++|.+|+||||+.+.++|..++.+++++||+
T Consensus 543 ~ekiGeGqFGEV-----hLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 543 KEKIGEGQFGEV-----HLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hhhhcCccccee-----EEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 567999999999 577666 48888444334444455788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc--
Q psy16292 89 PGGDLVNLMSNYDV---PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK-- 163 (245)
Q Consensus 89 ~~g~L~~~l~~~~~---~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~-- 163 (245)
++|+|.+++..+.. .......++.||.+|++||.+.+++|||+.++|+|++.++++|++|||.++.+........
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 99999999987742 3345667999999999999999999999999999999999999999999998765544322
Q ss_pred ----cCCCCchhhhhcCCC-cccCCCcccccceecCCc--cCCCCCCCCCCCC
Q psy16292 164 ----RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV--VPELSGDDDTSNF 209 (245)
Q Consensus 164 ----~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~--~~pf~~~~~~~~~ 209 (245)
...++++|.|...+| .++|+|++|+.+|++.+. .-||+..++.+..
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv 750 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV 750 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH
Confidence 255899999998888 789999999999987754 4778777665443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=210.32 Aligned_cols=198 Identities=29% Similarity=0.527 Sum_probs=162.1
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
-.++.|++|.|+ ++..+ |+.+| ++.+...........+.+|+.+++.++ ||||+++++++..++..+++|
T Consensus 7 ~~lg~g~~~~vy-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 7 KIIGEGSFSTVV-----LAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred eeecCCCceEEE-----EEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 358899999995 55554 88888 444434333445577899999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
|++++++|.+.+... .+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++++|||++.........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence 999999999988765 6899999999999999999999999999999999999999999999999998876433211
Q ss_pred ---------------------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 162 ---------------------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 162 ---------------------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
....++.+||....... .++|+||+|++++++++|.+||........+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 11234677887765544 67899999999999999999999887555555444
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=213.52 Aligned_cols=200 Identities=23% Similarity=0.253 Sum_probs=153.1
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA- 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~- 78 (245)
++++|.-...++.|+||.|+ +++.+ ++.+|+ .......+......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVY-----KARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred ccccEEEEEEeccCCCEEEE-----EEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 34555555568999999995 66655 777772 2222222233345678999999999999999999887543
Q ss_pred -------CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 79 -------KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 79 -------~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
..+++|+||+ ++++...+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~~~~-~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 81 DKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ccccccCceEEEEEecC-CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence 3579999999 4577776653 35899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCccc---------------cCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 150 GTCMRMNKTGTETK---------------RLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 150 g~a~~~~~~~~~~~---------------~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
|+++.......... ...+.+||.+.+.. + .++|+||+|+++++|++|++||.+.++...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99986543221111 22367888776532 3 678999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=205.96 Aligned_cols=193 Identities=16% Similarity=0.230 Sum_probs=148.0
Q ss_pred HhhhccccccchhhhHHH-HHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEY-LLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~-l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv~e 86 (245)
.-.+++|+||.|+.+-.. .....++.+|+... ........+.+.+|+.+++.++||||+++++++.. ...+++|+|
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL-QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEe-ccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 334899999999522110 01112777773221 11223446678999999999999999999998754 357899999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--c
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--T 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--~ 162 (245)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++........ .
T Consensus 88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 167 (284)
T cd05081 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167 (284)
T ss_pred ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceee
Confidence 99999999988643 4788999999999999999999999999999999999999999999999999876533221 1
Q ss_pred c-----cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 163 K-----RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 163 ~-----~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
. ...+.+||.+.+..+ .++|+||+|+++++++++..+..+.
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 1 112678888766555 6789999999999999987665433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=208.12 Aligned_cols=194 Identities=20% Similarity=0.219 Sum_probs=151.3
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-E-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-L-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e~ 87 (245)
.++.|++|.|+.+..... ..++.|| + +.+.........+.+.+|+.+++.++||||+++++++.+. ..+++|||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 488899999953332110 0367888 2 3322212234557788999999999999999999999988 889999999
Q ss_pred cCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC----CCcEEEEeeCceeecCC
Q psy16292 88 MPGGDLVNLMSN------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK----HGHLKLADFGTCMRMNK 157 (245)
Q Consensus 88 ~~~g~L~~~l~~------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~----~~~i~l~Dfg~a~~~~~ 157 (245)
++ +++.+.+.. ..+++..+..++.|++.||.|||+.+++||||||+||+++. ++.++|+|||++.....
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 86 AE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164 (316)
T ss_pred CC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence 95 577776642 24788999999999999999999999999999999999999 89999999999886543
Q ss_pred CCC-------ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 158 TGT-------ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 158 ~~~-------~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
... ......+.+||.+.+.. + .++|+||+|++++++++|.+||.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 223 (316)
T cd07842 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI 223 (316)
T ss_pred CcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccc
Confidence 322 11233478899886543 3 67899999999999999999998876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=203.04 Aligned_cols=190 Identities=20% Similarity=0.223 Sum_probs=151.7
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEE--Eehhhhhcc-------CchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKR-------SDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~-------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
.-.++.|++|+|+ ++... |+.+|+ ++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~lg~g~~~~vy-----~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 6 GELIGKGTYGRVY-----LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred cceecccCceEEE-----EEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 3458999999995 44433 777882 221111111 1235678899999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
...++||||+++++|.+++.. ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++++|||+++....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999998876 4588899999999999999999999999999999999999999999999999876532
Q ss_pred CCC------ccccCCCCchhhhhcCC---CcccCCCcccccceecCCccCCCCCCC
Q psy16292 158 TGT------ETKRLGRNGIEEIKAHP---FFINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 158 ~~~------~~~~~~~~~~e~i~~~~---~~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
... .....++.+||.+.... ..++|+||+|++++++++|.+||....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 211 12234477888876543 367899999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=206.94 Aligned_cols=198 Identities=24% Similarity=0.289 Sum_probs=156.5
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
.+++|.-.-.++.|.+|.|+ ++..+ |+.+| +..+...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~-----~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVY-----KARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEE-----EEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 45667777778999999994 55555 78887 222222223344567788999999999999999999987654
Q ss_pred ----------EEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEE
Q psy16292 80 ----------SLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 80 ----------~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
.+++|+||+++ ++...+... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 89999999965 777766643 58999999999999999999999999999999999999999999999
Q ss_pred eeCceeecCCCCC-----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 148 DFGTCMRMNKTGT-----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 148 Dfg~a~~~~~~~~-----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
|||++........ ......+.+||.+.+.. + .++|+||+||+++++++|++||....+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999987643321 11233477888876543 2 6789999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=212.32 Aligned_cols=194 Identities=19% Similarity=0.233 Sum_probs=151.8
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CC
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AK 79 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~ 79 (245)
|...-.+++|++|.|+ ++..+ |+.||+. -+...........+.+|+.+++.++||||+++++++.. ..
T Consensus 7 y~~~~~lg~g~~g~v~-----~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 7 YKPIENIGSGAYGVVC-----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred eeeeeeeecCCCeEEE-----EEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 3333457889999994 55544 8888822 22222223456778899999999999999999998863 35
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 789999999 5689888864 35899999999999999999999999999999999999999999999999999865432
Q ss_pred CCc--------cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 159 GTE--------TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 159 ~~~--------~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
... .....+.+||.+... .+ .++|+||+|++++++++|.+||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 211 122336788887553 33 6799999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=201.55 Aligned_cols=202 Identities=22% Similarity=0.227 Sum_probs=164.5
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhh-hccCchHHHHHHHHHHHhcCCccceeeeEEEEe----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQ-IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD---- 77 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---- 77 (245)
..+...-+++.|.||.| ++|+.+ |+.+|++++... .+.+.....++|+.+|+.++|+|++.++..|.+
T Consensus 17 ~~yek~~kigqGtfgeV-----FkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEV-----FKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHH-----HHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 45566778999999999 577777 888784444333 345667788999999999999999999877743
Q ss_pred ----CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCc
Q psy16292 78 ----AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 78 ----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
...+|+|+.+| ..+|.-++++. +++.+.+..++.+++.||.|+|++.|+|||+|+.|++++.+|.++|+|||+
T Consensus 92 ~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 23599999999 67888888765 589999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCC--cc------ccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 152 CMRMNKTGT--ET------KRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 152 a~~~~~~~~--~~------~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
++.+..... .. ..+.|.+||.+.+..- .+-|+|..||++.+|.++.|.++|.+.......|
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 976543322 11 1334788999988754 4569999999999999999999999887665543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=206.60 Aligned_cols=191 Identities=22% Similarity=0.280 Sum_probs=152.6
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.-.++.|.+|.|+ ++..+ |+.||+. .+...........+.+|+.+++.++|||++++++++.++...++++|
T Consensus 4 ~~~l~~g~~~~vy-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 4 VEKIGEGTYGVVY-----KARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred heEecCCCCeEEE-----EEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 3458889999994 55444 8888822 22222223344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 87 YMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
|+ +++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 79 FL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred cc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 99 57899888654 4899999999999999999999999999999999999999999999999999765432211
Q ss_pred --cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 162 --TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....+.+||.+... ++ .++|+||+|++++++++|.+||.+.++.
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 206 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI 206 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 113346788876543 33 6789999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=211.84 Aligned_cols=191 Identities=20% Similarity=0.253 Sum_probs=151.1
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc-----------CchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR-----------SDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
++.|+||.|+ ++..+ |+.|| ++++...... .....+.+|+.+++.++||||+++++++..
T Consensus 17 ig~G~~g~vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 17 LGEGTYGKVE-----KAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred ccCCCceeEE-----EEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 7889999994 55544 88888 2222211110 012257899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+...+++||++. ++|.+.+... .+++.....++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence 999999999995 6898888653 58999999999999999999999999999999999999999999999999998654
Q ss_pred CCC--------------C----ccccCCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 157 KTG--------------T----ETKRLGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 157 ~~~--------------~----~~~~~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
... . .....++.+||.+.+.. ..++|+||+||+++++++|.+||.+.++....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 110 0 11233467888876533 26789999999999999999999887765443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=209.38 Aligned_cols=187 Identities=20% Similarity=0.293 Sum_probs=149.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~l 83 (245)
.+++|+||+|+ ++++. |+.||++ .+...........+.+|+.+++.++||||+++++++... ..+|+
T Consensus 12 ~lg~G~~~~vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 12 PIGRGAYGIVC-----SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred EeccCCCeEEE-----EEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 47899999994 55554 8888832 222122333456788999999999999999999988654 35899
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
++||+ +++|.+.+.. +.+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........ .
T Consensus 87 v~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 165 (337)
T cd07858 87 VYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165 (337)
T ss_pred EEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccc
Confidence 99999 5789888865 4589999999999999999999999999999999999999999999999999987644311 1
Q ss_pred ---cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+.+||.+... .+ .++|+||+|++++++++|.+||.+.+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 123346788887642 23 78999999999999999999997754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=203.73 Aligned_cols=195 Identities=21% Similarity=0.245 Sum_probs=155.0
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEEeCCE----
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQDAKS---- 80 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~---- 80 (245)
-.+++|.+|.| ++++.+ ++.|| +..+...........+.+|+.+++++ +||||+++++++.....
T Consensus 5 ~~l~~g~~~~v-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 5 AEIGEGAYGTV-----YKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred EEecccCceEE-----EEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 35788999999 466665 78888 33332222233345577788888776 69999999999998876
Q ss_pred -EEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 81 -LYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 81 -~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++++||+++ ++|.+++... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 5888877642 48999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 157 KTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 157 ~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
...... ....+.+||.+.+.++ .++|+||+||++++|++|.+||.+..+...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~ 217 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK 217 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH
Confidence 443322 2334788998876665 789999999999999999999988776544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=218.00 Aligned_cols=192 Identities=24% Similarity=0.295 Sum_probs=154.5
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
-+++.|+|+.|. .+.++ ++.+| ++.+. .....+|+.++... +||||+++.+++.++.+.|+||
T Consensus 328 ~~~~~gs~s~~~-----~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 328 EELGEGSFSAVK-----YCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cccCCCCcccee-----eeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 347788999884 44444 77777 33333 22245688777666 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe-cCCCcEEEEeeCceeecCCC-CCccc
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL-DKHGHLKLADFGTCMRMNKT-GTETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~-~~~~~i~l~Dfg~a~~~~~~-~~~~~ 163 (245)
|.+.|+-+.+.+.........+..|+.+|+.|+.|||++|++||||||+|||+ ++.|+++|+|||.++..... .++.-
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 99999988887776654447777899999999999999999999999999999 68999999999999987655 23445
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC-CCCcccCc
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT-SNFDDIEK 214 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~-~~~~~~~~ 214 (245)
..+|.+||.....++ .++|+||+|++||+|++|..||....+. +....+..
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~ 528 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM 528 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC
Confidence 666899999987777 7889999999999999999999876655 33443433
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=199.49 Aligned_cols=193 Identities=22% Similarity=0.317 Sum_probs=158.7
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.....++.|.+|.|+ ++..+ |+.+++..- ..........+.+|+.++++++||+++++++.+......++++
T Consensus 3 ~~~~~l~~g~~~~v~-----~~~~~~~~~~~~~k~~-~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 3 EILEKIGKGGFGEVY-----KARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred eeeeeeccCCceEEE-----EEEECCCCcEEEEEEe-cccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 334568889999994 66554 666662221 1111146678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC---C
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---T 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---~ 160 (245)
|++++++|.+++... .+++..+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999999998765 68999999999999999999999999999999999999999999999999998776543 2
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....++.+||.+.+... .++|+||+|++++++++|.+||...+..
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 334455788888865554 7899999999999999999999876433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=210.54 Aligned_cols=187 Identities=20% Similarity=0.256 Sum_probs=151.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~ 87 (245)
.+++|.||.|+ +++.+ |+.+|++ .............+.+|+.+++.++||||+++++++.. ....++++|+
T Consensus 17 ~ig~g~~g~v~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 17 PVGMGAFGLVC-----SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eecccCCeEEE-----EEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 47889999994 56544 7888832 22222233455778899999999999999999999876 5678999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccccCC
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRLG 166 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~~ 166 (245)
+ +++|...++...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 92 ~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 170 (328)
T cd07856 92 L-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY 170 (328)
T ss_pred h-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCccccc
Confidence 8 77999988877788889999999999999999999999999999999999999999999999986543221 122344
Q ss_pred CCchhhhhc-CC-CcccCCCcccccceecCCccCCCCCCC
Q psy16292 167 RNGIEEIKA-HP-FFINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 167 ~~~~e~i~~-~~-~~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
+.+||.+.. .. ..++|+||+|++++++++|.+||.+..
T Consensus 171 y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 778887654 23 378999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=199.03 Aligned_cols=199 Identities=22% Similarity=0.325 Sum_probs=160.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|++|.|+ ++... ++.+| +..............+.+|+++++.++|||++++.+.+..+...++++|++
T Consensus 7 ~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 7 QIGKGSFGKVY-----LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred eeccCCCeEEE-----EEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 47889999995 45444 77777 222222223356677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 89 PGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 89 ~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
++++|.+.+.. ..+++..+..++.+++.||.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 99999998865 4588999999999999999999999999999999999999999999999999987654421
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||......+ .++|+||+|++++++++|.+||...............
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (258)
T cd08215 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG 218 (258)
T ss_pred ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC
Confidence 112233678888766665 6789999999999999999999777655544444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=200.56 Aligned_cols=198 Identities=21% Similarity=0.275 Sum_probs=156.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|++|.|+ ++..+ |..+| +..........+.+.+.+|+.+++.++||||+++++.+......++++||+
T Consensus 7 ~l~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 7 KIGEGSFGKIY-----LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred EecCCCcceEE-----EEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 47889999994 55554 77777 222222223345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc-EEEEeeCceeecCCCCCc---
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~-i~l~Dfg~a~~~~~~~~~--- 161 (245)
++++|.+++... .+++..+..++.+++.||.|||+++++|+||+|+||+++.++. ++++|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence 999999988643 3788999999999999999999999999999999999998865 699999998876533221
Q ss_pred -cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 -TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
.....+.+||......+ .++|+||+|++++++++|.+||.+.+.......+..
T Consensus 162 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred cCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 22333677887765554 688999999999999999999987665444444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=215.19 Aligned_cols=195 Identities=21% Similarity=0.257 Sum_probs=154.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE------EE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS------LY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~------~~ 82 (245)
.++.|.+|.| ++++.+ ++.||+.. +...........+.+|+.+++.++||||+++++++..... .+
T Consensus 22 ~ig~g~~g~v-----y~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 22 PVGSGAYGQV-----CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred EeccCCceEE-----EEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 3788899999 466655 77777322 2111223345668899999999999999999998876654 89
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
+|+|++ +++|.+++....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 97 lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (343)
T cd07851 97 LVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175 (343)
T ss_pred EEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccccccCC
Confidence 999999 78999999887899999999999999999999999999999999999999999999999999987643321 1
Q ss_pred cccCCCCchhhhhcC--CCcccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 162 TKRLGRNGIEEIKAH--PFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~--~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.....+.+||.+... ...++|+||+|++++++++|.+||.+.........+
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 222336788887542 337899999999999999999999877654444433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=213.86 Aligned_cols=199 Identities=18% Similarity=0.228 Sum_probs=158.3
Q ss_pred HHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-----E
Q psy16292 9 HRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-----S 80 (245)
Q Consensus 9 ~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~ 80 (245)
-...+++|.+|.|+ +|+.. |+.+|+. .+.........+.+.+|+.+++.++||||+++++++.... .
T Consensus 4 i~~~ig~g~~~~v~-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 4 LLKPIGSGAYGVVC-----SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred eeeeecCCCCeEEE-----EEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 34568899999995 55554 7888832 2222222345678999999999999999999999998775 7
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|++|||++ ++|.+.+... .+++..+..++.+++.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999999995 6888888754 58899999999999999999999999999999999999999999999999998765443
Q ss_pred C----cc---ccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 160 T----ET---KRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 160 ~----~~---~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
. .. ....+.+||.+.+. .. .++|+||+|++++++++|.+||.+.+....+..+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 1 11 12236788887665 33 78999999999999999999998887655444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=202.57 Aligned_cols=191 Identities=20% Similarity=0.247 Sum_probs=156.6
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
...+++|.+|+|+ +++.. ++.+| ++.+...........+..|+.+++.++||||+++++++.+.+..++|+|
T Consensus 4 ~~~ig~g~~~~vy-----~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 4 LEKLGEGTYGVVY-----KARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred ehcccccCcceEE-----EeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 3458899999994 55555 78888 3333222334556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
+++ ++|.+++... .+++..+..++.+++.||.+||+++++|+||+|+||+++.++.++|+|||+++........
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 996 6999998765 6899999999999999999999999999999999999999999999999999876543321
Q ss_pred -cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 162 -TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....+.+||.+... .+ .++|+||+|++++++++|.+||.+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 112336788887654 33 6789999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=204.10 Aligned_cols=194 Identities=24% Similarity=0.311 Sum_probs=155.2
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~ 85 (245)
.+++.|++|.| +++..+ |+.+| +.-+...........+.+|+.+++.++|||++++++++... +..++|+
T Consensus 5 ~~l~~g~~~~v-----y~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 5 AQIGEGTYGQV-----YKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred EEeccCCCeEE-----EEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 35788999999 466655 77888 22222222344556788999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--c
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--E 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--~ 161 (245)
||++ ++|.+++... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 9995 5888887654 689999999999999999999999999999999999999999999999999987654431 1
Q ss_pred ---cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 162 ---TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
.....+.+||.+.+. .+ .++|+||+|++++++++|.+||.+.+......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 112336788866542 33 67899999999999999999998776544333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=201.31 Aligned_cols=201 Identities=20% Similarity=0.246 Sum_probs=156.7
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc---CeEEE-E-Eehhh-------hhccCchHHHHHHHHHHHh-cCCccceeeeE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR---YTLYA-L-YSRYF-------QIKRSDSAFFWEERDIMAH-ANSEWIVQLHF 73 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~---~~~~a-v-~~k~~-------~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~ 73 (245)
|.-...++.|.||.|+ ++..+ ++.+| + +.... .........+..|+.++.+ ++||||+++++
T Consensus 2 y~~~~~ig~G~~~~v~-----~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 2 YAVLEHLGSGAFGCVY-----KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred chhhhhhcCCCCceEE-----EEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 5667789999999995 44433 56677 2 22111 1122345567788888875 69999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEE
Q psy16292 74 AFQDAKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
++..+++.+++|||+++++|.+++.. ..+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999999987632 348889999999999999999996 789999999999999999999999
Q ss_pred eeCceeecCCCCC---ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 148 DFGTCMRMNKTGT---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 148 Dfg~a~~~~~~~~---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
|||.+........ ......+.+||.+...++ .++|+||+|+++|++++|.+||...........+
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence 9999987654432 223344788888876655 6789999999999999999999766544333333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=201.56 Aligned_cols=192 Identities=27% Similarity=0.384 Sum_probs=152.8
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhhh-ccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQI-KRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.++.|++|.|+.+........++.+| ++++.... .......+.+|+.++.++ +||||+++++++..+...++||||
T Consensus 7 ~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (288)
T cd05583 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDY 86 (288)
T ss_pred EeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEec
Confidence 47889999995322111112267788 34443322 234556788999999999 699999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
+++++|.+.+.. ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||+++........
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 166 (288)
T cd05583 87 VNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166 (288)
T ss_pred CCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccc
Confidence 999999998765 45888999999999999999999999999999999999999999999999998865433221
Q ss_pred cccCCCCchhhhhcCC---CcccCCCcccccceecCCccCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHP---FFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~---~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....+.+||.+.+.. ..++|+||+|++++++++|.+||...
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 1234477888876543 36789999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=204.41 Aligned_cols=221 Identities=23% Similarity=0.250 Sum_probs=166.1
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehh-----hhhccCchHHHHHHHHHHHhcCCccceeeeEEEE-eCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRY-----FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ-DAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~-----~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv 84 (245)
-+|||+|+.||.+|++-- ++.+| ++... ...+..-.++..+|.+|-+.|+||.||++|++|. +.+.+|-|
T Consensus 470 LLGrGGFSEVyKAFDl~E---qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTE---QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HhccccHHHHHHhcccch---hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 389999999999988754 66666 22211 1122334677999999999999999999999996 55789999
Q ss_pred EeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCceEecCC---CcEEEEeeCceeecCCC
Q psy16292 85 MDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCL--GFVHRDVKPDNMLLDKH---GHLKLADFGTCMRMNKT 158 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~--~iih~dlkp~nil~~~~---~~i~l~Dfg~a~~~~~~ 158 (245)
+|||+|.+|.-+++.++ +++..++.|+-||+.||.||.+. .|+|-||||.|||+-.. |.+||+|||+++.+..+
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 99999999998888765 89999999999999999999974 59999999999998543 77999999999987644
Q ss_pred CCc--------cccCC---CCchhhhhc---CCC--cccCCCcccccceecCCccCCCCCCCCC-CC--CcccCcCCCCC
Q psy16292 159 GTE--------TKRLG---RNGIEEIKA---HPF--FINDQWTFSNLRECVPPVVPELSGDDDT-SN--FDDIEKDESPE 219 (245)
Q Consensus 159 ~~~--------~~~~~---~~~~e~i~~---~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~-~~--~~~~~~~~~~~ 219 (245)
... ....| |.+||.+.- +|- .+.|+||.||++|..+.|+-||...-.. .+ .+-|+++ ..
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA--tE 704 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA--TE 704 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc--ee
Confidence 321 12233 355665532 332 5679999999999999999999765322 22 2234443 33
Q ss_pred CCCCCCccccCCCCCccc
Q psy16292 220 ENFPVPKAFAGNHLPFVG 237 (245)
Q Consensus 220 ~~~~~~~~~~~~~~~f~~ 237 (245)
-+.|+.+..+..+++|+.
T Consensus 705 VqFP~KPvVsseAkaFIR 722 (775)
T KOG1151|consen 705 VQFPPKPVVSSEAKAFIR 722 (775)
T ss_pred ccCCCCCccCHHHHHHHH
Confidence 345566666777888864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=196.47 Aligned_cols=192 Identities=23% Similarity=0.297 Sum_probs=158.8
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLY 82 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 82 (245)
...-.+++|++|.|+ .+..+ ++.++ ++.+.........+.+.+|+.++++++||||+++++.+... ...+
T Consensus 3 ~~~~~i~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 3 TRGELLGRGSFGSVY-----LALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred eeeeEeeecCceEEE-----EEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 334458899999994 55555 77777 33222222235678899999999999999999999999988 8999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
+++|++++++|.+++... .+++..+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999999988765 689999999999999999999999999999999999999999999999999987765432
Q ss_pred -----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
......+.+||.+..... .++|+||+|++++++++|..||....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222334678888766544 78999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=201.97 Aligned_cols=149 Identities=13% Similarity=0.130 Sum_probs=119.3
Q ss_pred HHHHHhcCCccceeeeEEEEeCC----EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q psy16292 57 RDIMAHANSEWIVQLHFAFQDAK----SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDV 131 (245)
Q Consensus 57 ~~il~~l~hp~Iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl 131 (245)
...+..++|++|+++++++.... ..++++|++ ..++.+.+... ..++..+..++.|++.||.|||+++++||||
T Consensus 74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDi 152 (294)
T PHA02882 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDI 152 (294)
T ss_pred HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 34455678999999998876543 457888887 55777766554 3678889999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEeeCceeecCCCCC-----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCC
Q psy16292 132 KPDNMLLDKHGHLKLADFGTCMRMNKTGT-----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPE 199 (245)
Q Consensus 132 kp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~p 199 (245)
||+||+++.++.++|+|||+|+....... ......+.+||...+..+ .++|+||+||+++++++|.+|
T Consensus 153 Kp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 153 KPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred CHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999987642211 112333678888877766 778999999999999999999
Q ss_pred CCCCCCC
Q psy16292 200 LSGDDDT 206 (245)
Q Consensus 200 f~~~~~~ 206 (245)
|.+....
T Consensus 233 ~~~~~~~ 239 (294)
T PHA02882 233 WKGFGHN 239 (294)
T ss_pred CCccccc
Confidence 9887543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=204.22 Aligned_cols=194 Identities=22% Similarity=0.304 Sum_probs=153.2
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
...+++|++|+|+ .+..+ ++.+|+..-.......+.....+|+..+++++ ||||+++++++.+++..++|||
T Consensus 4 ~~~ig~g~~g~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 4 IKQLGDGTFGSVY-----LARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred heeeccCCceEEE-----EEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 3468999999995 55554 67777322111111223334567999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc
Q psy16292 87 YMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
++ +++|.+.+... .+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 88998877653 578999999999999999999999999999999999999999999999999987654433222
Q ss_pred c---CCCCchhhhhcCC--CcccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 164 R---LGRNGIEEIKAHP--FFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 164 ~---~~~~~~e~i~~~~--~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
. ..+.+||.+.... ..++|+||+|++++++++|.+||.+......+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence 2 3367788774433 36899999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=208.10 Aligned_cols=196 Identities=22% Similarity=0.258 Sum_probs=150.9
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
+-++..+|. ++.|+||.|+ ++..+ |+.+|+ ..+...........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVC-----SAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhccccceEEEEEeeecCCeEEE-----EEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 334445554 6788999995 55543 888883 22222222334566889999999999999999999987
Q ss_pred eCC------EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 77 DAK------SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 77 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
... ..++|+|++. .+|...+. ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 553 5699999994 57776553 468899999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCC-ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 151 TCMRMNKTGT-ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 151 ~a~~~~~~~~-~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
+++....... ......+.+||.+... .+ .++|+||+|++++++++|++||.+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred CCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9886543221 1122346788887653 33 6789999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=201.49 Aligned_cols=190 Identities=22% Similarity=0.305 Sum_probs=153.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.++.|.+|.|+ ++... |+.+|+ ..+...........+.+|+.+++.++||||+++++++.++...++++||
T Consensus 5 ~~i~~g~~~~v~-----~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 5 GKIGEGTYGVVY-----KARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred eeeecCCCceEE-----EEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 357889999994 45444 777772 2222222234567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----c
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~ 161 (245)
++ ++|.+.+... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 95 5888877654 688999999999999999999999999999999999999999999999999987654431 1
Q ss_pred cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....+.+||.+.+. .+ .++|+||+|++++++++|.+||.+.+..
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 205 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 122336788887654 33 7899999999999999999999876643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=202.79 Aligned_cols=194 Identities=21% Similarity=0.275 Sum_probs=152.7
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
+.++|...-.++.|++|.| ++++++ ++.+|+ ..+.. ........+.+|+.++..+ +||||+++++++.+.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v-----~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQV-----YKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred CcchheeeeEeeccCCeEE-----EEEEECCCCeEEEEEEEecc-CChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3556666777999999999 466666 888883 22211 1122345567777777666 599999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
...+++||++ ++++.+++.. ..+++..+..++.+++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++..+
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999999998 5677776654 358888999999999999999997 69999999999999999999999999998876
Q ss_pred CCCCCcc---ccCCCCchhhhhcCC-----CcccCCCcccccceecCCccCCCCCC
Q psy16292 156 NKTGTET---KRLGRNGIEEIKAHP-----FFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 156 ~~~~~~~---~~~~~~~~e~i~~~~-----~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
....... ...++.+||.+.... ..++|+||+|++++++++|++||...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 5433222 234578899886553 36789999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=196.54 Aligned_cols=177 Identities=24% Similarity=0.294 Sum_probs=140.1
Q ss_pred ccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 16 QKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 16 ~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
|.+++| ++|+++ |+.||+..-.. .. ...+|...+....||||+++++++......+++|||+++++|
T Consensus 4 g~~~~v-----~~~~~~~~~~~~~~K~i~~---~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKV-----LLVMDTRTQQTFILKGLRK---SS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceE-----EEEEEccCCcEEEEEeecc---hh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 788888 466666 77777221111 01 123455555566899999999999999999999999999999
Q ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccccCCCCchh
Q psy16292 94 VNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRLGRNGIE 171 (245)
Q Consensus 94 ~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e 171 (245)
.+.+... .+++..+..++.|++.||.|+|+.+++|+||||+||+++.++.++++|||.+........ ......+.+||
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 9987643 589999999999999999999999999999999999999999999999998766543221 11223378888
Q ss_pred hhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 172 EIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 172 ~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.+...++ .++|+||+|++++++++|.+|+...
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 8765554 6789999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=209.85 Aligned_cols=192 Identities=18% Similarity=0.218 Sum_probs=149.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----------
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA----------- 78 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----------- 78 (245)
.++.|+||.|+ ++..+ |+.+|+.. ....+....+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~Lg~g~~g~vy-----~~~~~~~~~~v~iK~-i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 12 PLGCGSNGLVF-----SAVDSDCDKRVAVKK-IVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred EecCCCCEEEE-----EEEECCCCcEEEEEE-EecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 47889999995 55554 77777221 1122235567789999999999999999999876644
Q ss_pred ---CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceee
Q psy16292 79 ---KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMR 154 (245)
Q Consensus 79 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~ 154 (245)
...|+|+||++ ++|.+.+..+.+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++++|||.++.
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccccee
Confidence 36899999995 699988887789999999999999999999999999999999999999854 5689999999986
Q ss_pred cCCCCCc-------cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 155 MNKTGTE-------TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 155 ~~~~~~~-------~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
....... .....+.+||.+... .+ .++|+||+||+++++++|.+||.+.++.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred cCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5432111 112336788877542 23 67899999999999999999998776544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=204.42 Aligned_cols=189 Identities=19% Similarity=0.213 Sum_probs=146.5
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEe-hhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC----CEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYS-RYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA----KSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~----~~~ 81 (245)
.+++|.||.|+ +++.+ ++.||+.. +...........+.+|+.+++++ +||||+++++.+... ..+
T Consensus 7 ~lg~G~~g~vy-----~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 7 ELGQGAYGIVC-----SARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred EccccCCeEEE-----EEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 47889999994 55544 55677322 21112223456788999999999 699999999875432 468
Q ss_pred EEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++++|++ +++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 82 ~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 82 YLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 8999998 5789888764 4589999999999999999999999999999999999999999999999999987643221
Q ss_pred c--------cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 E--------TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 ~--------~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
. .....+.+||.+.+ .++ .++|+||+|++++++++|.+||.+.+..
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~ 216 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence 1 12233678888765 233 7889999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-28 Score=209.77 Aligned_cols=204 Identities=20% Similarity=0.241 Sum_probs=164.7
Q ss_pred HHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC------CccceeeeEE
Q psy16292 9 HRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN------SEWIVQLHFA 74 (245)
Q Consensus 9 ~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~ 74 (245)
.+|. .|+|-||+| +.|+.. |..|| |+... +-....=+.|++||++|+ --++++++..
T Consensus 432 ~RY~V~~~~GkGvFs~V-----vra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTV-----VRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeee-----eeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 4666 467788888 555555 88888 43333 344555688999999994 3479999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc-EEEEee
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-LKLADF 149 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~-i~l~Df 149 (245)
|....++|+|+|.+ ..+|..+++.. ++....++.++.|+..||..|-.+||+|.||||+|||++...+ +|||||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 99999999999999 78999999864 4777889999999999999999999999999999999998755 699999
Q ss_pred CceeecCCCCCccc--cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCC
Q psy16292 150 GTCMRMNKTGTETK--RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222 (245)
Q Consensus 150 g~a~~~~~~~~~~~--~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (245)
|.|........... ..-|.+||.|.+.+| +.-|+||.||.||++.||+.-|.|.+...++.-...-+++.|..
T Consensus 582 GSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99987765543221 122899999999999 89999999999999999999999999888766554445554433
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=199.63 Aligned_cols=200 Identities=18% Similarity=0.244 Sum_probs=153.4
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhh--hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ--IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
...+++|+||+|+ +++.. +..++ ++++... ........+..|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~ig~g~~g~v~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 5 QQRLGKGSFGTVY-----LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred eeeecCCCCceEE-----EEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 4468999999995 44444 33333 2222221 123345567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 84 VMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++. +.++++|||.+......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999987753 35889999999999999999999999999999999999975 67999999998876433
Q ss_pred CC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 159 GT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 ~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
.. ......+.+||......+ .++|+||+|+++++++++..||.+.........+..+
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 22 122334678888766555 6789999999999999999999766544433344333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=201.29 Aligned_cols=175 Identities=21% Similarity=0.276 Sum_probs=146.3
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc--CCccceeeeEEEEeCC----EEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA--NSEWIVQLHFAFQDAK----SLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~~~~~~----~~~lv 84 (245)
-.+|+|+||+|| ..+++|+.|||+. ....+.+.+.+|.+|.+.+ +|+||+.++++=..+. .+|+|
T Consensus 217 e~IGkGRyGEVw-----rG~wrGe~VAVKi----F~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 217 EIIGKGRFGEVW-----RGRWRGEDVAVKI----FSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred EEecCcccccee-----eccccCCceEEEE----ecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 358999999997 8888899999622 3456777899999999985 9999999998865443 69999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC--------LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~--------~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
++|.+.|||.|++....++......++..+++||++||. ..|.|||||..||++.++|.+.|+|+|+|....
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 999999999999999999999999999999999999994 249999999999999999999999999998765
Q ss_pred CCC-----CccccCC---CCchhhhhcC-------CCcccCCCcccccceecC
Q psy16292 157 KTG-----TETKRLG---RNGIEEIKAH-------PFFINDQWTFSNLRECVP 194 (245)
Q Consensus 157 ~~~-----~~~~~~~---~~~~e~i~~~-------~~~~~Diws~g~~~~~~~ 194 (245)
... ..+.+.| |++||.+... .|.++||||+|.++|+++
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 442 2445556 7899887542 234579999999998764
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=198.60 Aligned_cols=183 Identities=19% Similarity=0.286 Sum_probs=152.0
Q ss_pred CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEEEEEeccCCCCHHHHHhcCCCCH
Q psy16292 33 YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLYMVMDYMPGGDLVNLMSNYDVPE 104 (245)
Q Consensus 33 ~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~ 104 (245)
++.+| ++.+. ..+....++..+|..++..++|+||++++.+|.-. ..+|+|||+| ..+|..++. -.+..
T Consensus 41 ~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~-~elDH 117 (369)
T KOG0665|consen 41 GRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL-MELDH 117 (369)
T ss_pred cCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH-Hhcch
Confidence 56666 22222 23356678899999999999999999999999543 3689999999 789998877 34677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCC---CCchhhhhcCCC-cc
Q psy16292 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG---RNGIEEIKAHPF-FI 180 (245)
Q Consensus 105 ~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~---~~~~e~i~~~~~-~~ 180 (245)
..+..++.|++.|+.|+|+.||+||||||+||++..++.+|+.|||+|+.....-..+.... |++||.|.++.+ ..
T Consensus 118 ~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~ 197 (369)
T KOG0665|consen 118 ETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN 197 (369)
T ss_pred HHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCccc
Confidence 88999999999999999999999999999999999999999999999997654422222222 789999999997 55
Q ss_pred cCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 181 NDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 181 ~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.||||.||++.+|++|...|.|.+..++|.++..-...
T Consensus 198 vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 198 VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 69999999999999999999999999999988665443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=222.64 Aligned_cols=187 Identities=20% Similarity=0.255 Sum_probs=151.8
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD---- 77 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---- 77 (245)
+.||.+---+|||+||.| ++|+++ |..||+++-.....+....++.+|+..|.+|+|||||+++.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~V-----vkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSV-----VKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhhhHHHHHhcCCCCceE-----EEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 467888778999999999 799999 999994332222245667789999999999999999999977610
Q ss_pred --------------------------------------------------------------------------------
Q psy16292 78 -------------------------------------------------------------------------------- 77 (245)
Q Consensus 78 -------------------------------------------------------------------------------- 77 (245)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CEEEEEEeccCCCCHHHHHhcCCCC--HHHHHHHHHHHHHHHHH
Q psy16292 78 ---------------------------A--------KSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALDA 120 (245)
Q Consensus 78 ---------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~i~~~l~~ 120 (245)
+ ..+||=||||+...+.++++.+.+. .....+++++|+.||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 1378999999888888888877653 67889999999999999
Q ss_pred HHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC-------------------CCCccccCC---CCchhhhhcCC-
Q psy16292 121 IHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK-------------------TGTETKRLG---RNGIEEIKAHP- 177 (245)
Q Consensus 121 lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~-------------------~~~~~~~~~---~~~~e~i~~~~- 177 (245)
+|+.|+|||||||.||++++++.|||.|||+|..... .+..+...| |.+||...+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9999999999999999999999999999999987220 011334455 68899887776
Q ss_pred --C-cccCCCcccccceecCC
Q psy16292 178 --F-FINDQWTFSNLRECVPP 195 (245)
Q Consensus 178 --~-~~~Diws~g~~~~~~~~ 195 (245)
| -+.|+||+|+++++|+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 4 57799999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=224.41 Aligned_cols=183 Identities=14% Similarity=0.077 Sum_probs=145.9
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.....+++|+||.|+ +++.+ |+.||+++... .. . ...+|+.++++++||||+++++++.+....++||
T Consensus 693 ~~~~~ig~G~~g~Vy-----~~~~~~~~~~vavK~~~~-~~-~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASY-----KGKSIKNGMQFVVKEIND-VN-S---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEE-----EEEECCCCcEEEEEEccC-Cc-c---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 344568999999994 66654 77888432211 11 1 1235788999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH---CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH---~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
||+++|+|.++++. +++.....++.+++.|+.|+| +.+++|||+||+||+++.++..++. +|............
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~ 839 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcc
Confidence 99999999999864 778889999999999999999 6699999999999999998887765 66554433222233
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
...+|.+||.+....+ .++||||+||++|++++|++||...
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 3456899999887766 7899999999999999999998543
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=185.64 Aligned_cols=198 Identities=21% Similarity=0.291 Sum_probs=151.9
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCC--
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAK-- 79 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~-- 79 (245)
|++++.---++|||.||.|.++..... +-+.+.++-|- -..+.+.+|+.||+.|. ||||+++++...+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~--~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITN--NEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCC--CceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 567777778899999999954433322 12222222221 12345889999999995 999999999997664
Q ss_pred EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~ 158 (245)
..-+++|++.+.+...+... ++.-.++.++.+++.||.|+|++||.|||+||.|+++|... .++|+|+|+|......
T Consensus 109 tpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred CchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 57899999988777665443 56678899999999999999999999999999999999875 4899999999988877
Q ss_pred CCccccCC---CCchhhhhcCCC--cccCCCcccccceecCCccCCC-CCCCCCCCC
Q psy16292 159 GTETKRLG---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPEL-SGDDDTSNF 209 (245)
Q Consensus 159 ~~~~~~~~---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf-~~~~~~~~~ 209 (245)
.....+.. ..+||.+-..+. +.-|+||+||++..|..-+.|| .|.+..+++
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 66665555 468888876655 6779999999999999888665 455544443
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=204.53 Aligned_cols=195 Identities=20% Similarity=0.300 Sum_probs=156.9
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+-++|.|.||.||+. +.++ .-.+|| |....+.-.++.|+.|+.+|+.++|||+|+|+++|..+..+|||+|||
T Consensus 272 khKLGGGQYGeVYeG----vWKkyslTvAV--KtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEG----VWKKYSLTVAV--KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeccCCCcccceeee----eeeccceeeeh--hhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 456888899999522 2223 444553 222233457889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccC
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~ 165 (245)
..|+|.+++++. .++.-.+..++.||.+|+.||..+++|||||..+|+|+..+..+|+.|||+++.+..+. .+...
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHA 424 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHA 424 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eeccc
Confidence 999999999854 36777788889999999999999999999999999999999999999999999876442 23333
Q ss_pred C------CCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 166 G------RNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 166 ~------~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
| +.+||.+.-.-| .++|+|+|||+||+++| |-.|+.|-+-...++-
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L 478 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL 478 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Confidence 3 678888776666 78999999999998884 6688888765554443
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=194.16 Aligned_cols=180 Identities=17% Similarity=0.202 Sum_probs=150.2
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc--CCccceeeeEEEEeCC----EEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA--NSEWIVQLHFAFQDAK----SLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~~~~~~----~~~lv~ 85 (245)
-+++|+||.|| +++..++.|||+. ....+.+.+.+|.+|.... +|+||++++++-.... .+|+|+
T Consensus 217 li~~Grfg~V~-----KaqL~~~~VAVKi----fp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 217 LIGRGRFGCVW-----KAQLDNRLVAVKI----FPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred HhhcCccceee-----hhhccCceeEEEe----cCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 47899999994 8887899999633 2235677899999999874 8999999998887655 899999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC---------LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~---------~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+|.+.|+|.++++.+..++....+++..+..||+|||+ ..|.|||||.+|||+.+++++.|+|||+|..+.
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99999999999999999999999999999999999994 359999999999999999999999999999887
Q ss_pred CCCCccc---cCC---CCchhhhhcCCC-------cccCCCcccccceecCCccCCC
Q psy16292 157 KTGTETK---RLG---RNGIEEIKAHPF-------FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 157 ~~~~~~~---~~~---~~~~e~i~~~~~-------~~~Diws~g~~~~~~~~~~~pf 200 (245)
....... ..| |++||.+.+--- .+.|+||+|.++|++++.-.-+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 5544332 233 789988754322 3459999999999998766544
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=183.35 Aligned_cols=193 Identities=19% Similarity=0.206 Sum_probs=151.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeE-EEEeCCEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHF-AFQDAKSLYMV 84 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~-~~~~~~~~~lv 84 (245)
|.-.-.++.|.||++ .||++|+..--++.|...........|.+|.+.--.| .|.||+.-|+ .|++.+.++++
T Consensus 26 y~I~k~lgeG~FgkI-----lL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKI-----LLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhHHHHhcccceeeE-----EeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 444445888999999 7999994333333333333345667799999988888 6899998664 57899999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC--CCcEEEEeeCceeecCCCCCcc
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK--HGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~--~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
+|++|.|+|.+-+...++-|.-...++.|+++|+.|+|+.+++|||||.+|||+-. ..++||+|||.++..+......
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~ 180 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYL 180 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhh
Confidence 99999999999998888999999999999999999999999999999999999843 3579999999998866543332
Q ss_pred -ccCCCCchhhhhc---CCC---cccCCCcccccceecCCccCCCCCCC
Q psy16292 163 -KRLGRNGIEEIKA---HPF---FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 163 -~~~~~~~~e~i~~---~~~---~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
....+.+||.... ..+ ..+|+|.||++++..++|.+|.+...
T Consensus 181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 2333556655432 233 34699999999999999999998553
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=202.07 Aligned_cols=203 Identities=16% Similarity=0.135 Sum_probs=164.0
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhh-hhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYF-QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
..+|.|.||.|+.+-=.... |+.+- .+|... .........|++|+.+|.+|+|||+++||++..+ ...-+|+|++
T Consensus 116 e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34999999999733222221 55554 222111 1112367889999999999999999999999988 6788999999
Q ss_pred CCCCHHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc--
Q psy16292 89 PGGDLVNLMSN-Y--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK-- 163 (245)
Q Consensus 89 ~~g~L~~~l~~-~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~-- 163 (245)
+.|+|.+.++. . .+....+..++.||+.|+.||.++++|||||-.+|+++.....|||+|||+.+.+...+....
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~ 272 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMA 272 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEec
Confidence 99999999876 2 378889999999999999999999999999999999999999999999999998876654332
Q ss_pred -----cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 164 -----RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 164 -----~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
...+.+||.++...| .++|+|++||.+|+|.+ |.-|+.|-....++..|-.++
T Consensus 273 p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 273 PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE 332 (1039)
T ss_pred CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence 223688899988888 67899999999999985 668999999888888877543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=180.46 Aligned_cols=201 Identities=27% Similarity=0.339 Sum_probs=160.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhcc-CchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKR-SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.++.|.+++|+ ++... ++.+|+..- ..... ...+.+.+|+..++.++|+|++++++.+......++++|++
T Consensus 6 ~i~~g~~~~v~-----~~~~~~~~~~~~iK~~-~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 6 KLGEGAFGKVY-----LARDKGTGELVAVKVL-KKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred EeecCCCeEEE-----EEEEcCCCcEEEEEee-ccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 46788899984 44444 566662111 11111 25778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-----Cc
Q psy16292 89 PGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-----TE 161 (245)
Q Consensus 89 ~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-----~~ 161 (245)
++++|.+++.... +++..+..++.+++.++.++|+++++|+|++|.|++++..+.++|+|||.+....... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9889999987654 7889999999999999999999999999999999999999999999999998876542 22
Q ss_pred cccCCCCchhhh-hcCCC-cccCCCcccccceecCCccCCCCC-CCCC-CCCcccCcCCCC
Q psy16292 162 TKRLGRNGIEEI-KAHPF-FINDQWTFSNLRECVPPVVPELSG-DDDT-SNFDDIEKDESP 218 (245)
Q Consensus 162 ~~~~~~~~~e~i-~~~~~-~~~Diws~g~~~~~~~~~~~pf~~-~~~~-~~~~~~~~~~~~ 218 (245)
.....+.+||.. ...++ .++|+|++|++++++++|++||.+ ..+. ...+.+..+.++
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 233346788877 44444 688999999999999999999988 4555 566666666544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=209.05 Aligned_cols=210 Identities=18% Similarity=0.170 Sum_probs=165.9
Q ss_pred HHHHhhhccccccchh-hhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 7 FMHRYRRYRQKYSEVP-RLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~-~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
++....+|.|+||+|+ .++.=..+.-...||+..+......+....+++|+-+|..++|||++++++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3445669999999997 222223222266777433333334455678999999999999999999999998776 88999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
+|++.|+|.++++.+ .+-....+.|+.||+.|+.|||+++++||||-.+|+|+.+...+|+.|||+++.+........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999999865 377788999999999999999999999999999999999999999999999999877665544
Q ss_pred cCC------CCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 164 RLG------RNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 164 ~~~------~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
..+ +.+-|.|..++| -.+|+||+||..|+++| |.-|+.|..-.++=+-+..++.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 433 344577888888 67899999999998885 5588888766665444455544
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-28 Score=194.69 Aligned_cols=199 Identities=15% Similarity=0.178 Sum_probs=156.3
Q ss_pred HhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-----EEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-----SLYM 83 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~l 83 (245)
.-.+|-|+||.||.+.+-.. |+.+| +.-.....+-...+++.+|+.+|...+|.|++...+..+-.. .+|.
T Consensus 58 DRPIGYGAFGVVWsVTDPRd---grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRS---GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEeccCCCC---ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34588899999984433222 88888 222222223345678999999999999999999988886543 4678
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
++|+| -.+|.+.|-+ ..++...+..+..||+.||.|||+.+|+||||||.|++++++..+||+|||+++.....+...
T Consensus 135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 88988 4578776644 357888899999999999999999999999999999999999999999999999765444332
Q ss_pred cc-----CCCCchhhhhcCCCc--ccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 163 KR-----LGRNGIEEIKAHPFF--INDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 163 ~~-----~~~~~~e~i~~~~~~--~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.. --|++||.+++-+.| ..||||.||++.+++..+..|...++.++++.|
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 21 226899999887654 459999999999999999999999888877665
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=203.21 Aligned_cols=192 Identities=19% Similarity=0.227 Sum_probs=156.1
Q ss_pred hhccccccchhhhHHH-HHhhc---CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEY-LLKYR---YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~-l~~~~---~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|.|.||+|+.+.-. +.... ...+|+..........+.+.++.|+.+|+.+ +||||+.+.+++...+.+++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 7999999999733322 11111 3344533323333347788999999999998 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 87 YMPGGDLVNLMSNYD-----------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 87 ~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
|+..|+|.++++..+ ++......++.||+.|++||++.+++||||-.+||++..+..+|++||
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDF 462 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADF 462 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccc
Confidence 999999999998766 888899999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCcc-------ccCCCCchhhhhcCCC-cccCCCcccccceecC-CccCCCCCC
Q psy16292 150 GTCMRMNKTGTET-------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVP-PVVPELSGD 203 (245)
Q Consensus 150 g~a~~~~~~~~~~-------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~-~~~~pf~~~ 203 (245)
|+|+......... -...+++||.+....| .++|+||+|+++|++. .|..|+.+-
T Consensus 463 Glar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 463 GLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred cceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999644332211 2233899999998877 7899999999999887 577889873
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=200.80 Aligned_cols=179 Identities=30% Similarity=0.419 Sum_probs=138.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|.-.-++++|.||+|| +++.. ++.|| ++++...........+.+|+.+++.++||||++++.++....++|
T Consensus 6 y~i~~~LG~G~fg~Vy-----~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 6 FVIVKPISRGAFGKVY-----LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred EEEEEEEecCCCeEEE-----EEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 3334458999999995 66666 88888 444444444445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 83 MVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
+||||+.+++|.+++... .+++..++.++.||+.||.|||.++|+||||||+||+++.++.++|+|||+++........
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~ 160 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccc
Confidence 999999999999988754 4788999999999999999999999999999999999999999999999999875433221
Q ss_pred ----cccCCCCchhhhh--cCCCcccCCCcccccc
Q psy16292 162 ----TKRLGRNGIEEIK--AHPFFINDQWTFSNLR 190 (245)
Q Consensus 162 ----~~~~~~~~~e~i~--~~~~~~~Diws~g~~~ 190 (245)
.....+.+|+... ......+++|++|...
T Consensus 161 ~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~ 195 (669)
T cd05610 161 MMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT 195 (669)
T ss_pred ccccccCccccCccccccCCCCceeeeeeecCcCC
Confidence 1122234444321 1122456788888543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=175.26 Aligned_cols=154 Identities=32% Similarity=0.549 Sum_probs=135.8
Q ss_pred hHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy16292 50 SAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVH 128 (245)
Q Consensus 50 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih 128 (245)
.+.+.+|+..+++++|+||+++++.+......++++|++++++|.+++.... ++...+..++.+++.++.+||+.+++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 6789999999999999999999999999999999999998889999987654 788999999999999999999999999
Q ss_pred CCCCCCceEecCCCcEEEEeeCceeecCCCC---CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 129 RDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 129 ~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+||+|+||+++.++.++++|||.+....... .......+.+||......+ .++|+||+|+++++++++.+||...
T Consensus 111 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 111 RDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999998876542 2223344678888765554 6889999999999999999999773
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=194.13 Aligned_cols=194 Identities=18% Similarity=0.219 Sum_probs=144.4
Q ss_pred hccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGG 91 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g 91 (245)
+|.|+-|+|- ++....|+.||| |... ..-.....+|+..|+.- +||||+++|+.-.+..+.||+.|.| ..
T Consensus 517 lG~Gs~Gt~V----f~G~ye~R~VAV--Krll--~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 517 LGYGSNGTVV----FRGVYEGREVAV--KRLL--EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred cccCCCCcEE----EEEeeCCceehH--HHHh--hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 4556555541 222223666664 2222 24456789999999998 7999999999999999999999999 77
Q ss_pred CHHHHHhcC--CCC--H-HHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CC--cEEEEeeCceeecCCCCC-
Q psy16292 92 DLVNLMSNY--DVP--E-KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HG--HLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 92 ~L~~~l~~~--~~~--~-~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~--~i~l~Dfg~a~~~~~~~~- 160 (245)
+|.+++... ... . -.......|++.||++||+.+|+||||||.|||+.. ++ +++|+|||+|+.+.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999999873 111 1 234667889999999999999999999999999976 34 578999999999875544
Q ss_pred ------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 ------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 ------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....-|+.+||.+...+- .+.||+|+||++|+.++ |..||.+....+ ..|+++..
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~ 730 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY 730 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc
Confidence 234456899999977665 56799999999976665 599998776552 23444433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=192.62 Aligned_cols=198 Identities=18% Similarity=0.143 Sum_probs=139.0
Q ss_pred hHHHHHHhhhccccccchhhhHHH------------HHhhc-CeEEEEEehhhhhc--------------cCchHHHHHH
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEY------------LLKYR-YTLYALYSRYFQIK--------------RSDSAFFWEE 56 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~------------l~~~~-~~~~av~~k~~~~~--------------~~~~~~~~~E 56 (245)
.++|....+||+|+||.|+.+... +.... ++.+|+++- .... ....+....|
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l-~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRV-NMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEe-cccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457788888999999999855421 11112 566663221 1111 1123344557
Q ss_pred HHHHHhcCCccc-----eeeeEEEEe--------CCEEEEEEeccCCCCHHHHHhcC-----------------------
Q psy16292 57 RDIMAHANSEWI-----VQLHFAFQD--------AKSLYMVMDYMPGGDLVNLMSNY----------------------- 100 (245)
Q Consensus 57 ~~il~~l~hp~I-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~----------------------- 100 (245)
+..+.+++|.++ ++++++|.. .+..|+|+||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 566666643 35689999999999999887531
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc-----cCCCCchhhh
Q psy16292 101 --DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK-----RLGRNGIEEI 173 (245)
Q Consensus 101 --~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~-----~~~~~~~e~i 173 (245)
..++..+..++.+++.+|.|+|+.+++||||||+||+++.++.++|+|||+++.......... ..+|.+||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 124566788999999999999999999999999999999999999999999976543322111 2457888887
Q ss_pred hcCCC-----------------------cccCCCcccccceecCCccC-CCCC
Q psy16292 174 KAHPF-----------------------FINDQWTFSNLRECVPPVVP-ELSG 202 (245)
Q Consensus 174 ~~~~~-----------------------~~~Diws~g~~~~~~~~~~~-pf~~ 202 (245)
..... ...|+||+||++++|+++.. |+.+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 54321 12599999999999998764 6653
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=173.77 Aligned_cols=202 Identities=20% Similarity=0.286 Sum_probs=157.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.|...-++|.|.|++|+.++......+++.+|+.. ... .+...++.+|++.|..+ .+.||+++.+++..++++.+|
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~-i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKA-IYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeee-ccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 34455679999999998777776422366777322 222 35667899999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~~---- 159 (245)
+||++.-...++... ++...+..+++.++.||.++|.+||+||||||.|++.+.. +.-.|+|||+|.......
T Consensus 114 lp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred ecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 999998888888776 4567889999999999999999999999999999999865 667899999997211000
Q ss_pred --------------C------------------------------ccccCCCCchhhhhcCCC--cccCCCcccccceec
Q psy16292 160 --------------T------------------------------ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECV 193 (245)
Q Consensus 160 --------------~------------------------------~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~ 193 (245)
. .....|+++||.+...+. .+.|+||.||++-.+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 0 223445677888877665 567999999999999
Q ss_pred CCccCCCC-CCCCCCCCccc
Q psy16292 194 PPVVPELS-GDDDTSNFDDI 212 (245)
Q Consensus 194 ~~~~~pf~-~~~~~~~~~~~ 212 (245)
+++..||- ..+|.....++
T Consensus 272 ls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 272 LSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred hccccccccCccccchHHHH
Confidence 98887754 55666665554
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=177.46 Aligned_cols=125 Identities=26% Similarity=0.385 Sum_probs=102.7
Q ss_pred HH-HHhh----hccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-----Cc---cceeee
Q psy16292 7 FM-HRYR----RYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-----SE---WIVQLH 72 (245)
Q Consensus 7 f~-~~y~----~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-----hp---~Iv~l~ 72 (245)
|. .||. +|=|.|++||.+++... .+.|| ++.|... .-.+..+.||.+|++++ |+ +||+|+
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~---~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQN---KRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccC---CeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 44 5665 45569999996666655 67788 5555542 45677899999999982 33 699999
Q ss_pred EEEEeC----CEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEe
Q psy16292 73 FAFQDA----KSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLL 138 (245)
Q Consensus 73 ~~~~~~----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~ 138 (245)
+.|... .++|+|+|++ |.+|..+|.. ++++...+..|+.||+.||.|||. +||+|.||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 999744 5999999999 8999998874 369999999999999999999997 799999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=190.40 Aligned_cols=184 Identities=18% Similarity=0.220 Sum_probs=120.3
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEE-----
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFA----- 74 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~----- 74 (245)
+|...-.||+|+||.|+ +++.. +..+|+++. . .....+...+|. +....+.++..+...
T Consensus 133 ~y~l~~~LG~G~FG~VY-----ka~~~~~~~~~~~~vAvK~~-~--~~~~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVY-----KASLVNKQSKKEGKYVLKKA-T--EYGAVEIWMNER--VRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CeEEeEEEeeCCCeEEE-----EEEEcCCccccCcEEEEEEe-c--ccchhHHHHHHH--HHhhchhhHHHHHHhhhccc
Confidence 33334458999999995 44433 566663321 1 112222222221 122222233222222
Q ss_pred -EEeCCEEEEEEeccCCCCHHHHHhcCCCC---------------------HHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q psy16292 75 -FQDAKSLYMVMDYMPGGDLVNLMSNYDVP---------------------EKWAKFYCAEVVLALDAIHCLGFVHRDVK 132 (245)
Q Consensus 75 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------~~~~~~~~~~i~~~l~~lH~~~iih~dlk 132 (245)
.......++|+||+++++|.+++.....+ +..+..++.|++.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 24556899999999999999988654321 23456789999999999999999999999
Q ss_pred CCceEecC-CCcEEEEeeCceeecCCCCC-----ccccCCCCchhhhhcCCC-----------------------cccCC
Q psy16292 133 PDNMLLDK-HGHLKLADFGTCMRMNKTGT-----ETKRLGRNGIEEIKAHPF-----------------------FINDQ 183 (245)
Q Consensus 133 p~nil~~~-~~~i~l~Dfg~a~~~~~~~~-----~~~~~~~~~~e~i~~~~~-----------------------~~~Di 183 (245)
|+||+++. ++.++|+|||+|+.+..... .....+|.+||.+..... .+.|+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57899999999986543221 122345788886632211 23599
Q ss_pred CcccccceecCCccCC
Q psy16292 184 WTFSNLRECVPPVVPE 199 (245)
Q Consensus 184 ws~g~~~~~~~~~~~p 199 (245)
||+||++++|+++..+
T Consensus 363 wSlGviL~el~~~~~~ 378 (566)
T PLN03225 363 YSAGLIFLQMAFPNLR 378 (566)
T ss_pred HHHHHHHHHHHhCcCC
Confidence 9999999999975443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=156.45 Aligned_cols=176 Identities=26% Similarity=0.315 Sum_probs=141.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
++.|.++.|+ +++.. |+.+++..-...........+.+|+..++.+.|++|+++++++......++++|++++
T Consensus 1 l~~g~~~~v~-----~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVY-----LARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEE-----EEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 4678888884 55554 6666622211111111357899999999999999999999999999999999999988
Q ss_pred CCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCCCC----Cccc
Q psy16292 91 GDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKTG----TETK 163 (245)
Q Consensus 91 g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~~----~~~~ 163 (245)
++|.+++... ..+...+..++.+++.++.+||+.+++|+||+|.||+++. ++.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9999999875 6889999999999999999999999999999999999999 8999999999998765432 2233
Q ss_pred cCCCCchhhhhc--CCCcccCCCcccccceec
Q psy16292 164 RLGRNGIEEIKA--HPFFINDQWTFSNLRECV 193 (245)
Q Consensus 164 ~~~~~~~e~i~~--~~~~~~Diws~g~~~~~~ 193 (245)
...+.+||.... ....++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 444778888766 334788999999999888
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=186.47 Aligned_cols=230 Identities=20% Similarity=0.261 Sum_probs=183.5
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++|.--.+++-|.||.| ++|+++ |+..| ++.|... ..+..-++.|+-+++..+||||+.+++.+.....+
T Consensus 15 ddyellqrvgsgTygdv-----yKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDV-----YKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred cchhheeeecCCcccch-----hhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 46667778999999999 688887 88878 4444332 45677789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-
Q psy16292 82 YMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG- 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~- 159 (245)
|++||||.+|+|.+.-. .+.+++-++...++..+.|+.|||+.|-+|||||-.||++...|.+++.|||.+..+...-
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 99999999999998654 3458888999999999999999999999999999999999999999999999998876542
Q ss_pred CccccCC---CCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCC
Q psy16292 160 TETKRLG---RNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNH 232 (245)
Q Consensus 160 ~~~~~~~---~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (245)
.+....| +++||...- ..| -.+|+|++|+...++..-.||..+..+..+.--.-+.-+.+|.+..+.--+...
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 2334455 467766532 223 568999999999999999999988888877666666656655665555545556
Q ss_pred CCcccceee
Q psy16292 233 LPFVGFTYS 241 (245)
Q Consensus 233 ~~f~~f~~~ 241 (245)
+.|+.-.|.
T Consensus 248 h~fvK~alt 256 (829)
T KOG0576|consen 248 HNFVKGALT 256 (829)
T ss_pred HHHHHHHhc
Confidence 666654444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=168.75 Aligned_cols=181 Identities=17% Similarity=0.123 Sum_probs=123.2
Q ss_pred HhhhccccccchhhhHHHHHhhc---CeEEEEEehhhh----hccCchHHHHHHHHHHHhcCCcccee-eeEEEEeCCEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR---YTLYALYSRYFQ----IKRSDSAFFWEERDIMAHANSEWIVQ-LHFAFQDAKSL 81 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~---~~~~av~~k~~~----~~~~~~~~~~~E~~il~~l~hp~Iv~-l~~~~~~~~~~ 81 (245)
.-.+|+|+||+|+ +|.++ +..+|+.+.... .+......+.+|+++|++++|+|++. +++. +..
T Consensus 23 ~~~IG~G~fg~Vy-----~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 23 TAVLKRDVFSTVE-----RGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred ccEEeecCcEEEE-----EEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 3358999999995 55443 666774322211 11223566899999999999999985 5432 458
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDV-KPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl-kp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|+||||++|++|... .. .. ...++.+++.+|.++|++||+|||| ||+||+++.++.++|+|||+|+.+.....
T Consensus 94 ~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 999999999999632 21 11 1457789999999999999999999 99999999999999999999997654321
Q ss_pred c------------cccCCCCchhhhhcCCC-------cccCCC-ccccccee-cCCccCCCCCCCC
Q psy16292 161 E------------TKRLGRNGIEEIKAHPF-------FINDQW-TFSNLREC-VPPVVPELSGDDD 205 (245)
Q Consensus 161 ~------------~~~~~~~~~e~i~~~~~-------~~~Diw-s~g~~~~~-~~~~~~pf~~~~~ 205 (245)
. .+...+.+||.+...+. ..+|-| .-|=+.+. ---|..-|.|..+
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~~~d~dG~l~~~gR~~ 233 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVYNFITRGLFSWSDGEG 233 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEEEEcCCCeEEEEecCc
Confidence 1 11222556665543332 234667 45555554 3555555555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-22 Score=187.96 Aligned_cols=141 Identities=15% Similarity=0.122 Sum_probs=107.9
Q ss_pred hcCC-ccceeeeEEE-------EeCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q psy16292 62 HANS-EWIVQLHFAF-------QDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDV 131 (245)
Q Consensus 62 ~l~h-p~Iv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl 131 (245)
.+.| +||..++++| .....++.++|++ +++|.+++... .+++..+..++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4456 5788888887 2334678889988 77999999753 4899999999999999999999999999999
Q ss_pred CCCceEecCCC-------------------cEEEEeeCceeecCCCCC--------------------ccccCCCCchhh
Q psy16292 132 KPDNMLLDKHG-------------------HLKLADFGTCMRMNKTGT--------------------ETKRLGRNGIEE 172 (245)
Q Consensus 132 kp~nil~~~~~-------------------~i~l~Dfg~a~~~~~~~~--------------------~~~~~~~~~~e~ 172 (245)
||+|||++..| .++++|||+++....... ......|++||.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 455666666653211000 001223789999
Q ss_pred hhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 173 IKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 173 i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+.+.++ .++||||+||++|+|+++.+|+...
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 988777 7889999999999999999987643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=150.27 Aligned_cols=137 Identities=14% Similarity=0.124 Sum_probs=102.0
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE--EEehhhhhccCc------h-----------------HHHHHHHHHHHhcCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA--LYSRYFQIKRSD------S-----------------AFFWEERDIMAHANS 65 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a--v~~k~~~~~~~~------~-----------------~~~~~E~~il~~l~h 65 (245)
.++.|++|.|+ +|... |+.|| ++++.......+ . ....+|+.++..+.+
T Consensus 4 ~ig~G~~~~Vy-----~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 4 CISTGKEANVY-----HATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred ccccccceEEE-----EEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 48999999994 66655 88999 333322111110 1 123459999999988
Q ss_pred ccceeeeEEEEeCCEEEEEEeccCCCCHHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCceEecCCCc
Q psy16292 66 EWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL-MSNYDVPEKWAKFYCAEVVLALDAI-HCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 66 p~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~l~~l-H~~~iih~dlkp~nil~~~~~~ 143 (245)
+++........ .. .++||||++++++... +....+++..+..++.|++.+|.++ |+.|++||||||+||+++ ++.
T Consensus 79 ~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 79 AGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 87754433322 22 3899999988777554 4556788999999999999999999 799999999999999998 578
Q ss_pred EEEEeeCceeecC
Q psy16292 144 LKLADFGTCMRMN 156 (245)
Q Consensus 144 i~l~Dfg~a~~~~ 156 (245)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=146.10 Aligned_cols=186 Identities=18% Similarity=0.191 Sum_probs=145.3
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCC-ccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+|-|+||.+ +++... |+.|| ++.... ....++..|..+.+.|++ ..|+.+..++....+-.+||+++
T Consensus 23 iGsGSFGdI-----y~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 23 IGSGSFGDI-----YLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ecCCchhhe-----eeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 556688888 466655 99999 433322 334457889999999965 67888888888999999999999
Q ss_pred CCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCceeecCCCCC---
Q psy16292 89 PGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 89 ~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a~~~~~~~~--- 160 (245)
|.||.++.. ++.++..+++.++.|++.-++|+|.++++||||||+|++.+-. ..+.++|||+|+.+....+
T Consensus 94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H 172 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH 172 (341)
T ss_pred -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence 999999875 5678999999999999999999999999999999999998654 4588999999997654332
Q ss_pred -----ccccCCCCchhhhhcCCC----cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF----FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~----~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.....|+..+..|.+|-- -+.|+-|+|.++-..--|..|++|-.....
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 122344444555655542 467999999888888889999988765443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=150.38 Aligned_cols=165 Identities=15% Similarity=0.208 Sum_probs=115.7
Q ss_pred HHH-HHhh----hccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHH------HHHHHHHHHhcCCccceeee
Q psy16292 6 AFM-HRYR----RYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAF------FWEERDIMAHANSEWIVQLH 72 (245)
Q Consensus 6 ~f~-~~y~----~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~------~~~E~~il~~l~hp~Iv~l~ 72 (245)
+|. ++|+ ++.|.||.|+ ++...+..+| +........+....+ +.+|+..+.++.||+|..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~-----l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVS-----LIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEE-----EEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 444 3666 4456999995 3333344556 333222222222233 57899999999999999999
Q ss_pred EEEEeC--------CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 73 FAFQDA--------KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 73 ~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
+++... +..+++|||++|.+|.+... .++ ....+++.++..+|+.|++|+|++|.|++++.+| +
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 887644 35899999999999988632 233 2356899999999999999999999999999988 9
Q ss_pred EEEeeCceeecCCCCCccccCCCCchhhhhcCCC-cccCCCcccccce
Q psy16292 145 KLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPF-FINDQWTFSNLRE 191 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~ 191 (245)
+++|||.+........... .+....+ .++|+||+|+.+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~--------~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR--------IDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred EEEECCCcccccchhhHHH--------HHHHhHhcccccccceeEeeh
Confidence 9999998876542221111 1222223 6899999998764
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-21 Score=170.94 Aligned_cols=197 Identities=31% Similarity=0.451 Sum_probs=162.2
Q ss_pred hccccccchhhhHHHHHhhc-----CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR-----YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~-----~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv 84 (245)
++.|.||+| .+|++- |..|| +.+|.....+... +...|..++..++ ||.+++++-+|+.+..++++
T Consensus 2 lg~g~~gkv-----fLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 2 LGQGSYGKV-----FLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCcCCCcch-----HHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHh
Confidence 578999999 444433 88888 6666555444444 7788999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc
Q psy16292 85 MDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
+++..+|.+...+... .+.+.....+...++.++.++|+.++++||+|++||+++.+|.+++.|||+++..-.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cg 155 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACG 155 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhccc
Confidence 9999999998877655 477888888999999999999999999999999999999999999999999997655544433
Q ss_pred cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
..-|++||.+.+| ...+|-||+|++.++|++|..||.+ +....|+..+.+.|
T Consensus 156 t~eymApEI~~gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p 207 (612)
T KOG0603|consen 156 TYEYRAPEIINGH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP 207 (612)
T ss_pred chhhhhhHhhhcc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc
Confidence 4447888888833 3578999999999999999999988 55566777666544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=144.88 Aligned_cols=135 Identities=12% Similarity=0.033 Sum_probs=101.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-----CCccceeeeEEEEeCC---
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-----NSEWIVQLHFAFQDAK--- 79 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~--- 79 (245)
...||+|+++.|+ . ++ +.. + +|+.........+.+.+|+.+++.+ +||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy-----~--hp~~~~k-~-IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCY-----A--HPEDAQR-C-IKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEE-----E--CCCCcCe-E-EEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 4568999999994 2 33 333 2 2222222233567799999999999 6799999999999873
Q ss_pred EEE-EEEec--cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCceEecCC----CcEEEEeeCc
Q psy16292 80 SLY-MVMDY--MPGGDLVNLMSNYDVPEKWAKFYCAEVVLAL-DAIHCLGFVHRDVKPDNMLLDKH----GHLKLADFGT 151 (245)
Q Consensus 80 ~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l-~~lH~~~iih~dlkp~nil~~~~----~~i~l~Dfg~ 151 (245)
.++ +|+|| +++++|.+++++..+++. ..++.+++.++ .|||+++|+||||||+||+++.. +.++|+|++.
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 544 88999 557999999987666665 35577888888 89999999999999999999743 3799999554
Q ss_pred eeec
Q psy16292 152 CMRM 155 (245)
Q Consensus 152 a~~~ 155 (245)
+...
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=143.07 Aligned_cols=138 Identities=15% Similarity=0.115 Sum_probs=104.5
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE--EEehhhhhcc------------------Cc-----hHHHHHHHHHHHhcCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA--LYSRYFQIKR------------------SD-----SAFFWEERDIMAHANS 65 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a--v~~k~~~~~~------------------~~-----~~~~~~E~~il~~l~h 65 (245)
.++.|++|.|+ +|+.. |+.|| ++++...... .. .....+|...+.++.|
T Consensus 4 ~ig~G~~~~Vy-----~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 4 CISTGKEANVY-----HARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred eeecCCCcEEE-----EEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 47899999994 66555 88999 3333211000 00 1234679999999999
Q ss_pred ccceeeeEEEEeCCEEEEEEeccCCCCHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCc
Q psy16292 66 EWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 66 p~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~ 143 (245)
+++.....+.... .++||||++|+++.. .+....++......++.+++.++.++|. .|++||||||+||+++ ++.
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 9886554444333 489999998875543 3555567888899999999999999999 9999999999999998 889
Q ss_pred EEEEeeCceeecCC
Q psy16292 144 LKLADFGTCMRMNK 157 (245)
Q Consensus 144 i~l~Dfg~a~~~~~ 157 (245)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=157.59 Aligned_cols=180 Identities=14% Similarity=0.188 Sum_probs=146.7
Q ss_pred cCchHHHHHHHHHHHhcCCccceeeeEEEE-eCCEEEEEEeccCCCCHHHHHhc---------CCCCHHHHHHHHHHHHH
Q psy16292 47 RSDSAFFWEERDIMAHANSEWIVQLHFAFQ-DAKSLYMVMDYMPGGDLVNLMSN---------YDVPEKWAKFYCAEVVL 116 (245)
Q Consensus 47 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~i~~ 116 (245)
+-++..++.|.-++..+.|||+..+.+++. +....+.++.++.-|+|..++.. ..++..++..++.|+..
T Consensus 328 ~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~ 407 (563)
T KOG1024|consen 328 QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAM 407 (563)
T ss_pred HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHH
Confidence 346778899999999999999999988885 45678899999989999998861 12566678889999999
Q ss_pred HHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCccccc
Q psy16292 117 ALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNL 189 (245)
Q Consensus 117 ~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~ 189 (245)
|+.|||+++++|.||..+|+++++.-.+||+|-.+++.+.+... ......++++|.+....| ..+|+|||||+
T Consensus 408 am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVl 487 (563)
T KOG1024|consen 408 AMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVL 487 (563)
T ss_pred HHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHH
Confidence 99999999999999999999999999999999999998765433 233444789999988888 67899999999
Q ss_pred ceecC-CccCCCCCCCCCCCCcccCcCCCCCCCCCCCc
Q psy16292 190 RECVP-PVVPELSGDDDTSNFDDIEKDESPEENFPVPK 226 (245)
Q Consensus 190 ~~~~~-~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (245)
+|+++ .|+.|+..-++.+...-+..|..-.++.-.|+
T Consensus 488 lWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPD 525 (563)
T KOG1024|consen 488 LWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPD 525 (563)
T ss_pred HHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcH
Confidence 99887 58889988777777666666655444443343
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=153.31 Aligned_cols=193 Identities=17% Similarity=0.143 Sum_probs=141.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc---CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCC----ccceeeeEEE-E
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR---YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANS----EWIVQLHFAF-Q 76 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~---~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~h----p~Iv~l~~~~-~ 76 (245)
+|.-.-+++.|+||.|+ +|... .+.+| ++..... ......+..|..++..+.. +++..+++.+ .
T Consensus 19 ~~~i~~~iG~G~fG~V~-----~v~~~~~~~~~~a~K~e~~~~--~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVY-----LVSDKSEKNKEYAKKLEKKEL--GSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEE-----EEEecCCCCeeEEEEEEEecc--cCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 34445568899999994 66544 24566 3333221 1222278889999999863 5899999999 5
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-----CcEEEEe
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-----GHLKLAD 148 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-----~~i~l~D 148 (245)
.+.+.|+||+.+ |.+|.++... +.++...+..++.|++.+|.++|+.|++||||||.|+.++.. ..+.+.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 888999999999 9999998753 458999999999999999999999999999999999999875 3589999
Q ss_pred eCcee--ecCCCCC---------ccccCCC---CchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 149 FGTCM--RMNKTGT---------ETKRLGR---NGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 149 fg~a~--~~~~~~~---------~~~~~~~---~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
||+|+ ....... .....|+ .++..-.+.+. .+.|+||++.++.++..|..|..+....
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 99999 4322211 1112243 23333233333 5679999999999999998888766543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=141.11 Aligned_cols=179 Identities=12% Similarity=0.015 Sum_probs=125.6
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhc---cCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIK---RSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~---~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.++++.||+| +++...+..++...-..... .-....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 9 ~l~~~~f~~v-----~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 9 PLKSDTFGRI-----LLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred eecCCCcceE-----EEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4789999999 36655555555211111111 112335789999999994 5889999886 346999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDV-KPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl-kp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
+.|.+|.+.+... ...++.+++.+|.++|++||+|||| ||+||+++.+|.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 80 LAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred ecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 9998987654321 1346789999999999999999999 799999999999999999999865533320
Q ss_pred ------------cccCCCCchhhh--h-cCCCcccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 ------------TKRLGRNGIEEI--K-AHPFFINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ------------~~~~~~~~~e~i--~-~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....++.+|++- . ...|.+.+-.+.|+-+|.++|+..+.-++.+
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 001223444432 2 2334556777899999999999887766543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=147.55 Aligned_cols=195 Identities=18% Similarity=0.233 Sum_probs=150.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+||.|+||... +.++- |+.+||. +...+++..++..|.+..+.| ..++|...|-+.+.+.+-.+|+|++
T Consensus 35 KIGeGsFG~lf-----~G~Nl~nne~VAIK---fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 35 KIGEGSFGVLF-----LGKNLYNNEPVAIK---FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccccCcceeee-----cccccccCceEEEE---eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57788999884 44444 8899942 223346777889999999998 6799999999999999999999999
Q ss_pred CCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-----cEEEEeeCceeecCCCCCc
Q psy16292 89 PGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-----HLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 89 ~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-----~i~l~Dfg~a~~~~~~~~~ 161 (245)
|.||.|+.. .++++...++.++.|++.-++++|++.+|.|||||+|+|++..+ .|.++|||+|+.+..+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 999999876 45699999999999999999999999999999999999998754 4899999999987766541
Q ss_pred --------cccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC---CCCCCcccCcC
Q psy16292 162 --------TKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD---DTSNFDDIEKD 215 (245)
Q Consensus 162 --------~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~---~~~~~~~~~~~ 215 (245)
....| |++...-.+.+- -+.|.-|+|=++...+-|..|+.|-. ..+-+.+|-..
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 11222 333333333333 56799999988888888999988764 33334445443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=146.71 Aligned_cols=188 Identities=30% Similarity=0.450 Sum_probs=149.4
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCc-cceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.++.|.|+.|+.+.+. +.+| ++.+...........+.+|+.++..+.|+ +|+++.+.+......+++++++
T Consensus 7 ~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 7 KLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 3567888888533222 4444 33333322223578899999999999888 7999999998888899999999
Q ss_pred CCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCC----
Q psy16292 89 PGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 89 ~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~---- 159 (245)
.++++.+++... .++......+..+++.++.++|+.+++|||+||+|++++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 999999877754 588999999999999999999999999999999999999998 69999999998655432
Q ss_pred ------CccccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 160 ------TETKRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 160 ------~~~~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
......++.+||.+... .. ...|+||+|++++.++++..||.....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22334447889988762 33 678999999999999999999776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=135.10 Aligned_cols=107 Identities=17% Similarity=0.117 Sum_probs=92.2
Q ss_pred CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCCCC
Q psy16292 91 GDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRN 168 (245)
Q Consensus 91 g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~~~ 168 (245)
|+|.+++.. ..+++..+..++.|++.||.|||+++ ||+||+++.++.+++ ||+++....... .....|.
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~-~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS-RVDPYFM 71 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccC-CCccccc
Confidence 688998874 34899999999999999999999998 999999999999998 999987654433 3346689
Q ss_pred chhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 169 GIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 169 ~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
+||.+.+.++ .++||||+||++|++++|.+||......
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 110 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 9999988877 7899999999999999999999776544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=159.41 Aligned_cols=154 Identities=19% Similarity=0.259 Sum_probs=126.7
Q ss_pred HHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q psy16292 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDV 131 (245)
Q Consensus 53 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dl 131 (245)
+..|.-+-..+.|||++.......+.....-.||||++ +|..++... .+....+..++.|++.||.|+|+.|+.|||+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 55566666778999998877777666555555999998 999988775 6888889999999999999999999999999
Q ss_pred CCCceEecCCCcEEEEeeCceeecCCCCCc--------cccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCC
Q psy16292 132 KPDNMLLDKHGHLKLADFGTCMRMNKTGTE--------TKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 132 kp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--------~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
|++|+++...|.+|++|||.+.....+... ....+|.+||.+...+| ...|+||.|+++..|.++..|++
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 999999999999999999998765433222 22333788999999888 55799999999999999999998
Q ss_pred CCCCCC
Q psy16292 202 GDDDTS 207 (245)
Q Consensus 202 ~~~~~~ 207 (245)
-+...+
T Consensus 527 ~a~~~~ 532 (601)
T KOG0590|consen 527 VAKKSD 532 (601)
T ss_pred cccccc
Confidence 765443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-17 Score=130.96 Aligned_cols=134 Identities=22% Similarity=0.261 Sum_probs=106.4
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhc------cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIK------RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+++|.+|.|+ +++..|..++ ++.+..... .....++.+|+.++..+.|++++....++.+....+++
T Consensus 3 ~l~~G~~~~vy-----~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 3 LIKRGAEAEIY-----LGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred ccccCceEEEE-----EEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 47899999995 4444555555 322211111 11234688999999999999998887777778889999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
|||++|++|.+.+..... ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++++|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998865432 6778889999999999999999999999999998 78899999998876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=129.71 Aligned_cols=131 Identities=17% Similarity=0.140 Sum_probs=100.8
Q ss_pred hccccccchhhhHHHHHhhcCeEEE-EEehhhhhc------cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIK------RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+++|.+|.|+ ++...|..++ +........ .....++.+|+.+++.+.|+++.....++......+++|
T Consensus 2 ig~G~~~~vy-----~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 2 IAKGAEAIIY-----LGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCceEEEE-----EeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 6889999995 4444555555 322211111 112466789999999999887666555566677789999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
|+++|++|.+.+..... .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||+++..
T Consensus 77 e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999988765321 6788999999999999999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=145.25 Aligned_cols=134 Identities=17% Similarity=0.182 Sum_probs=104.3
Q ss_pred HhhhccccccchhhhHHHHHhhcCeEEE---EEehhhhh----ccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYRYTLYA---LYSRYFQI----KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~~~~~a---v~~k~~~~----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
.-.+++|+||+|+ +++..+..++ ...+.... .....+++.+|+.+++.++|++++....++.+....+
T Consensus 338 ~~~iG~G~~g~Vy-----~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 338 DHLIGKGAEADIK-----KGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cceeccCCcEEEE-----EEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3458999999995 4444422222 11121111 1123467889999999999999998887777777889
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+||||+++++|.+.+. ....++.+++.+|.++|+.+++|||+||+||++ .++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999998775 346678999999999999999999999999999 67889999999998743
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=130.19 Aligned_cols=137 Identities=13% Similarity=0.054 Sum_probs=99.0
Q ss_pred hhccccccchhhhHHHHHh--hc-CeEEE-EEehhhhhcc-----------------C-----chHHHHHHHHHHHhcCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLK--YR-YTLYA-LYSRYFQIKR-----------------S-----DSAFFWEERDIMAHANS 65 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~--~~-~~~~a-v~~k~~~~~~-----------------~-----~~~~~~~E~~il~~l~h 65 (245)
.++.|++|.|+ +|. .+ |+.|| ++.+...... . ....+.+|+.+++++.+
T Consensus 35 ~Lg~G~~g~Vy-----~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 35 CISTGKEANVY-----HALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred eeccCcceeEE-----EEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 47888999994 665 33 88888 3222211000 0 11235789999999975
Q ss_pred cc--ceeeeEEEEeCCEEEEEEeccCCCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCceEecCC
Q psy16292 66 EW--IVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLG-FVHRDVKPDNMLLDKH 141 (245)
Q Consensus 66 p~--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-iih~dlkp~nil~~~~ 141 (245)
.. +++++. .. ..++|||++++.+|.... ............++.+++.++.++|+.| ++|+||||+||+++ +
T Consensus 110 ~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 32 334443 22 348999999888886654 3444556667889999999999999999 99999999999999 8
Q ss_pred CcEEEEeeCceeecCCC
Q psy16292 142 GHLKLADFGTCMRMNKT 158 (245)
Q Consensus 142 ~~i~l~Dfg~a~~~~~~ 158 (245)
+.++|+|||.+.....+
T Consensus 185 ~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 185 GKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCEEEEEChhhhccCCc
Confidence 89999999998865543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=124.71 Aligned_cols=138 Identities=17% Similarity=0.139 Sum_probs=100.0
Q ss_pred Hhhhc-cccccchhhhHHHHHhhcCeEEE--EEehhh----h------hccCchHHHHHHHHHHHhcCCccc--eeeeEE
Q psy16292 10 RYRRY-RQKYSEVPRLFEYLLKYRYTLYA--LYSRYF----Q------IKRSDSAFFWEERDIMAHANSEWI--VQLHFA 74 (245)
Q Consensus 10 ~y~~~-~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~----~------~~~~~~~~~~~E~~il~~l~hp~I--v~l~~~ 74 (245)
.|.++ .|+.|+|+ .++..|..++ .+.+.. . .......++.+|+.++..++|++| +..+++
T Consensus 36 ~~~lg~~~g~gtv~-----~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 36 ARVVGSAKGRGTTW-----FVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred CceeecCCCCccEE-----EEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 35565 67888884 4444444555 222110 0 111344678999999999998875 666666
Q ss_pred EEeC-C---EEEEEEeccCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 75 FQDA-K---SLYMVMDYMPG-GDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 75 ~~~~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
.... . ..++|||+++| .+|.+++....+++.. +.+++.+|.++|++||+|+||||+||+++.++.++|+||
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 4432 2 23599999987 6999888776555543 568999999999999999999999999999999999999
Q ss_pred CceeecC
Q psy16292 150 GTCMRMN 156 (245)
Q Consensus 150 g~a~~~~ 156 (245)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9988754
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=9e-17 Score=150.96 Aligned_cols=177 Identities=21% Similarity=0.293 Sum_probs=135.6
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC---CccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN---SEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+| ++|... |+.+| ++.|-. ....+.-=.+++.+|+ -+.|+.+..+....+.-++|+|
T Consensus 705 e~G~g~y~~v-----y~a~~~~~~~~alK~e~P~-----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 705 EIGEGSYGSV-----YVATHSNGKLVALKVEKPP-----NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred eeccccceEE-----EEeecCCCcEEEEEeecCC-----CceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 5899999999 577777 88888 544432 2222333344444444 3456667777777777899999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-------CcEEEEeeCceeecCC-
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-------GHLKLADFGTCMRMNK- 157 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-------~~i~l~Dfg~a~~~~~- 157 (245)
|.+.|+|.+++... .+++..+.++..|++..|..||.++|||+||||+|+++... --++|+|||.+..+..
T Consensus 775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf 854 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF 854 (974)
T ss_pred ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence 99999999999854 48999999999999999999999999999999999998432 3489999999876432
Q ss_pred -CC-Ccccc---CCCCchhhhhcCCC-cccCCCcccccceecCCccC
Q psy16292 158 -TG-TETKR---LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVP 198 (245)
Q Consensus 158 -~~-~~~~~---~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~ 198 (245)
.+ ..... -+...+|...+.|| |..|-|.+.-+++.|+.|+.
T Consensus 855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 22 22222 22466788899999 99999999999999998874
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=127.99 Aligned_cols=140 Identities=26% Similarity=0.386 Sum_probs=108.7
Q ss_pred CCccceeeeEEEEeC---------------------------CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHH
Q psy16292 64 NSEWIVQLHFAFQDA---------------------------KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVL 116 (245)
Q Consensus 64 ~hp~Iv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~ 116 (245)
+|||||++..+|.+. ..+|+||.-. ..+|..++-....+....+.+..|++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 699999999888442 3689999888 679999888777777778888999999
Q ss_pred HHHHHHhCCceeCCCCCCceEec--CCC--cEEEEeeCceeecCCC------CCccccCC----CCchhhhhcCC-----
Q psy16292 117 ALDAIHCLGFVHRDVKPDNMLLD--KHG--HLKLADFGTCMRMNKT------GTETKRLG----RNGIEEIKAHP----- 177 (245)
Q Consensus 117 ~l~~lH~~~iih~dlkp~nil~~--~~~--~i~l~Dfg~a~~~~~~------~~~~~~~~----~~~~e~i~~~~----- 177 (245)
|+.|||.+||.|||+|.+||++. .++ .+.++|||+|---... .+.....| .++||....-|
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999984 443 3678999987532211 11112222 46777776544
Q ss_pred --CcccCCCcccccceecCCccCCCCCCC
Q psy16292 178 --FFINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 178 --~~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
|-++|.|+.|.+.|++.+-.-||-+..
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccc
Confidence 357899999999999999999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-15 Score=119.68 Aligned_cols=132 Identities=17% Similarity=0.053 Sum_probs=96.4
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEE--ehhhhh----c---------------cCchHHHHHHHHHHHhcCCcc--
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALY--SRYFQI----K---------------RSDSAFFWEERDIMAHANSEW-- 67 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~--~k~~~~----~---------------~~~~~~~~~E~~il~~l~hp~-- 67 (245)
.++.|++|.|+ .+..+ |+.+|+. ...... . ........+|..++..+.|++
T Consensus 22 ~i~~G~~g~Vy-----~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 22 QIGVGKESDVY-----LALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred ccccCcceEEE-----EEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 47889999994 55555 8888832 211100 0 001123678999999997774
Q ss_pred ceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEE
Q psy16292 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 68 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
++..++ ....+++|||++|++|...... .....++.+++.++.++|+.|++|+||+|+||+++.++.++|+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~li 167 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYII 167 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEE
Confidence 444433 2456899999999988765431 3455678899999999999999999999999999999999999
Q ss_pred eeCceeecCC
Q psy16292 148 DFGTCMRMNK 157 (245)
Q Consensus 148 Dfg~a~~~~~ 157 (245)
|||.+.....
T Consensus 168 Dfg~~~~~~~ 177 (198)
T cd05144 168 DWPQMVSTDH 177 (198)
T ss_pred ECCccccCCC
Confidence 9999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-15 Score=122.74 Aligned_cols=178 Identities=15% Similarity=0.122 Sum_probs=137.9
Q ss_pred CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCC---CCHHHHH
Q psy16292 33 YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAK 108 (245)
Q Consensus 33 ~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~ 108 (245)
+.++| +++. ........+.|.+|.-.|+-..||||+.+++.+....++.++..||+-|+|+.++.+.. +..+++.
T Consensus 214 ndivakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav 292 (448)
T KOG0195|consen 214 NDIVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAV 292 (448)
T ss_pred cchhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHH
Confidence 56666 4333 33334455668899999999999999999999999999999999999999999998764 6778899
Q ss_pred HHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCCCCchhhhhcCCC----cccC
Q psy16292 109 FYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPF----FIND 182 (245)
Q Consensus 109 ~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~~~----~~~D 182 (245)
+++.+++.|++|||+.. |..-.|+...+++|.+-+.+|+- +-++...........+.+.+||.+...|- ..+|
T Consensus 293 ~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsfqe~gr~y~pawmspealqrkped~n~raad 371 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAAD 371 (448)
T ss_pred HHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeeeeccccccCcccCCHHHHhcCchhcchhhhh
Confidence 99999999999999854 44556889999999987766541 22222222333344555788999876553 5679
Q ss_pred CCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 183 QWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 183 iws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
+|||.++++++.|...||.+-++.+---++
T Consensus 372 mwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 372 MWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred HHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 999999999999999999988887765554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.3e-14 Score=111.44 Aligned_cols=135 Identities=13% Similarity=0.113 Sum_probs=91.0
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-E-EehhhhhccCchH---------------------HHHHHHHHHHhcCCcc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-L-YSRYFQIKRSDSA---------------------FFWEERDIMAHANSEW 67 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v-~~k~~~~~~~~~~---------------------~~~~E~~il~~l~hp~ 67 (245)
.+++|++|+|+ +|... |+.|| + ++........... ....|...+..+.+..
T Consensus 4 ~lg~G~~g~Vy-----~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 4 PIGTGKEADVY-----LALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred ccccccceeEE-----EEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 47899999994 66666 88888 3 2321111111111 1245666777764433
Q ss_pred --ceeeeEEEEeCCEEEEEEeccCCCCHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCc
Q psy16292 68 --IVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 68 --Iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~ 143 (245)
+.+.+++ ...+++|||++++++.. .+...... .....++.+++.++.++|. .+++|+||+|+||+++ ++.
T Consensus 79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4444443 23689999998854322 12211111 5677889999999999999 9999999999999999 899
Q ss_pred EEEEeeCceeecCC
Q psy16292 144 LKLADFGTCMRMNK 157 (245)
Q Consensus 144 i~l~Dfg~a~~~~~ 157 (245)
++++|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-15 Score=139.39 Aligned_cols=182 Identities=18% Similarity=0.154 Sum_probs=134.8
Q ss_pred hccccccchhhhHHHHHhhc-CeEEE-EEehhh-hhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYF-QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+|.++|=+| ..|+++ |.++. |.-|.. ...-....+-++|++ ...++|||.+.+--+.++.+..|+|-+|.
T Consensus 31 LGstRFlKv-----~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv- 103 (1431)
T KOG1240|consen 31 LGSTRFLKV-----ARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV- 103 (1431)
T ss_pred cCchhhhhh-----hhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence 677788888 688888 88766 333322 333344455556666 56679999999988888888889999998
Q ss_pred CCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC-CCCCc------
Q psy16292 90 GGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN-KTGTE------ 161 (245)
Q Consensus 90 ~g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~-~~~~~------ 161 (245)
..+|+|.++.+. +.....+.++-|++.||.-+|..||+|+|||.+|||+.+-+=+.|+||..=+... ...++
T Consensus 104 khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fF 183 (1431)
T KOG1240|consen 104 KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFF 183 (1431)
T ss_pred hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEE
Confidence 789999998876 4556677789999999999999999999999999999998889999998655422 11221
Q ss_pred ----cccCCCCchhhhhcCC-C----------c-ccCCCcccccceecC-CccCCCC
Q psy16292 162 ----TKRLGRNGIEEIKAHP-F----------F-INDQWTFSNLRECVP-PVVPELS 201 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~~-~----------~-~~Diws~g~~~~~~~-~~~~pf~ 201 (245)
..+.=|.+||.+-.+- . . +=||+|+||++.|++ .|.|||.
T Consensus 184 FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 184 FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1122267888875421 1 1 229999999998776 5689884
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.8e-14 Score=105.10 Aligned_cols=129 Identities=19% Similarity=0.151 Sum_probs=99.9
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCC--ccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANS--EWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+++.|.++.|+ .++..+..+++.. ... ... ...+.+|+.+++.+.| +++++++.+....+..+++||+++
T Consensus 5 ~i~~g~~~~v~-----~~~~~~~~~~iK~-~~~-~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 5 LLKGGLTNRVY-----LLGTKDEDYVLKI-NPS-REK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ecccccccceE-----EEEecCCeEEEEe-cCC-CCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 47788888884 5544444444211 111 111 4678999999999966 589999998888889999999998
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL---GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~---~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
++++... +......++.+++.++..+|.. +++|+|++|+|++++..+.++++|||.++.
T Consensus 77 g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777543 4455666788999999999984 699999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.4e-15 Score=121.94 Aligned_cols=189 Identities=16% Similarity=0.182 Sum_probs=114.6
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcC----------CccceeeeEEEEe-
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHAN----------SEWIVQLHFAFQD- 77 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~----------hp~Iv~l~~~~~~- 77 (245)
|+.|.++.| +.|++. |+.+|+ ..-.........+.+.+|......+. |-.++..++....
T Consensus 20 i~~g~~~~v-----~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 20 IGKGGFSIV-----FEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEETTEEE-----EEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred cccCCceEE-----EEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 566788888 455555 899992 22112334456778888876665532 2233333333321
Q ss_pred --------CC--------EEEEEEeccCCCCHHHHHhc----CCC----CHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q psy16292 78 --------AK--------SLYMVMDYMPGGDLVNLMSN----YDV----PEKWAKFYCAEVVLALDAIHCLGFVHRDVKP 133 (245)
Q Consensus 78 --------~~--------~~~lv~e~~~~g~L~~~l~~----~~~----~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp 133 (245)
.. +.+++|+-+ .++|.+++.. ... .......+..|++..+++||+.|++|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 11 346788877 6788887542 111 1122334458889999999999999999999
Q ss_pred CceEecCCCcEEEEeeCceeecCCCCCccc-cCCCCchhhhhcC--------CC-cccCCCcccccceecCCccCCCCCC
Q psy16292 134 DNMLLDKHGHLKLADFGTCMRMNKTGTETK-RLGRNGIEEIKAH--------PF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 134 ~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~-~~~~~~~e~i~~~--------~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+|++++.+|.+.|+||+.....+....... ..++.+||..... ++ ++.|.|++|+++|.++.+..||...
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999998877654433222 2334444443221 12 5569999999999999999999866
Q ss_pred CCCC
Q psy16292 204 DDTS 207 (245)
Q Consensus 204 ~~~~ 207 (245)
.+..
T Consensus 254 ~~~~ 257 (288)
T PF14531_consen 254 SPEA 257 (288)
T ss_dssp GGGS
T ss_pred Cccc
Confidence 5443
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=122.09 Aligned_cols=145 Identities=17% Similarity=0.198 Sum_probs=120.3
Q ss_pred HHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc-eeCCCCCCce
Q psy16292 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGF-VHRDVKPDNM 136 (245)
Q Consensus 60 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i-ih~dlkp~ni 136 (245)
|+.+.|.|+.++++.+.++...+.|.+||+.|+|.+.+... ++..-....+.+.++.|+.|+|...| .|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45789999999999999999999999999999999999764 46777778888999999999998765 9999999999
Q ss_pred EecCCCcEEEEeeCceeecCC------CCCccccCCCCchhhhhcC--------CCcccCCCcccccceecCCccCCCCC
Q psy16292 137 LLDKHGHLKLADFGTCMRMNK------TGTETKRLGRNGIEEIKAH--------PFFINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 137 l~~~~~~i~l~Dfg~a~~~~~------~~~~~~~~~~~~~e~i~~~--------~~~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
+++....+|++|||+...... ........-+.+||.++.. ...++|+||+|++++++++-..||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876632 1111223336788887764 22457999999999999999999976
Q ss_pred CC
Q psy16292 203 DD 204 (245)
Q Consensus 203 ~~ 204 (245)
..
T Consensus 161 ~~ 162 (484)
T KOG1023|consen 161 RN 162 (484)
T ss_pred cc
Confidence 44
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.8e-14 Score=134.24 Aligned_cols=162 Identities=28% Similarity=0.435 Sum_probs=118.1
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+-.|+||.| ++++++ .+.+| +++|..++-+. |+.....|++|
T Consensus 91 isngAygav-----ylvrh~~trqrfa~kiNkq~lilRn----------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 91 ISNGAYGAV-----YLVRHKETRQRFAMKINKQNLILRN----------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred eccCCCCce-----eeeeccccccchhhcccccchhhhc----------cccccCCccee--------------------
Confidence 456799999 689888 77777 44443322111 44445556655
Q ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--------
Q psy16292 90 GGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-------- 160 (245)
Q Consensus 90 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-------- 160 (245)
|+=..+++.- .++. +++.+++|+|+.||+|||+||+|.++...|.+|+.|||+++.......
T Consensus 136 -gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 -GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred -chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 3333334332 2332 237899999999999999999999999999999999999876432211
Q ss_pred --------ccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 --------ETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 --------~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
....+| |.+||.|....| ...|=|++|+++|+.+-|..||.|+++.+.|..++.....
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 112233 688899887777 6789999999999999999999999999999988766443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.2e-13 Score=123.89 Aligned_cols=190 Identities=21% Similarity=0.245 Sum_probs=143.8
Q ss_pred hccccccchhhhHHHHHhhc-CeEEE-EEehhhh--hccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEec
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQ--IKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~--~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
++.|+++.| .++... +...+ +.+.... .......++..|..+-+.+. |+|++++++........++++++
T Consensus 28 ig~gs~~~~-----~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 28 IGKGSFSSS-----ALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred ccccccchh-----hhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 567788888 355443 33333 2222221 22345566677888888886 99999999999999999999999
Q ss_pred cCCCCHHHHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCceEecCCC-cEEEEeeCceeecCC-CCC-
Q psy16292 88 MPGGDLVNLM-SNY--DVPEKWAKFYCAEVVLALDAIH-CLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNK-TGT- 160 (245)
Q Consensus 88 ~~~g~L~~~l-~~~--~~~~~~~~~~~~~i~~~l~~lH-~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~-~~~- 160 (245)
..++++...+ ... ..+.....+++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|..+.. .+.
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~ 182 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAE 182 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcc
Confidence 9999999887 433 4677788899999999999999 99999999999999999999 999999999987665 222
Q ss_pred --ccccCC----CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 --ETKRLG----RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 --~~~~~~----~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
....+| +.+||...+..+ -..|+||.|+++..+++|.-|...+....
T Consensus 183 ~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 183 RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 222333 455565555333 45699999999999999998876665444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.5e-11 Score=92.46 Aligned_cols=101 Identities=22% Similarity=0.225 Sum_probs=83.3
Q ss_pred chHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy16292 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVH 128 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih 128 (245)
...+..+|+.++.++.--.|....-++.+...-.|+|||++|..|.+.+... ...++..+-.-+.-||..||+|
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givH 115 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVH 115 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeec
Confidence 3467889999999997667766666777888889999999988888888765 2455667777788899999999
Q ss_pred CCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 129 RDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 129 ~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+||.++|+++...+ +.++|||++..-.
T Consensus 116 GDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 116 GDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CCCccceEEEeCCc-EEEEECCcccccc
Confidence 99999999997665 8999999988543
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.2e-13 Score=116.25 Aligned_cols=114 Identities=20% Similarity=0.331 Sum_probs=97.5
Q ss_pred CEEEEEEeccCCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNYD----VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++||.|++|...+|.+++.... .+......++.|+..|+.| ++.+|+|+||.||+...+..++|.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997542 5667788889999999999 9999999999999999999999999999887
Q ss_pred cCCCC-------CccccCC---CCchhhhhcCCC-cccCCCcccccceecCC
Q psy16292 155 MNKTG-------TETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPP 195 (245)
Q Consensus 155 ~~~~~-------~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~ 195 (245)
..... ..+...| |++||+|.+.-| .++||||+|+++++++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 66554 2333344 799999998777 89999999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-11 Score=107.38 Aligned_cols=101 Identities=18% Similarity=0.307 Sum_probs=69.6
Q ss_pred HHHHHHHHHhc----C-CccceeeeEEE-EeCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHH-HHHHHHh
Q psy16292 53 FWEERDIMAHA----N-SEWIVQLHFAF-QDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVL-ALDAIHC 123 (245)
Q Consensus 53 ~~~E~~il~~l----~-hp~Iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~-~l~~lH~ 123 (245)
+.+|+..+.++ . ++++ .+..++ ......++||||++|++|.+..... +.. ...++..++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 44555555554 2 3433 332232 2234578999999999998875432 222 2334444444 4677899
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.|++|+|++|.||+++.+|.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=6e-11 Score=91.80 Aligned_cols=124 Identities=16% Similarity=0.093 Sum_probs=85.3
Q ss_pred hccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCcc-ceeeeEEEEeCCEEEEEEeccCC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
+..|..+.|+ .++..|+.|+ ++.... ........+|+.+++.+.+.+ +++++.... ..-++|||+++|
T Consensus 6 l~~G~~~~vy-----~~~~~~~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 6 LKGGMTNKNY-----RVEVANKKYVVRIPGNG---TELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred cCCcccCceE-----EEEECCeEEEEEeCCCC---cccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 4566677773 5555566666 332211 112334678999999985544 445555443 234799999998
Q ss_pred CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 91 GDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGF-----VHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 91 g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~i-----ih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++... . ......+.++..++..||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 76 ~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877643 1 1123345789999999999885 9999999999998 67899999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-10 Score=90.65 Aligned_cols=99 Identities=14% Similarity=0.156 Sum_probs=75.2
Q ss_pred HHHHHHHHHhcCC--ccceeeeEEEEeCCEEEEEEeccCCCCHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcee
Q psy16292 53 FWEERDIMAHANS--EWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAEVVLALDAI-HCLGFVH 128 (245)
Q Consensus 53 ~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~~i~~~l~~l-H~~~iih 128 (245)
..+|+..|+++.. -++++++++ ..-++||||+.+..+. ..++...+++.....+..+++.++..+ |..|++|
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3489999999843 456666654 4568999999654332 234443455556667788999999988 8999999
Q ss_pred CCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 129 RDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 129 ~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+||++.||+++ ++.+.++|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999996 5779999999888764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=104.43 Aligned_cols=158 Identities=16% Similarity=0.180 Sum_probs=118.6
Q ss_pred chHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCce
Q psy16292 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH-CLGFV 127 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH-~~~ii 127 (245)
......+-++-|+.++||||+++++.++..+.+|+|+|-+. .|...+++.+ ...+...+.||+.||.||| +++++
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--~~~v~~Gl~qIl~AL~FL~~d~~lv 127 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--KEEVCLGLFQILAALSFLNDDCNLV 127 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--HHHHHHHHHHHHHHHHHHhccCCee
Confidence 34567888999999999999999999999999999999874 6666666533 5566677899999999998 68899
Q ss_pred eCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc----ccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCC
Q psy16292 128 HRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET----KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 128 h~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~----~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
|+++....++++..|.-+|.+|.++........+. ..-++..|+++.... ..-|.|-|||+.+++..| ++...
T Consensus 128 HgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-~s~D~~~Lg~li~el~ng--~~~~~ 204 (690)
T KOG1243|consen 128 HGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-WSIDSWGLGCLIEELFNG--SLLTK 204 (690)
T ss_pred eccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-cchhhhhHHHHHHHHhCc--ccCcc
Confidence 99999999999999999999998876544332111 111133444433222 345999999999999988 45555
Q ss_pred CCCCCCcccC
Q psy16292 204 DDTSNFDDIE 213 (245)
Q Consensus 204 ~~~~~~~~~~ 213 (245)
.+..+-..+.
T Consensus 205 ~~~~~~~~ip 214 (690)
T KOG1243|consen 205 TDLSNTGKIP 214 (690)
T ss_pred hhhhccCccc
Confidence 5555544443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=109.77 Aligned_cols=74 Identities=23% Similarity=0.393 Sum_probs=54.5
Q ss_pred CCEEEEEEeccCCCCHHHH--HhcCCC-----CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEE
Q psy16292 78 AKSLYMVMDYMPGGDLVNL--MSNYDV-----PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKL 146 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~--l~~~~~-----~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l 146 (245)
...-++||||+.|+++.+. +...+. .+..+..++.| +...|++|+|++|.||+++.+| .+++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 3456799999999999774 333332 22233333333 3468999999999999999888 8999
Q ss_pred EeeCceeecCCC
Q psy16292 147 ADFGTCMRMNKT 158 (245)
Q Consensus 147 ~Dfg~a~~~~~~ 158 (245)
+|||++..+...
T Consensus 306 lDFGivg~l~~~ 317 (537)
T PRK04750 306 LDFGIVGSLNKE 317 (537)
T ss_pred EecceEEECCHH
Confidence 999999987644
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.7e-11 Score=114.86 Aligned_cols=205 Identities=21% Similarity=0.229 Sum_probs=148.9
Q ss_pred cccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 15 RQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 15 ~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
+++++.+ ..++.. |-..+ +..+...+...+.+....+-.++-...+|.++.....+......+++++++.+
T Consensus 814 S~sp~ss-----~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 814 SGSPSSS-----FPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred CCCCccc-----ccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 3455555 344444 44444 32333333344566666677777667788888877777778889999999999
Q ss_pred CCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC------C--C-
Q psy16292 91 GDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT------G--T- 160 (245)
Q Consensus 91 g~L~~~l~~~~-~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~------~--~- 160 (245)
++|...++..+ ..++..+.....+..+.++||...+.|+|++|.|++...+|..++.|||.......- . .
T Consensus 889 ~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~ 968 (1205)
T KOG0606|consen 889 GDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSS 968 (1205)
T ss_pred CCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccc
Confidence 99999888654 555666677778899999999998999999999999999999999999844322100 0 0
Q ss_pred --------------------------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 161 --------------------------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 161 --------------------------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
......+.+||...+..- ..+|.|+.|+.+.+.++|.+||+++.+...|+.+.
T Consensus 969 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 969 SGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENIL 1048 (1205)
T ss_pred cCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccc
Confidence 011122445555544433 66799999999999999999999999999999999
Q ss_pred cCCCCCCCCCC
Q psy16292 214 KDESPEENFPV 224 (245)
Q Consensus 214 ~~~~~~~~~~~ 224 (245)
....|.|..+.
T Consensus 1049 ~~~~~~p~g~~ 1059 (1205)
T KOG0606|consen 1049 NRDIPWPEGPE 1059 (1205)
T ss_pred cCCCCCCCCcc
Confidence 99887665543
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.8e-09 Score=82.43 Aligned_cols=107 Identities=17% Similarity=0.236 Sum_probs=84.0
Q ss_pred chHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC-CCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC
Q psy16292 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG-GDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCL 124 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~ 124 (245)
...+...|+++|.++.--.|.-.--+|.+...-.|.|||++| .++.+++... .........++..+-..+.-||.+
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC
Confidence 356788999999998655666666677788888999999966 3677776542 223334467888999999999999
Q ss_pred CceeCCCCCCceEecCCCc---EEEEeeCceeec
Q psy16292 125 GFVHRDVKPDNMLLDKHGH---LKLADFGTCMRM 155 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~---i~l~Dfg~a~~~ 155 (245)
+++|+||.++||++.+++. +.++|||++..-
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999999999999987764 579999998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.2e-09 Score=85.70 Aligned_cols=103 Identities=12% Similarity=0.090 Sum_probs=79.7
Q ss_pred HHHHHHHHHHhcCCcccee--eeEEEEe-----CCEEEEEEeccCCC-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHH
Q psy16292 52 FFWEERDIMAHANSEWIVQ--LHFAFQD-----AKSLYMVMDYMPGG-DLVNLMSN---YDVPEKWAKFYCAEVVLALDA 120 (245)
Q Consensus 52 ~~~~E~~il~~l~hp~Iv~--l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~ 120 (245)
.+.+|...+..+..-+|.. +..+.+. ...-++|+|++++. +|.+++.. ...+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4789999998885444433 3444443 23578999999775 78888753 334556777889999999999
Q ss_pred HHhCCceeCCCCCCceEecC-------CCcEEEEeeCceee
Q psy16292 121 IHCLGFVHRDVKPDNMLLDK-------HGHLKLADFGTCMR 154 (245)
Q Consensus 121 lH~~~iih~dlkp~nil~~~-------~~~i~l~Dfg~a~~ 154 (245)
||..|++|+|+++.||+++. +..+.++||+.++.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999975 45789999998864
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.6e-10 Score=98.88 Aligned_cols=187 Identities=17% Similarity=0.099 Sum_probs=137.5
Q ss_pred hhcc--ccccchhhhHHHHH--hhcCeEEEE-EehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYR--QKYSEVPRLFEYLL--KYRYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~--~~~~~v~~~~~~l~--~~~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+++. |.++.|+ .-.+ +..+..+|+ ..+..........+=++|+.-...+ .|+|.++.+..++..+..++-+
T Consensus 121 ~~g~~~g~~~s~~---~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 121 RTGSLPGSKGSVF---KSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred ccccCCCCCceee---cccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 4555 6777663 2223 333777773 3333333234445557787777777 5999999999999999999999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCC
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVL----ALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKT 158 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~----~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~ 158 (245)
|++ +.+|..+...- -++...+.....+... ||.++|..+++|-|+||.|++...+ ..+++.|||+...+...
T Consensus 198 E~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~ 276 (524)
T KOG0601|consen 198 ELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG 276 (524)
T ss_pred ccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCC
Confidence 999 67887766542 3788888888888888 9999999999999999999999999 78899999999987655
Q ss_pred CCc---------cccCCCCchhhhhcCCCcccCCCcccccceecCCc-cCCCCC
Q psy16292 159 GTE---------TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPV-VPELSG 202 (245)
Q Consensus 159 ~~~---------~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~-~~pf~~ 202 (245)
.-. ...+-|.++|...+..-+.+|++++|.+..+...+ ..|-.|
T Consensus 277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 277 NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 421 12222678888887777899999999766544444 444444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.8e-09 Score=82.62 Aligned_cols=136 Identities=13% Similarity=0.083 Sum_probs=88.0
Q ss_pred hccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCC--ccceeeeEEEEeC---CEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANS--EWIVQLHFAFQDA---KSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~---~~~~lv~ 85 (245)
++.|..+.|+ +++.. |+.|+ ++...... ......+..|..+++.+.+ ..+++++.+.... +..++||
T Consensus 6 l~~G~~n~~~-----~v~~~~g~~~ilK~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 6 LSGGQSNLTY-----LLTAGGGRRLVLRRPPPGAL-LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred cCCCccceEE-----EEEecCCcceEEEeCCCccc-CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 5667777773 44334 45566 32221111 1235678999999999965 3467777776654 3678999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC------------------------------------------ 123 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~------------------------------------------ 123 (245)
|+++|.++.+.+....+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99998877664322223444444455555555555542
Q ss_pred --------------CCceeCCCCCCceEecC--CCcEEEEeeCceee
Q psy16292 124 --------------LGFVHRDVKPDNMLLDK--HGHLKLADFGTCMR 154 (245)
Q Consensus 124 --------------~~iih~dlkp~nil~~~--~~~i~l~Dfg~a~~ 154 (245)
..++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999988 56689999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=9e-09 Score=81.21 Aligned_cols=101 Identities=21% Similarity=0.240 Sum_probs=67.1
Q ss_pred hHHHHHHHHHHHhcCCc--cceeeeEEEEeCCEEEEEEeccC--CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhC
Q psy16292 50 SAFFWEERDIMAHANSE--WIVQLHFAFQDAKSLYMVMDYMP--GGDLVNLMSNYDVPEKWAKFYCAEVVLALDA-IHCL 124 (245)
Q Consensus 50 ~~~~~~E~~il~~l~hp--~Iv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~-lH~~ 124 (245)
..+..+|.+.|..+..- ++++++.+. .-.+||||++ |..+..+.. ..++......++.+++..+.. +|..
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhc
Confidence 45678899999999655 466666442 2469999997 544544332 222234455666777775554 6799
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
|++|+||.+.||+++.+ .+.++|||.+....
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999999877 89999999888764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.5e-08 Score=78.57 Aligned_cols=109 Identities=16% Similarity=0.205 Sum_probs=84.7
Q ss_pred CchHHHHHHHHHHHhcCCcc--ceeeeEEEEeC----CEEEEEEeccCCC-CHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Q psy16292 48 SDSAFFWEERDIMAHANSEW--IVQLHFAFQDA----KSLYMVMDYMPGG-DLVNLMSNY-DVPEKWAKFYCAEVVLALD 119 (245)
Q Consensus 48 ~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~~~i~~~l~ 119 (245)
-...+..+|...+..|..-. .+..+++.+.. ...++|+|.+++. +|.+++... ..+......++.++...+.
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 34567889999888874433 34445555542 2458999999874 788888752 3556677788899999999
Q ss_pred HHHhCCceeCCCCCCceEecCCC---cEEEEeeCceeecC
Q psy16292 120 AIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGTCMRMN 156 (245)
Q Consensus 120 ~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~a~~~~ 156 (245)
-||+.|++|+|+++.||+++.++ .+.++||+-++...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999999887 78999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.5e-07 Score=73.80 Aligned_cols=106 Identities=11% Similarity=0.121 Sum_probs=80.9
Q ss_pred chHHHHHHHHHHHhcCCcc--ceeeeEEEE-e----CCEEEEEEeccCC-CCHHHHHhcCC---CCHHHHHHHHHHHHHH
Q psy16292 49 DSAFFWEERDIMAHANSEW--IVQLHFAFQ-D----AKSLYMVMDYMPG-GDLVNLMSNYD---VPEKWAKFYCAEVVLA 117 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~--Iv~l~~~~~-~----~~~~~lv~e~~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~~ 117 (245)
....+.+|...|+.+..-+ +++.. ++. . ...-+||+|-+.| .+|.+++.+.. .+......+..++...
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 4567999999999984333 44443 222 1 1247899998843 58888876643 3566667888999999
Q ss_pred HHHHHhCCceeCCCCCCceEecCCCc--EEEEeeCceeec
Q psy16292 118 LDAIHCLGFVHRDVKPDNMLLDKHGH--LKLADFGTCMRM 155 (245)
Q Consensus 118 l~~lH~~~iih~dlkp~nil~~~~~~--i~l~Dfg~a~~~ 155 (245)
+.-||+.|+.|+|+.+.||+++.+|. +.++||.-++..
T Consensus 141 ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 141 FKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 99999999999999999999987777 899999876653
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.7e-08 Score=83.21 Aligned_cols=92 Identities=21% Similarity=0.412 Sum_probs=77.5
Q ss_pred HHHHHHhcCCccceeeeEEEEeCC-----EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy16292 56 ERDIMAHANSEWIVQLHFAFQDAK-----SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCL- 124 (245)
Q Consensus 56 E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~- 124 (245)
-.+-|-++.|.|||+++.+|.+.+ ...++.||+..|++.+++++ ..+......+|+.||++||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 445556678999999999997654 47899999999999999874 2367778889999999999999986
Q ss_pred -CceeCCCCCCceEecCCCcEEEE
Q psy16292 125 -GFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 125 -~iih~dlkp~nil~~~~~~i~l~ 147 (245)
.++|+++..+.+++..+|.+|+.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 49999999999999988887763
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-08 Score=90.19 Aligned_cols=192 Identities=19% Similarity=0.119 Sum_probs=128.1
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 83 (245)
|-.--.++.+.|+.|. ...-+.. +.+|+ .-.+.......+...-+.|+.+...+ .|.+++.++..|....+.++
T Consensus 267 f~~v~~i~~~~~~~~~---~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVF---KVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cceeEEccCCccccce---eeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 3333445555666662 1121112 77777 22222222222333346677777666 69999999999988888889
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~~~~ 161 (245)
=.|||.++++...+.- .-+.+...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||+...+.-...-
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~ 423 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV 423 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceeccc
Confidence 9999998888765532 236777888899999999999999999999999999999886 66789999988753322211
Q ss_pred -cccCCCC-chhhh-hcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 162 -TKRLGRN-GIEEI-KAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 162 -~~~~~~~-~~e~i-~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
....+.. ..+.+ ..++. -+.|++|+|.-..+..++.+.-.
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 1111222 23333 33444 56799999999988888875443
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-07 Score=82.67 Aligned_cols=138 Identities=18% Similarity=0.219 Sum_probs=105.3
Q ss_pred chHHHHHHHHHHHhcCCccceeeeEEEEeC----CEEEEEEeccCC-CCHHHHH----------------hcCCCCHHHH
Q psy16292 49 DSAFFWEERDIMAHANSEWIVQLHFAFQDA----KSLYMVMDYMPG-GDLVNLM----------------SNYDVPEKWA 107 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l----------------~~~~~~~~~~ 107 (245)
.......-++.++++.|+|+|.+.++|.+. ..+++|++|.|+ ++|.++. ...+.++..+
T Consensus 316 ~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~l 395 (655)
T KOG3741|consen 316 STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVL 395 (655)
T ss_pred CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHH
Confidence 344455668899999999999999999843 478999999985 5777643 1224788999
Q ss_pred HHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCCCCchhhhhcCCCcccCCCccc
Q psy16292 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFINDQWTFS 187 (245)
Q Consensus 108 ~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~~~~~~Diws~g 187 (245)
+.++.|+..||.++|+.|+..+-|.+.+|++..+.+++|+--|+...+..+. . +.+..+ -+.|.=.+|
T Consensus 396 W~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------~---~~le~~--Qq~D~~~lG 463 (655)
T KOG3741|consen 396 WSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------T---EPLESQ--QQNDLRDLG 463 (655)
T ss_pred HHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------C---cchhHH--hhhhHHHHH
Confidence 9999999999999999999999999999999999889888666555444332 0 112211 245777789
Q ss_pred ccceecCCccC
Q psy16292 188 NLRECVPPVVP 198 (245)
Q Consensus 188 ~~~~~~~~~~~ 198 (245)
.++..+.+|.-
T Consensus 464 ~ll~aLAt~~~ 474 (655)
T KOG3741|consen 464 LLLLALATGTE 474 (655)
T ss_pred HHHHHHhhccc
Confidence 88888888853
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.7e-06 Score=67.50 Aligned_cols=68 Identities=26% Similarity=0.496 Sum_probs=53.1
Q ss_pred CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
...+++|||++|..|.+... +++ .+...+..++.-+|+.|+.|+|+.|.|+++..++ ++++|++..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 35679999999988776532 222 2345677788999999999999999999998555 89999987664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.5e-08 Score=90.82 Aligned_cols=91 Identities=12% Similarity=0.126 Sum_probs=67.7
Q ss_pred eCCCCCC-ceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCC
Q psy16292 128 HRDVKPD-NMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPE 199 (245)
Q Consensus 128 h~dlkp~-nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~p 199 (245)
+++..|. |+++...+..++.|||.++....... .....+|++||.+.+.++ .++|+||+||++|++++|.+|
T Consensus 500 ~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~p 579 (669)
T cd05610 500 TQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPP 579 (669)
T ss_pred CCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 3455555 55666666678889998876543321 123445899999988877 788999999999999999999
Q ss_pred CCCCCCCCCCcccCcCCCC
Q psy16292 200 LSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 200 f~~~~~~~~~~~~~~~~~~ 218 (245)
|.+......+.+++....+
T Consensus 580 f~~~~~~~~~~~il~~~~~ 598 (669)
T cd05610 580 FNDETPQQVFQNILNRDIP 598 (669)
T ss_pred CCCCCHHHHHHHHHhcCCC
Confidence 9998887777777665444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.8e-06 Score=71.06 Aligned_cols=99 Identities=16% Similarity=0.176 Sum_probs=71.7
Q ss_pred hHHHHHHHHHHHhcCCc--cceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy16292 50 SAFFWEERDIMAHANSE--WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFV 127 (245)
Q Consensus 50 ~~~~~~E~~il~~l~hp--~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~ii 127 (245)
.....+|.++|+.|.-. .+++.+++ +...+|||++.|-.|...-- .......++..|+..+.-.-..|++
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~il~~il~~~~~~~~~GiV 224 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDEILDKILEEVRKAYRRGIV 224 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC----cccCHHHHHHHHHHHHHHHHHcCcc
Confidence 34578899999998544 56655543 45679999998766654321 2233444555666666666689999
Q ss_pred eCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 128 HRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 128 h~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
|+|+++-||+++.+|.+.++||--+....
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCcccccCC
Confidence 99999999999999999999997665543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.1e-05 Score=59.99 Aligned_cols=98 Identities=21% Similarity=0.247 Sum_probs=78.0
Q ss_pred HHHHHHHHhcCC-ccceeeeEEEEeCCEEEEEEeccCCCCHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy16292 54 WEERDIMAHANS-EWIVQLHFAFQDAKSLYMVMDYMPGGDLVN----LMSNYDVPEKWAKFYCAEVVLALDAIHC---LG 125 (245)
Q Consensus 54 ~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~----~l~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ 125 (245)
.+|.-+++.+++ +++++++|+|-. +++.|+...+++.. +.+-...++.....++.+++..+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999965 699999999843 56889997666542 1222346888999999999999999987 44
Q ss_pred ceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 126 FVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 126 iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+.-.|++++|+.++.+|+++++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=66.27 Aligned_cols=92 Identities=18% Similarity=0.314 Sum_probs=63.1
Q ss_pred CccceeeeEEEEeCCEEEEEEeccCCCCHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC
Q psy16292 65 SEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL--MSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG 142 (245)
Q Consensus 65 hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~ 142 (245)
.|++.-..=+++-...-.++|||+.|-.+.+. ++..+.+...+.....++ -+..+-..|+.|.|..|.||+++.+|
T Consensus 225 ~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g 302 (517)
T COG0661 225 DPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDG 302 (517)
T ss_pred CCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCC
Confidence 44443333344445567899999999888776 555566644333322221 12223348999999999999999999
Q ss_pred cEEEEeeCceeecCCC
Q psy16292 143 HLKLADFGTCMRMNKT 158 (245)
Q Consensus 143 ~i~l~Dfg~a~~~~~~ 158 (245)
.+.+.|||+...+.+.
T Consensus 303 ~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 303 RIVLLDFGIVGRLDPK 318 (517)
T ss_pred cEEEEcCcceecCCHH
Confidence 9999999999887644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=58.57 Aligned_cols=105 Identities=13% Similarity=0.044 Sum_probs=65.4
Q ss_pred hHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCCCHHHHH----------------h-cCCCCH-------
Q psy16292 50 SAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM----------------S-NYDVPE------- 104 (245)
Q Consensus 50 ~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l----------------~-~~~~~~------- 104 (245)
...+.+|+++++.+ .+--+++++.+....+..++|||+++|.++.... . -+..+.
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~ 114 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDR 114 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcch
Confidence 34577899999988 3445667788777777789999999887765331 0 011110
Q ss_pred H---HHHHHHH-------------------HHHHHHHHHH-------hCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 105 K---WAKFYCA-------------------EVVLALDAIH-------CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 105 ~---~~~~~~~-------------------~i~~~l~~lH-------~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
. ....... .+...+..|- ...++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 115 RLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0 0000000 0111112221 23489999999999999977778999997764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00017 Score=58.83 Aligned_cols=100 Identities=15% Similarity=0.162 Sum_probs=69.4
Q ss_pred HHHHHHHHHhc--CCccceeeeEEEEeCCEEEEEEeccCCCC-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcee
Q psy16292 53 FWEERDIMAHA--NSEWIVQLHFAFQDAKSLYMVMDYMPGGD-LVNLMSNYDVPEKWAKFYCAEVVLALDAIHC-LGFVH 128 (245)
Q Consensus 53 ~~~E~~il~~l--~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih 128 (245)
..+|+..|+++ -+=.+++.+.+.. ..+|||++.... -.-.++.-..+......+..+++..+.-|-. .+++|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVH 190 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVH 190 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence 45677777776 2444555555443 569999995431 1113333333333566677788888887666 99999
Q ss_pred CCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 129 RDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 129 ~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+||+.-|||++ ++.+.++|+|-|.....
T Consensus 191 gDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 191 GDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999 88999999998876653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00046 Score=56.17 Aligned_cols=131 Identities=11% Similarity=-0.005 Sum_probs=74.4
Q ss_pred hccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCcc--ceeeeEEEEeCCEEEEEEeccCC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEW--IVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
++.|..+.|+. . ..++.++.+... ......+.+|.++++.+..-. +++.+.+....+...+|||+++|
T Consensus 9 i~~G~t~~~y~-----~-~~~~~VlR~~~~----~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 9 TGEGGNGESYT-----H-KTGKWMLKLYNP----GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred ecCCCCcceeE-----e-cCCCEEEEeCCC----CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 56667777742 1 113333332221 223456789999999985333 46677777778888899999987
Q ss_pred CC-HHHH--------------H-------hcC---CCCHH-HHHHHHH----------HHHHH-HHHHH----hCCceeC
Q psy16292 91 GD-LVNL--------------M-------SNY---DVPEK-WAKFYCA----------EVVLA-LDAIH----CLGFVHR 129 (245)
Q Consensus 91 g~-L~~~--------------l-------~~~---~~~~~-~~~~~~~----------~i~~~-l~~lH----~~~iih~ 129 (245)
.+ +... + +.- ..+.. ....+.. .+... ..++. ...++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 53 1111 1 110 01100 0011100 01111 11222 1247899
Q ss_pred CCCCCceEecCCCcEEEEeeCceee
Q psy16292 130 DVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 130 dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
|+.|.|++++.++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00067 Score=54.06 Aligned_cols=96 Identities=15% Similarity=0.102 Sum_probs=73.0
Q ss_pred chHHHHHHHHHHHhcC------CccceeeeEEEEeCCEEEEEEeccCC------CCHHHHHhcCCCCHHHHHHHHHHHHH
Q psy16292 49 DSAFFWEERDIMAHAN------SEWIVQLHFAFQDAKSLYMVMDYMPG------GDLVNLMSNYDVPEKWAKFYCAEVVL 116 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~i~~ 116 (245)
..+...+|+.....+. +.+|.+++++.+++..+-+|+|.+.+ .+|.+++..+.+++ .... .+-.
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~---~L~~ 129 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQ---ALDE 129 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHH---HHHH
Confidence 3566778887777765 78999999999999999999998653 37888888777766 3332 2334
Q ss_pred HHHHHHhCCceeCCCCCCceEecCCC----cEEEEe
Q psy16292 117 ALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLAD 148 (245)
Q Consensus 117 ~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~D 148 (245)
-..+|-+++|+.+|++|.||++.... .+.++|
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 45678899999999999999996542 466676
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00026 Score=54.97 Aligned_cols=130 Identities=21% Similarity=0.186 Sum_probs=87.6
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccc-eeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWI-VQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|..|.| ++++++|..+| ++.+. ++....+..|+++|..+.-.++ .++|.+.. -++.|||+
T Consensus 28 ~~L~KG~~s~V-----yl~~~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 28 KELAKGTTSVV-----YLGEWRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhcccccEE-----EEeeccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 34788888888 68888876666 44433 3567779999999999875554 44555544 34569999
Q ss_pred CCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 89 PGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVK-PDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 89 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlk-p~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
.|-+|.+..... +...+ ..++..---|-..||-|..|. |...++..++.+.|+||..|+.-..+.
T Consensus 95 ~G~~L~~~~~~~--~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~ 160 (201)
T COG2112 95 DGRPLGKLEIGG--DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPR 160 (201)
T ss_pred cCcchhhhhhcc--cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCc
Confidence 888888765432 22222 234444333556899999886 666666677789999999888544333
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=97.65 E-value=4.9e-05 Score=69.55 Aligned_cols=94 Identities=18% Similarity=0.251 Sum_probs=71.1
Q ss_pred HHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-------------ccccCCCCchhhhhcCC
Q psy16292 112 AEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-------------ETKRLGRNGIEEIKAHP 177 (245)
Q Consensus 112 ~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-------------~~~~~~~~~~e~i~~~~ 177 (245)
.++..|+.++|. .++||+.|.|++|+++..+..|++.|+++.....+.. ......+.+||.+...-
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345589999997 5799999999999999999999999998876544211 11122256777776532
Q ss_pred C-cccCCCcccccceecC-CccCCCCCCCC
Q psy16292 178 F-FINDQWTFSNLRECVP-PVVPELSGDDD 205 (245)
Q Consensus 178 ~-~~~Diws~g~~~~~~~-~~~~pf~~~~~ 205 (245)
- .++|++|+||++|.+. .|++.+.+...
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~ 215 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGG 215 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCC
Confidence 2 6889999999999888 78877776643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00055 Score=55.08 Aligned_cols=106 Identities=17% Similarity=0.260 Sum_probs=57.5
Q ss_pred chHHHHHHHHHHHhcCCc--cceeeeEEE---EeCCEEEEEEeccCCCCHHH----------------HH---hcC----
Q psy16292 49 DSAFFWEERDIMAHANSE--WIVQLHFAF---QDAKSLYMVMDYMPGGDLVN----------------LM---SNY---- 100 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp--~Iv~l~~~~---~~~~~~~lv~e~~~~g~L~~----------------~l---~~~---- 100 (245)
....+.+|..+++.+... .+++++... ......+++|++++|.++.. .+ ...
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 456678899999888322 355666543 33456899999998887766 11 011
Q ss_pred -CCCHHH------HHHH---------------HHHHHH-HHHHHH-------hCCceeCCCCCCceEec-CCCcEEEEee
Q psy16292 101 -DVPEKW------AKFY---------------CAEVVL-ALDAIH-------CLGFVHRDVKPDNMLLD-KHGHLKLADF 149 (245)
Q Consensus 101 -~~~~~~------~~~~---------------~~~i~~-~l~~lH-------~~~iih~dlkp~nil~~-~~~~i~l~Df 149 (245)
...... .... ...+.. .+..++ ...++|+|+.|.||+++ .++.+.++||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 000000 0000 001111 222332 23489999999999999 6677789999
Q ss_pred Cceee
Q psy16292 150 GTCMR 154 (245)
Q Consensus 150 g~a~~ 154 (245)
+.+..
T Consensus 193 e~a~~ 197 (239)
T PF01636_consen 193 EDAGW 197 (239)
T ss_dssp TT-EE
T ss_pred ccceE
Confidence 98765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00034 Score=61.16 Aligned_cols=122 Identities=16% Similarity=0.151 Sum_probs=82.4
Q ss_pred EEEEEeccCCC-CHHHHHh----cC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 81 LYMVMDYMPGG-DLVNLMS----NY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 81 ~~lv~e~~~~g-~L~~~l~----~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
+-++|..+++. .+..+.+ .. ...+....+.++.++.+.+-||..|-+-+|++++|+++++++.+.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 66888887654 2333322 11 2677889999999999999999999999999999999999999999864322
Q ss_pred eecCCCCCccccCC---CCchhhhhcCC-C------cccCCCcccccceecCC-ccCCCCCC
Q psy16292 153 MRMNKTGTETKRLG---RNGIEEIKAHP-F------FINDQWTFSNLRECVPP-VVPELSGD 203 (245)
Q Consensus 153 ~~~~~~~~~~~~~~---~~~~e~i~~~~-~------~~~Diws~g~~~~~~~~-~~~pf~~~ 203 (245)
..-..+.......| +..|| ...-+ + -..|.+.++++++.++. |+.||+|-
T Consensus 165 qi~~ng~~~~cpVg~~eftPPE-lQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPE-LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccCCceEecccCccccCCHH-HhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 21111111122222 34444 33322 2 34699999999877664 59999874
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=97.43 E-value=6.9e-05 Score=68.33 Aligned_cols=87 Identities=32% Similarity=0.585 Sum_probs=74.3
Q ss_pred CCCccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccc-cCCCCC
Q psy16292 158 TGTETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-AGNHLP 234 (245)
Q Consensus 158 ~~~~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (245)
...++.++|. .+.++|+.||||++..|+...-.-.-.+++|-..++.|.++|++-...+.|..+++.+..+ +.+|.+
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l~~~~q~~ 683 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPLTEEEQEA 683 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCccccchhhHHH
Confidence 3446677775 6789999999999999999999999999999999999999999998888888887555554 447999
Q ss_pred cccceeecCC
Q psy16292 235 FVGFTYSGDY 244 (245)
Q Consensus 235 f~~f~~~~~~ 244 (245)
|.||+|.++.
T Consensus 684 F~~Fs~~~~~ 693 (694)
T KOG0694|consen 684 FRDFSFVAEW 693 (694)
T ss_pred hcCccccCCC
Confidence 9999999873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0014 Score=63.38 Aligned_cols=43 Identities=14% Similarity=0.218 Sum_probs=33.0
Q ss_pred hHHHHHHHHHHHhcC-Cccc--eeeeEEEEeC---CEEEEEEeccCCCC
Q psy16292 50 SAFFWEERDIMAHAN-SEWI--VQLHFAFQDA---KSLYMVMDYMPGGD 92 (245)
Q Consensus 50 ~~~~~~E~~il~~l~-hp~I--v~l~~~~~~~---~~~~lv~e~~~~g~ 92 (245)
...+.+|+.+++.+. |+++ ++++.++.+. +..|+|||+++|..
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 456889999999995 6765 7777777654 46889999998754
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00025 Score=64.76 Aligned_cols=148 Identities=18% Similarity=0.170 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHhcCCcc-ceeeeEEEEeCCEEEEEEeccCCC-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy16292 51 AFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGG-DLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGF 126 (245)
Q Consensus 51 ~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (245)
....-++++|.+++||| .+..++-+..+.+.++.++++.++ +-...+. .-.+.+-......+.-..+++++|+.--
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 44567899999999999 677777777788999999999765 2211111 0112223344455666778888888766
Q ss_pred eeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 127 VHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 127 ih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
+|+| ||+.. .+..+..||+....+.....+....+ ..+||.+....+ -..|.|+.++-...+.++.||-.+
T Consensus 358 ~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 358 VHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 7887 66553 46789999999887765544444444 456777766666 456999999988899999988877
Q ss_pred C
Q psy16292 203 D 203 (245)
Q Consensus 203 ~ 203 (245)
+
T Consensus 433 P 433 (829)
T KOG0576|consen 433 P 433 (829)
T ss_pred C
Confidence 3
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0022 Score=58.36 Aligned_cols=75 Identities=21% Similarity=0.334 Sum_probs=53.4
Q ss_pred EEEEEEeccCCCCHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC----CCcEEEEeeCcee
Q psy16292 80 SLYMVMDYMPGGDLVN--LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK----HGHLKLADFGTCM 153 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~----~~~i~l~Dfg~a~ 153 (245)
.-.++||||.|..+.+ .+.+.+++...+..-..+... .-+-..|++|+|-.|-||++.. ++.+.+.|||+..
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 4679999999886655 466667666544433222211 1233578999999999999984 5679999999988
Q ss_pred ecC
Q psy16292 154 RMN 156 (245)
Q Consensus 154 ~~~ 156 (245)
.+.
T Consensus 354 ~is 356 (538)
T KOG1235|consen 354 VIS 356 (538)
T ss_pred ccc
Confidence 765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.003 Score=51.52 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=25.8
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.+.|++++..+...++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998765567999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0016 Score=55.52 Aligned_cols=94 Identities=13% Similarity=0.129 Sum_probs=67.0
Q ss_pred HHHHHHHHHHhc-CCcc-ceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q psy16292 52 FFWEERDIMAHA-NSEW-IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHR 129 (245)
Q Consensus 52 ~~~~E~~il~~l-~hp~-Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~ 129 (245)
...+|...|+.| .|.+ +++.++ ....++|||++.|-+|..+-.-. ....+...++.-+.-|..+|+||+
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm~~Iv~la~~GlIHg 226 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLMGLIVRLANHGLIHG 226 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC-----ChHHHHHHHHHHHHHHHHcCceec
Confidence 357799999888 3433 333333 34578999999888887653221 122334455555666889999999
Q ss_pred CCCCCceEecCCCcEEEEeeCceee
Q psy16292 130 DVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 130 dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
|.+-=||++..++.++++||=-+..
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999965443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0067 Score=50.11 Aligned_cols=29 Identities=31% Similarity=0.475 Sum_probs=25.6
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++|+|+.|.|++++.++ +.++||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999998877 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0063 Score=51.28 Aligned_cols=31 Identities=29% Similarity=0.382 Sum_probs=27.1
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.|.|++++.++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887778999987764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.005 Score=55.05 Aligned_cols=80 Identities=40% Similarity=0.728 Sum_probs=59.3
Q ss_pred ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC----ccc-------c
Q psy16292 161 ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP----KAF-------A 229 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-------~ 229 (245)
+..++|..+.++|+.||||+...|.- +...-+++.|-..++.|.++|+.+..+..+.+..... +.. +
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~--l~~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~ 507 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDH--LREMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNS 507 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcch--hhcCCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCC
Confidence 55678888999999999999999963 3444478889899999999999887765554433221 222 2
Q ss_pred CCCCCcccceeec
Q psy16292 230 GNHLPFVGFTYSG 242 (245)
Q Consensus 230 ~~~~~f~~f~~~~ 242 (245)
....+|+||||-.
T Consensus 508 ~~~~~FvgfTyk~ 520 (550)
T KOG0605|consen 508 SKDINFVGFTYKN 520 (550)
T ss_pred cccccccceeeec
Confidence 3467799999954
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.00089 Score=40.44 Aligned_cols=45 Identities=33% Similarity=0.489 Sum_probs=28.2
Q ss_pred CCCCCCCCCCcccCcCCCCCCCCC-CCc-cccCCCCCcccceeecCC
Q psy16292 200 LSGDDDTSNFDDIEKDESPEENFP-VPK-AFAGNHLPFVGFTYSGDY 244 (245)
Q Consensus 200 f~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~f~~f~~~~~~ 244 (245)
.+++.|.++|+.....++|..+.+ .+. .....+..|+||+|.+++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~s 48 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNPS 48 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETCT
T ss_pred CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCCC
Confidence 367889999999777777665554 222 234456779999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0023 Score=55.80 Aligned_cols=83 Identities=30% Similarity=0.532 Sum_probs=66.4
Q ss_pred ccccCC--CCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccc-cCCCCCccc
Q psy16292 161 ETKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-AGNHLPFVG 237 (245)
Q Consensus 161 ~~~~~~--~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~~ 237 (245)
+..++| ..+.+.|+.|++|+..-|.-........+++|-.+..-+.++|++.....+|..++|....+ .-+|.+|+|
T Consensus 589 P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~nldq~eF~g 668 (683)
T KOG0696|consen 589 PGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMMNLDQSEFEG 668 (683)
T ss_pred CccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHhcCchhhcCc
Confidence 334444 45668899999999999998888889999999998888999999998887777766543332 336999999
Q ss_pred ceeecC
Q psy16292 238 FTYSGD 243 (245)
Q Consensus 238 f~~~~~ 243 (245)
|+|.++
T Consensus 669 FsfvNp 674 (683)
T KOG0696|consen 669 FSFVNP 674 (683)
T ss_pred eeeeCh
Confidence 999876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.01 Score=51.87 Aligned_cols=77 Identities=77% Similarity=1.322 Sum_probs=62.3
Q ss_pred CCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccceee
Q psy16292 165 LGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGFTYS 241 (245)
Q Consensus 165 ~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 241 (245)
.+..+.+++..|+|++.+.|....+.-...+..|......+...|+..........+...|..+..++..|+||+|.
T Consensus 293 ~~R~s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (370)
T cd05596 293 LGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPLPKAFAGNQLPFIGFTYS 369 (370)
T ss_pred cCCCCHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccccccccCCCccccccccCccCCCeec
Confidence 34567899999999999999988777677777777778888888888877765666667788888888889999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.026 Score=45.71 Aligned_cols=86 Identities=22% Similarity=0.317 Sum_probs=57.9
Q ss_pred hHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCce
Q psy16292 50 SAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC--LGFV 127 (245)
Q Consensus 50 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~--~~ii 127 (245)
..-+.++.+++.++. .|+++..- ....+-++.|.|-..... + .-++ ..=+.+|.-.|+ .+.+
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~--------~---~N~i-~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN--------F---SNFI-TAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc--------h---hHHH-HHhHHHHHHhhccCCCee
Confidence 344678888888874 56666532 333566888988432111 1 1111 111456777884 4699
Q ss_pred eCCCCCCceEecCCCcEEEEeeCc
Q psy16292 128 HRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 128 h~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
|+|..|+||+-|..|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999875
|
The function of this family is unknown. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.018 Score=50.31 Aligned_cols=78 Identities=69% Similarity=1.233 Sum_probs=60.1
Q ss_pred cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccceee
Q psy16292 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGFTYS 241 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 241 (245)
+.+..+.+++..|||++.+.|....+.....+..|......+.++|+.+........+.+.|..+-++...|+||+|.
T Consensus 292 r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (370)
T cd05621 292 RLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYY 369 (370)
T ss_pred ccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccccccccCCCCccccccccccCCCEec
Confidence 344567789999999998888776665555566677778888888988777776666677777766778999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.063 Score=46.68 Aligned_cols=72 Identities=22% Similarity=0.329 Sum_probs=50.1
Q ss_pred CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..+.|++|++- |+++... +. -..+++..++.+.+..+.-+.. -..-||++.-.||+++ .|+|.|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~i-k~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-KA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee-ec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34778888886 6666432 21 1234455555555554444443 3578999999999999 99999999999994
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.024 Score=49.56 Aligned_cols=81 Identities=68% Similarity=1.177 Sum_probs=61.5
Q ss_pred ccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccceeec
Q psy16292 163 KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGFTYSG 242 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 242 (245)
.+.+..+.+++..|+|++.+.|..-.+.....+..|......+.+.+.............+.|..+..+...|+||+|..
T Consensus 291 ~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T cd05622 291 VRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPKAFVGNQLPFVGFTYYS 370 (371)
T ss_pred hhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccCCCCccccccccccCCCeecC
Confidence 34445678999999999998887766555556666666777788888887777666666677877777789999999975
Q ss_pred C
Q psy16292 243 D 243 (245)
Q Consensus 243 ~ 243 (245)
+
T Consensus 371 ~ 371 (371)
T cd05622 371 N 371 (371)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.066 Score=45.80 Aligned_cols=30 Identities=23% Similarity=0.401 Sum_probs=27.2
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++|+|+.+.|++++..+-+-+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 479999999999999998899999998875
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.053 Score=47.23 Aligned_cols=101 Identities=16% Similarity=0.157 Sum_probs=65.5
Q ss_pred HHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCCCCHH--HHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeC
Q psy16292 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV--NLMSNYDVPEKWAKFYCAEVVLALDA-IHCLGFVHR 129 (245)
Q Consensus 53 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~--~~l~~~~~~~~~~~~~~~~i~~~l~~-lH~~~iih~ 129 (245)
...|++-|++|+.-.|+..--.... ...|||+++. .+-+ -.++...++...+..+-.+++.-+.- .+.+++||.
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA 289 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHA 289 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCceeee--cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence 3457777777765555543333322 3579999994 3322 23444456666666665555555543 367899999
Q ss_pred CCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 130 DVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 130 dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
||.--|+|+ .+|.+.++|.+-+.....
T Consensus 290 DLSEfN~Ly-hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 290 DLSEFNLLY-HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred chhhhhheE-ECCEEEEEEccccccCCC
Confidence 999999999 567789999887765443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.021 Score=55.96 Aligned_cols=146 Identities=14% Similarity=0.151 Sum_probs=93.4
Q ss_pred HHHHHHHHHHHhcCCccceeeeEEEEeCCE----EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q psy16292 51 AFFWEERDIMAHANSEWIVQLHFAFQDAKS----LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLG 125 (245)
Q Consensus 51 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~ 125 (245)
.....|..-+.++.|+|++.++.+-..... ..+..+++..-++.+.+..- ..+....+.+..+.+.|+.++|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 334456667777899999999888754432 23444677777887777654 4788889999999999999999986
Q ss_pred ceeCCCCCC---ceEecCCCcEEEE--eeCceeecCCCCCc---cccCCCCchhhhhcCCC---cccCCCcccccceecC
Q psy16292 126 FVHRDVKPD---NMLLDKHGHLKLA--DFGTCMRMNKTGTE---TKRLGRNGIEEIKAHPF---FINDQWTFSNLRECVP 194 (245)
Q Consensus 126 iih~dlkp~---nil~~~~~~i~l~--Dfg~a~~~~~~~~~---~~~~~~~~~e~i~~~~~---~~~Diws~g~~~~~~~ 194 (245)
..|.-+... +-..+.++.+..+ ||+.++.+...... .....+.+++....... ...|+|.+|.....+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 655554444 2333445556555 88887765433221 11122344455444444 3359999998765444
Q ss_pred Cc
Q psy16292 195 PV 196 (245)
Q Consensus 195 ~~ 196 (245)
.+
T Consensus 387 ~~ 388 (1351)
T KOG1035|consen 387 QG 388 (1351)
T ss_pred hc
Confidence 33
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.18 Score=40.33 Aligned_cols=84 Identities=29% Similarity=0.330 Sum_probs=57.4
Q ss_pred HHHHHHHHHHhc---CCccc--eeeeEEEEeC------------------CEEEEEEeccCCCCHHHHHhcCCCCHHHHH
Q psy16292 52 FFWEERDIMAHA---NSEWI--VQLHFAFQDA------------------KSLYMVMDYMPGGDLVNLMSNYDVPEKWAK 108 (245)
Q Consensus 52 ~~~~E~~il~~l---~hp~I--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 108 (245)
-|..|-+...+| .+.++ ++.+++..-. ...-||-||.+... ....
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~ 167 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI 167 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence 466677766665 45566 8888887322 02346777775533 1122
Q ss_pred HHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 109 ~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
.-+.+|++-+..+|..||+-+|+++.|.. +| +|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc---CC--EEEecccC
Confidence 23457888889999999999999999885 33 78999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.5 Score=41.83 Aligned_cols=42 Identities=10% Similarity=0.057 Sum_probs=31.0
Q ss_pred chHHHHHHHHHHHhc-C--CccceeeeEEEEeCCEEEEEEeccCCCC
Q psy16292 49 DSAFFWEERDIMAHA-N--SEWIVQLHFAFQDAKSLYMVMDYMPGGD 92 (245)
Q Consensus 49 ~~~~~~~E~~il~~l-~--hp~Iv~l~~~~~~~~~~~lv~e~~~~g~ 92 (245)
..++...|.+.|+.+ . ...+++++.+ +....++|||++++..
T Consensus 73 ~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 73 TLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 567888899999886 2 3467777766 4456789999998643
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.0035 Score=60.70 Aligned_cols=49 Identities=10% Similarity=0.083 Sum_probs=40.9
Q ss_pred CCchhhhhcCC-----C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 167 RNGIEEIKAHP-----F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 167 ~~~~e~i~~~~-----~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
|.+||.+++.. | ..+|-||+||.+|+|+.|.-||-.++-.+.+.+|.+-
T Consensus 242 YISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 242 YISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred ccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 56788876432 2 4679999999999999999999999988889988765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.086 Score=44.79 Aligned_cols=31 Identities=32% Similarity=0.485 Sum_probs=27.4
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.+.|++++.++...++||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5799999999999999888678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.14 Score=43.32 Aligned_cols=30 Identities=33% Similarity=0.607 Sum_probs=25.8
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.+.|++++. +.+.++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57899999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.066 Score=43.40 Aligned_cols=30 Identities=20% Similarity=0.409 Sum_probs=26.5
Q ss_pred CceeCCCCCCceEecC-CCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDK-HGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~ 154 (245)
+++|+|+.+.||+++. ++.+.++||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999998 57899999987764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.044 Score=46.72 Aligned_cols=31 Identities=26% Similarity=0.366 Sum_probs=26.3
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.|.||+++.+....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4799999999999998665568999998754
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.061 Score=46.10 Aligned_cols=84 Identities=36% Similarity=0.550 Sum_probs=63.4
Q ss_pred ccccCC-CCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCC--Cc-----cccC-C
Q psy16292 161 ETKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPV--PK-----AFAG-N 231 (245)
Q Consensus 161 ~~~~~~-~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~-~ 231 (245)
+..+.| ..+.++|+.||+|+.-.|..-.......+++|-..+..+.++|+.-.....+.++... |. .++. .
T Consensus 265 p~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (357)
T KOG0598|consen 265 PRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTY 344 (357)
T ss_pred HHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCccccccccccccc
Confidence 344554 5667889999999999999998888899999999999999999987666544433321 22 1222 4
Q ss_pred CCCcccceeecCC
Q psy16292 232 HLPFVGFTYSGDY 244 (245)
Q Consensus 232 ~~~f~~f~~~~~~ 244 (245)
...|.||+|..++
T Consensus 345 ~~~f~gft~~~~s 357 (357)
T KOG0598|consen 345 NKIFPGFTYVASS 357 (357)
T ss_pred ccccCCccccCCC
Confidence 7779999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.058 Score=45.62 Aligned_cols=30 Identities=33% Similarity=0.433 Sum_probs=26.5
Q ss_pred CceeCCCCCCceEecCC----CcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKH----GHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~----~~i~l~Dfg~a~~ 154 (245)
.++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 47999999999999874 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.34 Score=42.70 Aligned_cols=36 Identities=11% Similarity=0.247 Sum_probs=27.6
Q ss_pred HHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 54 WEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 54 ~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
.+|+.+++.+ .+..-+++++.+.. +++.||++|.++
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l 136 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTM 136 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccC
Confidence 6689999998 45566777888763 599999987655
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.32 Score=39.80 Aligned_cols=46 Identities=22% Similarity=0.339 Sum_probs=36.6
Q ss_pred CchHHHHHHHHHHHhc---CCccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 48 SDSAFFWEERDIMAHA---NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 48 ~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
.....+..|+.-|..+ +.-.+.+.+.+..+..+.|+||||++-+.+
T Consensus 50 ~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 50 EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 4556788898888777 345678888999999999999999986544
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.16 Score=42.51 Aligned_cols=45 Identities=29% Similarity=0.304 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHhC--CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 110 YCAEVVLALDAIHCL--GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 110 ~~~~i~~~l~~lH~~--~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+..+-.++.-.+.. -++|+|+.|+|++.+..+.+.|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444433 589999999999999989999999987764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.087 Score=41.52 Aligned_cols=30 Identities=27% Similarity=0.375 Sum_probs=25.8
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
..+|+|+.|.|+++..+| ++++||+.+..-
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 369999999999998777 889999988753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.077 Score=42.44 Aligned_cols=30 Identities=40% Similarity=0.703 Sum_probs=21.6
Q ss_pred CceeCCCCCCceEe-cCCCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLL-DKHGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~-~~~~~i~l~Dfg~a~~ 154 (245)
.++|+|+.+.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.48 Score=40.19 Aligned_cols=72 Identities=10% Similarity=-0.006 Sum_probs=51.3
Q ss_pred chHHHHHHHHHHHhcC-C--ccceeeeEEEEe---CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy16292 49 DSAFFWEERDIMAHAN-S--EWIVQLHFAFQD---AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH 122 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH 122 (245)
....+..|...|+.|. + -.++++++++.. .+..++|||++++.++.+. .........+..+++.+|.-||
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~----~~~~~~~~~l~~~l~~~La~LH 125 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP----ARTPERWEQLKDQIVEGLLAWH 125 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC----CCCHHHHHHHHHHHHHHHHHHh
Confidence 3457899999999984 2 367788877754 3678999999998877652 1223334455667788888899
Q ss_pred hC
Q psy16292 123 CL 124 (245)
Q Consensus 123 ~~ 124 (245)
+.
T Consensus 126 ~~ 127 (297)
T PRK10593 126 RI 127 (297)
T ss_pred CC
Confidence 74
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.21 Score=43.03 Aligned_cols=29 Identities=31% Similarity=0.573 Sum_probs=26.3
Q ss_pred ceeCCCCCCceEecCCCc-EEEEeeCceee
Q psy16292 126 FVHRDVKPDNMLLDKHGH-LKLADFGTCMR 154 (245)
Q Consensus 126 iih~dlkp~nil~~~~~~-i~l~Dfg~a~~ 154 (245)
+||+|+.|.|++++.+.. +.++||+.|..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999999885 78999998864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.17 E-value=0.18 Score=42.31 Aligned_cols=30 Identities=27% Similarity=0.533 Sum_probs=25.6
Q ss_pred CceeCCCCCCceEecCCCcE-EEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHL-KLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i-~l~Dfg~a~~ 154 (245)
.++|+|+.|.|++++.++++ -++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999875664 6999998775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 245 | ||||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-57 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-57 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-57 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-57 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-29 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-36 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-36 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-35 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-35 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 3e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 4e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-04 |
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-62
Identities = 110/182 (60%), Positives = 133/182 (73%), Gaps = 20/182 (10%)
Query: 1 MKNVEAFMHRYRRYRQKYSEV---PRLFE-------------YLLKYRYT--LYAL--YS 40
KN++ F+ RY+ K ++ +E L++++ T +YA+ S
Sbjct: 44 NKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 103
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ IKRSDSAFFWEERDIMA ANS W+VQL +AFQD + LYMVM+YMPGGDLVNLMSNY
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY 163
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
DVPEKWA+FY AEVVLALDAIH +GF+HRDVKPDNMLLDK GHLKLADFGTCM+MNK G
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 161 ET 162
Sbjct: 224 VR 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 54/84 (64%), Positives = 64/84 (76%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
RLGRNG+EEIK H FF NDQW + LR+ V PVVP+LS D DTSNFDD+E+D+ EE
Sbjct: 316 EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEET 375
Query: 222 FPVPKAFAGNHLPFVGFTYSGDYQ 245
FP+PKAF GN LPFVGFTY + +
Sbjct: 376 FPIPKAFVGNQLPFVGFTYYSNRR 399
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 72/184 (39%), Positives = 111/184 (60%), Gaps = 22/184 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEV---PRLFE-------------YLLKYRYT--LYAL--YS 40
K V F+ + EV FE ++K + T +YA+ +
Sbjct: 36 DKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ +KR + + F EERD++ + + WI QLHFAFQD LY+VM+Y GGDL+ L+S +
Sbjct: 96 KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF 155
Query: 101 DV--PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
P + A+FY AE+V+A+D++H LG+VHRD+KPDN+LLD+ GH++LADFG+C+++
Sbjct: 156 GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 159 GTET 162
GT
Sbjct: 216 GTVR 219
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 34/89 (38%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP--- 218
RLGR G + + HPFF W LR+ VPP P+ G DT NFD +E +
Sbjct: 314 ETRLGRGGAGDFRTHPFFFGLDWD--GLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVS 371
Query: 219 --EENFPVPK--AFAGNHLPFVGFTYSGD 243
E + A G HLPFVG++YS
Sbjct: 372 GGGETLSDIREGAPLGVHLPFVGYSYSCM 400
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 68/184 (36%), Positives = 120/184 (65%), Gaps = 22/184 (11%)
Query: 1 MKNVEAFMHRYRRYRQKYSEV---PRLFE-------------YLLKYRYT--LYAL--YS 40
KN+ ++ + + K ++ FE ++K + ++A+ +
Sbjct: 49 EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
++ +KR+++A F EERD++ + +S+WI LH+AFQD +LY+VMDY GGDL+ L+S +
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168
Query: 101 D--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+ +PE+ A+FY AE+V+A+D++H L +VHRD+KPDN+L+D +GH++LADFG+C+++ +
Sbjct: 169 EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 159 GTET 162
GT
Sbjct: 229 GTVQ 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 41/84 (48%), Positives = 50/84 (59%), Gaps = 4/84 (4%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
RLG+NGIE+ K HPFF W N+R C P +PE+S DTSNFD + E
Sbjct: 325 EHRLGQNGIEDFKKHPFFSGIDWD--NIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSET 382
Query: 222 FPVP--KAFAGNHLPFVGFTYSGD 243
P P AF+G+HLPFVGFTY+
Sbjct: 383 MPPPTHTAFSGHHLPFVGFTYTSS 406
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 1/108 (0%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
E IM ++V L ++FQD + ++MV+D + GGDL + E+ K + E+
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
V+ALD + +HRD+KPDN+LLD+HGH+ + DF + + T
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 12/66 (18%), Positives = 26/66 (39%), Gaps = 7/66 (10%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD-IEKDESPEE 220
+R + +++ P+ + W + +P +P + N D E +E E
Sbjct: 260 DQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIP----NKGRLNCDPTFELEEMILE 313
Query: 221 NFPVPK 226
+ P+ K
Sbjct: 314 SKPLHK 319
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-40
Identities = 38/109 (34%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERD+M+ + + V+L+F FQD + LY + Y G+L+ + E +FY AE+
Sbjct: 80 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
V AL+ +H G +HRD+KP+N+LL++ H+++ DFGT ++ + +
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 48/98 (48%), Positives = 69/98 (70%), Gaps = 1/98 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ERDI+ N +IV+LH+AFQ LY+++D++ GGDL +S + E+ KFY AE+
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
LALD +H LG ++RD+KP+N+LLD+ GH+KL DFG
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 5e-11
Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
RLG +G+EEIK H FF W RE PP P +DT FD ++P+
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFTAKTPK 325
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 39/98 (39%), Positives = 62/98 (63%), Gaps = 1/98 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ER+I+ +IV L +AFQ LY++++Y+ GG+L + + E A FY AE+
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+AL +H G ++RD+KP+N++L+ GH+KL DFG C
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 8e-11
Identities = 19/51 (37%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210
RLG E++AHPFF + W R+ PP P L ++D S FD
Sbjct: 261 ASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-38
Identities = 42/98 (42%), Positives = 67/98 (68%), Gaps = 1/98 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
ER +++ +I+++ FQDA+ ++M+MDY+ GG+L +L+ P AKFY AEV
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
LAL+ +H ++RD+KP+N+LLDK+GH+K+ DFG
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-11
Identities = 22/75 (29%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL-SGDDDTSNFDDIEKDE-- 216
++RLG +NG E++K HP+F W R P P + G DTS FD +++
Sbjct: 243 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDIN 302
Query: 217 -SPEENFPVPKAFAG 230
+ P F
Sbjct: 303 YGVQGEDPYADLFRD 317
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 39/112 (34%), Positives = 64/112 (57%), Gaps = 5/112 (4%)
Query: 56 ERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAE 113
ER ++ H ++V LH+AFQ L++++DY+ GG+L +S + E + Y E
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC---MRMNKTGTET 162
+VLAL+ +H LG ++RD+K +N+LLD +GH+ L DFG +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 17/50 (34%), Positives = 22/50 (44%), Gaps = 2/50 (4%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209
KRLG +EIK H FF W ++ P P + + D SNF
Sbjct: 306 KKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 39/107 (36%), Positives = 71/107 (66%), Gaps = 2/107 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
E+ I+ N ++V+L F+F+D +LYMVM+Y+ GG++ + + E A+FY A++
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN-KTGT 160
VL + +H L ++RD+KP+N+L+D+ G++++ DFG R+ +T T
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 27/72 (37%), Positives = 36/72 (50%), Gaps = 3/72 (4%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
TKR G +NG+ +IK H +F W R+ P +P+ G DTSNFDD E++E
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRV 337
Query: 220 E-NFPVPKAFAG 230
N K F
Sbjct: 338 SINEKCGKEFTE 349
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 39/98 (39%), Positives = 60/98 (61%), Gaps = 1/98 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAEV 114
E ++ + ++ L +AFQ L VM+Y GG+L +S V E+ A+FY AE+
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
V AL+ +H V+RD+K +N++LDK GH+K+ DFG C
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-13
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 10/93 (10%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
+RLG + +E+ H FF++ W ++ +PP P+++ + DT FDD +S
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 304
Query: 220 ENFPVPKAFAGNHLP--------FVGFTYSGDY 244
P G F F Y D+
Sbjct: 305 ITPPDRYDSLGLLELDQREEQEMFEDFDYIADW 337
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 44/110 (40%), Positives = 65/110 (59%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
+K+ + ER+++ ++V LHF+FQ A LY V+DY+ GG+L +
Sbjct: 77 LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF 136
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A+FY AE+ AL +H L V+RD+KP+N+LLD GH+ L DFG C
Sbjct: 137 LEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 8/87 (9%)
Query: 162 TKRLG-RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220
TKRLG ++ EIK+H FF W ++ PP P +SG +D +FD +E
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPN 338
Query: 221 NFPVP-------KAFAGNHLPFVGFTY 240
+ F+GF+Y
Sbjct: 339 AIGKAPDSVLVTASVKEAAEAFLGFSY 365
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 39/99 (39%), Positives = 61/99 (61%), Gaps = 2/99 (2%)
Query: 56 ERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAE 113
E+ +++ A + + FQ ++L+ VM+Y+ GGDL+ + + A FY AE
Sbjct: 67 EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
++L L +H G V+RD+K DN+LLDK GH+K+ADFG C
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 23/80 (28%), Positives = 34/80 (42%), Gaps = 3/80 (3%)
Query: 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
KRLG +I+ HP F W +E PP P++ D SNFD +E P +
Sbjct: 258 EKRLG--VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLS 315
Query: 222 FPVPKAF-AGNHLPFVGFTY 240
F + + F F++
Sbjct: 316 FADRALINSMDQNMFRNFSF 335
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 38/122 (31%), Positives = 64/122 (52%), Gaps = 4/122 (3%)
Query: 45 IKRSDSAFFWEERDIMAHANSEW---IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD 101
+ ER +++ ++ IV + +AF L ++D M GGDL +S +
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG 287
Query: 102 V-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
V E +FY AE++L L+ +H V+RD+KP N+LLD+HGH++++D G +K
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 161 ET 162
Sbjct: 348 HA 349
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
+RLG G +E+K PFF + W L++ PP++P + FD DE
Sbjct: 434 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDT 493
Query: 220 ENFPVPKAFAGNHLPFVGFTYS 241
+ + + + F +
Sbjct: 494 KGIKLL---DSDQELYRNFPLT 512
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 41/110 (37%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
I+ D E+ ++A ++ QLH FQ LY VM+Y+ GGDL+ +
Sbjct: 59 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 118
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A FY AE+ + L + G ++RD+K DN++LD GH+K+ADFG C
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 24/85 (28%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
KRLG G +IK H FF W +E PP P+ G + NFD P
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG-RNAENFDRFFTRHPPV 319
Query: 220 ENFPVPKAF-AGNHLPFVGFTYSGD 243
P + + F GF++
Sbjct: 320 LTPPDQEVIRNIDQSEFEGFSFVNS 344
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 43/110 (39%), Positives = 65/110 (59%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
D + E+ + A++ +V LH FQ L+ V++Y+ GGDL+ M
Sbjct: 48 NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 107
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
PE+ A+FY AE+ LAL+ +H G ++RD+K DN+LLD GH+KL D+G C
Sbjct: 108 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 25/83 (30%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 162 TKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
+RLG + G +I+ HPFF N W ++ VPP P +SG+ NFD +E
Sbjct: 259 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV 318
Query: 219 EENFPVPKAF-AGNHLPFVGFTY 240
+ + F GF Y
Sbjct: 319 QLTPDDDDIVRKIDQSEFEGFEY 341
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-35
Identities = 42/110 (38%), Positives = 64/110 (58%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
++ D E+ I++ A + ++ QL FQ L+ VM+++ GGDL+ +
Sbjct: 62 LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A+FY AE++ AL +H G ++RD+K DN+LLD GH KLADFG C
Sbjct: 122 DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 27/83 (32%), Positives = 31/83 (37%), Gaps = 4/83 (4%)
Query: 162 TKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
T RLG + G I HPFF W N R+ PP P + +D SNFD E P
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEP 323
Query: 219 EENFPVPKAF-AGNHLPFVGFTY 240
N F F Y
Sbjct: 324 VLTPIDEGHLPMINQDEFRNFEY 346
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 41/124 (33%), Positives = 68/124 (54%), Gaps = 5/124 (4%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL----VNLMSNY 100
KR E+ I+A +S +IV L +AF+ L +VM M GGD+ N+ +
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 101 DV-PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
E A FY A++V L+ +H ++RD+KP+N+LLD G+++++D G + +
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 160 TETK 163
T+TK
Sbjct: 344 TKTK 347
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-07
Identities = 16/71 (22%), Positives = 26/71 (36%), Gaps = 10/71 (14%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSG-----DDDTSNFDDIEK 214
KRLG + ++ HP F + W PP VP+ D F ++
Sbjct: 433 EKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKG 492
Query: 215 ---DESPEENF 222
+++ E F
Sbjct: 493 VAFEKADTEFF 503
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 43/110 (39%), Positives = 65/110 (59%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
D + E+ + A++ +V LH FQ L+ V++Y+ GGDL+ M
Sbjct: 91 NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 150
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
PE+ A+FY AE+ LAL+ +H G ++RD+K DN+LLD GH+KL D+G C
Sbjct: 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 25/83 (30%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 162 TKRLG---RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
+RLG + G +I+ HPFF N W ++ VPP P +SG+ NFD +E
Sbjct: 302 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV 361
Query: 219 EENFPVPKAF-AGNHLPFVGFTY 240
+ + F GF Y
Sbjct: 362 QLTPDDDDIVRKIDQSEFEGFEY 384
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 3/125 (2%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYD 101
KR A E+ I+ NS ++V L +A++ +L +V+ M GGDL + M
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
PE A FY AE+ L+ +H V+RD+KP+N+LLD HGH++++D G + + + T
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 162 TKRLG 166
R+G
Sbjct: 343 KGRVG 347
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 16/83 (19%), Positives = 25/83 (30%), Gaps = 11/83 (13%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSG--DDDTSNFDDIEKDES 217
+RLG E+K HP F + PP P+ D + + +
Sbjct: 429 AERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKG 488
Query: 218 PEENFPVPKAFAGNHLPFVGFTY 240
E P + F + F
Sbjct: 489 VELE-PTDQDF------YQKFAT 504
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 40/110 (36%), Positives = 64/110 (58%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-P 103
+ + + A E ++ ++ ++ L ++FQ L VM+Y GG+L +S V
Sbjct: 187 VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS 246
Query: 104 EKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A+FY AE+V ALD +H V+RD+K +N++LDK GH+K+ DFG C
Sbjct: 247 EDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-11
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 2/51 (3%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210
+RLG +EI H FF W ++ PP P+++ + DT FD
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFD 439
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 41/110 (37%), Positives = 60/110 (54%), Gaps = 2/110 (1%)
Query: 45 IKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
I+ D E+ ++A + QLH FQ LY VM+Y+ GGDL+ +
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
E A FY AE+ + L + G ++RD+K DN++LD GH+K+ADFG C
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 25/85 (29%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
KRLG G +IK H FF W +E PP P+ SG + NFD P
Sbjct: 582 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPV 640
Query: 220 ENFPVPKAFA-GNHLPFVGFTYSGD 243
P + + F GF++
Sbjct: 641 LTPPDQEVIRNIDQSEFEGFSFVNS 665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 13/166 (7%)
Query: 13 RYRQKYSEVPRLFE------YLLKYRYT--LYAL-YSRYFQIKRSDSAFFWEERDIMAH- 62
++Q + + RL + ++ + LYA+ S D A E
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 63 ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV--PEKWAKFYCAEVVLALDA 120
V+L A+++ LY+ + G L + PE Y + +LAL
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 121 IHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
+H G VH DVKP N+ L G KL DFG + + G + G
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-V 102
Q++R E +I +H I++++ F D K +Y+++++ P G+L + +
Sbjct: 60 QLRR--------EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
E+ + + E+ AL H +HRD+KP+N+L+ G LK+ADFG
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-29
Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-V 102
Q++R E +I +H I++L+ F DA +Y++++Y P G + +
Sbjct: 55 QLRR--------EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
E+ Y E+ AL H +HRD+KP+N+LL G LK+ADFG
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 18/117 (15%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---------V 94
K E I+ +E+ + + +Y++ +YM + +
Sbjct: 89 DFKN--------ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 95 NLMSNYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +P + K V+ + IH HRDVKP N+L+DK+G +KL+DFG
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 30/133 (22%), Positives = 63/133 (47%), Gaps = 15/133 (11%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKS-------------LYMVMDYMPGGDLVNLMS--N 99
E ++A N +++V+ + A+ + ++ L++ M+Y G L +L+ N
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
+ +++ AL IH G +HRD+KP N+ +D+ ++K+ DFG ++++
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 160 TETKRLGRNGIEE 172
K +N
Sbjct: 171 DILKLDSQNLPGS 183
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-25
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCA 112
E ++A+ IVQ +F++ SLY+VMDY GGDL ++ E +
Sbjct: 73 EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
++ LAL +H +HRD+K N+ L K G ++L DFG +N T +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 2/116 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV-PEKWAKFYCAE 113
EE A +S IV L+ A ++ + + M+ + GG L L+ PE A +Y +
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ 158
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGTETKRLGRN 168
+ L+ +H +H DVK DN+LL G L DFG + + G L +
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-24
Identities = 33/109 (30%), Positives = 62/109 (56%), Gaps = 2/109 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVV 115
E IM +V+++ ++ + L+++M+++ GG L +++S + E+ C V+
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL 151
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
AL +H G +HRD+K D++LL G +KL+DFG C ++ + KR
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKR 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-24
Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 2/110 (1%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEV 114
E +M + IV ++ L++VM+Y+ GG L ++++ + E C E
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ AL+ +H +HRD+K DN+LL G +KL DFG C ++ T ++KR
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKR 173
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 6e-24
Identities = 29/166 (17%), Positives = 55/166 (33%), Gaps = 23/166 (13%)
Query: 27 YLLKYRYTLYALYSRYFQIKRSDSAFFWE------ERDIMAHANSEWIVQLHFAFQDAKS 80
Y A + F +K A WE + + + ++ + A
Sbjct: 82 YEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141
Query: 81 LYMVMDYMPGGDLVNLMSNY------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
+V + G L+N ++ Y +P+ + ++ ++ +H +H D+KPD
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 135 NMLL-----------DKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
N +L D L L D G + M T +
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-24
Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 9/122 (7%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV---------PEKW 106
E M+ + IV + +F L++VM + GG +++++ + E
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
EV+ L+ +H G +HRDVK N+LL + G +++ADFG + G T+
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 167 RN 168
R
Sbjct: 183 RK 184
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-23
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 3/108 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG---DLVNLMSNYDVPEKWAKFYCA 112
E + N IV F L++V +M G DL+ + E +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
V+ ALD IH +G+VHR VK ++L+ G + L+ + + M G
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-23
Identities = 32/109 (29%), Positives = 62/109 (56%), Gaps = 2/109 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVV 115
E +++ +S ++ + + ++ L+++M+Y+ GG ++L+ + E E++
Sbjct: 70 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 129
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
LD +H +HRD+K N+LL +HG +KLADFG ++ T T+ KR
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 176
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 2e-23
Identities = 18/117 (15%), Positives = 46/117 (39%), Gaps = 9/117 (7%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPG--GDLVNLMSNY-----DVP 103
F D++ + ++++ +D S + + M ++ ++ +
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+V+ L ++H G VH ++P +++LD+ G + L F +R +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 7e-23
Identities = 22/117 (18%), Positives = 48/117 (41%), Gaps = 9/117 (7%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYM------PGGDLVNLMSNYDVPE 104
F D++ + ++++ +D S + + M G L++ S +
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 105 KWAKFYCA-EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
A+ +V+ L ++H G VH ++P +++LD+ G + L F +R
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-23
Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-----DVPEKWAKFY 110
E D++ N +++ + +F + L +V++ GDL ++ ++ +PE+ Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ AL+ +H +HRD+KP N+ + G +KL D G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 64 NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH 122
+S+ I++L+ + +YMVM+ DL + + + K Y ++ A+ IH
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
G VH D+KP N L+ G LKL DFG +M T +
Sbjct: 126 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 166
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 64 NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH 122
+S+ I++L+ + +YMVM+ DL + + + K Y ++ A+ IH
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
G VH D+KP N L+ G LKL DFG +M T +
Sbjct: 145 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 4/111 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E +I+A + +IV+L A+ L++++++ PGG + +M D E + C +
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
++ AL+ +H +HRD+K N+L+ G ++LADFG + T KR
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKR 174
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 64 NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH 122
+S+ I++L+ + +YMVM+ DL + + + K Y ++ A+ IH
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
G VH D+KP N L+ G LKL DFG +M T +
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-22
Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 19/131 (14%)
Query: 55 EERDIMAHANSEWIVQLHFAFQD----------------AKSLYMVMDYMPGGDLVNLMS 98
E +A + IV + + K L++ M++ G L +
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 99 NYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155
+ + A ++ +D IH ++RD+KP N+ L +K+ DFG +
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 156 NKTGTETKRLG 166
G T+ G
Sbjct: 173 KNDGKRTRSKG 183
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E IM +S +V+ + ++ L++VM+Y G + +++ + E
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+ L+ +H + +HRD+K N+LL+ GH KLADFG ++ T T KR
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKR 182
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-22
Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 4/125 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN--LMSNYDVP 103
SD +E M+ +V LH AF+D + M+ ++M GG+L + +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN-MLLDKHGH-LKLADFGTCMRMNKTGTE 161
E A Y +V L +H +VH D+KP+N M K + LKL DFG ++ +
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
Query: 162 TKRLG 166
G
Sbjct: 314 KVTTG 318
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-22
Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 16/112 (14%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMS 98
Q+ + E I+ H N +V+L D LYMV + + G ++ + +
Sbjct: 82 QVYQ--------EIAILKKLDHPN---VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 99 NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ E A+FY +++ ++ +H +HRD+KP N+L+ + GH+K+ADFG
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 29/125 (23%), Positives = 54/125 (43%), Gaps = 4/125 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN--LMSNYDVP 103
D E IM + ++ LH AF+D + ++++++ GG+L + +Y +
Sbjct: 88 YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 147
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFGTCMRMNKTGTE 161
E Y + L +H VH D+KP+N++ K +K+ DFG ++N
Sbjct: 148 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 162 TKRLG 166
Sbjct: 208 KVTTA 212
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 38/191 (19%), Positives = 65/191 (34%), Gaps = 48/191 (25%)
Query: 13 RYRQKYSEVPRLFE------YLLKYRYT--LYALYSRYFQIKRSDSAFFWEE------RD 58
RY ++ E+ ++ + R +YA IKRS R+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYA-------IKRSKKPLAGSVDEQNALRE 60
Query: 59 IMAHA---NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAKFY 110
+ AHA +V+ A+ + + + +Y GG L + +S E K
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL-------------------KLADFGT 151
+V L IH + VH D+KP N+ + + K+ D G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 152 CMRMNKTGTET 162
R++ E
Sbjct: 181 VTRISSPQVEE 191
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-21
Identities = 37/170 (21%), Positives = 59/170 (34%), Gaps = 33/170 (19%)
Query: 2 KNVEAFMHRYRRYRQ----KYSEVPRLFEYLLKYRYT--LYALYSRYFQIKR------SD 49
V Y ++ +S V L++ + YAL KR D
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYV-----DLVEGLHDGHFYAL-------KRILCHEQQD 69
Query: 50 SAFFWEERDIMAHANSEWIVQLHFAFQDAKS----LYMVMDYMPGGDLVNLMSNYDV--- 102
E D+ N I++L + ++++ + G L N +
Sbjct: 70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 103 --PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
E + + L+AIH G+ HRD+KP N+LL G L D G
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-21
Identities = 24/126 (19%), Positives = 54/126 (42%), Gaps = 5/126 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ E I+ ++ LH +++ + ++++ + GG+L + L + E
Sbjct: 55 RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE 114
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGT 160
+ A + +++ ++ +H H D+KP+N++L H+KL DFG +
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 161 ETKRLG 166
G
Sbjct: 175 FKNIFG 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 12/118 (10%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-------VNLMSNYDVPEKWAK 108
E I IV+L + LYMV ++M G DL + Y E A
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVAS 133
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGTETK 163
Y +++ AL H +HRDVKP +LL + +KL FG +++ ++G
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 3/107 (2%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAE 113
E + +Q + + ++VM+Y G +L+ + P E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHG 162
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+ L +H +HRDVK N+LL + G +KL DFG+ M +
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-21
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNY 100
K D++ E +++ + I++L +D+ S Y+V + GG+L + +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNK 157
E A +V + +H VHRD+KP+N+LL +K +K+ DFG +
Sbjct: 119 S--EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 158 TGTETKRLG 166
R+G
Sbjct: 177 NTKMKDRIG 185
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-21
Identities = 28/95 (29%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVV 115
R + H + I+ L +++ + +++V D M G+L + L + EK + ++
Sbjct: 154 RQVAGHPH---IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 116 LALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A+ +H VHRD+KP+N+LLD + ++L+DFG
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-21
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 8/103 (7%)
Query: 53 FWEERDIM----AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
+E DI+ H N I+QL ++ ++V D M G+L + L + EK
Sbjct: 70 TLKEVDILRKVSGHPN---IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ + A+H L VHRD+KP+N+LLD ++KL DFG
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-21
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 12/120 (10%)
Query: 56 ERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYD-----VPEKWAK 108
E +++ IV+ + D +LY+VM+Y GGDL ++++ + E++
Sbjct: 55 EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 109 FYCAEVVLALDAIHCLGF-----VHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
++ LAL H +HRD+KP N+ LD ++KL DFG +N + K
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-21
Identities = 25/126 (19%), Positives = 54/126 (42%), Gaps = 5/126 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ E +I+ I+ LH F++ + ++++ + GG+L + L + E
Sbjct: 48 RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE 107
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGT 160
A + +++ + +H H D+KP+N++L + +KL DFG ++
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 161 ETKRLG 166
G
Sbjct: 168 FKNIFG 173
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-21
Identities = 27/125 (21%), Positives = 58/125 (46%), Gaps = 4/125 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN--LMSNYDVP 103
D E +M + ++QL+ AF+ + +VM+Y+ GG+L + + +Y++
Sbjct: 126 GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN-MLLDKHGH-LKLADFGTCMRMNKTGTE 161
E + ++ + +H + +H D+KP+N + +++ +K+ DFG R
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 162 TKRLG 166
G
Sbjct: 246 KVNFG 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-21
Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN--LMSNYDVP 103
K +D +E I+ A I+ LH +F+ + L M+ +++ G D+ S +++
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN 100
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFG 150
E+ Y +V AL +H H D++P+N++ + +K+ +FG
Sbjct: 101 EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-21
Identities = 23/126 (18%), Positives = 55/126 (43%), Gaps = 5/126 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ E I+ ++ LH +++ + ++++ + GG+L + L + E
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE 113
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGT 160
+ A + +++ + +H L H D+KP+N++L +K+ DFG +++
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 161 ETKRLG 166
G
Sbjct: 174 FKNIFG 179
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 25/126 (19%), Positives = 54/126 (42%), Gaps = 5/126 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ E I+ I+ LH +++ + ++++ + GG+L + L + E
Sbjct: 55 RGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE 114
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGT 160
+ A + +++ ++ +H H D+KP+N++L H+KL DFG +
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 161 ETKRLG 166
G
Sbjct: 175 FKNIFG 180
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-20
Identities = 25/92 (27%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLAL 118
+AH + +V H F+D +++V++ L+ L + E A++Y ++VL
Sbjct: 98 LAHQH---VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H +HRD+K N+ L++ +K+ DFG
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNY 100
+ S ++ EE ++ + I++L+ F+D ++ Y+VM+ GG+L + +
Sbjct: 74 SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF 133
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNK 157
E A +V+ + +H VHRD+KP+N+LL +K +K+ DFG
Sbjct: 134 --NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 158 TGTETKRLG 166
+RLG
Sbjct: 192 QKKMKERLG 200
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-20
Identities = 25/109 (22%), Positives = 55/109 (50%), Gaps = 10/109 (9%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-- 101
+++ E I I++L+ F+D+ +Y+V++ G++ + N
Sbjct: 57 RVQN--------EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP 108
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
E A+ + +++ + +H G +HRD+ N+LL ++ ++K+ADFG
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 25/92 (27%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLAL 118
+AH + +V H F+D +++V++ L+ L + E A++Y ++VL
Sbjct: 72 LAHQH---VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H +HRD+K N+ L++ +K+ DFG
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 160
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 29/128 (22%), Positives = 58/128 (45%), Gaps = 8/128 (6%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYD 101
+++D E ++ + I++L+ F+D Y+V + GG+L + +
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF- 123
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKT 158
E A +V+ + +H VHRD+KP+N+LL K ++++ DFG +
Sbjct: 124 -SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 159 GTETKRLG 166
++G
Sbjct: 183 KKMKDKIG 190
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNY 100
K D++ E +++ + I++L +D+ S Y+V + GG+L + +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNK 157
E A +V + +H VHRD+KP+N+LL +K +K+ DFG +
Sbjct: 119 --SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 158 TGTETKRLG 166
R+G
Sbjct: 177 NTKMKDRIG 185
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 14/132 (10%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLM 97
++ D E I H N IV+LH + Q+ Y+V D + GG+L +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPN---IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 98 SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMR 154
Y E A +++ ++ H G VHR++KP+N+LL K +KLADFG +
Sbjct: 123 EFY--SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 155 MNKTGTETKRLG 166
+N + G
Sbjct: 181 VNDSEAWHGFAG 192
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 4e-20
Identities = 23/120 (19%), Positives = 37/120 (30%), Gaps = 11/120 (9%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYD--------V 102
D +A + QL D + ++M DL L S D
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDE 191
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
A+++ + G VH PDN+ + G L L D ++ G +
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP----EKWAKFY 110
EE + H + IVQ +F + + + M+ +PGG L L+ + P E+ FY
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGTETK 163
+++ L +H VHRD+K DN+L++ + G LK++DFGT R+ T+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-20
Identities = 37/127 (29%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
D F +E +IM + I++L+ F+D +Y+VM+ GG+L V +
Sbjct: 46 FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-- 103
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTG 159
E A +V+ A+ H L HRD+KP+N L LKL DFG R
Sbjct: 104 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 160 TETKRLG 166
++G
Sbjct: 164 MMRTKVG 170
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEV 114
E ++ NS +IV + AF + + M++M GG L ++ +PE+ V
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 115 VLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
+ L + +HRDVKP N+L++ G +KL DFG ++ + +
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 30/120 (25%), Positives = 58/120 (48%), Gaps = 12/120 (10%)
Query: 55 EERDIMA-HANSEWIVQLHFAF------QDAKSLYMVMDYMPGG---DLVNLMSNYDVPE 104
+E +++ +++ I + AF L++VM++ G DL+ + E
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
+W + C E++ L +H +HRD+K N+LL ++ +KL DFG ++ T +R
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-19
Identities = 30/157 (19%), Positives = 53/157 (33%), Gaps = 4/157 (2%)
Query: 13 RYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH 72
RY + E P L + + S + M +++ V
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 73 FAFQDAKSLYMVMDYMPGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLGFVH 128
LY+ M +L + M+ D ++ A++ +H G +H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 129 RDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165
RD+KP N+ +K+ DFG M++ E L
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-19
Identities = 28/124 (22%), Positives = 51/124 (41%), Gaps = 12/124 (9%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-------VNLMSNYDVPEK 105
E +++ + I+++ F+D ++Y+VM+ GG+L E
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEG 124
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGTET 162
+ +++ AL H VH+D+KP+N+L H +K+ DFG T
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 163 KRLG 166
G
Sbjct: 185 NAAG 188
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 31/127 (24%), Positives = 55/127 (43%), Gaps = 8/127 (6%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDV 102
K D E ++ + I++L F+ + +V++ + GG+L + Y
Sbjct: 88 KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY-- 145
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTG 159
E+ A +++ A+ +H G VHRD+KP+N+L LK+ADFG +
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 160 TETKRLG 166
G
Sbjct: 206 LMKTVCG 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 33/109 (30%), Positives = 62/109 (56%), Gaps = 5/109 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ + E +I+ N I+++ F DA+ Y+V++ M GG+L + ++ N + E
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE 238
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
K Y +++LA+ +H G +HRD+KP+N+LL ++ +K+ DFG
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-19
Identities = 38/132 (28%), Positives = 59/132 (44%), Gaps = 14/132 (10%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN---LM 97
++ D E I H N IV+LH + Q+ Y+V D + GG+L
Sbjct: 43 KLSARDFQKLEREARICRKLQHPN---IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 99
Query: 98 SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMR 154
Y E A +++ ++ H G VHR++KP+N+LL K +KLADFG +
Sbjct: 100 EFY--SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 155 MNKTGTETKRLG 166
+N + G
Sbjct: 158 VNDSEAWHGFAG 169
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 15/116 (12%)
Query: 45 IKRSDSAFFWEERDIM----AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLM 97
I + A +E + H N IV+LH F D ++VM+ + GG+L +
Sbjct: 44 ISKRMEANTQKEITALKLCEGHPN---IVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100
Query: 98 SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
++ E A + ++V A+ +H +G VHRD+KP+N+L + + +K+ DFG
Sbjct: 101 KHFS--ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 28/121 (23%), Positives = 51/121 (42%), Gaps = 10/121 (8%)
Query: 56 ERDIMAHANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDL----VNLMSNYDVPEKWAKF 109
E +++ N + IV+L ++ + ++M++ P G L + Y +PE
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGTETKRL 165
+VV ++ + G VHR++KP N++ D KL DFG +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 166 G 166
G
Sbjct: 177 G 177
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-19
Identities = 28/121 (23%), Positives = 51/121 (42%), Gaps = 10/121 (8%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKS--LYMVMDYMPGGDL----VNLMSNYDVPEKWAKF 109
E +++ N + IV+L ++ + ++M++ P G L + Y +PE
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTGTETKRL 165
+VV ++ + G VHR++KP N++ D KL DFG +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 166 G 166
G
Sbjct: 177 G 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-19
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 2/110 (1%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG-DLVNLMSNYDVPEKWAKFYCAEVVLA 117
++ + +IVQ F +++ M+ M + + +PE+ +V A
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 118 LDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
L + G +HRDVKP N+LLD+ G +KL DFG R+ + + G
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG 186
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 26/132 (19%), Positives = 56/132 (42%), Gaps = 11/132 (8%)
Query: 44 QIKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-----LM 97
+ + A E ++ A S ++ LH +++ + ++++Y GG++ + L
Sbjct: 66 RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125
Query: 98 SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMR 154
E +++ + +H VH D+KP N+LL G +K+ DFG +
Sbjct: 126 EMV--SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 155 MNKTGTETKRLG 166
+ + +G
Sbjct: 184 IGHACELREIMG 195
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNY 100
++ D E I IV+LH + + Y++ D + GG+L + Y
Sbjct: 48 KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY 107
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGT 151
E A +++ A+ H +G VHR++KP+N+LL K +KLADFG
Sbjct: 108 --SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 33/136 (24%), Positives = 60/136 (44%), Gaps = 8/136 (5%)
Query: 37 ALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL--- 93
YS + + E ++ + I++L F+D K Y+V ++ GG+L
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136
Query: 94 VNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
+ + E A +++ + +H VHRD+KP+N+LL + ++K+ DFG
Sbjct: 137 IINRHKF--DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 151 TCMRMNKTGTETKRLG 166
+K RLG
Sbjct: 195 LSSFFSKDYKLRDRLG 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 56 ERDIMA---HANSEWIVQLHFAFQDAKSLYMVMD-YMPGGDLVN-LMSNYDVPEKWAKFY 110
E I++ HAN I+++ F++ +VM+ + G DL + + + E A +
Sbjct: 79 EIAILSRVEHAN---IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++V A+ + +HRD+K +N+++ + +KL DFG
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-19
Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 15/111 (13%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN 99
+IKR E + H + I++L+ +MVM+Y+ GG+L + + +
Sbjct: 57 KIKR--------EIQNLKLFRHPH---IIKLYQVISTPTDFFMVMEYVSGGELFDYICKH 105
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
V E A+ +++ A+D H VHRD+KP+N+LLD H + K+ADFG
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-19
Identities = 37/111 (33%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN 99
Q+ + + E IM H N IV+L + K+LY++M+Y GG++ + L+++
Sbjct: 52 QLNPTSLQKLFREVRIMKILNHPN---IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH 108
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ EK A+ ++V A+ H VHRD+K +N+LLD ++K+ADFG
Sbjct: 109 GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-19
Identities = 31/111 (27%), Positives = 59/111 (53%), Gaps = 15/111 (13%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
IK+ E I H N +V+ + ++ Y+ ++Y GG+L + +
Sbjct: 51 NIKK--------EICINKMLNHEN---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 99
Query: 101 D-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+PE A+ + +++ + +H +G HRD+KP+N+LLD+ +LK++DFG
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-18
Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 19/107 (17%)
Query: 60 MAHANSEWIVQLHFAFQD------------AKSLYMVMDYMPGGDLVNLM----SNYDVP 103
+ H IV+ A+ + LY+ M +L + M + +
Sbjct: 60 LEHPG---IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ A++ +H G +HRD+KP N+ +K+ DFG
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDY-MPGGDLVN-LMSNYDVPEKWAKFYCAEV 114
H +++L F+ + +V++ +P DL + + + E ++ + +V
Sbjct: 92 GAGGGHPG---VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFG 150
V A+ H G VHRD+K +N+L+D + G KL DFG
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV--PEKWAKFYCAEVVLALD 119
H N +V L F+ + L++V +Y +++ + Y PE K + + A++
Sbjct: 61 HPN---LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRDVKP+N+L+ KH +KL DFG
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFG 147
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 32/154 (20%), Positives = 53/154 (34%), Gaps = 43/154 (27%)
Query: 40 SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL------ 93
++ QI D E +M + I +L+ ++D + + +VM+ GG L
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 94 -----------------------------------VNLMSNYDVPEKWAKFYCAEVVLAL 118
++ EK ++ AL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 119 DAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFG 150
+H G HRD+KP+N L +K +KL DFG
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 31/111 (27%), Positives = 59/111 (53%), Gaps = 15/111 (13%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
IK+ E I H N +V+ + ++ Y+ ++Y GG+L + +
Sbjct: 51 NIKK--------EICINKMLNHEN---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 99
Query: 101 D-VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+PE A+ + +++ + +H +G HRD+KP+N+LLD+ +LK++DFG
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-18
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
H N IV L + L +V ++M DL ++ + K Y +++ +
Sbjct: 78 HPN---IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L++ G LKLADFG
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFG 164
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 15/111 (13%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN 99
+I+R E + H + I++L+ ++MVM+Y+ GG+L + + N
Sbjct: 62 KIRR--------EIQNLKLFRHPH---IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN 110
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ EK ++ +++ +D H VHRD+KP+N+LLD H + K+ADFG
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 33/109 (30%), Positives = 62/109 (56%), Gaps = 5/109 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPE 104
+ + E +I+ N I+++ F DA+ Y+V++ M GG+L + ++ N + E
Sbjct: 55 EADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE 113
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
K Y +++LA+ +H G +HRD+KP+N+LL ++ +K+ DFG
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-18
Identities = 31/114 (27%), Positives = 56/114 (49%), Gaps = 6/114 (5%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG-----DLVNLMSNYDVPEKWAKFYCAE 113
+M ++ +IVQ + A ++ M+ M V + + +PE+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 114 VVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
V AL+ + L +HRD+KP N+LLD+ G++KL DFG ++ + +T+ G
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG 187
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 8/111 (7%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL---MSNYDV 102
+ E ++ E IV L ++ Y+VM + GG+L + Y
Sbjct: 46 PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-- 103
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
EK A +V+ A+ +H G VHRD+KP+N+L +++ + + DFG
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 4e-18
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
H+N IV+L+ K L +V +++ DL L+ + AK + +++ +
Sbjct: 59 HSN---IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L+++ G LK+ADFG
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFG 145
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 18/114 (15%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLH--FAFQDAKSLYMVMDYMPGG--DLVNL 96
+K+ E ++ H N ++QL ++ + +YMVM+Y G ++++
Sbjct: 52 NVKK--------EIQLLRRLRHKN---VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS 100
Query: 97 MSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ P A Y +++ L+ +H G VH+D+KP N+LL G LK++ G
Sbjct: 101 VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALG 154
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 10/110 (9%)
Query: 48 SDSAF---FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNY 100
SD F E + +V +H + LY+ M + G DL ++
Sbjct: 73 SDPVFRTRMQREARTAGRLQEPH---VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG 129
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ A ++ ALDA H G HRDVKP+N+L+ L DFG
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 8e-18
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 11/96 (11%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF-------YCAEV 114
H N IV+L+ L +V ++M DL M + V + ++
Sbjct: 62 HEN---IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ L H +HRD+KP N+L++K G LKL DFG
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-18
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 16/108 (14%)
Query: 54 WEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMSNYDVPEKW 106
EE +I+ H N I+ L + D K +Y+V + M GG+L + + E+
Sbjct: 63 TEEIEILLRYGQHPN---IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF--SERE 117
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL-DKHGH---LKLADFG 150
A + ++ +H G VHRD+KP N+L D+ G+ +++ DFG
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-17
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
H N IV+LH K L +V ++ DL + + + K + +++ L
Sbjct: 60 HKN---IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L++++G LKLA+FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFG 146
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 28/115 (24%), Positives = 55/115 (47%), Gaps = 15/115 (13%)
Query: 46 KRSDSAFFWEERDIM----AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL---VNLMS 98
+ + E +++ H N +++L F++ Y+V + M GG + ++
Sbjct: 50 PGHIRSRVFREVEMLYQCQGHRN---VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 99 NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
+++ E A +V ALD +H G HRD+KP+N+L ++ +K+ DF
Sbjct: 107 HFN--ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 22/91 (24%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
H N +V L + K Y+V +++ +++ + + + + Y +++ +
Sbjct: 83 HEN---LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP+N+L+ + G +KL DFG
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFG 169
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-17
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLAL 118
H N IV+L LY+V +++ DL M +P K Y +++ L
Sbjct: 61 HPN---IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L++ G +KLADFG
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
HAN IV LH KSL +V +Y+ DL + + K + +++ L
Sbjct: 59 HAN---IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H +HRD+KP N+L+++ G LKLADFG
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFG 145
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLAL 118
++H N IV + ++ Y+VM+Y+ G L + S+ + A + +++ +
Sbjct: 68 LSHQN---IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
H + VHRD+KP N+L+D + LK+ DFG
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG 156
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEVVLALD 119
H N I+ L AF ++ +V D+M DL ++ + + K Y + L+
Sbjct: 71 HPN---IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+H +HRD+KP+N+LLD++G LKLADFG
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFG 157
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 30/129 (23%), Positives = 62/129 (48%), Gaps = 13/129 (10%)
Query: 27 YLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEW--IVQLHFAFQDAKSLYMV 84
++ K R + + ++ E ++ +S + +++L F+ S ++
Sbjct: 75 HVEKDRISDWGELPNGTRVPM--------EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 85 MDY-MPGGDLVN-LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KH 141
++ P DL + + + E+ A+ + +V+ A+ H G +HRD+K +N+L+D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186
Query: 142 GHLKLADFG 150
G LKL DFG
Sbjct: 187 GELKLIDFG 195
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-17
Identities = 26/97 (26%), Positives = 43/97 (44%), Gaps = 5/97 (5%)
Query: 59 IMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD----VPEKWAKFYCAEV 114
M + + V + A +++ M+ M D +PE +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 115 VLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFG 150
V AL+ +H L +HRDVKP N+L++ G +K+ DFG
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-17
Identities = 29/111 (26%), Positives = 59/111 (53%), Gaps = 16/111 (14%)
Query: 44 QIKRSDSAFFWEERDIM---AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN 99
+++R E + H + I++L+ + MV++Y GG+L + ++
Sbjct: 55 RVER--------EISYLKLLRHPH---IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK 102
Query: 100 YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ E + + +++ A++ H VHRD+KP+N+LLD + ++K+ADFG
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 7e-17
Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 16/124 (12%)
Query: 48 SDSAF---FWEERDIMA---HANSEWIVQL-----HFAFQDAKSLYMVMDYMPGGDLVNL 96
D+ ER +A H + IVQ+ H Y+VM+Y+ G L
Sbjct: 118 GDAEAQAMAMAERQFLAEVVHPS---IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS 174
Query: 97 MSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156
+P A Y E++ AL +H +G V+ D+KP+N++L + LKL D G R+N
Sbjct: 175 KGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN 232
Query: 157 KTGT 160
G
Sbjct: 233 SFGY 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-17
Identities = 29/119 (24%), Positives = 50/119 (42%), Gaps = 21/119 (17%)
Query: 48 SDSAFFWEERDIM----AHANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDL-----V 94
D E ++ + IV++ +++ K L +VM+ + GG+L
Sbjct: 96 QDCPKARREVELHWRASQCPH---IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 152
Query: 95 NLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
+ E+ A + A+ +H + HRDVKP+N+L + LKL DFG
Sbjct: 153 RGDQAFT--EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 21/119 (17%)
Query: 48 SDSAFFWEERDIM----AHANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLVN---- 95
DS +E D + IV + +++ + L ++M+ M GG+L +
Sbjct: 63 YDSPKARQEVDHHWQASGGPH---IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE 119
Query: 96 -LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
+ E+ A ++ A+ +H HRDVKP+N+L +K LKL DFG
Sbjct: 120 RGDQAFT--EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 29/119 (24%), Positives = 51/119 (42%), Gaps = 21/119 (17%)
Query: 48 SDSAFFWEERDIMA----HANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLVN---- 95
D E ++ + IV++ +++ K L +VM+ + GG+L +
Sbjct: 52 QDCPKARREVELHWRASQCPH---IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108
Query: 96 -LMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFG 150
+ E+ A + A+ +H + HRDVKP+N+L + LKL DFG
Sbjct: 109 RGDQAF--TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-16
Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 1/84 (1%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFV 127
+ ++ +V +++ GG L + P A + A DA H G
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-AIRAMQSLAAAADAAHRAGVA 151
Query: 128 HRDVKPDNMLLDKHGHLKLADFGT 151
P + + G + LA T
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT 175
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 13/108 (12%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLM----SNYDVPEK 105
E IM N +V + L + M+Y GGDL + + + E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFG 150
+ +++ AL +H +HRD+KP+N++L K+ D G
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-16
Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 27/137 (19%)
Query: 45 IKR----SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
IK+ S+ F E ++ N IV+L+ A + + +VM+Y GG L N++
Sbjct: 36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGA 93
Query: 101 DVPE--------KWAKFYCAEVVLALDAIHCL---GFVHRDVKPDNMLLDKHG-HLKLAD 148
+ W + + +H + +HRD+KP N+LL G LK+ D
Sbjct: 94 EPLPYYTAAHAMSWCL----QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149
Query: 149 FGTC-----MRMNKTGT 160
FGT N G+
Sbjct: 150 FGTACDIQTHMTNNKGS 166
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-16
Identities = 24/118 (20%), Positives = 52/118 (44%), Gaps = 8/118 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLVNLMSNY-DVPEKWA 107
F EE +++ IV+ + +++ K + +V + M G L + + + K
Sbjct: 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 131
Query: 108 KFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGTET 162
+ +C +++ L +H +HRD+K DN+ + G +K+ D G + +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 23/128 (17%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
+E + A H N I+ L +L +VM++ GG L ++S +P
Sbjct: 53 VRQEAKLFAMLKHPN---IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVN 109
Query: 110 YCAEVVLALDAIHCLG---FVHRDVKPDNMLLDKHGH--------LKLADFGT------C 152
+ ++ ++ +H +HRD+K N+L+ + LK+ DFG
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 153 MRMNKTGT 160
+M+ G
Sbjct: 170 TKMSAAGA 177
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 24/70 (34%), Positives = 40/70 (57%), Gaps = 1/70 (1%)
Query: 82 YMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140
Y+VM+Y+ G L +++ + + K A A+ AL+ H G +HRDVKP N+++
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 141 HGHLKLADFG 150
+K+ DFG
Sbjct: 152 TNAVKVMDFG 161
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-16
Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 12/97 (12%)
Query: 62 HANSEWIVQLH-----FAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP---EKWAKFYCAE 113
H N +V+L + +V +++ DL + P + K +
Sbjct: 73 HPN---VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ LD +H VHRD+KP+N+L+ G +KLADFG
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-16
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 12/97 (12%)
Query: 62 HANSEWIVQLH-----FAFQDAKSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAE 113
H N +V+L L +V +++ DL + VP + K +
Sbjct: 73 HPN---VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ LD +H VHRD+KP N+L+ G +KLADFG
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-16
Identities = 25/133 (18%), Positives = 47/133 (35%), Gaps = 15/133 (11%)
Query: 44 QIKRSDSAFFWEERDIM----AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN 99
+I +F E ++ H N +++ +D + Y+ ++ L +
Sbjct: 55 RILPECFSFADREVQLLRESDEHPN---VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQ 110
Query: 100 YDV--PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-----LKLADFGTC 152
D + L +H L VHRD+KP N+L+ ++DFG C
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 153 MRMNKTGTETKRL 165
++ R
Sbjct: 171 KKLAVGRHSFSRR 183
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-16
Identities = 25/86 (29%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVVLALDAIHCLGF 126
IV+ L ++M+Y GG+L + + E A+F+ +++ + H +
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 127 VHRDVKPDNMLLDKH--GHLKLADFG 150
HRD+K +N LLD LK+ DFG
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFG 163
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-16
Identities = 33/124 (26%), Positives = 50/124 (40%), Gaps = 20/124 (16%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK--WA 107
F E IM H N IV A +L +V +Y+ G L L+ E+
Sbjct: 81 FLREVAIMKRLRHPN---IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 108 KFYCAEVVLALDA------IHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159
+ + +A D +H VHR++K N+L+DK +K+ DFG T
Sbjct: 138 RR----LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 160 TETK 163
+K
Sbjct: 194 LSSK 197
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 17/143 (11%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
F +E +M H N +++ K L + +Y+ GG L ++ + D W++
Sbjct: 54 FLKEVKVMRCLEHPN---VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ- 109
Query: 110 YCAEVVLALDA------IHCLGFVHRDVKPDNMLLDKHGHLKLADFG-TCMRMNKTGTET 162
V A D +H + +HRD+ N L+ ++ ++ +ADFG + +++
Sbjct: 110 ---RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166
Query: 163 KRLGRNGIEEIKAHPFFINDQWT 185
+ K + N W
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWM 189
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 62 HANSEWIVQLH--------FAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYC 111
H N +V L + S+Y+V D+ DL L+SN V K
Sbjct: 75 HEN---VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ L IH +HRD+K N+L+ + G LKLADFG
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 62 HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDA 120
H N I++L L+++ +Y DL M N DV + K + +++ ++
Sbjct: 92 HRN---IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 121 IHCLGFVHRDVKPDNMLLD-----KHGHLKLADFG 150
H +HRD+KP N+LL + LK+ DFG
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 56 ERDIMAHANSEWIVQLHFAF------QDAKSLYMVMDYMPGGDLVNLMSNY-----DVPE 104
E IM +V L F +D L +V++Y+P + +Y +P
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFG 150
K Y +++ +L IH +G HRD+KP N+LLD G LKL DFG
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-15
Identities = 32/142 (22%), Positives = 49/142 (34%), Gaps = 26/142 (18%)
Query: 56 ERDIMA----HANSEWIVQLHFAFQDAKS--------LYMVMDYMPGGDLVNLMSNYDV- 102
E M H N IVQ A K ++ + G + L
Sbjct: 75 EVCFMKKLSGHPN---IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 103 ----PEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFG--TCMR 154
FY + A+ +H +HRD+K +N+LL G +KL DFG T +
Sbjct: 132 PLSCDTVLKIFY--QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189
Query: 155 MNKTGTETKRLGRNGIEEIKAH 176
+ + + EEI +
Sbjct: 190 HYPDYSWSAQRRALVEEEITRN 211
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-15
Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 56 ERDIMAHANSEWIVQLHFAF------QDAKSLYMVMDYMPGGDLVNLM-----SNYDVPE 104
E IM + IV+L + F +D L +V+DY+P + + + +P
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV 155
Query: 105 KWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFG 150
+ K Y ++ +L IH G HRD+KP N+LLD LKL DFG
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-15
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 17/108 (15%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
F E H N +V A L ++ G L +++ + + K
Sbjct: 76 FKREVMAYRQTRHEN---VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKT 132
Query: 110 YCAEVVLALDA------IHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151
+A + +H G +H+D+K N+ D +G + + DFG
Sbjct: 133 ----RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 20/124 (16%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
F E IM++ N IV+L+ MVM+++P GDL + + + P KW+
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--- 124
Query: 113 EVVLALDA------IHCLG--FVHRDVKPDNMLLDKHG-----HLKLADFGT-CMRMNKT 158
+ L LD + VHRD++ N+ L K+ADFG ++
Sbjct: 125 -LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 159 GTET 162
Sbjct: 184 SGLL 187
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 23/126 (18%), Positives = 47/126 (37%), Gaps = 17/126 (13%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
F E ++ H N I+ + L +V + G L + + + + K
Sbjct: 67 FKNEVGVLRKTRHVN---ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKL 122
Query: 110 YCAEVVLALDA------IHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
+ +A +H +HRD+K +N+ L + +K+ DFG ++ +
Sbjct: 123 ----IDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 164 RLGRNG 169
+G
Sbjct: 179 FEQLSG 184
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 23/137 (16%), Positives = 53/137 (38%), Gaps = 27/137 (19%)
Query: 44 QIKRSDSAFFWEERDIM----AHANSEWIVQLHFAFQDAKSLYMVMDYMPGG--DLVNLM 97
++ E ++ H N +++ + + + LY+ ++ DLV
Sbjct: 46 RMLIDFCDIALMEIKLLTESDDHPN---VIRYYCSETTDRFLYIALELCNLNLQDLVESK 102
Query: 98 SNYD-----VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD------------- 139
+ D E ++ + +H L +HRD+KP N+L+
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 140 KHGHLKLADFGTCMRMN 156
++ + ++DFG C +++
Sbjct: 163 ENLRILISDFGLCKKLD 179
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 21/122 (17%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLM-SNYDVPEKW 106
F EE + H N ++ + A Q A ++ +MP G L N++ +
Sbjct: 54 FNEECPRLRIFSHPN---VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ 110
Query: 107 AKFYCAEVVLALDA------IHCLGF--VHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
++ V ALD +H L + ++++D+ +++
Sbjct: 111 SQ----AVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166
Query: 159 GT 160
G
Sbjct: 167 GR 168
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-14
Identities = 23/136 (16%), Positives = 48/136 (35%), Gaps = 20/136 (14%)
Query: 45 IKRSDSAFFWEERDIMA-----HANSEWIVQLHFA----FQDAKSLYMVMDYMPGGDLVN 95
D ++ E ++ H N I+ + + L+++ Y G L +
Sbjct: 39 FSSRDEKSWFRETELYNTVMLRHEN---ILGFIASDMTSRHSSTQLWLITHYHEMGSLYD 95
Query: 96 LMSNYDVPEKWAKFYCAEVVLALDAIHCLGF--------VHRDVKPDNMLLDKHGHLKLA 147
+ + + L +H F HRD+K N+L+ K+G +A
Sbjct: 96 YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155
Query: 148 DFGTCMRMNKTGTETK 163
D G + +++ +
Sbjct: 156 DLGLAVMHSQSTNQLD 171
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-14
Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 20/135 (14%)
Query: 45 IKRSDSAFFWEERDIMA-----HANSEWIVQLHFA----FQDAKSLYMVMDYMPGGDLVN 95
++ A ++ E +I H N I+ A LY++ DY G L +
Sbjct: 68 FFTTEEASWFRETEIYQTVLMRHEN---ILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 96 LMSNYDVPEKWAKFYCAEVVLALDAIHCLGF--------VHRDVKPDNMLLDKHGHLKLA 147
+ + + K V L +H F HRD+K N+L+ K+G +A
Sbjct: 125 YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
Query: 148 DFGTCMRMNKTGTET 162
D G ++ E
Sbjct: 185 DLGLAVKFISDTNEV 199
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 20/136 (14%)
Query: 45 IKRSDSAFFWEERDIMA-----HANSEWIVQLHFA----FQDAKSLYMVMDYMPGGDLVN 95
+ ++ E +I H N I+ A L++V DY G L +
Sbjct: 73 FSSREERSWFREAEIYQTVMLRHEN---ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129
Query: 96 LMSNYDVPEKWAKFYCAEVVLALDAIHC--------LGFVHRDVKPDNMLLDKHGHLKLA 147
++ Y V + L +H HRD+K N+L+ K+G +A
Sbjct: 130 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 148 DFGTCMRMNKTGTETK 163
D G +R +
Sbjct: 190 DLGLAVRHDSATDTID 205
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 27/133 (20%), Positives = 44/133 (33%), Gaps = 22/133 (16%)
Query: 45 IKRSDSAFFWEERDIMA-----HANSEWIVQL-----HFAFQDAKSLYMVMDYMPGGDLV 94
++ F E++I H N I + +VM+Y P G L
Sbjct: 44 FSFANRQNFINEKNIYRVPLMEHDN---IARFIVGDERVTADGRMEYLLVMEYYPNGSLX 100
Query: 95 NLMSNYDVPEKWAKFYCAEVVLALDAIH---------CLGFVHRDVKPDNMLLDKHGHLK 145
+S + + V L +H HRD+ N+L+ G
Sbjct: 101 KYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160
Query: 146 LADFGTCMRMNKT 158
++DFG MR+
Sbjct: 161 ISDFGLSMRLTGN 173
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 76 QDAKSLYMVMDYMPGGDLVNLM-----SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRD 130
K L ++M+Y+P L ++ S +P Y ++ A+ IH LG HRD
Sbjct: 108 SQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166
Query: 131 VKPDNMLLD-KHGHLKLADFG 150
+KP N+L++ K LKL DFG
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFG 187
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 16/107 (14%)
Query: 59 IMAHANSEWIVQLHFAFQDAKS-------LYMVMDYMPGGDLVNLMSNY-----DVPEKW 106
+A + IVQL F L +VM+Y+P L NY P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 107 AKFYCAEVVLALDAIHC--LGFVHRDVKPDNMLLDKH-GHLKLADFG 150
K + +++ ++ +H + HRD+KP N+L+++ G LKL DFG
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-11
Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFA--FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFY 110
+ +E DI+ E I++ A SL +VM+Y+P G L + + + + +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 139
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ + +H ++HRD+ N+LLD +K+ DFG
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 14/95 (14%)
Query: 62 HANSEWIVQLHFAFQDAKS--LYMVMDYMPGGDLVNLM---SNYDVPEKWAKFYCAEVVL 116
N I+ L +D S +V +++ D L ++YD+ +FY E++
Sbjct: 90 GPN---IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RFYMYEILK 141
Query: 117 ALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFG 150
ALD H +G +HRDVKP N+++D +H L+L D+G
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-11
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 20/105 (19%)
Query: 62 HANSEWIVQLH--FAFQDAKSLYMVMDYMPGGDLVNLM----------SNYDVPEKWAKF 109
H N ++ L F + ++++ DY DL +++ +P K
Sbjct: 77 HPN---VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFG 150
+++ + +H +HRD+KP N+L+ + G +K+AD G
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKS------LYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
E ++ H E ++ L F ++ Y+VM +M G DL LM + + E +F
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF 132
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L IH G +HRD+KP N+ +++ LK+ DFG
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 23/98 (23%), Positives = 46/98 (46%), Gaps = 7/98 (7%)
Query: 59 IMAHANSEWIVQLH-----FAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCA 112
I+ N + +V++ + LY+V++ D L + + E K
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ + +H G +HRD+KP N L+++ +K+ DFG
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFG 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKS------LYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
E ++ H E ++ L F A+S +Y+V M G DL N++ + + +F
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF 136
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L IH +HRD+KP N+ +++ LK+ DFG
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 27/99 (27%), Positives = 48/99 (48%), Gaps = 2/99 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYC 111
E ++M ++ +IV++ +A+S +VM+ G L L N V +K
Sbjct: 65 LLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 123
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+V + + + FVHRD+ N+LL + K++DFG
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 21/102 (20%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 53 FWEERDIMAHANSEWIVQLH--FAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAK 108
F E +I+ + IV+ ++L ++M+Y+P G L + + + +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y +++ ++ + ++HRD+ N+L++ +K+ DFG
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVL 116
+I+ + + + + S+Y+V +YM DL N++ + E+ A+ + +++
Sbjct: 74 FEIL-GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 117 ALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFG 150
L IH +HRD+KP N+ ++ LK+ DFG
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 20/76 (26%), Positives = 43/76 (56%), Gaps = 4/76 (5%)
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
F + +Y++ + M DL ++S + + +++ + + A+ +H +HRD+KP
Sbjct: 86 FNE---VYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141
Query: 135 NMLLDKHGHLKLADFG 150
N+L++ + LK+ DFG
Sbjct: 142 NLLINSNCDLKVCDFG 157
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 25/147 (17%)
Query: 45 IKR---SDSAFFWEERDI-----MAHANSEWIVQLHFA----FQDAKSLYMVMDYMPGGD 92
+K D + E ++ M H N I+Q A L+++ + G
Sbjct: 52 VKIFPIQDKQSWQNEYEVYSLPGMKHEN---ILQFIGAEKRGTSVDVDLWLITAFHEKGS 108
Query: 93 LVNLMSNYDVPEKWAKFYCAEVVLALDAIHC----------LGFVHRDVKPDNMLLDKHG 142
L + + V + L +H HRD+K N+LL +
Sbjct: 109 LSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 143 HLKLADFGTCMRMNKTGTETKRLGRNG 169
+ADFG ++ + G+ G
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVG 195
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 23/98 (23%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 59 IMAHANSEWIVQLHFAF------QDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
+M N + I+ L F ++ + +Y+VM+ M +L ++ ++ + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLY 171
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ + +H G +HRD+KP N+++ LK+ DFG
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 21/102 (20%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFA--FQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAK 108
F E +I+ + IV+ ++L ++M+Y+P G L + + + +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y +++ ++ + ++HRD+ N+L++ +K+ DFG
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
F E IM H N I++L +K + +V +YM G L + + +D +
Sbjct: 93 FLGEASIMGQFDHPN---IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 110 --YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ + + +G+VHRD+ N+L++ + K++DFG
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-09
Identities = 24/100 (24%), Positives = 46/100 (46%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F +E I+ + IV+L + +Y+VM+ + GGD + L + + K
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM 218
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ + +HRD+ N L+ + LK++DFG
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 8/103 (7%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
F E IM H N I++L + +V +YM G L + +D +
Sbjct: 97 FLSEASIMGQFDHPN---IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 110 --YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
V + + LG+VHRD+ N+L+D + K++DFG
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 59 IMAHANSEWIVQLHFAF-----QDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAE 113
I+ E I+ ++ + K +Y+V D M DL L+ + ++ +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ L IH +HRD+KP N+LL+ LK+ DFG
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 5/111 (4%)
Query: 75 FQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
+D +Y+V DYM DL ++ + ++ +++ + +H G +HRD+KP
Sbjct: 83 DRD---VYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS 138
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFINDQWT 185
N+LL+ H+K+ADFG R I E + T
Sbjct: 139 NILLNAECHVKVADFGLS-RSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 22/100 (22%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--Y 110
F E IM + I++L K + ++ +YM G L + D +
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ + + + +VHRD+ N+L++ + K++DFG
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 13/96 (13%)
Query: 57 RDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP--EKWAKFYCAEV 114
RDI H A LY+V + M DL ++ + + + +++ +
Sbjct: 95 RDIFVHFEEP-------AMHK---LYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 115 VLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+L L +H G VHRD+ P N+LL + + + DF
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 22/102 (21%), Positives = 46/102 (45%), Gaps = 4/102 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFA--FQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAK 108
+E +I+ + E IV+ + ++M+++P G L + + K
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y ++ +D + +VHRD+ N+L++ +K+ DFG
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-08
Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 3/100 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F E IM + + IV+L + + +++M+ P G+L + L N + Y
Sbjct: 60 FMSEAVIMKNLDHPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ A+ + + VHRD+ N+L+ +KL DFG
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 9/103 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
E IM + IV+L A++L +VM+ GG L + +
Sbjct: 57 MMREAQIMHQLDNPY---IVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 110 --YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+V + + + FVHRD+ N+LL + K++DFG
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 56 ERDIMAHANSEWIVQLHFAFQDAKS------LYMVMDYMPGGDLVNLMSNYDVPEKWAKF 109
E ++ H E ++ L F A S Y+VM +M DL +M E+ ++
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL-KFSEEKIQY 130
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ L IH G VHRD+KP N+ +++ LK+ DFG
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 53 FWEERDIMAHANSEWIVQLH--FAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAK 108
F E I+ +S++IV+ +SL +VM+Y+P G L + L + +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 109 FYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y +++ ++ + VHRD+ N+L++ H+K+ADFG
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 13/136 (9%)
Query: 59 IMAHANSEWIVQLH--------FAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKF 109
I+ S++I++L+ F + LY+V++ DL L + + E+ K
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDE---LYIVLEIA-DSDLKKLFKTPIFLTEEHIKT 133
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
++L + IH G +HRD+KP N LL++ +K+ DFG +N
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 170 IEEIKAHPFFINDQWT 185
EE H + Q T
Sbjct: 194 NEEPGPHNKNLKKQLT 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F +E +M E +VQL+ + + +Y+V +YM G L++ L + +
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A++ + + + +VHRD++ N+L+ ++ K+ADFG
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKF--Y 110
E IM ++ +IV+L A++L +VM+ GG L + +
Sbjct: 383 MMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+V + + + FVHR++ N+LL + K++DFG
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F++E M + +V+ + +Y+V +Y+ G L+N L S+ +
Sbjct: 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C +V + + F+HRD+ N L+D+ +K++DFG
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG 149
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 9/103 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYD-VPEKWA 107
F E + M H N +++L+ + MV + P G L++ L +
Sbjct: 68 FIREVNAMHSLDHRN---LIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
Y +V + + F+HRD+ N+LL +K+ DFG
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 22/101 (21%), Positives = 45/101 (44%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F +E +M +VQL Y++ ++M G+L++ L
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 322
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ A++ + F+HR++ N L+ ++ +K+ADFG
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-08
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F +E M + IV+L ++++M+ G+L + L Y + Y
Sbjct: 63 FLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ AL + FVHRD+ N+L+ + +KL DFG
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 21/103 (20%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYD-VPEKWA 107
+E +MA + + + +L ++ ++ MP G L++ + + D + ++
Sbjct: 64 ILDEAYVMASVDNPH---VCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+C ++ ++ + VHRD+ N+L+ H+K+ DFG
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F +E M + IV+L ++++M+ G+L + L + + Y
Sbjct: 438 FLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ AL + FVHRD+ N+L+ + +KL DFG
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 25/98 (25%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 59 IMAHANSEWIVQLHFAFQDAKS------LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
+M N + I+ L F KS +Y+VM+ M +L ++ ++ + +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLY 134
Query: 113 EVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+++ + +H G +HRD+KP N+++ LK+ DFG
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F +E +M E +VQL+ + + +Y+V +YM G L++ L + +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A++ + + + +VHRD++ N+L+ ++ K+ADFG
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 24/103 (23%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWA 107
F EE ++M H +VQL+ + + +V ++M G L + L + +
Sbjct: 50 FIEEAEVMMKLSHPK---LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL 106
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C +V + + +HRD+ N L+ ++ +K++DFG
Sbjct: 107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 149
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F E ++M + +V+LH A + +Y++ ++M G L++ L S+ + K
Sbjct: 230 FLAEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ A++ + I ++HRD++ N+L+ K+ADFG
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 23/103 (22%), Positives = 46/103 (44%), Gaps = 9/103 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYD-VPEKWA 107
+ + HA+ IV+L SL +V Y+P G L++ + + + +
Sbjct: 62 VTDHMLAIGSLDHAH---IVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL 117
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ + + G VHR++ N+LL +++ADFG
Sbjct: 118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 4/102 (3%)
Query: 53 FWEERDIMAHANSEWIVQLH-FAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF- 109
F E +M +VQL ++ LY+V +YM G LV+ L S
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 110 -YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V A++ + FVHRD+ N+L+ + K++DFG
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 21/103 (20%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYD-VPEKWA 107
+E +MA + + + +L ++ ++ MP G L++ + + D + ++
Sbjct: 64 ILDEAYVMASVDNPH---VCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+C ++ ++ + VHRD+ N+L+ H+K+ DFG
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-07
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 2/100 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F EE +M + + E +VQL+ + ++++ +YM G L+N L + +
Sbjct: 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
C +V A++ + F+HRD+ N L++ G +K++DFG
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-07
Identities = 20/108 (18%), Positives = 41/108 (37%), Gaps = 10/108 (9%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKFY 110
F+E +M+ + + +V + +V +++ G L L N + W
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL--------KLADFG 150
++ A+ + +H +V N+LL + KL+D G
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 32/117 (27%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
E IM+ H N IV L A + ++ +Y GDL+N L V E
Sbjct: 96 LMSELKIMSHLGQHEN---IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 108 KFYCAEVVLAL-DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
F A + D +H +HRDV N+LL K+ DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 53 FWEERDIMA---HANSEWIVQLH-FAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
F E +M H+N +VQL ++ LY+V +YM G LV+ L S
Sbjct: 233 FLAEASVMTQLRHSN---LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 108 KF--YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V A++ + FVHRD+ N+L+ + K++DFG
Sbjct: 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAK 108
F +E +M H N +VQL Y++ ++M G+L++ L
Sbjct: 56 FLKEAAVMKEIKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 109 F--YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
++ A++ + F+HRD+ N L+ ++ +K+ADFG
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 21/108 (19%), Positives = 42/108 (38%), Gaps = 11/108 (10%)
Query: 72 HFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVH 128
F K ++V+ + G L + + + E+ ++ AL+ +H +VH
Sbjct: 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182
Query: 129 RDVKPDNMLL--DKHGHLKLADFGTCMRMNKTGT-----ETKRLGRNG 169
+V +N+ + + + LA +G R +G E R G
Sbjct: 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 11/109 (10%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F E +M N +V+L + ++M+ M GDL + L S
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 110 --------YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
E+ + ++ FVHRD+ N ++ + +K+ DFG
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-06
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 81 LYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH-CLGFVHRDVKPDNMLLD 139
L++V+++ GG + M AK ++ +L L F HRD+ N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 140 KHGHLKLADFG 150
K KL
Sbjct: 197 KTSLKKLHYTL 207
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 20/119 (16%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPE 104
+K E R + + I Q+++ K MV++ + G L +L D
Sbjct: 44 MKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--- 99
Query: 105 KWAKFYCAEVVL--------ALDAIHCLGFVHRDVKPDNMLLDKHGHLK-----LADFG 150
+ + + VL ++ +H ++RDVKP+N L+ + G+ + DF
Sbjct: 100 ---RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 23/72 (31%), Positives = 34/72 (47%), Gaps = 5/72 (6%)
Query: 84 VMDYMPGGDLVNLMSNYDVPEK---WAKFY--CAEVVLALDAIHCLGFVHRDVKPDNMLL 138
+ YM G+L + D+P W + C L +H +HRDVK N+LL
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL 172
Query: 139 DKHGHLKLADFG 150
D++ K+ DFG
Sbjct: 173 DENFVPKITDFG 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 24/121 (19%), Positives = 37/121 (30%), Gaps = 26/121 (21%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN-----YDV 102
E +++ H N IV L A ++ +Y GDL+N L
Sbjct: 73 LMSELKVLSYLGNHMN---IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 103 PEKWAKFYCAEVVLALDAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADF 149
+ D + +HRD+ N+LL K+ DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 150 G 150
G
Sbjct: 190 G 190
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 18/103 (17%)
Query: 63 ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVL------ 116
I + + + +VMD + G L +L ++ + VL
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLF------NFCSRKLSLKTVLMLADQM 112
Query: 117 --ALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFGTCMR 154
++ +H F+HRD+KPDN L+ + + DFG +
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-06
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 23/118 (19%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAK 108
F E + A H N +V L + L M+ Y GDL L+ + +
Sbjct: 59 FRHEAMLRARLQHPN---VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 109 FYCAEVVLAL---DAIHCL-------------GFVHRDVKPDNMLLDKHGHLKLADFG 150
V AL D +H + VH+D+ N+L+ ++K++D G
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 23/118 (19%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAK 108
F E +++ H + IV+ + D L MV +YM GDL L ++
Sbjct: 64 FQREAELLTNLQHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 109 FYCAEVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ L +H FVHRD+ N L+ + +K+ DFG
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 16/114 (14%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCA 112
F E +++ + IV+ + + L MV +YM GDL + ++ K
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 113 EVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
L + L FVHRD+ N L+ + +K+ DFG
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 27/104 (25%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAK 108
F E ++M H +V+L +A + +Y++ +YM G LV+ L + + K
Sbjct: 55 FLAEANLMKQLQHQR---LVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 109 F--YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
A++ + I ++HRD++ N+L+ K+ADFG
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-06
Identities = 21/100 (21%), Positives = 40/100 (40%), Gaps = 20/100 (20%)
Query: 68 IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVL--------ALD 119
I +++ Q+ +V+D + G L +L+ + + + V +
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQ 120
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLK-----LADFGTCMR 154
+IH V+RD+KPDN L+ + + DFG
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 82 YMVMDYMPGGDLVNLM-SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD- 139
+MVM+ + G DL + N + ++ L+ IH +VH D+K N+LL
Sbjct: 128 FMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 140 -KHGHLKLADFG 150
+ LAD+G
Sbjct: 187 KNPDQVYLADYG 198
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 16/102 (15%)
Query: 63 ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVL------ 116
I + + + MVM+ + G L +L + KF V+L
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMI 115
Query: 117 -ALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMR 154
++ IH F+HRDVKPDN L+ K + + DFG +
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 13/117 (11%)
Query: 47 RSDSAFFWEERDIMAHANSEWIVQL------HFAFQDAKSLYMVMDYMPGGDLVNLMSNY 100
SD F E M + + +L A +++ +M GDL +
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 101 DVPEKWAKF-------YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ E + ++ ++ + F+HRD+ N +L + + +ADFG
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 24/119 (20%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSN---YDVPE 104
F E +++ H N I+ L A + LY+ ++Y P G+L++ L + P
Sbjct: 72 FAGELEVLCKLGHHPN---IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 105 KWAKFYCAEVVLALDAIHCL-------------GFVHRDVKPDNMLLDKHGHLKLADFG 150
A + + +H F+HRD+ N+L+ ++ K+ADFG
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 2/36 (5%)
Query: 117 ALDAIHCLGFVHRDVKPDNMLLD--KHGHLKLADFG 150
L+ IH +VH D+K N+LL+ + L D+G
Sbjct: 164 ILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 27/126 (21%), Positives = 45/126 (35%), Gaps = 31/126 (24%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-----------LM 97
E +M H N IV L A + +Y++ +Y GDL+N
Sbjct: 95 LMSELKMMTQLGSHEN---IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 98 SNYDVPEKWAKFYCAEVVLALDAIHC-------------LGFVHRDVKPDNMLLDKHGHL 144
Y+ ++ + V+ D + VHRD+ N+L+ +
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 211
Query: 145 KLADFG 150
K+ DFG
Sbjct: 212 KICDFG 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 11/109 (10%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYC 111
F E I++ N + IV+ + +++M+ M GGDL + L P + +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 112 AEVV-LALD-AIHC-----LGFVHRDVKPDNMLLDKHGH---LKLADFG 150
+++ +A D A C F+HRD+ N LL G K+ DFG
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 24/119 (20%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
E ++M H N I+ L A LY++++Y G+L L + +++
Sbjct: 133 LVSEMEMMKMIGKHKN---IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 108 KFYCAEVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ D + C +HRD+ N+L+ ++ +K+ADFG
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 248
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 24/120 (20%), Positives = 41/120 (34%), Gaps = 25/120 (20%)
Query: 53 FWEERDIMA----HANSEWIVQLHFA-FQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKW 106
E I+ H N +V L A + L +++++ G+L L S + +
Sbjct: 77 LMSELKILIHIGHHLN---VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 107 AKFYCAEVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
L I +HRD+ N+LL + +K+ DFG
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-05
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 53 FWEERDIMA---HANSEWIVQLH-FAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKW 106
F E IM H N ++ L + S +V+ YM GDL N + + ++ K
Sbjct: 73 FLTEGIIMKDFSHPN---VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 107 AKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V + + FVHRD+ N +LD+ +K+ADFG
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 11/109 (10%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKF-- 109
F E I++ N + IV+ + +++++ M GGDL + L P + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 110 -----YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFG 150
++ + F+HRD+ N LL G K+ DFG
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 26/119 (21%), Positives = 46/119 (38%), Gaps = 24/119 (20%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
E ++M H N I+ L A LY++++Y G+L L + +++
Sbjct: 121 LISEMEMMKMIGKHKN---IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 108 KFYCAEVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
L D + C +HRD+ N+L+ + +K+ADFG
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 24/119 (20%)
Query: 53 FWEERDIMA----HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWA 107
E ++M H N I+ L A LY++++Y G+L L + +++
Sbjct: 87 LVSEMEMMKMIGKHKN---IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 108 KFYCAEVVLAL---DAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ D + C +HRD+ N+L+ ++ +K+ADFG
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 27/111 (24%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 62 HANSEWIVQL--HFAFQDAKS--LYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEV 114
+ I++L HF + + MV + + G +L+ L+ Y+ +P + K ++
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 115 VLALDAIH-CLGFVHRDVKPDNMLLD------KHGHLKLADFGTCMRMNKT 158
+L LD +H G +H D+KP+N+L++ +K+AD G ++
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-05
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLH-FAFQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKF 109
F E +M N ++ L ++++ YM GDL+ + S + K
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V ++ + FVHRD+ N +LD+ +K+ADFG
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFG 169
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 3/101 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFA-FQDAKSLYMVMDYMPGGDLVN-LMSN-YDVPEKWAKF 109
F E IM + ++ L + S +V+ YM GDL N + + ++ K
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ +V + + FVHRD+ N +LD+ +K+ADFG
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 22/123 (17%), Positives = 42/123 (34%), Gaps = 25/123 (20%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN------------LMSNY 100
E +++ N +++L+ A L ++++Y G L L S
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 101 DVPEKWAKFYCAEVVLALDAIHC-------------LGFVHRDVKPDNMLLDKHGHLKLA 147
+ D I + VHRD+ N+L+ + +K++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 148 DFG 150
DFG
Sbjct: 193 DFG 195
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-05
Identities = 30/126 (23%), Positives = 50/126 (39%), Gaps = 31/126 (24%)
Query: 53 FWEERDIMA---HANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-----------VNLMS 98
F E +MA + N IV+L K + ++ +YM GDL V +S
Sbjct: 97 FQREAALMAEFDNPN---IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 99 NYDVPEKWAKFYCAEVVLAL-DAIHC-------------LGFVHRDVKPDNMLLDKHGHL 144
+ D+ + L+ + + FVHRD+ N L+ ++ +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 213
Query: 145 KLADFG 150
K+ADFG
Sbjct: 214 KIADFG 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 18/113 (15%)
Query: 53 FWEERDIMA---HANSEWIVQL-----HFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVP 103
F E M H N +++L + Q +++ +M GDL L+ +
Sbjct: 83 FLSEAACMKDFSHPN---VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 104 EKWA------KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150
+ ++ L ++ + F+HRD+ N +L + +ADFG
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-05
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 9/85 (10%)
Query: 62 HANSEWIVQLHFAFQ----DAKSLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEV 114
N E +VQL F+ + + MV + + G L+ + + +P K +V
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 115 VLALDAIH-CLGFVHRDVKPDNMLL 138
+ LD +H +H D+KP+N+LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILL 180
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 9e-05
Identities = 12/24 (50%), Positives = 16/24 (66%)
Query: 127 VHRDVKPDNMLLDKHGHLKLADFG 150
+HRDVK N+LLD+ + DFG
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFG 179
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 15/53 (28%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFGTCMRMNKT 158
+ + ++ LDA+H +H D+KP+N+LL +K+ DFG+ ++
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 3e-04
Identities = 12/24 (50%), Positives = 18/24 (75%)
Query: 127 VHRDVKPDNMLLDKHGHLKLADFG 150
+HRD+K N+LLD+ K++DFG
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFG 178
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.07 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.11 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.68 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 96.56 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 96.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.28 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 96.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.82 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 95.65 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 95.65 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 95.45 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 95.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 94.41 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.34 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 94.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 92.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.56 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 87.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 87.03 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 86.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.6 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 83.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.19 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=339.33 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=184.7
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| +++|....+....+++.+|+.+|++++|||||+++++|+++++
T Consensus 32 ~dy~i~~~lG~G~fg~V-----~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTV-----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEE-----EEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 33333345899999999 577776 99999 6667666677788999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999999998875 469999999999999999999999999999999999999999999999999999875332
Q ss_pred C---ccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 160 T---ETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 160 ~---~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
. ..+.+| |++||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..++...|.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~ 255 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE 255 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 2 233344 799999999888 7889999999999999999999999888888888887665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=330.53 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=174.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+| ++|+++ |+.|| ++++. +....+.+.+|+.+|++++|||||+++++|++++.+||||||
T Consensus 81 ~iG~G~fG~V-----~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 81 KIGEGSTGIV-----CIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEECSSCEE-----EEEEETTTCCEEEEEEEEGG---GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EeecCcCeEE-----EEEEECCCCCEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4899999999 577776 99999 33332 345567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccccCC
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRLG 166 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~~ 166 (245)
|+||+|.+++...++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..... ..+.+|
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 232 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 232 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccccc
Confidence 9999999999988899999999999999999999999999999999999999999999999999998764432 333444
Q ss_pred ---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 167 ---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 167 ---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
|++||.+.+.+| .++||||+||++|+|++|.+||.+.++...+..+....++
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~ 288 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 288 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 789999988888 7889999999999999999999998888777777665443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=325.04 Aligned_cols=203 Identities=19% Similarity=0.234 Sum_probs=163.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++....+.....++.+|+.+++.++||||+++++++++++.+|+||||
T Consensus 20 ~lG~G~fg~V-----~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 20 TLGEGSFGKV-----KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp EEEC---CCE-----EEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCcCeEE-----EEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4899999999 477666 99999 55565555566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc---
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK--- 163 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~--- 163 (245)
+ +|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.........+
T Consensus 95 ~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~G 173 (275)
T 3hyh_A 95 A-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG 173 (275)
T ss_dssp C-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------------
T ss_pred C-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeE
Confidence 9 7899998764 4699999999999999999999999999999999999999999999999999987665444333
Q ss_pred cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
+..|++||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+..+..+.|
T Consensus 174 T~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p 232 (275)
T 3hyh_A 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 232 (275)
T ss_dssp -CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 444799999998886 578999999999999999999999887777777777765544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=332.96 Aligned_cols=201 Identities=22% Similarity=0.282 Sum_probs=169.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+| ++|+++ |+.|| ++++.. ......+++.+|+.+|++++|||||++++++++++.+||||||
T Consensus 31 ~lG~G~fg~V-----~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 31 KIGEGSFGKA-----ILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EC------CE-----EEEEETTTCCEEEEEEEECTT-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCCeEE-----EEEEECCCCCEEEEEEEehHH-CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4899999999 577776 99999 344333 3345678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 88 MPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
|+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 184 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccc
Confidence 9999999998643 378999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
......|++||.+.+.+| .++||||+||++|+|++|.+||.+.+....+.++..+..|
T Consensus 185 ~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~ 243 (350)
T 4b9d_A 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243 (350)
T ss_dssp HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 123555899999999888 7899999999999999999999999888888888887665
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=330.96 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=175.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+| ++|+++ |+.|| ++++. +....+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 158 ~iG~G~fG~V-----~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 158 KIGEGSTGIV-----CIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEECSSCEE-----EEEEETTTCCEEEEEEEEST---TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeccCcCcEE-----EEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4899999999 577777 99999 33322 345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cc---c
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ET---K 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~---~ 163 (245)
|+||+|.+++...++++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..... .. .
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 309 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 309 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEE
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccccc
Confidence 9999999999988999999999999999999999999999999999999999999999999999998754432 22 3
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...|++||.+.+.+| .++||||+||++|+|++|.+||.+.++...+..+....++
T Consensus 310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~ 365 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 365 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 445899999998888 7889999999999999999999998888777777665444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=328.63 Aligned_cols=210 Identities=32% Similarity=0.458 Sum_probs=169.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhh-----cCeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKY-----RYTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~-----~~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+|.-.-.||+|+||+|+ +|++ .++.|| ++++.. .+..+..++.+|+.+|++++|||||+++++++++
T Consensus 25 ~Y~i~~~lG~G~fg~Vy-----~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVF-----LVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE 98 (304)
T ss_dssp GEEEEEEEECGGGCEEE-----EEEECSSTTTTCEEEEEEEESEE-EEEEECC------CCCCCCCCTTEECEEEEEEET
T ss_pred ccEEEEEEecCCCeEEE-----EEEEccCCCCCEEEEEEEEehHH-cChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 33333458999999995 6654 278899 444433 3334556789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+.+|+|||||+||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999999998875 4699999999999999999999999999999999999999999999999999987543
Q ss_pred CC-CccccCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 158 TG-TETKRLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 158 ~~-~~~~~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
.. ...+.+| |++||.+.+.++ .++|+||+||++|+|++|.+||.+.+..+.+.++..+.++.|.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~ 247 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 247 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence 32 2333444 799999998888 7889999999999999999999999888888888877665544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=320.53 Aligned_cols=196 Identities=23% Similarity=0.244 Sum_probs=166.8
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-+||+|+||+| ++|+++ |+.|| ++++.. ...+|+.+++.++|||||++++++.+++.+|||||
T Consensus 64 ~~lG~G~fG~V-----y~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 64 PRVGRGSFGEV-----HRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp EEEEEETTEEE-----EEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEeccCCCeEE-----EEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35999999999 577776 99999 333211 12479999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCCCc---
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~~~--- 161 (245)
||+||+|.++++. +.+++..+..++.||+.||.|||+++|+||||||+|||++.+| .+||+|||+|+.+......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999999999875 4699999999999999999999999999999999999999998 5999999999986543221
Q ss_pred ------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 162 ------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 162 ------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
..+..|++||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+.++.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence 12334799999999888 78999999999999999999999999888888887776543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=308.53 Aligned_cols=199 Identities=16% Similarity=0.168 Sum_probs=161.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~l 83 (245)
+||+|+||+|+ +|+++ |..|| ++.+. .......+++.+|+.++++++|||||+++++|++ +..+|+
T Consensus 33 ~iG~G~fg~Vy-----~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 33 EIGRGSFKTVY-----KGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEGG-GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEecCcCcEEE-----EEEECCCCeEEEEEEEchh-hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 48999999994 66666 88888 33332 3334567789999999999999999999999975 356899
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecC-CCcEEEEeeCceeecCCCC
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~~ 159 (245)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. +|.+||+|||+|+......
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 9999999999999875 46899999999999999999999998 999999999999975 7899999999998544322
Q ss_pred C--ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCC-CCcccCcCC
Q psy16292 160 T--ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTS-NFDDIEKDE 216 (245)
Q Consensus 160 ~--~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~-~~~~~~~~~ 216 (245)
. ...++.|++||.+.+....++||||+||++|+|++|.+||.+..+.. .+..+..+.
T Consensus 187 ~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~ 246 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246 (290)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC
Confidence 2 12344579999887643388999999999999999999998765433 334444443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=308.17 Aligned_cols=207 Identities=14% Similarity=0.134 Sum_probs=168.0
Q ss_pred hhccccccchhhhHHHHH--hhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLL--KYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~--~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+||+|+||+|+.+..... ...++.|||+.-.........+.+.+|+.++++++|||||++++++.+++.+++|||||+
T Consensus 33 ~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~ 112 (308)
T 4gt4_A 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 112 (308)
T ss_dssp EEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCS
T ss_pred EeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCC
Confidence 599999999963321111 112788884332222334556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 90 GGDLVNLMSN-----------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 90 ~g~L~~~l~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
+|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGla 192 (308)
T 4gt4_A 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192 (308)
T ss_dssp SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCB
T ss_pred CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccc
Confidence 9999999853 24788999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 153 MRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 153 ~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+....... .....+|++||.+...++ .++||||+||++|+++| |.+||.+.++.+....+..+..+
T Consensus 193 r~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 266 (308)
T 4gt4_A 193 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL 266 (308)
T ss_dssp CGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC
T ss_pred eeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 87643321 122345899999998888 78999999999999998 89999998887777777666543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=308.90 Aligned_cols=201 Identities=17% Similarity=0.206 Sum_probs=167.1
Q ss_pred hhccccccchhhhHHHHHhh------c-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY------R-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~------~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
+||+|+||+|+ +++. . |..||++.-. .......+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 20 ~lG~G~fG~Vy-----~a~~~~~~~~~~~~~vAvK~l~-~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 20 ELGEGAFGKVF-----LAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp EEEC--CCCEE-----EEEECSCC----CEEEEEEEEC-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeeCCCcEEE-----EEEECCcccCCCCEEEEEEEeC-CCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 58999999995 5443 2 7788832211 12234567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 85 MDYMPGGDLVNLMSNY--------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
||||++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcc
Confidence 9999999999998642 48999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 151 TCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 151 ~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+|+........ ....+|.+||.+...++ .++||||+||++|+|+| |.+||.+.++.+.+..+..+..+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99876443221 23445899999998888 78999999999999998 89999998888877777776544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=302.63 Aligned_cols=193 Identities=16% Similarity=0.151 Sum_probs=156.4
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
+||+|+||+|+ +++.++. +| ++.+.........+.+.+|+.++++++|||||++++++. ++.++||||||++
T Consensus 43 ~iG~G~fG~Vy-----~~~~~~~-vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~g 115 (307)
T 3omv_A 43 RIGSGSFGTVY-----KGKWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEG 115 (307)
T ss_dssp ECCCCSSSEEE-----EEESSSE-EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSS
T ss_pred EEeeCCCcEEE-----EEEECCc-EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCC
Confidence 48999999995 6666654 56 333333333455778999999999999999999999875 4568999999999
Q ss_pred CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------cc
Q psy16292 91 GDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ET 162 (245)
Q Consensus 91 g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~ 162 (245)
|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~ 195 (307)
T 3omv_A 116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT 195 (307)
T ss_dssp CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CC
T ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccc
Confidence 999999864 3589999999999999999999999999999999999999999999999999986543211 22
Q ss_pred ccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 163 KRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 163 ~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.+.+|++||.+... ++ .++||||+||++|+|++|.+||.+.++......
T Consensus 196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248 (307)
T ss_dssp CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 34558999999754 34 689999999999999999999988765544333
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.39 Aligned_cols=203 Identities=20% Similarity=0.225 Sum_probs=163.4
Q ss_pred HhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
..+||+|+||+|+ +++.+ ++.||++.-. ..+....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 46 ~~~LG~G~fG~Vy-----~a~~~~~~~~~~~~~vAvK~l~-~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 46 KWELGEGAFGKVF-----LAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp EEEEEECSSEEEE-----EEEESSSCC---CEEEEEEEES-CCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred EEEEccCCCcEEE-----EEEECCcccCCCCeEEEEEEEC-cCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4569999999995 55432 7888832211 123345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEE
Q psy16292 83 MVMDYMPGGDLVNLMSNY----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l 146 (245)
+|||||++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999999999998642 3788999999999999999999999999999999999999999999
Q ss_pred EeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 147 ADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+|||+|+....... .....+|++||.+...++ .++||||+||++|+|+| |.+||.+.++.+.+..+..+..+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~ 279 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987643322 112344899999998888 78999999999999998 89999998887777777766443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=295.89 Aligned_cols=190 Identities=18% Similarity=0.239 Sum_probs=148.1
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+|.+.|+ ||+|+||+| ++|+++ |+.||++.-.....+...+++.+|+.+|++++|||||+++++|.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V-----~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVV-----FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHHHHEEEEEEEEECC--EE-----EEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred CcchhCEEeeEEecCCCeEE-----EEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 5666554 899999999 577766 99999322111122334577999999999999999999999997544
Q ss_pred ------------EEEEEEeccCCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 80 ------------SLYMVMDYMPGGDLVNLMSNYD----VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 80 ------------~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
++|+|||||++|+|.+++.... .++..+..++.||+.||.|||++||+||||||+||+++.+|.
T Consensus 77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc
Confidence 4799999999999999998653 445678899999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCCc----------------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 144 LKLADFGTCMRMNKTGTE----------------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~~----------------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+||+|||+|+.+...... ..+..|++||.+.+.++ .++||||+||++|+|++ ||.+.
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 999999999876543221 13444899999998888 78999999999999985 67554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=320.98 Aligned_cols=197 Identities=24% Similarity=0.372 Sum_probs=166.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHH---HHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEER---DIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~---~il~~l~hp~Iv~l~~~~~ 76 (245)
+++|.-.-.||+|+||+| ++|+++ |+.|| +++|...........+.+|. .+++.++|||||+++++|+
T Consensus 188 lddf~i~k~LG~G~fG~V-----~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEV-----YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred hHHeEEEEEEecccCeEE-----EEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 344444445899999999 588777 99999 66776666666666667765 4555668999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+.+++|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999999875 46999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCccccCC---CCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 156 NKTGTETKRLG---RNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 156 ~~~~~~~~~~~---~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.... ..+.+| |.+||.+.. .+| .++|+||+||++|+|++|.+||.+.+..
T Consensus 343 ~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 343 SKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp SSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred CCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 6443 233444 789999964 556 7889999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.81 Aligned_cols=188 Identities=59% Similarity=0.934 Sum_probs=165.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++.........+.+.+|+.+++.++||||++++++|.+..++|+||||
T Consensus 76 ~LG~G~fG~V-----~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 76 VIGRGAFGEV-----QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEECSSEEE-----EEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEcCCCEEE-----EEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3899999999 477776 88999 56666666667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----cc
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~~ 162 (245)
+++|+|.+++....+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+|+....... ..
T Consensus 151 ~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~ 230 (410)
T 3v8s_A 151 MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230 (410)
T ss_dssp CTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCc
Confidence 9999999999988899999999999999999999999999999999999999999999999999987654432 22
Q ss_pred ccCCCCchhhhhcCC----C-cccCCCcccccceecCCccCCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHP----F-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~----~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
...+|.+||.+...+ + .++|+||+||++|+|++|.+||.+.+
T Consensus 231 gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp SCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 344478999998665 4 67899999999999999999996543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=305.49 Aligned_cols=198 Identities=18% Similarity=0.206 Sum_probs=162.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe------CCEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD------AKSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~~~~ 82 (245)
.||+|+||+| ++|+++ |+.|| ++.+.........+++.+|+.+|+.++|||||++++++.. .+++|
T Consensus 61 ~lG~G~fG~V-----~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 61 TIGNGAYGVV-----SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEECSSCEE-----EEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred EEecccCeEE-----EEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 4899999999 577776 99999 3333333334456789999999999999999999999864 36899
Q ss_pred EEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC--
Q psy16292 83 MVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-- 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-- 159 (245)
+||||| +|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+|+.+....
T Consensus 136 ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~ 214 (398)
T 4b99_A 136 VVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214 (398)
T ss_dssp EEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC------
T ss_pred EEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc
Confidence 999999 5789998865 469999999999999999999999999999999999999999999999999998764321
Q ss_pred ---Cccc---cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 160 ---TETK---RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ---~~~~---~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
...+ +..|++||.+.+..+ .++|+||+||++|+|++|.+||.|.++...+..|...
T Consensus 215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 1223 334789999887654 6789999999999999999999998877766665443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=312.99 Aligned_cols=201 Identities=22% Similarity=0.355 Sum_probs=174.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||.| ++|+++ |+.|| ++++.. ..+.+.+.+|+.+|+.++||||++++++|.+..++|+||||
T Consensus 164 ~lG~G~fg~V-----~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 164 ELGTGAFGVV-----HRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp EEEEETTEEE-----EEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeccCeEE-----EEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4789999999 477776 99999 333322 23467789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC--CcEEEEeeCceeecCCCCCccc
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH--GHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~--~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
|+||+|.+++.. +.+++..+..++.||+.||.|||+++|+||||||+||+++.+ +.+||+|||+|+.+........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998853 358999999999999999999999999999999999999864 8899999999999876655555
Q ss_pred cCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 164 RLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 164 ~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
.+| |++||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+.++.......+
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~ 376 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 555 689999999888 788999999999999999999999998888888777655433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.33 Aligned_cols=195 Identities=18% Similarity=0.183 Sum_probs=158.3
Q ss_pred hhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCC-ccceeeeEEEEeC-CEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDA-KSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~-~~~~ 82 (245)
+||+|+||+|+ +|+.+ ++.+|+..........+.+.+.+|+.+|.+++| ||||+++++|... +.++
T Consensus 71 ~LG~G~fG~Vy-----~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 71 PLGRGAFGQVI-----EADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEECSSEEEE-----EEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred EEecCCCeEEE-----EEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 48999999995 54433 467773322222233456779999999999965 9999999998664 5799
Q ss_pred EEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEE
Q psy16292 83 MVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLK 145 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~ 145 (245)
+|||||++|+|.++++.. .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+|
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEE
Confidence 999999999999998642 278899999999999999999999999999999999999999999
Q ss_pred EEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 146 LADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 146 l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
|+|||+|+.+...... .....|++||.+...++ .++||||+||++|+|+| |.+||.+......+.+
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999976544321 12345899999998888 78999999999999998 8999998765544433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.22 Aligned_cols=183 Identities=20% Similarity=0.275 Sum_probs=152.3
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+||+|+||+|+ +|+++ ++.||++.. .......++.+|+++|+.+ +||||++++++|.+.+++|+||
T Consensus 28 ~lG~G~fg~Vy-----~a~~~~~~~~~~~vAiK~i---~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 28 KIGEGTFSSVY-----LATAQLQVGPEEKIALKHL---IPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp EEEECSSEEEE-----EEEEEBTTSCEEEEEEEEE---CTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred EEecccCcEEE-----EEEEcccCCCCCEEEEEEE---ccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 37899999994 66543 677883221 1234566789999999998 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCCCC----
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~~~---- 160 (245)
||+++|+|.++++ .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 100 E~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 100 PYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp ECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred eCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 9999999999985 48999999999999999999999999999999999999877 7999999999986543221
Q ss_pred -------------------------cc---ccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 -------------------------ET---KRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 -------------------------~~---~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.. .+.+|++||.+.+.+ + .++|+||+||++|+|++|.+||.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 11 233478999998765 4 66799999999999999999996554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=283.90 Aligned_cols=185 Identities=18% Similarity=0.164 Sum_probs=150.3
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHH--HHHHHHHhcCCccceeeeEEEEeCC----EEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFW--EERDIMAHANSEWIVQLHFAFQDAK----SLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~--~E~~il~~l~hp~Iv~l~~~~~~~~----~~~lv~ 85 (245)
+||+|+||+|+ +++.+|+.||++.-. ....+.+. .|+..+.+++|||||++++++.+++ .+||||
T Consensus 10 ~iG~G~fG~Vy-----~~~~~g~~VAvK~l~----~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 10 SIGKGRFGEVW-----RGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEECSSSEEE-----EEEETTEEEEEEEEC----GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEeeCCCeEEE-----EEEECCEEEEEEEEC----ccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 58999999995 667779999942211 12223333 4555556789999999999998654 689999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL--------GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
|||++|+|.++++...+++.....++.|++.||.|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999999998999999999999999999999987 899999999999999999999999999987654
Q ss_pred CCCc--------cccCCCCchhhhhcCC------C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 158 TGTE--------TKRLGRNGIEEIKAHP------F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 158 ~~~~--------~~~~~~~~~e~i~~~~------~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.... ..+.+|++||.+.+.. + .++||||+||++|+|++|.+|+....+
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 3321 1234478999987653 2 468999999999999999998866544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=288.84 Aligned_cols=193 Identities=30% Similarity=0.492 Sum_probs=162.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK 79 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 79 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| ++++.........+.+.+|..++.++ +||||++++++|.+..
T Consensus 52 ~~y~~~~~LG~G~fG~V-----~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKV-----LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp GGEEEEEEEEECSSEEE-----EEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred hHcEEEEEEeeCCCeEE-----EEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 34444446899999999 477766 89999 56666555566778899999999887 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC-
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK- 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~- 157 (245)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||+|+....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999998865 5699999999999999999999999999999999999999999999999999986332
Q ss_pred CCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 158 TGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 158 ~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
...... ..+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 222233 344789999988877 788999999999999999999964
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=278.06 Aligned_cols=210 Identities=26% Similarity=0.377 Sum_probs=177.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+++|.-.-.+|+|+||+| ++|+++ |+.|| ++++...........+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V-----~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKV-----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEE-----EEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 445555556899999999 477666 89999 556655556677889999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999999998864 46899999999999999999999999999999999999999999999999999864332
Q ss_pred C-Cc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 G-TE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~-~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. .. ....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+..+...
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 223 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2 22 23445789999988777 7889999999999999999999988766666666555443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=274.09 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=179.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+++|.-.-.+++|+||+|+ +|+.+ |+.|| ++++.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVH-----LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEE-----EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEE-----EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 4445555568999999994 67666 89999 556655555677888999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++|+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999999998754 5899999999999999999999999999999999999999999999999999876533
Q ss_pred C-CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 159 G-TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 159 ~-~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
. .......|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 222 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 222 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 2 2233455889999988777 77899999999999999999999887776666666655443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=281.59 Aligned_cols=207 Identities=28% Similarity=0.409 Sum_probs=175.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.-.||+|+||+| ++|+++ |+.|| ++++.........+.+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 28 ~~~lG~G~fg~V-----~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 28 IRVLGKGSFGKV-----MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp EEEEEEETTEEE-----EEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEeeCCCEEE-----EEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 345899999999 477666 89999 56666556667888999999999998 799999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Ccc
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TET 162 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~~ 162 (245)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+|+...... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 182 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcccc
Confidence 999999999998865 569999999999999999999999999999999999999999999999999998643222 222
Q ss_pred ---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 163 ---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 163 ---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
...+|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+.++..+....|.
T Consensus 183 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 245 (353)
T 3txo_A 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245 (353)
T ss_dssp ---CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred ccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 3344789999987776 7889999999999999999999999888777777776655443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=290.15 Aligned_cols=198 Identities=35% Similarity=0.655 Sum_probs=170.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++...........+.+|+.++..++||||++++++|.+.+.+|+||||
T Consensus 81 ~LG~G~fG~V-----~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 81 VIGRGAFGEV-----AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEECSSEEE-----EEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeCCCEEE-----EEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4899999999 477766 89999 55565555666777799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+........
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 235 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCS
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccccc
Confidence 999999999976 46999999999999999999999999999999999999999999999999999876544332
Q ss_pred -cccCCCCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 -TKRLGRNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 -~~~~~~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
....+|.+||.+. ...+ .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 2334478999987 2334 678999999999999999999998887776666654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.17 Aligned_cols=205 Identities=21% Similarity=0.267 Sum_probs=172.2
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.+++|+||.|+ +|+++ |+.|| ++.+....+....+++.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 21 ~~lG~G~~g~V~-----~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 21 KTIGKGNFAKVK-----LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp EEEEECSSEEEE-----EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeCCCEEEE-----EEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 347899999994 77765 88999 32222223445677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCC
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~ 166 (245)
+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++............|
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~g 175 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSS
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccC
Confidence 999999998854 5699999999999999999999999999999999999999999999999999987665544444344
Q ss_pred ---CCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 167 ---RNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 167 ---~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
|.+||.+.+..+ .++|+||+||++++|++|.+||.+.+......++..+..+.|
T Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234 (328)
T ss_dssp SGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 789999988876 478999999999999999999998877666666666554433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.80 Aligned_cols=206 Identities=25% Similarity=0.427 Sum_probs=177.1
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||+| ++|+++ |+.|| ++++.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 46 ~~~lG~G~~g~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 46 IKTLGTGSFGRV-----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp EEEEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEeecCcCcEE-----EEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 345889999999 477766 88999 555665556677889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cccc
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~~~ 163 (245)
||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++...... ....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~g 200 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 200 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEE
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcccccC
Confidence 99999999998875 568999999999999999999999999999999999999999999999999999765432 2234
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
..+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+..+.|
T Consensus 201 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 258 (350)
T 1rdq_E 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258 (350)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 455889999988776 788999999999999999999998887777777766654433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.19 Aligned_cols=209 Identities=26% Similarity=0.448 Sum_probs=175.9
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 80 (245)
+|.-.-.+|+|+||+| ++|+++ |+.|| ++++.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 18 ~y~~~~~lG~G~fg~V-----~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKV-----FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp TEEEEEEEEECSSSEE-----EEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred HeEEEEEEeeCCCeEE-----EEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3333445899999999 477766 89999 55665555667788899999999987 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999999998875 569999999999999999999999999999999999999999999999999998643222
Q ss_pred -Ccc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 160 -TET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 160 -~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
... ...+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+.+..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 222 2344789999988777 78899999999999999999999887766666665554443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=275.67 Aligned_cols=205 Identities=28% Similarity=0.431 Sum_probs=174.8
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.-.+|+|+||+| ++|+++ |+.|| ++++.........+.+.+|..++..+ +||||+++++++.+.+.+|+|
T Consensus 25 ~~~lG~G~fg~V-----~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 25 LMVLGKGSFGKV-----MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp EEEEEEETTEEE-----EEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEeeCCCEEE-----EEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 345899999999 477776 88899 56666555667788999999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCcc
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTET 162 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~ 162 (245)
|||++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+|+..... ....
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 179 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccc
Confidence 999999999998875 56999999999999999999999999999999999999999999999999999864322 2222
Q ss_pred ---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 163 ---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 163 ---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
...+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++.......
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 240 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240 (353)
T ss_dssp CCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 2344789999988777 77899999999999999999999887777676666654443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.33 Aligned_cols=198 Identities=37% Similarity=0.686 Sum_probs=170.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|+|+||+| ++|+++ |+.|| ++++.........+.+.+|+.++..++||||+++++++.+.+++|+||||
T Consensus 68 ~lG~G~fG~V-----~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 68 VIGRGAFSEV-----AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeCCCeEE-----EEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 4889999999 577766 99999 55565555566777899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.+|.+||+|||+|+........
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 222 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSS
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccce
Confidence 999999999875 36999999999999999999999999999999999999999999999999999887544331
Q ss_pred -cccCCCCchhhhhc-------CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 162 -TKRLGRNGIEEIKA-------HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 162 -~~~~~~~~~e~i~~-------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
....+|.+||.+.. ..+ .++|+||+||++|+|++|.+||.+.+....+.++..
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 23344789999873 334 678999999999999999999998887776666654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=272.31 Aligned_cols=198 Identities=25% Similarity=0.418 Sum_probs=169.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+++|.-.-.+|+|+||+|+ +|+++ |+.|| ++++.........+.+.+|+.+++.++||||++++++|.+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~-----~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVC-----IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEE-----EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEE-----EEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3444444568999999994 67666 88899 556666566778889999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999999998765 5899999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCC---CCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 159 GTETKRLG---RNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 159 ~~~~~~~~---~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.......| |.+||.+... .+ .++|+||+||++|+|++|.+||.+....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 44444444 7889988643 34 6889999999999999999999865443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=271.14 Aligned_cols=212 Identities=22% Similarity=0.278 Sum_probs=173.8
Q ss_pred chHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE
Q psy16292 3 NVEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF 75 (245)
Q Consensus 3 ~~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 75 (245)
....|.++|+ +++|+||.|+ +|.++ |+.|| ++.+.........+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVR-----RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcccCeEEeeEEecCCCeEEE-----EEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456777776 7888999994 66555 88888 33222222344567899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEEeeCc
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGT 151 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~ 151 (245)
.+.+..|+||||+++|+|.+.+... .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999999999999988654 589999999999999999999999999999999999998654 599999999
Q ss_pred eeecCCCCCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 152 CMRMNKTGTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 152 a~~~~~~~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
++........ ....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+..+....
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9877644433 23445889999988777 78899999999999999999999887766666666554443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=278.07 Aligned_cols=213 Identities=21% Similarity=0.283 Sum_probs=174.1
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
..+|.++|+ +|+|+||+|+ +|.++ |+.+| ++.+.......+.+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~-----~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVR-----RCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEE-----EEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cccccCCeEEEEEeccCCCeEEE-----EEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 457888887 7889999994 66555 89999 322222223345677999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a 152 (245)
+.+..|+||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999999998765 45899999999999999999999999999999999999984 578999999999
Q ss_pred eecCCCCCc----cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 153 MRMNKTGTE----TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 153 ~~~~~~~~~----~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
+........ ....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+..+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 876544322 23445789999988777 7889999999999999999999998877777777666555443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.33 Aligned_cols=195 Identities=29% Similarity=0.485 Sum_probs=165.5
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
+++|.-.-.+++|+||+| ++|+++ |+.|| ++++.........+.+.+|+.+++++ +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V-----~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKV-----LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEE-----EEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEE-----EEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 445555556899999999 477766 89999 55555444455677899999999988 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
..+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999999998865 5699999999999999999999999999999999999999999999999999986432
Q ss_pred C-CCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 158 T-GTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 158 ~-~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
. .... ....|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 2 2222 2344789999988777 7889999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.00 Aligned_cols=209 Identities=27% Similarity=0.477 Sum_probs=164.3
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHH-HHhcCCccceeeeEEEEeCC
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDI-MAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~ 79 (245)
++|.-.-.||+|+||+| ++|+++ ++.|| ++++...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 38 ~~y~~~~~lG~G~fg~V-----~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKV-----LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEE-----EEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEE-----EEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 44444456899999999 477766 88899 5556555555667778888887 46789999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||+++.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999998875 46899999999999999999999999999999999999999999999999999864322
Q ss_pred -CCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 -GTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 -~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
... .....|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++......
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 257 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC
Confidence 222 23445789999988877 7889999999999999999999988877777776665443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.28 Aligned_cols=210 Identities=19% Similarity=0.227 Sum_probs=175.8
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+|.-.-.+|+|+||+|+ +|+++ |+.|| ++.+..........++.+|+.+++.++||||+++++++.+...+
T Consensus 10 ~Y~i~~~lG~G~~g~V~-----~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVK-----LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp TEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CEEEEEEEecCCCeEEE-----EEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 33334458999999994 67665 88888 55555555556677899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++||||+ +|+|.+.+. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999999 788888765 45699999999999999999999999999999999999999999999999999987654433
Q ss_pred cc---ccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 161 ET---KRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 161 ~~---~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
.. ...+|.+||.+.+..+ .++|+||+||++|++++|.+||.+......+.++.......|.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 229 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD 229 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCT
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcc
Confidence 33 3345789999887776 5789999999999999999999998888888877766555443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.48 Aligned_cols=201 Identities=16% Similarity=0.268 Sum_probs=168.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
+|+|+||+|+ +|+++ |+.|| ++++...... ...+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 20 LG~G~fg~V~-----~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 20 LGSGQFAIVK-----KCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEETTEEEE-----EEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeCcCEEEE-----EEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 7889999994 66666 88899 4444332211 24578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~Dfg~a~~~~~~~~ 160 (245)
||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~ 174 (361)
T 2yab_A 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174 (361)
T ss_dssp ECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc
Confidence 999999999998754 589999999999999999999999999999999999998877 799999999998765443
Q ss_pred ccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
... ..+|.+||.+...++ .++|+||+||++|+|++|.+||.+.++...+.++......
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (361)
T 2yab_A 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236 (361)
T ss_dssp CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 333 334789999988777 7889999999999999999999998877777666655443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=278.21 Aligned_cols=190 Identities=28% Similarity=0.465 Sum_probs=166.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++...........+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 191 ~LG~G~fG~V-----y~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 191 VLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEETTEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeCCCEEE-----EEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 4899999999 477666 99999 55665555667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcccc
Q psy16292 88 MPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164 (245)
Q Consensus 88 ~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~ 164 (245)
++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||+++...........
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 345 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECC
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccccc
Confidence 9999999988753 3899999999999999999999999999999999999999999999999999987655443333
Q ss_pred CC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 165 LG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 165 ~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.| |.+||.+.+.++ .++|+||+||++|+|++|.+||.+....
T Consensus 346 ~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp CSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred CCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 44 789999988776 7889999999999999999999887543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=286.90 Aligned_cols=205 Identities=29% Similarity=0.448 Sum_probs=178.1
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
..||+|+||+| ++|+++ |+.|| ++++.........+.+.+|..++..+ +||+|+++++++++.+.+|+||
T Consensus 347 ~~LG~G~fG~V-----~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 347 MVLGKGSFGKV-----MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp EESSBTTTBCE-----EEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred EEEccCCCEEE-----EEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 35999999999 577776 88899 56666566677888999999999988 7999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-Cc--
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-TE-- 161 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-~~-- 161 (245)
||+++|+|.+++.. +.+++..+..++.||+.||.|||+++|+||||||+||+++.+|.++|+|||+|+...... ..
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~ 501 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCC
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccccc
Confidence 99999999998875 569999999999999999999999999999999999999999999999999998743322 22
Q ss_pred -cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 162 -TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
....+|.+||.+...++ .++|+||+||++|+|++|.+||.+.+....+.++.......|
T Consensus 502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p 562 (674)
T 3pfq_A 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562 (674)
T ss_dssp CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC
T ss_pred ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 23445899999988887 788999999999999999999999988888888777665544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=257.27 Aligned_cols=194 Identities=20% Similarity=0.265 Sum_probs=164.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
++++|+||+|+ +|+++ |+.||+.... .......+.+.+|+.+++.++||||+++++++..++.+++||||++
T Consensus 27 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 27 KIGQGASGTVY-----TAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp EEEEETTEEEE-----EEEBTTTCCEEEEEEEE-GGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccCCCeEEE-----EEEECCCCcEEEEEEee-cccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 38899999995 66554 8888832211 1234556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----cccC
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----TKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----~~~~ 165 (245)
+++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... ....
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 180 (297)
T 3fxz_A 101 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180 (297)
T ss_dssp TCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCG
T ss_pred CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCc
Confidence 999999999888999999999999999999999999999999999999999999999999999876544322 2233
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
+|.+||.+.+.++ .++|+||+|+++|++++|.+||.+..+......
T Consensus 181 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp GGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4789999988877 788999999999999999999988765444333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=274.32 Aligned_cols=189 Identities=26% Similarity=0.388 Sum_probs=166.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++....+......+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 192 ~LG~G~fG~V-----y~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 192 VLGRGGFGEV-----FACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEECSSSEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeCCCeEE-----EEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 3899999999 477766 99999 56666666667788899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 88 MPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||+++.+......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~ 346 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence 9999999988643 4899999999999999999999999999999999999999999999999999987544332
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+..+
T Consensus 347 ~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 23445889999988777 788999999999999999999988754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.60 Aligned_cols=202 Identities=21% Similarity=0.220 Sum_probs=172.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|+|+||+|+ +|+++ |+.|| ++++...........+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 23 ~LG~G~fg~V~-----~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 23 TLGVGTFGKVK-----VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEECCSSSCEE-----EEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeCCCeEEE-----EEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 47899999994 66665 88999 45555444455678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc---c
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET---K 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~---~ 163 (245)
+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......... .
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~g 177 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG 177 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCS
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCC
Confidence 9999999998754 58999999999999999999999999999999999999999999999999999876543333 3
Q ss_pred cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+....+.++..+...
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 234 (476)
T 2y94_A 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234 (476)
T ss_dssp CSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC
T ss_pred CcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC
Confidence 444789999988776 5789999999999999999999988776666666665444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=273.00 Aligned_cols=210 Identities=21% Similarity=0.286 Sum_probs=177.2
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
..|.++|+ +++|+||+|+ +|+++ |+.|| ++.+.........+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVI-----LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcccCceEEeeEEecCCCEEEE-----EEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34677886 7889999994 66666 88899 444554444567888999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a 152 (245)
+.+.+++|||++.+++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999999998765 468999999999999999999999999999999999999 45788999999999
Q ss_pred eecCCCCCccc---cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 153 MRMNKTGTETK---RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 153 ~~~~~~~~~~~---~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
+.......... ..+|.+||.+.+....++|+||+||++|++++|.+||.+.++...+.++..+..+.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 87765544333 34478999988754478999999999999999999999988877777776665443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.80 Aligned_cols=204 Identities=15% Similarity=0.279 Sum_probs=167.9
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcCCccceeeeEE
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHANSEWIVQLHFA 74 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~ 74 (245)
++.++|+ +++|+||.|+ +|+++ |+.|| ++++...... ...+.+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVK-----KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEE-----EEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccceEeceEEeeCCCeEEE-----EEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4555565 7889999994 66665 88888 3333322111 246789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEEEee
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADF 149 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~Df 149 (245)
+.+...+++||||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+||
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999999998754 589999999999999999999999999999999999998887 7999999
Q ss_pred CceeecCCCCCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 150 GTCMRMNKTGTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 150 g~a~~~~~~~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
|+++........ ....+|.+||.+...++ .++|+||+||++|++++|.+||.+......+..+..
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 999987544332 23445789999987776 788999999999999999999988776555544433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.01 Aligned_cols=199 Identities=18% Similarity=0.290 Sum_probs=167.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+|+|+||+|+ +|+++ |+.+| +..+ ....+...+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 12 ~lG~G~~g~Vy-----~~~~~~~~~~~a~K~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 12 DLGRGEFGIVH-----RCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEEC---CCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEecCCCeEEE-----EEEECCCCcEEEEEEEe---cCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 37889999995 66555 88888 3222 12334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC--CCcEEEEeeCceeecCCCCCccc-
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK--HGHLKLADFGTCMRMNKTGTETK- 163 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~--~~~i~l~Dfg~a~~~~~~~~~~~- 163 (245)
++++|.+.+... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||+++..........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 999999999764 4899999999999999999999999999999999999987 78999999999998765443332
Q ss_pred --cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 --RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 --~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...+.+||.+.+.++ .++|+||+|+++|+|++|.+||.+.++...+.++..+..+
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 221 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence 334789999887765 7889999999999999999999988877766666665544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.05 Aligned_cols=211 Identities=21% Similarity=0.284 Sum_probs=173.8
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
.++|.++|+ ||+|+||+|+ +|+++ |+.|| ++.+...........+.+|+.++++++||||+++++++.
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVL-----KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEE-----EEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhcceEEeEEEeecCCEEEE-----EEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 467888886 7888999994 66665 88899 333333344566788999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec---CCCcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD---KHGHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~---~~~~i~l~Dfg~a 152 (245)
+...+|+||||+++++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999999998775 45689999999999999999999999999999999999995 4567999999999
Q ss_pred eecCCCCCccc---cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 153 MRMNKTGTETK---RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 153 ~~~~~~~~~~~---~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
+.......... ..+|.+||.+.+....++|+||+||++|++++|.+||.+.++...+.++..+..+.
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 86654433333 34478899887754478899999999999999999999988777777766665443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=257.90 Aligned_cols=192 Identities=20% Similarity=0.203 Sum_probs=159.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ +++++ |+.+| ++.+.........+++.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 18 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 18 KLGGGGMSTVY-----LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEETTEEEE-----EEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEccCCCEEEE-----EEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 47889999994 66655 88888 33332223334567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 93 ~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 172 (294)
T 4eqm_A 93 IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV 172 (294)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCcc
Confidence 9999999988754 589999999999999999999999999999999999999999999999999986543321 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
....++.+||.+.+.++ .++|+||+|+++|++++|.+||.+.+....
T Consensus 173 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp --CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred ccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 23455899999988777 678999999999999999999988765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=256.23 Aligned_cols=193 Identities=23% Similarity=0.288 Sum_probs=160.3
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc--cCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK--RSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
|.++|+ +++|+||+|+ +|+++ |+.|| ++++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVR-----RCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEE-----EEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 556666 7788999994 66655 88999 344333222 225678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEEe
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLAD 148 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~D 148 (245)
+.+.+|+||||+++++|.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 99999999999999999887643 23899999999999999999999999999999999999987654 99999
Q ss_pred eCceeecCCCCC-c---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 149 FGTCMRMNKTGT-E---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 149 fg~a~~~~~~~~-~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
||+++....... . .....|.+||.+...++ .++|+||+||++|+|++|.+||.+..
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 999988765432 1 23344789999988777 78899999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.56 Aligned_cols=204 Identities=26% Similarity=0.382 Sum_probs=160.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.||+|+||.|+ +|+++ |+.|| ++++...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 154 ~~lG~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 154 KLLGKGTFGKVI-----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEETTEEEE-----EEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred EEEeeCcCEEEE-----EEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 358899999994 66665 88999 5555544555667788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cc-
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ET- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~- 162 (245)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+|+....... ..
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 308 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccccc
Confidence 9999999998864 468999999999999999999998 9999999999999999999999999999986433221 22
Q ss_pred --ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 163 --KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 163 --~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
...+|.+||.+.+.++ .++|+||+||++++|++|.+||.+.+....+..+.....+.
T Consensus 309 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 368 (446)
T 4ejn_A 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368 (446)
T ss_dssp SSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 2344789999988777 78899999999999999999999887766666665554443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=253.41 Aligned_cols=197 Identities=20% Similarity=0.254 Sum_probs=161.4
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
++|+|+||+|+ +|+++ |+.|| ++.+...........+.+|+.++++++||||+++++++.++..+++||||++
T Consensus 28 ~lG~G~~g~V~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 28 KVGEGTYGVVY-----KAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEECSSCEEE-----EEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hccCCCCeEEE-----EEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 37889999995 56665 88888 3333333334456788999999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccc
Q psy16292 90 GGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETK 163 (245)
Q Consensus 90 ~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~ 163 (245)
++|.+.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ...
T Consensus 103 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 181 (311)
T 3niz_A 103 -KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181 (311)
T ss_dssp -EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCC
T ss_pred -CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcc
Confidence 5888877654 489999999999999999999999999999999999999999999999999987653322 123
Q ss_pred cCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 164 RLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 164 ~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
...+.+||.+.+. .+ .++|+||+||+++++++|.+||.+..+.....++..
T Consensus 182 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred cCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4457899998763 34 778999999999999999999999888777666544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=271.00 Aligned_cols=210 Identities=21% Similarity=0.293 Sum_probs=168.6
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
+++.++|+ ||+|+||+|+ +|+++ +..+| ++++. .........+.+|+.+++.++||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVL-----LCRDKVTHVERAIKIIRKT-SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEE-----EEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CchhcCeEEeeEEecCCCEEEE-----EEEECCCCcEEEEEEEecc-ccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 44666776 7889999994 67666 88888 33333 233455778999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a 152 (245)
+...+|+||||+++|+|.+.+. ...+++..+..++.|++.||.|||++||+||||||+||+++.. +.++|+|||++
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999999988775 4568999999999999999999999999999999999999764 45999999999
Q ss_pred eecCCCCCcc---ccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 153 MRMNKTGTET---KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 153 ~~~~~~~~~~---~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
+......... ...+|.+||.+......++|+||+||++|++++|.+||.+.++...+.++..+..+.+
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 8776443333 3344789998876544789999999999999999999999888777777766655433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=262.70 Aligned_cols=208 Identities=18% Similarity=0.179 Sum_probs=167.4
Q ss_pred hHHHHHHhhhccc--cccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQ--KYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~--~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
.++|.-.-.+++| +||+| ++|+++ |+.|| ++.+.........+.+.+|+.+++.++||||+++++++.++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V-----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTV-----NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEE-----EEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEE-----EEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 3444444468999 99999 477766 88899 33333333345567889999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+.+|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999999875 45899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCC--------c---cccCCCCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 156 NKTGT--------E---TKRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 156 ~~~~~--------~---~~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
..... . .....|.+||.+.+ ..+ .++|+||+||++++|++|.+||.+........++..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 32211 1 12233789999877 344 78899999999999999999999887776665555443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.52 Aligned_cols=204 Identities=21% Similarity=0.283 Sum_probs=152.7
Q ss_pred CcchHHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 1 MKNVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 1 ~~~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
|-..++|...-.+++|+||+|+ +|+++ |+.||++.-.........+.+.+|+.++++++||||+++++++.++
T Consensus 1 ms~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 1 MSSSSQFKQLEKLGNGTYATVY-----KGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ------------------CEEE-----EEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred CCcccceeEeeEECCCCCEEEE-----EEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 4556788888889999999994 66665 8888822211112344567889999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCc
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGT 151 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~ 151 (245)
+.+++||||++ ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999999996 699988753 2488999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCC----ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 152 CMRMNKTGT----ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 152 a~~~~~~~~----~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
++....... ......|.+||.+.+. ++ .++|+||+||++++|++|.+||.+.++.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 219 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 987653322 2234458899998764 34 78899999999999999999998876544433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=258.86 Aligned_cols=200 Identities=16% Similarity=0.182 Sum_probs=162.9
Q ss_pred hhccccccchhhhHHHHHhh--------c-CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY--------R-YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~--------~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
.||+|+||+|+ +|+. . +..||++.-.........+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 88 ~LG~G~fg~Vy-----~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 88 PLGEGCFGQVV-----MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EESCCSSSEEE-----EEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred EEeeCCCeeEE-----EEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 48899999995 4432 1 5567732221222334567899999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
|+||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCE
Confidence 9999999999999998753 36888999999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 145 KLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+|+|||+++........ ....+|.+||.+.+..+ .++|+||+||++|+|++ |.+||.+......+..+..+.
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 322 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999976543221 11234889999988777 78899999999999998 999999877666665555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=261.68 Aligned_cols=212 Identities=26% Similarity=0.407 Sum_probs=158.6
Q ss_pred HHHHhhhccccccchhhhHHHHHhhcCeEEE--EEehhhh-hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQ-IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-.-.+++|+||+|+.+........|+.|| ++++... ........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 3333458899999995222111112388899 4444322 223456678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 178 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178 (327)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------
T ss_pred EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccc
Confidence 9999999999998874 4589999999999999999999999999999999999999999999999999986433222
Q ss_pred --ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
......|.+||.+.+..+ .++|+||+|+++|+|++|.+||.+.+....+.++......
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 239 (327)
T 3a62_A 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239 (327)
T ss_dssp CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 223455889999987776 7789999999999999999999988776666666555443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=254.49 Aligned_cols=197 Identities=18% Similarity=0.183 Sum_probs=158.9
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-.+++|+||+|+ +|+..|+.+| ++.+.........+.+.+|+.++++++||||+++++++.+...+++||||++
T Consensus 43 ~~lG~G~~g~V~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 43 EKIGAGSFGTVH-----RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEECSSEEEE-----EEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred eEeecCCCeEEE-----EEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 358999999995 6666788888 3333222233456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----
Q psy16292 90 GGDLVNLMSNYD----VPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 90 ~g~L~~~l~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---- 159 (245)
+++|.+++.... +++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 197 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence 999999998654 899999999999999999999999 9999999999999999999999999997644332
Q ss_pred CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 160 TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
......+|.+||.+.+.++ .++|+||+|+++|++++|.+||.+.++......+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1233455899999988777 7889999999999999999999887665544433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=256.87 Aligned_cols=202 Identities=20% Similarity=0.259 Sum_probs=156.3
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEe
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQD 77 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 77 (245)
.+.++|+ +|+|+||.|+ +|.++ |+.|| ++.+..........++.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVW-----KSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHTTEEEEEC-------CEE-----EEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCceEEEEEeeeCCCeEEE-----EEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 3445665 7889999994 66555 88899 322222333456778899999999996 9999999999986
Q ss_pred CC--EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 78 AK--SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 78 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.+ .+|+||||+. ++|.+++....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+|+..
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CCCCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 54 7999999995 79999998888999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCC----------------------c---cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 156 NKTGT----------------------E---TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 156 ~~~~~----------------------~---~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
..... . .....|.+||.+.+ ..+ .++|+||+||++++|++|.+||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 43110 1 12333789999876 444 678999999999999999999998876655
Q ss_pred CcccC
Q psy16292 209 FDDIE 213 (245)
Q Consensus 209 ~~~~~ 213 (245)
+..+.
T Consensus 240 ~~~i~ 244 (388)
T 3oz6_A 240 LERII 244 (388)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=250.83 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=166.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
++++|+||.|+ +|+.+ |+.||++.- ........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 52 ~lg~G~~g~V~-----~a~~~~~g~~vavK~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 52 KIGEGSTGIVC-----LAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEE-ETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EeccCCCeEEE-----EEEECCCCcEEEEEEE-eccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 48999999994 66655 888883221 11234556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccccC
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~~~ 165 (245)
+++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .....
T Consensus 126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 205 (321)
T 2c30_A 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205 (321)
T ss_dssp SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCG
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCc
Confidence 99999999888899999999999999999999999999999999999999999999999999987654322 12334
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
+|.+||.+...++ .++|+||+|++++++++|.+||.+.........+...
T Consensus 206 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 256 (321)
T 2c30_A 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256 (321)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 4789999987766 7789999999999999999999877655444444333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=255.69 Aligned_cols=199 Identities=19% Similarity=0.182 Sum_probs=162.3
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+|+ +++.+ +..||+............+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 56 ~lG~G~~g~V~-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 56 IIGSGDSGEVC-----YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEETTTEEEE-----EEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred EEEeCCCcEEE-----EEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 48899999995 55543 555773222222233456779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
|+++++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.........
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEE
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceee
Confidence 99999999998643 58999999999999999999999999999999999999999999999999998765432211
Q ss_pred -----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 163 -----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 -----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
...+|.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 211 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 1224889999987776 67899999999999998 99999888776666655554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.94 Aligned_cols=189 Identities=16% Similarity=0.175 Sum_probs=156.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC--EEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK--SLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lv~e~ 87 (245)
.+++|+||+|+ +|+.+ |+.||++.-.........+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 16 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 16 ILGQGATANVF-----RGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EecCCCCeEEE-----EEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 37889999995 66666 88888322112222455778899999999999999999999998765 88999999
Q ss_pred cCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe----cCCCcEEEEeeCceeecCCCC
Q psy16292 88 MPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 88 ~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~----~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||++ +..+.++|+|||+++......
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~ 170 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence 9999999998753 28999999999999999999999999999999999998 777889999999999876554
Q ss_pred Cccc---cCCCCchhhhh--------cCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 160 TETK---RLGRNGIEEIK--------AHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 160 ~~~~---~~~~~~~e~i~--------~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.... ..++.+||.+. ..++ .++|+||+||+++++++|.+||.+...
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 4333 33478899886 2344 788999999999999999999976544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=247.13 Aligned_cols=200 Identities=18% Similarity=0.241 Sum_probs=158.9
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
++.++|+ +++|+||+|+ +|+.+ |+.+|+............+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVH-----LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEE-----EEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ChhhheeecceeccCCCeEEE-----EEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 4555554 7889999994 66665 77788322222223456788999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCc
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGT 151 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~ 151 (245)
..++||||+++++|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 99999999999999998742 458999999999999999999999999999999999999 4457899999999
Q ss_pred eeecCCCCCccc---cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCc
Q psy16292 152 CMRMNKTGTETK---RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFD 210 (245)
Q Consensus 152 a~~~~~~~~~~~---~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~ 210 (245)
++.......... ...+.+||.+......++|+||+|++++++++|.+||.+........
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 987654433322 33478899887665588999999999999999999998776544433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=257.56 Aligned_cols=193 Identities=18% Similarity=0.225 Sum_probs=153.1
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+|+|+||+|+ +++++ |+.|| ++.+ .....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 25 ~~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 25 VKDIGSGNFGVAR-----LMRDKLTKELVAVKYIER----GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp EEEESSSTTSSEE-----EEEETTTCCEEEEEEEES----STTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEeccCCCEEEE-----EEEECCCCcEEEEEEEec----CccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3458999999994 66666 88888 2322 1234467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc--EEEEeeCceeecCCCCC--
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH--LKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~--i~l~Dfg~a~~~~~~~~-- 160 (245)
||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++.......
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999999998864 56999999999999999999999999999999999999987765 99999999985433322
Q ss_pred -ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 161 -ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....+|.+||.+.+..+ .++|+||+||++|++++|.+||.+..+...+.+
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 229 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK 229 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 233445889999988776 347999999999999999999998877655544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.10 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=164.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc----------cCchHHHHHHHHHHHhcCCccceeeeEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK----------RSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~----------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 77 (245)
+||+|+||+|+ +|+++ ++.+| ++++..... ....+.+.+|+.++++++||||+++++++.+
T Consensus 43 ~lG~G~~g~V~-----~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 43 KLGSGAYGEVL-----LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEC--CEEEE-----EEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred EecccCCeEEE-----EEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 38889999994 66665 88888 444433221 1446789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEEeeCcee
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGTCM 153 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~a~ 153 (245)
...+|+||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 197 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCE
Confidence 9999999999999999987754 5699999999999999999999999999999999999998876 69999999999
Q ss_pred ecCCCCCcc---ccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 154 RMNKTGTET---KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 154 ~~~~~~~~~---~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
......... ....|.+||.+......++|+||+||++|++++|.+||.+.++...+..+..+...
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 198 FFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 876543333 34447899988765447889999999999999999999998877777776665543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=251.13 Aligned_cols=188 Identities=22% Similarity=0.283 Sum_probs=155.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||+|+ +|+++ |+.|| ++.... .....+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 14 ~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 14 TLGEGAYGEVQ-----LAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCCCEEEE-----EEEECCCCcEEEEEEEEccc--ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 48889999994 66655 88888 222221 123346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 9999999988765 589999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....+|.+||.+.+..+ .++|+||+||++++|++|.+||.+..+.
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 223344789999987775 4689999999999999999999877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.35 Aligned_cols=206 Identities=23% Similarity=0.264 Sum_probs=169.9
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
+++.++|+ +++|+||+|+ +++++ +..+| ++.+. .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVK-----IAVQKGTRIRRAAKKIPKY---FVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEE-----EEEeCCCCcEEEEEeehhh---ccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45667776 6788999995 66555 66777 22222 2356788999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a 152 (245)
+....++||||+++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||++ +.++.++|+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999999999999987764 458999999999999999999999999999999999999 77889999999999
Q ss_pred eecCCCCCcc---ccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 153 MRMNKTGTET---KRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 153 ~~~~~~~~~~---~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.......... ...++.+||.+.+....++|+||+|++++++++|.+||.+..+.....++..+..+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred eeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 8766443332 34447889988776558899999999999999999999988776666655555443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.55 Aligned_cols=208 Identities=23% Similarity=0.209 Sum_probs=162.7
Q ss_pred CcchHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeee
Q psy16292 1 MKNVEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH 72 (245)
Q Consensus 1 ~~~~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 72 (245)
|++...|.++|+ +++|+||+|+ +|+++ |+.|| ++++....+.....++.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 78 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVH-----LARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEE-----EEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEE
Confidence 344455556665 7888999994 67654 88888 33333223334456789999999999999999999
Q ss_pred EEEEeCC----EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEE
Q psy16292 73 FAFQDAK----SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 73 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
+++.... ..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~ 158 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEe
Confidence 9987654 45999999999999998864 458999999999999999999999999999999999999999999999
Q ss_pred eeCceeecCCCCC-------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 148 DFGTCMRMNKTGT-------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 148 Dfg~a~~~~~~~~-------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
|||+++....... .....+|.+||.+.+.++ .++|+||+|+++|++++|.+||.+...........
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 9999987644322 123455899999988776 67899999999999999999998876554433333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.55 Aligned_cols=205 Identities=17% Similarity=0.227 Sum_probs=164.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+.+.....+.+ ++.+|+..-.........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (314)
T 2ivs_A 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109 (314)
T ss_dssp EEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecC
Confidence 388899999964333222222 577773222222233456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 90 GGDLVNLMSNY-------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 90 ~g~L~~~l~~~-------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
+++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~ 189 (314)
T 2ivs_A 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189 (314)
T ss_dssp TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEE
T ss_pred CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCE
Confidence 99999998753 27888999999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 145 KLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+|+|||+++........ ....++.+||.+.+.++ .++|+||+|++++++++ |.+||.+......+..+..+.
T Consensus 190 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 269 (314)
T 2ivs_A 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH 269 (314)
T ss_dssp EECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC
Confidence 99999999876543321 11234789999988766 78899999999999999 999999887766665555443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=246.60 Aligned_cols=191 Identities=17% Similarity=0.219 Sum_probs=154.0
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+|.++|+ +++|+||.| ++|+++ |+.||++.-.........+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V-----~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVV-----FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEE-----EEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhhhcCceeeEecCCCCeEE-----EEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 5667776 688999999 467666 88888322111123445678999999999999999999999986543
Q ss_pred ---------------------------------------------------------EEEEEEeccCCCCHHHHHhcCC-
Q psy16292 80 ---------------------------------------------------------SLYMVMDYMPGGDLVNLMSNYD- 101 (245)
Q Consensus 80 ---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~- 101 (245)
++++||||+++++|.+++....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 4899999999999999997643
Q ss_pred ---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----------------cc
Q psy16292 102 ---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----------------ET 162 (245)
Q Consensus 102 ---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----------------~~ 162 (245)
.++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ..
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 45667889999999999999999999999999999999999999999999998754421 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
...++.+||.+.+.++ .++|+||+|++++++++|.+|+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 3344789999988776 78899999999999999887653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=260.94 Aligned_cols=193 Identities=18% Similarity=0.227 Sum_probs=155.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~ 81 (245)
.+|+|+||+|+ +|+++ |+.|| ++.+. .......+++.+|+.+++.++||||+++++++... ..+
T Consensus 69 ~lG~G~~g~V~-----~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 69 PIGSGAQGIVC-----AAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEECSSCEEE-----EEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred EeecCCCeEEE-----EEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 37899999995 66555 88899 33332 23445677899999999999999999999999654 468
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+........
T Consensus 143 ~lv~E~~~-~~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 220 (464)
T 3ttj_A 143 YLVMELMD-ANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220 (464)
T ss_dssp EEEEECCS-EEHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC
T ss_pred EEEEeCCC-CCHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCccc
Confidence 99999995 567776654 4899999999999999999999999999999999999999999999999999877654333
Q ss_pred cc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 162 TK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 162 ~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.. ..+|.+||.+.+.++ .++|+||+||++++|++|.+||.+.+....+.++
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i 275 (464)
T 3ttj_A 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275 (464)
T ss_dssp ----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33 344889999988877 7889999999999999999999987655444443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=258.33 Aligned_cols=195 Identities=19% Similarity=0.348 Sum_probs=162.2
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||+|+ +|.++ |+.+| ++.+.. ..+...+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 59 LG~G~~g~Vy-----~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 59 LGSGAFGVVH-----RCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp EEEETTEEEE-----EEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCCCEEEE-----EEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 7899999995 56555 88888 222221 224457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC--CCcEEEEeeCceeecCCCCCccc-
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK--HGHLKLADFGTCMRMNKTGTETK- 163 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~--~~~i~l~Dfg~a~~~~~~~~~~~- 163 (245)
++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++. .+.++|+|||+++..........
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 210 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence 999999988754 5899999999999999999999999999999999999974 46799999999998765443332
Q ss_pred --cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 164 --RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 164 --~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
..+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+..+...
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred ccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 344789999987776 7889999999999999999999988765555554443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=243.29 Aligned_cols=203 Identities=16% Similarity=0.217 Sum_probs=153.0
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||+|+ +|+.. |+.+| ++.+.........+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 16 ~~~lg~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 16 GNLLGKGSFAGVY-----RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp EEEEEECSSEEEE-----EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeecCCCceEEE-----EEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3347889999994 66654 88888 444444444556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
|++++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 999999999998764 589999999999999999999999999999999999999999999999999987653322
Q ss_pred -ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 -ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 -~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....++.+||.+...++ .++|+||+|++++++++|.+||.+........++.....
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc
Confidence 123345788998877666 789999999999999999999988876666665554433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=257.11 Aligned_cols=198 Identities=18% Similarity=0.260 Sum_probs=160.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.|++|+||.|+ +|+.+ |+.+| ++++.. ....+.+.+|+.++++++||||+++++++.+.+.+++||||
T Consensus 96 ~lG~G~~g~Vy-----~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 96 ILGGGRFGQVH-----KCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp ECC-----CEE-----EEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCcCEEEE-----EEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 38999999994 66655 88888 333221 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe--cCCCcEEEEeeCceeecCCCCCcc-
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFGTCMRMNKTGTET- 162 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~--~~~~~i~l~Dfg~a~~~~~~~~~~- 162 (245)
+++++|.+.+... .+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||+++.........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999999887643 48999999999999999999999999999999999999 567889999999999876544333
Q ss_pred --ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 163 --KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 163 --~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
...+|.+||.+....+ .++|+||+||++++|++|.+||.+.++...+.++.....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 305 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence 3445889999877766 688999999999999999999999887766666655433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=259.03 Aligned_cols=202 Identities=17% Similarity=0.153 Sum_probs=162.7
Q ss_pred hhccccccchhhhHHHHHh-----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLK-----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~-----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+|+|+||+|+ +|+ .. ++.||++.............+.+|+.++++++||||+++++++.+....++|
T Consensus 78 ~LG~G~fg~Vy-----~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 78 GLGHGAFGEVY-----EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp ECCCCSSSCEE-----EEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EeeeCCCEEEE-----EEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 48999999995 444 22 6778843322222334556789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEEeeCcee
Q psy16292 85 MDYMPGGDLVNLMSNY--------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGTCM 153 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~a~ 153 (245)
|||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 9999999999998642 388899999999999999999999999999999999999655 49999999998
Q ss_pred ecCCCC------CccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 154 RMNKTG------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 154 ~~~~~~------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...... ......+|.+||.+.+..+ .++|+||+||+++++++ |.+||.+.........+..+..+
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 543221 1122345889999987777 78899999999999998 99999988877766666655443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=253.95 Aligned_cols=211 Identities=19% Similarity=0.281 Sum_probs=167.7
Q ss_pred chHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhh--hccCchHHHHHHHHHHHhcCCccceeee
Q psy16292 3 NVEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ--IKRSDSAFFWEERDIMAHANSEWIVQLH 72 (245)
Q Consensus 3 ~~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 72 (245)
.+.++.++|+ +++|+||+|+ +|+++ ++.+| ++.+... ......+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVR-----VAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEE-----EEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhhheeecceeeecCCeEEE-----EEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 3567778886 7889999995 55555 88888 4444332 2345678899999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHhc-----------------------------------------CCCCHHHHHHHH
Q psy16292 73 FAFQDAKSLYMVMDYMPGGDLVNLMSN-----------------------------------------YDVPEKWAKFYC 111 (245)
Q Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------------------------------~~~~~~~~~~~~ 111 (245)
+++.+.+..++||||+++|+|.+++.. ..+++..+..++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 999999999999999999999998841 013567788899
Q ss_pred HHHHHHHHHHHhCCceeCCCCCCceEecCCC--cEEEEeeCceeecCCCCC--------ccccCCCCchhhhhc--CCC-
Q psy16292 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHG--HLKLADFGTCMRMNKTGT--------ETKRLGRNGIEEIKA--HPF- 178 (245)
Q Consensus 112 ~~i~~~l~~lH~~~iih~dlkp~nil~~~~~--~i~l~Dfg~a~~~~~~~~--------~~~~~~~~~~e~i~~--~~~- 178 (245)
.|++.||.|||+++++||||||+||+++.++ .++|+|||+++.+..... .....+|.+||.+.. ..+
T Consensus 175 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 9999999999999999999999999998776 899999999987643221 122344788998865 344
Q ss_pred cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 179 FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 179 ~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.++|+||+|++++++++|.+||.+..+......+......
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 294 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc
Confidence 6889999999999999999999988777666666555443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.56 Aligned_cols=198 Identities=22% Similarity=0.337 Sum_probs=156.7
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc-----------------------cCchHHHHHHHHHHHh
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK-----------------------RSDSAFFWEERDIMAH 62 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~-----------------------~~~~~~~~~E~~il~~ 62 (245)
.-.+++|+||.|+ +|+++ |+.|| ++.+..... ....+.+.+|+.+++.
T Consensus 18 ~~~lG~G~~g~Vy-----~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 18 KDEIGKGSYGVVK-----LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp EEEEEC--CCEEE-----EEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred EeEEeecCCEEEE-----EEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3458899999994 66555 88888 333322111 1234678999999999
Q ss_pred cCCccceeeeEEEEe--CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC
Q psy16292 63 ANSEWIVQLHFAFQD--AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140 (245)
Q Consensus 63 l~hp~Iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~ 140 (245)
++||||+++++++.+ ...+++||||+++++|.+++....+++..+..++.|++.||.|||+++++||||||+||+++.
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC
Confidence 999999999999987 578999999999999998877778999999999999999999999999999999999999999
Q ss_pred CCcEEEEeeCceeecCCCCC----ccccCCCCchhhhhcCCC----cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 141 HGHLKLADFGTCMRMNKTGT----ETKRLGRNGIEEIKAHPF----FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~----~~~~~~~~~~e~i~~~~~----~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
++.++|+|||+++....... ......|.+||.+...+. .++|+||+|+++|++++|.+||.+.........+
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 252 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252 (298)
T ss_dssp TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHH
Confidence 99999999999988654432 122344788998876542 4679999999999999999999876544433333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=250.91 Aligned_cols=206 Identities=19% Similarity=0.310 Sum_probs=167.8
Q ss_pred cchHHHHHHhh-----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeee
Q psy16292 2 KNVEAFMHRYR-----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLH 72 (245)
Q Consensus 2 ~~~~~f~~~y~-----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 72 (245)
+..++|.++|. +++|+||+|+ +|+.+ |+.|| ++.+...........+.+|+.+++.+ .||||++++
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVR-----QCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEE-----EEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 45778888876 5778999994 66555 88888 33332233344567899999999999 579999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEE
Q psy16292 73 FAFQDAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKL 146 (245)
Q Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l 146 (245)
+++...+.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999998854 35899999999999999999999999999999999999988 789999
Q ss_pred EeeCceeecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 147 ADFGTCMRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
+|||+++......... ...++.+||.+...++ .++|+||+|+++++|++|.+||.+......+..+
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 9999999875443322 3344789999987777 7889999999999999999999887665544443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.92 Aligned_cols=199 Identities=20% Similarity=0.222 Sum_probs=152.1
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ +++.. +..+|+............+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 22 ~lg~G~~g~Vy-----~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 22 CIGEGQFGDVH-----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEECSSSEEE-----EEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EeeecCCeeEE-----EEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 37889999995 44433 55566333222223345677999999999999999999999984 567899999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
|+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (281)
T 1mp8_A 96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175 (281)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccc
Confidence 99999999998754 4899999999999999999999999999999999999999999999999999876543221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.....|.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~ 234 (281)
T 1mp8_A 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234 (281)
T ss_dssp ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence 11234789999987776 67899999999999986 999999887766666555543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=245.37 Aligned_cols=201 Identities=19% Similarity=0.199 Sum_probs=161.0
Q ss_pred HHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhh--hccCchHHHHHHHHHHHhc---CCccceeeeEE
Q psy16292 8 MHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ--IKRSDSAFFWEERDIMAHA---NSEWIVQLHFA 74 (245)
Q Consensus 8 ~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~--~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~ 74 (245)
.++|+ +++|+||+|+ +|+++ |+.|| ++++... ........+.+|+.+++.+ +||||++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVY-----KARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp --CCEEEEEECCSSSCCEE-----EEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccceEEEEEEecCCCeEEE-----EEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 34555 7889999994 66655 88888 2222111 1223345678888888877 49999999999
Q ss_pred EEeCC-----EEEEEEeccCCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEE
Q psy16292 75 FQDAK-----SLYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146 (245)
Q Consensus 75 ~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l 146 (245)
+.... .+++|||++. ++|.+++.... +++..+..++.|++.||.|||+++++||||||+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence 98765 6899999995 69999887643 899999999999999999999999999999999999999999999
Q ss_pred EeeCceeecCCCCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 147 ADFGTCMRMNKTGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
+|||+++.......... ...|.+||.+.+.++ .++|+||+||+++++++|.+||.+.++.....++..
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999987654443333 444789999987777 788999999999999999999998877666555543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=248.22 Aligned_cols=191 Identities=20% Similarity=0.234 Sum_probs=156.9
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||+|+ +|+++ |+.+| +..+.........+.+.+|+.+++.++||||+++++++.+.+.+++|||+++
T Consensus 9 ~lg~G~~g~V~-----~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 9 KIGEGTYGVVY-----KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEETTEEEE-----EEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred hcccCCCEEEE-----EEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 48899999995 66656 88888 3222222334456788999999999999999999999999999999999995
Q ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccc
Q psy16292 90 GGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETK 163 (245)
Q Consensus 90 ~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~ 163 (245)
++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... ...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (288)
T 1ob3_A 84 -QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162 (288)
T ss_dssp -EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------C
T ss_pred -CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccc
Confidence 599988875 4589999999999999999999999999999999999999999999999999986543221 123
Q ss_pred cCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 164 RLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 164 ~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
...+.+||.+.+.. + .++|+||+||+++++++|.+||.+.++...
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45588999987643 4 778999999999999999999987665433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=248.94 Aligned_cols=194 Identities=14% Similarity=0.188 Sum_probs=163.4
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc-----cCchHHHHHHHHHHHhcCCccceee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK-----RSDSAFFWEERDIMAHANSEWIVQL 71 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l 71 (245)
++|.++|+ +++|+||+|+ +|+++ |+.|| ++++..... ......+.+|+.+++.++||||+++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy-----~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 94 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVW-----TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEE-----EEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred cccccceEEEeEEEecCCEEEE-----EEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 46778887 7889999994 66554 88898 333332211 2245678889999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCC-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 72 HFAFQDAKSLYMVMDYMPGG-DLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
++++.+.+.+++|||++.+| +|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+||
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999999998766 999988765 5899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCccc---cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC
Q psy16292 150 GTCMRMNKTGTETK---RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 150 g~a~~~~~~~~~~~---~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
|+++.......... ..+|.+||.+.+.++ .++|+||+|+++|++++|.+||.+.
T Consensus 175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 99998765544333 344789999988776 4679999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=243.02 Aligned_cols=201 Identities=22% Similarity=0.279 Sum_probs=166.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||.|+ +|.++ |+.+| ++.+.........+.+.+|+.++++++||||+++++++......++|||++
T Consensus 13 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 13 ELGKGAFSVVR-----RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhcCcCCeEEE-----EEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 47889999995 66555 88888 333333334455678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEEeeCceeecCCCCCcc--
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~Dfg~a~~~~~~~~~~-- 162 (245)
++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++|+|||++..........
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (284)
T 3kk8_A 88 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167 (284)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCS
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCC
Confidence 99999887654 45899999999999999999999999999999999999987655 9999999998776554432
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
...++.+||.+.+.++ .++|+||+|++++++++|.+||.+.........+..+..
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 224 (284)
T 3kk8_A 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc
Confidence 3344789999988776 778999999999999999999988876666555554433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=258.92 Aligned_cols=187 Identities=19% Similarity=0.202 Sum_probs=142.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-----CCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-----AKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~~~l 83 (245)
.||+|+||+|+ +|+++ |+.|| ++.+.........+++.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 60 ~lG~G~~g~V~-----~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 60 LIGTGSYGHVC-----EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp C-------CEE-----EEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EeeecCCeEEE-----EEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 48899999994 67666 88888 3222222333456789999999999999999999999943 357999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
|||++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.......
T Consensus 135 v~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 213 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213 (458)
T ss_dssp EECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCC
T ss_pred EEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccc
Confidence 99998 78999988765 489999999999999999999999999999999999999999999999999987643221
Q ss_pred --------------------------ccc---cCCCCchhhhh-cCCC-cccCCCcccccceecCC-----------ccC
Q psy16292 161 --------------------------ETK---RLGRNGIEEIK-AHPF-FINDQWTFSNLRECVPP-----------VVP 198 (245)
Q Consensus 161 --------------------------~~~---~~~~~~~e~i~-~~~~-~~~Diws~g~~~~~~~~-----------~~~ 198 (245)
... ...|.+||.+. ...+ .++|+||+||++|+|++ +.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p 293 (458)
T 3rp9_A 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293 (458)
T ss_dssp CCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCC
T ss_pred cccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccc
Confidence 111 33478999874 4445 67899999999999998 777
Q ss_pred CCCCCC
Q psy16292 199 ELSGDD 204 (245)
Q Consensus 199 pf~~~~ 204 (245)
+|.|.+
T Consensus 294 ~f~g~~ 299 (458)
T 3rp9_A 294 LFPGSS 299 (458)
T ss_dssp SCC---
T ss_pred cCCCCc
Confidence 777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=252.52 Aligned_cols=198 Identities=19% Similarity=0.195 Sum_probs=162.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||+|+ +|+.. |+.||+ +...........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 61 ~lG~G~~g~Vy-----~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 61 EIGHGSFGAVY-----FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEccCCCEEEE-----EEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 48999999994 66654 888883 3222222233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccC
Q psy16292 88 MPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRL 165 (245)
Q Consensus 88 ~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~ 165 (245)
+. |+|.+.+. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++............
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~ 214 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 214 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCG
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCCc
Confidence 95 68888774 3468999999999999999999999999999999999999999999999999998776555555556
Q ss_pred CCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 166 GRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 166 ~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
+|.+||.+.+ .++ .++|+||+||+++++++|.+||.+.+.......+...
T Consensus 215 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 268 (348)
T 1u5q_A 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268 (348)
T ss_dssp GGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 6899999853 334 6789999999999999999999877655444444443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.18 Aligned_cols=210 Identities=23% Similarity=0.298 Sum_probs=170.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
+++|.-.-.+++|+||.|+ +|+++ ++.+| ++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVY-----LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEE-----EEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 3444444458999999994 66655 77888 444544444556778999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
..++||||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999998865 46899999999999999999999999999999999999999999999999998665433
Q ss_pred CC--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GT--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.. ......+.+||.+.+..+ .++|+||+|++++++++|.+||.+.........+.....+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC
Confidence 21 233455789999887766 6889999999999999999999887665555555444333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=247.14 Aligned_cols=195 Identities=15% Similarity=0.204 Sum_probs=160.7
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
++|...-.+++|+||+|+ +++++ |+.+|++.- ........+.+.+|+.++++++||||+++++++.+++..+
T Consensus 10 ~~~~~~~~lG~G~~g~V~-----~~~~~~~~~~va~K~~-~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAI-----KVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGEEEEEEEECCSSEEEE-----EEEETTTCCEEEEEEE-SCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hHeeccceecCCCCEEEE-----EEEECCCCcEEEEEEe-ccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 334444458999999994 66665 888883221 1123455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999976 4589999999999999999999999999999999999999999999999999987643322
Q ss_pred c------------------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 E------------------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ~------------------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
. ....+|.+||.+.+.++ .++|+||+|++++++++|.+|+.+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 1 12334789999988776 788999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=249.83 Aligned_cols=190 Identities=16% Similarity=0.104 Sum_probs=157.0
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC----EEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK----SLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~~lv~ 85 (245)
-.+++|+||+|+ +++..|+.||+ +.+. .........+|+.++++++||||+++++++.... .+++||
T Consensus 30 ~~lg~G~~g~Vy-----~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 30 EVKARGRFGCVW-----KAQLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEECSTTCEEE-----EEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred heecccCceEEE-----EEEECCCEEEEEEeec---CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 358999999995 66667999993 2221 1233445667999999999999999999998754 579999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL----------GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~----------~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
||+++|+|.+++....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 999999999999988899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc------cccCCCCchhhhhcCCC------cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 156 NKTGTE------TKRLGRNGIEEIKAHPF------FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 156 ~~~~~~------~~~~~~~~~e~i~~~~~------~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
...... .....|.+||.+.+... .++|+||+||++|++++|.+||.+..+...
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 543321 22344788999876322 467999999999999999999998766443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=249.07 Aligned_cols=201 Identities=14% Similarity=0.205 Sum_probs=153.9
Q ss_pred hhccccccchhhhHHHHHhhc--C---eEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE----
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y---TLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL---- 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~---~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~---- 81 (245)
.+++|+||+|+ +|+.+ + ..+| ++.+.........+.+.+|+.++++++||||+++++++......
T Consensus 30 ~lg~G~~g~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 30 MLGKGEFGSVR-----EAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp EEEEETTEEEE-----EEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eecccCCeEEE-----EEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 47899999995 55444 2 2567 33333333445678899999999999999999999999877655
Q ss_pred --EEEEeccCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 82 --YMVMDYMPGGDLVNLMSNY-------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 82 --~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccc
Confidence 9999999999999988532 4889999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 153 MRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 153 ~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
+........ .....+.+||.+.+.++ .++|+||+|++++++++ |.+||.+.........+..+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 876433221 11234789999988777 78899999999999999 9999998887776666655543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.38 Aligned_cols=200 Identities=20% Similarity=0.224 Sum_probs=162.7
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+|+|+||+|+ +++.+ |+.||++.-.........+.+.+|+.++++++||||+++++++...+.+++||||+
T Consensus 120 ~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 120 EQIGRGNFGEVF-----SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp EEEEEETTEEEE-----EEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCCeEE-----EEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 458899999994 66665 88888332212222334557889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~ 274 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence 999999988753 489999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+....+ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 112344889999987776 78899999999999998 99999887655544444333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=239.95 Aligned_cols=188 Identities=21% Similarity=0.256 Sum_probs=152.5
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-++++|+||+|+ +|+++ |+.|| ++.+...........+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 8 ~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 8 EKIGEGTYGTVF-----KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEECSSSEEE-----EEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEecCCCCeEEE-----EEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 358899999995 66665 88888 32222223344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++ ++.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 964 66665543 46899999999999999999999999999999999999999999999999999876533222
Q ss_pred cccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCC-CCCCC
Q psy16292 162 TKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPE-LSGDD 204 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~p-f~~~~ 204 (245)
....++.+||.+.+.+ + .++|+||+||+++++++|..| |.+.+
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 2234478999987765 4 778999999999999977666 55444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=255.92 Aligned_cols=196 Identities=21% Similarity=0.260 Sum_probs=156.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC------EEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK------SLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~~~ 82 (245)
.+|+|+||.|+ +|.++ |+.||+++ ..........+++.+|+.+++.++||||+++++++.... .+|
T Consensus 32 ~lG~G~~g~V~-----~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 32 PVGSGAYGAVC-----SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EC------CEE-----EEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EeeecCCeEEE-----EEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 48899999994 66655 88888332 222223345678899999999999999999999998663 569
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
+|||++ +++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 107 lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185 (367)
T ss_dssp EEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSS
T ss_pred EEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccccCcC
Confidence 999999 89999999888899999999999999999999999999999999999999999999999999998654322 1
Q ss_pred cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 162 TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 162 ~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
.....|.+||.+.+ ..+ .++|+||+||++++|++|.+||.+.+....+.++.
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22344789999876 444 78899999999999999999999887655555443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=245.92 Aligned_cols=184 Identities=21% Similarity=0.285 Sum_probs=140.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+|+|+||+|+ +|+++ |+.||++.- .......+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus 19 lG~G~~g~V~-----~~~~~~~~~~vavK~~----~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 19 LGEGSFSICR-----KCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SEEETTEEEE-----EEEETTTCCEEEEEEE----EGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cccCCCeEEE-----EEEECCCCCEEEEEEE----ChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 7889999994 66665 888883221 1234466789999999996 9999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEEeeCceeecCCCCC----c
Q psy16292 90 GGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLADFGTCMRMNKTGT----E 161 (245)
Q Consensus 90 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~Dfg~a~~~~~~~~----~ 161 (245)
+++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||+++....... .
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 169 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence 99999988755 589999999999999999999999999999999999998766 799999999987654322 2
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
....++.+||.+...++ .++|+||+|++++++++|.+||.+...
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 22445789999888777 678999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=246.54 Aligned_cols=205 Identities=16% Similarity=0.274 Sum_probs=168.2
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcCCccceeeeEE
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHANSEWIVQLHFA 74 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~ 74 (245)
++.++|+ +++|+||.|+ +|+++ |+.+| ++++...... ...+.+.+|+.++++++||||++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVK-----KCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhccEEEeeEeeecCCEEEE-----EEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4556665 7888999994 66655 88888 3333222111 146779999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEEEee
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADF 149 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~Df 149 (245)
+.+...+++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999999998764 489999999999999999999999999999999999999887 7999999
Q ss_pred CceeecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 150 GTCMRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 150 g~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
|+++......... ...++.+||.+.+.++ .++|+||+|++++++++|.+||.+.........+...
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9998876543322 2344789999887776 7889999999999999999999887765555544443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=259.03 Aligned_cols=201 Identities=16% Similarity=0.188 Sum_probs=154.2
Q ss_pred HhhhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.-.+|+|+||.|+ +++.+ +..+|++.-.........+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 50 ~~~lG~G~fg~Vy-----~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 50 DKVVGAGEFGEVC-----SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp CEEEEECSSSEEE-----EC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeEEE-----EEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 3458999999995 44432 6667732222222334567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 85 MDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
|||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++........
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 9999999999999764 4899999999999999999999999999999999999999999999999999876533211
Q ss_pred ------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 ------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+|.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266 (373)
T ss_dssp ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 11235889999987776 77899999999999886 99999877665555444433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=254.19 Aligned_cols=200 Identities=17% Similarity=0.197 Sum_probs=162.8
Q ss_pred hhccccccchhhhHHHHHhhc---------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
.||+|+||+|+ +|+.. +..+|++.............+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 76 ~LG~G~~g~Vy-----~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 76 PLGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEECSSEEEE-----EEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EEecCCCeEEE-----EEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 38899999995 44421 4667732211223334567899999999999 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
++||||+++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcE
Confidence 9999999999999998753 38999999999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 145 KLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+|+|||+++....... .....++.+||.+.+..+ .++|+||+||+++++++ |.+||.+......+..+..+.
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987653321 112234789999988776 68899999999999998 999998877666555554443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=244.35 Aligned_cols=206 Identities=22% Similarity=0.274 Sum_probs=169.1
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
+|.-.-.+++|+||.|+ +|+.+ ++.+| ++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVY-----LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp GEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hceeeheecCCCCeEEE-----EEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 33333458889999994 66555 78888 44444444455567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++|||++++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999999999998864 4689999999999999999999999999999999999999999999999999987653322
Q ss_pred --ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.....++.+||.+.+.++ .++|+||+|++++++++|.+||.+.........+....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 228 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc
Confidence 223444789999887766 78899999999999999999998876655554444443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=252.44 Aligned_cols=188 Identities=20% Similarity=0.266 Sum_probs=154.4
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFA 74 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 74 (245)
...|.++|+ +|+|+||+|+ +|+++ |+.|| ++++.. ....+|+.++.++ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~ 84 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCK-----RCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDV 84 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccCccccEEEEEEEeeCCCEEEE-----EEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEE
Confidence 345777776 6889999994 66665 88999 333321 1245788999888 89999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC----CcEEEEee
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH----GHLKLADF 149 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~----~~i~l~Df 149 (245)
+.++..+|+||||+++|+|.+.+... .+++..+..++.|++.||.|||++||+||||||+||++... +.++|+||
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 99999999999999999999988654 58999999999999999999999999999999999998443 35999999
Q ss_pred CceeecCCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 150 GTCMRMNKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 150 g~a~~~~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
|+++....... ......|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 99997654322 222445789999987666 6889999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=258.97 Aligned_cols=197 Identities=21% Similarity=0.283 Sum_probs=163.6
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-EEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-SLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~lv~e~~ 88 (245)
-.+++|+||+|+ +++.+|+.||+ +.+. ....+.+.+|+.++++++||||+++++++.... .+++||||+
T Consensus 199 ~~lG~G~fg~V~-----~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 199 QTIGKGEFGDVM-----LGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp EEEEECSSEEEE-----EEEETTEEEEEEEESS----CTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCcCCeeEE-----EEEecCCeEEEEEeCC----chHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 358999999995 66667888883 2221 235678999999999999999999999987665 799999999
Q ss_pred CCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-cccc
Q psy16292 89 PGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKR 164 (245)
Q Consensus 89 ~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~ 164 (245)
++|+|.+++...+ +++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++....... ....
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 349 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence 9999999987532 68899999999999999999999999999999999999999999999999986543322 2234
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
..+.+||.+....+ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 350 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 403 (450)
T 1k9a_A 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403 (450)
T ss_dssp TTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC
T ss_pred cceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 45899999988777 78899999999999998 999999887777666665553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.71 Aligned_cols=190 Identities=16% Similarity=0.225 Sum_probs=154.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC---CccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN---SEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+|+.+.....+.. ++.||+..- .......+.+|+.+++.++ |+||+++++++...+..++|||
T Consensus 72 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~----~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ----KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEECSSEEEEEEEC-------CCCCEEEEEE----SSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EeeccCCEEEEEEEecCCcccccCcEEEEEEe----CCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 489999999963321111223 888883221 1245567888999999886 9999999999999999999999
Q ss_pred ccCCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-----------CCcEEEEee
Q psy16292 87 YMPGGDLVNLMS------NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-----------HGHLKLADF 149 (245)
Q Consensus 87 ~~~~g~L~~~l~------~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-----------~~~i~l~Df 149 (245)
|+++|+|.+++. ...+++..+..++.|++.||.|||+++|+||||||+||+++. ++.++|+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DF 227 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCC
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeC
Confidence 999999999986 345999999999999999999999999999999999999998 899999999
Q ss_pred CceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 150 GTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 150 g~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
|+|+.+..... .....+|.+||.+.+.++ .++|+||+||++|+|++|.+||....+
T Consensus 228 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp TTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred chhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 99986542211 223455899999988887 789999999999999999999876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.52 Aligned_cols=201 Identities=17% Similarity=0.181 Sum_probs=163.0
Q ss_pred hhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+++|+||.|+ +++.+ ++.+|++.-.........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 54 ~lg~G~~g~Vy-----~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 54 DIGEGAFGRVF-----QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp EEEECSSCEEE-----EEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeecCCeeEE-----EEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 48899999995 55544 3777732211112234467799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec
Q psy16292 85 MDYMPGGDLVNLMSN-------------------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~ 139 (245)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 999999999999865 4588899999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCceeecCCCC------CccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 140 KHGHLKLADFGTCMRMNKTG------TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~------~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.++.++|+|||+++...... ......++.+||.+...++ .++|+||+|+++|++++ |.+||.+.........
T Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 288 (343)
T 1luf_A 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288 (343)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHH
Confidence 99999999999998654321 1222344889999987776 78899999999999998 9999988776555555
Q ss_pred cCcCCC
Q psy16292 212 IEKDES 217 (245)
Q Consensus 212 ~~~~~~ 217 (245)
+..+..
T Consensus 289 ~~~~~~ 294 (343)
T 1luf_A 289 VRDGNI 294 (343)
T ss_dssp HHTTCC
T ss_pred HhCCCc
Confidence 544433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=237.45 Aligned_cols=195 Identities=18% Similarity=0.199 Sum_probs=161.7
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAF 75 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 75 (245)
..+|.++|+ +++|+||+|+ +|+++ |+.|| +..+...........+.+|+..+..+ +||||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVF-----KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEE-----EEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 346777776 7888999995 66665 88888 32222223334567789999999999 999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---------
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH--------- 141 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~--------- 141 (245)
.+.+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 999999999999999999998864 458999999999999999999999999999999999999844
Q ss_pred ----------CcEEEEeeCceeecCCCCCccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC
Q psy16292 142 ----------GHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 142 ----------~~i~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
..++|+|||.+..............+.+||.+..... .++|+||+|+++++++++.+++...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 4799999999998876665555666899999877633 5889999999999999999887544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=245.94 Aligned_cols=198 Identities=17% Similarity=0.171 Sum_probs=163.8
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.+++|+||.|+ +++.. ++.+|+ +.+. .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 15 ~~~lg~G~~g~V~-----~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 15 VQEIGSGQFGLVH-----LGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp EEEEEECSSCEEE-----EEEETTTEEEEEEEECT---TSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eheecCCCccEEE-----EEEecCCCeEEEEEecc---cccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3458999999995 66665 777772 2221 223456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----- 160 (245)
+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9999999999754 389999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence 112234789999987776 78899999999999998 99999988776666665554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=243.94 Aligned_cols=186 Identities=17% Similarity=0.155 Sum_probs=156.7
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.+++|+||+|+ +++++ |+.||+ +.+. ....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 15 ~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 15 KKIGCGNFGELR-----LGKNLYTNEYVAIKLEPM----KSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp EECCC-CTTSEE-----EEEETTTTEEEEEEEEET----TCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EEeeccCCceEE-----EEEECCCCcEEEEEEecc----ccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 348899999994 66654 888883 2221 23345688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc-----EEEEeeCceeecCCCC
Q psy16292 87 YMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-----LKLADFGTCMRMNKTG 159 (245)
Q Consensus 87 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~-----i~l~Dfg~a~~~~~~~ 159 (245)
++ +++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||+++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 9999999874 56999999999999999999999999999999999999998887 9999999999765432
Q ss_pred C-----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 160 T-----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 160 ~-----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
. ......|.+||.+.+.++ .++|+||+|++++++++|.+||.+....
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 2 223445789999988777 6789999999999999999999886544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.77 Aligned_cols=205 Identities=17% Similarity=0.231 Sum_probs=162.4
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEE--EEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLY--ALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~--av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 80 (245)
+|.-.-.+++|+||.|+ +|+.+ |..+ |++...........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 26 ~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVL-----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp GCEEEEEEECGGGCEEE-----EEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HccceeeeecCCCceEE-----EEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 33334458999999994 66665 6655 422211222344567799999999999 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
+++|||++++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 99999999999999998754 4899999999999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCC---ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 144 LKLADFGTCMRMNKTGT---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
++|+|||+++....... .....++.+||.+...++ .++|+||+|++++++++ |.+||.+......+..+..+
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999985432221 222345889999987766 78899999999999998 99999888766555555544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=249.00 Aligned_cols=200 Identities=18% Similarity=0.207 Sum_probs=158.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+|+|+||.|+.+........ +..+| ++.+ ........+.+.+|+.+++++ +||||+++++++...+.+++||||
T Consensus 52 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 130 (344)
T 1rjb_A 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 130 (344)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEEC-C------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eecCCCCceeEEeeeeccccCCcceEEEEEecc-cccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEec
Confidence 488999999953222111112 56677 2222 222345678899999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc
Q psy16292 88 MPGGDLVNLMSNYD------------------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH 143 (245)
Q Consensus 88 ~~~g~L~~~l~~~~------------------------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~ 143 (245)
+++|+|.+++.... +++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 131 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~ 210 (344)
T 1rjb_A 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210 (344)
T ss_dssp CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE
T ss_pred CCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCc
Confidence 99999999987532 688899999999999999999999999999999999999999
Q ss_pred EEEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 144 LKLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
++|+|||++......... ....++.+||.+...++ .++|+||+|++++++++ |.+||.+......+...
T Consensus 211 ~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 287 (344)
T 1rjb_A 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287 (344)
T ss_dssp EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHH
Confidence 999999999876543321 12234889999987776 78899999999999998 99999887655544443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.52 Aligned_cols=195 Identities=21% Similarity=0.246 Sum_probs=147.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||+|+ +|+.+ ++.|| ++.+. ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 60 ~lG~G~~g~Vy-----~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 60 ELGRGATSIVY-----RCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeCCCEEEE-----EEEECCCCcEEEEEEecc----chhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 47899999994 66665 78888 22221 123456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCCCCcc--
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++. ++.++|+|||+++.........
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 999999988754 4899999999999999999999999999999999999976 7899999999998765433222
Q ss_pred -ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC-CCcccCcC
Q psy16292 163 -KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS-NFDDIEKD 215 (245)
Q Consensus 163 -~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~-~~~~~~~~ 215 (245)
...+|.+||.+.+.++ .++|+||+||++|++++|..||.+..... .+..+...
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~ 266 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT
T ss_pred cCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC
Confidence 3445789999988776 78899999999999999999998765443 34444444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=241.31 Aligned_cols=199 Identities=18% Similarity=0.260 Sum_probs=165.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||+|+ +|+++ ++.+| ++.+....+....+.+.+|+.+++.++||||+++++++.+.+..++|||+
T Consensus 22 ~lg~G~~g~Vy-----~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 22 FLGKGGFAKCF-----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeecCCEEEE-----EEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 47889999994 66665 88888 44444433445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----cc
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~ 162 (245)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 176 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccccc
Confidence 999999998865 4689999999999999999999999999999999999999999999999999987653322 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
...++.+||.+....+ .++|+||+|++++++++|.+||.+......+..+...
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 230 (294)
T 2rku_A 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230 (294)
T ss_dssp SCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Confidence 3445789999877766 6889999999999999999999877654444444333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=251.47 Aligned_cols=185 Identities=20% Similarity=0.254 Sum_probs=151.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHh-cCCccceeeeEEEEe----CCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAH-ANSEWIVQLHFAFQD----AKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~----~~~~~lv 84 (245)
.||+|+||+|+ +++++ |+.||++.- .....+.+|+.++.+ .+||||+++++++.. ..++|+|
T Consensus 69 ~LG~G~~g~V~-----~~~~~~~~~~vAiK~~------~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 69 VLGLGINGKVL-----QIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEE------ECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeeeccCeEEE-----EEEECCCCCEEEEEEe------CcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 37899999994 66655 888883211 022457789998855 589999999999976 5689999
Q ss_pred EeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCC
Q psy16292 85 MDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~ 158 (245)
|||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 9999999999999764 3899999999999999999999999999999999999998 788999999999976544
Q ss_pred CCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 159 GTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 159 ~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
..... ..+|.+||.+....+ .++|+||+||++|+|++|.+||.+.....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 33333 445889999877777 78899999999999999999998876554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.92 Aligned_cols=198 Identities=17% Similarity=0.196 Sum_probs=163.3
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|+||.|+ +++.+ +..+| ++.+. .....+.+.+|+.++++++||||+++++++.+....++|||++
T Consensus 14 ~~lg~G~~g~V~-----~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 14 KELGSGQFGVVK-----LGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp EEEEEETTEEEE-----EEEETTTEEEEEEEECB---TTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeeccCCCceEE-----EEEecCceeEEEEEecc---CCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 348899999995 66666 66777 22221 2234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--c-
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET--K- 163 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~--~- 163 (245)
++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......... .
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 999999988753 48999999999999999999999999999999999999999999999999998765443221 1
Q ss_pred --cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 164 --RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 164 --~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
..++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 222 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC
Confidence 223789999988776 78899999999999998 999998777665555554443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.19 Aligned_cols=200 Identities=15% Similarity=0.181 Sum_probs=156.6
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEE----EEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLY----ALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~----av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
.-.+++|+||+|+ +|++. |+.+ |+..-.........+.+.+|+.++++++||||+++++++.++. .++
T Consensus 20 ~~~lG~G~~g~Vy-----~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 20 IKVLGSGAFGTVY-----KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp EEEEEEETTEEEE-----EEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred ceEEeeCCCeEEE-----EEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 3458999999995 55543 4443 4222122233456678999999999999999999999998765 788
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
++|++++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++........
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 99999999999988753 5899999999999999999999999999999999999999999999999999876543322
Q ss_pred c------ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 T------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
. ...+|.+||.+.+..+ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence 1 1234789999988877 78899999999999999 99999887665554444333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=246.49 Aligned_cols=198 Identities=18% Similarity=0.257 Sum_probs=165.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ +++++ ++.+| ++.+.........+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 48 ~lg~G~~g~Vy-----~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 48 FLGKGGFAKCF-----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeCCCeEEE-----EEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 48889999994 66655 78888 44444433445677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----cc
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ET 162 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~ 162 (245)
+.+++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++....... ..
T Consensus 123 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (335)
T 2owb_A 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 202 (335)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred CCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccC
Confidence 999999998865 4689999999999999999999999999999999999999999999999999987653322 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
...++.+||.+....+ .++|+||+|++++++++|.+||.+......+..+..
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp SCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 3445789999987776 688999999999999999999987654444333333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=246.80 Aligned_cols=193 Identities=18% Similarity=0.158 Sum_probs=162.0
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
...+++|+||+|+ +++.+ |+.+|++... .......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 44 ~~~lg~G~~g~Vy-----~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 44 KFLIGHGVFGKVY-----KGVLRDGAKVALKRRT-PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCSCBCSSSEEE-----EEECTTCCEEEEEECC-SCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred cceeecCCCeeEE-----EEEECCCCEEEEEEec-ccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 3458999999995 55555 8888843322 223455778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 89 PGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 89 ~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999988653 388899999999999999999999999999999999999999999999999987543221
Q ss_pred ---ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 ---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.....+|.+||.+...++ .++|+||+|++++++++|.+||.+..+...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 123456899999987776 788999999999999999999988766544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=255.52 Aligned_cols=197 Identities=14% Similarity=0.081 Sum_probs=151.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHH---HHhcCCccceeee-------EEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDI---MAHANSEWIVQLH-------FAFQD 77 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~i---l~~l~hp~Iv~l~-------~~~~~ 77 (245)
.+++|+||+|+ +|+.+ |+.|| ++++.........+.+.+|+.+ ++.++||||++++ +++.+
T Consensus 80 ~lG~G~~g~V~-----~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 80 VLGQEDPYAYL-----EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEETTEEEE-----EEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred eeecCCCEEEE-----EEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 48899999994 66654 88999 4443333444567889999954 4555899999998 66665
Q ss_pred CC-----------------EEEEEEeccCCCCHHHHHhcC-CCCH-------HHHHHHHHHHHHHHHHHHhCCceeCCCC
Q psy16292 78 AK-----------------SLYMVMDYMPGGDLVNLMSNY-DVPE-------KWAKFYCAEVVLALDAIHCLGFVHRDVK 132 (245)
Q Consensus 78 ~~-----------------~~~lv~e~~~~g~L~~~l~~~-~~~~-------~~~~~~~~~i~~~l~~lH~~~iih~dlk 132 (245)
.+ ..|++|||+ +|+|.+++... .+++ ..+..++.|++.||.|||++||+|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 233 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 53 289999999 78999988743 2444 7777899999999999999999999999
Q ss_pred CCceEecCCCcEEEEeeCceeecCCCCC-ccccCCCCchhhhhcC-----------CC-cccCCCcccccceecCCccCC
Q psy16292 133 PDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAH-----------PF-FINDQWTFSNLRECVPPVVPE 199 (245)
Q Consensus 133 p~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~-----------~~-~~~Diws~g~~~~~~~~~~~p 199 (245)
|+||+++.++.+||+|||+|+....... ... .+|.+||.+... ++ .++|+||+||++|+|++|.+|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999997543222 223 668999999876 55 788999999999999999999
Q ss_pred CCCCCCCCCCcccCcC
Q psy16292 200 LSGDDDTSNFDDIEKD 215 (245)
Q Consensus 200 f~~~~~~~~~~~~~~~ 215 (245)
|.+.........+...
T Consensus 313 f~~~~~~~~~~~~~~~ 328 (377)
T 3byv_A 313 ITKDAALGGSEWIFRS 328 (377)
T ss_dssp C------CCSGGGGSS
T ss_pred Ccccccccchhhhhhh
Confidence 9988877777666553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.87 Aligned_cols=197 Identities=17% Similarity=0.194 Sum_probs=154.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC------EEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK------SLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~~~ 82 (245)
.+|+|+||.|+ +|+++ |+.|| ++.+.........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 32 ~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 32 PIGSGAQGIVC-----AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEecCCEEEE-----EEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 48899999995 56554 88888 222222223345677899999999999999999999997665 799
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 107 lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 184 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184 (371)
T ss_dssp EEEECCS-EEHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----------
T ss_pred EEEEcCC-CCHHHHHhh-ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccC
Confidence 9999995 688888764 5889999999999999999999999999999999999999999999999999876543222
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
....+|.+||.+.+.++ .++|+||+||++++|++|.+||.+.++...+.++...
T Consensus 185 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp -----CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred CceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 23445889999988777 7889999999999999999999988766655555443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.48 Aligned_cols=193 Identities=18% Similarity=0.210 Sum_probs=157.1
Q ss_pred hhccccccchhhhHHHHHh-----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC-EEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLK-----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK-SLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~-----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~-~~~ 82 (245)
.+|+|+||.|+ +|+ .. ++.||++.-.........+.+.+|+.+++++ +||||+++++++...+ .++
T Consensus 29 ~lG~G~~g~Vy-----~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 29 PLGRGAFGQVI-----EADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEECSSEEEE-----EEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eecCCCCceEE-----EEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 48889999995 554 23 6888832222222334567799999999999 8999999999998765 499
Q ss_pred EEEeccCCCCHHHHHhcCC-------------------------------------------------------------
Q psy16292 83 MVMDYMPGGDLVNLMSNYD------------------------------------------------------------- 101 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~------------------------------------------------------------- 101 (245)
+||||+++|+|.+++....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 9999999999999987532
Q ss_pred ------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCc
Q psy16292 102 ------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNG 169 (245)
Q Consensus 102 ------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~ 169 (245)
+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... .....+|.+
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 78889999999999999999999999999999999999999999999999987643322 122334889
Q ss_pred hhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCC
Q psy16292 170 IEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNF 209 (245)
Q Consensus 170 ~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~ 209 (245)
||.+.+..+ .++|+||+|+++|++++ |.+||.+......+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 305 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH
Confidence 999988776 78899999999999998 99999887654443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=242.32 Aligned_cols=200 Identities=19% Similarity=0.187 Sum_probs=155.8
Q ss_pred HHHHhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhc--cCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIK--RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
|.-.-.+++|+||.|+ ++++.|+.+| ++.+..... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 9 ~~~~~~lg~G~~g~V~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVY-----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp EEEEEEEEEETTEEEE-----EEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred eeeeeeeccCCCeEEE-----EEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3334468999999995 6666688888 332222111 2346789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCceEecC--------CCcEEEEeeCce
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLG---FVHRDVKPDNMLLDK--------HGHLKLADFGTC 152 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~---iih~dlkp~nil~~~--------~~~i~l~Dfg~a 152 (245)
||||+++++|.+++....+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999998888999999999999999999999999 899999999999986 678999999999
Q ss_pred eecCCCCC--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 153 MRMNKTGT--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 153 ~~~~~~~~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
+....... .....++.+||.+.+.++ .++|+||+|++++++++|.+||.+..+......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 225 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence 86553322 223445789999988776 678999999999999999999988765544333
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=251.91 Aligned_cols=198 Identities=20% Similarity=0.230 Sum_probs=153.7
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.-.+++|+||+|+ +|+++ |+.|| ++.+.........+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 39 ~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 39 ITKLGEGTYGEVY-----KAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp EEEEEECSSSEEE-----EEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEecCCeEEE-----EEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 3357889999995 66554 88888 3332222333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-----CCCcEEEEeeCceeecCCCCC
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-----KHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-----~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|++ ++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++ ..+.++|+|||+++.......
T Consensus 114 ~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 114 YAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp CCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred cCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 995 6999988754 589999999999999999999999999999999999994 445699999999986643322
Q ss_pred ----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 161 ----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
.....+|.+||.+.+.. + .++|+||+||+++++++|.+||.+..+.....++.
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 12245589999987644 4 78899999999999999999998877655544443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=254.00 Aligned_cols=190 Identities=16% Similarity=0.171 Sum_probs=155.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC--EEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK--SLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lv~e~ 87 (245)
.+++|+||+|+ +|+++ |+.||++.-.........+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 16 ~LG~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 16 ILGQGATANVF-----RGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred EEEcCCCeEEE-----EEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 37889999995 66666 88888222112222355678899999999999999999999998765 78999999
Q ss_pred cCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe----cCCCcEEEEeeCceeecCCCC
Q psy16292 88 MPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 88 ~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~----~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||+++......
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~ 170 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC
Confidence 9999999998753 28999999999999999999999999999999999998 777889999999998865443
Q ss_pred Ccc---ccCCCCchhhhhc--------CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 160 TET---KRLGRNGIEEIKA--------HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 160 ~~~---~~~~~~~~e~i~~--------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
... ...+|.+||.+.. .++ .++|+||+||++|++++|.+||.+..+.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 322 3445789998864 233 6789999999999999999999865443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.48 Aligned_cols=198 Identities=16% Similarity=0.151 Sum_probs=158.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeE----EEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTL----YALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~----~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.+|+|+||+|+ +|+++ |+. +|+..............+.+|+.+++.++||||+++++++. +...++||
T Consensus 20 ~lG~G~~g~Vy-----~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 20 VLGSGVFGTVH-----KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEECCSSCEEE-----EEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred eeeecCCceEE-----EEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 48999999995 66544 444 34211111223345567889999999999999999999986 45689999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 173 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccccc
Confidence 999999999998764 588899999999999999999999999999999999999999999999999987644322
Q ss_pred ---ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ---ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+|.+||.+....+ .++|+||+|+++|++++ |.+||.+.........+..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 122335889999987777 78899999999999999 99999987766655555444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=241.15 Aligned_cols=202 Identities=20% Similarity=0.175 Sum_probs=159.4
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE-EeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF-QDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~~~lv~ 85 (245)
.+++|+||+|+ +++.. +..+|++...........+.+.+|+.++++++||||+++++++ ..++..++||
T Consensus 32 ~lg~G~~g~Vy-----~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 32 VIGRGHFGCVY-----HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEETTEEEE-----EEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred eeeecCCceEE-----EEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 48999999995 44432 3345532222223334567899999999999999999999985 4566889999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcc
Confidence 999999999999753 488999999999999999999999999999999999999999999999999986543221
Q ss_pred --c---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 --E---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 --~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. ....++.+||.+.+.++ .++|+||+|++++++++ +.+||.+.........+..+..+
T Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp -----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 1 11234788999987776 78899999999999998 77888887776665555554433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=247.30 Aligned_cols=194 Identities=20% Similarity=0.276 Sum_probs=160.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-----CccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-----SEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv~l~~~~~~~~~~~l 83 (245)
++++|+||+|+ +|+++ |+.|| ++.+. .....+....|+.+++.+. ||||+++++++...+..++
T Consensus 42 ~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 42 KMGDGTFGRVL-----LCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred EEcccCCeEEE-----EEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 48899999994 66665 88888 32221 1234556788999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC--------------------
Q psy16292 84 VMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-------------------- 140 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-------------------- 140 (245)
|||++ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999 99999998754 3899999999999999999999999999999999999975
Q ss_pred -----CCcEEEEeeCceeecCCCC-CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 141 -----HGHLKLADFGTCMRMNKTG-TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 141 -----~~~i~l~Dfg~a~~~~~~~-~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
++.++|+|||+++...... .......|.+||.+.+.++ .++|+||+||++|+|++|.+||.+..+......+.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 7889999999998754432 2233445889999988877 78899999999999999999998877655554443
Q ss_pred c
Q psy16292 214 K 214 (245)
Q Consensus 214 ~ 214 (245)
.
T Consensus 273 ~ 273 (360)
T 3llt_A 273 S 273 (360)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=258.34 Aligned_cols=199 Identities=19% Similarity=0.281 Sum_probs=163.9
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.||+|+||.|+ +++.+ +..||++.-. ......+.+.+|+.++++++||||+++++++.....+++||||
T Consensus 225 ~~~lG~G~fg~Vy-----~~~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 225 KHKLGGGQYGEVY-----EGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp EEESGGGTTSSEE-----EEEEGGGTEEEEEEECC--SSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEecCCCCeEEE-----EEEEcCCCeEEEEEEec--CcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3458999999995 55555 7888832211 1234578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 999999999874 34889999999999999999999999999999999999999999999999999876433211
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+....+ .++|+||+|++++++++ |.+||.+.+.......+..+
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 435 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 11234789999987776 68899999999999998 99999887765554444433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=243.46 Aligned_cols=194 Identities=20% Similarity=0.296 Sum_probs=155.6
Q ss_pred HHHHHhh-----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEE
Q psy16292 6 AFMHRYR-----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAF 75 (245)
Q Consensus 6 ~f~~~y~-----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 75 (245)
+|.++|+ +++|+||+|+ +|+++ |+.|| ++++. .....+.+.+|+.++.++ +||||+++++++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQ-----TCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEE-----EEECSSSCCEEEEEEEECC---SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceeEEecCceecCCceEEEE-----EEEEcCCCcEEEEEEEeeC---cchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3455664 5889999994 66655 88888 32222 234567899999999985 799999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEEeeCc
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADFGT 151 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~Dfg~ 151 (245)
.+++.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999999998865 45899999999999999999999999999999999999988776 99999999
Q ss_pred eeecCCCCC-----------ccccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 152 CMRMNKTGT-----------ETKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 152 a~~~~~~~~-----------~~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
++....... ......+.+||.+.. .++ .++|+||+||++++|++|.+||.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 886542211 113344788998864 223 68899999999999999999998876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=240.16 Aligned_cols=193 Identities=20% Similarity=0.263 Sum_probs=162.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+ +++.+ |+.||+..-.........+.+.+|+.+++.++||||+++++++.....+++||||++
T Consensus 29 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 29 KIGKGSFGEVF-----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEECSSSEEE-----EEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhcccCCeEEE-----EEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 48899999995 55544 888882221122224567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccccC
Q psy16292 90 GGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~~~ 165 (245)
+++|.+++..+.+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........ .....
T Consensus 104 ~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 183 (303)
T 3a7i_A 104 GGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 183 (303)
T ss_dssp TEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCG
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCc
Confidence 99999999888899999999999999999999999999999999999999999999999999987654322 12233
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
.+.+||.+...++ .++|+||+|++++++++|.+||.+..+....
T Consensus 184 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 4789999887776 7889999999999999999999876554433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=250.93 Aligned_cols=183 Identities=22% Similarity=0.229 Sum_probs=147.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~l 83 (245)
.+|+|+||.|+ +|+++ |+.|| ++.+.........+++.+|+.+|+.++||||+++++++... ..+|+
T Consensus 33 ~lG~G~~g~V~-----~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 33 LIGRGSYGYVY-----LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEETTEEEE-----EEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEeecCCEEEE-----EEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 37899999995 66555 88899 32222223334567899999999999999999999999876 57999
Q ss_pred EEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 84 VMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
|||++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+|+.......
T Consensus 108 v~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 186 (432)
T 3n9x_A 108 VLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186 (432)
T ss_dssp EEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------
T ss_pred EEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccc
Confidence 99998 57999998865 489999999999999999999999999999999999999999999999999997654321
Q ss_pred ------------------------ccccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCC
Q psy16292 161 ------------------------ETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 161 ------------------------~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf 200 (245)
......|.+||.+.. ..+ .++|+||+||++++|++|..|+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 112334789998744 444 6789999999999999844433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=248.85 Aligned_cols=195 Identities=24% Similarity=0.220 Sum_probs=157.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--------CCE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--------AKS 80 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--------~~~ 80 (245)
.+++|+||+|+ +|+++ |+.||+ +.............+.+|+.+++.++||||+++++++.. .+.
T Consensus 24 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 24 KIGQGTFGEVF-----KARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp ECSSCSTTSEE-----EEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred EEecCCCcEEE-----EEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 48999999994 66665 888883 222223334456678999999999999999999999987 457
Q ss_pred EEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++||||+. ++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 99 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 177 (351)
T 3mi9_A 99 IYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177 (351)
T ss_dssp EEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCC
T ss_pred EEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccc
Confidence 899999995 578777765 35899999999999999999999999999999999999999999999999999876422
Q ss_pred CC-----cc---ccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 159 GT-----ET---KRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 159 ~~-----~~---~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.. .. ...+|.+||.+.+. .+ .++|+||+||+++++++|.+||.+.++......+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp SSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 11 11 23347899988764 34 7889999999999999999999987765554444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.71 Aligned_cols=201 Identities=17% Similarity=0.155 Sum_probs=160.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||+|+.+........ ++.+|+..-.........+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 109 (313)
T 1t46_A 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC 109 (313)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecC
Confidence 488999999953221111122 6777722211112223567899999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 89 PGGDLVNLMSNY-------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 89 ~~g~L~~~l~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
++|+|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+||
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 189 (313)
T 1t46_A 110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189 (313)
T ss_dssp TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCC
T ss_pred CCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccc
Confidence 999999998754 2789999999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCccc
Q psy16292 150 GTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDI 212 (245)
Q Consensus 150 g~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~ 212 (245)
|+++........ ....++.+||.+.+.++ .++|+||+|++++++++ |.+||.+......+...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp GGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred cccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 999876544321 12234889999887776 78899999999999998 99999887655444333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=264.24 Aligned_cols=200 Identities=20% Similarity=0.216 Sum_probs=162.1
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+|+ ++..+ +..||++...........+.+.+|+.++++++||||+++++++.. +.+++||||
T Consensus 343 ~LG~G~fG~Vy-----~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVR-----QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEE-----EEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EEecCCCcEEE-----EEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 58999999995 54432 556773222222334567889999999999999999999999976 569999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+......
T Consensus 417 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999988643 4899999999999999999999999999999999999999999999999999875433211
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....+|.+||.+....+ .++|+||+||+++++++ |.+||.+....+....+..+..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~ 557 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 11245899999987777 78899999999999998 9999998877776666665543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=249.97 Aligned_cols=198 Identities=21% Similarity=0.257 Sum_probs=154.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+|+|+||+|+ +|+.+ |+.||++.-...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 8 DKLGEGTYATVY-----KGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp EEEEECSSEEEE-----EEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred EEEcCCCCEEEE-----EEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 358999999995 66665 88888222111112233334568999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----c
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----T 162 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----~ 162 (245)
+ ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........ .
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 161 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccccc
Confidence 5 6898887653 4889999999999999999999999999999999999999999999999999865433221 2
Q ss_pred ccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 163 KRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 163 ~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
...++.+||.+.+ .++ .++|+||+||++++|++|.+||.+.+.......+..
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2444789998876 344 678999999999999999999998876655555443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=238.20 Aligned_cols=201 Identities=21% Similarity=0.222 Sum_probs=163.0
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
-.+++|+||.|+ +++++ |+.+| ++.+.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 17 DTLGVGTFGKVK-----IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp EEEEECSSEEEE-----EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeecCCCCeEEE-----EEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 347889999994 66555 88888 4444444445667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---c
Q psy16292 87 YMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---T 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---~ 162 (245)
++++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++......... .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 171 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceeccc
Confidence 9999999998864 46899999999999999999999999999999999999999999999999999876543322 2
Q ss_pred ccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 163 KRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+.+||.+.+..+ .++|+||+|++++++++|.+||.+......+..+..+.
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (276)
T 2h6d_A 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227 (276)
T ss_dssp -----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 2344788999887765 57899999999999999999998766554444444443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=246.69 Aligned_cols=207 Identities=20% Similarity=0.255 Sum_probs=166.8
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhh------ccCchHHHHHHHHHHHhc-CCcccee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQI------KRSDSAFFWEERDIMAHA-NSEWIVQ 70 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~------~~~~~~~~~~E~~il~~l-~hp~Iv~ 70 (245)
.+|.++|+ +++|+||.|+ +|+.+ |+.|| ++.+.... .....+.+.+|+.+++++ +||||++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy-----~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVR-----RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hhhhhhcccceEEecCCCEEEE-----EEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 56667765 7889999994 66665 88888 32221110 012256788999999999 8999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEee
Q psy16292 71 LHFAFQDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 71 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
+++++......++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999999998875 46899999999999999999999999999999999999999999999999
Q ss_pred CceeecCCCCCcccc---CCCCchhhhhcC------CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 150 GTCMRMNKTGTETKR---LGRNGIEEIKAH------PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 150 g~a~~~~~~~~~~~~---~~~~~~e~i~~~------~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
|++..+......... .+|.+||.+.+. ++ .++|+||+||++|++++|.+||.+.........+..+.
T Consensus 245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 999887654433333 347889988643 33 67899999999999999999998776555444444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.29 Aligned_cols=195 Identities=22% Similarity=0.293 Sum_probs=161.4
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
|.++|+ +++|+||.|+ +|+++ |+.+|+..-.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQ-----LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEE-----EEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eecceEEEEEeecCCCcEEE-----EEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 566665 7788999994 66555 888882221111223456789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
.++|||++++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999999988754 58999999999999999999999999999999999999999999999999998654322
Q ss_pred ------CccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 160 ------TETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 160 ------~~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
......++.+||.+...++ .++|+||+|++++++++|..||.+..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 1122344788999877665 5689999999999999999999887654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=242.06 Aligned_cols=198 Identities=19% Similarity=0.239 Sum_probs=160.7
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-.+++|+||.|+ +++.+ +..+| ++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 29 ~~~lg~G~~g~V~-----~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 29 LKELGTGQFGVVK-----YGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp EEECC---CEEEE-----EEEETTTEEEEEEEECT---TSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HhhcCCCCCceEE-----EEEEcCCCeEEEEEecC---CCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3458999999995 66666 66777 22221 223456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----- 160 (245)
+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 999999999875 4689999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 112234789999987776 67899999999999998 99999887766655555544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=256.00 Aligned_cols=199 Identities=23% Similarity=0.318 Sum_probs=154.1
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhh-----ccCchHHHHHHHHHHHhcCCccceee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQI-----KRSDSAFFWEERDIMAHANSEWIVQL 71 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l 71 (245)
..+.++|+ +|+|+||+|+ +|.++ ++.|| ++.+.... .......+.+|+.++++++||||+++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~-----~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 205 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVK-----LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEE-----EEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEE-----EEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence 45666776 7899999994 66555 88899 44443321 12233458899999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC---cEEEE
Q psy16292 72 HFAFQDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG---HLKLA 147 (245)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~---~i~l~ 147 (245)
++++. .+..++||||+++++|.+.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++..+ .++|+
T Consensus 206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 206 KNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp CEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 99985 4568999999999999998765 4589999999999999999999999999999999999997654 59999
Q ss_pred eeCceeecCCCCCcc---ccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 148 DFGTCMRMNKTGTET---KRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 148 Dfg~a~~~~~~~~~~---~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
|||+++......... ...+|.+||.+.+ ..+ .++|+||+||++|+|++|.+||.+.......
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 999998765443322 3445789998753 344 5789999999999999999999876655443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=265.11 Aligned_cols=200 Identities=19% Similarity=0.180 Sum_probs=163.6
Q ss_pred hhccccccchhhhHHHHHhh--c--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY--R--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~--~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
+||+|+||.|+ ++.. + ++.|| ++.+.........+.+.+|+.++++++||||+++++++.. +.+++|||
T Consensus 376 ~LG~G~fG~Vy-----~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E 449 (635)
T 4fl3_A 376 ELGSGNFGTVK-----KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 449 (635)
T ss_dssp EEEECSSEEEE-----EEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred EeccCCCEEEE-----EEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence 58999999995 4422 2 67788 4334334444557889999999999999999999999965 45889999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
|+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.+......
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999998765 5899999999999999999999999999999999999999999999999999876443221
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....+|.+||.+....+ .++|+||+||+++++++ |.+||.+.........+..+..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~ 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 11234789999988777 78899999999999998 9999998877766666655543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=239.76 Aligned_cols=191 Identities=22% Similarity=0.240 Sum_probs=155.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||+|+ +|+++ |+.||+. -..........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 10 KIGEGSYGVVF-----KCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEeecCCeEEE-----EEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 47889999994 66665 8888832 2222222233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccc
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETK 163 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~ 163 (245)
++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....... ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 164 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcC
Confidence 99999888774 4589999999999999999999999999999999999999999999999999987653322 122
Q ss_pred cCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 164 RLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 164 ~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
..++.+||.+.+ .++ .++|+||+|++++++++|.+||.+..+..
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp -GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 334789999876 344 78899999999999999999998876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=251.40 Aligned_cols=201 Identities=20% Similarity=0.168 Sum_probs=152.7
Q ss_pred hhccccccchhhhHHHHHhhc---C--eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE-eCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---Y--TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ-DAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~--~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~ 85 (245)
.+++|+||+|+ +++.. + ..+|++...........+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 96 ~LG~G~fg~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 96 VIGRGHFGCVY-----HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEECCSSSEEE-----EEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred EeeeCCCeEEE-----EEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 48999999995 55432 2 3445322222233345678999999999999999999999865 456889999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||+++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 999999999999754 478889999999999999999999999999999999999999999999999986543221
Q ss_pred -----ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.....++.+||.+...++ .++|+||+|+++|++++ +.+||.+.+.......+..+..
T Consensus 251 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~ 314 (373)
T 3c1x_A 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314 (373)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence 111234789999988776 78899999999999998 7899988776665555544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=240.58 Aligned_cols=189 Identities=17% Similarity=0.164 Sum_probs=154.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--C-------eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--Y-------TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~-------~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
.-.+++|+||+|+ +++.+ + ..+|+.. .........+.+.+|+.++++++||||+++++++.+++.
T Consensus 13 ~~~lg~G~~g~V~-----~~~~~~~~~~~~~~~~~va~K~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 13 NESLGQGTFTKIF-----KGVRREVGDYGQLHETEVLLKV-LDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp EEEEEEETTEEEE-----EEEEEEECGGGCEEEEEEEEEE-ECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred eeeeccCCCceEE-----EEEEecccccccccchhhhhhh-cccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3458899999995 55544 3 4466211 111234566789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc--------EEEEeeC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH--------LKLADFG 150 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~--------i~l~Dfg 150 (245)
.++||||+++++|.+++.... +++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 999999999999999997654 899999999999999999999999999999999999998887 9999999
Q ss_pred ceeecCCCCCccccCCCCchhhhhc-CCC-cccCCCcccccceecCCc-cCCCCCCC
Q psy16292 151 TCMRMNKTGTETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPV-VPELSGDD 204 (245)
Q Consensus 151 ~a~~~~~~~~~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~-~~pf~~~~ 204 (245)
++.............++.+||.+.. ..+ .++|+||+|++++++++| .+|+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 9976654444445667899999976 434 678999999999999995 55555443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=243.71 Aligned_cols=198 Identities=19% Similarity=0.233 Sum_probs=157.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
++|...-.+++|+||.|+ +|+.+ |+.||++ -..........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVM-----KCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEE-----EEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeEEeecCCEEEE-----EEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 333334468999999994 66666 8888832 222222223356688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999998888887654 4689999999999999999999999999999999999999999999999999987543322
Q ss_pred ----ccccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.....++.+||.+.+. .+ .++|+||+|++++++++|.+||.+..+..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 2234457899998765 34 67899999999999999999998876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=236.38 Aligned_cols=198 Identities=16% Similarity=0.287 Sum_probs=160.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
.+++|+||+|+ +|+.+ |+.+| ++++...... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 12 ~lg~G~~g~V~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 12 ELGSGQFAIVR-----KCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcccCceEEE-----EEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 37888999994 66665 88888 3333322211 2467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEEEeeCceeecCCCC
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADFGTCMRMNKTG 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~Dfg~a~~~~~~~ 159 (245)
||++++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++.......
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~ 166 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence 999999999998864 4689999999999999999999999999999999999998877 79999999998765443
Q ss_pred Ccc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 160 TET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 160 ~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
... ....+.+||.+...++ .++|+||+|++++++++|.+||.+......+..+..
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 322 2334788999877666 788999999999999999999988766555444433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=241.83 Aligned_cols=206 Identities=14% Similarity=0.157 Sum_probs=153.8
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-----EEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-----SLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv~ 85 (245)
.+++|+||+|+.+........++.+| +..+.........+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~ 120 (313)
T 3brb_A 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120 (313)
T ss_dssp EEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEE
T ss_pred ceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEE
Confidence 37889999995321111111145677 322222223345677999999999999999999999998765 459999
Q ss_pred eccCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 86 DYMPGGDLVNLMSN-------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 86 e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
|++++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.....
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC------
T ss_pred ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccc
Confidence 99999999998832 34899999999999999999999999999999999999999999999999999876433
Q ss_pred CC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 159 GT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 159 ~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
.. ......+.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+..
T Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ----------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred cccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 21 122334788999887776 77899999999999999 9999998877766666555543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=238.81 Aligned_cols=199 Identities=20% Similarity=0.218 Sum_probs=160.2
Q ss_pred hhccccccchhhhHHHHHhh----cCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY----RYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~----~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ ++.. .+..+|+..-.........+.+.+|+.++++++||||+++++++ ..+..++|||+
T Consensus 17 ~lg~G~~g~Vy-----~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 90 (287)
T 1u59_A 17 ELGCGNFGSVR-----QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 90 (287)
T ss_dssp EEECCTTEEEE-----EEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred cccccCceeEE-----EeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence 57889999995 4432 27777722211112334567899999999999999999999999 45679999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 999999999864 34899999999999999999999999999999999999999999999999999876543221
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~ 230 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC
Confidence 11244789999887666 78899999999999998 999998877655555554443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.07 Aligned_cols=192 Identities=18% Similarity=0.250 Sum_probs=156.5
Q ss_pred hhccccccchhhh-HHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRL-FEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~-~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e~~ 88 (245)
.+++|+||+|+.+ |.......|+.||++.-.........+.+.+|+.+++.++||||+++++++.+. ..+++||||+
T Consensus 38 ~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (318)
T 3lxp_A 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117 (318)
T ss_dssp EEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCC
T ss_pred eecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecc
Confidence 3889999999522 111111228888832211222234567799999999999999999999999884 6899999999
Q ss_pred CCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-------
Q psy16292 89 PGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE------- 161 (245)
Q Consensus 89 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~------- 161 (245)
++++|.+++....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 197 (318)
T 3lxp_A 118 PLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197 (318)
T ss_dssp TTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---C
T ss_pred cCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCC
Confidence 9999999999888999999999999999999999999999999999999999999999999999987544321
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....+.+||.+.+.++ .++|+||+|++++++++|..||...
T Consensus 198 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 11223789999988776 6889999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.21 Aligned_cols=196 Identities=19% Similarity=0.185 Sum_probs=161.6
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEE--Eehhhh-hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYAL--YSRYFQ-IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av--~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-.+|+|+||.|+ +++..++.+|+ +.+... ......+.+.+|+.++++++||||+++++++.+.+..++|||+
T Consensus 37 ~~lg~G~~g~Vy-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 37 NKMGEGGFGVVY-----KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp CEEEECSSEEEE-----EEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CccccCCCeEEE-----EEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 458999999995 55556888882 222221 2234467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 88 MPGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 88 ~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 999999998863 3489999999999999999999999999999999999999999999999999987654322
Q ss_pred ---ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 161 ---ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 161 ---~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....++.+||.+.+....++|+||+|++++++++|.+||.+.........
T Consensus 192 ~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred ccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 122344788998876555789999999999999999999988766554433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=254.29 Aligned_cols=196 Identities=19% Similarity=0.300 Sum_probs=161.6
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|+||+|+ +++.+ +..+|+ ..+. .....+.+.+|+.++++++||||+++++++. ...+++||||+
T Consensus 194 ~~lG~G~fg~V~-----~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 194 KKLGAGQFGEVW-----MATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp EEEECCSSEEEE-----EEEETTTEEEEEEEECT---TSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred EEcccCCceEEE-----EEEECCccEEEEEEecC---CCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 358999999995 56655 777883 2221 2345788999999999999999999999986 56789999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-----C
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-----T 160 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-----~ 160 (245)
++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 999999998753 58889999999999999999999999999999999999999999999999998754321 1
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+...++ .++|+||+|++++++++ |.+||.+.+.......+..+
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 112334889999987777 78899999999999998 99999987766555555444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=237.84 Aligned_cols=208 Identities=21% Similarity=0.289 Sum_probs=169.7
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
.++|.++|+ +++|+||+|+ +|+.+ |+.|| ++.+.........+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~-----~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVL-----KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEE-----EEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEE-----EEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 467888887 6788999994 66655 88888 333333334456788999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a 152 (245)
..+..++|||++++++|.+.+. ...+++..+..++.|++.||.+||++|++|+||||+||+++.. +.++|+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999999988775 4568999999999999999999999999999999999999764 46999999999
Q ss_pred eecCCCCCc---cccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 153 MRMNKTGTE---TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 153 ~~~~~~~~~---~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
......... .....+.+||.+.+....++|+||+|++++++++|.+||.+.+.......+..+.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 866543322 2334578999887765578999999999999999999998877655555554443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=243.85 Aligned_cols=205 Identities=16% Similarity=0.157 Sum_probs=160.5
Q ss_pred hhhccccccchhhhHHHHH---h-hcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLL---K-YRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~---~-~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
-.+++|+||+|+.+..... + ..+..+|++.-.........+.+.+|+.+++.+ +||||+++++++...+.+++||
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 120 (334)
T 2pvf_A 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120 (334)
T ss_dssp EEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEE
T ss_pred eEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEE
Confidence 3488899999953222110 0 116677732222222334567799999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEe
Q psy16292 86 DYMPGGDLVNLMSNYD-----------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~D 148 (245)
||+++++|.+++.... +++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 200 (334)
T 2pvf_A 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200 (334)
T ss_dssp ECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred ECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcc
Confidence 9999999999987542 78889999999999999999999999999999999999999999999
Q ss_pred eCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 149 FGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 149 fg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
||+++........ ....++.+||.+.+..+ .++|+||+|++++++++ |.+||.+......+..+..+
T Consensus 201 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp CTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred ccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 9999876543221 11234789999877766 77899999999999998 99999887655554444443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=240.64 Aligned_cols=199 Identities=19% Similarity=0.189 Sum_probs=156.6
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE-EEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL-YMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~-~lv~ 85 (245)
.+++|+||+|+ +|+.. +..+|+............+.+.+|+.+++.++||||+++++++.+.+.. +++|
T Consensus 28 ~lg~G~~g~Vy-----~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 28 VIGKGHFGVVY-----HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEETTEEEE-----EEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred eeccCCCceEE-----EEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 38999999995 55432 3356632222223334567899999999999999999999999876655 9999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC----
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---- 159 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---- 159 (245)
|++.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999999976 358889999999999999999999999999999999999999999999999998653321
Q ss_pred ----CccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 ----TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ----~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.......+.+||.+.+.++ .++|+||+|++++++++ +.||+.+.........+...
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence 1122334788999887776 68899999999999999 66767666655544444444
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=241.06 Aligned_cols=204 Identities=22% Similarity=0.316 Sum_probs=164.5
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
.++.++|+ +++|+||+|+ +|+.+ |+.+| ++++.. ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVF-----LVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYE 76 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhccceeeeeccCCCCceEE-----EEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence 34566666 7888999994 66655 88888 333221 233456889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCce
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTC 152 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a 152 (245)
+....++|||++++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred cCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999999999998764 468999999999999999999999999999999999999 77889999999998
Q ss_pred eecCCCCC--ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 153 MRMNKTGT--ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 153 ~~~~~~~~--~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
+....... .....++.+||.+.+.++ .++|+||+|++++++++|.+||.+......+.++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 223 (304)
T 2jam_A 157 KMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY 223 (304)
T ss_dssp CCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred eecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 76543321 123455889999887776 67899999999999999999998877665555555443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=238.65 Aligned_cols=191 Identities=24% Similarity=0.258 Sum_probs=150.4
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
|.++|+ +|+|+||+|+ +|+.+ |+.||++ .+..............|+..+..+ +||||+++++++.++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVF-----KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEE-----EEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhheeeeheeccCCCeEEE-----EEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 456664 8999999995 66665 8888833 222222223344556666666555 999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+.+++|||++ +++|.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999999 7899887764 358999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCccc---cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCC
Q psy16292 157 KTGTETK---RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 157 ~~~~~~~---~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
....... ..+|.+||.+.+....++|+||+||+++++++|.+|+.+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4433333 3457899988875447899999999999999997666544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=243.71 Aligned_cols=199 Identities=15% Similarity=0.181 Sum_probs=155.1
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE---EEeh-hhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA---LYSR-YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a---v~~k-~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
-.+++|+||+|+ +|+++ |+.+| +++. .........+.+.+|+.+++.++||||+++++++..+. .+++
T Consensus 21 ~~lG~G~~g~Vy-----~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 21 KVLGSGAFGTVY-----KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEECSSEEEE-----EEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred EEeeeCCCeEEE-----EEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 348899999995 66554 55443 1121 12223456788999999999999999999999998765 7889
Q ss_pred EeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 85 MDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
+|++.+|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.........
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 999999999998875 358999999999999999999999999999999999999999999999999998764332211
Q ss_pred ---c---cCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 163 ---K---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 ---~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
. ...|.+||.+.+.++ .++|+||+|+++|++++ |.+||.+.........+...
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 1 224789999988877 78899999999999999 99999887766555444444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=244.38 Aligned_cols=187 Identities=18% Similarity=0.146 Sum_probs=154.8
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.-.+++|+||+|+ +++.+ |+.||++.-...........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 35 ~~~lg~G~~g~V~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 109 (326)
T 3uim_A 35 KNILGRGGFGKVY-----KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 109 (326)
T ss_dssp TTEEECCSSSEEE-----EECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECC
T ss_pred ceeEecCCCcEEE-----EEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEec
Confidence 3458999999995 55555 88888322222222334447899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 89 PGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCL---GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 89 ~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
++++|.+++... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++.......
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 999999998754 288999999999999999999999 999999999999999999999999999987653322
Q ss_pred c--c---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCC
Q psy16292 161 E--T---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 161 ~--~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
. . ...++.+||.+.+.++ .++|+||+|++++++++|.+||.
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 1 1 2344789999877766 67899999999999999999995
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=238.10 Aligned_cols=198 Identities=20% Similarity=0.290 Sum_probs=163.7
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|+||.|+ +++++ ++.+|+..- .......+.+.+|+.++++++||||+++++++.+....++|||++
T Consensus 19 ~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 19 HKLGGGQYGEVY-----EGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp EESGGGTTCSEE-----EEEEGGGTEEEEEEEE--CSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eecCCCCceeEE-----EeEecCCCEEEEEEec--CcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 358999999995 56555 888883221 123345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 89 PGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
++++|.+++... .+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 999999998752 4899999999999999999999999999999999999999999999999999866533321
Q ss_pred -cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 -TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
....++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+...
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~ 228 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence 11234789999987776 78899999999999999 99999887766555544443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=238.80 Aligned_cols=199 Identities=19% Similarity=0.171 Sum_probs=160.1
Q ss_pred hhccccccchhhhHHHHHh--hc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLK--YR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~--~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+++|+||+|+ ++. .+ ++.+| ++.+.........+.+.+|+.+++.++||||+++++++ ..+..++|||
T Consensus 24 ~lg~G~~g~Vy-----~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 24 ELGSGNFGTVK-----KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEECSSEEEE-----EEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred ccccccCeeeE-----eeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 57889999995 552 22 67777 33333323334467899999999999999999999999 5677899999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc---
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET--- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~--- 162 (245)
++++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccccc
Confidence 99999999998765 48999999999999999999999999999999999999999999999999998765443211
Q ss_pred ----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 163 ----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 163 ----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
....+.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 237 (291)
T 1xbb_A 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237 (291)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 1234789999987776 68899999999999998 999998877655554444443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=244.90 Aligned_cols=200 Identities=16% Similarity=0.172 Sum_probs=155.4
Q ss_pred hhhccccccchhhhHHHHHhhc------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 84 (245)
-.+++|+||+|+ +++.+ +..+|+..-...........+.+|+.+++.++||||+++++++...+..++|
T Consensus 50 ~~lG~G~~g~Vy-----~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 50 KVIGAGEFGEVY-----KGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp EEEEECSSSEEE-----EEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cEEecCCCeEEE-----EEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 348999999995 44433 3346622211112234456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-
Q psy16292 85 MDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE- 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~- 161 (245)
||++++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 999999999999875 35899999999999999999999999999999999999999999999999999876533211
Q ss_pred ---c---ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 ---T---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ---~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
. ....+.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 1 1234789999987776 67899999999999998 99999877665555555444
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=246.20 Aligned_cols=194 Identities=19% Similarity=0.228 Sum_probs=142.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEe-hhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYS-RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~-k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~ 82 (245)
.+|+|+||.|+ +|.++ |+.||++. +.........+++.+|+.+++.++||||+++++++... ..++
T Consensus 36 ~lG~G~~g~V~-----~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 36 PVGSGAYGSVC-----AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp ECC----CCEE-----EEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEeecCCeEEE-----EEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 48899999995 56544 88888322 22222234567889999999999999999999999754 5689
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
+++|++ +++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 111 lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 189 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189 (367)
T ss_dssp EEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred EEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccCCCc
Confidence 999999 88999999888899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 162 TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 162 ~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....|.+||.+.+ ..+ .++|+||+||++++|++|.+||.+.+....+..
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 241 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 23445789999876 444 678999999999999999999998775444433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=240.65 Aligned_cols=203 Identities=11% Similarity=0.077 Sum_probs=165.8
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KS 80 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 80 (245)
+++|.-.-.+++|+||.|+ +++.+|+.+| ++.+.........+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEE-----EEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred HHHhHHHHHhcCCCcceEE-----EEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3444445568999999994 6777788888 33333333344567799999999999999999999999887 78
Q ss_pred EEEEEeccCCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 81 LYMVMDYMPGGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.++||||+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999999998653 899999999999999999999999 999999999999999999999988887654
Q ss_pred CCCCCccccCCCCchhhhhcCCCc----ccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 156 NKTGTETKRLGRNGIEEIKAHPFF----INDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 156 ~~~~~~~~~~~~~~~e~i~~~~~~----~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
... .......+.+||.+.+.++. ++|+||+|++++++++|.+||.+.........+
T Consensus 164 ~~~-~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 164 QSP-GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp SCT-TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred ccc-CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 332 22334568999999876652 589999999999999999999877655544433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=233.64 Aligned_cols=189 Identities=17% Similarity=0.158 Sum_probs=156.4
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv 84 (245)
.+++|+||+|+ +|.+. +..+| +..+.........+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 33 ~lg~G~~g~Vy-----~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 33 EIGRGSFKTVY-----KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred eccCCCCeEEE-----EeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 48899999995 55555 77788 3333333344567889999999999999999999999875 4579999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEec-CCCcEEEEeeCceeecCCCCC
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++........
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 187 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc
Confidence 999999999999876 56899999999999999999999999 99999999999997 788999999999975443322
Q ss_pred --ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....++.+||.+.+....++|+||+|++++++++|.+||.+..+
T Consensus 188 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 188 KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 223455789998876655889999999999999999999987544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=242.17 Aligned_cols=204 Identities=17% Similarity=0.173 Sum_probs=159.6
Q ss_pred hhccccccchhhhHHHH-Hhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYL-LKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l-~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||+|+.+.... .+.. ++.+|+..-...........+.+|+.+++.++||||+++++++.+.+..++|||+++
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 111 (322)
T 1p4o_A 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 111 (322)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCC
Confidence 47889999995322111 1111 566773222222223345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 90 GGDLVNLMSN-----------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 90 ~g~L~~~l~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence 9999998864 34688999999999999999999999999999999999999999999999999865433
Q ss_pred CCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 159 GTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 159 ~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
... ....++.+||.+.+.++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 211 12334889999987776 77899999999999998 89999887655544444443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=238.13 Aligned_cols=197 Identities=17% Similarity=0.164 Sum_probs=161.8
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-.+++|+||.|+ +++.. ++.+| +..+. .....+.+.+|+.+++.++||||+++++++.+.+..++|||++
T Consensus 14 ~~lg~G~~g~V~-----~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 14 QEIGSGQFGLVH-----LGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp EEEEEETTEEEE-----EEEETTTEEEEEEEECT---TTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred eEecCCCceeEE-----EEEecCCCeEEEEEccc---cCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 358899999995 56555 77777 22221 1234467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-----Cc
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-----TE 161 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-----~~ 161 (245)
++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++...... ..
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 999999998754 48999999999999999999999999999999999999999999999999998653321 11
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~ 221 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence 12234789999987766 77899999999999999 89999887766555555544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.36 Aligned_cols=189 Identities=20% Similarity=0.183 Sum_probs=151.1
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EE-ehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LY-SRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~-~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+++|+||+|+ +++++ |+.|| ++ ++....+....+.+.+|+.+++.++||||+++++++..++.+++|||++
T Consensus 42 lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 42 VGRGGMGDVY-----EAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEECSSSEEE-----EEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EcCCCCeeEE-----EEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 6788999994 66655 88888 32 2222222334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----cc
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----ET 162 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~~ 162 (245)
++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........ ..
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 196 (309)
T 2h34_A 117 NGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196 (309)
T ss_dssp CCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccC
Confidence 99999998875 4589999999999999999999999999999999999999999999999999886543321 12
Q ss_pred ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 163 KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 163 ~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
....+.+||.+.+..+ .++|+||+|++++++++|.+||.+....
T Consensus 197 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred CCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 3344788998877666 7899999999999999999999876543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=244.66 Aligned_cols=195 Identities=19% Similarity=0.225 Sum_probs=159.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv 84 (245)
.+|+|+||.|+ +|+++ |+.||++.-.........+.+.+|+.++++++||||+++++++... ...++|
T Consensus 34 ~lG~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 34 YIGEGAYGMVC-----SAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EeecCCCeEEE-----EEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 47899999995 66555 8888832221222234457789999999999999999999999765 479999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
||++. ++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 187 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187 (364)
T ss_dssp EECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred EcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcccc
Confidence 99994 69999999888999999999999999999999999999999999999999999999999999876533221
Q ss_pred ----cccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 162 ----TKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 162 ----~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
....+|.+||.+... ++ .++|+||+||+++++++|.+||.+.+.......+
T Consensus 188 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 244 (364)
T 3qyz_A 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244 (364)
T ss_dssp TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence 223347889987544 34 6789999999999999999999988766655554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=242.90 Aligned_cols=197 Identities=18% Similarity=0.187 Sum_probs=158.9
Q ss_pred hhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 83 (245)
.+++|+||+|+ +++.. ++.+|+..-.........+.+.+|+.+++.+ +||||+++++++...+.+++
T Consensus 53 ~lG~G~~g~Vy-----~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 53 TLGAGAFGKVV-----EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEECSSEEEE-----EEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeccCCCcceE-----EEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 48899999995 44433 3466622211112234567799999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEe
Q psy16292 84 VMDYMPGGDLVNLMSN---------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~D 148 (245)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECc
Confidence 9999999999998853 2478899999999999999999999999999999999999999999999
Q ss_pred eCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccC
Q psy16292 149 FGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 149 fg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~ 213 (245)
||+++....... .....++.+||.+.+.++ .++|+||+|++++++++ |.+||.+......+.++.
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 999987643322 112235889999887776 78899999999999998 999998876655444443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-34 Score=245.28 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=156.7
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEEE-Eehh-hhh--ccCchHHHHHHHHHHHhcCCccceeeeEE
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRY-FQI--KRSDSAFFWEERDIMAHANSEWIVQLHFA 74 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~-~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 74 (245)
+...++|+ +++|+||+|+ +|+++ |+.||+ +-+. ... .....+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVY-----KARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp -------CEEEEEEEETTEEEE-----EEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHhcccEEEeEEeecCCEEEE-----EEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 33445554 7889999994 66665 888882 2221 111 12234578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
+.+.+..++||||++ ++|.+.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 81 FGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp ECCTTCCEEEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EeeCCceEEEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999999999996 5888888754 4888899999999999999999999999999999999999999999999999
Q ss_pred eecCCCCC----ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 153 MRMNKTGT----ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 153 ~~~~~~~~----~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
+....... .....+|.+||.+.+.. + .++|+||+||+++++++|.+||.+.++...+.++.
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 87643322 22344478999986643 4 67899999999999999999999887655544443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-34 Score=246.11 Aligned_cols=189 Identities=17% Similarity=0.115 Sum_probs=139.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhc--CCccceeee-------EEEEeC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHA--NSEWIVQLH-------FAFQDA 78 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~-------~~~~~~ 78 (245)
.+++|+||.|+ +|+++ |+.|| ++++.........+.+.+|+.+++.+ +||||++++ +++...
T Consensus 69 ~lG~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 69 PLRVGDRSVVF-----LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eccCCCCEEEE-----EEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 48999999994 67655 88899 44443332345567788896655555 699988755 455433
Q ss_pred -----------------CEEEEEEeccCCCCHHHHHhcC--CCCHHHH------HHHHHHHHHHHHHHHhCCceeCCCCC
Q psy16292 79 -----------------KSLYMVMDYMPGGDLVNLMSNY--DVPEKWA------KFYCAEVVLALDAIHCLGFVHRDVKP 133 (245)
Q Consensus 79 -----------------~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~------~~~~~~i~~~l~~lH~~~iih~dlkp 133 (245)
..+|+||||++ ++|.+++... .+++... ..++.|++.||.|||++||+||||||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 34899999997 8999998753 3444444 56779999999999999999999999
Q ss_pred CceEecCCCcEEEEeeCceeecCCCC-CccccCCCCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 134 DNMLLDKHGHLKLADFGTCMRMNKTG-TETKRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 134 ~nil~~~~~~i~l~Dfg~a~~~~~~~-~~~~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
+||+++.++.++|+|||+|+...... ......+|.+||.+.. .++ .++|+||+||++|+|++|.+||.+..+.
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred HHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence 99999999999999999999765433 2222355899999976 445 7889999999999999999999988543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=236.01 Aligned_cols=186 Identities=17% Similarity=0.165 Sum_probs=152.1
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHh--cCCccceeeeEEEEeC----CEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAH--ANSEWIVQLHFAFQDA----KSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~----~~~~lv 84 (245)
-.+++|+||+|+ +++..|+.||++.. .......+.+|.+++.. ++||||+++++++... ..+++|
T Consensus 14 ~~lg~G~~g~V~-----~~~~~~~~vavK~~----~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 14 ECVGKGRYGEVW-----RGSWQGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp EEEEECSSEEEE-----EEEETTEEEEEEEE----CGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeccCCCcEEE-----EEEECCEEEEEEEe----ccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 348899999995 66667999993221 12344567778888877 7999999999987543 568999
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH--------CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
|||+++|+|.++++...+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 164 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164 (301)
T ss_dssp ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence 99999999999998888999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCc--------cccCCCCchhhhhcCC------C-cccCCCcccccceecCCc----------cCCCCCCCC
Q psy16292 157 KTGTE--------TKRLGRNGIEEIKAHP------F-FINDQWTFSNLRECVPPV----------VPELSGDDD 205 (245)
Q Consensus 157 ~~~~~--------~~~~~~~~~e~i~~~~------~-~~~Diws~g~~~~~~~~~----------~~pf~~~~~ 205 (245)
..... ....+|.+||.+.+.. + .++|+||+|+++|++++| .+||.+..+
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred cccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 43322 2334478999987762 2 478999999999999999 778766543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=240.51 Aligned_cols=186 Identities=22% Similarity=0.235 Sum_probs=149.9
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCC--ccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANS--EWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+|+ ++..+ ++.|| ++.+.........+.+.+|+.+++.++| |||+++++++.++..+++|||+
T Consensus 16 ~lG~G~~g~Vy-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 16 QIGSGGSSKVF-----QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EESCCSSEEEE-----EEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEecCCCeEEE-----EEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 48899999995 55555 88888 3222222333456788999999999976 9999999999999999999995
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
.+++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++ ++.++|+|||+++.......
T Consensus 91 -~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 168 (343)
T 3dbq_A 91 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 168 (343)
T ss_dssp -CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----------
T ss_pred -CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCC
Confidence 588999988764 589999999999999999999999999999999999996 68899999999987643322
Q ss_pred ccccCCCCchhhhhc-----------CCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKA-----------HPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~-----------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+|.+||.+.. ..+ .++|+||+||++++|++|.+||.+..
T Consensus 169 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp -CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 223455889999865 333 67899999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-34 Score=246.35 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=161.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhh-----cCeEEE--EEehhhh-hccCchHHHHHHHHHHHhc-CCccceeeeEEE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKY-----RYTLYA--LYSRYFQ-IKRSDSAFFWEERDIMAHA-NSEWIVQLHFAF 75 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~-----~~~~~a--v~~k~~~-~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 75 (245)
++|...-.|++|+||+|+ +|+. .|+.|| ++++... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVF-----LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEE-----EEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cceEEEEEeccCCCEEEE-----EEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 344444458999999995 5544 388899 3333221 2234566788899999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.....+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999998865 4689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC-----ccccCCCCchhhhhcCC--C-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 155 MNKTGT-----ETKRLGRNGIEEIKAHP--F-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 155 ~~~~~~-----~~~~~~~~~~e~i~~~~--~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
...... .....+|.+||.+.+.. + .++|+||+||++|++++|.+||........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 270 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch
Confidence 643222 12345588999987532 3 678999999999999999999987655443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-34 Score=252.38 Aligned_cols=197 Identities=19% Similarity=0.272 Sum_probs=157.9
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-++++|+||+|+ +++.+ +..+|++.-. ......+.+.+|+.++++++||||+++++++.. +.+++||||++
T Consensus 190 ~~lG~G~fg~Vy-----~~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 190 VKLGQGCFGEVW-----MGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp EEEEECSSCEEE-----EEEETTTEEEEEEECC--TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred eeecCCCCeEEE-----EEEECCCceEEEEEec--cCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 358999999995 66666 5667732211 112345789999999999999999999999876 67899999999
Q ss_pred CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 90 GGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 90 ~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++....... .
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 341 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence 9999999863 3489999999999999999999999999999999999999999999999999987643321 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+...++ .++|+||+|++++++++ |.+||.+....+....+..+
T Consensus 342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 12234789999987776 78899999999999999 99999988766665555544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-34 Score=239.43 Aligned_cols=203 Identities=18% Similarity=0.191 Sum_probs=157.1
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 81 (245)
|.-.-.+++|+||+|+ +++.. +..+|+..-.........+.+.+|+.+++.++||||+++++++.++ ..
T Consensus 14 y~~~~~lg~G~~g~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVY-----EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp EEEEEEEEECSSSEEE-----EEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred eEEEEEEEecCCeeEE-----EeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 3333458899999995 55422 3446622211112234567899999999999999999999998754 56
Q ss_pred EEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++|||++++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 8999999999999988643 48999999999999999999999999999999999999999999999999998654332
Q ss_pred C-----ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 160 T-----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 160 ~-----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
. .....++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~ 230 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC
Confidence 1 112234889999987776 77899999999999998 99999877665554444433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-35 Score=241.72 Aligned_cols=207 Identities=20% Similarity=0.304 Sum_probs=162.8
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKS 80 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 80 (245)
+|.-...+++|+||+|+ +++.+ |+.+| +..+.........+.+.+|+.++++++||||+++++++.+ ...
T Consensus 7 ~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQ-----KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GEEEEEEEEECSSSEEE-----EEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred heeeehhccCCCCcEEE-----EEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 33334458899999994 66655 88888 3222222233456789999999999999999999998854 678
Q ss_pred EEEEEeccCCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-----DVPEKWAKFYCAEVVLALDAIHCLG-----FVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-----iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
+++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999988642 3899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 151 TCMRMNKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 151 ~a~~~~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
+++....... ......+.+||.+.+.++ .++|+||+|++++++++|.+||.+.........+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 9987653322 123455889999988776 678999999999999999999988765554444544433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-33 Score=243.86 Aligned_cols=188 Identities=20% Similarity=0.247 Sum_probs=157.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||+|+ +++++ |+.+| ++.+. .......+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 40 ~lg~G~~g~V~-----~~~~~~~~~~va~K~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 40 ELGAGNGGVVF-----KVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp EEEECSSCEEE-----EEEETTTCCEEEEEEEEC-CCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred eecCCCCeEEE-----EEEECCCCcEEEEEEecc-ccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 48899999994 66666 88888 22221 123345677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeecCCC--CCcccc
Q psy16292 89 PGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT--GTETKR 164 (245)
Q Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~--~~~~~~ 164 (245)
++++|.+++.. ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ......
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt 193 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 193 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCC
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCC
Confidence 99999998875 4689999999999999999999995 9999999999999999999999999998754322 122344
Q ss_pred CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 165 LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 165 ~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.++.+||.+.+.++ .++|+||+|++++++++|..||.+.+.
T Consensus 194 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp CTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred CCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 56899999988776 778999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-34 Score=237.07 Aligned_cols=197 Identities=21% Similarity=0.272 Sum_probs=154.8
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-CEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-KSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~ 89 (245)
..+++|+||+|+ +++.+|+.+|+..- ......+.+.+|+.++++++||||+++++++... +.+++|||+++
T Consensus 27 ~~lg~G~~g~V~-----~~~~~~~~vavK~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 27 QTIGKGEFGDVM-----LGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp EEEEECSSCEEE-----EEEETTEEEEEEEC---CCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred eEEecCCCceEE-----EEEEcCCEEEEEEe---cchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 348889999995 66667888883221 1234667899999999999999999999997554 57899999999
Q ss_pred CCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccccC
Q psy16292 90 GGDLVNLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~~---~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~ 165 (245)
+++|.+++.... +++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........ .....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 178 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 178 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccc
Confidence 999999887542 78899999999999999999999999999999999999999999999999986543322 23344
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
++.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred cccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 5899999987776 78899999999999998 99999887665555555444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=234.53 Aligned_cols=207 Identities=21% Similarity=0.261 Sum_probs=164.3
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhh------hccCchHHHHHHHHHHHhcC-Cccce
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ------IKRSDSAFFWEERDIMAHAN-SEWIV 69 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~------~~~~~~~~~~~E~~il~~l~-hp~Iv 69 (245)
..|.++|+ +++|+||.|+ +|+++ |+.|| +++.... ......+.+.+|+.+++++. ||||+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVR-----RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred cchhhccceeeeecCCCceEEE-----EEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34555665 7888999994 66655 88888 3322210 11223567889999999995 99999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEe
Q psy16292 70 QLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 70 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~D 148 (245)
++++++......++|||++++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999999988754 689999999999999999999999999999999999999999999999
Q ss_pred eCceeecCCCCCccc---cCCCCchhhhhc------CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 149 FGTCMRMNKTGTETK---RLGRNGIEEIKA------HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 149 fg~a~~~~~~~~~~~---~~~~~~~e~i~~------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
||++........... ...+.+||.+.. .++ .++|+||+|++++++++|.+||.+.........+..+.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 999988765433332 334788998752 233 67899999999999999999998876655555444443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=232.73 Aligned_cols=186 Identities=18% Similarity=0.238 Sum_probs=151.9
Q ss_pred hhccccccchhhhHHHHHh----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC--CEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLK----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~l 83 (245)
.+++|+||.|+ +|+ +. |+.||++.-.........+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 28 ~lg~G~~g~V~-----~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 28 DLGEGHFGKVE-----LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEECSSEEEE-----EEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred ccCCCCceEEE-----EEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 38899999995 554 22 8888832211222345678899999999999999999999999877 67999
Q ss_pred EEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 182 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCE
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcc
Confidence 9999999999999843 35899999999999999999999999999999999999999999999999999876544321
Q ss_pred -------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 162 -------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 162 -------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
.....+.+||.+.+..+ .++|+||+|++++++++|.+|+..
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 11222789999888776 678999999999999999988643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=235.94 Aligned_cols=186 Identities=22% Similarity=0.277 Sum_probs=153.5
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEEe--CCEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQD--AKSL 81 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~ 81 (245)
|.-.-.+++|+||+|+ +|+++ |+.||++.- +....+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 38 y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~----~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVF-----EAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEE----CSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred eEEEEEecccCCeEEE-----EEEECCCCcEEEEEEe----cccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3333458999999994 66554 888883221 1344677999999999996 9999999999998 6789
Q ss_pred EEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCCC
Q psy16292 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~~ 160 (245)
++|||++++++|.+++.. +++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.......
T Consensus 109 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred EEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 999999999999998864 78899999999999999999999999999999999999777 899999999987665444
Q ss_pred ccccCC---CCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 161 ETKRLG---RNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 ~~~~~~---~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....+ +.+||.+.. ..+ .++|+||+||++++|++|..||...
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 333333 688998876 344 7889999999999999999998543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-33 Score=233.30 Aligned_cols=197 Identities=20% Similarity=0.286 Sum_probs=159.4
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-.+++|+||+|+ +++.+ +..+|+..-. ......+.+.+|+.+++.++||||+++++++.. +..++|||+++
T Consensus 19 ~~lg~G~~g~Vy-----~~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 19 ERLGAGQFGEVW-----MGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp EEEEEETTEEEE-----EEEETTTEEEEEEEEC--TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred eeecCCCCeEEE-----EEEEcCCcEEEEEEec--CCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 347899999995 55555 6677732111 123456789999999999999999999999864 46899999999
Q ss_pred CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 90 GGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 90 ~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
+++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 99999998753 5899999999999999999999999999999999999999999999999999876543221
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....+.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 12334889999887666 67899999999999998 99999887665554444443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=244.67 Aligned_cols=191 Identities=18% Similarity=0.243 Sum_probs=144.4
Q ss_pred HHHHHh-----hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE
Q psy16292 6 AFMHRY-----RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ 76 (245)
Q Consensus 6 ~f~~~y-----~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 76 (245)
++.+.| +||+|+||+|+ +|+.+ ++.||++.-. .......+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy-----~~~~~~~~~~~~vaiK~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVY-----KAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp CHHHHEECSSCCCC-----EEE-----EEEESSSSCCCCEEEEECS---SSSCCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEE-----EEEEccCCCCeEEEEEEEC---CCCCCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 345555 47999999994 66643 7778832211 2234567899999999999999999999995
Q ss_pred e--CCEEEEEEeccCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe----cC
Q psy16292 77 D--AKSLYMVMDYMPGGDLVNLMSNY----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL----DK 140 (245)
Q Consensus 77 ~--~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~----~~ 140 (245)
. ...+++||||+ +++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||++ +.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 4 67999999999 56888876421 38999999999999999999999999999999999999 67
Q ss_pred CCcEEEEeeCceeecCCCCC-------ccccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 141 HGHLKLADFGTCMRMNKTGT-------ETKRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~-------~~~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
++.++|+|||+|+....... ......|.+||.+.+.. + .++|+||+||++|+|++|.+||.+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 78999999999987653211 12244488999987744 4 678999999999999999999987754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=240.61 Aligned_cols=205 Identities=16% Similarity=0.121 Sum_probs=156.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||+|+.+........ ++.||+..-...........+.+|+.++++++||||+++++++......++||||++
T Consensus 37 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (327)
T 2yfx_A 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 116 (327)
T ss_dssp ECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCC
Confidence 488999999964332211122 777883322222233456678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC---CcEEEEeeCceeecCCC
Q psy16292 90 GGDLVNLMSNY--------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLADFGTCMRMNKT 158 (245)
Q Consensus 90 ~g~L~~~l~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~---~~i~l~Dfg~a~~~~~~ 158 (245)
+++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.+ ..++|+|||+++.....
T Consensus 117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~ 196 (327)
T 2yfx_A 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196 (327)
T ss_dssp TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence 99999998753 37888999999999999999999999999999999999854 46999999998754322
Q ss_pred CC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 159 GT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 159 ~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
.. .....+|.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+.
T Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp -----CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 11 122345889999987776 78899999999999998 999998876655555554443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=235.95 Aligned_cols=186 Identities=15% Similarity=0.260 Sum_probs=149.9
Q ss_pred hhccccccchhhhHHHHHh----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLK----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 83 (245)
.+++|+||+|+ +|+ .. |+.||++.- ........+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 17 ~lg~G~~g~V~-----~~~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 17 QLGKGNFGSVE-----MCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp EEEECSSEEEE-----EEEECTTCSSCCEEEEEEEE-SCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred eeeccCCEEEE-----EEEEecccCCCCcEEEEEEc-ccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 48899999995 554 22 888883221 11223455778999999999999999999999864 356899
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
||||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.......
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--------
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce
Confidence 99999999999998764 389999999999999999999999999999999999999999999999999987643322
Q ss_pred ------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 161 ------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 ------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
......+.+||.+.+.++ .++|+||+|++++++++|..|+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 112223789999988777 7889999999999999999988654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=242.86 Aligned_cols=186 Identities=23% Similarity=0.236 Sum_probs=149.7
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC--CccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN--SEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+|+ +|.++ |+.|| ++.+.........+.+.+|+.+++.++ ||||+++++++...+.+|+|||
T Consensus 63 ~LG~G~fg~Vy-----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 63 QIGSGGSSKVF-----QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEECCSSEEEE-----EEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred EEccCCCeEEE-----EEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 48899999995 55555 88888 322222223445678999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
+.+++|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++ ++.++|+|||+++.+.....
T Consensus 137 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 215 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 215 (390)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CC
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCC
Confidence 5588999988754 588889999999999999999999999999999999995 68899999999987653321
Q ss_pred ccccCCCCchhhhhcC-----------CC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKAH-----------PF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~-----------~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....+|.+||.+... .+ .++|+||+||++|+|++|.+||.+..
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 1234447899998752 23 67899999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=229.09 Aligned_cols=186 Identities=17% Similarity=0.131 Sum_probs=155.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.+++|+||.|+ +|++. |+.||++.. ......+.+.+|+.+++.+ +|+|++++++++......++|||++
T Consensus 17 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~---~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 17 RIGEGSFGVIF-----EGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEECSSCEEE-----EEEETTTTEEEEEEEE---ECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEeecCCEEEE-----EEEECCCCcEEEEEEe---ccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 47889999994 66644 888883211 1223445688999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc-----EEEEeeCceeecCCCCC-
Q psy16292 89 PGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH-----LKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 89 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~-----i~l~Dfg~a~~~~~~~~- 160 (245)
+++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||+++.......
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 9999999975 35899999999999999999999999999999999999987776 99999999987654322
Q ss_pred ----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 ----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 ----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
.....+|.+||.+.+.++ .++|+||+|++++++++|.+||.+..+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 123345789999988776 7889999999999999999999886543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=240.45 Aligned_cols=190 Identities=24% Similarity=0.319 Sum_probs=150.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe------------
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD------------ 77 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------------ 77 (245)
.+|+|+||+|+ +|+++ |+.||+++-. .+.....+|+.+++.++||||+++++++..
T Consensus 14 ~lG~G~fg~V~-----~a~~~~~~~~vAiK~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 14 TLGTGSFGIVC-----EVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEECC-CEEEE-----EEEETTTCCEEEEEEEE-----CCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEeccCEEEE-----EEEECCCCCEEEEEEEe-----cCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 37899999994 66554 8999932211 111223479999999999999999999944
Q ss_pred --------------------------CCEEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy16292 78 --------------------------AKSLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGF 126 (245)
Q Consensus 78 --------------------------~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (245)
..++++||||++ ++|.+.+.. ..+++..+..++.|++.||.|||++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 345899999996 687776642 458999999999999999999999999
Q ss_pred eeCCCCCCceEec-CCCcEEEEeeCceeecCCCCCccc---cCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCC
Q psy16292 127 VHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGTETK---RLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 127 ih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~~~~~~---~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf 200 (245)
+||||||+||+++ .++.++|+|||+|+.......... ...|.+||.+.+.. + .++|+||+||++++|++|.+||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999998 578999999999997655443333 33478999987654 4 6789999999999999999999
Q ss_pred CCCCCCCCCccc
Q psy16292 201 SGDDDTSNFDDI 212 (245)
Q Consensus 201 ~~~~~~~~~~~~ 212 (245)
.+.++.+.+.++
T Consensus 243 ~~~~~~~~~~~i 254 (383)
T 3eb0_A 243 SGETSIDQLVRI 254 (383)
T ss_dssp CCSSHHHHHHHH
T ss_pred CCCChHHHHHHH
Confidence 988765544443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-33 Score=234.58 Aligned_cols=198 Identities=22% Similarity=0.311 Sum_probs=155.1
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhh-----hccCchHHHHHHHHHHHhcCCccceee
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQ-----IKRSDSAFFWEERDIMAHANSEWIVQL 71 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l 71 (245)
..+.++|+ +++|+||.|+ +|+++ |+.|| ++.+... ........+.+|+.+++.++||||+++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVK-----LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhceeEeeEEecCCCEEEE-----EEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 45667776 6788999994 66555 88888 3333221 112334568899999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEE
Q psy16292 72 HFAFQDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLA 147 (245)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~ 147 (245)
++++..+. .++||||+++++|.+.+... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++|+
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 99997665 89999999999999987654 5899999999999999999999999999999999999987664 9999
Q ss_pred eeCceeecCCCCCc---cccCCCCchhhhhc---CCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 148 DFGTCMRMNKTGTE---TKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 148 Dfg~a~~~~~~~~~---~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
|||+++........ ....++.+||.+.. ..+ .++|+||+|++++++++|.+||.+......
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 99999886543221 23455889998742 333 678999999999999999999987665433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-33 Score=240.37 Aligned_cols=188 Identities=14% Similarity=0.066 Sum_probs=147.4
Q ss_pred hhccccccchhhhHHHHHhhc-------CeEEE-EE-ehhhh--------hccCchHHHHHHHHHHHhcCCccceeeeEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-------YTLYA-LY-SRYFQ--------IKRSDSAFFWEERDIMAHANSEWIVQLHFA 74 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-------~~~~a-v~-~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 74 (245)
.||+|+||.|+ +|+++ ++.|| ++ .+... ...-.......|+..++.++||||++++++
T Consensus 42 ~lG~G~~g~Vy-----~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 42 PIGQGGFGCIY-----LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp ECCCC-CCEEE-----EEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEecCCCeEEE-----EeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 48999999995 55443 46777 22 22110 011122234556666777789999999999
Q ss_pred EEeC----CEEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec--CCCcEEE
Q psy16292 75 FQDA----KSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD--KHGHLKL 146 (245)
Q Consensus 75 ~~~~----~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~--~~~~i~l 146 (245)
+... .+.++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.++|
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl 195 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYL 195 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEE
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEE
Confidence 9765 5689999999 9999999875 3589999999999999999999999999999999999999 8899999
Q ss_pred EeeCceeecCCCCCc-----------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 147 ADFGTCMRMNKTGTE-----------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~~-----------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
+|||+++.+...... ....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+...
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp CCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred EECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 999999876433211 13445789999988776 788999999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-33 Score=238.00 Aligned_cols=189 Identities=18% Similarity=0.231 Sum_probs=153.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~l 83 (245)
-.+++|+||.|+ +++++ |+.||++.-...........+.+|+.+++.++||||+++++++... ...++
T Consensus 17 ~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 17 SLLGEGAYGVVC-----SATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp EEEEECSSEEEE-----EEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred eEEcCCCCeEEE-----EEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 347899999994 66655 8888832211112223456788999999999999999999988754 67999
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc--
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-- 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-- 161 (245)
|||++. ++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 92 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 170 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170 (353)
T ss_dssp EECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred EEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccccc
Confidence 999995 79999998888999999999999999999999999999999999999999999999999999876532211
Q ss_pred ------------cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 162 ------------TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 162 ------------~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+.+||.+.. ..+ .++|+||+||+++++++|.+||.+.+.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 12333788998765 344 678999999999999999999987653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-33 Score=234.66 Aligned_cols=190 Identities=22% Similarity=0.296 Sum_probs=147.5
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.+++|+||.|+ +|+.. |+.+| ++++...........+.+|+.+++.++||||+++++++...+..++||
T Consensus 37 ~~~lg~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 37 EKKIGRGQFSEVY-----RAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp EEEEECC--CEEE-----EEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEeecCCCCceEE-----EEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3458889999994 66544 88888 232222233345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|++++++|.+++.. ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999998863 3489999999999999999999999999999999999999999999999999986543322
Q ss_pred ----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
......+.+||.+....+ .++|+||+|++++++++|..||.+..
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 223445889999887776 77899999999999999999997653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-33 Score=238.38 Aligned_cols=196 Identities=17% Similarity=0.193 Sum_probs=155.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCC-EEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAK-SLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~-~~~lv~e~ 87 (245)
.+++|+||+|+.+........ ++.||++.-.........+.+.+|+.+++++ +||||+++++++...+ .+++||||
T Consensus 34 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~ 113 (316)
T 2xir_A 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113 (316)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred EEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEc
Confidence 378899999952221111122 6778822211112233556789999999999 7999999999988754 59999999
Q ss_pred cCCCCHHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 88 MPGGDLVNLMSNYD-----------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 88 ~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
+++++|.+++.... +++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 193 (316)
T 2xir_A 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193 (316)
T ss_dssp CTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred CCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCc
Confidence 99999999997543 7888999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCC
Q psy16292 151 TCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTS 207 (245)
Q Consensus 151 ~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~ 207 (245)
+++........ ....++.+||.+.+.++ .++|+||+|++++++++ |.+||.+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp GGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred cccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99876443221 12235889999988776 78899999999999998 999998776443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=240.29 Aligned_cols=186 Identities=24% Similarity=0.299 Sum_probs=146.0
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC------EEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK------SLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~~~lv 84 (245)
.+|+|+||+|+ +|+.+ +..+|+++... +.....+|+.+++.++||||+++++++...+ ++++|
T Consensus 47 ~lG~G~~g~V~-----~a~~~~~~~~aikk~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 47 VIGNGSFGVVF-----QAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEETTEEEE-----EEEETTTEEEEEEEEEC-----CTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred EEeeCCCeEEE-----EEEECCCCeEEEEEEec-----CcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 48899999994 66665 55566322211 1112247999999999999999999996543 48999
Q ss_pred EeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-CCCcEEEEeeCceeecCCC
Q psy16292 85 MDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~ 158 (245)
|||+++ ++...+. ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||+|+.....
T Consensus 117 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 999965 4444332 34689999999999999999999999999999999999999 7899999999999987544
Q ss_pred CCccccC---CCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 159 GTETKRL---GRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 159 ~~~~~~~---~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
....... .|.+||.+.+.. + .++|+||+||++|+|++|.+||.+.+....
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 250 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ 250 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4333333 378999987653 4 678999999999999999999998765433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-33 Score=247.86 Aligned_cols=192 Identities=19% Similarity=0.257 Sum_probs=157.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhc------CCccceeeeEEEEeCCEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA------NSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~~~~~~ 82 (245)
.||+|+||+|+ +|+++ |+.|| ++.+. .....+.+.+|+.+++.+ +|+||+++++++.....++
T Consensus 104 ~LG~G~fg~V~-----~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 104 VIGKGSFGQVV-----KAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp EEEESSSEEEE-----EEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred EcccCccEEEE-----EEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 47899999995 66555 88888 32221 123446678899988887 5789999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc--EEEEeeCceeecCC
Q psy16292 83 MVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH--LKLADFGTCMRMNK 157 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~--i~l~Dfg~a~~~~~ 157 (245)
+|||++ +++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||+++....
T Consensus 176 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 176 MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 999999 57999988754 3899999999999999999999999999999999999999987 99999999987543
Q ss_pred CCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 158 TGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 158 ~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
... ......|.+||.+.+.++ .++|+||+||++++|++|.+||.+.++...+..+
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i 311 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 322 223444899999988777 7889999999999999999999988765554443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=238.58 Aligned_cols=200 Identities=22% Similarity=0.312 Sum_probs=163.0
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE--EEehhhhhccCch--------------HHHHHHHHHHHhcCCccceeeeEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQIKRSDS--------------AFFWEERDIMAHANSEWIVQLHFA 74 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~~~~~~~--------------~~~~~E~~il~~l~hp~Iv~l~~~ 74 (245)
-.+++|+||.|+ +|+..|+.|| ++.+......... +.+.+|+.+++.++||||++++++
T Consensus 37 ~~lg~G~~g~V~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 37 RTLNQGKFNKII-----LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEECCSSCCEE-----EEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred EEEcCCCCeEEE-----EEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 348889999995 5555788999 4443333222222 889999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcE
Q psy16292 75 FQDAKSLYMVMDYMPGGDLVNL------MSN---YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~------l~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i 144 (245)
+.+.+.+++||||+++++|.++ +.. ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~ 191 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCE
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcE
Confidence 9999999999999999999998 553 458999999999999999999999 999999999999999999999
Q ss_pred EEEeeCceeecCCC--CCccccCCCCchhhhhcC-CC--cccCCCcccccceecCCccCCCCCCCC-CCCCcccCcC
Q psy16292 145 KLADFGTCMRMNKT--GTETKRLGRNGIEEIKAH-PF--FINDQWTFSNLRECVPPVVPELSGDDD-TSNFDDIEKD 215 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~--~~~~~~~~~~~~e~i~~~-~~--~~~Diws~g~~~~~~~~~~~pf~~~~~-~~~~~~~~~~ 215 (245)
+|+|||++...... ........+.+||.+.+. ++ .++|+||+|++++++++|.+||.+..+ ...+..+..+
T Consensus 192 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp EECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred EEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 99999999876433 112233447899998877 44 378999999999999999999988766 4444444444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=259.92 Aligned_cols=200 Identities=20% Similarity=0.221 Sum_probs=159.7
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.+|+|+||+|+ +++.+ +..+|+............+.+.+|+.++++++||||+++++++. ++..|+|||
T Consensus 397 ~LG~G~fG~Vy-----~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 397 CIGEGQFGDVH-----QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp EEECCSSCCEE-----EEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEeeCCCEEEE-----EEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence 38899999995 55443 45566332222223344578999999999999999999999985 456899999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
|+++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++........
T Consensus 471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 550 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550 (656)
T ss_dssp CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-------
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceecc
Confidence 99999999998754 4889999999999999999999999999999999999999999999999999876443221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....+|.+||.+...++ .++|+||+|++++++++ |.+||.+.........+..+..
T Consensus 551 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 610 (656)
T 2j0j_A 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610 (656)
T ss_dssp ---CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence 11235889999987777 67899999999999986 9999998876666655555443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-33 Score=235.55 Aligned_cols=192 Identities=21% Similarity=0.255 Sum_probs=152.6
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+.++|.-.-.+++|+||+|+ +++.+++.+|+..- ......+.+.+|+.++++++||||+++++++.+ ..+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~-----~~~~~~~~vavK~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEE-----EEEETTEEEEEEEC---SSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CHhHeeeeeEeecCCCceEE-----EEEECCeeEEEEEe---cChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 34445445568999999994 66667888883222 123456789999999999999999999998874 478
Q ss_pred EEEeccCCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCceEecCCCc-EEEEeeCceee
Q psy16292 83 MVMDYMPGGDLVNLMSNYD----VPEKWAKFYCAEVVLALDAIHC---LGFVHRDVKPDNMLLDKHGH-LKLADFGTCMR 154 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~l~~lH~---~~iih~dlkp~nil~~~~~~-i~l~Dfg~a~~ 154 (245)
+||||+++++|.+++.... +++..+..++.|++.||.|||+ ++++||||||+||+++.++. ++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997643 6788999999999999999999 89999999999999998886 79999999986
Q ss_pred cCCCC-CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 155 MNKTG-TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 155 ~~~~~-~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
..... ......++.+||.+.+.++ .++|+||+|++++++++|.+||.+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 156 IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 54332 2234556899999988776 78899999999999999999997643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-34 Score=242.12 Aligned_cols=193 Identities=15% Similarity=0.059 Sum_probs=153.3
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeEEE--EEehhhh-----hccCchHHHHHHHHHHHhcC---------Ccc
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQ-----IKRSDSAFFWEERDIMAHAN---------SEW 67 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~-----~~~~~~~~~~~E~~il~~l~---------hp~ 67 (245)
.++|...-.+|+|+||+|+ +|++.|+.|| ++++... ......+.+.+|+.+++.++ |||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~-----~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVF-----QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEE-----EEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEE-----EEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 3556656668999999995 6666789999 3333221 12334578999999999886 555
Q ss_pred ceeeeEE-----------------EEe-------------CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHH
Q psy16292 68 IVQLHFA-----------------FQD-------------AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLA 117 (245)
Q Consensus 68 Iv~l~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~ 117 (245)
|+++.++ +.+ ...+|+||||+++|++.+.+....+++..+..++.|++.|
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 5555554 443 7899999999999977776666678999999999999999
Q ss_pred HHHHH-hCCceeCCCCCCceEecCCC--------------------cEEEEeeCceeecCCCCCccccCCCCchhhhhcC
Q psy16292 118 LDAIH-CLGFVHRDVKPDNMLLDKHG--------------------HLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAH 176 (245)
Q Consensus 118 l~~lH-~~~iih~dlkp~nil~~~~~--------------------~i~l~Dfg~a~~~~~~~~~~~~~~~~~~e~i~~~ 176 (245)
|.||| +++|+||||||+||+++.++ .+||+|||+|+..... .......|.+||.+.+.
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence 99999 99999999999999999887 8999999999976543 23344558999999887
Q ss_pred CCcccCCCccccc-ceecCCccCCCCC
Q psy16292 177 PFFINDQWTFSNL-RECVPPVVPELSG 202 (245)
Q Consensus 177 ~~~~~Diws~g~~-~~~~~~~~~pf~~ 202 (245)
...++||||+++. .+.+++|.+||.+
T Consensus 253 ~~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 253 GDYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp SSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CccceehhhhhCCCCcccccccCCCcc
Confidence 7788999998766 7889999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=235.84 Aligned_cols=192 Identities=19% Similarity=0.225 Sum_probs=141.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+ +++.. |+.||+..-.........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 22 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 22 VIGSGATAVVQ-----AAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp ECC---CCCEE-----EEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred eeccccceEEE-----EEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 48889999995 55544 777883322121223456678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 90 GGDLVNLMSN---------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 90 ~g~L~~~l~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 9999998863 3489999999999999999999999999999999999999999999999999876543211
Q ss_pred ---------ccccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 ---------ETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 ---------~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.....++.+||.+.. ..+ .++|+||+|++++++++|.+||.+..+...
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 123444788998865 333 788999999999999999999987655443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=239.52 Aligned_cols=190 Identities=22% Similarity=0.239 Sum_probs=151.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEE------E
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL------Y 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~------~ 82 (245)
.+|+|+||+|+ +|+++ |+.|| ++.+..........++.+|+.+++.++||||+++++++...+.. +
T Consensus 49 ~lG~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 49 HVGSGAYGSVC-----SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEecCCCeEEE-----EEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 48999999995 66555 88999 32222222334467889999999999999999999999877654 9
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
+|||++. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 124 lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 201 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 201 (371)
T ss_dssp EEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------CT
T ss_pred EEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCc
Confidence 9999995 788887754 489999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 162 ~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
....+|.+||.+.+ ..+ .++|+||+||+++++++|.+||.+.+..+.
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 250 (371)
T 4exu_A 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250 (371)
T ss_dssp TCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 33455889999876 344 788999999999999999999988764433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-33 Score=233.31 Aligned_cols=190 Identities=25% Similarity=0.277 Sum_probs=153.6
Q ss_pred HHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 8 MHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 8 ~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
..+..+++|+||.|+ +++++ ++.+|+..- ........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 25 ~~~~~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 25 GDRVVLGKGTYGIVY-----AGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp SSBCEEEECSSSEEE-----EEEETTTCCEEEEEEE-ECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcEEEeecCcEEEE-----EEEECCCCeEEEEEEc-cCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 334569999999995 66654 777772211 1122345678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-CCcEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-HGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|++++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999999998754 3568889999999999999999999999999999999988 89999999999987653221
Q ss_pred ----ccccCCCCchhhhhcCC--C-cccCCCcccccceecCCccCCCCCC
Q psy16292 161 ----ETKRLGRNGIEEIKAHP--F-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 ----~~~~~~~~~~e~i~~~~--~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....++.+||.+...+ + .++|+||+|++++++++|.+||.+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 22334478999987653 3 6789999999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=226.91 Aligned_cols=187 Identities=19% Similarity=0.246 Sum_probs=154.4
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-- 77 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 77 (245)
.|..+|+ +++|+||.|+ +|+++ |+.||+..-. ...+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVF-----KAKHRIDGKTYVIKRVK-----YNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEE-----EEEETTTCCEEEEEEEE-----CCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEE-----EEEEcCCCeEEEEEEec-----cccHHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 4556665 7788999994 66665 8888832111 112457889999999999999999999865
Q ss_pred --------------CCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC
Q psy16292 78 --------------AKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140 (245)
Q Consensus 78 --------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~ 140 (245)
...+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 4568999999999999999864 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeCceeecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 141 HGHLKLADFGTCMRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 141 ~~~i~l~Dfg~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
++.++|+|||++.......... ...++.+||.+.+.++ .++|+||+|++++++++|..|+.+
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999999998876543322 3445789999987776 788999999999999999988754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-33 Score=243.47 Aligned_cols=189 Identities=25% Similarity=0.342 Sum_probs=148.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~~l 83 (245)
.||+|+||.|+ +|+++ |+.||+++-.. +.....+|+.+++.++||||+++++++... .++++
T Consensus 61 ~lG~G~fg~Vy-----~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 61 VIGNGSFGVVY-----QAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEC-----CTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeCCCEEEE-----EEEECCCCcEEEEEEecc-----cchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 48999999994 66665 88888322111 112234799999999999999999998542 25789
Q ss_pred EEeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCC
Q psy16292 84 VMDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNK 157 (245)
Q Consensus 84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~ 157 (245)
||||++ +++.+.+. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 131 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 999995 46666553 2458999999999999999999999999999999999999965 5689999999997654
Q ss_pred CCCccc---cCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 158 TGTETK---RLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 158 ~~~~~~---~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
...... ...|.+||.+.+. .+ .++|+||+||++|+|++|.+||.+.++.+.+.+
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~ 268 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 433322 3447899998764 44 678999999999999999999998765444333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-33 Score=252.85 Aligned_cols=196 Identities=19% Similarity=0.280 Sum_probs=160.4
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
-+|++|+||.|+ +++.+ +..||+ +.+. .....+.+.+|+.+|++++||||+++++++.+ +.+++||||+
T Consensus 273 ~~lG~G~fg~Vy-----~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 273 VKLGQGCFGEVW-----MGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp EEEEECSSEEEE-----EEEETTTEEEEEEEECT---TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred eecccCCCeEEE-----EEEECCCceEEEEEeCC---CCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 358999999995 66666 566773 2221 12345789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC-----C
Q psy16292 89 PGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG-----T 160 (245)
Q Consensus 89 ~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~-----~ 160 (245)
.+|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 99999999864 348999999999999999999999999999999999999999999999999998654221 1
Q ss_pred ccccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 161 ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
......+.+||.+....+ .++|+||+|++++++++ |.+||.+....+....+..+
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 112234789999987777 78899999999999999 99999887766655555444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=228.15 Aligned_cols=187 Identities=21% Similarity=0.275 Sum_probs=153.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
.+++|+||.|+ +++++ |+.||+..-. .....+.+.+|+.+++.++||||+++++++...+.+++||||++
T Consensus 36 ~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 36 KLGEGSYGSVY-----KAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp ECC----CEEE-----EEEETTTCCEEEEEEEE---TTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccCCCeEEE-----EEEECCCCCEEEEEecC---chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 37789999995 55555 8888832111 13456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----ccc
Q psy16292 90 GGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT----ETK 163 (245)
Q Consensus 90 ~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~----~~~ 163 (245)
+++|.+++. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 187 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG 187 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCS
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCC
Confidence 999999886 45689999999999999999999999999999999999999999999999999987654321 122
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
..++.+||.+....+ .++|+||+|++++++++|.+||.+..+.
T Consensus 188 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 231 (314)
T 3com_A 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM 231 (314)
T ss_dssp CGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Confidence 344788999877766 7889999999999999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-33 Score=239.36 Aligned_cols=196 Identities=21% Similarity=0.230 Sum_probs=156.5
Q ss_pred hhhccccccchhhhHHHHHhh--c-CeEEE-EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEE-----eC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKY--R-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQ-----DA 78 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~--~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~-----~~ 78 (245)
-.+++|+||+|+ +|++ . |+.|| ++.+...........+.+|+.+++.+ +||||+++++++. ..
T Consensus 17 ~~lg~G~~g~V~-----~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 17 AEIGEGAYGKVF-----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp EEEEEETTEEEE-----EEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred eeecccccEEEE-----EEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 347889999995 6654 2 78888 32222222233445677888888877 8999999999987 55
Q ss_pred CEEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
..+++|||++. ++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 68999999995 7999988753 3899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 156 NKTGTE---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 156 ~~~~~~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...... ....++.+||.+...++ .++|+||+|++++++++|.+||.+..+.....++
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 533222 23445789999987776 7789999999999999999999887655444333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-33 Score=230.97 Aligned_cols=190 Identities=17% Similarity=0.179 Sum_probs=146.7
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
++++|+||+|+ +++.++. +| ++.+.........+.+.+|+.++++++||||++++++. .....++||||+++
T Consensus 31 ~lG~G~~g~Vy-----~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~ 103 (289)
T 3og7_A 31 RIGSGSFGTVY-----KGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEG 103 (289)
T ss_dssp EEEECSSEEEE-----EEESSSE-EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred EecCCCCeEEE-----EEEEcCc-eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCC
Confidence 47899999995 5555554 56 33333333445567899999999999999999999954 55678999999999
Q ss_pred CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------cc
Q psy16292 91 GDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ET 162 (245)
Q Consensus 91 g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~~ 162 (245)
++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++....... ..
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 183 (289)
T 3og7_A 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183 (289)
T ss_dssp EEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccC
Confidence 999998854 3589999999999999999999999999999999999999999999999999986543211 12
Q ss_pred ccCCCCchhhhh---cCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 163 KRLGRNGIEEIK---AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 163 ~~~~~~~~e~i~---~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
....+.+||.+. ..++ .++|+||+|++++++++|..||.+..+...
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 233 (289)
T 3og7_A 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233 (289)
T ss_dssp CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred CCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence 345578999886 3444 578999999999999999999987655443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=230.23 Aligned_cols=185 Identities=21% Similarity=0.227 Sum_probs=148.7
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc--CCccceeeeEEEEeC--
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA--NSEWIVQLHFAFQDA-- 78 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~~~~~-- 78 (245)
+.++|+ +++|+||.|+ +++.+|+.||++.. .........+|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~vavK~~----~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVW-----MGKWRGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEE-----EEEETTEEEEEEEE----EGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccceEEEeEeecCCCeEEE-----EEEECCceEEEEEE----eccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 345555 7888999995 66667999993221 122334556677777665 999999999999887
Q ss_pred --CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCceEecCCCcEEEEe
Q psy16292 79 --KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL--------GFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 79 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~iih~dlkp~nil~~~~~~i~l~D 148 (245)
..+++||||+++|+|.++++...+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7899999999999999999988899999999999999999999998 999999999999999999999999
Q ss_pred eCceeecCCCCCc--------cccCCCCchhhhhcCCCc-------ccCCCcccccceecCCccCCC
Q psy16292 149 FGTCMRMNKTGTE--------TKRLGRNGIEEIKAHPFF-------INDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 149 fg~a~~~~~~~~~--------~~~~~~~~~e~i~~~~~~-------~~Diws~g~~~~~~~~~~~pf 200 (245)
||+++........ ....+|.+||.+....+. ++|+||+||++|+|++|..|+
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 9999876443221 233447899998776552 279999999999999994443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=233.66 Aligned_cols=199 Identities=17% Similarity=0.193 Sum_probs=153.2
Q ss_pred hhhccccccchhhhHHHHHhhc---Ce--EEE-E-EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR---YT--LYA-L-YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~---~~--~~a-v-~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
-.+++|+||+|+ +++.. ++ .+| + +++.........+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 24 ~~lg~G~~g~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 24 EKLGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp EECC----CCCE-----EEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred eeecCCCceeEE-----EEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 348889999995 55532 33 455 2 22222223345678999999999999999999999998765 889
Q ss_pred EEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|||++++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 9999999999998865 34899999999999999999999999999999999999999999999999999876543321
Q ss_pred -------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 162 -------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 162 -------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
....++.+||.+...++ .++|+||+|++++++++ |.+||.+.+.......+...
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 12224789999887776 68899999999999999 99999887766555554433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-33 Score=233.05 Aligned_cols=191 Identities=18% Similarity=0.222 Sum_probs=142.0
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|.-.-.+++|+||+|+ +|+++ |+.|| +..+.........+.+.++...++.++||||+++++++.+++..+
T Consensus 8 ~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVE-----KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp GEEEEEEEEECSSEEEE-----EEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred hhhhHHhcCCCCCeEEE-----EEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 33344458999999994 66664 89899 333322222233444555666678889999999999999999999
Q ss_pred EEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 83 MVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
+||||++ ++|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||+++...
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999995 688776642 4689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc---cccCCCCchhhhh----cCCC-cccCCCcccccceecCCccCCCCC
Q psy16292 157 KTGTE---TKRLGRNGIEEIK----AHPF-FINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 157 ~~~~~---~~~~~~~~~e~i~----~~~~-~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
..... ....++.+||.+. ...+ .++|+||+|++++++++|.+||.+
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 44333 2344478999873 3333 678999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-33 Score=233.80 Aligned_cols=196 Identities=21% Similarity=0.313 Sum_probs=155.7
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+++|+||.|+ +|+++ |+.+| ++.+. ......+.+.+|+.+++.++||||+++++++...+..++|||+++
T Consensus 27 lg~G~~g~V~-----~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 27 LGDGAFGKVY-----KAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EECSTTCCEE-----EEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eccCCCeEEE-----EEEEcCCCcEEEEEEecC--CCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 7889999994 66666 78888 22221 234567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC----CCCccc
Q psy16292 90 GGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK----TGTETK 163 (245)
Q Consensus 90 ~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~----~~~~~~ 163 (245)
+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 179 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----C
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccC
Confidence 9999998764 5689999999999999999999999999999999999999999999999998764321 111223
Q ss_pred cCCCCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 164 RLGRNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 164 ~~~~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
...+.+||.+. ..++ .++|+||+|++++++++|.+||.+.+.......+...
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (302)
T 2j7t_A 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237 (302)
T ss_dssp CGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence 44578899874 3344 6789999999999999999999877654444444333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=235.46 Aligned_cols=197 Identities=18% Similarity=0.220 Sum_probs=149.4
Q ss_pred HHHHHHhh----hccccccchhhhHHHHHhhc-CeEEEEE-ehhhhhc---------cCchHHHHHHHHHHHhcCCccce
Q psy16292 5 EAFMHRYR----RYRQKYSEVPRLFEYLLKYR-YTLYALY-SRYFQIK---------RSDSAFFWEERDIMAHANSEWIV 69 (245)
Q Consensus 5 ~~f~~~y~----~~~~~~~~v~~~~~~l~~~~-~~~~av~-~k~~~~~---------~~~~~~~~~E~~il~~l~hp~Iv 69 (245)
..+.++|+ +++|+||.|+ ++.+. |+.||++ -+..... ....+.+.+|+.++++++||||+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVC-----AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEE-----EEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHhccceEEeEEeccCCCEEEE-----EEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 44445665 7889999995 55455 8888822 2111111 11237899999999999999999
Q ss_pred eeeEEEEe-----CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC
Q psy16292 70 QLHFAFQD-----AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG 142 (245)
Q Consensus 70 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~ 142 (245)
++++++.. ...+|+|||++. |+|.+.+... .+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN 171 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence 99999954 347899999995 7888887654 489999999999999999999999999999999999999999
Q ss_pred cEEEEeeCceeecCCCCCcccc---CCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 143 HLKLADFGTCMRMNKTGTETKR---LGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 143 ~i~l~Dfg~a~~~~~~~~~~~~---~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.++|+|||+++........... ..+.+||.+.+ ..+ .++|+||+||+++++++|.+||.+.+...
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999865444333333 33788998876 334 67899999999999999999998876433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=226.52 Aligned_cols=188 Identities=19% Similarity=0.176 Sum_probs=150.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEe--hhhhhcc----CchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYS--RYFQIKR----SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~--k~~~~~~----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
.+++|+||+|+ +|+.+ ++.||++. +...... ...+.+.+|+.++++++||||+++++++.+.. ++
T Consensus 26 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 26 QIGKGGFGLVH-----KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp ECCCCSSSCEE-----EEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ccccCCceeEE-----EEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 48899999994 66655 88888322 2111111 12378999999999999999999999997776 69
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCc-----EEEEeeCceee
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGH-----LKLADFGTCMR 154 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~-----i~l~Dfg~a~~ 154 (245)
||||+++++|.+.+... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++. ++|+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~ 178 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence 99999999999887543 5899999999999999999999999 999999999999988776 99999999986
Q ss_pred cCCCCC-ccccCCCCchhhhhc--CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 155 MNKTGT-ETKRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 155 ~~~~~~-~~~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
...... ......+.+||.+.. .++ .++|+||+|+++|++++|.+||.+....
T Consensus 179 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred ccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 543321 223445788998843 333 6789999999999999999999876544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=236.24 Aligned_cols=191 Identities=14% Similarity=0.042 Sum_probs=145.1
Q ss_pred hhccccccchhhhHHHHHhhcCeEEE--EEehhhh--------hccCchHHHHHHHHHHHhcCCccceeeeEEEEe----
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQ--------IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD---- 77 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---- 77 (245)
.+++|+||+|+.+........++.+| +..+... ...-....+.+|+.+++.++||||+++++++..
T Consensus 44 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~ 123 (345)
T 2v62_A 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123 (345)
T ss_dssp EC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSS
T ss_pred eEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCC
Confidence 48889999995332221111356667 2222110 011123457788999999999999999999988
Q ss_pred CCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC--cEEEEeeCceee
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG--HLKLADFGTCMR 154 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~--~i~l~Dfg~a~~ 154 (245)
....|+|||++ +++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||+++.
T Consensus 124 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 124 RSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202 (345)
T ss_dssp CEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred CcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence 78999999999 99999998754 589999999999999999999999999999999999999887 999999999987
Q ss_pred cCCCCC-----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 155 MNKTGT-----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 155 ~~~~~~-----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+..... ......|.+||.+.+.++ .++|+||+||++|++++|.+||.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred cccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 643211 123445789999988776 7889999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=234.44 Aligned_cols=205 Identities=20% Similarity=0.264 Sum_probs=142.4
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHH-HHHhcCCccceeeeEEEEeCCEEE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERD-IMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
|...-.+++|+||.|+ +++.+ |+.||+ ..+.. ........+.+|+. +++.++||||+++++++...+..+
T Consensus 24 y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVN-----KMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp EEC-CEEEECSSEEEE-----EEEETTTTEEEEEEEEECC-CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred hhehheeccCCCEEEE-----EEEEcCCCCEEEEEEeecc-cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 3334458999999994 66665 888882 22211 12233445566666 677789999999999999999999
Q ss_pred EEEeccCCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 83 MVMDYMPGGDLVNLMS------NYDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
+||||++ ++|.+++. ...+++..+..++.+++.||.|||+. |++|+||||+||+++.++.++|+|||+++..
T Consensus 98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999995 58877765 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcc---ccCCCCchhhhh----cCCC-cccCCCcccccceecCCccCCCCCCCC-CCCCcccCcCCCC
Q psy16292 156 NKTGTET---KRLGRNGIEEIK----AHPF-FINDQWTFSNLRECVPPVVPELSGDDD-TSNFDDIEKDESP 218 (245)
Q Consensus 156 ~~~~~~~---~~~~~~~~e~i~----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~-~~~~~~~~~~~~~ 218 (245)
....... ...++.+||.+. ..++ .++|+||+|++++++++|.+||.+... ......+..+.++
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 5443322 334478888873 3334 678999999999999999999987543 3444555555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=231.60 Aligned_cols=188 Identities=19% Similarity=0.270 Sum_probs=154.7
Q ss_pred hhhccccccchhhhHHHHHh----hc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE--eCCEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLK----YR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ--DAKSLY 82 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~----~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~ 82 (245)
-.+++|+||+|+ +|+ .. |+.||++.- ........+.+.+|+.++++++||||+++++++. ....++
T Consensus 29 ~~lg~G~~g~V~-----~~~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 29 SQLGKGNFGSVE-----LCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp EEEEEETTEEEE-----EEEECTTSSSCSEEEEEEEE-SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhccCCCCeEEE-----EEEeccCCCCcceEEEEEEe-ccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 358899999995 555 22 888883221 1112344567899999999999999999999987 456799
Q ss_pred EEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 99999999999999875 3589999999999999999999999999999999999999999999999999997654432
Q ss_pred c-------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 E-------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ~-------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
. .....+.+||.+.+.++ .++|+||+|++++++++|.+||.+..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 1 11222789999988776 78899999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=225.23 Aligned_cols=187 Identities=17% Similarity=0.148 Sum_probs=150.8
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeE-EEEeCCEEEEEEeccC
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHF-AFQDAKSLYMVMDYMP 89 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~~~~lv~e~~~ 89 (245)
+++|+||+|+ +++++ |+.||++... .......+.+|+.+++.++|++++..+. ++......++|||++
T Consensus 17 lg~G~~g~V~-----~~~~~~~~~~vavK~~~---~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 17 IGSGSFGDIY-----LGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEECSSSEEE-----EEEETTTTEEEEEEEEE---C---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ecCCCCeEEE-----EEEEcCCCceEEEEeec---ccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 7889999994 66654 8888832211 1223345889999999998877666554 457788999999999
Q ss_pred CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCceeecCCCCC----
Q psy16292 90 GGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 90 ~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+++|.+++. ...+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||+++.......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 999999987 4468999999999999999999999999999999999999 7889999999999987654322
Q ss_pred -------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 -------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 -------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
......+.+||.+.+.++ .++|+||+||+++++++|.+||.+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh
Confidence 123344788999988777 688999999999999999999988665543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=233.06 Aligned_cols=191 Identities=21% Similarity=0.319 Sum_probs=151.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe------CCEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD------AKSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~------~~~~~ 82 (245)
.+++|+||.|+ +|++. |+.+|+..-. ......+.+.+|+.+++++ +||||+++++++.. ...++
T Consensus 31 ~lg~G~~g~Vy-----~~~~~~~~~~vaiK~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 31 LVGNGTYGQVY-----KGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEE--CCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EeccCCCEEEE-----EEEECCCCCeEEEEEEe--cCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 37889999994 66664 8888822111 2234567899999999999 89999999999987 56899
Q ss_pred EEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 99999999999999875 358999999999999999999999999999999999999999999999999988754332
Q ss_pred C----ccccCCCCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 160 T----ETKRLGRNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 160 ~----~~~~~~~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
. ......+.+||.+. ...+ .++|+||+|++++++++|.+||.+..+....
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 1 12334478899886 2333 6789999999999999999999876654433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=230.79 Aligned_cols=199 Identities=20% Similarity=0.280 Sum_probs=155.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc-cCchHHHHHHHHHHHhcCCccceeeeEEEE--eCCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK-RSDSAFFWEERDIMAHANSEWIVQLHFAFQ--DAKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~lv 84 (245)
.+++|+||.|+ +|+++ |+.+| ++++..... ......+.+|+.+++.++||||+++++++. .....++|
T Consensus 12 ~lg~G~~g~V~-----~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 12 LLGEGSYGKVK-----EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp EEEECSSCEEE-----EEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred EEecCCCeEEE-----EEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 37889999995 55554 88888 344333222 345678999999999999999999999984 45689999
Q ss_pred EeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-
Q psy16292 85 MDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~- 160 (245)
|||+.++ |.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 9999765 7666653 4589999999999999999999999999999999999999999999999999987643211
Q ss_pred -----ccccCCCCchhhhhcCCC---cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCC
Q psy16292 161 -----ETKRLGRNGIEEIKAHPF---FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~~~~---~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 216 (245)
......+.+||.+.+... .++|+||+|++++++++|.+||.+......+..+..+.
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 229 (305)
T 2wtk_C 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229 (305)
T ss_dssp CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC
Confidence 122344788998876443 57899999999999999999998876555555444443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=234.87 Aligned_cols=188 Identities=22% Similarity=0.230 Sum_probs=151.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE------EE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS------LY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~------~~ 82 (245)
.+++|+||.|+ +|+++ |+.|| +.-+.........+++.+|+.+++.++||||+++++++..... ++
T Consensus 31 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 31 HVGSGAYGSVC-----SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEecCCCeEEE-----EEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 47899999994 66655 88888 3222222233446778999999999999999999999987654 59
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E 161 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~ 161 (245)
+|||++. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....... .
T Consensus 106 lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 183 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183 (353)
T ss_dssp EEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------
T ss_pred EEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCcccc
Confidence 9999995 688887754 589999999999999999999999999999999999999999999999999986543322 2
Q ss_pred cccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 162 TKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 162 ~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
....++.+||.+.+ ..+ .++|+||+|++++++++|.+||.+.+..
T Consensus 184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 230 (353)
T 3coi_A 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 230 (353)
T ss_dssp CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH
T ss_pred ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 33455889998876 334 7789999999999999999999887643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=228.69 Aligned_cols=194 Identities=18% Similarity=0.210 Sum_probs=149.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEE-------------
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQ------------- 76 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------------- 76 (245)
.+++|+||.|+ +|+++ |+.||++.- ...+....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~lg~G~~g~V~-----~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 18 PLGCGGNGLVF-----SAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp ECC-----CEE-----EEEETTTTEEEEEEEE-ECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred EeccCCCeEEE-----EEEECCCCeEEEEEEE-ecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 37889999994 66655 888883221 1122345677899999999999999999999873
Q ss_pred -eCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-CCCcEEEEeeCceee
Q psy16292 77 -DAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFGTCMR 154 (245)
Q Consensus 77 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-~~~~i~l~Dfg~a~~ 154 (245)
.....++||||+. |+|.+++..+.+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||+++.
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred cccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 4468999999996 6999999888899999999999999999999999999999999999997 467899999999987
Q ss_pred cCCCCC-------ccccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 155 MNKTGT-------ETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 155 ~~~~~~-------~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...... ......+.+||.+.. ..+ .++|+||+|++++++++|.+||.+..+......+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 543211 122344788998865 344 6789999999999999999999987765444333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=228.44 Aligned_cols=181 Identities=19% Similarity=0.199 Sum_probs=150.5
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHh--cCCccceeeeEEEEeCC-
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAH--ANSEWIVQLHFAFQDAK- 79 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~- 79 (245)
+.++|+ +++|+||+|+ +++..|+.||++.- .......+.+|+++++. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy-----~~~~~~~~vavK~~----~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEE-----EEEETTEEEEEEEE----CGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccEEEEeeecCCCCcEEE-----EEEEcCccEEEEEe----CchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 445555 6888999995 66667888883221 12344668889999988 69999999999998876
Q ss_pred ---EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCceEecCCCcEEEEe
Q psy16292 80 ---SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH--------CLGFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 80 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~iih~dlkp~nil~~~~~~i~l~D 148 (245)
.+++||||+++|+|.+++....+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999999888999999999999999999999 89999999999999999999999999
Q ss_pred eCceeecCCCCC--------ccccCCCCchhhhhcCCC-------cccCCCcccccceecCCc
Q psy16292 149 FGTCMRMNKTGT--------ETKRLGRNGIEEIKAHPF-------FINDQWTFSNLRECVPPV 196 (245)
Q Consensus 149 fg~a~~~~~~~~--------~~~~~~~~~~e~i~~~~~-------~~~Diws~g~~~~~~~~~ 196 (245)
||+++....... ......+.+||.+.+... .++|+||+|+++|++++|
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999987654432 123344788998876532 468999999999999999
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=254.18 Aligned_cols=185 Identities=24% Similarity=0.296 Sum_probs=153.3
Q ss_pred hhccccccchhhhHHHHHhhc---CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE-----EEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS-----LYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-----~~l 83 (245)
.+++|+||+|+ +++++ |+.||++.-...........+.+|+.++++++||||+++++++...+. .|+
T Consensus 87 ~lg~G~~g~Vy-----~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 87 CIAHGGLGWIY-----LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEETTEEEE-----EEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred EEeeCCCeEEE-----EEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 37889999995 55443 788884322112222345678999999999999999999999987665 799
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccc
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
||||+++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+ .++|+|||+++..........
T Consensus 162 v~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~~g 239 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYG 239 (681)
T ss_dssp EEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCSCCCC
T ss_pred EEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccCCccCC
Confidence 9999999999987766 78999999999999999999999999999999999999875 899999999998776655556
Q ss_pred cCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
..+|.+||.+...+..++|+||+||++++|++|.+|+.+.
T Consensus 240 t~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred CccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccc
Confidence 6779999999888778899999999999999999998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=235.12 Aligned_cols=187 Identities=19% Similarity=0.247 Sum_probs=151.8
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC--------CccceeeeEEEE----
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN--------SEWIVQLHFAFQ---- 76 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~--------hp~Iv~l~~~~~---- 76 (245)
.+++|+||+|+ +|+++ |+.|| ++.+. .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 44 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 44 KLGWGHFSTVW-----LSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred EeeecCCeeEE-----EEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47889999995 66554 88888 32221 1234567899999999984 888999999998
Q ss_pred eCCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCC----------
Q psy16292 77 DAKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHG---------- 142 (245)
Q Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~---------- 142 (245)
...++|+|||++ +++|.+.+.. ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 556899999999 6677665543 3489999999999999999999998 999999999999998775
Q ss_pred ---------------------------------------cEEEEeeCceeecCCCCC-ccccCCCCchhhhhcCCC-ccc
Q psy16292 143 ---------------------------------------HLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FIN 181 (245)
Q Consensus 143 ---------------------------------------~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~ 181 (245)
.++|+|||+++....... .....+|.+||.+.+.++ .++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 799999999987654322 223445899999988777 788
Q ss_pred CCCcccccceecCCccCCCCCCCCCC
Q psy16292 182 DQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 182 Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
|+||+||++|+|++|.+||.+.+...
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 99999999999999999998776543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=235.15 Aligned_cols=191 Identities=18% Similarity=0.184 Sum_probs=146.8
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHH--hcCCccceeeeEEEEe-----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMA--HANSEWIVQLHFAFQD----- 77 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~--~l~hp~Iv~l~~~~~~----- 77 (245)
++|.-.-.+++|+||.|+ +++..|+.||++... ......+..|..++. .++||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy-----~~~~~~~~vavK~~~----~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVY-----KGSLDERPVAVKVFS----FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TSEEEEEEEEECSSEEEE-----EEEETTEEEEEEEEE----GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred HHhheeeecccCCCeEEE-----EEEECCeEEEEEEee----ccchhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 334444468999999995 566668999932211 122344555555544 5799999999986542
Q ss_pred CCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCceEecCCCcEEEEe
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL---------GFVHRDVKPDNMLLDKHGHLKLAD 148 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~---------~iih~dlkp~nil~~~~~~i~l~D 148 (245)
...+++||||+++|+|.+++.....++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 33689999999999999999988889999999999999999999999 999999999999999999999999
Q ss_pred eCceeecCCCCC------------ccccCCCCchhhhhcC-------CC-cccCCCcccccceecCCccCCC-CCCC
Q psy16292 149 FGTCMRMNKTGT------------ETKRLGRNGIEEIKAH-------PF-FINDQWTFSNLRECVPPVVPEL-SGDD 204 (245)
Q Consensus 149 fg~a~~~~~~~~------------~~~~~~~~~~e~i~~~-------~~-~~~Diws~g~~~~~~~~~~~pf-~~~~ 204 (245)
||+++.+..... ......|.+||.+.+. ++ .++|+||+||++|++++|..|+ .+..
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999987653221 1123447889988763 22 5689999999999999996554 4443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=226.44 Aligned_cols=170 Identities=11% Similarity=-0.055 Sum_probs=141.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEeh-hhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSR-YFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k-~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|| +|++. |+.|| ++.+ .........+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 38 ~lg~G~~g~Vy-----~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 38 FHGGVPPLQFW-----QALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEBSTTCEEE-----EEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEcccCCeEEE-----EEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 47889999995 66655 88898 3222 2222233457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCccccCCC
Q psy16292 88 MPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGR 167 (245)
Q Consensus 88 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~~~~ 167 (245)
++|++|.++++.+ .....+..++.|++.||.|||++||+||||||+||+++.+|.++|+++|..
T Consensus 113 ~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~--------------- 176 (286)
T 3uqc_A 113 IRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM--------------- 176 (286)
T ss_dssp CCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC---------------
T ss_pred cCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc---------------
Confidence 9999999999765 455678889999999999999999999999999999999999999855432
Q ss_pred CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 168 NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 168 ~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
+ ....++|+||+||++|+|++|.+||.+.+..+..
T Consensus 177 -~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 177 -P------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp -T------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred -C------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 1 1236789999999999999999999998776644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=235.24 Aligned_cols=194 Identities=21% Similarity=0.277 Sum_probs=144.2
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-------EE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-------SL 81 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-------~~ 81 (245)
-.+|+|+||+|+ +++++ |+.||++.- ........+..+|+..++.++||||+++++++...+ ++
T Consensus 29 ~~lg~G~~g~V~-----~~~~~~~~~~vavK~~--~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 29 RMAGQGTFGTVQ-----LGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp ----------CE-----EEEETTTCCEEEEEEE--ECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred EEEecCCCeEEE-----EEEECCCCCEEEEEEE--ecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 348899999994 66665 888883221 112344556788888999999999999999997543 38
Q ss_pred EEEEeccCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCceEecC-CCcEEEEeeCcee
Q psy16292 82 YMVMDYMPGGDLVNLMS-----NYDVPEKWAKFYCAEVVLALDAIH--CLGFVHRDVKPDNMLLDK-HGHLKLADFGTCM 153 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~l~~lH--~~~iih~dlkp~nil~~~-~~~i~l~Dfg~a~ 153 (245)
++||||+++ +|...+. ...+++..+..++.|++.||.||| ++||+||||||+||+++. ++.++|+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 999999965 5554432 235889999999999999999999 999999999999999997 8999999999998
Q ss_pred ecCCCCCccc---cCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 154 RMNKTGTETK---RLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 154 ~~~~~~~~~~---~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.......... ..+|.+||.+.+.. + .++|+||+||+++++++|.+||.+.+....+..+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 7765443333 33478999986654 4 7889999999999999999999987665444443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=221.63 Aligned_cols=187 Identities=17% Similarity=0.156 Sum_probs=151.4
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeee-EEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH-FAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~~~~~~~~~lv~e~ 87 (245)
-.+++|+||+|+ +++++ |+.||++.. ......+.+.+|+.+++.++|++++..+ .+.......++|||+
T Consensus 15 ~~lg~G~~g~V~-----~~~~~~~~~~vavK~~---~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 15 RKIGSGSFGDIY-----LGTDIAAGEEVAIKLE---CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp EEEEEETTEEEE-----EEEETTTTEEEEEEEE---ESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEccCCCeEEE-----EEEEcCCCcEEEEEEe---cCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 347889999994 66654 888883221 1123345689999999999888765554 444677889999999
Q ss_pred cCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCceeecCCCCC--
Q psy16292 88 MPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 88 ~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
+ +++|.+++. ...+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 9 999999987 3468999999999999999999999999999999999999 4788999999999987654322
Q ss_pred ---------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCC
Q psy16292 161 ---------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDT 206 (245)
Q Consensus 161 ---------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~ 206 (245)
......+.+||.+.+.++ .++|+||+|++++++++|.+||.+....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 223444789999988776 6889999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=227.92 Aligned_cols=186 Identities=19% Similarity=0.202 Sum_probs=149.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYMV 84 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv 84 (245)
-.+++|+||.|+ +|+.+ |+.||++.- ........+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 35 ~~lg~G~~g~V~-----~~~~~~~~~~vavK~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 35 QKLGEGGFSYVD-----LVEGLHDGHFYALKRI-LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEC--CEEEE-----EEEETTTCCEEEEEEE-EESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEecCCCCeEEE-----EEEecCCCcEEEEEEE-ecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 348899999994 66654 888883211 11223456778999999999999999999999973 3478999
Q ss_pred EeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 85 MDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 999999999998864 458999999999999999999999999999999999999999999999999988653221
Q ss_pred C-------------ccccCCCCchhhhhcCC----CcccCCCcccccceecCCccCCCCC
Q psy16292 160 T-------------ETKRLGRNGIEEIKAHP----FFINDQWTFSNLRECVPPVVPELSG 202 (245)
Q Consensus 160 ~-------------~~~~~~~~~~e~i~~~~----~~~~Diws~g~~~~~~~~~~~pf~~ 202 (245)
. .....++.+||.+...+ ..++|+||+|++++++++|.+||.+
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 1 11144578899886554 2678999999999999999999965
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=238.69 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=158.6
Q ss_pred HHHHh----hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-Cc-----cceeeeE
Q psy16292 7 FMHRY----RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-SE-----WIVQLHF 73 (245)
Q Consensus 7 f~~~y----~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~ 73 (245)
|.++| .+++|+||+|+ +|+++ |+.|| ++.+. .....+.+.+|+.+++.++ |+ +|+++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~-----~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVV-----KAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEE-----EEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeeEEEEEEEeecCCEEEE-----EEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 44555 48899999995 66555 88888 32221 1234566788999998884 55 4999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCceEec--CCCcEEE
Q psy16292 74 AFQDAKSLYMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIH--CLGFVHRDVKPDNMLLD--KHGHLKL 146 (245)
Q Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH--~~~iih~dlkp~nil~~--~~~~i~l 146 (245)
++...+.+++|||++ +++|.+++... .+++..+..++.|++.||.||| +.||+||||||+||+++ .++.++|
T Consensus 124 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999999 56999988754 4899999999999999999999 57899999999999995 4678999
Q ss_pred EeeCceeecCCCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccC
Q psy16292 147 ADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIE 213 (245)
Q Consensus 147 ~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~ 213 (245)
+|||+++....... ......|.+||.+.+.++ .++|+||+||++++|++|.+||.+.++...+.++.
T Consensus 203 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 203 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp CCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999988754322 223444889999988777 78999999999999999999999887665555443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=225.99 Aligned_cols=187 Identities=14% Similarity=0.141 Sum_probs=153.7
Q ss_pred hhccccccchhhhHHHHHhh---cCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCcc------ceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY---RYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEW------IVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~---~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~~~~~~~~~~ 81 (245)
.+++|+||+|+ +|.+ .|+.|| ++.+. .....+.+.+|+.+++.++|++ ++++++++...+.+
T Consensus 21 ~lg~G~~g~V~-----~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 21 TLGEGAFGKVV-----ECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp EEEEETTEEEE-----EEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred EEecCCCeEEE-----EEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 37889999995 5543 288888 32221 1234567889999999987654 99999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC------------------
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK------------------ 140 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~------------------ 140 (245)
++|||++ +++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 89999988754 4789999999999999999999999999999999999987
Q ss_pred -CCcEEEEeeCceeecCCCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 141 -HGHLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 141 -~~~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
++.++|+|||+++....... .....++.+||.+.+.++ .++|+||+|++++++++|.+||.+.+...
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp SCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66799999999987554322 233445889999988776 78899999999999999999998776543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=229.46 Aligned_cols=193 Identities=17% Similarity=0.171 Sum_probs=138.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcC-CccceeeeEEEE--------eCCE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQ--------DAKS 80 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--------~~~~ 80 (245)
.+++|+||.|+ +++++ |+.||++.- ........+.+.+|+.+++++. ||||+++++++. ....
T Consensus 35 ~lg~G~~g~V~-----~~~~~~~~~~vavK~~-~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 35 VLAEGGFAFVY-----EAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEECCSSEEEE-----EEEETTTCCEEEEEEE-EESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred EEccCCceEEE-----EEEECCCCcEEEEEEe-cCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 48899999994 66664 888883211 1112344567899999999995 999999999994 3446
Q ss_pred EEEEEeccCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 81 LYMVMDYMPGGDLVNLMSN----YDVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
++++||++ +|+|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 109 FLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 89999999 5799887753 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC----------------ccccCCCCchhhh---hcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 155 MNKTGT----------------ETKRLGRNGIEEI---KAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 155 ~~~~~~----------------~~~~~~~~~~e~i---~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
...... ......|.+||.+ ...++ .++|+||+|++++++++|.+||.+.........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 654322 1133447888887 33344 678999999999999999999987765544433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=221.68 Aligned_cols=183 Identities=17% Similarity=0.273 Sum_probs=145.7
Q ss_pred HHHHHhh----hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--
Q psy16292 6 AFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-- 77 (245)
Q Consensus 6 ~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 77 (245)
+|.++|+ +++|+||.|+ +|+++ |+.||++.-. ......+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEE-----EEEETTTCCEEEEEEEE--EEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred cccccchhhheeccCCcEEEE-----EEEEcCCCeEEEEEEEe--ccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 3555555 7788999994 66654 8888822111 122446778999999999999999999999865
Q ss_pred -----------CCEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 78 -----------AKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 78 -----------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
....++||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence 35789999999999999999754 36788899999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCC------------------CccccCCCCchhhhhcC-CC-cccCCCcccccceecCC
Q psy16292 145 KLADFGTCMRMNKTG------------------TETKRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPP 195 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~------------------~~~~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~ 195 (245)
+|+|||+++...... .......+.+||.+.+. .+ .++|+||+|++++++++
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999998654221 11233447899998764 34 78899999999999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=235.42 Aligned_cols=186 Identities=17% Similarity=0.181 Sum_probs=153.8
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEE-ehhhhhccCchHHHHHHHHHHHhcCC-ccceeeeEEEEeCCEEEEEE
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALY-SRYFQIKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~-~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~ 85 (245)
.-.|++|+||.|+ +++++ |+.||++ .+. ......+.+|+.+++.++| ++|..+..++......++||
T Consensus 12 ~~~LG~G~fG~Vy-----~a~~~~~~~~vAvK~~~~----~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 12 GRKIGSGSFGEIY-----LGTNIQTNEEVAIKLENV----KTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp CCCCEECSSCEEE-----EEEETTTCCEEEEEEEET----TCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeeCCCEEEE-----EEEECCCCcEEEEEEecc----ccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3458899999994 66655 8888832 222 2233458899999999976 56667777778889999999
Q ss_pred eccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe---cCCCcEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~---~~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
||+ +++|.+++. ...+++..+..++.||+.||.|||+++|+||||||+||++ +.++.++|+|||+++.......
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999 999999997 4569999999999999999999999999999999999999 5789999999999987654432
Q ss_pred -----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 -----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 -----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.....+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 223445789999988777 688999999999999999999988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=231.98 Aligned_cols=186 Identities=13% Similarity=0.076 Sum_probs=147.6
Q ss_pred hhhccccccchhhhHHHHHhh-----cCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCcccee--------------
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKY-----RYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQ-------------- 70 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~-----~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~-------------- 70 (245)
-.+++|+||.|+.+....... .++.|| ++.+. .+.+.+|+.++++++||||++
T Consensus 48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-------DGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEETTEEEEEEEECC-----------CEEEEEEET-------TSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEecCCCCeEEEEEeecCCccccccccCceEEEEEecc-------cchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 348889999996332211100 256777 22211 146889999999999999988
Q ss_pred -eeEEEEe-CCEEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC--c
Q psy16292 71 -LHFAFQD-AKSLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG--H 143 (245)
Q Consensus 71 -l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~--~ 143 (245)
+++++.. +...++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 5667766 78999999999 9999999975 4699999999999999999999999999999999999999998 8
Q ss_pred EEEEeeCceeecCCCCC-----------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 144 LKLADFGTCMRMNKTGT-----------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 144 i~l~Dfg~a~~~~~~~~-----------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
++|+|||+++.+..... ......|.+||.+.+.++ .++|+||+|++++++++|.+||.+..
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 99999999987643321 123345789999988766 78899999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-33 Score=233.96 Aligned_cols=198 Identities=15% Similarity=0.147 Sum_probs=154.0
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-.+++|+||.|+ +++.++. +| ++.+.........+.+.+|+.++++++||||+++++++.+...+++|||+++
T Consensus 39 ~~lg~G~~g~V~-----~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 39 ELIGKGRFGQVY-----HGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp CBCCCSSSSEEE-----EEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEeccCCceEEE-----EEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 358899999995 5555554 55 3333233334456678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC------C-
Q psy16292 90 GGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG------T- 160 (245)
Q Consensus 90 ~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~------~- 160 (245)
+++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++ ++.++|+|||+++...... .
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 191 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL 191 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence 99999999865 389999999999999999999999999999999999998 6899999999987543111 1
Q ss_pred --ccccCCCCchhhhhc---------CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcC
Q psy16292 161 --ETKRLGRNGIEEIKA---------HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~---------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 215 (245)
.....++.+||.+.. .++ .++|+||+|++++++++|..||.+.........+..+
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 123344788998864 223 5789999999999999999999887655544444444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.69 Aligned_cols=186 Identities=16% Similarity=0.256 Sum_probs=152.3
Q ss_pred hhccccccchhhhHHHHHh-----hc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC--EEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLK-----YR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK--SLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~-----~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~l 83 (245)
.+++|+||.|+ +|+ .. |+.||++.-. .......+.+.+|+.+++.++||||+++++++...+ .+++
T Consensus 48 ~lg~G~~g~V~-----~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 48 QLGKGNFGSVE-----MCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp EEECCSSEEEE-----EEEECTTSSSCCEEEEEEEES-SCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred eeccCCCeEEE-----EEEeccccCCCceEEEEEEec-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 48889999995 554 22 8888832211 123345678999999999999999999999987654 7899
Q ss_pred EEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc
Q psy16292 84 VMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~ 161 (245)
|||++++++|.+++... .+++..+..++.|++.||.+||+++++|+||||+||+++.++.++|+|||+++........
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~ 201 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence 99999999999998764 4899999999999999999999999999999999999999999999999999887544321
Q ss_pred -------cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 162 -------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 162 -------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....+.+||.+.+.++ .++|+||+|++++++++|..|+...
T Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 11223789999887776 7889999999999999999988643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=242.31 Aligned_cols=165 Identities=16% Similarity=0.172 Sum_probs=119.9
Q ss_pred CeEEE--EEehhhh-------hccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCC-
Q psy16292 33 YTLYA--LYSRYFQ-------IKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD- 101 (245)
Q Consensus 33 ~~~~a--v~~k~~~-------~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~- 101 (245)
|+.|| ++.+... ..+...+.+.+|+++|+++ .|+||+++++++++++.+||||||++|++|.+++..++
T Consensus 259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~ 338 (569)
T 4azs_A 259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE 338 (569)
T ss_dssp CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC
T ss_pred cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC
Confidence 88888 3333211 1223456799999999999 79999999999999999999999999999999998764
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccc---cCCCCchhhhhcCC
Q psy16292 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETK---RLGRNGIEEIKAHP 177 (245)
Q Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~---~~~~~~~e~i~~~~ 177 (245)
+++. .++.||+.||.|+|++||+||||||+|||++.+|.+||+|||+|+....... ..+ ..+|.+||.+.+..
T Consensus 339 l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~ 415 (569)
T 4azs_A 339 IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENK 415 (569)
T ss_dssp CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----
T ss_pred CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCC
Confidence 5543 4789999999999999999999999999999999999999999997654432 222 33478899998877
Q ss_pred CcccCCCcccccceecCCccCCC
Q psy16292 178 FFINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 178 ~~~~Diws~g~~~~~~~~~~~pf 200 (245)
.+.+|+||+|++++.++++..++
T Consensus 416 ~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 416 SWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -------------CCCCTTHHHH
T ss_pred CCcccccccccchhhhccccchh
Confidence 78899999999999998876554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=234.50 Aligned_cols=184 Identities=14% Similarity=0.189 Sum_probs=141.7
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPG 90 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~ 90 (245)
.+|+|+||+|+ ......|+.||++.-. ....+.+.+|+.+++++ +||||+++++++.+++.+|+|||++ +
T Consensus 22 ~LG~G~~g~V~----~~~~~~g~~vAvK~~~----~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~ 92 (434)
T 2rio_A 22 ILGYGSSGTVV----FQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-N 92 (434)
T ss_dssp EEEECSTTCEE----EEEESSSSEEEEEEEE----GGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred eEeeCCCeEEE----EEEEECCeEEEEEEEc----HHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-C
Confidence 48999999994 1222238889933211 12245678999999886 8999999999999999999999999 5
Q ss_pred CCHHHHHhcCCCC--------HHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-------------CcEEEEee
Q psy16292 91 GDLVNLMSNYDVP--------EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-------------GHLKLADF 149 (245)
Q Consensus 91 g~L~~~l~~~~~~--------~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-------------~~i~l~Df 149 (245)
|+|.+++...... +..+..++.|++.||.|||+++|+||||||+||+++.+ +.++|+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 7999999765422 22346789999999999999999999999999999754 47999999
Q ss_pred CceeecCCCCC--------ccccCCCCchhhhhc-------CCC-cccCCCcccccceecCC-ccCCCCCCC
Q psy16292 150 GTCMRMNKTGT--------ETKRLGRNGIEEIKA-------HPF-FINDQWTFSNLRECVPP-VVPELSGDD 204 (245)
Q Consensus 150 g~a~~~~~~~~--------~~~~~~~~~~e~i~~-------~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~ 204 (245)
|+++....... .....++.+||.+.+ ..+ .++|+||+||+++++++ |.+||.+..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 99998654322 223455889999865 333 67899999999999998 999997654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=228.24 Aligned_cols=196 Identities=22% Similarity=0.266 Sum_probs=148.3
Q ss_pred chHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhc----CCcc
Q psy16292 3 NVEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHA----NSEW 67 (245)
Q Consensus 3 ~~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l----~hp~ 67 (245)
..+.|.++|+ +++|+||.|+ +|+++ |+.|| ++++...... .....+.+|+.+++++ +|||
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVF-----AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp --------CEEEEEEEEETTEEEE-----EEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred chhhhhhceEEeeEEEcCCCEEEE-----EEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 3456777777 6788999995 66554 88888 3222221111 2344567899999998 8999
Q ss_pred ceeeeEEEEeCCEEEEEEec-cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-CCCcE
Q psy16292 68 IVQLHFAFQDAKSLYMVMDY-MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHL 144 (245)
Q Consensus 68 Iv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-~~~~i 144 (245)
|+++++++...+..++|+|+ +.+++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++ .++.+
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence 99999999999999999999 788999998875 4589999999999999999999999999999999999999 78999
Q ss_pred EEEeeCceeecCCCCC--ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC
Q psy16292 145 KLADFGTCMRMNKTGT--ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~--~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
+|+|||+++....... .....++.+||.+....+ .++|+||+|++++++++|..||.+.
T Consensus 180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999999987654322 223445889999887776 4789999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=249.00 Aligned_cols=194 Identities=18% Similarity=0.216 Sum_probs=157.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-----
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----- 77 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----- 77 (245)
++|.-.-.+|+|+||+|+ ++.++ |+.||+..-.........+++.+|+.+++.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vy-----la~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVL-----RWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCC-----CCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEE-----EEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 344444458889999994 66665 888883221112233456779999999999999999999999765
Q ss_pred -CCEEEEEEeccCCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCc---EEEEee
Q psy16292 78 -AKSLYMVMDYMPGGDLVNLMSNY----DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGH---LKLADF 149 (245)
Q Consensus 78 -~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~---i~l~Df 149 (245)
++..++||||+++++|.+++... .+++..+..++.+++.||.|||++|++|+||||+||+++.++. ++|+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 67889999999999999998753 4888999999999999999999999999999999999997765 899999
Q ss_pred CceeecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCC
Q psy16292 150 GTCMRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 150 g~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
|++.......... ...++.+||.+.+.++ .++|+||+|++++++++|.+||.+.
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9999876544333 3344788998877766 7889999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=222.17 Aligned_cols=168 Identities=21% Similarity=0.288 Sum_probs=136.7
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHH-HhcCCccceeeeEEEEe----CCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIM-AHANSEWIVQLHFAFQD----AKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~----~~~~~lv~ 85 (245)
+++|+||+|+ +|+++ |+.||+..- .....+.+|+.++ +.++||||+++++++.. ...+++||
T Consensus 26 lg~G~~g~V~-----~~~~~~~~~~vaiK~~------~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 26 LGLGINGKVL-----QIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEETTEEEE-----EEEETTTCCEEEEEEE------ECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccCCCeEEE-----EEEEcCCCcEEEEEEe------cccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 6789999994 66554 888883211 1234577899988 55699999999999987 67899999
Q ss_pred eccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCCC
Q psy16292 86 DYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 86 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~~ 159 (245)
||+++++|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++. ++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 172 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-- 172 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence 999999999998754 4899999999999999999999999999999999999998 78899999999986542
Q ss_pred CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCC
Q psy16292 160 TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNF 209 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~ 209 (245)
.++ .++|+||+||++++|++|.+||.+..+....
T Consensus 173 ----------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 207 (299)
T 3m2w_A 173 ----------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 207 (299)
T ss_dssp ----------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred ----------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence 122 5789999999999999999999887655443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=228.75 Aligned_cols=204 Identities=20% Similarity=0.257 Sum_probs=142.7
Q ss_pred HHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEE
Q psy16292 6 AFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82 (245)
Q Consensus 6 ~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 82 (245)
+|...-.+++|+||.|+ +|+.+ |+.|| ++.+.........+.+.++..+++.++||||+++++++...+.++
T Consensus 26 ~y~~~~~lg~G~~g~V~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVW-----KMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp GEEEEEEC------CEE-----EEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeecCCeeEE-----EEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 33334458899999994 66665 88888 222222122223344555666788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 83 MVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|||++ ++.+..+.. ...+++..+..++.+++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 666666654 35689999999999999999999995 99999999999999999999999999998765433
Q ss_pred Cc---cccCCCCchhhhh-----cCCC-cccCCCcccccceecCCccCCCCCCC-CCCCCcccCcC
Q psy16292 160 TE---TKRLGRNGIEEIK-----AHPF-FINDQWTFSNLRECVPPVVPELSGDD-DTSNFDDIEKD 215 (245)
Q Consensus 160 ~~---~~~~~~~~~e~i~-----~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~-~~~~~~~~~~~ 215 (245)
.. .....+.+||.+. ...+ .++|+||+|++++++++|.+||.+.. +...+..+..+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence 22 2344578899884 2333 67899999999999999999998643 33333344443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=226.47 Aligned_cols=186 Identities=19% Similarity=0.211 Sum_probs=130.6
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEEEEe
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYMVMD 86 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~e 86 (245)
+|+|+||+|+ +|+++ |+.||++.-. .......+....++.++||||+++++++.. ...+++|||
T Consensus 37 lG~G~~g~V~-----~~~~~~~~~~vavK~~~-----~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 37 LGLGVNGKVL-----ECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp EEEETTEEEE-----EEEETTTCCEEEEEEEE-----SSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeCCCeEEE-----EEEECCCCCEEEEEEec-----CcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 6889999994 66666 8888832110 111222333344566799999999999976 456899999
Q ss_pred ccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCCCC
Q psy16292 87 YMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||+++.......
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~ 186 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence 99999999999764 4899999999999999999999999999999999999976 45599999999987653322
Q ss_pred --ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.....+|.+||.+...++ .++|+||+|++++++++|.+||.+......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 223445788998876666 678999999999999999999987765544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=223.83 Aligned_cols=187 Identities=14% Similarity=0.124 Sum_probs=151.5
Q ss_pred hhccccccchhhhHHHHHhhc--C-eEEE-EEehhhhhccCchHHHHHHHHHHHhcCCcc------ceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--Y-TLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEW------IVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~-~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~~~~~~~~~~ 81 (245)
.+++|+||+|+ +|+.+ + +.|| ++.+. .....+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 26 ~lg~G~~g~V~-----~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 26 NLGEGTFGKVV-----ECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp EEEEETTEEEE-----EEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred EeeccCCeEEE-----EEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 37889999995 55544 4 6788 32221 1234567889999999997665 89999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEe-------------------c
Q psy16292 82 YMVMDYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL-------------------D 139 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~-------------------~ 139 (245)
++|||++ ++++.+.+... .+++..+..++.|++.||.|||++||+||||||+||++ +
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9999999 67777766543 48999999999999999999999999999999999999 5
Q ss_pred CCCcEEEEeeCceeecCCCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 140 KHGHLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.++.++|+|||+++....... .....++.+||.+.+.++ .++|+||+||++|+|++|.+||.+..+..
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp SCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999987544322 233445789999987776 78899999999999999999998776543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-31 Score=222.76 Aligned_cols=186 Identities=23% Similarity=0.238 Sum_probs=148.2
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC--CccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN--SEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.+++|+||.|+ +++++ |+.|| ++.+.........+.+.+|+.++++++ ||||+++++++.....+++|||
T Consensus 35 ~lg~G~~g~Vy-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 35 QIGSGGSSKVF-----QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEECCSSEEEE-----EEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EecCCCCEEEE-----EEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 48899999995 55555 88888 322222223345678999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------ 160 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------ 160 (245)
+.+++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++ ++.++|+|||+++.......
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 187 (313)
T 3cek_A 109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 187 (313)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccC
Confidence 4588999988754 589999999999999999999999999999999999996 48999999999987643322
Q ss_pred ccccCCCCchhhhhc-----------CCC-cccCCCcccccceecCCccCCCCCCC
Q psy16292 161 ETKRLGRNGIEEIKA-----------HPF-FINDQWTFSNLRECVPPVVPELSGDD 204 (245)
Q Consensus 161 ~~~~~~~~~~e~i~~-----------~~~-~~~Diws~g~~~~~~~~~~~pf~~~~ 204 (245)
.....++.+||.+.. ..+ .++|+||+|++++++++|.+||.+..
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 123444788998865 223 67899999999999999999997653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-31 Score=223.11 Aligned_cols=186 Identities=19% Similarity=0.168 Sum_probs=153.3
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcC--CccceeeeEEEEeCCEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHAN--SEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~l 83 (245)
+++|+||.|+ +|+++ |+.|| ++++...... ....++.+|+.++++++ ||||+++++++...+..++
T Consensus 51 lg~G~~g~Vy-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l 125 (320)
T 3a99_A 51 LGSGGFGSVY-----SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125 (320)
T ss_dssp CSSSSSCEEE-----EEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EeeCCCeEEE-----EEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence 7889999995 56544 88888 3333322111 23456788999999995 5999999999999999999
Q ss_pred EEeccCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec-CCCcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPG-GDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~-g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|+|++.+ ++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++ .++.++|+|||+++.......
T Consensus 126 v~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~ 205 (320)
T 3a99_A 126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205 (320)
T ss_dssp EEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB
T ss_pred EEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc
Confidence 9999975 899998864 4689999999999999999999999999999999999999 678999999999987654322
Q ss_pred --ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
.....++.+||.+...++ .++|+||+|++++++++|.+||.+.
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 123344789999987776 5679999999999999999999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-31 Score=231.57 Aligned_cols=185 Identities=15% Similarity=0.146 Sum_probs=142.0
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-.+|+|+||+|+ +.+...|+.||++.-. ......+.+|+.+++++ +||||+++++++.+....|+|||++
T Consensus 30 ~~LG~G~~G~V~----~~~~~~~~~vAvK~~~----~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~- 100 (432)
T 3p23_A 30 DVLGHGAEGTIV----YRGMFDNRDVAVKRIL----PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC- 100 (432)
T ss_dssp EEEEECGGGCEE----EEEESSSSEEEEEEEC----TTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred CeeecCcCEEEE----EEEEeCCeEEEEEEEC----HHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC-
Confidence 458999999973 2233338888843211 12233467899999999 8999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---C--CcEEEEeeCceeecCCCCC--
Q psy16292 90 GGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---H--GHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 90 ~g~L~~~l~~~~--~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~--~~i~l~Dfg~a~~~~~~~~-- 160 (245)
+|+|.+++.... .++..+..++.|++.||.|||+++|+||||||+||+++. + ..++|+|||+|+.......
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 579999987653 445566789999999999999999999999999999953 2 3578999999987653321
Q ss_pred -----ccccCCCCchhhhhc---CCC-cccCCCcccccceecCC-ccCCCCCCC
Q psy16292 161 -----ETKRLGRNGIEEIKA---HPF-FINDQWTFSNLRECVPP-VVPELSGDD 204 (245)
Q Consensus 161 -----~~~~~~~~~~e~i~~---~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~ 204 (245)
.....+|.+||.+.. ..+ .++|+||+||+++++++ |.+||.+..
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 223455789999864 222 57899999999999999 999996543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-31 Score=227.01 Aligned_cols=186 Identities=22% Similarity=0.280 Sum_probs=149.0
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcC-----------CccceeeeEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHAN-----------SEWIVQLHFAFQ 76 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~~~~ 76 (245)
-.+++|+||+|+ +|+++ |+.|| ++.+. +....+.+.+|+.++++++ ||||+++++++.
T Consensus 25 ~~lg~G~~g~V~-----~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 25 RKLGWGHFSTVW-----LAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp EEEEECSSEEEE-----EEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred EeeeecCCeEEE-----EEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 347899999994 66654 88888 22221 1234566889999999885 899999999998
Q ss_pred eCC----EEEEEEeccCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCceEecC------CC
Q psy16292 77 DAK----SLYMVMDYMPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCL-GFVHRDVKPDNMLLDK------HG 142 (245)
Q Consensus 77 ~~~----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~iih~dlkp~nil~~~------~~ 142 (245)
..+ .++++||++ +++|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+||+++. .+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 899999999 9999998875 3489999999999999999999998 9999999999999953 34
Q ss_pred cEEEEeeCceeecCCCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 143 HLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 143 ~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.++|+|||+++....... .....+|.+||.+.+.++ .++|+||+||++|++++|.+||.+...
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 799999999987654322 233445889999988877 788999999999999999999987653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=228.78 Aligned_cols=197 Identities=14% Similarity=0.057 Sum_probs=146.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEeh-hhhhccCchHHHHHHHHHHHhcCC-ccc---------eeee-----
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSR-YFQIKRSDSAFFWEERDIMAHANS-EWI---------VQLH----- 72 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k-~~~~~~~~~~~~~~E~~il~~l~h-p~I---------v~l~----- 72 (245)
.||+|+||.|+ +|+++ |+.|| ++.+ .........+.+.+|+.+++.+.| +|. +...
T Consensus 85 ~LG~G~fG~Vy-----~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 85 VLGQEDPYAYL-----EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred ccccCCCEEEE-----EEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 48999999994 77755 99999 3322 222333457889999999999976 221 1111
Q ss_pred -------EEEEe-----CCEEEEEEeccCCCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q psy16292 73 -------FAFQD-----AKSLYMVMDYMPGGDLVNLMS--------NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVK 132 (245)
Q Consensus 73 -------~~~~~-----~~~~~lv~e~~~~g~L~~~l~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlk 132 (245)
.++.. ...++++|+.+ +++|.++++ ...+++..+..++.|++.||.|||+++|+|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 11111 22467888876 789999884 2236677888889999999999999999999999
Q ss_pred CCceEecCCCcEEEEeeCceeecCCCCC-ccccCCCCchhhhh----------cCCC-cccCCCcccccceecCCccCCC
Q psy16292 133 PDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRLGRNGIEEIK----------AHPF-FINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 133 p~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~----------~~~~-~~~Diws~g~~~~~~~~~~~pf 200 (245)
|+||+++.++.+||+|||+++....... ... .+|.+||.+. ..++ .++|+||+||++|+|++|.+||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999987654322 233 6789999984 2233 5789999999999999999999
Q ss_pred CCCCCCCCCcccCcC
Q psy16292 201 SGDDDTSNFDDIEKD 215 (245)
Q Consensus 201 ~~~~~~~~~~~~~~~ 215 (245)
.+.........+...
T Consensus 318 ~~~~~~~~~~~~~~~ 332 (413)
T 3dzo_A 318 TDDAALGGSEWIFRS 332 (413)
T ss_dssp CTTGGGSCSGGGGSS
T ss_pred CCcchhhhHHHHHhh
Confidence 988877777766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.8e-25 Score=198.65 Aligned_cols=173 Identities=13% Similarity=0.005 Sum_probs=125.6
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhh------hccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQ------IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
-.+++|+||+|+ +++..++.+| +...... ......+++.+|+.++++++||||+++..++......|+
T Consensus 342 ~~LG~G~fg~Vy-----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 342 HLIGKGAEADIK-----RDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ------CCEEEE-----EEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CEEeeCCCEEEE-----EEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 368999999995 5554577667 2211111 111234668999999999999999966666667778899
Q ss_pred EEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 84 VMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||||+++++|.+++.. ...++.|++.||.|||+++|+||||||+||+++. .++|+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 5678999999999999999999999999999998 999999999998765322
Q ss_pred --------ccccCCCCchhhhhc--CCC-cccCCCcccccceecCCcc
Q psy16292 161 --------ETKRLGRNGIEEIKA--HPF-FINDQWTFSNLRECVPPVV 197 (245)
Q Consensus 161 --------~~~~~~~~~~e~i~~--~~~-~~~Diws~g~~~~~~~~~~ 197 (245)
......+.+||.+.. ..| ...|.||...-..+....+
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 122344678888876 333 3469998776554444333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-20 Score=157.50 Aligned_cols=129 Identities=11% Similarity=0.058 Sum_probs=99.3
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhc-c---------------CchHHHHHHHHHHHhcCCccceeeeE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIK-R---------------SDSAFFWEERDIMAHANSEWIVQLHF 73 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~-~---------------~~~~~~~~E~~il~~l~hp~Iv~l~~ 73 (245)
.+++|+||.|+ +|+.. |+.+| ++.+..... . .....+.+|+.+++.++ | +++++
T Consensus 97 ~iG~G~~g~Vy-----~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 97 LMGEGKESAVF-----NCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEECSSEEEE-----EEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EeccCCCceEE-----EEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 48899999995 55555 88888 332211111 1 13456899999999998 4 55656
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 74 AFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
++.. +..|+||||++|++|.+ +.. .....++.|++.||.+||++|++||||||+||+++ ++.++|+|||+|+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred EEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 5544 45699999999999988 422 23456899999999999999999999999999999 9999999999998
Q ss_pred ecC
Q psy16292 154 RMN 156 (245)
Q Consensus 154 ~~~ 156 (245)
...
T Consensus 241 ~~~ 243 (282)
T 1zar_A 241 EVG 243 (282)
T ss_dssp ETT
T ss_pred ECC
Confidence 654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.5e-18 Score=140.69 Aligned_cols=132 Identities=15% Similarity=0.067 Sum_probs=96.3
Q ss_pred hhccccccchhhhHHHHHhh--cCeE--EE-EEehhh-hhcc---------------------CchHHHHHHHHHHHhcC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY--RYTL--YA-LYSRYF-QIKR---------------------SDSAFFWEERDIMAHAN 64 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~--~~~~--~a-v~~k~~-~~~~---------------------~~~~~~~~E~~il~~l~ 64 (245)
.+++|+||.| ++|+. .|+. +| ++.+.. .... .....+.+|+.+|+.+.
T Consensus 54 ~ig~G~~g~V-----y~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 54 VISTGKEANV-----FYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEECSSEEE-----EEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred EEeecceEEE-----EEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 3789999999 47776 3888 88 332211 1000 01136889999999998
Q ss_pred Cccc--eeeeEEEEeCCEEEEEEeccCC-C----CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCce
Q psy16292 65 SEWI--VQLHFAFQDAKSLYMVMDYMPG-G----DLVNLMSNYDVPEKWAKFYCAEVVLALDAIH-CLGFVHRDVKPDNM 136 (245)
Q Consensus 65 hp~I--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH-~~~iih~dlkp~ni 136 (245)
|+++ +.++.. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| ++|++||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8764 333332 246899999942 3 67665433 234567788999999999999 99999999999999
Q ss_pred EecCCCcEEEEeeCceeecC
Q psy16292 137 LLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 137 l~~~~~~i~l~Dfg~a~~~~ 156 (245)
+++. .++|+|||+|....
T Consensus 203 Ll~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EESS--SEEECCCTTCEETT
T ss_pred EEcC--cEEEEECcccccCC
Confidence 9988 89999999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.2e-16 Score=133.62 Aligned_cols=133 Identities=15% Similarity=0.071 Sum_probs=88.9
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhc------------cCchHH--------HHHHHHHHHhcCCccce
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIK------------RSDSAF--------FWEERDIMAHANSEWIV 69 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~------------~~~~~~--------~~~E~~il~~l~hp~Iv 69 (245)
.||.|.+|.|+ +|... |+.+| ++-+..... ...... ..+|...|.++.+.++.
T Consensus 102 ~IG~Gk~a~VY-----~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 102 RIGVGKESDIM-----IVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp EEEECSSEEEE-----EEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EeeeCCceEEE-----EEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 37889999994 66656 99999 433321110 011111 23456666666444432
Q ss_pred eeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-------
Q psy16292 70 QLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG------- 142 (245)
Q Consensus 70 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~------- 142 (245)
...-+.... .++||||+.|++|..+... .....++.|++.+|.++|++|++||||||.|||++.+|
T Consensus 177 vp~p~~~~~--~~LVME~i~G~~L~~l~~~-----~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~ 249 (397)
T 4gyi_A 177 VPEPIAQSR--HTIVMSLVDALPMRQVSSV-----PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSS 249 (397)
T ss_dssp CCCEEEEET--TEEEEECCSCEEGGGCCCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTS
T ss_pred CCeeeeccC--ceEEEEecCCccHhhhccc-----HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccc
Confidence 222222222 3799999998888665322 23456789999999999999999999999999998776
Q ss_pred ---cEEEEeeCceeecC
Q psy16292 143 ---HLKLADFGTCMRMN 156 (245)
Q Consensus 143 ---~i~l~Dfg~a~~~~ 156 (245)
.+.++||+-+....
T Consensus 250 ~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 250 ITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECCCTTCEETT
T ss_pred cccceEEEEeCCcccCC
Confidence 38899999887654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-10 Score=95.10 Aligned_cols=139 Identities=14% Similarity=0.064 Sum_probs=97.4
Q ss_pred HHHHHHhhh----ccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 5 EAFMHRYRR----YRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 5 ~~f~~~y~~----~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
......|++ +.++.+.|+ .+...|..++ ++..... ......+.+|+.+++.+ .+..++++++++...
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~-----~~~~~~~~~vlK~~~~~~--~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 82 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVY-----KLVGENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEE-----EEECSSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHhccceeEeeccCCCCCeEE-----EEECCCCcEEEEeCCccc--CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence 334445642 233445563 4443455555 3333221 13345689999999998 467788999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC----------------------------------- 123 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~----------------------------------- 123 (245)
+..|+|||+++|.+|.+.+.. ......++.++..++..||+
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred CceEEEEEecCCeehhhccCC----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999999998775321 12234567788889999998
Q ss_pred ------------------------CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 ------------------------LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ------------------------~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..++|+|++|.||+++..+.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998755567999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.4e-09 Score=93.08 Aligned_cols=104 Identities=15% Similarity=0.193 Sum_probs=81.5
Q ss_pred hHHHHHHHHHHHhcC--CccceeeeEEEEeC---CEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q psy16292 50 SAFFWEERDIMAHAN--SEWIVQLHFAFQDA---KSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC- 123 (245)
Q Consensus 50 ~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~- 123 (245)
...+.+|+.+++.+. +..+++++.++.+. +..|+|||+++|.++.+.. ...++......++.++...|..||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 456888999999996 45578888888776 4589999999987774421 1235677778888999999999996
Q ss_pred ---------------------------------------------------------CCceeCCCCCCceEecCCCc--E
Q psy16292 124 ---------------------------------------------------------LGFVHRDVKPDNMLLDKHGH--L 144 (245)
Q Consensus 124 ---------------------------------------------------------~~iih~dlkp~nil~~~~~~--i 144 (245)
..++|+|+++.||+++.++. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~ 238 (359)
T 3dxp_A 159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL 238 (359)
T ss_dssp CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence 35899999999999987753 5
Q ss_pred EEEeeCceee
Q psy16292 145 KLADFGTCMR 154 (245)
Q Consensus 145 ~l~Dfg~a~~ 154 (245)
.++||+.+..
T Consensus 239 ~viDwe~a~~ 248 (359)
T 3dxp_A 239 AVLDWELSTL 248 (359)
T ss_dssp EECCCTTCEE
T ss_pred EEECcccccc
Confidence 8999998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=88.57 Aligned_cols=99 Identities=15% Similarity=0.170 Sum_probs=73.2
Q ss_pred hHHHHHHHHHHHhcCCcc--ceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q psy16292 50 SAFFWEERDIMAHANSEW--IVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLG-- 125 (245)
Q Consensus 50 ~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 125 (245)
...+.+|+.+++.+.+.+ +++++.+...++..++|||+++|.++. ... ... ..++.++...+..+|+..
T Consensus 57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~--~~~---~~~~~~l~~~l~~lh~~~~~ 129 (264)
T 1nd4_A 57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH--LAP---AEKVSIMADAMRRLHTLDPA 129 (264)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC--CCH---HHHHHHHHHHHHHHTTSCGG
T ss_pred chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc--CCH---hHHHHHHHHHHHHHhCCCCC
Confidence 356789999999984434 667888888888899999999988873 211 111 234556666666666532
Q ss_pred --------------------------------------------------------ceeCCCCCCceEecCCCcEEEEee
Q psy16292 126 --------------------------------------------------------FVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 126 --------------------------------------------------------iih~dlkp~nil~~~~~~i~l~Df 149 (245)
++|+|++|.||+++.++.+.++||
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 999999999999987665679999
Q ss_pred Cceeec
Q psy16292 150 GTCMRM 155 (245)
Q Consensus 150 g~a~~~ 155 (245)
+.+...
T Consensus 210 ~~a~~g 215 (264)
T 1nd4_A 210 GRLGVA 215 (264)
T ss_dssp TTCEEE
T ss_pred hhcccC
Confidence 987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.6e-05 Score=64.65 Aligned_cols=102 Identities=13% Similarity=0.197 Sum_probs=72.7
Q ss_pred hHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----
Q psy16292 50 SAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCL---- 124 (245)
Q Consensus 50 ~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~---- 124 (245)
...+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.++.+...... .....+..++...|.-||..
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~---~~~~~~~~~l~~~L~~Lh~~~~~~ 139 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP---DSGENIVDALAVFLRRLHSIPVCN 139 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG---GGHHHHHHHHHHHHHHHHTSCGGG
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH---HHHHHHHHHHHHHHHHhcCCCccc
Confidence 456788999999883 3346788889999999999999999888776543211 11222334444444444411
Q ss_pred ------------------------------------------------------CceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 125 ------------------------------------------------------GFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 125 ------------------------------------------------------~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
.++|+|+.+.||+++..+.+-|+||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe 219 (272)
T 4gkh_A 140 CPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG 219 (272)
T ss_dssp CCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred CCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence 26899999999999887767799999
Q ss_pred ceee
Q psy16292 151 TCMR 154 (245)
Q Consensus 151 ~a~~ 154 (245)
.+..
T Consensus 220 ~a~~ 223 (272)
T 4gkh_A 220 RVGI 223 (272)
T ss_dssp TCEE
T ss_pred cccc
Confidence 8875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.07 E-value=7.3e-06 Score=68.19 Aligned_cols=151 Identities=16% Similarity=0.224 Sum_probs=93.4
Q ss_pred chHHHHHHHHHHHhc-CCcc--ceeeeEEEEeCC---EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy16292 49 DSAFFWEERDIMAHA-NSEW--IVQLHFAFQDAK---SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH 122 (245)
Q Consensus 49 ~~~~~~~E~~il~~l-~hp~--Iv~l~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH 122 (245)
....+.+|+.+++.+ .+.. +++.+....... ..|+||++++|.++..... ..++......++.++...+..||
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH 131 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELH 131 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHH
Confidence 356789999999988 4433 344444433333 3589999999887764322 12455555566666666666666
Q ss_pred h----------------------------------------------------------CCceeCCCCCCceEecC--CC
Q psy16292 123 C----------------------------------------------------------LGFVHRDVKPDNMLLDK--HG 142 (245)
Q Consensus 123 ~----------------------------------------------------------~~iih~dlkp~nil~~~--~~ 142 (245)
+ ..++|+|++|.||+++. .+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~ 211 (304)
T 3sg8_A 132 SINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT 211 (304)
T ss_dssp HSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE
T ss_pred cCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCC
Confidence 4 23799999999999988 45
Q ss_pred cEEEEeeCceeecCCCCCccccC---CCCchhhhh----cCC-----------CcccCCCcccccceecCCccCCC
Q psy16292 143 HLKLADFGTCMRMNKTGTETKRL---GRNGIEEIK----AHP-----------FFINDQWTFSNLRECVPPVVPEL 200 (245)
Q Consensus 143 ~i~l~Dfg~a~~~~~~~~~~~~~---~~~~~e~i~----~~~-----------~~~~Diws~g~~~~~~~~~~~pf 200 (245)
.+.++||+.+..-.......... ...+++... ..+ -+-.+.|+++.+++.+.+|.+++
T Consensus 212 ~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 212 ICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp EEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred EEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 57899999987643210000000 001221111 000 01247899999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=5.1e-05 Score=63.28 Aligned_cols=47 Identities=11% Similarity=0.002 Sum_probs=34.7
Q ss_pred chHHHHHHHHHHHhcCCc---cceeeeEEEE-eCCEEEEEEeccCCCCHHH
Q psy16292 49 DSAFFWEERDIMAHANSE---WIVQLHFAFQ-DAKSLYMVMDYMPGGDLVN 95 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~hp---~Iv~l~~~~~-~~~~~~lv~e~~~~g~L~~ 95 (245)
....+.+|..+|+.+.+. .+++.+.+.. ..+..++|||+++|.++..
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 356789999999999642 3566666664 4556789999999877765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=6.7e-05 Score=63.60 Aligned_cols=43 Identities=9% Similarity=0.117 Sum_probs=31.7
Q ss_pred HHHHHHHHHHHhcC-C--ccceeeeEEEEeC---CEEEEEEeccCCCCH
Q psy16292 51 AFFWEERDIMAHAN-S--EWIVQLHFAFQDA---KSLYMVMDYMPGGDL 93 (245)
Q Consensus 51 ~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~---~~~~lv~e~~~~g~L 93 (245)
..+.+|+.+++.+. + -.+++++.+..+. +..|+|||+++|.++
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 46788999999883 3 3567777777655 457899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.003 Score=52.65 Aligned_cols=31 Identities=23% Similarity=0.318 Sum_probs=27.9
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0016 Score=55.98 Aligned_cols=30 Identities=17% Similarity=0.287 Sum_probs=25.8
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..++|+|+.+.||+++.++ +.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 5689999999999997654 88999987775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0061 Score=50.90 Aligned_cols=32 Identities=28% Similarity=0.416 Sum_probs=27.4
Q ss_pred CCceeCCCCCCceEecCC----CcEEEEeeCceeec
Q psy16292 124 LGFVHRDVKPDNMLLDKH----GHLKLADFGTCMRM 155 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~----~~i~l~Dfg~a~~~ 155 (245)
..++|+|+.+.||+++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67899999988753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0034 Score=54.47 Aligned_cols=82 Identities=39% Similarity=0.684 Sum_probs=49.5
Q ss_pred CccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC-------CCCCCCccccCCC
Q psy16292 160 TETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE-------ENFPVPKAFAGNH 232 (245)
Q Consensus 160 ~~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 232 (245)
.+..+.|..+.++++.||||+...|.-. .....++.|.+.++.|.++|+....+.... .+...+....+.+
T Consensus 312 ~p~~Rlgr~~~~ei~~Hpff~~i~w~~l--~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (412)
T 2vd5_A 312 PPETRLGRGGAGDFRTHPFFFGLDWDGL--RDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVH 389 (412)
T ss_dssp CGGGCTTTTTHHHHHTSGGGTTCCSTTS--TTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTT
T ss_pred ChhhcCCCCCHHHHhcCCCcCCCCHHHH--hhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccC
Confidence 3556777778899999999999889754 334567788888889999998765442221 1111112223457
Q ss_pred CCcccceeecC
Q psy16292 233 LPFVGFTYSGD 243 (245)
Q Consensus 233 ~~f~~f~~~~~ 243 (245)
..|+||+|..+
T Consensus 390 ~~f~g~~~~~~ 400 (412)
T 2vd5_A 390 LPFVGYSYSCM 400 (412)
T ss_dssp GGGTTCCBSCC
T ss_pred CCCCCCcccCc
Confidence 89999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0028 Score=53.71 Aligned_cols=84 Identities=32% Similarity=0.433 Sum_probs=59.5
Q ss_pred ccccCCC---CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccc-cCCCCCcc
Q psy16292 161 ETKRLGR---NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-AGNHLPFV 236 (245)
Q Consensus 161 ~~~~~~~---~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~ 236 (245)
+..|.+. .+.+++..||||+.-.|..........++.|...+..+.++|+.....+.|..++...... ..++..|.
T Consensus 263 P~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~ 342 (353)
T 3txo_A 263 PTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFR 342 (353)
T ss_dssp GGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSGGGSCGGGGT
T ss_pred HHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccccCcccccccC
Confidence 3445443 3458899999999988987666666778888888999999999866655554443322222 23578999
Q ss_pred cceeecCC
Q psy16292 237 GFTYSGDY 244 (245)
Q Consensus 237 ~f~~~~~~ 244 (245)
||+|.++.
T Consensus 343 ~f~~~~~~ 350 (353)
T 3txo_A 343 NFEYVSPE 350 (353)
T ss_dssp TCCEECC-
T ss_pred CceeeCcc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.022 Score=47.52 Aligned_cols=45 Identities=11% Similarity=0.047 Sum_probs=36.7
Q ss_pred chHHHHHHHHHHHhcC---CccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 49 DSAFFWEERDIMAHAN---SEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 49 ~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
....+..|...|+.|. ...+++++.+....+..|+|||++++.++
T Consensus 71 ~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 71 YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3567889999999883 35688888888888899999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0057 Score=53.50 Aligned_cols=81 Identities=48% Similarity=0.871 Sum_probs=52.2
Q ss_pred cccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCC--CccccCCCCCcccce
Q psy16292 162 TKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPV--PKAFAGNHLPFVGFT 239 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~f~~f~ 239 (245)
..+.+..+.++++.||||+...|.-. ...-.++.|...++.+.++|+.......+..+.++ +..+++....|+||+
T Consensus 325 ~~r~~r~~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~ 402 (437)
T 4aw2_A 325 EHRLGQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFT 402 (437)
T ss_dssp GGCTTTTTTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC------------------CCTTGGGTTCC
T ss_pred ccccCCCCHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcccccccccCCCCCccccccccCccccCCC
Confidence 34555667899999999999889754 34556788889999999999876544333222222 234556678999999
Q ss_pred eecCC
Q psy16292 240 YSGDY 244 (245)
Q Consensus 240 ~~~~~ 244 (245)
|.+++
T Consensus 403 ~~~~~ 407 (437)
T 4aw2_A 403 YTSSC 407 (437)
T ss_dssp EESSC
T ss_pred cCCch
Confidence 98764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0099 Score=48.93 Aligned_cols=29 Identities=21% Similarity=0.205 Sum_probs=25.0
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++|+|+.+.|++ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667789999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.02 Score=49.06 Aligned_cols=102 Identities=20% Similarity=0.185 Sum_probs=63.5
Q ss_pred chHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCCCHHH--------------HH---hcC-----C-C--
Q psy16292 49 DSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN--------------LM---SNY-----D-V-- 102 (245)
Q Consensus 49 ~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~--------------~l---~~~-----~-~-- 102 (245)
......+|..+++.+ .+.-.+++++.+.+ .+||||++|.+|.. .+ ... + .
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 455667899999888 34444667766654 29999998754321 11 111 1 1
Q ss_pred CHHHHHHHHHHHHH-------------------HHHHHH----h----CCceeCCCCCCceEecCC----CcEEEEeeCc
Q psy16292 103 PEKWAKFYCAEVVL-------------------ALDAIH----C----LGFVHRDVKPDNMLLDKH----GHLKLADFGT 151 (245)
Q Consensus 103 ~~~~~~~~~~~i~~-------------------~l~~lH----~----~~iih~dlkp~nil~~~~----~~i~l~Dfg~ 151 (245)
....+..+..++.. .+.+|. . ..++|+|+.+.||+++.+ +.+.++||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 12344444433311 223332 2 248999999999999876 6899999998
Q ss_pred eee
Q psy16292 152 CMR 154 (245)
Q Consensus 152 a~~ 154 (245)
|..
T Consensus 252 a~~ 254 (379)
T 3feg_A 252 SSY 254 (379)
T ss_dssp CEE
T ss_pred CCc
Confidence 874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0026 Score=58.77 Aligned_cols=83 Identities=30% Similarity=0.497 Sum_probs=61.1
Q ss_pred ccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCcccc-CCCCCccc
Q psy16292 161 ETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFA-GNHLPFVG 237 (245)
Q Consensus 161 ~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~~ 237 (245)
+..+++. .+.++++.|+||+.-.|....-.....+++|...+ .+.++|+.....+++..+++...... .++..|.|
T Consensus 581 P~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~ 659 (674)
T 3pfq_A 581 PGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEG 659 (674)
T ss_dssp STTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCHHHHTTCCGGGGTT
T ss_pred HHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCchhhhhcccccccCC
Confidence 3445543 45689999999999899876666666778877777 78889999888877765554443332 35789999
Q ss_pred ceeecCC
Q psy16292 238 FTYSGDY 244 (245)
Q Consensus 238 f~~~~~~ 244 (245)
|+|.++.
T Consensus 660 f~~~~~~ 666 (674)
T 3pfq_A 660 FSFVNSE 666 (674)
T ss_dssp CCEECSS
T ss_pred CcccChh
Confidence 9999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0037 Score=52.73 Aligned_cols=75 Identities=29% Similarity=0.543 Sum_probs=54.1
Q ss_pred chhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccc-cCCCCCcccceeecC
Q psy16292 169 GIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-AGNHLPFVGFTYSGD 243 (245)
Q Consensus 169 ~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~~f~~~~~ 243 (245)
+.+++..||||+...|....-.....++.|...++.+.++|+.....+++..+...+... +..+..|.||+|.++
T Consensus 269 ~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 269 GFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp HHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSCCCCCHHHHTTSCGGGGTTCCEECC
T ss_pred CHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccCCCccccccccccccccCCCEeeCC
Confidence 468999999999988976655556677888888888999999765555443333332222 235789999999886
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0095 Score=50.09 Aligned_cols=83 Identities=27% Similarity=0.439 Sum_probs=54.4
Q ss_pred ccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCc----cc----cC
Q psy16292 161 ETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPK----AF----AG 230 (245)
Q Consensus 161 ~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----~~ 230 (245)
+..|.|. .+.+++..|+|++...|.-........++.|...++.+.++|+.....+.+..+++... .. ..
T Consensus 244 P~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRE 323 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-------------------
T ss_pred HHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCccccccccccccccc
Confidence 4445543 36799999999999889876666667788888889999999987554443332222111 01 11
Q ss_pred CCCCcccceeecC
Q psy16292 231 NHLPFVGFTYSGD 243 (245)
Q Consensus 231 ~~~~f~~f~~~~~ 243 (245)
.+..|.||+|.++
T Consensus 324 ~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 324 EQEMFEDFDYIAD 336 (337)
T ss_dssp -CCTTTTCCEECC
T ss_pred ccccCCCceecCC
Confidence 4689999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=95.20 E-value=0.0042 Score=52.67 Aligned_cols=83 Identities=29% Similarity=0.490 Sum_probs=56.3
Q ss_pred ccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccc-cCCCCCccc
Q psy16292 161 ETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-AGNHLPFVG 237 (245)
Q Consensus 161 ~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~~ 237 (245)
+..|.+. .+.++++.|+||+.-.|..........++.|...++ |.++|+......++..+.+.+... ...+..|.|
T Consensus 260 P~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~ 338 (353)
T 2i0e_A 260 PGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEG 338 (353)
T ss_dssp TTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCCHHHHHHSCTTTTCS
T ss_pred HHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCccccccccccccccCC
Confidence 3445543 467999999999998897665566667788877777 899998866655554443333222 236789999
Q ss_pred ceeecCC
Q psy16292 238 FTYSGDY 244 (245)
Q Consensus 238 f~~~~~~ 244 (245)
|+|..+.
T Consensus 339 f~~~~~~ 345 (353)
T 2i0e_A 339 FSFVNSE 345 (353)
T ss_dssp CCEECTT
T ss_pred CeeeCcc
Confidence 9998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=94.41 E-value=0.014 Score=49.79 Aligned_cols=84 Identities=31% Similarity=0.517 Sum_probs=31.6
Q ss_pred ccccCCC-CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCC-CCCc------cccCCC
Q psy16292 161 ETKRLGR-NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF-PVPK------AFAGNH 232 (245)
Q Consensus 161 ~~~~~~~-~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~~ 232 (245)
+..|.+. ...++++.|+||+.-.|.--.-.....++.|...++.|.++|+.....+.+..+. ..+. .....+
T Consensus 278 p~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (373)
T 2r5t_A 278 RTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAA 357 (373)
T ss_dssp GGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-------------------------------------
T ss_pred HHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCcccccccccccccc
Confidence 4455553 4568999999999988986655666678888888999999999755554432211 1111 111236
Q ss_pred CCcccceeecCC
Q psy16292 233 LPFVGFTYSGDY 244 (245)
Q Consensus 233 ~~f~~f~~~~~~ 244 (245)
..|.||+|.+++
T Consensus 358 ~~f~~f~~~~~~ 369 (373)
T 2r5t_A 358 EAFLGFSYAPPT 369 (373)
T ss_dssp ------------
T ss_pred ccCCCCcccCch
Confidence 779999998875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.037 Score=47.84 Aligned_cols=32 Identities=9% Similarity=0.228 Sum_probs=27.9
Q ss_pred hCCceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 123 CLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 123 ~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
...++|+|+.|.||+++.++ +.++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 56799999999999998877 999999988753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=94.03 E-value=0.011 Score=49.91 Aligned_cols=74 Identities=26% Similarity=0.398 Sum_probs=27.1
Q ss_pred hhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCcc-ccCCCCCcccceeecCC
Q psy16292 171 EEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKA-FAGNHLPFVGFTYSGDY 244 (245)
Q Consensus 171 e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~f~~f~~~~~~ 244 (245)
++++.|||++.-.|..-.......++.|...++.|.++|+.....+.+..+...+.. .+..+..|.||+|.++.
T Consensus 265 ~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 339 (345)
T 1xjd_A 265 GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPG 339 (345)
T ss_dssp SCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------CCTTTTCCC----
T ss_pred HHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCcccccccccccccccCCCeeeChh
Confidence 389999999998897655555667788888888999999975555444333332222 23467899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.29 E-value=0.045 Score=45.20 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=26.2
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3589999999999998776568999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=92.03 E-value=0.6 Score=37.76 Aligned_cols=24 Identities=25% Similarity=0.336 Sum_probs=19.9
Q ss_pred CceeCCCCCCceEecCCCcEEEEee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Df 149 (245)
.++|+|+.+.|++++.++. .++|-
T Consensus 189 ~LvHGDlw~gNvl~~~~g~-~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDGA-VVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTEE-EECSC
T ss_pred eeeecCCCCCcEEEcCCCe-EEEec
Confidence 5899999999999998874 46664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.14 E-value=0.18 Score=41.54 Aligned_cols=29 Identities=17% Similarity=0.224 Sum_probs=25.0
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3589999999999998 4 789999988765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.82 E-value=0.28 Score=40.98 Aligned_cols=31 Identities=19% Similarity=0.375 Sum_probs=27.4
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
..++|+|+.+.|++++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999998888899999987765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.56 E-value=0.22 Score=42.04 Aligned_cols=29 Identities=28% Similarity=0.432 Sum_probs=24.2
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.++|+|+.+.||+++.++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 489999999999997654 89999987764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=87.41 E-value=0.35 Score=39.95 Aligned_cols=74 Identities=30% Similarity=0.470 Sum_probs=37.6
Q ss_pred ccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCC-CCCCCCCCcccCcCCCCCCCCCCCccccCCCCCccc
Q psy16292 161 ETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELS-GDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVG 237 (245)
Q Consensus 161 ~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~ 237 (245)
+..+.+. .+.+++..|||++.-.|.-........+..|+.. +..|.++|+.......+... ......+..|.|
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~~~~~~~~~~----~~~~~~~~~f~~ 317 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGV----QGEDPYADLFRD 317 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC----------------CCCTTC----CSCCTTGGGSCC
T ss_pred HHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCCCccccccCc----cCCchhhhhccC
Confidence 3445543 3679999999999988987666666678888887 57888999876544332211 111223567877
Q ss_pred c
Q psy16292 238 F 238 (245)
Q Consensus 238 f 238 (245)
|
T Consensus 318 f 318 (318)
T 1fot_A 318 F 318 (318)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=87.03 E-value=0.32 Score=42.62 Aligned_cols=35 Identities=14% Similarity=0.136 Sum_probs=24.4
Q ss_pred HHHHHHHHhcCCcc-ceeeeEEEEeCCEEEEEEeccCCCC
Q psy16292 54 WEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDYMPGGD 92 (245)
Q Consensus 54 ~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~e~~~~g~ 92 (245)
.+|..+++.|...+ .+++++.+. + .+|+||++|.+
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 58999999985433 466777763 2 25999998643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=86.62 E-value=0.88 Score=38.05 Aligned_cols=65 Identities=34% Similarity=0.605 Sum_probs=46.2
Q ss_pred CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccc
Q psy16292 168 NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGF 238 (245)
Q Consensus 168 ~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f 238 (245)
.+.+++..|+|++...|..........+..|.+.++.|.++|+....++.. .+ .....+..|.||
T Consensus 286 ~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~-~~-----~~~~~~~~f~~f 350 (350)
T 1rdq_E 286 NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR-VS-----INEKCGKEFTEF 350 (350)
T ss_dssp TTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCCCCCCCC-CC-----SSCCSTTTTTTC
T ss_pred CCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccccccccccc-cC-----CCcchhhhcCCC
Confidence 457999999999998897665566677888889999999999865443322 11 112245678887
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.60 E-value=0.24 Score=42.96 Aligned_cols=37 Identities=16% Similarity=0.153 Sum_probs=25.6
Q ss_pred HHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEeccCCC
Q psy16292 51 AFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDYMPGG 91 (245)
Q Consensus 51 ~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~~g 91 (245)
..+.+|..+++.+. +.-.+++++.+.. .+|+||++|.
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~ 157 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 157 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCc
Confidence 56678999999883 3334667766542 2899999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=83.62 E-value=0.58 Score=43.16 Aligned_cols=79 Identities=25% Similarity=0.425 Sum_probs=51.2
Q ss_pred ccccCCC--CchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCccccCCCCCcccc
Q psy16292 161 ETKRLGR--NGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFAGNHLPFVGF 238 (245)
Q Consensus 161 ~~~~~~~--~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f 238 (245)
+..+.+. .+.++++.||||++-.|..........++.|+..+..+.+.|+--.-.+.. +.. ......++..|.+|
T Consensus 433 P~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~--~~~-~~~~~~d~~~f~~F 509 (689)
T 3v5w_A 433 VNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEED--TKG-IKLLDSDQELYRNF 509 (689)
T ss_dssp GGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC-----------CC-CCCCHHHHTTTTTC
T ss_pred HhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccc--cCC-CCCCchHHHHHhCC
Confidence 5556663 568999999999999998877777788899988888877777632221111 011 11112247789999
Q ss_pred eeec
Q psy16292 239 TYSG 242 (245)
Q Consensus 239 ~~~~ 242 (245)
+|+.
T Consensus 510 s~~~ 513 (689)
T 3v5w_A 510 PLTI 513 (689)
T ss_dssp CEEC
T ss_pred CccC
Confidence 8853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.19 E-value=0.63 Score=39.84 Aligned_cols=29 Identities=34% Similarity=0.541 Sum_probs=24.8
Q ss_pred ceeCCCCCCceEe------cCCCcEEEEeeCceee
Q psy16292 126 FVHRDVKPDNMLL------DKHGHLKLADFGTCMR 154 (245)
Q Consensus 126 iih~dlkp~nil~------~~~~~i~l~Dfg~a~~ 154 (245)
++|+|+.+.||++ +.++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 245 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-29 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-26 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-26 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-26 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-10 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-24 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-08 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-22 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-22 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-22 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-13 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-21 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-12 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-05 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-19 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-19 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-11 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-30
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 2/120 (1%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VP 103
+ + E DI+A + IV+L AF +L++++++ GG + +M + +
Sbjct: 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT 108
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
E + C + + AL+ +H +HRD+K N+L G +KLADFG + +T
Sbjct: 109 ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-29
Identities = 33/140 (23%), Positives = 65/140 (46%), Gaps = 4/140 (2%)
Query: 27 YLLKYRYT--LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMV 84
+ + ++ + + A + +IK + E ++ NS +IV + AF + +
Sbjct: 23 FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82
Query: 85 MDYMPGGDLVNLMSNYD-VPEKWAKFYCAEVVLALDAIH-CLGFVHRDVKPDNMLLDKHG 142
M++M GG L ++ +PE+ V+ L + +HRDVKP N+L++ G
Sbjct: 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 142
Query: 143 HLKLADFGTCMRMNKTGTET 162
+KL DFG ++ + +
Sbjct: 143 EIKLCDFGVSGQLIDSMANS 162
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 6e-29
Identities = 41/126 (32%), Positives = 71/126 (56%), Gaps = 1/126 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VP 103
IK + + ERD+M+ + + V+L+F FQD + LY + Y G+L+ +
Sbjct: 47 IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 106
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
E +FY AE+V AL+ +H G +HRD+KP+N+LL++ H+++ DFGT ++ + +
Sbjct: 107 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
Query: 164 RLGRNG 169
G
Sbjct: 167 ANSFVG 172
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 1e-28
Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 1/119 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VP 103
K E +I +H I++L+ F DA +Y++++Y P G + +
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 104
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ Y E+ AL H +HRD+KP+N+LL G LK+ADFG + + T
Sbjct: 105 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-28
Identities = 32/118 (27%), Positives = 58/118 (49%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEK 105
++ E +M + IV ++ L++VM+Y+ GG L ++++ + E
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETK 163
C E + AL+ +H +HRD+K DN+LL G +KL DFG C ++ ++
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 8e-27
Identities = 34/137 (24%), Positives = 61/137 (44%), Gaps = 12/137 (8%)
Query: 41 RYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMS 98
Y + ++ E +++ IV+ + D +LY+VM+Y GGDL ++++
Sbjct: 38 DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 97
Query: 99 NYD-----VPEKWAKFYCAEVVLALDAIHCLG-----FVHRDVKPDNMLLDKHGHLKLAD 148
+ E++ ++ LAL H +HRD+KP N+ LD ++KL D
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157
Query: 149 FGTCMRMNKTGTETKRL 165
FG +N + K
Sbjct: 158 FGLARILNHDTSFAKAF 174
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 2e-26
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 1/109 (0%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYC 111
+E + +Q + + ++VM+Y G + + + E
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+ L +H +HRDVK N+LL + G +KL DFG+ M +
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 101 bits (252), Expect = 3e-26
Identities = 32/116 (27%), Positives = 59/116 (50%), Gaps = 2/116 (1%)
Query: 53 FWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFY 110
+E DI+ + I+QL ++ ++V D M G+L + ++ + EK +
Sbjct: 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 115
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
++ + A+H L VHRD+KP+N+LLD ++KL DFG +++ + G
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 3e-26
Identities = 37/225 (16%), Positives = 71/225 (31%), Gaps = 13/225 (5%)
Query: 18 YSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77
+ EV L R A+ + F E IM + ++ L
Sbjct: 39 FGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98
Query: 78 AKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
+ + ++ ++M G L + + D + + + + +VHRD+ N
Sbjct: 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN 158
Query: 136 MLLDKHGHLKLADFGTCMRMNKTG---TETKRLGRNGIEEIKAHPFFIN-------DQWT 185
+L++ + K++DFG + T T LG A D W+
Sbjct: 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218
Query: 186 FSN-LRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFA 229
+ + E + + + IE+D P A
Sbjct: 219 YGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-26
Identities = 30/111 (27%), Positives = 59/111 (53%), Gaps = 1/111 (0%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKFYC 111
+E I N E +V+ + ++ Y+ ++Y GG+L + + + +PE A+ +
Sbjct: 50 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 109
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
+++ + +H +G HRD+KP+N+LLD+ +LK++DFG E
Sbjct: 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-26
Identities = 21/119 (17%), Positives = 44/119 (36%), Gaps = 3/119 (2%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFY 110
F E ++ I+ + A L +V + G L + + +
Sbjct: 51 FKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
+ +D +H +HRD+K +N+ L + +K+ DFG ++ + +G
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 100 bits (251), Expect = 1e-25
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 4/119 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM--SNYDVP 103
SD +E M+ +V LH AF+D + M+ ++M GG+L + + +
Sbjct: 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 122
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL--DKHGHLKLADFGTCMRMNKTGT 160
E A Y +V L +H +VH D+KP+N++ + LKL DFG ++ +
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 100 bits (251), Expect = 1e-25
Identities = 29/125 (23%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMS--NYDVP 103
D E IM + ++ LH AF+D + ++++++ GG+L + ++ +Y +
Sbjct: 66 YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 125
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD--KHGHLKLADFGTCMRMNKTGTE 161
E Y + L +H VH D+KP+N++ + K +K+ DFG ++N
Sbjct: 126 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
Query: 162 TKRLG 166
Sbjct: 186 KVTTA 190
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (251), Expect = 1e-25
Identities = 35/107 (32%), Positives = 60/107 (56%), Gaps = 1/107 (0%)
Query: 55 EERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVPEKWAKFYCAE 113
+++ + +IV + +AF L ++D M GGDL +L + E +FY AE
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 114 VVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
++L L+ +H V+RD+KP N+LLD+HGH++++D G +K
Sbjct: 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.2 bits (140), Expect = 1e-10
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219
+RLG G +E+K PFF + W L++ PP++P + FD DE
Sbjct: 249 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDT 308
Query: 220 ENFPVPKAFAGNHLPFVGFTYS 241
+ + + + + F +
Sbjct: 309 KGIKLLDS---DQELYRNFPLT 327
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 9e-25
Identities = 27/128 (21%), Positives = 59/128 (46%), Gaps = 4/128 (3%)
Query: 43 FQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM--SNY 100
++K +D +E I+ A I+ LH +F+ + L M+ +++ G D+ + S +
Sbjct: 38 VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF 97
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD--KHGHLKLADFGTCMRMNKT 158
++ E+ Y +V AL +H H D++P+N++ + +K+ +FG ++
Sbjct: 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157
Query: 159 GTETKRLG 166
Sbjct: 158 DNFRLLFT 165
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 1e-24
Identities = 38/197 (19%), Positives = 69/197 (35%), Gaps = 12/197 (6%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-- 101
+++D+ E IM ++ +IV+L Q ++L +VM+ GG L +
Sbjct: 47 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE 105
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
+P +V + + + FVHRD+ N+LL + K++DFG + +
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165
Query: 162 TKRLGRNGIEEIKAHPFFIN--------DQWTFS-NLRECVPPVVPELSGDDDTSNFDDI 212
P IN D W++ + E + I
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
Query: 213 EKDESPEENFPVPKAFA 229
E+ + E P
Sbjct: 226 EQGKRMECPPECPPELY 242
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 4e-24
Identities = 39/191 (20%), Positives = 69/191 (36%), Gaps = 7/191 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLH-FAFQDAKSLYMVMDYMPGGDLVNLMSNYD--- 101
+ + F E +M +VQL ++ LY+V +YM G LV+ + +
Sbjct: 40 NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 99
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
+ + +V A++ + FVHRD+ N+L+ + K++DFG + T
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159
Query: 162 TKRLGRNGIEEI--KAHPFFINDQWTF-SNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218
K + E + +D W+F L E +EK
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219
Query: 219 EENFPVPKAFA 229
+ P A
Sbjct: 220 DAPDGCPPAVY 230
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 5e-24
Identities = 26/127 (20%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLVNLMSN 99
++ +S+ F EE +++ IV+ + +++ K + +V + M G L +
Sbjct: 46 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 105
Query: 100 YDV-PEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLL-DKHGHLKLADFGTCMRM 155
+ V K + +C +++ L +H +HRD+K DN+ + G +K+ D G
Sbjct: 106 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165
Query: 156 NKTGTET 162
+ +
Sbjct: 166 RASFAKA 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.0 bits (233), Expect = 2e-23
Identities = 46/139 (33%), Positives = 82/139 (58%), Gaps = 5/139 (3%)
Query: 27 YLLKYRYT--LYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLY 82
+L++ R+ YA+ + ++ +ER +++ +I+++ FQDA+ ++
Sbjct: 21 HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80
Query: 83 MVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141
M+MDY+ GG+L +L+ + P AKFY AEV LAL+ +H ++RD+KP+N+LLDK+
Sbjct: 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 140
Query: 142 GHLKLADFGTCMRMNKTGT 160
GH+K+ DFG +
Sbjct: 141 GHIKITDFGFAKYVPDVTY 159
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.4 bits (125), Expect = 1e-08
Identities = 22/75 (29%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL-SGDDDTSNFDDIEKDE-- 216
++RLG +NG E++K HP+F W R P P + G DTS FD +++
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDIN 300
Query: 217 -SPEENFPVPKAFAG 230
+ P F
Sbjct: 301 YGVQGEDPYADLFRD 315
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.7 bits (227), Expect = 6e-23
Identities = 34/187 (18%), Positives = 68/187 (36%), Gaps = 11/187 (5%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL--MSNYDVPEKWAKFY 110
F EE +M + + E +VQL+ + ++++ +YM G L+N + +
Sbjct: 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 105
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI 170
C +V A++ + F+HRD+ N L++ G +K++DFG + T +G
Sbjct: 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFP 164
Query: 171 EEIKAHPFFIN-------DQWTFSN-LRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222
+ D W F + E ++ + I +
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 223 PVPKAFA 229
+
Sbjct: 225 LASEKVY 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.9 bits (225), Expect = 2e-22
Identities = 37/188 (19%), Positives = 76/188 (40%), Gaps = 12/188 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKF 109
F +E +M +VQL Y++ ++M G+L++ + + +V +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
++ A++ + F+HRD+ N L+ ++ +K+ADFG R+ T T G
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKF 178
Query: 170 IEEIKAHPFFINDQWTFSN--------LRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
+ A ++++ + L E + G D + ++ +EKD E
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 222 FPVPKAFA 229
P+
Sbjct: 239 EGCPEKVY 246
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 3e-22
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 12/175 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFY 110
F E + M + +++L+ + MV + P G L++ + + Y
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI 170
+V + + F+HRD+ N+LL +K+ DFG + + +
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 171 EEIKAHPFFIN--------DQWTFS-NLRECVPPVVPELSGDDDTSNFDDIEKDE 216
P + D W F L E G + + I+K+
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 4e-22
Identities = 32/132 (24%), Positives = 55/132 (41%), Gaps = 12/132 (9%)
Query: 41 RYFQIKR-SDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLV 94
F +K D E ++ A IV++ +++ K L +VM+ + GG+L
Sbjct: 38 EKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 97
Query: 95 NLMSNYD---VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH---GHLKLAD 148
+ + + E+ A + A+ +H + HRDVKP+N+L LKL D
Sbjct: 98 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157
Query: 149 FGTCMRMNKTGT 160
FG +
Sbjct: 158 FGFAKETTSHNS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 4e-22
Identities = 33/188 (17%), Positives = 67/188 (35%), Gaps = 13/188 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM---SNYDVPEKWAKF 109
F E ++M + +V+L+ + +Y++ +YM G LV+ + S +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
A++ + I ++HRD++ N+L+ K+ADFG + + G
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKF 172
Query: 170 IEEIKAHPFFINDQWTFSN--------LRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
+ A +T + L E V G + ++E+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 222 FPVPKAFA 229
P+
Sbjct: 233 DNCPEELY 240
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 4e-22
Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 2/110 (1%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFY 110
F EE ++M + +VQL+ + + +V ++M G L + + +
Sbjct: 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 106
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
C +V + + +HRD+ N L+ ++ +K++DFG +
Sbjct: 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 8e-22
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 10/221 (4%)
Query: 18 YSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD 77
+ +V + + A+ + S F +E M + IV+L +
Sbjct: 20 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79
Query: 78 AKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDN 135
++++M+ G+L + + + Y ++ AL + FVHRD+ N
Sbjct: 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138
Query: 136 MLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI-----EEIKAHPFFI-NDQWTFSN- 188
+L+ + +KL DFG M + G+ I E I F +D W F
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 189 LRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFA 229
+ E + V G + IE E P
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 9e-22
Identities = 38/188 (20%), Positives = 74/188 (39%), Gaps = 13/188 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP---EKWAKF 109
F +E +M E +VQL+ A + +Y+V +YM G L++ +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNG 169
A++ + + + +VHRD++ N+L+ ++ K+ADFG R+ + T R G
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKF 176
Query: 170 IEEIKAHPFFINDQWTFSN--------LRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
+ A + ++T + L E G + D +E+
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236
Query: 222 FPVPKAFA 229
P++
Sbjct: 237 PECPESLH 244
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.3 bits (221), Expect = 1e-21
Identities = 30/124 (24%), Positives = 54/124 (43%), Gaps = 4/124 (3%)
Query: 47 RSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEK 105
E ++ IV L ++ LY++M + GG+L + + E+
Sbjct: 48 EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 107
Query: 106 WAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLL---DKHGHLKLADFGTCMRMNKTGTET 162
A +V+ A+ +H LG VHRD+KP+N+L D+ + ++DFG + +
Sbjct: 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167
Query: 163 KRLG 166
G
Sbjct: 168 TACG 171
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 1e-21
Identities = 41/119 (34%), Positives = 63/119 (52%), Gaps = 1/119 (0%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVP 103
I + + A E ++ + ++ L +AFQ L VM+Y GG+L L
Sbjct: 44 IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT 103
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
E+ A+FY AE+V AL+ +H V+RD+K +N++LDK GH+K+ DFG C G
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (162), Expect = 1e-13
Identities = 23/92 (25%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 163 KRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220
+RLG + +E+ H FF++ W ++ +PP P+++ + DT FDD +S
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 305
Query: 221 NFPVPKAFAG--------NHLPFVGFTYSGDY 244
P G F F Y D+
Sbjct: 306 TPPDRYDSLGLLELDQREEQEMFEDFDYIADW 337
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 1e-21
Identities = 33/218 (15%), Positives = 69/218 (31%), Gaps = 34/218 (15%)
Query: 46 KRSDSAFFWEERDIMAH-ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--- 101
S+ E +M + E IV L A + +Y++ +Y GDL+N + +
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 102 ---------------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK 140
+ + + +V ++ + VHRD+ N+L+
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199
Query: 141 HGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL 200
+K+ DFG + R + A +T + ++ E+
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 201 --------SGDDDTSNFDDI-EKDESPEENFPVPKAFA 229
G +NF + + ++ F +
Sbjct: 260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.0 bits (217), Expect = 3e-21
Identities = 35/210 (16%), Positives = 64/210 (30%), Gaps = 33/210 (15%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD----------- 101
F E +MA ++ IV+L K + ++ +YM GDL + +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 102 --------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLA 147
+ +V + + FVHRD+ N L+ ++ +K+A
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 148 DFGTCMRMNK------TGTETKRLGRNGIEEIKAHPF-FINDQWTF-SNLRECVPPVVPE 199
DFG + G + + E I + + +D W + L E +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 200 LSGDDDTSNFDDIEKDESPEENFPVPKAFA 229
G + P
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPENCPLELY 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 4e-21
Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 1/115 (0%)
Query: 51 AFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLM-SNYDVPEKWAKF 109
E+R + ++ + FQ ++L+ VM+Y+ GGDL+ + S + A F
Sbjct: 48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 107
Query: 110 YCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR 164
Y AE++L L +H G V+RD+K DN+LLDK GH+K+ADFG C +T
Sbjct: 108 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 2e-12
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 171 EEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAF-A 229
+I+ HP F W +E PP P++ D SNFD +E P +F +
Sbjct: 250 GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINS 309
Query: 230 GNHLPFVGFTY 240
+ F F++
Sbjct: 310 MDQNMFRNFSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 6e-21
Identities = 29/187 (15%), Positives = 69/187 (36%), Gaps = 11/187 (5%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFY 110
+E +MA ++ + +L ++ ++ MP G L++ + + ++ ++ +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI 170
C ++ ++ + VHRD+ N+L+ H+K+ DFG + E G
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 171 EEIKAHPFFINDQWTFSN--------LRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222
+ A ++ +T + + E + G + +EK E +
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236
Query: 223 PVPKAFA 229
Sbjct: 237 ICTIDVY 243
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 7e-21
Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 11/187 (5%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYC 111
E ++M ++ +IV++ + +S +VM+ G L L N V +K
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 113
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI- 170
+V + + + FVHRD+ N+LL + K++DFG + K
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 171 ------EEIKAHPF-FINDQWTFS-NLRECVPPVVPELSGDDDTSNFDDIEKDESPEENF 222
E I + F +D W+F + E G + +EK E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 223 PVPKAFA 229
P+
Sbjct: 234 GCPREMY 240
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 8e-21
Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 1/116 (0%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVP 103
+ K + E ++ + I+ L AF ++ +V D+M V + N V
Sbjct: 38 EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL 97
Query: 104 -EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
K Y + L+ +H +HRD+KP+N+LLD++G LKLADFG
Sbjct: 98 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 1e-20
Identities = 32/149 (21%), Positives = 52/149 (34%), Gaps = 14/149 (9%)
Query: 27 YLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLY 82
+ K+R A+ + F + S F E E I+ A L+
Sbjct: 20 WRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77
Query: 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC--------LGFVHRDVKPD 134
+V DY G L + ++ Y V + L +H HRD+K
Sbjct: 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137
Query: 135 NMLLDKHGHLKLADFGTCMRMNKTGTETK 163
N+L+ K+G +AD G +R +
Sbjct: 138 NILVKKNGTCCIADLGLAVRHDSATDTID 166
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 1e-20
Identities = 28/168 (16%), Positives = 53/168 (31%), Gaps = 20/168 (11%)
Query: 53 FWEERDIMAH-ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD---------- 101
E ++++ N IV L A ++ +Y GDL+N +
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 102 ---------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
+ + + +V + + +HRD+ N+LL K+ DFG
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 153 MRMNKTGTETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL 200
+ + + A N +TF + + EL
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 1e-19
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 8 MHRYRRYRQ----KYSEVPRLFEYLLKYRYTLYA---LYSRYFQIKRSDSAFFWEERDIM 60
+ + + Y +V + + LYA L K + ER ++
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 61 AHAN-SEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVVLAL 118
H S ++V LH+AFQ L++++DY+ GG+L L E + Y E+VLAL
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
+ +H LG ++RD+K +N+LLD +GH+ L DFG TE
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 4e-05
Identities = 14/46 (30%), Positives = 19/46 (41%), Gaps = 2/46 (4%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDD 205
KRLG +EIK H FF W ++ P P + + D
Sbjct: 276 KKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 2e-19
Identities = 33/188 (17%), Positives = 59/188 (31%), Gaps = 11/188 (5%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD--VPEKWAKFY 110
F E IM + I++L K + ++ +YM G L + D
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 111 CAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGI 170
+ + + + +VHRD+ N+L++ + K++DFG + T I
Sbjct: 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 171 EEIKAHPFFIN--------DQWTFSN-LRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221
P I+ D W+F + E + + I
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235
Query: 222 FPVPKAFA 229
P A
Sbjct: 236 MDCPSAIY 243
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 82.1 bits (202), Expect = 3e-19
Identities = 31/120 (25%), Positives = 52/120 (43%), Gaps = 5/120 (4%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQD----AKSLYMVMDYMPGGDLVNLMSNYD-VPEKWA 107
F E A N IV ++ + Y+VM+Y+ G L +++ + K A
Sbjct: 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 113
Query: 108 KFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGR 167
A+ AL+ H G +HRDVKP N+++ +K+ DFG + +G +
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 81.9 bits (201), Expect = 4e-19
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 1/120 (0%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-V 102
+ + E I+ IV+L+ K L +V +++ L +
Sbjct: 38 KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL 97
Query: 103 PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162
AK + +++ + H +HRD+KP N+L+++ G LK+ADFG +
Sbjct: 98 ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.7 bits (201), Expect = 6e-19
Identities = 35/175 (20%), Positives = 64/175 (36%), Gaps = 5/175 (2%)
Query: 18 YSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH-FAFQ 76
+ V + A+ S + + F E IM + ++ L +
Sbjct: 40 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99
Query: 77 DAKSLYMVMDYMPGGDLVNLM--SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134
S +V+ YM GDL N + ++ K + +V + + FVHRD+
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 159
Query: 135 NMLLDKHGHLKLADFGTCMRM--NKTGTETKRLGRNGIEEIKAHPFFINDQWTFS 187
N +LD+ +K+ADFG M + + + G + A ++T
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 7e-19
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 13/131 (9%)
Query: 41 RYFQIK--RSDSAFFWEERDIMAHANSEWIVQLHFAF------QDAKSLYMVMDYMPGGD 92
IK D F E IM + IV+L + F +D L +V+DY+P
Sbjct: 46 ELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 105
Query: 93 LVNLM----SNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLA 147
+ +P + K Y ++ +L IH G HRD+KP N+LLD LKL
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 165
Query: 148 DFGTCMRMNKT 158
DFG+ ++ +
Sbjct: 166 DFGSAKQLVRG 176
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 1e-18
Identities = 32/229 (13%), Positives = 65/229 (28%), Gaps = 26/229 (11%)
Query: 27 YLLKYRYTLYALYSRYFQIKR-------SDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79
Y + + IK + F E +M N +V+L +
Sbjct: 37 YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96
Query: 80 SLYMVMDYMPGGDLVNLMSNYD-----------VPEKWAKFYCAEVVLALDAIHCLGFVH 128
++M+ M GDL + + + E+ + ++ FVH
Sbjct: 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156
Query: 129 RDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFINDQWTFS- 187
RD+ N ++ + +K+ DFG + +T K + + +T
Sbjct: 157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 216
Query: 188 -------NLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKAFA 229
L E G + + + ++ P
Sbjct: 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-18
Identities = 24/174 (13%), Positives = 60/174 (34%), Gaps = 18/174 (10%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFA-FQDAKSLYMVMDYMPGGDLVNLMSNYD-- 101
A E + ++ + +V L A + L +++++ G+L + +
Sbjct: 56 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 115
Query: 102 ---------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146
+ + Y +V ++ + +HRD+ N+LL + +K+
Sbjct: 116 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 175
Query: 147 ADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL 200
DFG + K ++ + A + +T + ++ E+
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (196), Expect = 3e-18
Identities = 36/208 (17%), Positives = 74/208 (35%), Gaps = 23/208 (11%)
Query: 45 IKRSDSAFFWEERDIMAH-ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDV- 102
+ D F E +++ + I+ L A + LY+ ++Y P G+L++ + V
Sbjct: 49 ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 108
Query: 103 ----------------PEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146
+ + A+V +D + F+HRD+ N+L+ ++ K+
Sbjct: 109 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 147 ADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFIN----DQWTFSN-LRECVPPVVPELS 201
ADFG +T I++ + + D W++ L E V
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228
Query: 202 GDDDTSNFDDIEKDESPEENFPVPKAFA 229
G ++ + + E+
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVY 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 4e-18
Identities = 26/143 (18%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 53 FWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-VPEKWAKFYC 111
E I+ ++ LH +++ + ++++ + GG+L + ++ + + E+ A +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 112 AEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADFGTCMRMNKTGTETKRLGR 167
+++ + +H L H D+KP+N++L +K+ DFG +++ G
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 168 NGI---EEIKAHPF-FINDQWTF 186
E + P D W+
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSI 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 5e-18
Identities = 25/123 (20%), Positives = 49/123 (39%), Gaps = 4/123 (3%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA----KSLYMVMDYMPGGDLVNLMSNYD 101
++ E I+ E I+ ++ + ++ ++ G DL L+
Sbjct: 46 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH 105
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE 161
+ ++ +++ L IH +HRD+KP N+LL+ LK+ DFG +
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 162 TKR 164
T
Sbjct: 166 TGF 168
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 5e-18
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 9/116 (7%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS--------LYMVMDYMPGGDL-VNL 96
K E I+ E +V L + S +Y+V D+ +
Sbjct: 49 KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 108
Query: 97 MSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152
K ++ L IH +HRD+K N+L+ + G LKLADFG
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 7e-18
Identities = 31/211 (14%), Positives = 64/211 (30%), Gaps = 25/211 (11%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYD-- 101
++ S E + + I+ L A LY++++Y G+L +
Sbjct: 57 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 102 ---------------VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKL 146
+ K +V ++ + +HRD+ N+L+ + +K+
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 176
Query: 147 ADFGTCMRMNKTGTETKRLGRNGIEEIKAHPFFIN-------DQWTFS-NLRECVPPVVP 198
ADFG ++ K + A + D W+F L E
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 199 ELSGDDDTSNFDDIEKDESPEENFPVPKAFA 229
G F +++ ++
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELY 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 7e-18
Identities = 26/122 (21%), Positives = 57/122 (46%), Gaps = 5/122 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEW--IVQLHFAFQDAKSLYMVMDYMPGGDLVN--LMSNYD 101
+ + E ++ +S + +++L F+ S ++++ + +
Sbjct: 47 ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 106
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGT 160
+ E+ A+ + +V+ A+ H G +HRD+K +N+L+D + G LKL DFG+ + T
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 161 ET 162
Sbjct: 167 TD 168
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.1 bits (194), Expect = 7e-18
Identities = 45/162 (27%), Positives = 87/162 (53%), Gaps = 14/162 (8%)
Query: 8 MHRYRRYRQ----KYSEVPRLFEYLLKYRYT--LYAL--YSRYFQIKRSDSAFFWEERDI 59
+ ++ R + + V L+K++ + YA+ + +K E+ I
Sbjct: 40 LDQFDRIKTLGTGSFGRV-----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 60 MAHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVN-LMSNYDVPEKWAKFYCAEVVLAL 118
+ N ++V+L F+F+D +LYMVM+Y+ GG++ + L E A+FY A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 119 DAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+ +H L ++RD+KP+N+L+D+ G++++ DFG R+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 61.0 bits (147), Expect = 1e-11
Identities = 26/66 (39%), Positives = 35/66 (53%), Gaps = 5/66 (7%)
Query: 162 TKRLG--RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDE--- 216
TKR G +NG+ +IK H +F W R+ P +P+ G DTSNFDD E++E
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRV 337
Query: 217 SPEENF 222
S E
Sbjct: 338 SINEKC 343
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 78.3 bits (192), Expect = 1e-17
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 44 QIKRSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDA--KSLYMVMDYMPGGDLVNLMSNY 100
+K E I+ + I+ L +D ++ +V +++ D L
Sbjct: 67 ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL 126
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTG 159
+ +FY E++ ALD H +G +HRDVKP N+++D +H L+L D+G +
Sbjct: 127 --TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 160 TETKRLG 166
R+
Sbjct: 185 EYNVRVA 191
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (185), Expect = 8e-17
Identities = 37/167 (22%), Positives = 64/167 (38%), Gaps = 13/167 (7%)
Query: 8 MHRYRRYRQ----KYSEVPRLFEYLLKYRYT--LYAL-YSRYFQIKRSDSAFFWEERDIM 60
M +Y + + Y V + K R T + AL R + E ++
Sbjct: 1 MQKYEKLEKIGEGTYGTV-----FKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 61 AHANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLV-NLMSNYDVPEKWAKFYCAEVVLALD 119
+ IV+LH K L +V ++ N D+ + K + +++ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 120 AIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKRLG 166
H +HRD+KP N+L++++G LKLA+FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (183), Expect = 2e-16
Identities = 26/128 (20%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS------LYMVMDYMPGGDLVNLMS 98
++ + + E +M N + I+ L F K+ +Y+VM+ M +
Sbjct: 55 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 114
Query: 99 NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
D + + +++ + +H G +HRD+KP N+++ LK+ DFG +
Sbjct: 115 ELD--HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 159 GTETKRLG 166
T +
Sbjct: 173 FMMTPYVV 180
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 6e-16
Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 2/119 (1%)
Query: 44 QIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMPGG--DLVNLMSNYD 101
+ E ++ N IV+L LY+V +++ ++ +
Sbjct: 39 TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 102 VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+P K Y +++ L H +HRD+KP N+L++ G +KLADFG
Sbjct: 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 2e-15
Identities = 36/177 (20%), Positives = 67/177 (37%), Gaps = 8/177 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL-----YMVMDYMPGGDLVNLMSNY 100
+ + E ++ H E ++ L F A+SL ++ ++ G DL N++
Sbjct: 57 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 101 DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT 160
+ + +F +++ L IH +HRD+KP N+ +++ LK+ DFG + T
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 161 ETKRLGRNGIEEI---KAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214
EI H D W+ + + G D I +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 2e-15
Identities = 33/122 (27%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 45 IKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSL------YMVMDYMPGGDLVNLMS 98
+ + E ++ H E ++ L F ++L Y+VM +M G DL LM
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK 114
Query: 99 NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158
+ + E +F +++ L IH G +HRD+KP N+ +++ LK+ DFG + +
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 159 GT 160
T
Sbjct: 175 MT 176
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 1e-14
Identities = 29/132 (21%), Positives = 54/132 (40%), Gaps = 10/132 (7%)
Query: 45 IKRSDSAFFWEERDIMAHANS---EWIVQLHFAFQDAKS-----LYMVMDYMPGGDLVNL 96
+ E ++ H + +V+L +++ L +V +++ L
Sbjct: 46 GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL 105
Query: 97 MSNYD--VPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154
+ VP + K +++ LD +H VHRD+KP N+L+ G +KLADFG
Sbjct: 106 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165
Query: 155 MNKTGTETKRLG 166
+ T +
Sbjct: 166 YSFQMALTSVVV 177
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 69.1 bits (168), Expect = 2e-14
Identities = 25/125 (20%), Positives = 48/125 (38%), Gaps = 7/125 (5%)
Query: 46 KRSDSAFFWEERDIMAH-ANSEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNL-MSNYDVP 103
+RSD+ +E A I +++ Q+ +V+D + L +
Sbjct: 40 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS 99
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-----HGHLKLADFGTCMRMNKT 158
K +++ + +IH V+RD+KPDN L+ + + + DFG
Sbjct: 100 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159
Query: 159 GTETK 163
T+
Sbjct: 160 VTKQH 164
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 64.1 bits (155), Expect = 9e-13
Identities = 24/122 (19%), Positives = 42/122 (34%), Gaps = 5/122 (4%)
Query: 46 KRSDSAFFWEERDIMAHANSE-WIVQLHFAFQDAKSLYMVMDYMPGGDL-VNLMSNYDVP 103
++ E I I + + + MVM+ + + +
Sbjct: 42 VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS 101
Query: 104 EKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNML---LDKHGHLKLADFGTCMRMNKTGT 160
K +++ ++ IH F+HRDVKPDN L K + + DFG + T
Sbjct: 102 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 161 ET 162
Sbjct: 162 HQ 163
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.6 bits (117), Expect = 1e-07
Identities = 27/154 (17%), Positives = 56/154 (36%), Gaps = 8/154 (5%)
Query: 55 EERDIMAHANSEWIVQL--HFAFQDAKSLYMVMDYMPGG----DLVNLMSNYDVPEKWAK 108
+ + I++L HF + +++VM + G L+ + +P + K
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 109 FYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGH-LKLADFGTCMRMNKTGTETKRLG 166
+++L LD +H G +H D+KP+N+L++ L N +
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 167 RNGIEEIKAHPFFINDQWTFSNLRECVPPVVPEL 200
E ++ + W ++ EL
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.2 bits (114), Expect = 1e-07
Identities = 17/135 (12%), Positives = 46/135 (34%), Gaps = 11/135 (8%)
Query: 26 EYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLH----FAFQDAKSL 81
E ++K+ + + + + + F A + +L +
Sbjct: 26 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85
Query: 82 YMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141
++M+ + + Y V + ++ + + G VH D+ N+L+ +
Sbjct: 86 AVLMELIDAKE------LYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE 139
Query: 142 GHLKLADFGTCMRMN 156
G + + DF + +
Sbjct: 140 G-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.51 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 92.61 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 86.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 85.91 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=312.07 Aligned_cols=211 Identities=24% Similarity=0.308 Sum_probs=181.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| ++.+....+....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~V-----y~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNV-----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEE-----EEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 33333335899999999 477766 88999 5566665666778889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999999998875 469999999999999999999999999999999999999999999999999998765443
Q ss_pred Cc--cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 160 TE--TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 160 ~~--~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
.. .....|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++....++.|
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p 224 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 224 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 22 23445899999998887 788999999999999999999999888777777777665544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=310.59 Aligned_cols=202 Identities=20% Similarity=0.297 Sum_probs=172.9
Q ss_pred HHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 8 MHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 8 ~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
.++|+ ||+|+||+| ++|+++ |+.|| ++++. +....+.+.+|+.++++++||||+++++++.+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~V-----y~a~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTV-----YTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEE-----EEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccccEEEEEEecCcCcEE-----EEEEECCCCCEEEEEEEecc---cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 34566 889999999 477666 99999 33322 3345678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
++|+||||+++|+|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+|+.+....
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999875443
Q ss_pred C-cccc---CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCC
Q psy16292 160 T-ETKR---LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 160 ~-~~~~---~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
. .... ..|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+.......+.....
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 2 2333 33789999998887 789999999999999999999998877666555554433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=312.52 Aligned_cols=212 Identities=26% Similarity=0.418 Sum_probs=179.6
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| ++++....+....+.+.+|++++++++||||+++++++.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~V-----y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTV-----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEE-----EEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 34433345899999999 577766 89999 5566665666778899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+|+.+....
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999999998764 569999999999999999999999999999999999999999999999999999765332
Q ss_pred C---cc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 160 T---ET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 160 ~---~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
. .. ....|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+.++.......|.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 231 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc
Confidence 1 22 2344799999988887 7889999999999999999999998888878877777655443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=317.67 Aligned_cols=214 Identities=25% Similarity=0.367 Sum_probs=185.2
Q ss_pred chHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 3 NVEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 3 ~~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
++++|.-.-.||+|+||+| ++|+++ |+.|| +++|.........+++.+|+.+|+.++||||++++++|+++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V-----~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKV-----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred chHhcEEEEEEecCcCeEE-----EEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 3455555556899999999 577776 99999 66676666677889999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+++|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+|+....
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999999998875 4689999999999999999999999999999999999999999999999999997654
Q ss_pred CC-Cccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 158 TG-TETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 158 ~~-~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
.. .... ...|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+..+.|.
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~ 226 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc
Confidence 32 2233 344789999988888 7889999999999999999999999888888888777655443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-45 Score=310.75 Aligned_cols=212 Identities=27% Similarity=0.438 Sum_probs=182.4
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| ++++....+....+++.+|+.+++.++||||+++++++.+++.
T Consensus 4 ~dy~i~~~lG~G~fg~V-----y~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRV-----HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEE-----EEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe
Confidence 34444456899999999 578776 99999 5566666666788999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+||||++||+|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+|+......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999999999988754 58899999999999999999999999999999999999999999999999999865432
Q ss_pred -CccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 160 -TETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 160 -~~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
......+|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+..+.|+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 222 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence 2334455899999988877 7889999999999999999999998887777777777655443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=310.00 Aligned_cols=210 Identities=22% Similarity=0.313 Sum_probs=162.4
Q ss_pred hHHHHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEE
Q psy16292 4 VEAFMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAF 75 (245)
Q Consensus 4 ~~~f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 75 (245)
.+++.++|+ ||+|+||+| ++|+++ |+.|| ++.+... ......+.+|+.+|++++||||+++++++
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~V-----y~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 76 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEV-----ILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIY 76 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGE-----EEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCCccceEEEEEEeeccCeEE-----EEEEECCCCCEEEEEEEchHHh--hhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344555565 889999999 477766 89999 4444332 23346688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec---CCCcEEEEeeCc
Q psy16292 76 QDAKSLYMVMDYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD---KHGHLKLADFGT 151 (245)
Q Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~---~~~~i~l~Dfg~ 151 (245)
.+++++|+||||++||+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||++. .++.+||+|||+
T Consensus 77 ~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 77 ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence 9999999999999999999988754 699999999999999999999999999999999999995 468899999999
Q ss_pred eeecCCCCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 152 CMRMNKTGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 152 a~~~~~~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
|+.......... ...|.+||.+.+.++ .++|+||+||++|+|++|.+||.+......+..+..+..+.+
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC
Confidence 987655444333 344899999998887 789999999999999999999999887777777777655443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=304.56 Aligned_cols=190 Identities=23% Similarity=0.285 Sum_probs=159.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++.. .....+++.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 12 ~lG~G~fg~V-----~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 12 TLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp EEEEETTEEE-----EEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCcCeEE-----EEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4789999999 577776 89999 333322 223456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC---Cccc
Q psy16292 88 MPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG---TETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~---~~~~ 163 (245)
+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+...... ....
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 9999999988754 59999999999999999999999999999999999999999999999999999764332 1223
Q ss_pred ---cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 164 ---RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 164 ---~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
+..|.+||.+.+.++ .++|+||+||++|+|++|.+||.+..+...
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 344789999988876 468999999999999999999988766544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-45 Score=307.25 Aligned_cols=208 Identities=20% Similarity=0.189 Sum_probs=175.2
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+..+|+ ||+|+||+| ++|+++ |+.|| ++++....+....+.+.+|+.+|++++||||+++++++.++
T Consensus 13 p~~~y~~l~~lG~G~fg~V-----y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAV-----YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp HHHHEEEEEEEEECSSSEE-----EEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cHHhcEeeEEEecCCCeEE-----EEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 445565 999999999 477665 89999 44443333344567799999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+.+|+|||||++|+|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+....
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999999998877654 45699999999999999999999999999999999999999999999999999998776
Q ss_pred CCCccccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 158 TGTETKRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 158 ~~~~~~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
........+|.+||.+.+. ++ .++||||+||++|+|++|.+||.+.+..+.+.++..+..|.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6656666678999998653 34 57899999999999999999999888777666666665443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=300.75 Aligned_cols=201 Identities=22% Similarity=0.336 Sum_probs=170.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+| ++|+++ |+.|| ++++. .....+++.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 19 ~iG~G~fg~V-----y~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 19 ELGDGAFGKV-----YKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEETTEEE-----EEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEeeCCCcEE-----EEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3899999999 477766 88888 33322 345677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC----CCc
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT----GTE 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~----~~~ 161 (245)
+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+..... ...
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 999999998753 45899999999999999999999999999999999999999999999999999875432 223
Q ss_pred cccCCCCchhhhhc-----CCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 162 TKRLGRNGIEEIKA-----HPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 162 ~~~~~~~~~e~i~~-----~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
.....|.+||.+.. .++ .++||||+||++|+|++|.+||.+.++.+.+.++..+.+|..
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 34555899999853 334 678999999999999999999999988888887777765543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=309.68 Aligned_cols=205 Identities=25% Similarity=0.434 Sum_probs=179.7
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.|| ++++....+....+++.+|+.+|+.++||||+++++++.+...+++|||+
T Consensus 48 ~lG~G~fg~V-----y~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 48 TLGTGSFGRV-----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EeecCcCcEE-----EEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 5899999999 577776 99999 55566666667788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC-CCccccC
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT-GTETKRL 165 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~-~~~~~~~ 165 (245)
+.+|+|.+.+.. +.+++..+..++.||+.||.|||+++|+||||||+||+++.+|.+||+|||+|+.+... .......
T Consensus 123 ~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~ 202 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 202 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECG
T ss_pred ccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccccccCcc
Confidence 999999998764 46999999999999999999999999999999999999999999999999999987543 2233455
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
.|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+.++.++
T Consensus 203 ~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 259 (350)
T d1rdqe_ 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259 (350)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred ccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc
Confidence 5899999998887 7889999999999999999999998887777777777655443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-43 Score=304.16 Aligned_cols=201 Identities=19% Similarity=0.342 Sum_probs=171.6
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+|+ +|+++ |+.|| ++++.. ..+...+.+|+.+|++++||||++++++|.+++.+|+||||
T Consensus 36 ~lG~G~fg~V~-----~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 36 ELGSGAFGVVH-----RCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp EEEEETTEEEE-----EEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCCCeEEE-----EEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 48999999994 77766 99999 333322 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec--CCCcEEEEeeCceeecCCCCCccc
Q psy16292 88 MPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD--KHGHLKLADFGTCMRMNKTGTETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~--~~~~i~l~Dfg~a~~~~~~~~~~~ 163 (245)
|+||+|.+.+... .+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+|+.+........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 9999999877643 589999999999999999999999999999999999998 568999999999998876554443
Q ss_pred cCC---CCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 164 RLG---RNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 164 ~~~---~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
..| +.+||.+.+.++ .++||||+||++|+|++|.+||.+.++...+.++.....+.+
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 248 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 344 689999988887 789999999999999999999999888887777776655433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=301.61 Aligned_cols=189 Identities=20% Similarity=0.236 Sum_probs=161.6
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-+||+|+||+|+ +|+++ |+.|| ++.+. ..+....+++.+|+.+|++++||||++++++|.+++++|+||||
T Consensus 12 ~~iG~G~fg~V~-----~~~~~~~~~~vAiK~i~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 12 SELGAGNGGVVF-----KVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp EEEECCSSCCEE-----EEEETTTTEEEEEEEEEC-CCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCCeEEE-----EEEECCCCcEEEEEEECh-hhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999994 67766 89999 22221 22345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC--Cccc
Q psy16292 88 MPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG--TETK 163 (245)
Q Consensus 88 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~--~~~~ 163 (245)
+++|+|.+++.+ +.+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||+|+...... ....
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~G 165 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccC
Confidence 999999998864 469999999999999999999997 599999999999999999999999999998764332 2233
Q ss_pred cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 164 RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
+..|++||.+.+.++ .++||||+||++|+|++|.+||.+.+.
T Consensus 166 T~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp SSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 455899999999888 788999999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=301.62 Aligned_cols=206 Identities=25% Similarity=0.433 Sum_probs=177.8
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHH-hcCCccceeeeEEEEeCCEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMA-HANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
-.||+|+||+| ++|+++ |+.|| ++++.........+.+.+|..++. .++||||+++++++.+++++|+||
T Consensus 8 ~~iG~G~fg~V-----y~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 8 KMLGKGSFGKV-----FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEECSSSEE-----EEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEecCCCcEE-----EEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 35899999999 467776 99999 566666666677888888888876 589999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccc
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETK 163 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~ 163 (245)
||+++|+|.+++.. ..+++..++.++.||+.||.|||+++++||||||+||+++.++.++|+|||+|+....... ...
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~ 162 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccc
Confidence 99999999999865 4699999999999999999999999999999999999999999999999999987553322 222
Q ss_pred cC---CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCC
Q psy16292 164 RL---GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEEN 221 (245)
Q Consensus 164 ~~---~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (245)
.. .+.+||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+.++..+.++.|.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~ 224 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224 (320)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 33 3789999998888 7889999999999999999999999988888888777665543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=300.92 Aligned_cols=209 Identities=20% Similarity=0.306 Sum_probs=164.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--CC
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--AK 79 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~ 79 (245)
++|.-...||+|+||+| ++|+++ |+.|| ++-+....++...+.+.+|+.++++++||||+++++++.+ ++
T Consensus 4 edy~~~~~iG~G~fg~V-----y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRC-----QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEE-----EEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEE-----EEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 34444456899999999 577776 89999 3222223344567789999999999999999999999964 46
Q ss_pred EEEEEEeccCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCceEecCCCcEEEEee
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-----YDVPEKWAKFYCAEVVLALDAIHCLG-----FVHRDVKPDNMLLDKHGHLKLADF 149 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-----iih~dlkp~nil~~~~~~i~l~Df 149 (245)
.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 78999999999999998853 35899999999999999999999865 999999999999999999999999
Q ss_pred CceeecCCCCC----ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 150 GTCMRMNKTGT----ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 150 g~a~~~~~~~~----~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
|+|+.+..... .....+|.+||.+.+.++ .++||||+||++|+|++|.+||.+.+..+...++..+..+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~ 232 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99987654322 223455899999988877 7889999999999999999999988877777777666554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=297.08 Aligned_cols=201 Identities=15% Similarity=0.278 Sum_probs=170.9
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
||+|+||+| ++|+++ |+.|| ++++...... ...+.+.+|+.+|++++||||++++++|.+++++|+||
T Consensus 18 lG~G~fg~V-----y~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 18 LGSGQFAVV-----KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEECSSEEE-----EEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EecCCCeEE-----EEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 889999999 477766 99999 4444332221 24678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC----cEEEEeeCceeecCCCCC
Q psy16292 86 DYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG----HLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~----~i~l~Dfg~a~~~~~~~~ 160 (245)
||+++|+|.+++.. +.+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+|++|||+|+.......
T Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~ 172 (293)
T d1jksa_ 93 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172 (293)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB
T ss_pred EcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc
Confidence 99999999998865 4699999999999999999999999999999999999998876 499999999998765544
Q ss_pred ccccC---CCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 ETKRL---GRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 ~~~~~---~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
..... .|.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+..+.+..+.....+
T Consensus 173 ~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 44333 3799999988776 7889999999999999999999998877777766665443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-43 Score=302.87 Aligned_cols=198 Identities=22% Similarity=0.346 Sum_probs=170.3
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
||+|+||+| ++|+++ |+.|| ++.+. ...+.+.+.+|+.+|++++||||+++++++.+++++|+||||+
T Consensus 34 lG~G~fg~V-----y~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 34 LGTGAFGVV-----HRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp EEEETTEEE-----EEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EecCcCeEE-----EEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 899999999 577766 99999 23222 2234677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC--CCcEEEEeeCceeecCCCCCccc-
Q psy16292 89 PGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK--HGHLKLADFGTCMRMNKTGTETK- 163 (245)
Q Consensus 89 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~--~~~i~l~Dfg~a~~~~~~~~~~~- 163 (245)
++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+|+.+........
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 99999998853 35999999999999999999999999999999999999964 57899999999998776554433
Q ss_pred --cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 164 --RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 164 --~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
...|++||.+.+.++ .++||||+||++|+|++|.+||.+.++.+.+.++......
T Consensus 186 ~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243 (350)
T ss_dssp CSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 344789999998887 7899999999999999999999998887777777666544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.5e-43 Score=290.41 Aligned_cols=203 Identities=21% Similarity=0.224 Sum_probs=170.3
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhc------cCchHHHHHHHHHHHhcC-CccceeeeEEEEeCC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIK------RSDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAK 79 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 79 (245)
-.||+|+||+|+ +|+++ |+.|| ++++..... +...+++.+|+.++++++ ||||+++++++.+++
T Consensus 9 ~~iG~G~~g~V~-----~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 9 EILGRGVSSVVR-----RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp EEEEECSSEEEE-----EEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred eEEecCcCeEEE-----EEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 348899999994 77766 99999 444433221 123457899999999996 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
++|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.+...
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 163 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC
Confidence 99999999999999999864 46899999999999999999999999999999999999999999999999999988765
Q ss_pred CCccccCC---CCchhhhhcCCC-------cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GTETKRLG---RNGIEEIKAHPF-------FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~~~~~~~---~~~~e~i~~~~~-------~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.......| +.+||.+.+.+. .++|+||+||++|+|++|.+||.+.++...+..+..+...
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 55444444 578888864322 4689999999999999999999999887777777776544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=296.28 Aligned_cols=202 Identities=15% Similarity=0.186 Sum_probs=157.7
Q ss_pred hhccccccchhhhHHHHHhhc--Ce---EEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YT---LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~---~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.||+|+||+|+ +|+.+ |+ .+|++...........+.+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus 33 ~lG~G~fg~Vy-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 33 VIGAGEFGEVC-----SGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEECSSSEEE-----EEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCCeEEE-----EEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 58999999995 66554 33 3443322222233456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--
Q psy16292 87 YMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
|+++|+|.+++... .+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+|+.+.......
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~ 187 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCccee
Confidence 99999999988753 48999999999999999999999999999999999999999999999999998765432211
Q ss_pred -------ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 163 -------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 163 -------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
....|.+||.+...++ .++||||+||++|+|++ |.+||.+.++.+....+..+..+
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252 (299)
T ss_dssp --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 1234788999887776 67899999999999997 89999998887777777666444
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=288.80 Aligned_cols=200 Identities=16% Similarity=0.163 Sum_probs=160.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe----CCEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD----AKSLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv 84 (245)
+||+|+||+|+ +|+++ |+.|| +..+.....+...+.+.+|+++|++++||||+++++++.+ +..+|+|
T Consensus 16 ~iG~G~fg~Vy-----~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 16 EIGRGSFKTVY-----KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEECSSEEEE-----EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEecCcCcEEE-----EEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 58999999994 66665 88888 3222222334557789999999999999999999999975 4578999
Q ss_pred EeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCceEec-CCCcEEEEeeCceeecCCCCC
Q psy16292 85 MDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLG--FVHRDVKPDNMLLD-KHGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--iih~dlkp~nil~~-~~~~i~l~Dfg~a~~~~~~~~ 160 (245)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+|+.......
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 999999999998865 46899999999999999999999998 99999999999996 478999999999986443322
Q ss_pred --ccccCCCCchhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCC-CcccCcCC
Q psy16292 161 --ETKRLGRNGIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSN-FDDIEKDE 216 (245)
Q Consensus 161 --~~~~~~~~~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~-~~~~~~~~ 216 (245)
......|.+||.+.+....++||||+||++|+|++|.+||.+..+... +..+..+.
T Consensus 171 ~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229 (270)
T ss_dssp EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC
Confidence 123445789998876544889999999999999999999987654433 34444443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=290.72 Aligned_cols=202 Identities=20% Similarity=0.217 Sum_probs=164.7
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
+||+|+||+|+ ++..+ +..||++.-.........+++.+|+.+|++++|||||++++++.++ .+|+||||
T Consensus 16 ~iG~G~fg~Vy-----~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~ 89 (285)
T d1u59a_ 16 ELGCGNFGSVR-----QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEM 89 (285)
T ss_dssp EEECCTTEEEE-----EEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EEecccCeEEE-----EEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEe
Confidence 58999999995 54333 5567732211222344567899999999999999999999998754 58999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+......
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 999999998754 35899999999999999999999999999999999999999999999999999987544321
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
.....+.+||.+...++ .++||||+||++|++++ |.+||.+.++.+....+..+..+.
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 12234789999987776 78899999999999887 899999888777777777665543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=290.29 Aligned_cols=201 Identities=19% Similarity=0.171 Sum_probs=164.6
Q ss_pred hhccccccchhhhHHHHHhhc----CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR----YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~----~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
+||+|+||+|+ +|..+ ++.|| ++-+....+....+.+.+|+.+|++++||||+++++++.++ ..++|||
T Consensus 14 ~iG~G~fG~Vy-----~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 14 ELGSGNFGTVK-----KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEECSSEEEE-----EEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CcccCCCeEEE-----EEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 59999999995 55332 57788 33333333344567899999999999999999999998654 5789999
Q ss_pred ccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----
Q psy16292 87 YMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE---- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~---- 161 (245)
|+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.++++|||+|+.+......
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999999988764 5899999999999999999999999999999999999999999999999999976544321
Q ss_pred ---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 162 ---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 162 ---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.....|.+||.+...++ .++||||+||++|++++ |.+||.+.++.+....+..+..+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~ 229 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 12334789999988877 78999999999999987 89999998877766667666544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=297.02 Aligned_cols=205 Identities=17% Similarity=0.275 Sum_probs=171.9
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA 78 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 78 (245)
+.+||+ ||+|+||+| ++|.++ |+.|| ++++. ..+...+.+|+++|+.++||||++++++|+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~V-----y~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIV-----HRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEE-----EEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred CccceEEEEEEecCCCeEE-----EEEEECCCCcEEEEEEEcCC----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345564 689999999 477766 89999 33322 23345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC--CcEEEEeeCceee
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH--GHLKLADFGTCMR 154 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~--~~i~l~Dfg~a~~ 154 (245)
+++|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.+ +.++|+|||+++.
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 9999999999999999999754 58999999999999999999999999999999999999854 4799999999998
Q ss_pred cCCCCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCC
Q psy16292 155 MNKTGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEE 220 (245)
Q Consensus 155 ~~~~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~ 220 (245)
......... ...+.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+....+.++..+....+
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 223 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 765544333 334688898887776 778999999999999999999999988887887777655433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-42 Score=296.73 Aligned_cols=198 Identities=23% Similarity=0.351 Sum_probs=163.1
Q ss_pred HHHHHHhhhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHH---HHHHHhcCCccceeeeEEEEe
Q psy16292 5 EAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEE---RDIMAHANSEWIVQLHFAFQD 77 (245)
Q Consensus 5 ~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~~~~ 77 (245)
++|.-.-.||+|+||+| ++|+++ |+.|| ++.+...........+.+| +.+++.++||||++++++|.+
T Consensus 4 ddy~i~~~lG~G~fg~V-----y~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEV-----YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEE-----EEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred HhCeeeeEEecCCCeEE-----EEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 44444446899999999 477776 99999 5555555444555555555 556666789999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecC
Q psy16292 78 AKSLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMN 156 (245)
Q Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~ 156 (245)
.+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+|+...
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999998864 458999999999999999999999999999999999999999999999999999876
Q ss_pred CCCC--ccccCCCCchhhhhc-CCC-cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 157 KTGT--ETKRLGRNGIEEIKA-HPF-FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 157 ~~~~--~~~~~~~~~~e~i~~-~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
.... ......|.+||.+.. ..+ .++|+||+||++|+|++|.+||.+.....
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5432 223444789999864 445 67899999999999999999998765443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-42 Score=288.35 Aligned_cols=199 Identities=20% Similarity=0.287 Sum_probs=161.8
Q ss_pred HhhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.-+||+|+||+|+ +|+++ |+.||++.- ..+....+++.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 22 ~~~iG~G~fg~Vy-----~a~~~~~~~~vAvK~i--~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 22 KHKLGGGQYGEVY-----EGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp EEETTTTTTSSEE-----EEEEGGGTEEEEEEEC--CTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEE-----EEEECCCCeEEEEEEE--CCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3458999999994 67665 888993221 12345677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc--
Q psy16292 88 MPGGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET-- 162 (245)
Q Consensus 88 ~~~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~-- 162 (245)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 999999998864 358999999999999999999999999999999999999999999999999998765443221
Q ss_pred ---ccCCCCchhhhhcCCC-cccCCCcccccceecCCcc-CCCCCCCCCCCCcccCcC
Q psy16292 163 ---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVV-PELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 163 ---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~-~pf~~~~~~~~~~~~~~~ 215 (245)
....+.+||.+...++ .++||||+||++|+|+++. ||+.+.+....+..+..+
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence 2334679999988877 7899999999999999865 555555444444444333
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=292.38 Aligned_cols=199 Identities=18% Similarity=0.183 Sum_probs=161.1
Q ss_pred hhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 83 (245)
.||+|+||+|+ +|+.+ +..||++.............+.+|+.++.++ +|||||++++++.+.+.+++
T Consensus 44 ~lG~G~fG~Vy-----~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 44 VLGSGAFGKVM-----NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEECSSEEEE-----EEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EEeeCCCeEEE-----EEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 48999999994 66543 2345632222223345677899999999998 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEec
Q psy16292 84 VMDYMPGGDLVNLMSNY------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLD 139 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~ 139 (245)
||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc
Confidence 99999999999998643 278889999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcc
Q psy16292 140 KHGHLKLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDD 211 (245)
Q Consensus 140 ~~~~i~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~ 211 (245)
.++.+||+|||+|+........ ....+|.+||.+...++ .++||||+||++|+|++ |.+||.+.+....+.+
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999876544332 12445899999988777 78899999999999997 8999998877666665
Q ss_pred cCcC
Q psy16292 212 IEKD 215 (245)
Q Consensus 212 ~~~~ 215 (245)
+...
T Consensus 279 ~~~~ 282 (325)
T d1rjba_ 279 LIQN 282 (325)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 5544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=288.37 Aligned_cols=198 Identities=23% Similarity=0.270 Sum_probs=160.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhh--ccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQI--KRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.||+|+||+| ++|+++ |+.|| ++++.... ++...+++.+|+.++++++||||+++++++.+++++|+||
T Consensus 5 ~lG~G~fg~V-----y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 5 FLGEGQFATV-----YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEETTEEE-----EEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred EeccCcCeEE-----EEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 4899999999 477766 89999 33332221 1223567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-c-
Q psy16292 86 DYMPGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE-T- 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~-~- 162 (245)
||+.++++..+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+........ .
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 999887777666543 5899999999999999999999999999999999999999999999999999876544322 2
Q ss_pred --ccCCCCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 163 --KRLGRNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 163 --~~~~~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
....|.+||.+.... + .++||||+||++|+|++|.+||.+.++.+.+.++..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 234478999987654 3 678999999999999999999998877666555543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=283.73 Aligned_cols=202 Identities=16% Similarity=0.147 Sum_probs=160.0
Q ss_pred HhhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 10 RYRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 10 ~y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
.-+||+|+||+|+ +|+.+ ++.||++.-. ......+.+.+|+.++++++||||+++++++..++.+++||||+
T Consensus 10 ~~~iG~G~fg~Vy-----~~~~~~~~~vAvK~i~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 10 VQEIGSGQFGLVH-----LGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp EEEEECCSSCCEE-----EEEETTTEEEEEEECC--SSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEEeeCCCeEEE-----EEEECCCCEEEEEEEC--CCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3458999999995 66666 7778843211 12345577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc-----
Q psy16292 89 PGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----- 161 (245)
Q Consensus 89 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----- 161 (245)
++|+|.+++... .+++..+..++.|++.||.|+|+++|+||||||+||+++.++.+||+|||+|+........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 999999988653 4788999999999999999999999999999999999999999999999999876543221
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.....|.+||.+...++ .++||||+||++|++++ +.||+.+.+.......+..+..+
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 221 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 22345889999988777 67899999999999988 67888877766666666665443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.1e-42 Score=283.34 Aligned_cols=202 Identities=22% Similarity=0.197 Sum_probs=167.0
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC----EEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK----SLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~~l 83 (245)
.+|+|+||+|+ +|+++ |+.|| ++++....+.....++.+|+.+++.++||||+++++++.... .+|+
T Consensus 14 ~lG~G~fg~Vy-----~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 14 ILGFGGMSEVH-----LARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEECSSEEEE-----EEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEeeCCCeEEE-----EEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 48999999994 77665 99999 444444444455678999999999999999999999998654 4899
Q ss_pred EEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC--
Q psy16292 84 VMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
||||++|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+........
T Consensus 89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~ 168 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168 (277)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------
T ss_pred EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccc
Confidence 9999999999987764 4699999999999999999999999999999999999999999999999999876543321
Q ss_pred --c---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 --E---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 --~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. .....|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+.++..+.+.
T Consensus 169 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp ----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence 1 23445899999988877 7899999999999999999999998877777666666544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=283.43 Aligned_cols=194 Identities=16% Similarity=0.132 Sum_probs=155.8
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-+||+|+||+|+ +++.++. || ++.+....+....+.+.+|+.++++++||||+++++++. ...+++||||++
T Consensus 14 ~~lG~G~fg~Vy-----~~~~~~~-vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 14 QRIGSGSFGTVY-----KGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp SEEEECSSCEEE-----EEESSSE-EEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EEEeeCCCcEEE-----EEEECCE-EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 358999999995 6655554 67 333333344566788999999999999999999999865 456899999999
Q ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC------c
Q psy16292 90 GGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT------E 161 (245)
Q Consensus 90 ~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~------~ 161 (245)
+|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+....... .
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 166 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------C
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccc
Confidence 9999998864 3489999999999999999999999999999999999999999999999999986543221 1
Q ss_pred cccCCCCchhhhhcC---CC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 162 TKRLGRNGIEEIKAH---PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~---~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
.....|.+||.+... ++ .++||||+||++|+|++|.+||.+.++......
T Consensus 167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~ 220 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220 (276)
T ss_dssp CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 223447899998653 34 678999999999999999999988766544433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=280.89 Aligned_cols=201 Identities=20% Similarity=0.231 Sum_probs=156.7
Q ss_pred hhccccccchhhhHHHHHhhc-----CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEe
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-----YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMD 86 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-----~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 86 (245)
.||+|+||+|+ +|+++ +..+|++...........+.+.+|+.++++++||||+++++++. .+.+|+|||
T Consensus 14 ~iG~G~fg~Vy-----~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 14 CIGEGQFGDVH-----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEECSSSEEE-----EEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEeeCCCcEEE-----EEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 48999999995 55543 34555433333334455678999999999999999999999996 467899999
Q ss_pred ccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc---
Q psy16292 87 YMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE--- 161 (245)
Q Consensus 87 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~--- 161 (245)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+|+........
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~ 167 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecc
Confidence 9999999997654 35899999999999999999999999999999999999999999999999999876433221
Q ss_pred --cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 162 --TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 162 --~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.....|.+||.+...++ .++||||+||++|+|++ |.+||.+.+..+.+.++..+..+
T Consensus 168 ~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 12344788999988777 78899999999999876 89999999888888777776544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=282.99 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=158.1
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEec
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
-+||+|+||+| ++|+++ |+.|| ++-+.....+...+++.+|+.+|++++||||+++++++.++.++|+||||
T Consensus 8 ~~lG~G~fg~V-----y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 8 EKIGEGTYGVV-----YKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp EEEEECSSSEE-----EEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEecCcCeEE-----EEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 35899999999 577766 99999 33333333445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHH-h--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-c--
Q psy16292 88 MPGGDLVNLM-S--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-E-- 161 (245)
Q Consensus 88 ~~~g~L~~~l-~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~-- 161 (245)
+.+ ++.+.+ . ..++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+....+.. .
T Consensus 83 ~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred cCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 954 544444 2 33589999999999999999999999999999999999999999999999999987654322 2
Q ss_pred -cccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 162 -TKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 162 -~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
.....+.+||.+...++ .++|+||+||++|+|++|.+||.+.++...+.++
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i 215 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence 23344788998877765 6789999999999999999999887655444443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=279.82 Aligned_cols=200 Identities=20% Similarity=0.273 Sum_probs=162.3
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-+||+|+||+|+ +|+.+ +..||++.-. ......+.+.+|+.++++++|||||++++++.+ +.+++||||++
T Consensus 19 ~~iG~G~fg~Vy-----~~~~~~~~~vAvK~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 19 ERLGAGQFGEVW-----MGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp EEEEEETTEEEE-----EEEETTTEEEEEEEEC--TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEecCCCcEEE-----EEEECCCCEEEEEEEc--cCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 358999999995 66666 7788832211 123456789999999999999999999998754 56799999999
Q ss_pred CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 90 GGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 90 ~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+....... .
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 99999876532 489999999999999999999999999999999999999999999999999998754432 2
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
....+|.+||.+...++ .++||||+||++|+|++ +.||+.+.+..+.+..+..+..+
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~ 229 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 23345899999987776 78899999999999998 56777777666666666555443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=277.95 Aligned_cols=206 Identities=18% Similarity=0.232 Sum_probs=172.1
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc-CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR-YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~-~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
.++|.-.-.||+|+||+| ++++.+ ++.||+ +++ +....+.+.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~iG~G~fg~V-----y~~~~~~~~~vAvK~l~~----~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEE-----EEEEETTTEEEEEEEEES----SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred hHHCEEeEEEecCCCeEE-----EEEEECCCCEEEEEEECc----CcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 345554556999999999 577777 778883 232 23345679999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
+++||||+++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999999999998654 35889999999999999999999999999999999999999999999999999876544
Q ss_pred CCcc-----ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GTET-----KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~~~-----~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
.... ....|.+||.+...++ .++||||+|+++|+|++ |.+||.+.+..+...++..+..+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 220 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC
Confidence 3221 2233688999988877 68999999999999987 89999999888777777766444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=282.40 Aligned_cols=188 Identities=20% Similarity=0.248 Sum_probs=154.5
Q ss_pred hccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEe----CCEEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQD----AKSLYMVM 85 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~~~~~lv~ 85 (245)
||+|+||+| ++|+++ |+.||++.- .....+.+|+.++.++ +||||++++++|++ +.++|+||
T Consensus 20 lG~G~fg~V-----y~a~~~~~~~~vAiK~i------~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 20 LGLGINGKV-----LQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp EEECSSCEE-----EEEEETTTCCEEEEEEE------ECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeccCeEE-----EEEEECCCCCEEEEEEE------CCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 788999999 477765 899993211 1234578899987654 89999999999976 46799999
Q ss_pred eccCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCCC
Q psy16292 86 DYMPGGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 86 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~~ 159 (245)
|||+||+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. .+.+||+|||+|+......
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999999753 4899999999999999999999999999999999999986 4679999999999876554
Q ss_pred Ccccc---CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 160 TETKR---LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 160 ~~~~~---~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
..... ..|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.+.......
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~ 224 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH
Confidence 44444 44789999888777 788999999999999999999998877665443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=276.79 Aligned_cols=202 Identities=16% Similarity=0.160 Sum_probs=157.0
Q ss_pred hhccccccchhhhHHHHHhhc------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 85 (245)
.||+|+||+|+ +|+.+ ...||++.-...........+.+|+.++++++|||||++++++.+.+.+++||
T Consensus 14 ~iG~G~fG~Vy-----~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 14 VIGAGEFGEVY-----KGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEECSSSEEE-----EEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEeeCCCeEEE-----EEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 48999999995 55544 23566322222223344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC---
Q psy16292 86 DYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT--- 160 (245)
Q Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~--- 160 (245)
||+.++++.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 168 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccce
Confidence 99999999987764 3589999999999999999999999999999999999999999999999999987643321
Q ss_pred -c---cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 161 -E---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 161 -~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
. .....|.+||.+....+ .++||||+||++|+|++ +.||+.+.+..+.+..+..+..+
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 1 12334789999988777 78899999999999998 56667666666666666655443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=280.79 Aligned_cols=210 Identities=17% Similarity=0.233 Sum_probs=169.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhc--CeEEE-EEeh-hhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSR-YFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA 78 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k-~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 78 (245)
.++|.-.-.||+|+||+|+ +|+++ |..++ ++++ .........+.+.+|+.+|+++ +||||+++++++.++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy-----~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVL-----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEE-----EEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred HHHcEEEEEEeeCCCcEEE-----EEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 3455445569999999994 77666 66655 3333 2333345667899999999998 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC
Q psy16292 79 KSLYMVMDYMPGGDLVNLMSN-----------------YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH 141 (245)
Q Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~ 141 (245)
+.+++||||+++|+|.+++.. ..+++..+..++.||+.||.|+|+++++||||||+||+++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 999999999999999998853 348999999999999999999999999999999999999999
Q ss_pred CcEEEEeeCceeecCCCCCcc---ccCCCCchhhhhcCCC-cccCCCcccccceecCCc-cCCCCCCCCCCCCcccCcCC
Q psy16292 142 GHLKLADFGTCMRMNKTGTET---KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV-VPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 142 ~~i~l~Dfg~a~~~~~~~~~~---~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~-~~pf~~~~~~~~~~~~~~~~ 216 (245)
+.+||+|||+|+......... ....+.+||.+...++ .++|+||+||++|+|++| .+||.+.+.......+..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999999998655443332 2344789999988887 678999999999999986 57898888777777777765
Q ss_pred CC
Q psy16292 217 SP 218 (245)
Q Consensus 217 ~~ 218 (245)
.+
T Consensus 244 ~~ 245 (309)
T d1fvra_ 244 RL 245 (309)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-40 Score=277.01 Aligned_cols=196 Identities=18% Similarity=0.171 Sum_probs=161.0
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
+||+|+||+|+ +|+++ |+.|| ++-+....++...+++.+|+.+|++++||||+++++++.+++..++++|++.
T Consensus 9 ~iG~G~fg~Vy-----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 9 KIGEGTYGVVY-----KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEETTEEEE-----EEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EEecCCCcEEE-----EEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 48999999994 77777 89999 3222223345567889999999999999999999999999999999999997
Q ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCc----ccc
Q psy16292 90 GGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTE----TKR 164 (245)
Q Consensus 90 ~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~----~~~ 164 (245)
++.+..+... +.+++..+..++.||+.||.|||+++|+||||||+||+++.++.+|++|||.|.....+... ...
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 163 (286)
T d1ob3a_ 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163 (286)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CC
T ss_pred hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceeccc
Confidence 7766666653 45899999999999999999999999999999999999999999999999999876543221 233
Q ss_pred CCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 165 LGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 165 ~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
..+.+||.+.+... .++|+||+||++++|++|.+||.+.++.+.+.++
T Consensus 164 ~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i 213 (286)
T d1ob3a_ 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (286)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred chhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 44788999876543 7889999999999999999999887655444443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=270.03 Aligned_cols=201 Identities=20% Similarity=0.261 Sum_probs=160.8
Q ss_pred hhhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~~~ 89 (245)
-.||+|+||.| ++|+.+|+.||++.- .++...+.+.+|+.++++++||||+++++++.+ .+.+|+||||++
T Consensus 13 ~~lG~G~fg~V-----y~~~~~~~~vAvK~i---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 13 QTIGKGEFGDV-----MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEECSSCEE-----EEEEETTEEEEEEEC---CCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEEecCCCeEE-----EEEEECCeEEEEEEE---CcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 34889999999 467778999993221 234566789999999999999999999999854 467899999999
Q ss_pred CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccccC
Q psy16292 90 GGDLVNLMSNY---DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETKRL 165 (245)
Q Consensus 90 ~g~L~~~l~~~---~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~~~ 165 (245)
+|+|.+++... .+++..+..++.||+.||.|||+++++||||||+||+++.++.++++|||+++....... .....
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence 99999998643 389999999999999999999999999999999999999999999999999987544322 23345
Q ss_pred CCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCCC
Q psy16292 166 GRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESPE 219 (245)
Q Consensus 166 ~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~~ 219 (245)
.+.+||.+.+.++ .++||||+|+++|+|++ |.+||.+.+..+....+..+..|.
T Consensus 165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~ 220 (262)
T d1byga_ 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 220 (262)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 5889999988777 68899999999999987 799999888877777777665443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=274.37 Aligned_cols=204 Identities=16% Similarity=0.184 Sum_probs=158.1
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc-----CeEEE--EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR-----YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~-----~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
|.-.-+||+|+||.|+ +|+.. +..|| ++++....+....+.+.+|+.+|++++||||+++++++.++
T Consensus 10 ~~~~~~iG~G~fg~Vy-----~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp EEEEEECC----CCCE-----EEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred eEEEEEEecCCCeEEE-----EEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 3333458999999994 65533 33566 23333333444567899999999999999999999999764
Q ss_pred EEEEEEeccCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
.+++||||+++|++.+.+.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999987653 3589999999999999999999999999999999999999999999999999998755
Q ss_pred CCCcc-------ccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 158 TGTET-------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 158 ~~~~~-------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
..... ....+.+||.+.+.++ .++|+||+|+++|+|++ |.+||.+.+..+...++....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence 43321 1234678999988877 67899999999999997 899999998888777775553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=276.03 Aligned_cols=206 Identities=16% Similarity=0.193 Sum_probs=162.5
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc--Ce----EEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCE
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR--YT----LYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKS 80 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~--~~----~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 80 (245)
|..--.||+|+||+|+ +|+++ |+ .+|+++..........+.+.+|+.++++++|||||++++++.++ .
T Consensus 11 y~~~~~lG~G~fG~Vy-----~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVY-----KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp EEEEEEEEECSSEEEE-----EEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CEEeeEEecCCCeEEE-----EEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3334468999999995 55554 44 34422211223345677899999999999999999999999875 5
Q ss_pred EEEEEeccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++++|++.+|+|.+.+... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 67888999999999877643 5899999999999999999999999999999999999999999999999999876543
Q ss_pred CCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCCC
Q psy16292 159 GTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 159 ~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
... .....|.+||.+.+.++ .++||||+||++|+|++ |.+||.+.+.......+..+..+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 322 12345899999988887 78999999999999998 89999988777766666665443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=277.24 Aligned_cols=207 Identities=17% Similarity=0.165 Sum_probs=168.9
Q ss_pred HHHHhhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 7 FMHRYRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 7 f~~~y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
|.-.-+||+|+||+|+ +|+.+ ++.||++.-.........+++.+|+.++++++||||+++++++.+.+
T Consensus 15 ~~~~~~lG~G~fG~Vy-----~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVF-----QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CEEEEEEEECSSCEEE-----EEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cEEeEEEeeCCCeEEE-----EEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 3334469999999995 66543 47788433222223344677999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSNY-------------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPD 134 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-------------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~ 134 (245)
..+++||++++|+|.+++... .+++..+..++.|++.||.|||+++++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999988532 2678889999999999999999999999999999
Q ss_pred ceEecCCCcEEEEeeCceeecCCCCC------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCc-cCCCCCCCCC
Q psy16292 135 NMLLDKHGHLKLADFGTCMRMNKTGT------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV-VPELSGDDDT 206 (245)
Q Consensus 135 nil~~~~~~i~l~Dfg~a~~~~~~~~------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~-~~pf~~~~~~ 206 (245)
||+++.++.+||+|||+|+....... ......+.+||.+...++ .++||||+||++|+|+++ .+||.+.++.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999986543321 122334789999998887 688999999999999877 5899999888
Q ss_pred CCCcccCcCCCC
Q psy16292 207 SNFDDIEKDESP 218 (245)
Q Consensus 207 ~~~~~~~~~~~~ 218 (245)
+....+..+..+
T Consensus 250 e~~~~v~~~~~~ 261 (301)
T d1lufa_ 250 EVIYYVRDGNIL 261 (301)
T ss_dssp HHHHHHHTTCCC
T ss_pred HHHHHHHcCCCC
Confidence 887777777654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=277.22 Aligned_cols=196 Identities=21% Similarity=0.199 Sum_probs=157.0
Q ss_pred hhccccccchhhhHHHHHhhc---CeEEE-EEehhhhhccCchHHHHHHHHHHHhc---CCccceeeeEEEEe-----CC
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHA---NSEWIVQLHFAFQD-----AK 79 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-----~~ 79 (245)
+||+|+||+|+ +|+++ ++.|| ++-+....++.....+.+|+.+++.+ +||||++++++|.. ..
T Consensus 14 ~LG~G~fg~V~-----~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 14 EIGEGAYGKVF-----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEETTEEEE-----EEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEecccCeEEE-----EEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 58999999995 66653 67788 32222223344455678899888776 79999999999863 34
Q ss_pred EEEEEEeccCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
+++++||++.++++..... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++....
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~ 168 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc
Confidence 7899999997776654443 34589999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccc---cCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 158 TGTETK---RLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 158 ~~~~~~---~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...... +..|.+||.+.+.++ .++|+||+||++|+|++|.+||.+.++...+.++
T Consensus 169 ~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 433333 344789999988888 7899999999999999999999988765554444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=270.37 Aligned_cols=199 Identities=19% Similarity=0.262 Sum_probs=159.0
Q ss_pred hhhccccccchhhhHHHHHhhc-CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEeccC
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYMP 89 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 89 (245)
-+||+|+||+|+ +|+.+ ++.||++.- . ......+.+.+|+.++++++|||||++++++.+ +.+++||||++
T Consensus 23 ~~iG~G~fg~Vy-----~~~~~~~~~vAiK~l-~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 23 VKLGQGCFGEVW-----MGTWNGTTRVAIKTL-K-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp EEEEECSSCEEE-----EEEETTTEEEEEEEC-C-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred eEEeeCCCeEEE-----EEEECCCCEEEEEEE-C-cccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 358999999994 77667 677883221 1 223456789999999999999999999999854 56789999999
Q ss_pred CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-----c
Q psy16292 90 GGDLVNLMSN---YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-----E 161 (245)
Q Consensus 90 ~g~L~~~l~~---~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-----~ 161 (245)
+|+|..++.. ..+++..+..++.+|+.||.|||+++++||||||+||+++.++.+||+|||+|+....... .
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 9999987753 4589999999999999999999999999999999999999999999999999987643322 1
Q ss_pred cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCCC
Q psy16292 162 TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDES 217 (245)
Q Consensus 162 ~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~~ 217 (245)
....+|.+||.+....+ .++||||+||++|+|++ +.||+.+..+.+.+..+..+..
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~ 232 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 22344789999988777 78899999999999988 5677877777777777666543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=273.43 Aligned_cols=195 Identities=22% Similarity=0.235 Sum_probs=157.7
Q ss_pred HHHHhh----hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC
Q psy16292 7 FMHRYR----RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK 79 (245)
Q Consensus 7 f~~~y~----~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 79 (245)
|.++|+ ||+|+||+|+ +|+++ |+.|| ++-+....++...+++.+|+.+|++++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~-----~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVC-----SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEE-----EEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEE-----EEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 455665 8899999995 66665 99999 332323334455778999999999999999999999997654
Q ss_pred ------EEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 80 ------SLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 80 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
++|+||||+ +.+|..+++...+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||+|+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccccee
Confidence 579999999 7889998888899999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCC-ccccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCC
Q psy16292 154 RMNKTGT-ETKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTS 207 (245)
Q Consensus 154 ~~~~~~~-~~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~ 207 (245)
....... ......|++||.+.+..+ .++|+||+||++++|++|.+||.+.++..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226 (346)
T ss_dssp ECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH
Confidence 8765432 223344789999977544 68899999999999999999998876443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=268.42 Aligned_cols=202 Identities=20% Similarity=0.150 Sum_probs=155.6
Q ss_pred hhccccccchhhhHHHHHhhc---C--eEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe-CCEEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---Y--TLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD-AKSLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---~--~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~ 85 (245)
.||+|+||+|+ +++.. + ..|||+.-....+....+++.+|+.+|++++||||+++++++.. ++..++||
T Consensus 34 ~iG~G~fg~Vy-----k~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 34 VIGRGHFGCVY-----HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEETTEEEE-----EEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred EEeecCCeEEE-----EEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 48999999995 55443 2 34563222222344566889999999999999999999999875 46899999
Q ss_pred eccCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc-
Q psy16292 86 DYMPGGDLVNLMSNY--DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET- 162 (245)
Q Consensus 86 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~- 162 (245)
||+++|+|.+++... ..++..+..++.|++.||.|+|+++|+||||||+||+++.++.+||+|||+++.........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988755 36788889999999999999999999999999999999999999999999998765443221
Q ss_pred -------ccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCC-CCCCCCCCCcccCcCCCC
Q psy16292 163 -------KRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPEL-SGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 163 -------~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf-~~~~~~~~~~~~~~~~~~ 218 (245)
....+.+||.+....+ .++||||+|+++|+++++..|| .+.+..+....+..+..+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~ 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2234788999887776 7889999999999999865554 444555555556665544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-40 Score=277.90 Aligned_cols=211 Identities=25% Similarity=0.376 Sum_probs=168.2
Q ss_pred hHHHHHHhhhccccccchhhhHHHHHhhcCeEEE--EEehhhh-hccCchHHHHHHHHHHHhcCC-ccceeeeEEEEeCC
Q psy16292 4 VEAFMHRYRRYRQKYSEVPRLFEYLLKYRYTLYA--LYSRYFQ-IKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDAK 79 (245)
Q Consensus 4 ~~~f~~~y~~~~~~~~~v~~~~~~l~~~~~~~~a--v~~k~~~-~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~ 79 (245)
+++|.-.-.||+|+||+|+.+....-+..|+.|| ++++... .+....+++.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 3444444468999999995222211222389999 3444332 233456789999999999966 89999999999999
Q ss_pred EEEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCC
Q psy16292 80 SLYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKT 158 (245)
Q Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~ 158 (245)
.++++|||+.+|+|.+.+.. +.+++..+..++.|++.||.|+|+++++||||||+||+++.+|.++|+|||+|+.+...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999998865 45889999999999999999999999999999999999999999999999999876432
Q ss_pred CC-----ccccCCCCchhhhhcCCC---cccCCCcccccceecCCccCCCCCCCCCCCCcccCc
Q psy16292 159 GT-----ETKRLGRNGIEEIKAHPF---FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEK 214 (245)
Q Consensus 159 ~~-----~~~~~~~~~~e~i~~~~~---~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~ 214 (245)
.. ......+.+||.+...++ .++||||+||++|+|++|.+||.+.+.......+..
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22 223344788999876543 478999999999999999999999988877666644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-39 Score=264.48 Aligned_cols=186 Identities=19% Similarity=0.189 Sum_probs=153.3
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhcc---CchHHHHHHHHHHHhcC--CccceeeeEEEEeCCEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKR---SDSAFFWEERDIMAHAN--SEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~l 83 (245)
||+|+||+| ++|+++ |+.|| ++++....+. ....++.+|+.++++++ ||||+++++++.+++.+++
T Consensus 12 lG~G~fg~V-----y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 12 LGSGGFGSV-----YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEETTEEE-----EEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EeeCCCeEE-----EEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence 788999999 467665 89999 4444433222 22345788999999996 8999999999999999999
Q ss_pred EEeccCC-CCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCC-CcEEEEeeCceeecCCCCC
Q psy16292 84 VMDYMPG-GDLVNLMS-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKH-GHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 84 v~e~~~~-g~L~~~l~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~-~~i~l~Dfg~a~~~~~~~~ 160 (245)
|||++.+ +++.+++. ...+++..++.++.|++.||.|||+++|+||||||+||+++.+ +.++|+|||+|+.......
T Consensus 87 v~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~ 166 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166 (273)
T ss_dssp EEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCB
T ss_pred EEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccccc
Confidence 9999975 57777775 4569999999999999999999999999999999999999854 7899999999987654322
Q ss_pred c--cccCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCC
Q psy16292 161 E--TKRLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGD 203 (245)
Q Consensus 161 ~--~~~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~ 203 (245)
. .....|.+||.+...++ .++|+||+||++|+|++|.+||.+.
T Consensus 167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 1 22344789999988876 4579999999999999999999765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=266.47 Aligned_cols=201 Identities=17% Similarity=0.193 Sum_probs=149.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC-CEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA-KSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-~~~~lv~e~ 87 (245)
+||+|+||+|+.+......+. ++.||+..-.........+.+.+|..++.++ +||||+.+++++... ..+++||||
T Consensus 20 ~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~ 99 (299)
T d1ywna1 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99 (299)
T ss_dssp EEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred EEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEe
Confidence 479999999953322222222 5778833222222334566788888888877 789999999987654 578999999
Q ss_pred cCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeC
Q psy16292 88 MPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFG 150 (245)
Q Consensus 88 ~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg 150 (245)
+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFG 179 (299)
T d1ywna1 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179 (299)
T ss_dssp CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC--
T ss_pred cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCc
Confidence 9999999998532 37889999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCCc-cCCCCCCCCCCCCccc
Q psy16292 151 TCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV-VPELSGDDDTSNFDDI 212 (245)
Q Consensus 151 ~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~-~~pf~~~~~~~~~~~~ 212 (245)
+|+........ .....|.+||.+.+.++ .++||||+||++|+|+++ .+||.+......+.++
T Consensus 180 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp ----CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred chhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99875433221 12334789999988877 788999999999999876 6789877655554443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=265.56 Aligned_cols=202 Identities=17% Similarity=0.188 Sum_probs=160.1
Q ss_pred hhccccccchhhhHHHHHhhc---------CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR---------YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~---------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 81 (245)
.||+|+||.|+ +|+.. +..||++.............+.+|...+.++ +||||+++++++.+++.+
T Consensus 20 ~iG~G~fg~Vy-----~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 20 PLGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp ECC-----CEE-----EEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EEeecCCcEEE-----EEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 37899999995 55433 3467743322223334567788899999888 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 82 YMVMDYMPGGDLVNLMSNY-----------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
++||||+.+|+|.+++... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCe
Confidence 9999999999999998643 37999999999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcCC
Q psy16292 145 KLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKDE 216 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~~ 216 (245)
||+|||+++........ ....+|.+||.+...++ .++||||+|+++|+|++ |.+||.+.+....+..+..+.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~ 254 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999976544321 22334789999988888 77899999999999997 799999888777777666654
Q ss_pred CC
Q psy16292 217 SP 218 (245)
Q Consensus 217 ~~ 218 (245)
.+
T Consensus 255 ~~ 256 (299)
T d1fgka_ 255 RM 256 (299)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=257.88 Aligned_cols=185 Identities=20% Similarity=0.200 Sum_probs=155.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEEEEecc
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYMVMDYM 88 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 88 (245)
+||+|+||+|+ +|+++ |+.|| ++-+..........++.+|+.+|+.++||||+++++++.+..+.+++++++
T Consensus 9 ~LG~G~fg~V~-----~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 9 KIGEGTYGTVF-----KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEECSSSEEE-----EEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEecCcCeEEE-----EEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 48999999994 77766 88899 332323334456788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcccc---
Q psy16292 89 PGGDLVNLMSNY-DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTETKR--- 164 (245)
Q Consensus 89 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~~~--- 164 (245)
.+++|..++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.|+...........
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 163 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeecc
Confidence 998888877654 5899999999999999999999999999999999999999999999999999987655433222
Q ss_pred -CCCCchhhhhcCCC--cccCCCcccccceecCCccCCCC
Q psy16292 165 -LGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELS 201 (245)
Q Consensus 165 -~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~ 201 (245)
..+.+||.+..... .++|+||+||++++|++|..||.
T Consensus 164 ~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 22567777766553 67899999999999999987754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=270.77 Aligned_cols=188 Identities=25% Similarity=0.343 Sum_probs=149.5
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE--EehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC------CEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL--YSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA------KSL 81 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av--~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~~ 81 (245)
.||+|+||+| ++|+++ |+.||+ +++. . ....+|+.+|++++||||++++++|... .++
T Consensus 27 ~LG~G~fg~V-----y~a~~~~~~~~vAiK~i~~~----~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 27 VIGNGSFGVV-----YQAKLCDSGELVAIKKVLQD----K---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEETTEEE-----EEEEETTTCCEEEEEEEECC----S---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred EEeeCcCeEE-----EEEEECCCCCEEEEEEECcc----c---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4899999999 477776 999993 2221 1 1234799999999999999999999543 468
Q ss_pred EEEEeccCCCCHHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecC
Q psy16292 82 YMVMDYMPGGDLVNLM---S-NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMN 156 (245)
Q Consensus 82 ~lv~e~~~~g~L~~~l---~-~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~ 156 (245)
|+||||++++.+..+. . ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999655333332 2 33599999999999999999999999999999999999999875 89999999999876
Q ss_pred CCCCccccC---CCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 157 KTGTETKRL---GRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 157 ~~~~~~~~~---~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
......+.. .+.+||.+.+. .+ .++||||+||++|+|++|.+||.+.+..+.+.+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~ 234 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH
Confidence 554444433 37889988764 44 778999999999999999999988765544433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=267.31 Aligned_cols=188 Identities=19% Similarity=0.209 Sum_probs=149.2
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCC-----EEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAK-----SLYMV 84 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv 84 (245)
+||+|+||+|+ +|+++ |+.||++.-.........+++++|+.+|++++||||+++++++.... +++++
T Consensus 15 ~LG~G~fg~Vy-----~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 15 YIGEGAYGMVC-----SAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp ECC---CCCEE-----EEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEeeccCeEEE-----EEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 48999999995 66655 99999322111223445678999999999999999999999997653 35555
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC----
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT---- 160 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~---- 160 (245)
+ ++.+|+|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.......
T Consensus 90 ~-~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~ 168 (345)
T d1pmea_ 90 T-HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168 (345)
T ss_dssp E-ECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred E-eecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcccee
Confidence 5 45599999999988999999999999999999999999999999999999999999999999999987644322
Q ss_pred cccc---CCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 161 ETKR---LGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 161 ~~~~---~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.... ..+.+||.+... .+ .++|+||+||++++|++|.+||.+.+.
T Consensus 169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 1222 236788887544 44 567999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=267.42 Aligned_cols=203 Identities=16% Similarity=0.168 Sum_probs=166.3
Q ss_pred hhhccccccchhhhHHHHHhhc-------CeEEEEEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeCCEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR-------YTLYALYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~-------~~~~av~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 83 (245)
-+||+|+||+|+ +|+++ +..|||+.-...........+.+|+.++++++||||+++++++......++
T Consensus 26 ~~lG~G~fG~Vy-----~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 26 RELGQGSFGMVY-----EGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp EEEEECSSSEEE-----EEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeCCCeEEE-----EEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 358999999995 55443 567884322222233455678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCce
Q psy16292 84 VMDYMPGGDLVNLMSNY-----------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTC 152 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a 152 (245)
||||+++|+|.+++... ..++..+..++.+++.||.|||+++|+||||||+||+++.++++||+|||+|
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccc
Confidence 99999999999987531 2578889999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCCc-cCCCCCCCCCCCCcccCcCCCC
Q psy16292 153 MRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPV-VPELSGDDDTSNFDDIEKDESP 218 (245)
Q Consensus 153 ~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~-~~pf~~~~~~~~~~~~~~~~~~ 218 (245)
+........ .....+.+||.+.+.++ .++|+||+|+++++|+++ .+||.+.+....+..+.++..+
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 876543221 22344789999988877 678999999999999987 5899998888888777766544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=267.23 Aligned_cols=196 Identities=21% Similarity=0.154 Sum_probs=155.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe--------CCE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD--------AKS 80 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--------~~~ 80 (245)
+||+|+||+|+ +|+++ |+.|| ++-+.....+....++.+|+.+|++++||||+++++++.. .++
T Consensus 17 ~LG~G~fg~Vy-----~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 17 KIGQGTFGEVF-----KARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEECSSSEEE-----EEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEecCcCeEEE-----EEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 58999999995 67665 99999 3222333345667889999999999999999999999855 346
Q ss_pred EEEEEeccCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCC
Q psy16292 81 LYMVMDYMPGGDLVNLMSN-YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTG 159 (245)
Q Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~ 159 (245)
+|+|||++.++.+...... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||+|+.+....
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~ 171 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC--
T ss_pred EEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccc
Confidence 8999999976655544433 358999999999999999999999999999999999999999999999999998765322
Q ss_pred C-----cc---ccCCCCchhhhhcC-CC-cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 160 T-----ET---KRLGRNGIEEIKAH-PF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 160 ~-----~~---~~~~~~~~e~i~~~-~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
. .. ....|.+||.+.+. ++ .++|+||+||++++|++|.+||.+.++...+..+
T Consensus 172 ~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i 234 (318)
T d3blha1 172 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234 (318)
T ss_dssp ---CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence 1 11 23447899998765 45 7889999999999999999999887766555444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=264.82 Aligned_cols=199 Identities=17% Similarity=0.151 Sum_probs=161.8
Q ss_pred hhccccccchhhhHHHHHhh------c-CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKY------R-YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYM 83 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~------~-~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 83 (245)
.||+|+||.|+ +|+. . ++.|||+.-.......+...+.+|+.+++++ +||||+++++++.++..+++
T Consensus 30 ~iG~G~fg~Vy-----~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 30 TLGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEECSSEEEE-----EEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EEeecCCeEEE-----EEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 47999999995 4432 2 6788832221222334566799999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcE
Q psy16292 84 VMDYMPGGDLVNLMSNY-------------------DVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHL 144 (245)
Q Consensus 84 v~e~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i 144 (245)
||||+++|+|.+++... .+++..+..++.||+.||.|||+++++||||||+||+++.++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcc
Confidence 99999999999988642 37889999999999999999999999999999999999999999
Q ss_pred EEEeeCceeecCCCCCc------cccCCCCchhhhhcCCC-cccCCCcccccceecCC-ccCCCCCCCCCCCCcccCcC
Q psy16292 145 KLADFGTCMRMNKTGTE------TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPP-VVPELSGDDDTSNFDDIEKD 215 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~~------~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~-~~~pf~~~~~~~~~~~~~~~ 215 (245)
+++|||+++........ .....+.+||.+....+ .++||||+||++|+|++ |.||+.+.+....+.++...
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999999976543321 12334788999987776 78899999999999997 78888887776665555443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=265.43 Aligned_cols=195 Identities=18% Similarity=0.172 Sum_probs=154.3
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEeC-----CEEEEE
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQDA-----KSLYMV 84 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv 84 (245)
||+|+||+|+ +|+++ |+.|| ++.+....+....+++.+|+.+|++++||||+++++++... ...+++
T Consensus 26 LG~G~fg~Vy-----~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 26 VGSGAYGSVC-----AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp CGGGTTSSEE-----EEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EecCCCeEEE-----EEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 8899999994 77655 99999 33232333344567889999999999999999999999643 234556
Q ss_pred EeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCC-ccc
Q psy16292 85 MDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGT-ETK 163 (245)
Q Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~-~~~ 163 (245)
++++.+|+|.+++..+++++..++.++.||+.||.|||++||+||||||+||+++.+|.++++|||++........ ...
T Consensus 101 ~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g 180 (348)
T d2gfsa1 101 VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180 (348)
T ss_dssp EEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCH
T ss_pred EEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcccccccc
Confidence 6677799999999888899999999999999999999999999999999999999999999999999986543321 222
Q ss_pred cCCCCchhhhhcCCC--cccCCCcccccceecCCccCCCCCCCCCCCCccc
Q psy16292 164 RLGRNGIEEIKAHPF--FINDQWTFSNLRECVPPVVPELSGDDDTSNFDDI 212 (245)
Q Consensus 164 ~~~~~~~e~i~~~~~--~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~ 212 (245)
...+.+||.+.+..+ .++|+||+||++|+|++|.+||.+.+.......+
T Consensus 181 ~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i 231 (348)
T d2gfsa1 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231 (348)
T ss_dssp HHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 333788998777654 6789999999999999999999887655444333
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-37 Score=262.47 Aligned_cols=184 Identities=22% Similarity=0.290 Sum_probs=153.5
Q ss_pred hhhccccccchhhhHHHHHhhc--CeEEEEEehhhhhccCchHHHHHHHHHHHhc-CCccceeeeEEEEeC--CEEEEEE
Q psy16292 11 YRRYRQKYSEVPRLFEYLLKYR--YTLYALYSRYFQIKRSDSAFFWEERDIMAHA-NSEWIVQLHFAFQDA--KSLYMVM 85 (245)
Q Consensus 11 y~~~~~~~~~v~~~~~~l~~~~--~~~~av~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~~lv~ 85 (245)
-+||+|+||+|+ +|+++ |+.||++. .+....+++.+|+.+|+++ .||||++++++|... ..+++||
T Consensus 41 ~~LG~G~fg~V~-----~a~~~~~~~~vAiK~----i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 41 RKLGRGKYSEVF-----EAINITNNEKVVVKI----LKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp EEEEECSSEEEE-----EEEETTTTEEEEEEE----ECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred EEEecCcCeEEE-----EEEECCCCCEEEEEE----ECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 358999999994 77776 99999322 1234567789999999999 599999999999854 5799999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCC-cEEEEeeCceeecCCCCCcccc
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHG-HLKLADFGTCMRMNKTGTETKR 164 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~-~i~l~Dfg~a~~~~~~~~~~~~ 164 (245)
||+.+++|.... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||+|+...........
T Consensus 112 e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~ 189 (328)
T d3bqca1 112 EHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189 (328)
T ss_dssp ECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSC
T ss_pred eecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccccc
Confidence 999999997764 3589999999999999999999999999999999999998765 5899999999987665544444
Q ss_pred CC---CCchhhhhcCC-C-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 165 LG---RNGIEEIKAHP-F-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 165 ~~---~~~~e~i~~~~-~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
.+ +.+||.+.+.. + .++|+||+||+++++++|.+||....+
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 44 68999987654 3 678999999999999999999976643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=262.58 Aligned_cols=190 Identities=17% Similarity=0.187 Sum_probs=148.1
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEE-EEehhhhhccCchHHHHHHHHHHHhcCCccceeeeEEEEe------CCEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYA-LYSRYFQIKRSDSAFFWEERDIMAHANSEWIVQLHFAFQD------AKSLY 82 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~a-v~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~~~~ 82 (245)
.||+|+||+|+ +|+++ |+.|| ++.+....+.....++.+|+.++++++||||++++++|.. ..++|
T Consensus 24 ~LG~G~fg~V~-----~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 24 PIGSGAQGIVC-----AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp ECSCC--CEEE-----EEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EeecCcCeEEE-----EEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 48999999995 77766 99999 3222223344556789999999999999999999999963 46899
Q ss_pred EEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCceeecCCCCCcc
Q psy16292 83 MVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNKTGTET 162 (245)
Q Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~~~~~~ 162 (245)
+||||+.+ ++.+.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||+++.........
T Consensus 99 iv~Ey~~~-~l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~ 176 (355)
T d2b1pa1 99 LVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176 (355)
T ss_dssp EEEECCSE-EHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred EEEeccch-HHHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccc
Confidence 99999955 5555443 458999999999999999999999999999999999999999999999999988766554433
Q ss_pred cc---CCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 163 KR---LGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 163 ~~---~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
.. ..+.+||.+.+.++ .++|+||+||+++++++|++||.+.++...
T Consensus 177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~ 226 (355)
T d2b1pa1 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_dssp ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH
Confidence 33 34789999988877 778999999999999999999988765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-37 Score=256.80 Aligned_cols=185 Identities=19% Similarity=0.194 Sum_probs=149.5
Q ss_pred hhccccccchhhhHHHHHhhcCeEEEEEehhhhhccCchHHHHHHHHHH--HhcCCccceeeeEEEEeCC----EEEEEE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYRYTLYALYSRYFQIKRSDSAFFWEERDIM--AHANSEWIVQLHFAFQDAK----SLYMVM 85 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~~~~~av~~k~~~~~~~~~~~~~~E~~il--~~l~hp~Iv~l~~~~~~~~----~~~lv~ 85 (245)
+||+|+||.|| +++.+|+.||++.- +.+..+...+|.+++ .+++||||+++++++.+.+ .+|+||
T Consensus 10 ~iG~G~fg~Vy-----~~~~~g~~vAvK~~----~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 10 SIGKGRFGEVW-----RGKWRGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEECCSSSEEE-----EEEETTEEEEEEEE----CGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEeeCCCeEEE-----EEEECCEEEEEEEE----CccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 58999999994 77777999993221 112233444555544 5679999999999998654 689999
Q ss_pred eccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCceEecCCCcEEEEeeCceeecCC
Q psy16292 86 DYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHC--------LGFVHRDVKPDNMLLDKHGHLKLADFGTCMRMNK 157 (245)
Q Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~--------~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~~~ 157 (245)
||+++|+|.+++++.++++.....++.+++.||.|+|+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999999998889999999999999999999996 5899999999999999999999999999987654
Q ss_pred CCC--------ccccCCCCchhhhhcCCC-------cccCCCcccccceecCCccCCCCCCCC
Q psy16292 158 TGT--------ETKRLGRNGIEEIKAHPF-------FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 158 ~~~--------~~~~~~~~~~e~i~~~~~-------~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
... .....+|.+||.+..... .++||||+||++|++++|.+|+....+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 332 122445789998876542 367999999999999999988865543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-35 Score=246.83 Aligned_cols=187 Identities=17% Similarity=0.173 Sum_probs=155.3
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCC-ccceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANS-EWIVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+| ++|+++ |+.||+ +.+. ..+...+.+|+++++.+.| +|++.+++++..+...++|||+
T Consensus 12 ~iG~G~fG~V-----y~a~~~~~~~~vAvK~~~~----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 12 RIGEGSFGVI-----FEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp EEEECSSCEE-----EEEEETTTTEEEEEEEEEC----CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCCeEE-----EEEEECCCCCEEEEEEEcc----ccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 3799999999 477665 899993 2211 2334557889999999965 8999999999999999999999
Q ss_pred cCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC-----CCcEEEEeeCceeecCCCCC
Q psy16292 88 MPGGDLVNLMSN--YDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK-----HGHLKLADFGTCMRMNKTGT 160 (245)
Q Consensus 88 ~~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~-----~~~i~l~Dfg~a~~~~~~~~ 160 (245)
+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++. .+.++|+|||+|+.......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 8899998864 35899999999999999999999999999999999999974 57899999999997643321
Q ss_pred --------c---cccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCC
Q psy16292 161 --------E---TKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSN 208 (245)
Q Consensus 161 --------~---~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~ 208 (245)
. ..+..|.+||.+.+.++ .++|+||+||++|+|++|.+||.+......
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 1 12345789999988877 788999999999999999999988766543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-34 Score=241.95 Aligned_cols=190 Identities=17% Similarity=0.173 Sum_probs=147.9
Q ss_pred hhccccccchhhhHHHHHhhc--CeEEEE-EehhhhhccCchHHHHHHHHHHHhcCCcc-ceeeeEEEEeCCEEEEEEec
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR--YTLYAL-YSRYFQIKRSDSAFFWEERDIMAHANSEW-IVQLHFAFQDAKSLYMVMDY 87 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~--~~~~av-~~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~e~ 87 (245)
.||+|+||+|+ +|+++ |+.||+ +.+. +.....+.+|+++++.++|++ |+.+..++.++...++|||+
T Consensus 14 ~iG~G~fG~Vy-----~a~~~~~~~~vAvK~~~~----~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 14 KIGSGSFGDIY-----LGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp EEEECSSSEEE-----EEEETTTTEEEEEEEEES----CTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEeeCCCcEEE-----EEEECCCCCEEEEEEEch----hccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 48899999994 66665 899993 3222 223345789999999997665 55566777888999999999
Q ss_pred cCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecC---CCcEEEEeeCceeecCCCCC--
Q psy16292 88 MPGGDLVNLMS--NYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDK---HGHLKLADFGTCMRMNKTGT-- 160 (245)
Q Consensus 88 ~~~g~L~~~l~--~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~---~~~i~l~Dfg~a~~~~~~~~-- 160 (245)
+ ++++.+.+. ...+++..+..++.|++.||.|||++||+||||||+||+++. +..++++|||+|+.+.....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 9 677776654 346999999999999999999999999999999999998764 45799999999998654322
Q ss_pred ---------ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCCCCCCcc
Q psy16292 161 ---------ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDDTSNFDD 211 (245)
Q Consensus 161 ---------~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~ 211 (245)
......|.+||.+.+.++ .++|+||+||++++|++|.+||.+.........
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 122344789999988877 789999999999999999999988766554443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=8.6e-29 Score=211.37 Aligned_cols=184 Identities=21% Similarity=0.281 Sum_probs=139.7
Q ss_pred hccccccchhhhHHHHHhhc--CeEEE--EEehhhhhccCchHHHHHHHHHHHhcC-----------CccceeeeEEEEe
Q psy16292 13 RYRQKYSEVPRLFEYLLKYR--YTLYA--LYSRYFQIKRSDSAFFWEERDIMAHAN-----------SEWIVQLHFAFQD 77 (245)
Q Consensus 13 ~~~~~~~~v~~~~~~l~~~~--~~~~a--v~~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~~~~~ 77 (245)
||+|+||+| ++|+++ |+.|| ++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 21 LG~G~fg~V-----y~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 21 LGWGHFSTV-----WLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp EEECSSEEE-----EEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred EeeCCCeEE-----EEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 788999999 478766 99999 33322 123466788999988874 5789999988864
Q ss_pred --CCEEEEEEeccCCCCH-HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCceEecCCCc------E
Q psy16292 78 --AKSLYMVMDYMPGGDL-VNLMS---NYDVPEKWAKFYCAEVVLALDAIHC-LGFVHRDVKPDNMLLDKHGH------L 144 (245)
Q Consensus 78 --~~~~~lv~e~~~~g~L-~~~l~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~iih~dlkp~nil~~~~~~------i 144 (245)
....+++++++..+.. ..... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 4567777776654433 22222 3358999999999999999999998 89999999999999987653 8
Q ss_pred EEEeeCceeecCCCCC-ccccCCCCchhhhhcCCC-cccCCCcccccceecCCccCCCCCCCC
Q psy16292 145 KLADFGTCMRMNKTGT-ETKRLGRNGIEEIKAHPF-FINDQWTFSNLRECVPPVVPELSGDDD 205 (245)
Q Consensus 145 ~l~Dfg~a~~~~~~~~-~~~~~~~~~~e~i~~~~~-~~~Diws~g~~~~~~~~~~~pf~~~~~ 205 (245)
+++|||.|........ ......+.+||.+...++ .++|+||+||++++|++|++||.+...
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 9999999987654332 223444789999988877 788999999999999999999986643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=1.9e-20 Score=145.55 Aligned_cols=131 Identities=12% Similarity=0.049 Sum_probs=97.3
Q ss_pred hhccccccchhhhHHHHHhhc-CeEEE-EEehhhhhc----------------cCchHHHHHHHHHHHhcCCccceeeeE
Q psy16292 12 RRYRQKYSEVPRLFEYLLKYR-YTLYA-LYSRYFQIK----------------RSDSAFFWEERDIMAHANSEWIVQLHF 73 (245)
Q Consensus 12 ~~~~~~~~~v~~~~~~l~~~~-~~~~a-v~~k~~~~~----------------~~~~~~~~~E~~il~~l~hp~Iv~l~~ 73 (245)
+||+|+||+|+ +|+.. |+.|| ++.+..... ........+|...+.++.|++++..++
T Consensus 7 ~IG~G~~g~Vy-----~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 7 LMGEGKESAVF-----NCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEECSSEEEE-----EEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred EeeeCcceEEE-----EEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 58999999995 66655 89999 332211100 001233567888999999999998876
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCceEecCCCcEEEEeeCcee
Q psy16292 74 AFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIHCLGFVHRDVKPDNMLLDKHGHLKLADFGTCM 153 (245)
Q Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH~~~iih~dlkp~nil~~~~~~i~l~Dfg~a~ 153 (245)
+.. .+++||++++..+.. ++......++.|++.++.+||++|++||||||+||+++.++ ++|+|||.|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~ 150 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150 (191)
T ss_dssp EET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCE
T ss_pred ecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcc
Confidence 532 279999997765433 34455667889999999999999999999999999998654 8899999998
Q ss_pred ecCCC
Q psy16292 154 RMNKT 158 (245)
Q Consensus 154 ~~~~~ 158 (245)
....+
T Consensus 151 ~~~~~ 155 (191)
T d1zara2 151 EVGEE 155 (191)
T ss_dssp ETTST
T ss_pred cCCCC
Confidence 76533
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=1e-05 Score=63.52 Aligned_cols=103 Identities=14% Similarity=0.081 Sum_probs=68.7
Q ss_pred CchHHHHHHHHHHHhcC-CccceeeeEEEEeCCEEEEEEeccCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----
Q psy16292 48 SDSAFFWEERDIMAHAN-SEWIVQLHFAFQDAKSLYMVMDYMPGGDLVNLMSNYDVPEKWAKFYCAEVVLALDAIH---- 122 (245)
Q Consensus 48 ~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~l~~lH---- 122 (245)
.....+.+|...++.+. +--+.+++.+...++..++||++++|.++.+...... . ...++.++...+.-+|
T Consensus 51 ~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-~---~~~~~~~l~~~l~~lH~~~~ 126 (263)
T d1j7la_ 51 GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-S---PEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-C---HHHHHHHHHHHHHHHHTSCC
T ss_pred cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc-c---HHHHHHHHHHHHHHHhccCc
Confidence 34556788999988873 4346778888888999999999998877755432111 0 1111222222222233
Q ss_pred -------------------------------------------------h------CCceeCCCCCCceEecCCCcEEEE
Q psy16292 123 -------------------------------------------------C------LGFVHRDVKPDNMLLDKHGHLKLA 147 (245)
Q Consensus 123 -------------------------------------------------~------~~iih~dlkp~nil~~~~~~i~l~ 147 (245)
. ..++|+|+.|.||+++.++.+.++
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lI 206 (263)
T d1j7la_ 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEe
Confidence 1 126899999999999876666799
Q ss_pred eeCceee
Q psy16292 148 DFGTCMR 154 (245)
Q Consensus 148 Dfg~a~~ 154 (245)
||+.+..
T Consensus 207 Dwe~a~~ 213 (263)
T d1j7la_ 207 DLGRSGR 213 (263)
T ss_dssp CCTTCEE
T ss_pred echhccc
Confidence 9998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.43 E-value=0.00013 Score=56.62 Aligned_cols=44 Identities=14% Similarity=0.145 Sum_probs=33.5
Q ss_pred hHHHHHHHHHHHhcCC--ccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 50 SAFFWEERDIMAHANS--EWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 50 ~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
...+..|...++.+.. -.+++++.+..+++..++||++++|.++
T Consensus 48 ~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 48 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3457889999988732 2367778888888899999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.60 E-value=0.0023 Score=53.12 Aligned_cols=30 Identities=17% Similarity=0.279 Sum_probs=25.8
Q ss_pred CceeCCCCCCceEecCCCcEEEEeeCceeec
Q psy16292 125 GFVHRDVKPDNMLLDKHGHLKLADFGTCMRM 155 (245)
Q Consensus 125 ~iih~dlkp~nil~~~~~~i~l~Dfg~a~~~ 155 (245)
.++|+|+.|.||+++.++ ++++||..|..-
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 589999999999998765 899999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.50 E-value=0.0054 Score=50.67 Aligned_cols=39 Identities=18% Similarity=0.174 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHhc-CCccceeeeEEEEeCCEEEEEEeccCCCCH
Q psy16292 51 AFFWEERDIMAHA-NSEWIVQLHFAFQDAKSLYMVMDYMPGGDL 93 (245)
Q Consensus 51 ~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~~g~L 93 (245)
....+|..+++.+ .+.-.+++++++.. .+|+||++|.++
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3456899999988 45556678887753 589999976433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.51 E-value=0.0054 Score=48.81 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=27.5
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.|++|+|+.++|++++.+...-++||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4699999999999999887778999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.61 E-value=0.029 Score=45.14 Aligned_cols=76 Identities=25% Similarity=0.410 Sum_probs=44.6
Q ss_pred chhhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCC--------ccccCCCCCccccee
Q psy16292 169 GIEEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVP--------KAFAGNHLPFVGFTY 240 (245)
Q Consensus 169 ~~e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~f~~f~~ 240 (245)
..+++..|||++...|.--.......+..|-...+.+..+|+.......+..+++.. ......+..|+||+|
T Consensus 254 ~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 333 (337)
T d1o6la_ 254 DAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDY 333 (337)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCE
T ss_pred cHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccchhhhhccCCCEe
Confidence 468899999999888875443344445555566777777887643333322221111 111235788999999
Q ss_pred ecCC
Q psy16292 241 SGDY 244 (245)
Q Consensus 241 ~~~~ 244 (245)
..++
T Consensus 334 v~d~ 337 (337)
T d1o6la_ 334 IADW 337 (337)
T ss_dssp ECCC
T ss_pred eCCC
Confidence 9874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.66 E-value=0.067 Score=42.55 Aligned_cols=70 Identities=27% Similarity=0.448 Sum_probs=22.7
Q ss_pred hhhhcCCCcccCCCcccccceecCCccCCCCCCCCCCCCcccCcCCCCCCCCCCCcc-ccCCCCCccccee
Q psy16292 171 EEIKAHPFFINDQWTFSNLRECVPPVVPELSGDDDTSNFDDIEKDESPEENFPVPKA-FAGNHLPFVGFTY 240 (245)
Q Consensus 171 e~i~~~~~~~~Diws~g~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~f~~f~~ 240 (245)
.+++.|||++.-.|.-......-.+..|...++.|..+|+.....+.|..+...... .+.++..|.||+|
T Consensus 250 ~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 250 GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp SCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------CCTTTTCCC
T ss_pred HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcccccCchhhcccCcCcC
Confidence 368899999876675432222233555666777788888876555444444433322 3446889999997
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=85.91 E-value=0.14 Score=40.49 Aligned_cols=29 Identities=21% Similarity=0.316 Sum_probs=23.8
Q ss_pred CCceeCCCCCCceEecCCCcEEEEeeCceee
Q psy16292 124 LGFVHRDVKPDNMLLDKHGHLKLADFGTCMR 154 (245)
Q Consensus 124 ~~iih~dlkp~nil~~~~~~i~l~Dfg~a~~ 154 (245)
.+++|+|+.+.||+++. + ..++||+.|..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 35899999999999964 3 45899998875
|